Contributing Authors
Massimo Avoli, Department of Neurology and Neurosurgery, McGill University, Montreal, Canada
mental, Universidade Federal de Sao Paulo, Sao Paulo, Brazil
Roy A. Bakay, Department of Neurological Surgery, Chicago Institute of Neurosurgery and Neuroresearch, Rush Presbyterian-St. Luke’s Medical Center, Chicago, IL
Wei-Ping Chen, Department of Physiology and Pharmacology, SUNY Health Science Center, Brooklyn, NY Suzanne Clark, Department of Biomedical Science, Colorado State University, Fort Collins, CO
Scott C. Baraban, Department of Neurological Surgery, University of California San Francisco, San Francisco, CA
Miguel A. Cortez, Department of Neurology, Hospital for Sick Children, Toronto, Ontario, Canada
Tallie Z. Baram, Departments of Pediatrics and Anatomy and Neurobiology, University of California Irvine, Irvine, CA
Marco de Curtis, Department of Experimental Neurophysiology, Instituto Nazionale Neurologico Carlo Besta, Milan, Italy
Stefania Bassanini, National Neurological Institute Carlo Besta, Milan, Italy
Antoine Depaulis, Université Joseph Fourier, Grenoble, France
Giorgio Battaglia, National Neurological Institute Carlo Besta, Milan, Italy Christophe Bernard, INMED-INSERM U29, Marseilles, France
Marc A. Dichter, Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, PA
Edward H. Bertram, Department of Neurology, University of Virginia, Charlottesville, VA
Céline Dinocourt, Department of Physiology, University of Maryland, Baltimore, MD
Ronald A. Browning, Department of Physiology, Southern Illinois University School of Medicine, Springfield, IL
Céliné M. Dubé, Department of Anatomy and Neurobiology, University of California Irvine, Irvine, CA
Paul S. Buckmaster, Department of Comparative Medicine, Stanford University, Stanford, CA
F. Edward Dudek, Department of Physiology, University of Utah, Salt Lake City, UT
Daniel L. Burgess, Department of Neurology, Baylor College of Medicine, Houston, TX
Jerome Engel, Jr., Reed Neurological Research Center, Department of Neurology, UCLA School of Medicine, Los Angeles, CA
Thomas Budde, Institut fur Physiologie, Otto-vonGuericke-Universitat, Universitatsklinikum, Magdeburg, Germany
Aristea S. Galanopoulou, Departments of Neurology and Neuroscience, Albert Einstein College of Medicine, Bronx, NY
Xiang Cai, Department of Physiology, University of Maryland, Baltimore, MD
Mary E. Gilbert, Neurotoxicology Division, US Environmental Protection Agency, Research Triangle Park, NC
Esper A. Cavalheiro, Escola Paulista de Medicina (UNIFESP/EPM), Laboratorio de Neurologia Experi-
xi
xii
Contributing Authors
Jeffrey H. Goodman, Center for Neural Recovery and Rehabilitation Research, Helen Hayes Hospital, West Haverstraw, NY Ali Gorji, Institut fur Physiologie, Universitat Munster, Munster, Germany Heidi Grabenstatter, Department of Biomedical Science, Colorado State University, Fort Collins, CO Kevin D. Graber, Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA Uwe Heinemann, Institute of Neurophysiology, Charite, Humboldt University, Berlin, Germany Gregory L. Holmes, Dartmouth Medical School, Dartmouth-Hitchcock Medical Center, Lebanon, NH
Joseph J. LoTurco, Department of Physiology and Neurobiology, University of Connecticut, Storrs, CT Heiko J. Luhmann, Institut fur Physiologie und Pathophysiologie, Johannes-Gutenberg-Mainz Universitat, Mainz, Germany Gilles van Luijtelaar, Department of Biological Psychology, Radboud University of Nijmegen, Nijmegen, The Netherlands Pavel Maresˇ, Institute of Physiology, Academy of Sciences, Videnska, Prague, Czech Republic Gary W. Mathern, Department of Neurological Surgery, University of California Los Angeles, Los Angeles, CA
John R. Huguenard, Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA
Andrey M. Mazarati, University of California Los Angeles, West Los Angeles VA Medical Center, Los Angeles, CA
John G.R. Jefferys, Department of Neurophysiology, University of Birmingham Medical School, Birmingham, United Kingdom
Tracy K. McIntosh, Traumatic Brain Injury Laboratory, Department of Neurosurgery, University of Pennsylvania, Philadelphia, PA
Frances E. Jensen, Department of Neurology, Children’s Hospital, Harvard Medical School, Boston, MA
Dan C. McIntyre, Department of Psychology, Carleton University, Ottawa, Ontario, Canada
Phillip C. Jobe, Biomedical and Therapeutic Sciences, University of Illinois College of Medicine, Peoria, IL
James O. McNamara, Department of Neurobiology, Duke University Medical Center, Durham, NC
Oliver Kann, Institute of Neurophysiology, Charite, Humboldt University, Berlin, Germany
Luiz E. Mello, Department of Physiology, Universidade Federal de Sao Paulo, Sao Paulo, Brazil
Kevin M. Kelly, Department of Neurology, AlleghenySinger Research Institute, Allegheny General Hospital, Pittsburgh, PA
Solomon L. Moshé, Departments of Neurology, Neuroscience and Pediatrics, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY
Irina Kharatishvilli, Department of Neurobiology, AI Virtanen Institute for Molecular Science, University of Kuopio, Kuopio, Finland
Maria G. Naffah-Mazzacoratti, Escola Paulista de Medicina (UNIFESP/EPM), Laboratorio de Neurologia Experimental, Universidade Federal de Sao Paulo, Sao Paulo, Brazil
Rüdiger Köhling, University of Rostock, Institute of Physiology, Rostock, Germany Hana Kubová, Institute of Physiology, Academy of Sciences, Videnska, Prague, Czech Republic Sanjay S. Kumar, Department of Comparative Medicine, Stanford University, Stanford, CA
Astrid Nehlig, Faculty of Medicine, University of Strasbourg, Strasbourg, France Prosper N’Gouemo, Department of Pharmacology, Georgetown University Medical Center, Washington, DC
João P. Leite, Department of Neurology, Universidade Federal de Sao Paulo, Sao Paulo, Brazil
Jari Nissinen, Department of Neurobiology, AI Virtanen Institute for Molecular Sciences, University of Kuopio, Kuopio, Finland
Laura Librizzi, Department of Experimental Neurophysiology, Instituto Nazionale Neurologico Carlo Besta, Milan, Italy
Jeffrey L. Noebels, Developmental Neurogenetics Laboratory, Department of Neurology, Baylor College of Medicine, Houston, TX
Dean D. Lin, Brain Institute, Department of Neurological Surgery, University of Florida, Gainesville, FL
Michael W. Nestor, Department of Physiology, University of Maryland, Baltimore, MD
Wolfgang Löscher, Department of Pharmacology, Toxicology & Pharmacy, School of Veterinary Medicine, Hannover, Germany
Andre Obenaus, Department of Radiation Medicine, Radiobiology Program, Loma Linda University, Loma Linda, CA
Contributing Authors
xiii
Jeffrey Ockuly, Department of Neurology, University of Wisconsin, Madison, WI
O. Carter Snead III, Department of Neurology, The Hospital for Sick Children, Toronto, Ontario, Canada
Hans-Christian Pape, Institut fur Physiologie, Otto-vonGuericke-Universitat, Universitatsklinikum, Magdeburg, Germany
Erwin-Josef Speckmann, Institut fur Physiologie, Universitat Munster, Munster, Germany
Asla Pitkänen, Department of Neurobiology, AI Virtanen Institute for Molecular Sciences, University of Kuopio, Kuopio, Finland John Pollard, Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, PA David A. Prince, Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA Dominick P. Purpura, Dean, Albert Einstein College of Medicine, Bronx, NY Raddy L. Ramos, Department of Physiology and Neurobiology, University of Connecticut, Storrs, CT Charles E. Ribak, Department of Anatomy and Neurobiology, University of California Irvine, Irvine, CA Michael A. Rogawski, Epilepsy Research Section, Porter Neuroscience Research Center, National Institute of Neurological Disorders and Stroke, Bethesda, MD Steven N. Roper, Brain Institute, Neurological Surgery, University of Florida, Gainesville, FL Russell M. Sanchez, Department of Pharmacology, University of Texas Health Science Center, San Antonio, TX Raman Sankar, Departments of Neurology and Pediatrics, Brain Research Institute, University of California Los Angeles, Los Angeles, CA Sebastian Schuchmann, Institute of Neurophysiology, Charite, Humboldt University, Berlin, Germany Philip A. Schwartzkroin, Department of Neurological Surgery, University of California Davis, Davis, CA Laszlo Seress, Central Electron Microscopic Laboratory, Faculty of Medicine, University of Pecs, Pecs, Szigeti, Hungary Lee A. Shapiro, Department of Anatomy and Neurobiology, University of California Irvine, Irvine, CA Yukiyoshi Shirasaka, University of California Los Angeles, West Los Angeles VA Medical Center, Los Angeles, CA
Ajay Srivastava, Department of Pharmacology & Toxicology, Anticonvulsant Drug Development Program, University of Utah, Salt Lake City, UT Carl E. Stafstrom, Department of Neurology, University of Wisconsin, Madison, WI Mark Stewart, Department of Physiology and Pharmacology, SUNY Health Science Center, Brooklyn, NY Janet L. Stringer, Department of Pharmacology, Baylor College of Medicine, Houston, TX Lucie Suchomelova, University of California Los Angeles, West Los Angeles VA Medical Center, Los Angeles, CA Thomas P. Sutula, Departments of Neurology and Anatomy, University of Wisconsin Medical School, Madison, WI Kerry W. Thompson, University of California Los Angeles, West Los Angeles VA Medical Center, Los Angeles, CA Scott M. Thompson, Department of Physiology, University of Maryland, Baltimore, MD William J. Triggs, Department of Neurology, College of Medicine, University of Florida, Gainesville, FL Yuto Ueda, Department of Psychiatry, Miyazaki Medical College, Miyazaki, Japan Laura Uva, Department of Experimental Neurophysiology, Instituto Nazionale Neurologico Carlo Besta, Milan, Italy Libor Velísˇek, Departments of Neurology and Neuroscience, Albert Einstein College of Medicine, Bronx, NY Jana Velísˇková, Departments of Neurology and Neuroscience, Albert Einstein College of Medicine, Bronx, NY Matthew C. Walker, Institute of Neurology, University College London, London, UK Claude Wasterlain, Brain Research Institute, University of California Los Angeles, Los Angeles, CA
Margaret N. Shouse, Department of Neurobiology, University of California Los Angeles, Los Angeles, CA
H. Jürgen Wenzel, Department of Neurological Surgery, University of California Davis, Davis, CA
Misty Smith-Yockman, Department of Pharmacology and Toxicology, Anticonvulsant Drug Development Program, University of Utah, Salt Lake City, UT
H. Steve White, Department of Pharmacology & Toxicology, Anticonvulsant Drug Development Program, University of Utah, Salt Lake City, UT
xiv
Contributing Authors
Karen S. Wilcox, Department of Pharmacology & Toxicology, Anticonvulsant Drug Development Program, University of Utah, Salt Lake City, UT
Robert K.S. Wong, Department of Physiology and Pharmacology, SUNY Health Science Center, Brooklyn, NY
Philip A. Williams, Department of Biomedical Science, Colorado State University, Fort Collins, CO
Qian Zhao, Department of Medicine, Dartmouth Medical School, Dartmouth-Hitchcock Medical Center, Lebanon, NH
L. James Willmore, Department of Neurology, Saint Louis University School of Medicine, St. Louis, MO
Foreword
In 1972, J. Kiffin Penry and I co-edited a volume entitled “Experimental Models of Epilepsy.” The field of epilepsy research had advanced to such a level by that date to warrant, we thought, a manual that would assist laboratory workers to identify and apply optimal model systems for their investigations. The intervening years have borne witness to advances in our understanding of seizures, of epilepsy, and of epileptogenic mechanisms that could not have been envisioned thirty years ago. This progress has come about largely through the study of animal model systems that have allowed us to reconstruct many of the intimate details—e.g., of what controls excitation and inhibition—that give rise to seizures in cortical and sub-cortical brain regions. Fundamental to these studies has been the growing appreciation of the genetic factors influencing neuronal activity, and of the specific role of developmental events in the emergence of seizure disorders. Our increasing sophistication has led, in turn, to a growing complexity of features—systems, cellular, molecular, and genetic—that need to be factored into our vision of seizure mechanisms and epileptic syndromes. To meet that challenge, the number of “model systems” has grown exponentially. The use of animal models has a critical role for all of modern biomedical research. Developing such models, that reproduce critical features of clinical syndromes and phenotypes, has long been a major aspect of epilepsy research. The number of different directions and testable hypotheses offered through these models is sometimes intimidating. The models themselves—ranging from “simple systems” to intact models of complex epilepsy syndromes—provide access to questions about seizures, epileptogenesis, and various forms of the epilepsies, some with important agespecific features. Research using these systems has yielded important insights into human epileptic syndromes, with respect to mechanisms of disease processes and potential
therapeutic interventions—including antiepileptogenic and antiepileptic treatments. The current volume provides an invaluable resource for the modern investigator who hopes to make an intelligent choice of subjects for future research studies. There has been no other attempt to gather together major model possibilities since the 1972 publication of “Experimental Models of Epilepsy.” The current volume is therefore not only useful, but timely—especially given the major advances of recent research efforts, and the sense that modern epilepsy research is on the threshold of still more important and dramatic advances. There is much being said today for the value of “translational research.” While not specifically identified as such thirty years ago, research in epilepsy has always recognized the links between experimental and clinical studies. Indeed, some of the most significant advances in understanding epileptogenic processes have come from investigators with a keen awareness of the problems of detection and management of epilepsy at the clinical level. Conversely, some of the important improvements in treatment have been made possible by laboratory bench research. This complementary approach to the field is intrinsic to the history of research in epilepsy—one of the earliest recognized disorders in medicine, mistakenly considered a “Sacred Disease.” We now stand at the cusp of great advances still to come—in basic understanding and clinical treatments. The present volume highlights one of the most critical considerations that most investigators face—the choice of models—in their determination of how to go about “epilepsy research.” These choices, and the related experimental strategies, will determine if, how, and when we reach our ultimate goal—seizure elimination and epilepsy cures. Dominick P. Purpura, M.D. December 2004
xv
Preface
new emphasis on “developmental” issues—to which only one chapter was devoted in the 1972 book, but which is an important discussion point in many of the current chapters. This renewed overview also offers some hints about what we might learn in studying certain types of model systems. Such guidance is certainly useful for the young epilepsy researcher. We hope it is also helpful to those investigators studying related disorders and/or phenomena, to clinicians interested in the current state of the research art, and to the experienced laboratory investigator who is looking for fresh ways of addressing experimental questions. To help us in this effort, we’ve enlisted the assistance of a large group of epilepsy researchers, each of whom has particular expertise in the application of a given model or model type. We’ve asked the author(s) of each chapter to describe the model of interest within the context of the following outline: What does the model model? How is it generated? What are the characteristic and defining features of the model? What are its limitations? And what insights have been developed (through research on this model) into human epileptic disorders? While the ease with which these points are covered varies considerably from chapter to chapter (model to model), the contributing authors have done a superb job in presenting experimentally-useful information as well as conceptually challenging discussions. We have also charged a set of investigators with the task of describing some of the most generally applied technical approaches for investigating epilepsy-relevant models. Again, these chapters not only offer technical overviews, but also provide important discussions about the requirements, advantages, and limitations of these experimental approaches. We hope that the reader will find that these descriptions are useful in thinking about how to do productive epilepsy research.
In 1972, Purpura and colleagues (Purpura, Penry, Tower, Woodbury, and Walter) published a “definitive” volume describing the available models for epilepsy research (Experimental Models of Epilepsy—A Manual for the Laboratory Worker, Raven Press, New York). At the time, epilepsy research was still in its early stages—perhaps not its infancy, but certainly its childhood. The authors could have hardly imagined either the long-reaching influence of their publication, or the incredible maturation of this field. Research on the basic mechanisms of, and treatments for, the epilepsies has become a significant part of many clinical and basic neuroscience programs. Technical advances in cellular and molecular biology have provided a driving force for much of this research, making feasible previously onlydreamed-of experiments. There has been a rush of excitement with the realization that we can study almost any experimental subject—from gene to intact human subject. This excitement has been tempered with a perhaps not-sorapid development of our conceptual sophistication. What questions are important to ask? And in what systems can these questions be best addressed? The response to the latter of the questions is reflected in an explosion of potentially useful “models”—models of epileptiform cellular activity, models of seizure generation, models of epilepsy and epileptogenesis. On the one hand, these models constitute the life-blood of our research efforts. They allow us to examine—in ways that are not available in clinical studies—hypotheses about basic mechanisms. They provide us with opportunities to test the efficacy of new treatments and novel therapies. On the other hand, the plethora of such models confronts us with a need for significant choices. To be effective in our quest for answers (and cures), we need to be intelligent about how best to use the model systems that are available. The current volume represents, in part, an attempt to provide an updated “list” of epilepsy models. While some of the models described in Purpura et al. are still in general use, others have fallen out of favor. One noteworthy change is the
Asla Pitkänen (Kuopio, Finland) Philip A. Schwartzkroin (Davis, California) Solomon L. Moshé (Bronx, New York)
xvii
C
H
A
P
T
E
R
1 What Should Be Modeled? JEROME ENGEL, JR. AND PHILIP A. SCHWARTZKROIN
Epilepsy accounts for a significant portion of the disease burden worldwide (Murray and Lopez, 1994). The economic, social, and personal costs of this disorder are due largely to uncontrolled seizures (Begley et al., 2000), which underscores the need for more research into new approaches for the diagnosis, treatment, and prevention of epilepsy and its consequences. Although one could argue that research on human epilepsy ideally should be carried out on humans with epilepsy, this approach is not always possible or practical (Engel, 1998). Obvious ethical constraints exist, particularly those associated with the invasive techniques often needed to pursue important investigative questions. It is difficult to control for clinical variables, and control data can be impossible to obtain. Statistical analysis frequently requires larger populations than can be obtained from most clinical practices. Finally, the cost of carrying out research projects on patients would be prohibitive. Consequently, despite a tremendous increase in the opportunities for noninvasive research on the human brain provided by modern neuroimaging and growing access to direct investigations in the setting of epilepsy surgery, animal models of epilepsy and epileptic seizures are—and most likely will remain for the foreseeable future—essential to epilepsy research. This book provides an update on the large variety of animal models available to neuroscientists interested in carrying out research on epilepsy. This introductory chapter reviews the various reasons why animal models might be used, what specifically can and should be modeled, and how these models might provide insight into questions of interest and concern (i.e., what can be measured).
(usually epilepsy related) and normal brain function. Animal models of epilepsy are also important, however, for research designed specifically to devise new diagnostic approaches or to test the efficacy of new antiepileptic drugs or other novel therapeutic interventions. It is likely that in the future animal models will be needed to test preventive (i.e., antiepileptogenic) measures as well.
Modeling to Understand Basic Mechanisms Elucidation of the fundamental mechanisms of epilepsy and epilepsy-related phenomena is essential for devising new diagnostic, therapeutic, and preventative approaches to human epilepsy and its consequences. Until relatively recently, almost everything we knew, or thought we knew, about neuronal events underlying epileptic phenomena derived from research using animals. From the outset, however, the most pertinent questions that needed to be answered about epilepsy derived from observations of patients. Answers obtained in the animal laboratory required validation of clinical relevance, again by observing patients. Although the use of animal models to understand the fundamental mechanisms of epilepsy and its consequences is the major theme of this volume, it is important to recognize that animal models of epilepsy, and of epileptic seizures, also have been used to elucidate neuronal mechanisms of normal brain function (Engel et al., 2001). For instance, the discrete perturbations induced by various epileptogenic insults have served as a valuable tool for mapping pathways and synaptically related regions in the brain, both anatomically (e.g., using histological 2-deoxyglucose [2DG] autoradiography and immediate early gene methodologies) and physiologically (e.g., with strychnine neuronography). Epileptic seizures have also been commonly used by physiological psychologists for a variety of investigational
WHY MODEL? Animal models of epilepsy most often are used to investigate fundamental neuronal mechanisms of both abnormal
Models of Seizures and Epilepsy
1
Copyright © 2006, Elsevier Inc. All rights of reproduction in any form reserved.
2
Chapter 1/What Should Be Modeled?
paradigms that require controlled interruption of behavior. Studies of oscillatory brain waves—a prominent feature of normal cerebral function—have been approached through the window of epileptiform phenomena. Our understanding of inhibitory control of brain excitability has been based largely on studies of epilepsy models. Perhaps most important is that modern investigations into brain “plasticity” mechanisms have a significant basis in studies of epileptogenesis. Research using models of different aspects of epilepsyand seizure-related phenomena provides different types of insights into basic mechanistic questions: Acute seizure models: Studies of acute seizures in otherwise normal animals have made us aware of a host of potentially important cellular and molecular processes that might be involved in both the generation and the termination of epileptic seizure, and these possibilities remain the focus of much of today’s research (Avanzini et al., 1998; Engel, 1992; Purpura et al., 1972; Schwartzkroin, 1993). Early workers produced acute generalized epileptic seizures in animals using maximal electroshock and various chemoconvulsants (laboratory procedures that are still commonly used today) as well as a variety of other insults, such as insulin shock and trauma. Localized acute epileptic seizures were created by focal electrical stimulation and by local application of convulsant drugs such as strychnine and penicillin. Such techniques provoked acute ictal (i.e., seizure) activity in otherwise normal brains, permitting investigations of the fundamental neuronal basis of ictal discharge and seizure termination. These studies led to a number of hypotheses regarding the cellular bases of seizure activity, including alterations in intrinsic properties of neurons, loss of inhibition or increased excitatory synaptic activity, and changes in the extracellular milieu. This research also led to theories about seizure termination, such as energy depletion, desynchronization, depolarization block, and release of antiseizure substances like adenosine. Although it was often possible to determine why experimental interventions produced seizures, these manipulations were artificial and there was little or no way to relate these mechanisms of seizure initiation to those of spontaneous generation of seizures in patients. Acute seizures have also been useful, as indicated previously, as a perturbation for those interested in investigating normal brain function. Chronic epilepsy models: Neuroscientists interested in understanding mechanisms of epilepsy have developed a number of chronic animal models with which to investigate persistent epileptogenic abnormalities present between seizures, or interictally. Chronic animal models have offered opportunities to investigate a large set of potentially important and clinically relevant mechanisms,
including excitotoxicity and synaptic reorganization, altered voltage-gated channel functions, sprouting with synaptic reorganization, the development of novel receptors and receptor complements, and astrocyte activation. Many chronic epilepsy models were created specifically to reproduce particular types of human epilepsy, particularly the most common form, mesial temporal lobe epilepsy (MTLE) (Wieser et al., 2004). Seizures in MTLE originate in mesial temporal limbic structures, particularly the hippocampus and adjacent parahippocampal cortex. Most patients with MTLE have a unique epileptogenic structural disturbance— hippocampal sclerosis—but the cause of this disturbance is unknown. Many other lesions in this area, such as tumors, malformations, and infections, can also cause MTLE. A popular laboratory model of MTLE is amygdala kindling, which brings the process of limbic epileptogenesis under experimental control but, as usually performed, does not result in spontaneous seizures. Nevertheless, kindling does induce an enduring epileptogenic process that can be studied profitably. Chronic models of MTLE that give rise to spontaneous seizures can be produced by a variety of interventions, including systemic or intrahippocampal application of excitotoxic agents, such as kainic acid or pilocarpine, as well as focal electrical stimulation that gives rise to self-sustained status epilepticus. Chronic neocortical models include freeze lesions; the partially isolated cortical slab; application of metals such as alumina, cobalt, tungstic acid, and ferric chloride; tetanus toxin; and antimonosialogangioslide (GM1) antibodies. With the advent of high-resolution magnetic resonance imaging (MRI), it has become apparent that malformations of cortical development, particularly cortical dysplasia, account for a large percentage of intractable epilepsies in patients (Schwartzkroin and Walsh, 2000). These conditions have been modeled by in utero chemical exposures and early irradiation or by localized freeze lesions in the neonate. The genetic basis of epilepsy is receiving increasing attention (Noebels, 2003), and a large number of genetic epilepsies also occur in animals. Some of these resemble human genetic epilepsies, such as the Genetic Absence Epilepsy Rat from Strasbourg (GAERS) model of human absence epilepsy. Research with these models, too, have revealed a large number of potential epileptogenic mechanisms, such as voltage-gated channel abnormalities or deletions, aberrant neuronal–glial interactions, and abnormalities in energy metabolism. For most of these genetic models, however, the relevance to human epilepsy remains to be demonstrated. Multifactorial models: It is becoming increasingly apparent that the etiologies of many human epileptic conditions, particularly those that are refractory to medication, are
Why Model?
likely to be multifactorial. Most commonly this would involve both a genetic predisposition and a specific insult. For instance, patients with MTLE are more likely than the general population to have a family history of epilepsy and either a complex febrile seizure or some other initial precipitating insult within the first 5 years of life, insults that are now believed to be important contributors to the cell loss and neuronal reorganization characteristic of hippocampal sclerosis (Wieser et al., 2004). Such pathophysiologic disturbances, when superimposed on a genetic predisposition for seizure activity, may greatly increase the likelihood that a sclerotic hippocampus will ultimately become epileptogenic. Just as there was a major paradigm shift for epilepsy researchers to realize that seizures in a normal brain are not the same as chronic epilepsy, we are now facing the realization that chronic epilepsy induced in a normal brain is not the same as chronic epilepsy induced in a brain that is genetically predisposed to specific epileptogenic disturbances (Engel and Bertram, 2004). There is a great need to identify epilepsy “susceptibility genes” in patients so that multifactorial animal models can be devised and the interactions of multiple etiologic contributions studied.
Modeling to Devise New Approaches for Diagnosis Electrophysiologic Diagnosis The first laboratory test capable of measuring human cerebral function was the electroencephalogram (EEG), which rapidly became the premier diagnostic tool for epilepsy and provided a key element for the classification of epileptic seizures (Commission on Classification, 1981). Interictal and ictal epileptiform discharges on EEG are not only useful for making a general diagnosis of epilepsy, but they also provide a basis for determining what type of epilepsy is present and for localizing the epileptogenic abnormality when surgical treatment is being considered. Animal models of epilepsy played an important role in understanding the neuronal mechanisms responsible for the interictal EEG spike and wave as well as for the various ictal EEG patterns that characterize specific seizure types. Much still can be done using model systems to improve the diagnostic value of EEG: 1. Surrogate markers of epileptogenicity and epileptogenesis. Interictal spikes are too often falsely localizing because it is difficult (at least at times) to distinguish among spikes generated by the primary epileptogenic region, those that are propagated into the area under the recording electrode,
3
and those that occur in epileptogenic areas incapable of generating spontaneous seizures. Furthermore, interictal epileptiform EEG discharges can be seen in some people who do not have epileptic seizures. In patients who do have epileptic seizures, interictal spikes can be recorded from areas distant from the primary epileptogenic regions. Finally, for most patients with epilepsy, the characteristics of the interictal epileptiform discharges provide no information about the frequency or severity of seizure occurrence. Consequently, these EEG events have limited value as markers of epileptogenicity and epileptogenesis. There is a great need, therefore, for more accurate surrogate or biological markers of epilepsy to (1) localize the epileptogenic region for surgical resection, (2) predict whether someone will develop epilepsy following a potentially epileptogenic insult, and (3) determine the efficacy of a therapeutic intervention (for instance, an antiepileptic drug) without the need to wait for another seizure to occur. One possible surrogate marker under investigation is a very high frequency (250–600 Hz) EEG oscillation, termed fast ripples (FR) (Bragin et al., 1999). FR are uniquely seen in association with interictal EEG spikes recorded from areas capable of generating spontaneous seizures. Although FR are easily identified with depth electrode recordings from patients with MTLE, they cannot yet be recorded noninvasively. Therefore ascertaining the diagnostic value of FR will require investigations in animal models. 2. Seizure prediction. There is much current interest in developing methods for anticipating the onset of seizure activity with sufficient latency to allow automated interventions to abort the seizure. Development of computational paradigms, based on EEG signals, is the basis for current approaches to this goal (Lehnertz and Litt, 2005). Most of this research has been carried out directly on patients with epilepsy; however, animal models in which seizures occur unpredictably, but with reasonable frequency, could become crucial for developing practical analysis paradigms and eventually for devising and testing seizure-aborting interventions that can be triggered from alarm signals. Neuroimaging Technical progress in the neuroimaging field has led to a revolution in diagnostic procedures for epilepsy. Modern neuroimaging now allows us to assess structural, functional, and metabolic features of suspect brain areas. Although this revolution has often proceeded at the level of clinical investigation, the possibility of addressing specific imagingrelated questions lies primarily in the application of these techniques to animal models. In particular we still do not understand the relationship of abnormalities revealed by
4
Chapter 1/What Should Be Modeled?
neuroimaging to epileptogenesis, to seizure initiation, and to seizure propagation. These clinical diagnostic approaches will help us to define more clearly what features of brain abnormality are strongly coupled to epilepsy and epileptogenesis for further investigations in animal models. The following are examples of such features: 1. Structural abnormalities. Magnetic resonance imaging (MRI) is the most important diagnostic test for identifying potentially epileptogenic structural lesions in patients with epilepsy, and the clinical value of this diagnostic approach was developed through extensive clinical application. It has also been used in clinical studies to document the progressive nature of some epileptogenic lesions. Small-animal MRI has become available at many centers throughout the world. Application of this structural imaging tool in animal models should lead to improved efficacy of clinical applications as well as a clearer definition of epilepsyrelated structural abnormalities. Putative structural surrogate markers of epileptogenicity and epileptogenesis, for example, axon sprouting in MTLE or specific patterns of cortical dysplasia, could be investigated in animals using high-resolution MRI. Whereas clinical studies are normally cross-sectional, much more valuable longitudinal paradigms can be constructed in small animal models to investigate early epileptogenesis as well as epilepsy-induced progressive disturbances (still a controversial issue). 2. Functional abnormalities. Functional neuroimaging is playing an increasingly important role in the diagnosis of epilepsy (Henry et al., 2000). The most frequently used functional neuroimaging approach, positron emission tomography with fluorodeoxyglucose (FDG-PET), was based on animal experiments with 2DG autoradiography. FDG-PET studies in human temporal lobe epilepsy, for instance, were preceded by 2DG autoradiography studies of amygdala kindling. Now a number of other tracers are being used clinically for diagnostic purposes in epilepsy, not only with PET, but with single-photon emission computed tomography (SPECT). One tracer, alphamethyl-tryptophan (AMT), may also be a surrogate marker of epileptogenicity (Chugani et al., 1998). Development of these diagnostic tools in animal models can help to focus their capabilities. A unique capacity of functional MRI (fMRI) as a functional neuroimaging tool is its high temporal resolution. This capability makes it possible to image the evolution of ictal activity throughout the brain, in three dimensions, during the course of a seizure and then to examine the postictal consequences of this activity. Furthermore, this temporal resolution permits imaging of the anatomic substrates of brief EEG transients, such as
interictal spikes. Consequently, the use of EEG together with fMRI has great potential for localizing the epileptogenic region in surgical candidates without requiring expensive long-term monitoring to capture ictal events. Whereas interictal spikes on the EEG can be falsely localizing, EEG-fMRI eventually may be able to discriminate between interictal spikes from the primary epileptogenic region and those that are propagated or occur in areas not capable of generating spontaneous seizures. Such EEG-fMRI events could be surrogate markers for predicting which patients are likely to develop epilepsy following insult or for determining which antiepileptic intervention is most likely to be effective without waiting for another seizure to occur. At present EEG-fMRI research is being carried out almost exclusively in patients; however, realization of the full potential of this technique will require much more extensive research with experimental animal models. Animal models are also likely to play an important role in the development and effective clinical application of newer diagnostic techniques, such as magnetoencephalography (MEG), magnetic resonance spectroscopy (MRS), microdialysis, optical imaging, and transcranial magnetic stimulation (TMS).
Modeling to Test New Therapies Pharmacotherapy Beginning with studies of phenytoin, investigations in animal models have been used to determine the efficacy and safety of new antiepileptic compounds before they are tried in patients. Animal models of epileptic seizures have been indispensable for this purpose. With one exception (levetiracetam), however, all potential new antiepileptic compounds have been screened against only two mouse models of epileptic seizures: maximal electroshock and subcutaneous Metrazol (Levy et al., 2002). Undoubtedly testing drugs in these models of generalized tonic-clonic seizures and absence seizures, respectively, has resulted in identification of many drugs effective against epilepsies associated with these two seizure types. However, this approach has been less useful in the discovery of drugs for treating other seizure types, particularly focal seizures and atonic seizures. Consequently epilepsy associated with focal and atonic seizures are often medically refractory. It is likely that many compounds that might have been excellent for preventing focal and atonic ictal events were discarded because they did not have anticonvulsant or antiabsence properties. These two acute seizure mouse models continue to be used for drug screening because large numbers of compounds can be screened inexpensively. In contrast it is very expensive to
5
What to Model
screen large numbers of compounds against chronic models (e.g., the amygdala kindling model of MTLE). There is therefore a great need to develop new animal models of those seizure types that are particularly refractory to current pharmacotherapy that could be cost-effectively used for drug screening. Development of model systems based on surrogate markers might possibly fill this role.
Alternative Therapies Alternative treatments for epilepsy also benefit from animal research. Vagus nerve stimulation (VNS), for instance, was first investigated with acute seizures in dogs and then with chronic epilepsy in monkeys before it was tried in humans (Schachter and Wheless, 2002). Animal research is also playing an important role in developing the techniques of deep brain stimulation as a treatment for epilepsy. Epilepsy surgery, gamma knife surgery, and the ketogenic diet (KD) have been used effectively in patients without preliminary studies in animals. However, animal research continues to be of value in our efforts to understand how these therapeutic interventions work, what might be done to improve them, and which patients are most likely to benefit from their use. Identifying appropriate animal models for testing therapeutic interventions is a prime concern. For example, because KD is principally used in children, understanding and improving KD-based approaches require comparable immature brain experimental animal models (Stafstrom and Rho, 2004).
Antiepileptogenesis Currently no treatments are available that focus explicitly on the issue of preventing the development of chronic epilepsy (antiepileptogenesis) or on ameliorating the biological consequences of chronic seizure activity. Although there has been much discussion about the need for such approaches, the few existent clinical studies (e.g., prophylactic treatments for posttraumatic epilepsy) have been disappointing. None of our current antiepileptic drugs is known to be antiepileptogenic. Whereas clinical studies on this important theme cannot be cost-effectively pursued without better prognostic indications, current animal model systems provide an important opportunity to begin to assess novel treatments that could prevent the development of chronic seizures following a known epileptogenic manipulation (Loescher, 2002). Animal models can also be used to help identify treatments that might decrease the morbidity associated with seizures, including the progression of the epileptogenic process, interictal disturbances in behavior (e.g., learning
and memory deficits in MTLE), the occurrence of depression, and developmental delay in infants and small children. Although these disturbances represent a major cause of disability in patients, their causal relationship to seizures remains controversial because this association is difficult to document clinically, let alone investigate in a controlled fashion (Sutula and Pitkänen, 2002). Animal studies, however, have shown that kindling causes seizures to become more severe, that rats exposed to repeated seizures when they are young are deficient in some learning and memory behaviors (even though the initial seizure exposure does not result in spontaneous seizures in the adult or in demonstrable neuropathologic changes), and that seizures can alter behavior in ways that suggest psychiatric disturbances (Engel et al., 1991). Such animal models present opportunities for assessing therapies that might treat or prevent these progressive disturbances.
WHAT TO MODEL The International League against Epilepsy (ILAE) agreed on the following definitions for epileptic seizures and epilepsy (Fisher et al., 2005). “An epileptic seizure is a transient occurrence of signs and/or symptoms due to abnormal excessive or synchronous neuronal activity in the brain.” “Epilepsy is a chronic disorder of the brain characterized by an enduring predisposition to generate epileptic seizures, and by the neurobiological, cognitive, psychological, and social consequences of this condition. The definition of epilepsy requires the occurrence of at least one epileptic seizure.” When devising models of human epileptic seizures and epilepsy, therefore, it is essential to distinguish between (1) models of acute epileptic seizures that occur in a normal brain and do not necessarily indicate the presence of an epileptic condition and (2) models of epilepsy that are associated with permanent “epileptogenic” disturbances. The latter is present whether or not seizures are occurring and can be associated not only with seizure phenomena but also with enduring or progressive nonepileptic consequences of these disturbances. There are many different types of epileptic seizures, and each may be associated with different epileptogenic mechanisms (Commission on Classification, 1981; Engel and Pedley, 1997); such likely differences need to be considered when creating animal models. There are also many different epilepsy syndromes that are characterized by the occurrence of one or more specific seizure type(s) as well as by other clinical features such as age of onset, response to antiepileptic drugs, family history, interictal disturbances, pathophysiologic mechanisms and anatomic substrates (Commission on Classification, 1989; Engel and Pedley, 1997). The variety of these
6
Chapter 1/What Should Be Modeled?
syndromes also needs to be considered when animal models are created. It is debatable whether animal models exist—or can be created—that faithfully reproduce any given human epilepsy syndrome. Consequently, one approach to modeling human epilepsy is to define the component parts of epileptic disorders and to model each part individually. Even a single epileptic seizure (with a few exceptions) consists of an evolution of events, each event with different mechanisms and anatomic substrates that can be individually modeled and independently studied. Laboratory phenomena that either represent a basic component part of an epileptic disturbance or provide information about such a disturbance have been referred to as epilepsy equivalents (Engel, 1992); some surrogate markers can serve as epilepsy equivalents.
Epileptic Seizures The ILAE classified epileptic seizures most recently in 1981 (Commission on Classification, 1981) (Table 1), and this classification is undergoing revision (Engel, 2001). The 1981 classification is based solely on clinical and EEG descriptive phenomena. It defines seizures that begin in a part of one hemisphere as partial seizures and those that begin in both hemispheres at the same time as generalized seizures. Generalized seizures are often divided into
TABLE 1 International Classification of Epileptic Seizures I.
Partial (focal, local) seizures A. Simple partial seizures 1. With motor signs 2. With somatosensory or special sensory symptoms 3. With autonomic symptoms or signs 4. With psychic symptoms B. Complex partial seizures 1. Simple partial onset followed by impairment of consciousness 2. With impairment of consciousness at onset C. Partial seizures evolving to secondarily generalized seizures 1. Simple partial seizures evolving to generalized seizures 2. Complex partial seizures evolving to generalized seizures 3. Simple partial seizures evolving to complex partial seizures evolving to generalized seizures
II. Generalized seizures (convulsive or nonconvulsive) A. Absence seizures 1. Typical absences 2. Atypical absences B. Myoclonic seizures C. Clonic seizures D. Tonic seizures E. Tonic-clonic seizures F. Atonic seizures (astatic seizures) III. Unclassified epileptic seizures From Commission on Classification, 1981, with permission.
convulsive and nonconvulsive types. The convulsive types include generalized tonic-clonic seizures (previously called grand mal seizures) as well as seizures that are purely clonic, seizures that are purely tonic, and various combinations of these ictal manifestations. Nonconvulsive generalized seizures include typical absence seizures (previously called petit mal seizures) as well as atypical absence seizures. Typical absences involve brief losses of consciousness, without warning or postictal symptoms, associated with a regular three-per-second generalized spike-and-wave EEG discharge. Atypical absences last longer, there can be postictal symptoms, and the EEG patterns are more irregular. Other nonconvulsive generalized seizures are generalized myoclonic seizures, which consist of sudden bilateral myoclonic jerks, and atonic seizures, which involve sudden losses of muscle tone. Myoclonic, atonic, and brief clonic seizures can all result in falls, referred to as astatic seizures or “drop attacks.” Generalized convulsive seizures, typical absences, and myoclonic seizures occur in the benign genetic epileptic disorders that are unassociated with brain damage; in contrast generalized convulsive seizures, atypical absences, and atonic seizures occur in conditions in which brain damage is so diffuse that seizures begin bilaterally. The 1981 ILAE classification divides partial seizures into simple if there is no alteration of consciousness or complex if consciousness is impaired. Simple partial seizures can have motor, sensory, autonomic, or psychic signs or symptoms, depending on the function of the cortex where the seizures arise. The term complex partial seizures has been erroneously used synonymously with temporal lobe seizures because most often these events begin in mesial temporal limbic structures. It is important to understand, however, that consciousness can be impaired as a result of ictal activity in other brain areas so that not all complex partial seizures are of mesial temporal origin. Furthermore, mesial temporal seizures often do not propagate to produce impaired consciousness; they can give rise to characteristic simple partial signs and symptoms that occur with clear consciousness, typically sensations of epigastric rising, emotional experiences such as fear, and autonomic changes. Partial seizures commonly evolve. Simple partial seizures can progress to complex partial seizures, and both simple and complex partial seizures can progress to secondarily generalized seizures. Simple partial seizures without motor signs that proceed to complex partial or secondarily generalized seizures are commonly referred to as auras. Clearly the pathophysiologic mechanisms and anatomic substrates of ictal events change during this evolution. Similarly, different mechanisms and different brain areas (e.g., forebrain and brainstem) are involved at different times during progression of a generalized tonic seizure to the clonic phase.
7
What to Model
Because partial seizures often involve widespread disturbances, sometimes involving both hemispheres, the term partial was preferred over focal when the 1981 classification was devised. The often-used term epileptic focus gives the misleading impression that epileptogenic abnormalities are limited to a small, discrete area of the brain. This impression resulted in part from early research on the experimental penicillin focus, which did involve seizures generated from activation of a small cluster of neurons. The more accurate replacement term, partial, however, has also caused confusion because it can be misinterpreted to mean part of a seizure rather than an entire seizure. Consequently the ILAE recommends returning to the earlier term, focal seizure (Engel, 2001), but with the explicit understanding that most “focal” epilepsies involve a widely distributed epileptogenic substrate; indeed, in chronic focal epilepsies, the entire brain may be abnormal. The ILAE is also planning to eliminate the distinction between simple and complex events based on impaired consciousness (Engel, 2001). Although impairment of consciousness is clinically important, it is difficult to assess in many patients and is no longer considered an appropriate criterion for classification of ictal phenomena. The concept of complex is, in any event, suspect with respect to animal models; indeed it is usually difficult or impossible to determine the state of consciousness of a rat or mouse. It will be much easier to justify a claim that seizures in an animal model reproduce human seizure types when these clinical ictal events are better defined based on pathophysiologic mechanisms and anatomic substrates. There is also concern about the designation of generalized seizures because there is a question as to whether any seizures are truly generalized at their onset (Engel, 2001). Although advanced EEG and functional neuroimaging techniques can help to determine the true site of ictal onset for various types of human “generalized” seizures, animal models of these ictal events will greatly enhance our ability to answer this important question. Within the context of this current volume on animal models, it is noteworthy that clinicians have had such difficulty in defining epileptic phenomena. Certainly it would be much easier to justify a claim that seizures in an animal model reproduce human seizure types if these clinical ictal events were better defined. To eliminate confusion and misconceptions caused by the 1981 seizure classification, the ILAE is currently attempting to identify ictal events that represent discrete pathophysiologic mechanisms and anatomic substrates that can be used as diagnostic entities rather than to rely only on phenomenologic designations developed for descriptive purposes (Engel, 2001). This attempt at redefinition is important and welcome news for animal research in areas where human phenomenology may be difficult to reproduce but pathophysiologic mechanisms and anatomic
substrates can be effectively modeled and verified. There was insufficient information to base seizure classification on mechanistic and anatomic criteria when the current ILAE classification was accepted in 1981, and concern remains as to whether our knowledge of basic mechanisms of epileptic seizures today is adequate to permit a more “diagnostic” classification. Nevertheless, a tentative list of discrete seizure types, based on this new classification scheme, has been published (Engel, 2001) (Table 2). These seizure types are being individually evaluated to determine whether there is sufficient justification to consider them discrete diagnostic entities. This evaluation will take into account the following criteria: pathophysiologic mechanisms (e.g., electrophysiology, neural networks, and neurotransmitter actions), anatomic substrates, response to antiepileptic drugs, ictal EEG patterns, propagation patterns and postictal features, and associated epilepsy syndromes. The list in Table 2 includes a number of seizure types that are characteristic of specific epilepsy syndromes but that are not part of the 1981 classification, such as myoclonic atonic seizures, myoclonic absences, negative myoclonus, gelastic seizures, and epileptic spasms. Whereas epileptic spasms were previously referred to as infantile spasms and considered to be purely an age-related ictal phenomenon characteristic of West syndrome, it is now accepted that epileptic spasms can also occur in older children and adults. No valid animal model of this often intractable and devastating seizure type exists. Some of these epileptic seizure types are easily treated by antiepileptic drugs, and others are highly refractory to pharmacotherapy. The development of animal models of the more refractory seizure types is obviously valuable to understanding their fundamental neuronal mechanisms and to devising better treatments. There is also a great need to identify surrogate markers or epilepsy equivalents of these phenomena that could serve to develop costeffective screening procedures for potential antiepileptic compounds.
Epilepsies and Epilepsy Syndromes The current ILAE classification of epilepsies and epilepsy syndromes (Table 3) was approved in 1989 (Commission on Classification, 1989) and is also now undergoing revision (Engel, 2001). The 1989 classification divides epilepsies into generalized and localization-related categories, depending on whether the characteristic seizures begin simultaneously on both sides of the brain or in a part of one hemisphere. Generalized epilepsies are never associated with partial seizures, but localization-related epilepsies can be associated with generalized seizures if they are secondarily generalized. Epilepsy syndromes are further divided by this classification into idiopathic and symptomatic categories. The term
8
Chapter 1/What Should Be Modeled?
TABLE 2 Epileptic seizure types and precipitating stimuli for reflex seizures Self-limited seizure types Generalized seizures Tonic-clonic seizures (includes variations beginning with a clonic or myoclonic phase) Clonic seizures Without tonic features With tonic features Typical absence seizures Atypical absence seizures Myoclonic absence seizures Tonic seizures Spasms Myoclonic seizures Eyelid myoclonia Without absences With absences Myoclonic atonic seizures Negative myoclonus Atonic seizures Focal seizures Focal sensory seizures With elementary sensory symptoms (e.g., occipital and parietal lobe seizures) With experiential sensory symptoms (e.g., temporoparietooccipital junction seizures) Focal motor seizures With elementary clonic motor signs With asymmetric tonic motor seizures (e.g., supplementary motor seizures) With typical (temporal lobe) automatisms (e.g., mesial temporal lobe seizures) With hyperkinetic automatisms With focal negative myoclonus With inhibitory motor seizures Gelastic seizures Hemiclonic seizures Secondarily generalized seizures Continuous seizure types Generalized status epilepticus Generalized tonic-clonic status epilepticus Clonic status epilepticus Absence status epilepticus Tonic status epilepticus Myoclonic status epilepticus Focal status epilepticus Epilepsia partialis continua of Kojevnikov Aura continua Limbic status epilepticus (psychomotor status) Hemiconvulsive status Precipitating stimuli for reflex seizures Visual stimuli Flickering light: color to be specified when possible Patterns Other visual stimuli Thinking Music Eating Praxis Somatosensory Proprioceptive Reading Hot water Startle Modified from Engel 2001, with permission.
TABLE 3 International Classification of Epilepsies, Epileptic Syndromes, and Related Seizure Disorders 1. Localization-related (focal, local, partial) 1.1. Idiopathic (primary) Benign childhood epilepsy with centrotemporal spikes Childhood epilepsy with occipital paroxysms Primary reading epilepsy 1.2. Symptomatic (secondary) Temporal lobe epilepsies Frontal lobe epilepsies Parietal lobe epilepsies Occipital lobe epilepsies Chronic progressive epilepsia partialis continua of childhood Syndromes characterized by seizures with specific modes of precipitation 1.3. Cryptogenic, defined by: Seizure type Clinical features Etiology Anatomical localization 2. Generalized 2.1. Idiopathic (primary) Benign neonatal familial convulsions Benign neonatal convulsions Benign myoclonic epilepsy in infancy Childhood absence epilepsy (pyknolepsy) Juvenile absence epilepsy Juvenile myoclonic epilepsy (impulsive petit mal) Epilepsies with grand mal seizures (GTCS) on awakening Other generalized idiopathic epilepsies Epilepsies with seizures precipitated by specific modes of activation 2.2. Cryptogenic or symptomatic West syndrome (infantile spasms, Blitz-Nick-Salaam Krämpfe) Lennox-Gastaut syndrome Epilepsy with myoclonic-astatic seizures Epilepsy with myoclonic absences 2.3. Symptomatic (secondary) 2.3.1. Nonspecific etiology Early myoclonic encephalopathy Early infantile epileptic encephalopathy with suppression bursts Other symptomatic generalized epilepsies 2.3.2. Specific syndromes Epileptic seizures may complicate many disease states 3. Undetermined epilepsies 3.1. With both generalized and focal seizures Neonatal seizures Severe myoclonic epilepsy in infancy Epilepsy with continuous spike-waves during slow wave sleep Acquired epileptic aphasia (Landau-Kleffner syndrome) Other undetermined epilepsies 3.2. Without unequivocal generalized or focal features 4. Special syndromes 4.1. Situation-related seizures (Gelegenheitsanfälle) Febrile convulsions Isolated seizures or isolated status epilepticus Seizures occurring only when there is an acute or toxic event due to factors such as alcohol, drugs, eclampsia, nonketotic hyperglycemia From Commission on Classification, 1989, with permission.
9
What to Model
idiopathic derives from the Greek idio, meaning “self,” and it refers to conditions that are only epilepsy (and nothing else). The term idiopathic does not mean “cause unknown” (epilepsies of unknown cause are called cryptogenic). Idiopathic epilepsies are genetic conditions without structural abnormalities and usually are without interictal clinical signs or symptoms. They are age-related and almost always benign in that seizures are highly responsive to pharmacotherapy and, for many syndromes, remit spontaneously as the brain matures. Symptomatic epilepsies are due to structural or metabolic disturbances, which can be acquired (e.g., from infections, trauma, or other insults), endogenous (e.g., tumors or congenital malformations), or genetic disturbances associated with structural or metabolic disturbances (e.g., tuberous sclerosis and phenylkentonuria). More than half of epilepsies are symptomatic, and these represent essentially all the conditions that are typically refractory to pharmacotherapy. The prognosis for symptomatic localizationrelated epilepsies depends on their etiology. The most common of these, and also the most common form of human epilepsy, is MTLE with hippocampal sclerosis (Wieser et al., 2004). MTLE is among the most difficult of the epilepsies to treat medically, although it is usually amenable to surgical therapy. Symptomatic generalized epilepsies are due to diffuse brain damage and manifest differently at different ages (e.g., severe myoclonic epilepsy shortly after birth, West syndrome in infants, and the Lennox-Gastaut syndrome in older children). These conditions are extremely difficult to treat and are usually associated with mental retardation and other neurologic deficits that contribute greatly to the disability. The ILAE also established a revised list of epilepsy syndromes (Engel, 2001) (Table 4) and is attempting to validate their existence as discrete diagnostic entities according to the following criteria: epileptic seizure type(s), age of onset, progressive nature, interictal EEG pattern, associated interictal signs and symptoms, pathophysiologic mechanisms, anatomic substrates, and etiologies. Justifications for the generalized versus localization-related dichotomy and for the idiopathic versus symptomatic dichotomy are being reevaluated; these dichotomies are not likely to be carried into any new classification scheme (Engel, 2001). Epilepsy experts now believe that none of these conditions is likely to be truly generalized and that both genetic and structural factors play a role in many (if not most) of these syndromes. Research with appropriate animal models could help to confirm this point of view. Several familial syndromes are listed in Table 4 that were not included in the 1989 classification, such as autosomaldominant nocturnal frontal lobe epilepsy and familial lateral and mesial temporal lobe epilepsies; these syndromes were recognized after the 1989 classification was completed. Further, some syndromes, such as familial focal epilepsy
TABLE 4 Epilepsy syndromes and related conditions Benign familial neonatal seizures Early myoclonic encephalopathy Ohtahara syndrome * Migrating partial seizures of infancy West syndrome Benign myoclonic epilepsy in infancy Benign familial infantile seizures Benign infantile seizures (nonfamilial) Dravet’s syndrome HHE syndrome * Myoclonic status in nonprogressive encephalopathies Benign childhood epilepsy with centrotemporal spikes Early onset benign childhood occipital epilepsy (Panayiotopoulos type) Late onset childhood occipital epilepsy (Gastaut type) Epilepsy with myoclonic absences Epilepsy with myoclonic-astatic seizures Lennox-Gastaut syndrome Landau-Kleffner syndrome (LKS) Epilepsy with continuous spike-and-waves during slow-wave sleep (other than LKS) Childhood absence epilepsy Progressive myoclonus epilepsies Idiopathic generalized epilepsies with variable phenotypes Juvenile absence epilepsy Juvenile myoclonic epilepsy Epilepsy with generalized tonic-clonic seizures only Reflex epilepsies Idiopathic photosensitive occipital lobe epilepsy Other visual sensitive epilepsies Primary reading epilepsy Startle epilepsy Autosomal dominant nocturnal frontal lobe epilepsy Familial mesial temporal lobe epilepsy Familial lateral temporal lobe epilepsy * Generalized epilepsies with febrile seizures plus * Familial focal epilepsy with variable foci Symptomatic (or probably symptomatic) focal epilepsies Limbic epilepsies Mesial temporal lobe epilepsy with hippocampal sclerosis Mesial temporal lobe epilepsy defined by specific etiologies Other types defined by location and etiology Neocortical epilepsies Rasmussen syndrome Other types defined by location and etiology Conditions with epileptic seizures that do not require a diagnosis of epilepsy Benign neonatal seizures Febrile seizures Reflex seizures Alcohol withdrawal seizures Drug or other chemically induced seizures Immediate and early post cerebral insult seizures Single seizures or isolated clusters of seizures Rarely repeated seizures (oligoepilepsy) * Syndromes in development Modified from Engel 2001, with permission.
10
Chapter 1/What Should Be Modeled?
with variable foci and generalized epilepsy with febrile seizures plus (GEFS+), deviate from previous concepts of syndromes because they are syndromes of families rather than of individuals; that is, the diagnosis can be made only if the appropriate family history is available. There is nothing characteristic about the proband otherwise. Genetic discovery is now a major area of investigation in epilepsy. The search for new genetic syndromes, and for epilepsy genes, will undoubtedly yield information that will help to elucidate mechanisms of epilepsy and to provide a more objective basis for classification. At the same time, this work has greatly complicated efforts to classify and categorize specific epilepsy syndromes because we now recognize that “clearly defined” syndromes can be caused by several different gene abnormalities and that a given identified epilepsy gene abnormality can cause different epilepsy syndromes in different members of the same family. Animal models based on gene discovery will play an important role in sorting through this extremely important, highly complicated field of inquiry. Along with the reevaluation of epilepsy syndromes, a new concept of epileptic encephalopathy was introduced (Engel, 2001). This refers to epilepsy syndromes in which progressive behavioral and epileptic features are believed to be due to repeated ictal events rather than to the underlying etiology. A number of such syndromes are now recognized, including the Landau–Kleffner syndrome, epilepsy with continuous spike-and-wave during slow sleep, early myoclonic encephalopathy, Ohtahara syndrome, Dravet syndrome, myoclonic status in nonprogressive encephalopathies, West syndrome, Lennox-Gastaut syndrome, and perhaps even MTLE with hippocampal sclerosis. For these syndromes seizures appear to cause progressive deterioration, suggesting that early effective therapeutic intervention can prevent severe long-term disability resulting from nonepileptic deficits. Here, too, animal models will be essential in efforts to elucidate mechanisms that cause progression in the various epileptic encephalopathies, to devise diagnostic techniques that will determine when to intervene, and to develop more effective therapeutic interventions. Another interesting addition to the new list of syndromes is hypothalamic hamartoma with gelastic seizures, which may be an epileptic encephalopathy. Although this condition has been recognized for many years, it has only recently been demonstrated that the gelastic seizures appear to arise from the hamartoma itself and that in some cases the seizures can be abolished by surgical removal of the hamartoma (Berkovic et al., 2003). How a hypothalamic hamartoma can give rise to seizures is an interesting and still unanswered question; at present no animal model of this condition is available to help investigators unravel the mystery.
Component Parts of Epilepsy It should be clear from this review of epileptic seizure types and epilepsy syndromes that it may not be possible to develop accurate animal models in which the complex features of a seizure or syndrome are faithfully reproduced. Therefore animal modeling must adopt strategies that will help define and address the critical questions associated with the varied and complex seizure and syndrome phenotypes that have been clinically described. Perhaps the most widely accepted (explicit or implicit) strategy has been to focus on key components of seizures and syndromes (Engel, 1998). Examples of component parts that can be individually modeled are described in the following sections. This list is undoubtedly incomplete but will give the reader a sense of how such a strategy can be applied in the animal laboratory. Epileptogenesis Acquired epilepsies that begin with an epileptogenic insult require time to develop. This is likely to be the case even if the insult occurs on a background of preexisting seizure susceptibility. The period during which the insultinitiated processes give rise to a condition of spontaneous seizure discharge has been referred to as the latent period. For instance, for MTLE with hippocampal sclerosis (HS), there is thought to be an initial precipitating insult (within the first 5 years of life) that presumably results in the death of selective hippocampal neurons, with subsequent axonal spratting, synaptic reorganization and gliosis (Wieser et al., 2004). Other changes can also be associated with this epileptogenic process, including alterations in receptors and channels on key hippocampal cell populations as well as changes in the relative rates of neurogenesis and apoptosis. These changes appear to promote spontaneous hypersynchronous discharges that over time will recruit other limbic and distant structures into the epileptogenic process. At some later time—perhaps several years later—spontaneous seizures will emerge. This hypothesized mechanism of epileptogenesis has been modeled in animals using agents or techniques that cause similar damage to the hippocampus, such as kainic acid, pilocarpine, and stimulation-induced selfsustained status epilepticus. The subsequent recruitment of other limbic and distant structures into the epileptogenic process has been brought under laboratory control with amygdala and hippocampal kindling. For other types of epilepsy, it is likely that the epileptogenic process is very different. For instance, in agedependent idiopathic epilepsies, there may be no epileptogenic process per se (certainly no identifiable discrete initiating insult) but rather a substrate that is unmasked during a particular period of brain maturation. Such epilepsies often appear to be expressed during that period of brain development in which synaptogenesis reaches a peak, particularly
What to Model
when N-methyl-d-aspartate (NMDA)-type glutamate receptors are highly expressed. Even for the acquired epilepsies, such developmental processes influence epileptogenesis, determine an age-related expression of seizure activity, and must be considered when animal models are created. The Interictal State One of the most intriguing—and puzzling—features of epilepsy is that seizures occur sporadically, intermittently. That is, most of the time, there are no seizures, but the brain is still characterized by an epileptic condition. Given this seizure capability, the chronic interictal period is perhaps most interesting for the natural homeostatic mechanisms that prevent seizure generation. What factors are responsible for maintaining an interictal state and assuring that seizures do not occur continuously? What are the bases for the breakdown of such protective mechanisms when seizures do occur? Given that mechanisms of ictal onset differ among the various epileptic seizure types and epilepsy syndromes, it is possible that the protective seizuresuppressing mechanisms also differ. This area of investigation, which can be most easily pursued in the animal laboratory, should provide insights into novel clinical approaches to treat or prevent epilepsy. Ictal Onset Much remains to be learned regarding the transition from the interictal to the ictal state. This transition clearly differs markedly from one seizure type to another. In some conditions the transition can take considerable time, opening the potential for the application of electrophysiologic techniques to predict seizure onset minutes to hours before they occur (Lehnertz and Litt, 2004). In some cases, the preictal EEG findings merely reflect changes in normal brain function that decrease the threshold for seizure occurrence; in other cases they could reflect the accrual of pathological changes that slowly build up to the generation of a clinical ictal event. Animal models of these electrophysiologic phenomena could help to improve technologies for seizure prediction and to reveal “reversible” mechanisms that could be targeted by new strategies for seizure prevention. Ictus and Seizure Termination The ictal event for typical absence seizures is stereotypically repetitive and most likely represents a single pathophysiologic mechanism. However, for the vast majority of ictal events, there is a pattern of evolution that reflects a sequence of pathophysiologic disturbances at the neuronal level and in the extracellular space that results in recruitment of adjacent and distant anatomic structures. Depending on the seizure type, various ictal phases can be further broken
11
down and studied independently using appropriate animal models. In addition, the mechanisms of synchrony—the feature that defines most seizure states—can be analyzed, potentially yielding insight into how to interfere with ongoing seizure activity. Desynchronization could represent a naturally occurring process that terminates seizure events. Unfortunately little information about the mechanisms of seizure termination is available. It is perhaps reasonable to assume that there are as many different neuronal mechanisms for terminating seizures as there are seizures types. Using animal models of different seizure types, we should be able to determine why different types of seizures stop and also why this process fails in status epilepticus. Epilepsia partialis continua, or focal seizures that can continue for hours or years, is an interesting condition because it indicates that the mechanisms that prevent seizure spread are not necessarily the same as the mechanisms that terminate seizures. Much could be learned from an animal model of this phenomenon. The Postictal Period Most seizures are followed by a period of focal or generalized neurologic deficit, ranging from generalized “postictal depression” to focal signs and symptoms, such as aphasia and Todd paralysis. The features of these postictal disturbances depend on the seizure type. For some patients, these disturbances can be more disabling than the seizures themselves. Often postictal deficits are a consequence of the natural mechanisms that act to terminate the seizure, suggesting that interventions designed to exploit these homeostatic events to stop seizures could exacerbate postictal dysfunction. More animal research is needed to elucidate the neuronal events responsible for these disturbances. Long-Term Consequences It is widely hypothesized that “seizures beget seizures” and that a significant consequence of a seizure (or series of seizures) is alteration in subsequent seizure manifestations, such as increased frequency and severity. In addition, clinical investigators have documented the development of interictal behavioral disturbances that are thought to be direct consequences of the seizures (Sutula and Pitkänen, 2002). Similar behavioral changes, such as kindling, have been shown in animal models. Alternatively such behavioral changes could reflect the effects of homeostatic seizuresuppressing mechanisms that act to maintain the interictal state. Long-term consequences of seizures could be potentially reversible (functional) or permanent (structural). Many patients are more disabled by interictal behavioral disturbances than they are by their seizures. These behavioral consequences are particularly crippling for the epileptic encephalopathies. There is an urgent need to understand the
12
Chapter 1/What Should Be Modeled?
mechanisms of these consequences of epilepsy to prevent and treat them more effectively.
WHAT TO MEASURE Research on epilepsy with animal models, as with experimental animal research in all areas of biomedicine, begins with the identification of clinically relevant questions— questions that cannot easily be answered by studying patients but might be answered by studies in “simpler” systems in which the key variables can be brought under experimental control. The selection of the model depends on the question of interest as well as on the technical expertise of the investigators and available facilities. Regardless of whether the question can be addressed using models of epileptic seizures induced in a normal brain, of chronic epilepsy, or of epileptic equivalents, the investigator has a choice of experimental subjects (ranging from primates to flies), preparations (from oocytes to intact behaving animals), and technical approaches. Animal models can be studied electrophysiologically in vivo, either acutely (in which the animal is sacrificed at the end of the experiment) or chronically (where the same animal can be studied repeatedly over long periods). In vitro electrophysiologic investigations can be carried out on normal tissue that is made epileptic “in the dish” or on tissue removed from animal models of chronic epilepsy. In vitro preparations can be acute (e.g., slices, dissociated cells) or long-term (e.g., tissue culture). Live tissue used for electrophysiologic, imaging, and metabolic studies can be fixed later and studied in detail for structural elements. Whereas morphologic investigations in the past have required that animals be sacrificed and brains removed, it is now possible to perform both functional and structural in vivo neuroimaging in chronic animal models. Ictal and interictal behavioral investigations typically require in vivo experimental paradigms, but ictal and interictal electrophysiologic equivalents can be investigated in vitro. Neurochemical investigations are usually performed in vitro; however, they can now also be carried out in vivo using techniques such as microdialysis, PET, and MRS. Pharmacologic investigations can be pursued in awake behaving animals, with tissue preparations, and with PET and SPECT. Genetic investigations are now feasible in complex animal models by using new microarray techniques; surveys of thousands of genes (from excised cell or tissue samples) that may be altered by specific epileptogenic interventions can be assessed and quantified. Such powerful technology complements ongoing studies of population genetics carried out in mice or simpler organisms (such as flies). Gene discovery in turn leads to identification of gene products. Such discoveries raise new questions about mechanisms that must be addressed using in vitro molecular neurobiological techniques or in vivo gene
manipulations (e.g., knockouts, conditional transgenics, vector gene manipulations). Finally data derived from animal research can be used to create mathematical and computational models where variables are maximally controlled. All these approaches, however, provide information that is of clinical value only if it is subsequently validated as relevant to the human condition. All answers obtained from questions asked of animal models therefore ultimately require follow-up questions that must be pursued with patients. The number of animal models for epilepsy investigations is quite remarkable, and the techniques available for probing these models are extremely powerful. The experimenter is therefore faced with a set of difficult choices. 1. Which model should I use? As indicated, the choice of model depends critically on what questions are to be addressed. There is no easy answer. The following chapters provide some alternatives and, it is hoped, some guidance. 2. What should I measure, particularly with respect to “validating” the model for epilepsy relevance? The issues at this level are realistically dictated (as suggested previously) by the investigator’s expertise, colleagues, and facilities. There is, however, a standard set of possible measures that will be invaluable for characterizing any epilepsy model and for comparing the model to the relevant human condition. Validation, therefore, can be based on one or more of these measures. Electrophysiologic Characterization Clinical epilepsies are defined in part by typical interictal and ictal EEG patterns (whether in vivo or in vitro). Models of human absence epilepsy, for instance, are validated by ictal EEG discharges that resemble the threeper-second spike-and-wave discharges seen in humans (Avoli et al., 1990). Local circuit populations can provide important information about epilepsy surrogate markers and equivalents such as FR or long-term potentiation. At the single cell level, it is critical to describe the electrical features of neurons (or glia) that participate in the epileptic phenomena, such as burst discharge and details of current flux. Behavioral Manifestations The defining feature of epileptic seizures is the clinical behavioral nature of the ictal phenotype. Careful description of the behaviors characterizing a rat or a mouse seizure, although perhaps difficult, is extremely important, perhaps not so much as a means of validating the seizures with respect to human epilepsies (it may well be that a mouse does not reproduce human behavioral phenotypes) but for providing other investigators with a useful set of measures to replicate and to extend studies on a given model. An
13
What to Measure
example is the Racine scale, which is always used to define the various stages of kindled seizures (Racine, 1972). Similarly, a description of the behavioral deficits associated with a given seizure or epilepsy model provides information necessary to assess the consequences of seizures that characterize particular epilepsy syndromes (Engel et al., 1991). Structural Measures At least some epilepsy syndromes are characterized by specific abnormalities in structural organization. An example is the hippocampal sclerosis of MTLE which is reproduced in the chronic animal models of this condition (Wieser et al., 2004). Detailed histologic and immunocytochemical measures provide important data about cell organization, structural plasticity, and changes in receptor complements. Ultrastructural analysis can help to identify more subtle changes (e.g., in synapse morphology, number, and targets). These traditional measures are now complemented by information obtained with sophisticated imaging approaches, which in noninvasive paradigms can provide longitudinal information about progressive structural changes in the same animal. Age (Development), Gender, Species, and Strain Specificity Increasingly laboratory studies are discovering differences between adult and immature animals with respect to seizure sensitivity, seizure types, and seizure mechanisms. It is clear that the immature brain is not simply a small version of the adult brain (Schwartzkroin et al., 1995). These results parallel the growing awareness of such differences in patients. For instance, the immature brain is more susceptible to acute seizures than the adult brain, but it is less susceptible to the development of chronic epilepsy in both animal models and humans. Similarly, it is clear that there are seizure phenomena that appear to be “sex-linked,” whether because of sex-linked genes attributable to specific hormonal issues or related to specific differences in brain structure. These powerful influences must be acknowledged, controlled, and preferably measured in animal model studies. In addition, differences between animal species, and even between strains of the same species, must be taken into consideration when designing studies and interpreting results. Genetic Background and Predisposition As indicated previously, it is clear that there are not only epilepsy genes (i.e., genes that, when mutated, result in a seizure phenotype) but also genetic predispositions in both humans and animals. Many epilepsy genes are now well documented. We continue to struggle, however, with the
issue of genetic background as a basis for seizure predisposition. Explicit reporting of genetic background (particularly in mouse models) has become an important feature of all epilepsy studies. Identification of “susceptibility” genes will constitute a major focus for modern epilepsy research. Genetic abnormalities identified in humans can then be reproduced in animals, and genetic disturbances identified as causing or influencing epileptic manifestations in animals can then be sought in patients. Response to Therapy Our ultimate goal in studying animal models of epilepsy is to develop more effective treatments and to design preventive measures for seizures and epilepsies in the human population. Characterization of animal models on the basis of their responsiveness to antiepileptic (or antiepileptogenic) treatment is therefore a key element in their validation. The number of therapeutic strategies available to the laboratory investigator precludes any complete characterization for a given model. However, as one nears the point of establishing a model as clinically relevant and offers hypotheses regarding underlying mechanisms that might give rise to specific treatments, assessing the model with respect to responses to conventional pharmacologic therapy is both useful and necessary.
Acknowledgments Original research reported by the authors was supported in part by grants NS-02808, NS-15654, NS-33310 (JE), and NS-18895 (PAS) from the National Institutes of Health.
References Avanzini, G., Moshé, S.L., Schwartzkroin, P.A., and Engel, J. Jr. 1998. Animal models of partial epilepsy. In Epilepsy: A Comprehensive Textbook Ed. J. Engel, Jr., and T.A. Pedley. pp. 427–442. Philadelphia: Lippincott–Raven. Avoli, M., Gloor, P., Kostopoulos, G., and Naquet, R. (Eds.) 1990. Generalized Epilepsy. Boston: Birkhäusen. Begley, C.E., Famulari, M., Annegers, J.F., Lairson, D.R., Reynolds, T.F., Coan, S., Dubinsky, S., et al. 2000. The cost of epilepsy in the United States: An estimate from population-based clinical and survey data. Epilepsia 41: 342–351. Berkovic, S.F., Arzimanoglou, A., Kuzniecky, R., Harvey, A.S., Palmini, A., and Andermann, F. 2003. Hypothalamic hamartoma and seizures: A treatable epileptic encephalopathy. Epilepsia 44: 969–973. Bragin, A., Engel, J. Jr., Wilson, C.L., Fried, I., and Mathern, G.W. 1999. Hippocampal and entorhinal cortex high frequency oscillations (100–500 Hz) in kainic acid-treated rats with chronic seizures and human epileptic brain. Epilepsia 40: 127–137. Chugani, D.C., Chugani, H.T., Muzik, O., Shah, J.R., Shah, A.K., Canady, A., Mangner, T.J., et al. 1998. Imaging epileptogenic tubers in children with tuberous sclerosis complex using alpha-[11C]methyl-L-tryptophan positron emission tomography. Ann Neurol 44: 858–866. Commission on Classification and Terminology of the International League Against Epilepsy. 1981. Proposal for revised clinical and
14
Chapter 1/What Should Be Modeled?
electroencephalographic classification of epileptic seizures. Epilepsia 22: 489–501. Commission on Classification and Terminology of the International League Against Epilepsy. 1989. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30: 389–399. Engel, J. Jr. 1992. Experimental animal models of epilepsy: Classification and relevance to human epileptic phenomena. Epilepsy Res (Suppl 8): 9–20. Engel, J. Jr. 1998. Research on the human brain in an epilepsy surgery setting. Epilepsy Res 32: 1–11. Engel, J. Jr. 2001. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: Report of the ILAE Task Force on Classification and Terminology. Epilepsia 42: 796–803. Engel, J. Jr., Bandler, R., Griffith, N.C., and Caldecott-Hazard, S. 1991. Neurobiological evidence for epilepsy-induced interictal disturbances. In Advances in Neurology, vol. 55 Ed. D. Smith, D. Treiman, and M. Trimble. pp. 97–111. New York: Raven Press. Engel, J. Jr., and Bertram, E.H. 2004. The search for pharmacological and non-pharmacological targets for curing epilepsy. Epilepsy Res 60: 125–131. Engel, J. Jr., and Pedley, T.A. (Eds.) 1997. Epilepsy: A Comprehensive Textbook, vol 1, 2, and 3. Philadelphia: Lippincott–Raven. Engel, J. Jr., Schwartzkroin, P.A., Moshé, S.L., and Lowenstein, D.H. (Eds.) 2001. Brain Plasticity and Epilepsy: A Tribute to Frank Morrell. San Diego: Academic Press. Fisher, R.S., van Emde Boas, W., Blume, W., Elger, C., Genton, P., Lee, P., and Engel, J. Jr. 2005. Epileptic seizures and epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 46: 470–472. Henry, T.R., Duncan, J.S., and Berkovic, S.F. (Eds.) 2000. Functional Imaging in the Epilepsies. Philadelphia: Lippincott Williams & Wilkins. Lehnertz, K., and Litt, B. (Eds.) 2005. The First International Collaborative Workshop on Seizure Prediction. Clin Neurophysiol 116: 493–505.
Levy, R.H., Mattson, R.H., Meldrum, B.S., and Perucca, E. (Eds.) 2002. Antiepileptic Drugs, 5th ed. Philadelphia: Lippincott Williams & Wilkins. Loescher, W. 2002. Animal models of epilepsy for the development of antiepielptogenic and disease-modifying drugs: A comparison of the pharmacology of kindling and post status epilepticus models of temporal lobe epilepsy. Epilepsy Res 50: 105–123. Murray, C.J.L., and Lopez, A.D. (Eds.) 1994. Global Comparative Assessment in the Health Sector; Disease Burden, Expenditures, and Intervention Packages. Geneva: World Health Organization. Noebels, J.L. 2003. The biology of epilepsy genes. Ann Rev Neurosci 26: 599–625. Purpura, D.P., Penry, J.K., Tower, D.B., Woodbury, D.M., and Walter R.D. (Eds.) 1972. Experimental Models of Epilepsy—A Manual for the Laboratory Worker. New York: Raven Press. Racine, R.J. 1972. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 32: 281–294. Schachter, S.C., and Wheless, J.W. (Guest Eds.) 2002. Vagus nerve stimulation therapy 5 years after approval: A comprehensive update. Neurology 59(Suppl 4): S1–S61. Schwartzkroin, P.A. (Ed.) 1993. Epilepsy: Models, Mechanisms and Concepts. Cambridge, UK: Cambridge University Press. Schwartzkroin, P.A., Moshe, S.L., Noebels, J.L., and Swann, J.W. (Eds.) 1995. Brain Development and Epilepsy. New York: Oxford University Press. Schwartzkroin, P.A., and Walsh, C.A. 2000. Cortical malformations and epilepsy. Ment Retard Dev Disabilities Res Rev 6: 268–280. Stafstrom, C.E., and Rho, J.M. (Eds.) 2004. Epilepsy and the Ketogenic Diet. Totowa, NJ: Humana Press. Sutula, T., and Pitkänen, A. (Eds.) 2002. Do Seizures Damage the Brain? Progress in Brain Research, vol 135. Amsterdam: Elsevier. Wieser, H.-G. 2004. Mesial temporal lobe epilepsy with hippocampal sclerosis: Report of the Commission on Neurosurgery. Epilepsia 45: 695–714.
C
H
A
P
T
E
R
2 Single Nerve Cells Acutely Dissociated from Animal and Human Brains for Studies of Epilepsy MARK STEWART, WEI-PING CHEN, AND ROBERT K. S. WONG
generation and patterning. One of the most significant advantages of the acutely dissociated cell preparation is that different stages of neuron development or different pathological conditions can be studied by harvesting cells from animals of different ages or from brains with existing pathology. This procedure can be carried out not only on animal models of interest but also on tissues obtained from human surgery (e.g., resections for medically refractory epilepsy). Important technical advantages of the preparation make possible some approaches to studying electrogenesis that are difficult or impossible with other preparations. First, acutely dissociated cells have reduced dendritic appendages, and as such they are more suitable for voltage clamp studies because space clamping is considerably improved. Second, ionic currents are more amenable to pharmacologic isolation. Thus it is possible to study the currents underlying action potential and firing-pattern generation, as contributed by both the soma and proximal dendrites. Studies of ionic currents in acutely dissociated cells have been used to define stereotypical and distinct firing patterns from different populations of acutely dissociated primary cells (e.g., hippocampal CA3 and CA1 and subicular pyramidal cells) as well as the features of other cell populations (e.g., subtypes of interneurons in CA1 (Fan and Wong, 1996). Similar studies have been used to compare developmental changes in firing properties and to contrast “normal” and “abnormal” cells from the same region.
GENERAL DESCRIPTION OF THE MODEL The study of the basic mechanisms of epilepsy has benefited from the use of many different in vitro experimental preparations, including the intact whole-brain model and progressively more “reduced” preparations, such as brain slices, acutely dissociated neurons, neuron fragments (e.g., dendritic fragments), and single-channel patch preparations. The acutely dissociated neuron remains sufficiently intact to generate many kinds of cellular activity, including action potentials, voltagegated currents, and currents associated with activation of specific receptor-transmitter systems. The acutely dissociated neuron preparation is particularly well suited for some types of investigations involving intrinsic properties of neurons; in addition, it has several advantages when recordings from dissociated cells are compared with recordings from single neurons embedded within intact brains or brain slices or with recordings from single neurons in culture. In this chapter we discuss the usefulness of the acutely dissociated cell preparation for the study of epilepsy and offer our own procedures for preparing and studying isolated neurons.
Advantages of the Acutely Dissociated Cell Preparation A critical feature of the acutely dissociated cell is that action potential electrogenesis is preserved. The action potential is not only a sensitive indicator of channel activity, but it is also the output mechanism of the neuron. Most studies of the acutely dissociated cell aim toward understanding the roles of ion channels in action potential
Models of Seizures and Epilepsy
Disadvantages of the Acutely Dissociated Cell Preparation There are obvious disadvantages to studying the acutely dissociated cell. It has been literally torn from the brain
15
Copyright © 2006, Elsevier Inc. All rights of reproduction in any form reserved.
16
Chapter 2/Acutely Dissociated Cell Preparation
during the isolation process. Perhaps surprisingly the main disadvantage is not poor cell condition. Indeed acutely dissociated cells routinely remain viable during recordings for tens of minutes to hours. The main disadvantage is that the partial preservation of the cell produces a distorted view of the intact cell’s properties. For example, complex firing properties that depend on distributed conductances along the somatodendritic axis are no longer available for analysis. In this context, however, we note that different firing patterns for the soma and dendrites of CA1 pyramidal cells in guinea pig brain slices have been demonstrated (Wong and Stewart, 1992). Another important disadvantage is the absence of synaptic connectivity, a feature that disallows analysis of cell-to-cell interactions. This feature of the acutely dissociated cell preparation does preclude using this system to model epileptiform activity per se; that is, it is not possible for an isolated, acutely dissociated cell to generate seizurelike discharge. However, as discussed later, this limitation does not mean that dissociated cells are unsuitable for epilepsy research. On the contrary, we believe that the preparation offers important advantages (see later) that, when used in combination with other animal models (or human tissue), provide powerful insights into epilepsy-related mechanisms.
Overview To illustrate the usefulness of the acutely dissociated cell preparation for the study of epilepsy, we offer a number of examples of how this preparation has been or can be used. In the following sections we describe (1) our method for preparing acutely dissociated cells, (2) studies of intrinsic membrane properties, and (3) studies of receptor properties of acutely dissociated cells. The examples we highlight here are by no means a complete review of the studies that have used acutely dissociated cells to elucidate the basic mechanisms of epilepsy. Our examples are meant to demonstrate the range of applications of the acutely dissociated cell preparation for epilepsy research.
METHODS OF GENERATION Animal Issues Acutely dissociated cells from many different animal species have been studied. Cells from all the most common animal models (e.g., rat, mouse, guinea pig), and even humans (surgical resections) have been studied. In fact the acutely dissociated cell preparation is particularly appropriate for studies of human tissue that has been removed during a surgical biopsy or resection where individual tissue samples can be quite small. An important aspect of the acutely dissociated cell preparation is that cells can be harvested from animals of any age
(Mody et al., 1989; Oh et al., 1995; Thompson and Wong, 1991) or from animals that are at different stages in a disease process, for example, at some particular time after a convulsive treatment. This feature of the preparation gives the investigator the ability to study neuronal maturation processes or to contrast “normal” and “abnormal” cell function as part of a disease process.
Dissociation There are many variations on the isolation protocol. Indeed we have varied our own protocol at times (Chen et al., 1998; Fan et al., 1994; Kay and Wong, 1986). We describe our current protocol in this chapter and provide references for many other variations in the bibliography. Sprague-Dawley rats (of essentially any age; we have been using animals that are 21 to 35 days old) are deeply anesthetized with 2-bromo-2-chloro-1,1,-trifluoethane (halothane) and decapitated. The brain is quickly removed from the skull by first cutting the scalp along the dorsal surface of the head and then splitting the skull and carefully removing bone and dura mater from over the dorsal surface of the brain. A small spatula is used to lift the brain from the skull as it cuts through the cranial nerves. The whole brain is placed in ice-cold artificial cerebrospinal fluid (ACSF) containing (in millimolars [mM]) 124 NaCl, 26 NaHCO3, 3 KCl, 2 CaCl2, 2 MgCl2, and 10 glucose, which is bubbled with 95% O2/5% CO2 to maintain a pH of 7.4. Blocks of tissue (several millimeters thick) are cut from the regions of interest (e.g., ventral hippocampal regions cut in the horizontal plane) from each hemisphere. These blocks are sectioned using a motorized sectioning system to make brain slices. Slices are cut at 400 to 500 mm (slightly thicker than slices used for electrophysiologic studies in a slice chamber) using a Vibratome sectioning system (Pelco, Redding, CA) and transferred to ACSF solution at room temperature. Each slice is dissected to isolate a particular brain region (e.g., CA3 or subiculum). The resulting pieces of tissue are approximately 1 mm square and the thickness of the slice. Microdissection of brain slices is a useful way to refine the isolation of a specific brain region and cell population. Microdissection of slices is relatively straightforward in hippocampal-limbic system slices because the boundaries for many subregions are clearly visible using a dissecting microscope. At least one (sometimes more) enzyme treatment is used to facilitate cell dissociation. The specific enzyme, its concentration, and the duration of exposure vary considerably among the investigators using these techniques (Oyama et al., 1990). Our current enzyme protocol for acutely dissociating cells starts as we first transfer tissue pieces (<1 mm3) to a small chamber containing a piperazine diethanesulfonic acid (PIPES) dissociation solution (in mM) as follows: 120 NaCl, 5 KCl, 1 CaCl2, 1 MgCl2, 20 PIPES, 25 glucose, and
Methods of Generation
1 mg/ml protease type XIV (pH 7.0 with NaOH) at a temperature of 31° C, where the tissue remains for 30 to 40 minutes. After enzymatic treatment, the tissue is washed three times with enzyme-free PIPES solution, and pieces remain in this solution until they are ready for dissociation. For the final step, a single piece of the enzyme-treated tissue is triturated by passing it through progressively smaller tip sizes of fire-polished pipettes (approximately, 0.8-, 0.4-, 0.2mm tip diameters). The dissociated neurons are placed in an uncoated 35-mm petri dish (Corning, NY) containing ACSF solution bubbled with 95% O2 / 5% CO2. Cells are allowed to settle for 3 to 5 minutes by stopping the gas supply to the dish. Cellular debris can be reduced by gently replacing ACSF and allowing the cells to resettle in the petri dish. The petri dish is moved to the microscope stage for cell selection and recording.
Characterization of Intrinsic Neuronal Behavior The acutely dissociated cell is an intermediate preparation—between single cells from neurons in situ (brain slice, whole brain, or tissue culture) and subcellular preparations (all forms of frank patch recording: inside-out, outside-out, etc.). Enough of the cell remains intact to permit the investigator to study macroscopic (whole-cell) current behavior, including action potential generation. Also the isolated cell soma maintains many of its signaling cascades. Action potential discharge properties are studied using current clamp techniques. Voltage-clamping methods can be used to study currents and take advantage of the dissociated cell’s relatively compact electrical structure (for effective space clamping). Pharmacologic isolation of currents is particularly effective in this preparation because the cell’s membrane is entirely exposed to the extracellular environment. Because there are no synaptic connections in this preparation, dissociated cell studies focus on intrinsic cellular properties. Although the absence of synaptic connections can be seen as a limitation of the preparation, the relative ease of characterizing intrinsic cell properties in the complete absence of synaptic activity may also be viewed as a significant advantage of this preparation. The most commonly used recording methods (we will not discuss any of these in detail here) employ low-resistance pipettes for whole-cell recording techniques (various configurations: whole-cell mode, perforated patch mode, cell-attached patch mode). The selection of recording configuration and pipette solution depend on the specific goals of the study. The ionic composition of the lowresistance pipettes can itself be a significant variable in such studies because ingredients of the pipette solution can block some channels or substantially alter the kinetic properties of these channels. For example, Kay and colleagues (1986) showed that intracellular fluoride (com-
17
monly used in patch pipettes) accelerated the inactivation kinetics of the L-type calcium current in hippocampal neurons. Thus, as in all studies of current kinetics, such studies on dissociated cells must be interpreted with attention to these details. In general, to assess the firing properties of neurons, the pipette solution should be “physiologic.” Alternatively the investigator chooses a recording configuration (such as perforated patch (Kanemoto et al., 2002)) that will minimally alter the intracellular contents of a cell. To study particular currents, one can also choose pipette solutions that will be helpful in isolating currents of interest (e.g., QX-314 to block sodium channels or cesium ions to block potassium channels). Any study of how a particular cellular “pathology” (such as pacemaker bursting) or a genetic mutation of ionic channels (channelopathy) contributes to epileptogenic mechanisms requires an understanding of the baseline characteristics of intrinsic currents of the neuron. Such measurements can be made on cells from “normal” and “experimental” tissue to compare cells on properties of interest. The following is a general plan for characterizing the acutely dissociated cell: 1. Determine the basic properties of a cell type by recording the cell’s behavior in current-clamp mode to define the action potential firing capabilities and patterns of the neurons. This behavior can be compared with the firing patterns of comparable cells in slices or in “intact” preparations. What discharge features characterize the dissociated cell? Injected current (steady direct current or brief pulses) can be used as the stimulus to evoke action potential firing. The action potentials (burst versus single spike after potentials) and the firing patterns (e.g., burst conversion to single spikes and spike frequency as a function of stimulus amplitude) are sensitive indicators of channel function. 2. Make a qualitative assessment of currents that are activated in response to hyperpolarizing or depolarizing stimuli. Determine the channels that are involved in suprathreshold activity (e.g., burst firing versus regular spiking, firing rates) and subthreshold changes (e.g., membrane oscillations) by testing the effects of specific channel blockers (one at a time). 3. Make a quantitative assessment of currents by using voltage-clamp techniques in the presence of drugs that will block all channels except the one you wish to study. Given the ease of obtaining an accurate image of the cell itself, it will be possible to relate the sizes of currents (from a well space-clamped cell) to the actual size of the neuron. It will also be possible to relate the sizes of different currents (recorded separately) to one another. Such quantitative details will allow the investigator to draw specific inferences about channel distribution and channel density.
18
Chapter 2/Acutely Dissociated Cell Preparation
4. Finally, use the computer to reconstruct the neuron (electrically) using the quantitative data you have collected on ionic currents. Will the computer “predict” the suprathreshold and subthreshold properties you have recorded from your acutely dissociated cells? Obviously, data on as many ionic currents as possible are likely to result in “better” computer simulations. However, even relatively simple computer models can help to identify “critical” currents for particular kinds of suprathreshold and subthreshold behavior. From a practical standpoint, experimental emphasis on a small subset of these guidelines (e.g., studies of a single current) can be used to compare cells from animals of different ages or to compare cells from normal animals with cells from a disease model (e.g., following kainic acid treatment or kindling). In studies of neurons removed from human patients (tissue resection as part of a surgical treatment), it is difficult to establish the suprathreshold and subthreshold parameters for “normal” cells. As such, conclusions about disease-related features of human cells are risky.
used to apply drug to a regionally restricted portion of a single cell while comparing properties of somatic and dendritic compartments (Huguenard et al., 1989). A final interesting example is the “concentration-jump” technique (Akaike et al., 1989), which employs rapid flow changes in tubing to create a “push” or “pull” of drug from the tubing. In general, because functional transmitter receptors are present on the acutely dissociated cell, studies of receptor function can be carried out that exploit the flexibility of the preparation for drug application.
STUDIES OF IONIC CURRENTS In the previous section we discussed some of the techniques used to study acutely dissociated cells. In the next two sections we describe some of the experiments that have employed the acutely dissociated cell approach specifically for epilepsy research. These examples are meant to illustrate the preparation “in action” and to suggest other possible applications.
Endogenous Bursting and Pacemaker Cells Characterization of Receptor Properties As much as the acutely dissociated cell cannot, by definition, be used as a model to study seizures per se (abnormal neuronal synchronization—involving multiple neurons—is an essential component of the definition of a seizure), the preparation can be used to study abnormalities in cellular properties that contribute to seizure generation. Indeed the investigator is not completely limited to the study of voltage- and calcium-dependent currents. It is also possible to study receptor properties in the dissociated cell preparation. Here again, the dissociated cell has some important advantages as an experimental preparation. First, drugs can be applied to a recorded cell using any of a variety of methods; pressure ejection, iontophoresis, and bath application are all appropriate methods. The special advantage of the dissociated cell preparation is that a drug delivery device can be placed anywhere in relation to the recorded cell and can be moved within the recording chamber without substantially disturbing the recording. This feature permits the rapid application not only of single drugs but also of multiple drugs to a given cell. As one example, g-aminobutyric acid (GABA) receptor rundown has been studied in acutely dissociated hippocampal neurons by pressure application of GABA (Stelzer et al., 1988). As another example, the effect of N-methyl-d-aspartate (NMDA) receptor activation on GABA-receptor-mediated currents was studied with a piezo-electric switching device that allows the experimenter to change pipette solutions rapidly (Chen and Wong, 1995). A pair of pipettes, both streaming solutions (one drug-containing and one control solution), has been
We propose that a basic definition for a seizure generator is a brain region containing “pacemaker” neurons and connectivity to cause synchrony (Miles and Wong, 1983; Wong et al., 1986). Given such a starting point, the acutely dissociated cell preparation is ideal for the study of pacemaker properties—that is, those intrinsic neuronal properties that lead to a burst firing pattern—of neurons in a generator region. These properties may be observed as properties of normal cells (physiologic pacemakers), such as hippocampal CA3 pyramidal cells (Wong et al., 1986) and subicular pyramidal cells (Harris and Stewart, 2001; Harris et al., 2001; Stewart and Wong, 1993), which have endogenous burst firing properties and recurrent connections. We have compared properties of acutely dissociated CA1 pyramidal cells in hippocampus with subicular pyramidal cells (Figure 1) and found that the acutely dissociated subicular cells generate a pattern of inward currents (when the cells are stimulated with depolarizing current) that is consistent with action potential burst generation. Burst electrogenesis is a complex phenomenon that appears to vary across cell types (even among closely related areas such as CA1, CA3, and subiculum) and is a key determinant of a pacemaker region (Funahashi et al., 1999; Jung et al., 2001; Sah et al., 1988; Staff et al., 2000; Stewart and Wong, 1993; Wong and Prince, 1978; Wong and Stewart, 1992; Wong et al., 1979).
T-Current and Absence Seizures The acutely dissociated cell, with its advantages for voltage-clamp studies of ionic currents, has been useful for
Studies of Receptor Properties
19
FIGURE 1 Examples of acutely dissociated cells and their electrophysiologic discharge patterns. Top row shows images of pyramidal neurons from rat subiculum (left) and hippocampal CA1 (right). Below the cell images are examples of current-clamp responses to small hyperpolarizing and depolarizing current pulses to illustrate differences in the intrinsic firing properties of these cells. Note that the subicular cell (left) discharge consists of an initially complex action potential, which is composed of prominent sodium- and calcium-dependent components (pharmacologic data to dissect out these currents, using tetrodotoxin and cadmium salts, are not shown). The initial response is followed by simpler action potentials that more closely resemble the action potentials generated by the CA1 cell (right). Size, voltage, and time calibrations are given in the figure.
evaluating the role of the transient, low-threshold (T-type), voltage-gated calcium current in absence seizures (Coulter et al., 1989; Huguenard et al., 1991). “Rebound” bursting in thalamic relay neurons was suppressed by ethosuximide (a drug commonly used to treat absence seizures), and the acutely dissociated cell preparation was used to demonstrate that ethosuximide selectively blocks the T-current in these thalamic cells. A similar study of the T-type calcium current showed that this current is prominent in hippocampal pyramidal cells before postnatal day 30, but it disappears after this age. It is noteworthy that ethosuximide did not appear to affect the Tcurrents in hippocampal CA1 pyramidal cells (Thompson and Wong, 1991), suggesting that different subtypes of Tchannels are present in thalamic versus hippocampal neurons. These studies illustrate how the acutely dissociated cell preparation can be used for the study of specific drug actions.
Other Specific Currents Action potential generation, and more specifically burst electrogenesis, depends on voltage-gated sodium and calcium currents. Accordingly, these currents have been
studied in various animal models of epilepsy and in cells from human patients with epilepsy. Calcium and potassium currents were altered in acutely dissociated neurons from rat dentate gyrus (Mody et al., 1992) and hippocampal CA1 (Vreugdenhil and Wadman, 1992, 1995) after kindling. Changes in calcium currents from neurons of human dentate gyrus (Beck et al., 1999; Nagerl and Mody, 1998), potassium currents from human neocortical neurons (Ruschenschmidt et al., 2004), and sodium currents from human entorhinal (Agrawal et al., 2003; Cummins et al., 1994) and subicular (Vreugdenhil et al., 2004) neurons have all been hypothesized as possibly contributing to seizure generation (or at least characterizing an epileptic brain region). Currents in isolated dendritic segments have also been studied (Kavalali et al., 1997). Thus alterations in dendritic currents during epileptogenesis can be studied in isolation using this dissociated cell fragment preparation.
STUDIES OF RECEPTOR PROPERTIES The hypersynchronized activity that defines a seizure is largely dependent on glutamate receptor activation and is prevented (at least to some extent) by synaptic inhibition.
20
Chapter 2/Acutely Dissociated Cell Preparation
Because many synaptic receptors are well preserved in acutely dissociated cells, the preparation offers the investigator the possibility of studying postsynaptic receptor properties in normal and pathological tissue.
Ionotropic Receptors Many dissociated cell studies have aimed at defining the properties of ionotropic receptor types, such as GABA and NMDA, as well as defining the pharmacologic modulation of receptor-ion channel properties (Chen and Wong, 1995; ffrench-Mullen et al., 1993; Hussy et al., 1997; Numann and Wong, 1984; Oh et al., 1995; Stelzer et al., 1988). An important aspect of these studies has been the comparison of the receptor properties of normal versus abnormal neurons. For example, larger-amplitude NMDA receptor-mediated currents were found in dentate granule cells isolated from kindled rat brains (Kohr et al., 1993) compared with currents in normal control granule cells. As with the experiments specifically to antagonize voltage-gated channels with anticonvulsant drug application, receptor-gated channels have also been studied in the acutely dissociated cell preparation. For example, the sedative and anticonvulsant properties of drugs such as pentobarbital and phenobarbital were examined in acutely dissociated CA1 neurons in studies that contrasted the differential drug actions on calcium currents and GABA receptor–mediated currents (ffrench-Mullen et al., 1993).
Metabotropic Receptors The preservation of an intact cell soma in acutely dissociated cells suggests that many intracellular signaling pathways—for example, involving g-protein–coupled receptors (“metabotropic” receptors)—remain intact. Previously it was thought that such structurally complex receptors would not survive the enzymatic action used for the cell dissociation. However, through careful monitoring of enzymatic concentration and duration of treatment, robust gprotein–coupled receptor activity can be preserved. This development, together with the accessibility of the intracellular space in the acutely dissociated cell, made it possible to characterize intracellular signaling cascades activated by these g-protein—coupled receptors (Penington, 1996; Penington and Kelly, 1990; Penington et al., 1991). However, one prominent metabotropic receptor-mediated current, the M-current, is not seen in acutely dissociated cells. This absence may be explained by the recent finding that these channels are localized near the axon hillock (Devaux et al., 2004). The cholinergic receptors coupled to the M-current may be located on the membrane of acutely dissociated cells, but the coupled potassium channels (KCNQ) required for the M-current appear to be eliminated by the dissociation process.
Currents recorded as a consequence of receptor activation in the acutely dissociated cell preparation (as well as other preparations that employ “bulk” drug application) will necessarily include an unknown combination of synaptic and extrasynaptic receptor-mediated channel activation. To study synaptically mediated channel activation specifically, it is possible to include vesicle-containing boutons with the isolation of neuronal somata during the dissociation process (Drewe et al., 1988). The dissociation process is similar to the one described in this chapter but with critical differences in the concentrations of calcium (0 to 0.2 mM) and magnesium (5 mM) salts used during the isolation and incubation steps. This procedure permits the observation of miniature synaptic currents in a preparation that is well suited for highresolution voltage-clamp recordings.
STUDY OF GENETIC MODELS The genetically altered animal is an increasingly useful tool for the neuroscientist. Channels, pumps, or signaling cascades that determine channel behavior can be studied in acutely dissociated cells to determine the consequences of genetic manipulations at the level of simple cell properties. The acutely dissociated cell preparation can be useful for testing the physiologic consequences of altered channels in genetically engineered animals or in search of altered channel behavior as a possible basis for the seizures in a diseased animal or human. Specific channelopathies have been associated with some seizure disorders such as severe myoclonic epilepsy of infancy (Rhodes et al., 2004; Sugawara et al., 2002; Wallace et al., 2003). As an adjunct to physiologic studies on tissue with potential genetic abnormalities, a potentially useful manipulation is to employ single-cell polymerase chain reaction (PCR) techniques to amplify and identify specific genetic material (or its absence or modification in the case of knockout or transgenic animals). This process for identifying a cell’s genetic makeup is facilitated in the acutely dissociated cell preparation. With the dissociated cell preparation, one is spared the task of aspirating the contents of a cell (the required procedure when single-cell PCR is applied to neurons, e.g., in slices) because the whole cell can be processed directly and with minimal risk of contamination from other cells.
CONCLUSION This chapter highlights some examples of how the acutely dissociated cell preparation can be useful for studying the properties of neurons (or, in theory, even glia) that might contribute to epilepsy (e.g., burst electrogenesis), for studying the changes in cells that could provide the basis for
References
seizure activity, and for testing the effects of drugs that may act to interfere with channels and receptors that participate in epileptiform activity. As the genetic bases for cell physiology are defined, we predict that the acutely dissociated cell soma—with its intact nucleus—will be further developed into a preparation that allows the direct correlation of genetic and physiologic studies. Thus the preparation has great utility in elucidating the basic properties that may be involved in seizure-related cellular behavior. Because dissociated cells cannot in themselves generate seizure-like “models,” the dissociated cell approach is most powerful when applied in combination with studies of animal models or human epileptic tissue.
References Agrawal, N., Alonso, A., and Ragsdale, D.S. 2003. Increased persistent sodium currents in rat entorhinal cortex layer V neurons in a post-status epilepticus model of temporal lobe epilepsy. Epilepsia 44(12): 1601–1604. Akaike, N., Kostyuk, P.G., and Osipchuk, Y.V. 1989. Dihydropyridinesensitive low-threshold calcium channels in isolated rat hypothalamic neurones. J Physiol 412: 181–195. Beck, H., Steffens, R., Heinemann, U., and Elger, C.E. 1999. Ca(2+)dependent inactivation of high-threshold Ca(2+) currents in hippocampal granule cells of patients with chronic temporal lobe epilepsy. J Neurophysiol 82(2): 946–954. Chen, Q.X., Perkins, K.L., and Wong, R.K. 1998. Zn2+ blocks the NMDAand Ca2+-triggered postexposure current ipe in hippocampal pyramidal cells. J Neurophysiol 79(2): 1124–1126. Chen, Q.X., and Wong, R.K. 1995. Suppression of GABAA receptor responses by NMDA application in hippocampal neurones acutely isolated from the adult guinea-pig. J Physiol 482 (Pt 2): 353–362. Coulter, D.A., Huguenard, J.R., and Prince, D.A. 1989. Characterization of ethosuximide reduction of low-threshold calcium current in thalamic neurons. Ann Neurol 25(6): 582–593. Cummins, T.R., Xia, Y., and Haddad, G.G. 1994. Functional properties of rat and human neocortical voltage-sensitive sodium currents. J Neurophysiol 71(3): 1052–1064. Devaux, J.J., Kleopa, K.A., Cooper, E.C., and Scherer, S.S. 2004. KCNQ2 is a nodal K+ channel. J Neurosci 24(5): 1236–1244. Drewe, J.A., Childs, G.V., and Kunze, D.L. 1988. Synaptic transmission between dissociated adult mammalian neurons and attached synaptic boutons. Science 241(4874): 1810–1813. Fan, S., Stewart, M., and Wong, R.K. 1994. Differences in voltagedependent sodium currents exhibited by superficial and deep layer neurons of guinea pig entorhinal cortex. J Neurophysiol 71(5): 1986–1991. Fan, S.H., and Wong, R.K. 1996. Selective expression of transient outward currents in different types of acutely isolated hippocampal interneurons. J Neurophysiol 76(5): 3563–3567. ffrench-Mullen, J.M., Barker, J.L., and Rogawski, M.A. 1993. Calcium current block by (-)-pentobarbital, phenobarbital, and CHEB but not (+)-pentobarbital in acutely isolated hippocampal CA1 neurons: comparison with effects on GABA-activated Cl- current. J Neurosci 13(8): 3211–3221. Funahashi, M., Harris, E., and Stewart, M. 1999. Re-entrant activity in a presubiculum-subiculum circuit generates epileptiform activity in vitro. Brain Res 849(1-2): 139–146. Harris, E., and Stewart, M. 2001. Intrinsic connectivity of the rat subiculum: II. Properties of synchronous spontaneous activity and a demonstration of multiple generator regions. J Comp Neurol 435(4): 506–518.
21
Harris, E., Witter, M.P., Weinstein, G., and Stewart, M. 2001. Intrinsic connectivity of the rat subiculum: I. Dendritic morphology and patterns of axonal arborization by pyramidal neurons. J Comp Neurol 435(4): 490–505. Huguenard, J.R., Coulter, D.A., and D. A. Prince, D.A. 1991. A fast transient potassium current in thalamic relay neurons: kinetics of activation and inactivation. J Neurophysiol 66(4): 1304–1315. Huguenard, J.R., Hamill, O.P., and Prince, D.A. 1989. Sodium channels in dendrites of rat cortical pyramidal neurons. Proc Natl Acad Sci U S A 86(7): 2473–2477. Hussy, N., Deleuze, C., Pantaloni, A., Desarmenien, M.G., and Moos, F. 1997. Agonist action of taurine on glycine receptors in rat supraoptic magnocellular neurones: possible role in osmoregulation. J Physiol 502 (Pt 3): 609–621. Jung, H.Y., Staff, N.P., and Spruston, N. 2001. Action potential bursting in subicular pyramidal neurons is driven by a calcium tail current. J Neurosci 21(10): 3312–3321. Kanemoto, Y., Ishibashi, H., Doi, A., Akaike, N., and Ito, Y. 2002. An electrophysiological study of muscarinic and nicotinic receptors of rat paratracheal ganglion neurons and their inhibition by Z-338. Br J Pharmacol 135(6): 1403–1414. Kavalali, E.T., Zhuo, M., Bito, H., and Tsien, R.W. 1997. Dendritic Ca2+ channels characterized by recordings from isolated hippocampal dendritic segments. Neuron 18(4): 651–663. Kay, A.R., Miles, R., and Wong, R.K. 1986. Intracellular fluoride alters the kinetic properties of calcium currents facilitating the investigation of synaptic events in hippocampal neurons. J Neurosci 6(10): 2915–2920. Kay, A.R., and Wong, R.K. 1986. Isolation of neurons suitable for patchclamping from adult mammalian central nervous systems. J Neurosci Methods 16(3): 227–238. Kohr, G., De Koninck, Y., and Mody, I. 1993. Properties of NMDA receptor channels in neurons acutely isolated from epileptic (kindled) rats. J Neurosci 13(8): 3612–3627. Miles, R., and Wong, R.K. 1983. Single neurones can initiate synchronized population discharge in the hippocampus. Nature 306(5941): 371–373. Mody, I., Kohr, G., Otis, T.S., and Staley, K.J. 1992. The electrophysiology of dentate gyrus granule cells in whole-cell recordings. Epilepsy Res Suppl 7: 159–168. Mody, I., Salter, M.W., and MacDonald, J.F. 1989. Whole-cell voltageclamp recordings in granule cells acutely isolated from hippocampal slices of adult or aged rats. Neurosci Lett 96(1): 70–75. Nagerl, U.V., and Mody, I. 1998. Calcium-dependent inactivation of highthreshold calcium currents in human dentate gyrus granule cells. J Physiol 509(Pt 1): 39–45. Numann, R.E., and Wong, R.K. 1984. Voltage-clamp study on GABA response desensitization in single pyramidal cells dissociated from the hippocampus of adult guinea pigs. Neurosci Lett 47(3): 289–294. Oh, K.S., Lee, C.J., Gibbs, J.W., and Coulter, D.A. 1995. Postnatal development of GABAA receptor function in somatosensory thalamus and cortex: whole-cell voltage-clamp recordings in acutely isolated rat neurons. J Neurosci 15(2): 1341–1351. Oyama, Y., Hori, N., Allen, C.N., and Carpenter, D.O. 1990. Influences of trypsin and collagenase on acetylcholine responses of physically isolated single neurons of Aplysia californica. Cell Mol Neurobiol 10(2): 193–205. Penington, N.J. 1996. Actions of methoxylated amphetamine hallucinogens on serotonergic neurons of the brain. Prog Neuropsychopharmacol Biol Psychiatry 20(6): 951–965. Penington, N.J., and Kelly, J.S. 1990. Serotonin receptor activation reduces calcium current in an acutely dissociated adult central neuron. Neuron 4(5): 751–758. Penington, N.J., Kelly, J.S., and Fox, A.P. 1991. A study of the mechanism of Ca2+ current inhibition produced by serotonin in rat dorsal raphe neurons. J Neurosci 11(11): 3594–3609.
22
Chapter 2/Acutely Dissociated Cell Preparation
Rhodes, T.H., Lossin, C., Vanoye, C.G., Wang, D.W., and George A.L. Jr. 2004. Noninactivating voltage-gated sodium channels in severe myoclonic epilepsy of infancy. Proc Natl Acad Sci U S A 101(30): 11147–11152. Ruschenschmidt, C., Kohling, R., Schwarz, M., Straub, H., Gorji, A., Siep, E., Ebner, A. et al. 2004. Characterization of a fast transient outward current in neocortical neurons from epilepsy patients. J Neurosci Res 75(6): 807–816. Sah, P., Gibb, A.J., and Gage, P.W. 1988. The sodium current underlying action potentials in guinea pig hippocampal CA1 neurons. J Gen Physiol 91(3): 373–398. Staff, N. P., Jung, H.Y., Thiagarajan, T., Yao, M., and Spruston, N. 2000. Resting and active properties of pyramidal neurons in subiculum and CA1 of rat hippocampus. J Neurophysiol 84(5): 2398–2408. Stelzer, A., Kay, A.R., and Wong, R.K. 1988. GABAA-receptor function in hippocampal cells is maintained by phosphorylation factors. Science 241(4863): 339–341. Stewart, M., and Wong, R.K. 1993. Intrinsic properties and evoked responses of guinea pig subicular neurons in vitro. J Neurophysiol 70(1): 232–245. Sugawara, T., Mazaki-Miyazaki, E., Fukushima, K., Shimomura, J., Fujiwara, T., Hamano, S., Inoue, Y. et al. 2002. Frequent mutations of SCN1A in severe myoclonic epilepsy in infancy. Neurology 58(7): 1122–1124. Thompson, S.M., and Wong, R.K. 1991. Development of calcium current subtypes in isolated rat hippocampal pyramidal cells. J Physiol 439: 671–689.
Vreugdenhil, M., Hoogland, G., van Veelen, C.W., and Wadman, W.J. 2004. Persistent sodium current in subicular neurons isolated from patients with temporal lobe epilepsy. Eur J Neurosci 19(10): 2769–2678. Vreugdenhil, M., and W.J. 1992. Enhancement of calcium currents in rat hippocampal CA1 neurons induced by kindling epileptogenesis. Neuroscience 49(2): 373–381. Vreugdenhil, M., and Wadman, W.J. 1995. Potassium currents in isolated CA1 neurons of the rat after kindling epileptogenesis. Neuroscience 66(4): 805–813. Wallace, R.H., Hodgson, B.L., Grinton, B.E., Gardiner, R.M., Robinson, R., V. Rodriguez-Casero, V. et al. 2003. Sodium channel alpha1-subunit mutations in severe myoclonic epilepsy of infancy and infantile spasms. Neurology 61(6): 765–769. Wong, R.K., and Prince, D.A. 1978. Participation of calcium spikes during intrinsic burst firing in hippocampal neurons. Brain Res 159(2): 385–390. Wong, R.K., Prince, D.A., and Basbaum, A.I. 1979. Intradendritic recordings from hippocampal neurons. Proc Natl Acad Sci U S A 76(2): 986–990. Wong, R.K., and Stewart, M. 1992. Different firing patterns generated in dendrites and somata of CA1 pyramidal neurones in guinea-pig hippocampus. J Physiol 457: 675–687. Wong, R.K., Traub, R.D., and Miles, R. 1986. Cellular basis of neuronal synchrony in epilepsy. Adv Neurol 44: 583–592.
C
H
A
P
T
E
R
3 Cell Culture Models for Studying Epilepsy MARC A. DICHTER AND JOHN POLLARD
In the early 1970s, it became clear to a number of investigators that to begin to understand neurobiology at a cellular and ultimately molecular level, in vitro preparations of mammalian CNS were needed. Almost simultaneously a small number of investigators began to grow and maintain embryonic mammalian CNS in dissociated cell cultures (Dichter, 1975, 1978; Fischbach and Dichter, 1974) while others learned how to maintain viable sections of more mature CNS in slice chambers (Schwartzkroin, 1975; Schwartzkroin and Prince, 1976, 1977; Schwartzkroin and Wester, 1975). These discoveries led to a virtual explosion of new information about the physiology and pharmacology of mammalian CNS and, in parallel, a great expansion of our knowledge of epilepsy mechanisms and the mechanisms of action of antiepileptic drugs. Thus it is impossible to separate “pure epilepsy research” using cell culture models from basic “neurobiological research” that led to major insights into epilepsy mechanisms. For example, once the physiology of glutamate-mediated excitatory synaptic function was analyzed in cell cultures, and AMPA and N-methyld-aspartate (NMDA) receptors were identified, our understanding of the role of glutamate receptor-mediated events in seizures could develop. Similarly, once GABA and its receptors were identified and characterized in cell cultures, it was possible to understand the role of GABAmediated inhibition in epileptiform events as well as the mechanisms of action of several of our most important antiepileptic drugs. In this chapter, we briefly review techniques for establishing and maintaining dissociated cell cultures of those parts of mammalian CNS that are most relevant to epilepsy studies, referring to primary sources for more detailed methodology. We then discuss the kinds of questions about epilepsy mechanisms and antiepileptic drugs that can best be answered by studies employing this model, and offer
INTRODUCTION AND HISTORICAL REVIEW To understand the role of cell culture models in epilepsy research, one must start at the time cell culture models were first “invented” for the study of mammalian central nervous system (CNS). Much work was performed in the 1960s and early 1970s to investigate the cellular phenomena occurring in the mammalian brain during interictal discharges and seizures (Ayala et al., 1970a, b; Dichter and Spencer, 1969a, b; Matsumoto and Ajmone Marsan, 1964; Matsumoto et al., 1969; Prince, 1968a, b, 1969; Prince and Futamachi, 1968, 1970; Prince and Gutnick, 1971; Prince and Wilder, 1967). This research developed in parallel with neurophysiologic studies of neuronal and synaptic function in general. At that time there was a basic understanding of neuronal physiology, still based on the Hodgkin and Huxley model of the squid giant axon, although even such elementary discoveries as the presence of Ca-dependent action potentials in mammalian neurons had not yet been made. In addition, there was a rudimentary understanding of synaptic physiology and pharmacology. The identities of the inhibitory neurotransmitters were just being discovered, and the identities of the excitatory transmitters were still somewhat a mystery, as was even the basic physiology of excitatory synaptic potentials. Almost nothing was known about the pharmacology of g-aminobutyric acid (GABA) or glutamate receptors. All the epilepsy research until then was performed in intact animals that had been made to exhibit seizures by either chemical or electrical stimulation. Mechanisms underlying the seizures had to be inferred from these in vivo experiments and were based on the then-current understanding of neurophysiology. At the same time, relatively little was known about the mechanisms of action of any of the then-available antiseizure drugs.
Models of Seizures and Epilepsy
23
Copyright © 2006, Elsevier Inc. All rights of reproduction in any form reserved.
24
Chapter 3/Cell Culture Models for Studying Epilepsy
examples from the literature to illustrate how these strategies can produce important information. We focus on how these cell culture models can be used to approach some of the unanswered questions about epilepsy and epileptogenesis. Finally, we discuss limitations of the model.
CELL CULTURE METHODS Species Used Dissociated cell cultures of CNS tissue can be prepared from essentially any mammalian species. Most cultures used to date, however, are derived from rat and mouse embryos or early postnatal animals. Rats and mice are small, abundant, and relatively inexpensive. Animal supply facilities can produce timed pregnant dams so that embryos or pups can be obtained at the appropriate age. Data derived from the cultured tissue can be compared with results from analysis of intact tissue (although questions remain about what constitutes comparable age) because rat and mouse brain slices are also commonly employed as experimental preparations. In addition, there are substantial numbers of studies on intact rat (or mouse) models with seizures or epilepsy with which one can compare both slice and culture in vitro preparations. Because so much of the original in vivo work and culture work developed in rats, this species was the preferred laboratory subject for many years. Later, as research on transgenic mice become widespread, more cell culture work has focused on mouse tissue. It is noteworthy that there is little literature on potential differences between rat and mouse CNS neurons. Comparisons in culture would be extremely useful, given that clear differences between species have been identified in intact systems. Most forms of epilepsy occur in cortex-archicortex or neocortex. As such, studies of cellular mechanisms most relevant to epilepsy or antiepileptic drugs have been performed on cultures developed from embryonic cortex or hippocampus (Banker and Cowan, 1977; Dichter, 1978). Other brain regions can also be studied as dictated by specific research questions. These regions include thalamus, cerebellum, and brainstem. In addition, many studies involving mechanisms of action of antiepileptic drugs (AEDs) have utilized dissociated cultures of spinal cord (Fischbach, 1972; Hosli et al., 1972) or dorsal root ganglion (DRG) (Dichter and Fischbach, 1977); these regions produce large, relatively easily studied neurons with reproducible characteristics (Dichter and Fischbach, 1977).
Specific Culture Methods CNS neurons can be cultured in a variety of formats, depending on the desired experimental paradigm. For most physiologic experiments, neurons are cocultured with glial
cells in a relatively enriched medium (Dichter, 1978). For other experiments neurons can be grown in an almost glialfree environment with carefully controlled and characterized media (Brewer, 1995; Brewer et al., 1993; Evans et al., 1998). Cells can be grown at varying densities, depending on the nature of the experiment to be performed. For example, for routine physiology and pharmacology, neurons are often grown at relatively high density on top of proliferating astrocytes. These neurons are best studied at a density that allows identification of individual cells (soma and dendrites) in a microscopic field filled with many neurons. Under these conditions the neurons are healthy, synapse formation is abundant, and small networks develop (Dichter, 1978). For biochemical experiments, cultures such as these can be grown on the surface of large plates or in flasks. One drawback of the usual “high-density” cultures is that finding pairs of synaptically connected neurons is difficult. In these cultures, all the neurons receive abundant excitatory and inhibitory synaptic inputs, but when one records from pairs of neurons near one another, connections are rarely found. By growing cultures at very low densities, such that only two or three neurons are visible in a microscopic field, coupled pairs are easily found (Wilcox and Dichter, 1994; Wilcox et al., 1994). An extreme example of this arrangement is found when neurons are cultured in isolation, often seeded at very low densities onto astrocytes or microdots of adherent substrate (Segal, 1991; Segal and Furshpan, 1990). Under these conditions, neurons form abundant autapses onto themselves such that each neuron is both presynaptic and postsynaptic to itself. When the neuron is glutamatergic, receptor antagonists must be included in the medium to prevent excitotoxic autostimulation. There are many subtle variations on the main methodologic scheme employed to establish CNS cell cultures. These can best be obtained from either original papers or from texts devoted to CNS cell cultures (Buchhalter and Dichter, 1991; Dichter, 1978; Wilcox et al., 1994). In general, pregnant rats (or mice) are anesthetized, fetuses are removed, and hippocampus or neocortex is dissected (hippocampus at 18 to 21 days of gestational age, neocortex at 15 to 21 days). The brain tissue is dissociated by incubation in trypsin, minced into smaller pieces, and triturated by drawing the tissue back and forth through a pipette tip. Some investigators prefer to avoid enzymes, and dissociate the cells by mechanical methods alone. This latter procedure tends to produce a much larger number of cells, but with a much lower viability. Particulate matter settles out of the mixture; remaining single cells are suspended in media, counted, and plated onto special glass coverslips or plastic tissue culture plates at specific densities. Both the coverslips and plates are coated with an adherent substrate, most often polylysine or polyornithine. Collagen can also be utilized, but neurons grown on collagen have more of a tendency to develop in clumps and remain less dispersed. For routine
Cell Culture Methods
cultures, cells are plated at 400 to 600/mm2 in media containing 5% or 10% serum. A variety of enriched growth media can be employed (Banker, 2002). For very-lowdensity cultures, cells are plated at 100 to 110/mm2 in medium containing high (20 mM) potassium concentration. Cultures remain in CO2 incubators at 37° C until they are used. Figure 1 illustrates sample microscopic fields from hippocampal cultures grown under three conditions: high density (400,000 cells/35-mm plate) with serum; low density (60,000 cells/35-mm plate) with serum and high K; and intermediate density (100,000 cells/35-mm plate) in neurobasal medium without serum. In the phase-contrast images of the top row, one can see astrocytes underlying the neurons at 2 and 3 weeks. These cells are absent or very sparse in the neurobasal cultures. Within hours of plating, most viable cells settle on the substrate, adhere, and begin sending out processes. Even at this early point, some neurons appear pyramidal, some stellate, and some bipolar. Whether these morphologies correspond to what the cells were destined to become in vivo has never been determined. By 3 to 5 days in vitro (DIV), the neurons have clearly differentiated and have developed extensive processes. Depending on the brain region being cultured and the age at which it was dissected, synapses begin to appear at about 4 to 7 DIV and increase in density and complexity for days thereafter. Given the nature of the
25
connectivity in the high density cultures, it is likely that axons extend fairly significant distances before synapses are made. Cultures of this kind can be maintained in a robust state for 4 to 6 weeks or longer. As the cultures age, there appears to be a gradual decline in the number of viable neurons, although those that remain often are quite large and have extensive dendritic trees and abundant spines. When cultures are grown in high density with astrocytes, it is often necessary to use mitotic inhibitors (for example cytosine arabinoside at 10 mM) at about 4 to 7 DIV to prevent overgrowth of glia and loss of neurons. This procedure does not appear to affect the neurons adversely. Highdensity cultures grown in defined media have minimal astrocytes and do not require mitotic inhibition. Despite the lack of astrocytes in low-density cultures, the neurons appear quite normal and form abundant excitatory and inhibitory synapses. When synaptic interactions are to be studied using paired recordings, cultures are often grown at very low density. These cultures are maintained in lower volumes of media containing higher than usual amounts of potassium (e.g., 20 mM) (Mattson and Kater, 1988, 1989). Under these conditions, glial cells grow very slowly and do not overgrow the cultures (Wilcox et al., 1994). The basic properties of these neurons appear similar or identical to those grown at higher density, although this similarity has not been rigorously studied.
FIGURE 1 Three sets of hippocampal dissociated cell cultures: at 1 day (left column), 2 weeks (middle column), and 3 weeks (right column) in vitro. For each field, there is a photomicrograph of the same field (40¥ magnification) in phase contrast (left) and after neuronal staining with antibodies to MAP2 (right). The top row shows cultures grown at high density (400,000 cells/35-mm plate) with serum; the middle row shows cultures grown at low density (60,000 cells/35-mm plate) with serum and high K; the bottom row shows cultures grown at intermediate density (100,000 cells/35-mm plate) in neurobasal medium without serum. In the phase-contrast images of the top and middle row, one can see astrocytes at 2 and 3 weeks. These cells are absent or very sparse in the neurobasal cultures.
26
Chapter 3/Cell Culture Models for Studying Epilepsy
UTILITY OF CNS CELL CULTURES AS A MODEL TO HELP UNDERSTAND THE PATHOPHYSIOLOGY OF EPILEPSY AND THE MECHANISMS OF ACTION OF ANTIEPILEPTIC DRUGS Neuronal and Synaptic Physiology and Pharmacology Ionic Currents Underlying Action Potentials in Cortical Neurons Our understanding of the physiologic basis of the action potential (AP) was derived from pioneering studies of the squid giant axon and other similar preparations. In these cells and axons, APs are generated by the opening of voltage-dependent Na channels followed by a rapid voltagesensitive inactivation. In addition, voltage-dependent K channels open to facilitate repolarization in many neurons. In a few invertebrate neurons, investigators also demonstrated that voltage-dependent Ca currents could sustain APs. Early studies in cell culture demonstrated that some vertebrate, including mammalian, neurons had Cadependent APs as well. These were first demonstrated in chick DRG neurons (Dichter and Fischbach, 1977), a preparation that then became very useful for studying mechanisms by which neuromodulators were able to affect Ca currents (Dunlap and Fischbach, 1978). Voltage-dependent Ca APs were also demonstrated in mammalian cortical neurons, both in slice preparations (Schwartzkroin and Slawsky, 1977) and in culture. Under baseline conditions, these currents were not apparent because of the rapid depolarizationrepolarization sequence initiated by Na and K currents, but when Na currents were inhibited, the cortical neurons developed slower, powerful Ca-dependent APs (Dichter and Zona, 1989; Dichter et al., 1983). Once the Ca APs were identified, it was noted that some groups of neurons in cortex, hippocampus, and thalamus had quite prominent Ca APs and tended to fire bursts of action potentials when depolarized. These neurons appeared capable of acting as “pacemaker” neurons for seizure-like discharges (Wong and Prince, 1978), and hypotheses about the origin of rhythmic discharges in cortex, hippocampus, and thalamocortical circuits were developed based on these findings. Similar observations were made on various K currents that were characterized in cortical and hippocampal neurons, some of which contributed to a neuron’s having a propensity for endogenous bursting. Physiology and Pharmacology of Inhibitory Synapses Earlyin vivo studies demonstrated that inhibitory postsynaptic potentials (IPSPs) were generated by opening Cl channels and were associated with an increase in membrane conductance. GABA had been tentatively identified as the
likely inhibitory neurotransmitter in mammalian forebrain, but glycine was also thought to be significant as a neurotransmitter. Studies in mammalian CNS cell culture demonstrated that GABA was the main, if not exclusive, neurotransmitter responsible for postsynaptic inhibition (Dichter, 1980; White et al., 1980) and that glycine likely played no, or very little, role in forebrain inhibition. These studies also showed that GABAergic inhibition was very labile at most synapses and declined rapidly with repetitive stimulation, mostly as a result of presynaptic factors (Wilcox and Dichter, 1994) (i.e., not due to receptor desensitization or changes in Cl gradient). These discoveries in cell culture led to extensive examinations of the pharmacology of GABAergic synapses, including the elucidation of the mechanisms of action of some of the most important AEDs available. From both biochemical (e.g., receptor binding) studies on processed brain tissue and from studies at the cellular level in cell culture, the GABAA receptor was recognized as a GABA receptor complex (GRC). Studies utilizing cell cultures first described the allosteric modulation of the GRC by benzodiazepines (Choi et al., 1977), a group of drugs used extensively to treat status epilepticus and other forms of seizures but whose mechanism of action had been unknown. Similar studies demonstrated that barbiturates, another class of antiepileptic drug, could allosterically modulate the GRC at a different site (Macdonald and Barker, 1977, 1978; Macdonald and McLean, 1982). Further, unlike the benzodiazepines, barbiturates at high concentrations could directly activate the GRC. Studies of membrane patches removed from cultured neurons also demonstrated how these drugs worked at the single channel level (Macdonald et al., 1988). Other work focused on a number of new AEDs that were developed based on animal models and whose mechanisms of action are unknown. At least one of these drugs, topiramate, appears to work partially by potentiating GABAmediated inhibition as demonstrated in hippocampal cultures (White et al., 1997, 2000). GABA also activates other classes of receptors, most notably GABAB receptors which are found on both somas and axon terminals, and GABAC receptors which are most prominent in retina. Much of what we know of the physiology of GABAB receptors is derived from studies in cell culture. These receptors are G-protein coupled to Ca channels in axon terminals, where they block Ca entry and thereby downregulate neurotransmitter release. They are also G-protein coupled to K channels on somas and dendrites, where they mediate slow and prolonged inhibition (Bowery et al., 1983, 1984, 1989; Bowery et al., 1984). Both these sets of events have important implications for epileptiform mechanisms. For example, it is thought that activation of GABAB-mediated inhibition plays a role in the termination of interictal discharges and possibly in the termination of seizures (Sperk et al., 2004). In addition, increased activation of GABAB receptors is thought to
27
Utility of CNS Cell Cultures
contribute to enhanced bursting in thalamocortical relay neurons and the generation of spike-wave discharges in primary generalized epilepsy (Hosford et al., 1992, 1995). Inhibition of GABA release by activation of GABAB receptors at GABAergic terminals has also been implicated in the reduction of inhibition seen with repetitive activation of inhibitory synapses (Deisz and Prince, 1989). In addition, activation of GABAB receptors is likely to be responsible for the complex effects of two new AEDs that were designed to increase GABA levels at inhibitory synapses: tiagabine (by blocking GABA uptake) and vigabatrin (by blocking GABA metabolism). Both agents are antiseizure drugs effective against partial seizures. However, both can also enhance primary generalized absence seizures and possibly status epilepticus, presumably by allowing released GABA to act on presynaptic GABA terminals and paradoxically decreasing inhibition (Oh and Dichter, 1994) or by enhancing hyperpolarization on thalamocortical neurons and thereby enhancing synchronized spike-wave activity. Physiology and Pharmacology of Excitatory Synapses The physiology of excitatory synapses was much less well understood than even inhibitory synapses before the introduction of neuronal cell cultures. Unlike IPSPs, excitatory PSPs (EPSPs) were often not associated with measurable conductance changes and had unusual current-voltage (I-V) characteristics. The main hypothesis to explain these observations was that EPSPs occurred far out on dendrites and the characteristics that one could measure in the soma were distorted by the cable properties of the neurons. In addition, although glutamate and aspartate were hypothesized to be the excitatory neurotransmitters in the brain, their identities had not been confirmed and the cellular mechanisms by which these acidic amino acids depolarized neurons were not understood. This picture changed relatively rapidly once these properties could be analyzed in vitro. The response of neurons to applied glutamate was characterized (Ransom et al., 1977); the odd I-V curve was attributed to a voltage-dependent block by Mg of a subpopulation of glutamate receptors (Ascher and Nowak, 1988; Ascher et al., 1988); different glutamate receptor subtypes (e.g., AMPA, NMDA, kainate) were identified and characterized (Dingledine et al., 1990; McLennan, 1983; Westbrook, 1994), and the physiology of excitatory synapses was much better understood. Moreover, a virtual “industry” of glutamate pharmacology was born. Each of the advances in our understanding of the mechanisms of excitatory transmission had direct impact on epilepsy research. The nature of the large depolarizing events seen both during interictal discharges and ictal events was characterized within the framework of different glutamate receptor events. The role of NMDA receptors especially was emphasized as an important component of
epileptiform activity, and the autoregenerative nature of NMDA-mediated synaptic events (with depolarization reducing the Mg block of NMDA receptors, which in turn promoted further depolarization by glutamate) became a critical part of the explanation for the all-or-nothing development of some forms of epileptic activity. The characterization of excitatory synaptic transmission was also determined at the single-channel level. AMPA receptors were demonstrated to have very rapid and unusual desensitization properties such that they opened once in response to agonist and then desensitized until agonist was removed (Tang et al., 1989; Trussell et al., 1988). NMDA receptor-coupled channels, however, continued to open and close for as long as glutamate remained present. In addition, it was demonstrated that NMDA receptors were very sensitive to changes in extracellular pH, becoming inhibited at acidic values and enhanced by alkalosis, within pH ranges that were found in the brain during physiologic or pathological stimuli (Tang et al., 1990). Investigators also demonstrated that most AMPA receptors were permeable to only monovalent cations, whereas NMDA receptors were permeable to Ca as well. As the molecular biology of the receptors was further understood, AMPA receptors that lacked a properly edited version of the GluR2 subunit were found to be permeable to Ca. These channels occurred naturally on some inhibitory interneurons (Hollmann et al., 1991) and were proposed as a contributing component of some disease states (Bennett et al., 1996; Pellegrini-Giampietro et al., 1997). Each of these discoveries had great implications for our understanding of epileptic processes and for current theories of epileptogenesis. For example, the use of hyperventilation to stimulate epileptic changes in the electroencephalogram (EEG) may be due to the brief metabolic alkalosis induced by this procedure. In addition, the vulnerability of subsets of inhibitory interneurons to hypoxia may be related to their Ca-permeable AMPA receptors. In addition to the fast depolarization mediated by ionotrophic glutamate receptors, it was also noted that glutamate could produce a slow and long-lasting change in neuronal properties as a result of activation of “metabotropic” glutamate receptors. The discovery and characterization of these receptors also added significantly to our understanding of how epileptiform events could become established and propagate throughout the brain (Ghauri et al., 1996; Lee et al., 2002).
Synaptic Plasticity Most studies of synaptic plasticity in the vertebrate CNS were performed using the preparation of in vitro brain slices, most commonly hippocampal slices. A vast literature on long-term potentiation and long-term depression is derived from these studies. In general, with a few exceptions, such studies rely on pathway stimulation and on single-cell or
28
Chapter 3/Cell Culture Models for Studying Epilepsy
field recordings to infer synaptic mechanisms. Parallel studies in cell cultures have allowed direct investigation of synaptic plasticity using intracellular recordings from both the presynaptic and postsynaptic elements of the synaptic pair. This approach provides more precise control over the relevant synaptic events. However, this preparation also has significant drawbacks for these studies. The cell culture tissue appears to be more immature than the tissue usually studied in slices; the nature of the synaptic interactions may be different from those that develop in the more complex CNS; and it may be very difficult or impossible to activate multiple inputs to the same postsynaptic neuron in culture preparations. In addition, some cellular mechanisms “wash out” during the intracellular dialysis that occurs with wholecell patch-clamp recordings (although this problem is not unique to cell culture preparations). The latter issue is particularly important when considering longer-term changes in synaptic efficacy. Nevertheless, important observations about short-term plasticity have been made utilizing cell culture preparations. In general, when studied with paired recordings, inhibitory synapses almost always decrement when repetitively activated. After even a single action potential, the probability of release of GABA declines for as long as several seconds. With brief trains of action potentials, inhibitory synaptic efficacy may decline by more than 50%, all because of presynaptic factors independent of GABAB autoreceptor feedback (Wilcox and Dichter, 1994). Such decreases in inhibitory efficacy may have profound implications for ictogenesis. Repetitive firing of excitatory principal cells may excite inhibitory interneurons, but the resulting firing of the inhibitory interneurons may become less and less effective in inhibiting principal cells. By contrast, excitatory neurons have different response characteristics to repetitive activation. They also often demonstrate a decrease in release of synaptic transmitter after single action potentials, but this decrease is much more variable than at inhibitory synapses (Kaplan et al., 2003; Wilcox and Dichter, 1994). With trains of high-frequency stimuli, some excitatory synaptic responses potentiate, some appear to remain stable, and some decrement (Kaplan et al., 2003). The net result is that if both excitatory and inhibitory synapses are part of a recurrent circuit, and if they are simultaneously activated repetitively, net inhibition will decline with respect to net excitation and the circuit will become unstable. This developing instability is likely one of the critical mechanisms underlying the development and spread of seizures through the brain.
Single-Cell Molecular Profiling and Physiology One of the most widely employed techniques in molecular biology is expression profiling of various tissues under
various physiologic and pathological conditions. Changes in gene expression, as measured at the mRNA level, are often analyzed to determine how a specific group of cells reacts to a change in physiology. For the complicated CNS, such expression profiling is most informatively performed on single identified neurons (or at least on small groups of identified neurons) to allow an appropriate understanding of how changes in gene expression produce changes in network behavior. Some of the earliest applications of single-cell gene-expression profiling were performed on identified neurons in cell culture (Eberwine et al., 1995). These studies were then extended to neurons identified in live brain slices. Subsequently it was determined that RNA could be relatively faithfully amplified and analyzed even from fixed tissues (Crino et al., 1996). Initial studies focused on molecular differences between identified inhibitory and excitatory neurons. Surprisingly little difference was found in the relative expressions of most channels and receptors. Even more surprising, however, was the finding of relatively large amounts of mRNA for glutamic acid decarboxylase (GAD), the enzyme responsible for the synthesis of the inhibitory neurotransmitter, GABA, in all excitatory neurons in culture (Cao et al., 1996). High levels of GAD mRNA were found, despite the fact that these neurons were not synthesizing GAD protein or GABA. These observations were then extended to more intact CNS tissues, where it was also found that excitatory pyramidal cells, granule cells in hippocampus, and granule cells in cerebellum also contained relatively large amounts of GAD mRNA (Cao et al., 1996). A new hypothesis was proposed, the “standby neurotransmitter hypothesis,” which suggested that under some circumstances normally excitatory neurons could become inhibitory (Cao et al., 1996). Important from the point of view of epilepsy research, it was subsequently demonstrated that just such a “switch” to GABA synthesis could occur during prolonged seizures. Dentate gyrus granule cells, which are normally excitatory, after seizures exhibit dense staining for GAD and GABA all the way out into axon terminals; these cells can produce inhibition on downstream neurons (Sloviter et al., 1996). Subsequent to this demonstration, investigators have shown that the number of GAD-positive neurons in particular brain nuclei varies significantly (and reversibly) under other physiologic circumstances, such as diurnal and estrus cycles. Obviously control of inhibitory elements in critical brain circuits can have a profound effect on excitability and seizure development and spread. The application of single-cell molecular profiling has been extended well beyond the early studies in cell culture. Much work focuses on changes in gene expression in different cells within the hippocampus after status epilepticusinduced epileptogenesis (Brooks-Kayal et al., 1998; Becker et al., 2002; Chen et al., 2001; Crino et al., 2002; Zhang et al., 2004). Changes in receptor numbers and subtypes, and
Utility of CNS Cell Cultures
alterations in ion channels, have been implicated in the development of the hyperexcitable state (Beck et al., 1996; 1997a, b; Bernard et al., 2004; Brooks-Kayal et al., 1998; Coulter, 1999; Reckziegel et al., 1998).
Excitotoxicity The concept of excitotoxicity is so common at present that it is perhaps surprising to recognize that this hypothesis was only developed in the 1970s and 1980s. Although initial observations by Olney and others were based on in vivo work (Coyle et al., 1981; Olney, 1969, 1976; Olney and Ho, 1970; Olney et al., 1974; Rothman and Olney, 1986), much of the subsequent progress in understanding underlying mechanisms proceeded in studies of CNS cell cultures. These developments included the role played by the various glutamate receptor subtypes (Choi, 1993), the cellular mechanisms involved in both the necrotic and apoptotic components of cell death (Choi, 1993), and the effects of drugs on these processes. It would be unrealistic to attempt to summarize all these activities in this chapter, but the reader is referred to a number of excellent recent reviews (Mattson, 2003; Sattler and Tymianski, 2001). This literature makes it clear that excitotoxicity plays in an important role in epileptogenesis and in seizure-induced brain damage.
Mechanisms of Action of Antiepileptic Drugs Cultures of mammalian CNS have played a critical role in our modern understanding of the cellular and molecular mechanisms of antiepileptic drugs. Almost all the currently available AEDs were developed based on animal screening models. The mechanisms of action of these drugs were completely unknown when the drugs were introduced, and to some extent these mechanisms remain unknown for several important “old” and “new” AEDs. However, we have a sophisticated understanding of the mechanisms by which many of our currently used AEDs work. Sodium Channel Blockers Several very potent AEDs have as a primary mechanism of action the ability to block voltage-dependent Na channels in a voltage- or use-dependent fashion. Using preparations of mammalian spinal cord or cortical cell cultures, several groups demonstrated that phenytoin, carbamazepine, lamotrigine, and zonisamide could block sustained repetitive firing (SRS) in neurons as induced by prolonged depolarizing current pulses (Macdonald and McLean, 1982; Macdonald et al., 1985). Early action potentials in the train were generally minimally affected, but as the neurons remained depolarized, the drugs were able increasingly to block more and more channels. Subsequent voltage-clamp experiments demonstrated the voltage-dependent nature of the block.
29
GABA Receptor Complex Allosteric Modulators Several of our more commonly employed AEDs work as allosteric modulators of the GABA receptor complex (GRC), mechanisms first elucidated by studies of cell cultures. Benzodiazepines enhance the affinity of GABA at the receptor and allow enhanced channel openings (Macdonald et al., 1986); barbiturates prolong channel openings and can produce channel openings even in the absence of GABA (Macdonald et al., 1988). Topirimate also appears to enhance GABA-mediated inhibition (White et al., 1997, 2000). GABA Uptake Inhibitors Tiagabine was developed as an inhibitor of GABA uptake. It was hypothesized that such inhibition would result in more GABA extracellularly, and thus there would be enhanced inhibition. Studies in cell culture have produced evidence that this assumption may reflect an oversimplification of the processes involved. In the cell culture system, enhanced GABA at the synapse may not produce stronger inhibition, either at GABAA or GABAB receptors. Paradoxically the increased GABA primarily affects presynaptic GABAB receptors on interneurons and therefore downregulates GABA release, thereby producing less inhibition (Oh and Dichter, 1994). This surprising result may account for the complex response of some seizure types to tiagabine. This drug appears to exacerbate absence-like seizures and possibly some forms of status epilepticus, but it reduces partial seizures (Eckardt and Steinhoff, 1998; Ettinger et al., 1999; Fitzek et al., 2001; Genton, 2000; Knake et al., 1999; Piccinelli et al., 2000; Schapel and Chadwick, 1996; Shinnar et al., 2001; Skardoutsou et al., 2003; Skodda et al., 2001; Solomon and Labar, 1998; Steinhoff and Eckardt, 1999). Similarly complex results were obtained when analyzing the effects of glutamate transport inhibitors on excitatory synaptic physiology. Instead of simply enhancing excitation, these agents often dampened excitatory synapses by an action of the excess synaptic glutamate on presynaptic metabotropic glutamate receptors (mGluRs), which decreased transmitter release from excitatory terminals (Maki et al., 1994). Glutamate Receptor Antagonists It has been hypothesized that antagonists of either the AMPA or NMDA receptor subtype could be effective AEDs—if such antagonism were not too toxic. Many of the drugs that work as antagonists at these receptors were developed and characterized using a CNS cell culture system. So far, however, drugs that target these receptors have not been as useful as hoped, partly because of toxicity and partly because of limited efficacy. One of the new AEDs,
30
Chapter 3/Cell Culture Models for Studying Epilepsy
topiramate, has been shown to act by blocking kainate receptors (Gibbs et al., 2000; Gryder and Rogawski, 2003) in addition to its effect on GABA receptors. This type of multiple targeting, with drugs that affect multiple receptor (or channel) types, may prove to be a new avenue for AED development. Other drugs that act as weak noncompetitive antagonists at AMPA or NMDA receptors are being developed, and these may prove to be more effective than the earlier compounds tested (Rogawski, 2000; Donevan and Rogawski, 2000). Potassium Channel Modulators Another new class of possible AEDs is being developed based on a mechanism that was first demonstrated in CNS cell cultures. These agents enhance the opening of subclasses of voltage-dependent K channels or in some cases open the channels directly. The net effect is to dampen neuronal excitability.
Circuit Behavior and Ictogenesis: Do Cell Cultures Exhibit “Seizure-like” Phenomena? Models of Epilepsy in Cell Culture When neurons from cortex or hippocampus are grown in dissociated cell culture, they form extensive synaptic interactions and local circuits. The nature of the circuitry has not been extensively examined, but a few principles have emerged. Neurons in routine high-density culture do not tend to form synapses with neighbors in culture, despite extensive overlap of processes. Instead synapses are formed with more distant targets. When neurons are monitored by intracellular recordings, they tend to fire in bursts at either irregular, or occasionally, regular intervals. These bursts, which resemble those seen in epileptic tissue in vivo, occur despite an inability of these neurons to generate endogenous bursts in response to depolarizing pulses (Buchhalter and Dichter, 1991; Dichter, 1978) (as opposed to some endogenous bursting neurons in intact cortex and hippocampus). When pairs of neurons in culture are recorded, it is common for the neurons to exhibit synchronous bursting or synchronous activation, presumably driven by synaptic events originating elsewhere in the cultures. Thus the circuit organization and synaptic interactions among neocortical and hippocampal neurons maintained in dissociated cell cultures spontaneously re-create the kinds of circuits needed to sustain epileptiform types of activity. Synchronous bursting in the cultures can be enhanced by many of the same stimuli that provoke epileptic activity in intact cortex (e.g., GABA receptor antagonists and NMDA receptor activators). Such epileptogenicity occurs in the absence of endogenous bursting cells, electrical interactions between the neurons, or ephaptic interactions among the neurons (as a result of large extracellular currents flowing in
the media). This synchronous discharge can also occur when neurons are grown in the virtual absence of astrocytes. Surprisingly this “epileptic-type activity” and epileptogenic circuitry have been largely ignored by epilepsy researchers using cell cultures to study other aspects of cellular biophysics, physiology and pharmacology, or mechanisms of action of AEDs. One prominent exception is the work of DeLorenzo and colleagues (Gibbs et al., 1997; Pal et al., 2001; Sombati and DeLorenzo, 1995), who have exploited the enhanced synchrony produced by low magnesium exposure to create a cell culture model of epilepsy. Reducing Mg in the media in which neurons are bathed enhances activity of NMDA receptors and produces an increase in excitability of the cultures. When cells are maintained in this condition for longer than 3 hours, the cultures remain hyperexcitable for the life of the cells, even when normal Mg is restored. The DeLorenzo laboratory uses hippocampal cultures that are plated on a 2-week-old astrocyte feeder layer. After about 2 weeks, the culture media is replaced with media containing no magnesium and a small amount of glycine, sufficient for activation of NMDA receptors. During exposure to this lowmagnesium media, the neurons exhibit a continuous synchronous firing pattern reminiscent of a status epilepticus (Sombati and DeLorenzo, 1995). After 3 hours of exposure to this activating media, the cell cultures are switched back to the original media. Following this treatment, the neurons exhibit activity that has been dubbed spontaneous recurrent epileptiform discharges (SREDs) (DeLorenzo et al., 1998). In contrast to control tissue, the low Mg-exposed neurons have a much higher likelihood of synchronous depolarizations; this tendency persists for the life of the cells, typically more than 2 weeks. DeLorenzo’s group has carried out a number of experiments to support their view that this model simulates focal epileptogenesis, dependent on aberrant activation of NMDA receptors. They showed that blockade of the NMDA receptors during the low-Mg treatment of these cultures prevents the development of hyperexcitability (as evidenced by SREDs) (DeLorenzo et al., 1998). Prolonged direct activation of the NMDA receptors, using the physiologic agonist glutamate instead of low magnesium, resulted in a similar long-term hyperexcitability and disruption of calcium homeostasis, likely through alteration in calcium/calmodulin kinase II activity (Sun et al., 2001). These alterations in calcium homeostasis may also lead to increased GABAA receptor endocytosis or altered GABAA receptor composition. Low-magnesium-treated cells exhibit a lower current density for a given concentration of GABA and show a lower sensitivity to the benzodiazepine, clonazepam. Blocking clathrin-mediated endocytosis in postsynaptic cells reverses hyperexcitability caused by the low-magnesium treatment (Blair et al., 2004). The proposed mechanism of this clathrin action is by blockade of GABAA receptor
Summary: Insights Into Human Epilepsy Derived from Studies of Neuronal Cell Cultures
endocytosis, which in turn causes the levels of GABAA receptor to return to baseline; concommitantly, the hyperexcitability of the cell cultures returns to baseline (Blair et al., 2004). Chronic Cultures of Dissociated Neurons Maintained on a Chip Another recent approach to analyzing epileptic-like events in cell culture has developed around an interesting new way of culturing the neurons. Cells can be grown on microchips with multiple exposed electrodes (Potter and DeMarse, 2001). When a neuron lands on one of these electrodes, an extracellular recording from that cell can be maintained, often for weeks at a time. Because the microchip contains many electrodes, many individual cells or small groups of neurons can be monitored simultaneously. Under these conditions, the neurons tend to fire in bursts, and there are varying degrees of synchrony occurring in the cultures (Potter, personal communication). Because the neurons can be monitored for weeks, this preparation has the potential for important studies of dynamic circuit behaviors, including the response of these synchronously discharging cells to AEDs or other possible antiseizure therapies.
LIMITATIONS Despite the extensive studies performed on dissociated cell cultures since they were first “invented” in the early 1970s, there are a number of limitations that must be mentioned about “models” of epilepsy developed with this approach. Many different laboratories now maintain cell cultures, and there is undoubtedly significant variability in cultures (methods of generation and maintenance, cell types, etc.) from one laboratory to the next. For some types of experiments, this variability may be unimportant. However, for some studies that focus on epileptic-like events and conditions, such differences could be quite important; for example, a variation in the percent of inhibitory neurons, from 30 to 40% of the culture (Cao et al., 1996; White et al., 1980) to less than 10% (Benson et al., 1994). Similarly, the presence or absence of astrocytes may be important for some kinds of studies. Another issue that always arises with respect to cell cultures is how faithfully they mimic their in vivo counterparts. Surprisingly, for most properties studied, the resemblance is remarkable. However, for other properties, there may be very significant differences between cultured neurons and neurons in the intact brain. For example, one group of GABAB receptors (K-channel–coupled GABAB receptors on cell bodies and dendrites) are absent from cultured neurons. Similarly, as we understand more about developmental expression of different ion channels and transmitter receptors, it will be necessary to validate culture studies with in
31
vivo data. It is now clear that different mechanisms of epileptogenesis, seizure generation, and response to AEDs are characteristic of CNS neurons at different stages of maturity. It will therefore be important to determine what maturational level is reproduced in cell cultures before drawing general conclusions from culture data for the intact brain. Perhaps the most interesting aspect of the comparison between cell cultures and the intact brain relates to the epileptiform activity expressed by neurons in culture. Do the circuits that form after cells are completely dissociated and then plated onto a two dimensional surface (covered with an artificial substrate) re-create the kinds of circuits that are capable of developing and sustaining epileptiform activity? Depending on how one defines epileptic, it appears that cell cultures can do just that. What insights will this preparation provide about the developing brain and the response to injury? How will culture-determined properties of cells and circuits be useful for designing strategies to prevent seizures or the hyperexcitability that underlies human epilepsy?
SUMMARY: INSIGHTS INTO HUMAN EPILEPSY DERIVED FROM STUDIES OF NEURONAL CELL CULTURES Studies utilizing the preparation of dissociated cell cultures have already provided significant insights into the basic physiology, pharmacology, and molecular biology of neocortical and hippocampal neurons and synapses and have led to many advances in our understanding of epileptiform events. Such studies have contributed greatly to our current understanding of the mechanisms of action of AEDs. Further work on receptor (or channel) subtype-specific pharmacology will likely lead to new classes of AEDs—drugs that have more focused targets and better side-effect profiles. Other studies focusing on mechanisms underlying shortterm synaptic plasticity and on the local circuitry involved in synchronous neuronal activation may also lead to new strategies for suppressing seizures. Each of these areas may result in new targets for AED screening. One of the main areas of neglect in epilepsy research is that of epileptogenesis. Studies in cell culture on such issues as axonal sprouting, new synapse formation and altered molecular phenotype in response to activity or injury may provide new insights into these processes and may lead to new hypotheses about how to control them. It is clear that we need multiple models in our struggle to understand the mechanisms underlying seizures, the changes in brain structure and function that underlie epilepsy, and the best methods for developing new antiseizure and antiepileptogenic strategies. This volume provides an introduction to many of these models, both in the intact animals and in vitro. It is important to remember, however, that it is “the question” to be answered that
32
Chapter 3/Cell Culture Models for Studying Epilepsy
remains the most important focus of our research, not the model per se. As critical questions are posed, experimenters must make use of—and develop—those models that can best answer those questions.
References Ascher, P., and Nowak, L. 1988. The role of divalent cations in the Nmethyl-D-aspartate responses of mouse central neurones in culture. J Physiol 399: 247–266. Ascher, P., Bregestovski, P., and Nowak, L. 1988. N-methyl-d-aspartateactivated channels of mouse central neurones in magnesium-free solutions. J Physiol 399: 207–226. Ayala, G.F., Matsumoto, H., and Gumnit, R.J. 1970a. Inhibitory mechanisms during tonic-clonic seizures. Electroencephalogr Clin Neurophysiol 28: 96. Ayala, G.F., Matsumoto, H., and Gumnit, R.J. 1970b. Excitability changes and inhibitory mechanisms in neocortical neurons during seizures. J Neurophysiol 33: 73–85. Banker, G.A., and Cowan, W.M. 1977. Rat hippocampal neurons in dispersed cell culture. Brain Res 126: 397–342. Banker, G. 2002. Culturing Nerve Cells, 2nd ed. Cambridge, MA: The MIT Press. Beck, H., Steffens, R., Heinemann, U., and Elger, C.E. 1997a. Properties of voltage-activated Ca2+ currents in acutely isolated human hippocampal granule cells. J Neurophysiol 77: 1526–1537. Beck, H., Clusmann, H., Kral, T., Schramm, J., Heinemann, U., and Elger, C.E. 1997b. Potassium currents in acutely isolated human hippocampal dentate granule cells. J Physiol 498(Pt 1): 73–85. Beck, H., Blumcke, I., Kral, T., Clusmann, H., Schramm, J., Wiestler, O.D., Heinemann, U. et al. 1996. Properties of a delayed rectifier potassium current in dentate granule cells isolated from the hippocampus of patients with chronic temporal lobe epilepsy. Epilepsia 37: 892–901. Becker, A.J., Chen J., Paus, S., Normann, S., Beck, H., Elger, C.E., Wiestler, O.D. et al. 2002. Transcriptional profiling in human epilepsy: expression array and single cell real-time qRT-PCR analysis reveal distinct cellular gene regulation. Neuroreport 13: 1327–1333. Bennett, M.V., Pellegrini-Giampietro, D.E., Gorter, J.A., Aronica, E., Connor, J.A., and Zukin, R.S. 1996. The GluR2 hypothesis: Ca(++)permeable AMPA receptors in delayed neurodegeneration. Cold Spring Harb Symp Quant Biol 61: 373–384. Benson, D.L., Watkins, F.H., Steward, O., and Banker, G. 1994. Characterization of GABAergic neurons in hippocampal cell cultures. J Neurocytol 23: 279–295. Bernard, C., Anderson, A., Becker, A., Poolos, N.P., Beck, H., and Johnston, D. 2004. Acquired dendritic channelopathy in temporal lobe epilepsy. Science 305: 532–535. Blair, R.E., Sombati, S., Lawrence, D.C., McCay, B.D., and DeLorenzo, R.J. 2004. Epileptogenesis causes acute and chronic increases in GABAA receptor endocytosis that contributes to the induction and maintenance of seizures in the hippocampal culture model of acquired epilepsy. J Pharmacol Exp Ther 310: 871–880. Bowery, N. 1989. GABAB receptors and their significance in mammalian pharmacology. Trends Pharmacol Sci 10: 401–407. Bowery, N.G. 1993. GABAB receptor pharmacology. Annu Rev Pharmacol Toxicol 33: 109–147. Bowery, N.G., Price, G.W., Hudson, A.L., Hill, D.R., Wilkin, G.P., and Turnbull, M.J. 1984. GABA receptor multiplicity. Visualization of different receptor types in the mammalian CNS. Neuropharmacology 23: 219–231. Brewer, G.J. 1995. Serum-free B27/neurobasal medium supports differentiated growth of neurons from the striatum, substantia nigra, septum,
cerebral cortex, cerebellum, and dentate gyrus. J Neurosci Res 42: 674–683. Brewer, G.J., Torricelli, J.R., Evege, E.K., and Price, P.J. 1993. Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination. J Neurosci Res 35: 567–576. Brooks-Kayal, A.R., Shumate, M.D., Jin, H., Rikhter, T.Y., and Coulter, D.A. 1998. Selective changes in single cell GABA(A) receptor subunit expression and function in temporal lobe epilepsy. Nat Med 4: 1166–1172. Buchhalter, J.R., and Dichter, M.A. 1991. Electrophysiological comparison of pyramidal and stellate nonpyramidal neurons in dissociated cell culture of rat hippocampus. Brain Res Bull 26: 333–338. Cao, Y., Wilcox, K.S., Martin, C.E., Rachinsky, T.L., Eberwine, J., and Dichter, M.A. 1996. Presence of mRNA for glutamic acid decarboxylase in both excitatory and inhibitory neurons. Proc Natl Acad Sci U S A 93: 9844–9849. Chen, J., Sochivko, D., Beck, H., Marechal, D., Wiestler, O.D., and Becker, A.J. 2001. Activity-induced expression of common reference genes in individual CNS neurons. Lab Invest 81: 913–916. Choi, D.W. 1993. NMDA receptors and AMPA/kainate receptors mediate parallel injury in cerebral cortical cultures subjected to oxygen-glucose deprivation. Prog Brain Res 96: 137–143. Choi, D.W., Farb, D.H., and Fischbach, G.D. 1977. Chlordiazepoxide selectively augments GABA action in spinal cord cell cultures. Nature 269: 342–344. Coulter, D.A. 1999. Chronic epileptogenic cellular alterations in the limbic system after status epilepticus. Epilepsia 40(Suppl 1): S23—33; discussion S40–21. Coyle, J.T., Bird, S.J., Evans, R.H., Gulley, R.L., Nadler, J.V., Nicklas, W.J., and Olney, J.W. 1981. Excitatory amino acid neurotoxins: selectivity, specificity, and mechanisms of action. Based on an NRP one-day conference held June 30, 1980. Neurosci Res Program Bull 19: 1– 427. Crino, P.B., Trojanowski, J.Q., Dichter, M.A., and Eberwine, J. 1996. Embryonic neuronal markers in tuberous sclerosis: single-cell molecular pathology. Proc Natl Acad Sci U S A 93: 14152–14157. Crino, P.B., Jin, H., Shumate, M.D., Robinson, M.B., Coulter, D.A., and Brooks-Kayal, A.R. 2002. Increased expression of the neuronal glutamate transporter (EAAT3/EAAC1) in hippocampal and neocortical epilepsy. Epilepsia 43: 211–218. Deisz, R.A., and Prince, D.A. 1989. Frequency-dependent depression of inhibition in guinea-pig neocortex in vitro by GABAB receptor feedback on GABA release. J Physiol 412: 513–541. DeLorenzo, R.J., Pal, S., and Sombati, S. 1998. Prolonged activation of the N-methyl-d-aspartate receptor-Ca2+ transduction pathway causes spontaneous recurrent epileptiform discharges in hippocampal neurons in culture. Proc Natl Acad Sci U S A 95: 14482–14487. Dichter, M., and Spencer, W.A. 1969a. Penicillin-induced interictal discharges from the cat hippocampus. II. Mechanisms underlying origin and restriction. J Neurophysiol 32: 663–687. Dichter, M., and Spencer, W.A. 1969b. Penicillin-induced interictal discharges from the cat hippocampus. I. Characteristics and topographical features. J Neurophysiol 32: 649–662. Dichter, M.A. 1975. Physiological properties of vertebrate nerve cells in tissue culture. UCLA Forum Med Sci 18: 101–114. Dichter, M.A. 1978. Rat cortical neurons in cell culture: culture methods, cell morphology, electrophysiology, and synapse formation. Brain Res 149: 279–293. Dichter, M.A. 1980. Physiological identification of GABA as the inhibitory transmitter for mammalian cortical neurons in cell culture. Brain Res 190: 111–121. Dichter, M.A., and Fischbach, G.D. 1977. The action potential of chick dorsal root ganglion neurones maintained in cell culture. J Physiol 267: 281–298.
References Dichter, M.A., and Zona, C. 1989. Calcium currents in cultured rat cortical neurons. Brain Res 492: 219–229. Dichter, M.A., Lisak, J., and Biales, B. 1983. Action potential mechanism of mammalian cortical neurons in cell culture. Brain Res 289: 99– 107. Dingledine, R., McBain, C.J., and McNamara, J.O. 1990. Excitatory amino acid receptors in epilepsy. Trends Pharmacol Sci 11: 334–338. Dunlap, K., and Fischbach, G.D. 1978. Neurotransmitters decrease the calcium component of sensory neurone action potentials. Nature 276: 837–839. Eberwine, J., Cao, Y., Nair, S., Miyashiro, K., Mackler, S., Finnell, R., Surmeier, J. et al. 1995. Mechanisms of neuronal plasticity as analyzed at the single cell level. Prog Brain Res 105: 117–126. Eckardt, K.M., and Steinhoff, B.J. 1998. Nonconvulsive status epilepticus in two patients receiving tiagabine treatment. Epilepsia 39: 671–674. Ettinger, A.B., Bernal, O.G., Andriola, MR, Bagchi, S., Flores, P., Just, C., Pitocco, C. et al. 1999. Two cases of nonconvulsive status epilepticus in association with tiagabine therapy. Epilepsia 40: 1159–1162. Evans, M.S., Collings, M.A., and Brewer, G.J. 1998. Electrophysiology of embryonic, adult and aged rat hippocampal neurons in serum-free culture. J Neurosci Methods 79: 37–46. Fischbach, G.D. 1972. Synapse formation between dissociated nerve and muscle cells in low density cell cultures. Dev Biol 28: 407–429. Fischbach, G.D., and Dichter, M.A. 1974. Electrophysiologic and morphologic properties of neurons in dissociated chick spinal cord cell cultures. Dev Biol 37: 100–116. Fitzek, S., Hegemann, S., Sauner, D., Bonsch, D., and Fitzek, C. 2001. Drug-induced nonconvulsive status epilepticus with low dose of tiagabine. Epileptic Disord 3: 147–150. Genton, P. 2000. When antiepileptic drugs aggravate epilepsy. Brain Dev 22: 75–80. Ghauri, M., Chapman, A.G., and Meldrum, B.S. 1996. Convulsant and anticonvulsant actions of agonists and antagonists of group III mGluRs. Neuroreport 7: 1469–1474. Gibbs, J.W. III, Sombati, S., DeLorenzo, R.J., and Coulter, D.A. 1997. Physiological and pharmacological alterations in postsynaptic GABA(A) receptor function in a hippocampal culture model of chronic spontaneous seizures. J Neurophysiol 77: 2139–2152. Gibbs, J.W. III, Sombati, S., DeLorenzo, R.J., and Coulter, D.A. 2000. Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neurons. Epilepsia 41(Suppl 1): S10–S16. Gryder, D.S., and Rogawski, M.A. 2003. Selective antagonism of GluR5 kainate-receptor-mediated synaptic currents by topiramate in rat basolateral amygdala neurons. J Neurosci 23: 7069–7074. Hollmann, M., Hartley, M., and Heinemann, S. 1991. Ca2+ permeability of KA-AMPA–gated glutamate receptor channels depends on subunit composition. Science 252: 851–853. Hosford, D.A., Lin, F.H., Kraemer, D.L., Cao, Z., Wang, Y., and Wilson, J.T. Jr. 1995. Neural network of structures in which GABAB receptors regulate absence seizures in the lethargic (lh/lh) mouse model. J Neurosci 15: 7367–7376. Hosford, D.A., Clark, S., Cao, Z., Wilson, W.A. Jr., Lin, F.H., Morrisett, R.A., and Huin, A. 1992. The role of GABAB receptor activation in absence seizures of lethargic (lh/lh) mice. Science 257: 398–401. Hosli, E., Ljungdahl, A., Hokfelt, T., and Hosli, L. 1972. Spinal cord tissue cultures—a model for autoradiographic studies on uptake of putative neurotransmitters such as glycine and GABA. Experientia 28: 1342–1344. Kaplan, M.P., Wilcox, K.S., and Dichter, M.A. 2003. Differences in multiple forms of short-term plasticity between excitatory and inhibitory hippocampal neurons in culture. Synapse 50: 41–52. Knake, S., Hamer, H.M., Schomburg, U., Oertel, W.H., and Rosenow, F. 1999. Tiagabine-induced absence status in idiopathic generalized epilepsy. Seizure 8: 314–317.
33
Lee, A.C., Wong, R.K., Chuang, S.C., Shin, H.S., and Bianchi, R. 2002. Role of synaptic metabotropic glutamate receptors in epileptiform discharges in hippocampal slices. J Neurophysiol 88: 1625–1633. Macdonald, R.L., and Barker, J.L. 1977. Phenobarbital enhances GABAmediated postsynaptic inhibition in cultured mammalian neurons. Trans Am Neurol Assoc 102: 139–140. Macdonald, R.L., and Barker, J.L. 1978. Different actions of anticonvulsant and anesthetic barbiturates revealed by use of cultured mammalian neurons. Science 200: 775–777. Macdonald, R.L., McLean, M.J. 1982. Cellular bases of barbiturate and phenytoin anticonvulsant drug action. Epilepsia 23(Suppl 1): S7–18. Macdonald, R.L., McLean, M.J., and Skerritt, J.H. 1985. Anticonvulsant drug mechanisms of action. Fed Proc 44: 2634–2639. Macdonald, R.L., Weddle, M.G., and Gross, R.A. 1986. Benzodiazepine, beta-carboline, and barbiturate actions on GABA responses. Adv Biochem Psychopharmacol 41: 67–78. Macdonald, R.L., Twyman, R.E., Rogers, C.J., and Weddle, M.G. 1988. Pentobarbital regulation of the kinetic properties of GABA receptor chloride channels. Adv Biochem Psychopharmacol 45: 61–71. Maki, R., Robinson, M.B., and Dichter, M.A. 1994. The glutamate uptake inhibitor L-trans-pyrrolidine-2,4-dicarboxylate depresses excitatory synaptic transmission via a presynaptic mechanism in cultured hippocampal neurons. J Neurosci 14: 6754–6762. Matsumoto, H., and Ajmone Marsan, C. 1964. Cellular mechanisms in experimental epileptic seizures. Science 144: 193–194. Matsumoto, H., Ayala, G.F., and Gumnit, R.J. 1969. Neuronal behavior and triggering mechanism in cortical epileptic focus. J Neurophysiol 32: 688–703. Mattson, M.P. 2003. Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders. Neuromolecular Med 3: 65–94. Mattson, M.P., and Kater, S.B. 1988. Isolated hippocampal neurons in cryopreserved long-term cultures: development of neuroarchitecture and sensitivity to NMDA. Int J Dev Neurosci 6: 439–452. Mattson, M.P., and Kater, S.B. 1989. Development and selective neurodegeneration in cell cultures from different hippocampal regions. Brain Res 490: 110–125. McLennan, H. 1983. Receptors for the excitatory amino acids in the mammalian central nervous system. Prog Neurobiol 20: 251–271. Oh, D.J., and Dichter, M.A. 1994. Effect of a gamma-aminobutyric acid uptake inhibitor, NNC-711, on spontaneous postsynaptic currents in cultured rat hippocampal neurons: implications for antiepileptic drug development. Epilepsia 35: 426–430. Olney, J.W. 1969. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 164: 719–721. Olney, J.W. 1976. Brain damage and oral intake of certain amino acids. Adv Exp Med Biol 69: 497–506. Olney, J.W., and Ho, O.L. 1970. Brain damage in infant mice following oral intake of glutamate, aspartate or cysteine. Nature 227: 609–611. Olney, J.W., Rhee, V., and Ho, O.L. 1974. Kainic acid: a powerful neurotoxic analogue of glutamate. Brain Res 77: 507–512. Pal, S., Sun, D., Limbrick, D., Rafiq, A., and DeLorenzo, R.J. 2001. Epileptogenesis induces long-term alterations in intracellular calcium release and sequestration mechanisms in the hippocampal neuronal culture model of epilepsy. Cell Calcium 30: 285–296. Pellegrini-Giampietro, D.E., Gorter, J.A., Bennett M.V., and Zukin, R.S. 1997. The GluR2 (GluR-B) hypothesis: Ca(2+)-permeable AMPA receptors in neurological disorders. Trends Neurosci 20:464–470. Piccinelli, P., Borgatti, R., Perucca, E., Tofani, A., Donati, G., and Balottin, U. 2000. Frontal nonconvulsive status epilepticus associated with high-dose tiagabine therapy in a child with familial bilateral perisylvian polymicrogyria. Epilepsia 41: 1485–1488. Potter, S.M., and DeMarse, T.B. 2001. A new approach to neural cell culture for long-term studies. J Neurosci Methods 110: 17–24.
34
Chapter 3/Cell Culture Models for Studying Epilepsy
Prince, D.A. 1968a. Inhibition in “epileptic” neurons. Exp Neurol 21: 307–321. Prince, D.A. 1968b. The depolarization shift in “epileptic” neurons. Exp Neurol 21: 467–485. Prince, D.A. 1969. Electrophysiology of “epileptic” neurons: spike generation. Electroencephalogr Clin Neurophysiol 26: 476–487. Prince, D.A., and Wilder, B.J. 1967 Control mechanisms in cortical epileptogenic foci. Surround inhibition. Arch Neurol 16: 194–202. Prince, D.A., and Futamachi, K.J. 1968. Intracellular recordings in chronic focal epilepsy. Brain Res 11: 681–684. Prince, D.A., and Futamachi, K.J. 1970. Intracellular recordings from chronic epileptogenic foci in the monkey. Electroencephalogr Clin Neurophysiol 29: 496–510. Prince, D.A., and Gutnick, M.J. 1971. Neuronal activities in epileptogenic foci of immature cortex. Trans Am Neurol Assoc 96: 88–91. Ransom, B.R., Bullock, P.N., and Nelson, P.G. 1977. Mouse spinal cord in cell culture. III. Neuronal chemosensitivity and its relationship to synaptic activity. J Neurophysiol 40: 1163–1177. Reckziegel, G., Beck, H., Schramm, J., Elger, C.E., and Urban, B.W. 1998. Electrophysiological characterization of Na+ currents in acutely isolated human hippocampal dentate granule cells. J Physiol 509(Pt 1): 139–150. Rogawski, M.A. 2000. Low affinity channel blocking (uncompetitive) NMDA receptor antagonists as therapeutic agents–toward an understanding of their favorable tolerability. Amino Acids 19: 133– 149. Rogawski, M.A., and Donevan, S.D. 1999. AMPA receptors in epilepsy and as targets for antiepileptic drugs. Adv Neurol 79: 947–963. Rothman, S.M., and Olney, J.W. 1986. Glutamate and the pathophysiology of hypoxic–ischemic brain damage. Ann Neurol 19: 105–111. Sattler, R., and Tymianski, M. 2001. Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death. Mol Neurobiol 24: 107–129. Schapel, G., and Chadwick, D. (1996) Tiagabine and non-convulsive status epilepticus. Seizure 5: 153–156. Schwartzkroin, P.A. 1975. Characteristics of CA1 neurons recorded intracellularly in the hippocampal in vitro slice preparation. Brain Res 85: 423–436. Schwartzkroin, P.A., and Wester, K. 1975. Long-lasting facilitation of a synaptic potential following tetanization in the in vitro hippocampal slice. Brain Res 89:107–119. Schwartzkroin, P.A., and Prince, D.A. 1976. Epileptogenesis in mammalian cortex studied in vitro. Trans Am Neurol Assoc 101: 288– 291. Schwartzkroin, P.A., and Prince, D.A. 1977. Penicillin-induced epileptiform activity in the hippocampal in vitro prepatation. Ann Neurol 1: 463–469. Schwartzkroin, P.A., and Slawsky, M. 1977. Probable calcium spikes in hippocampal neurons. Brain Res 135: 157–161. Segal, M.M. 1991. Epileptiform activity in microcultures containing one excitatory hippocampal neuron. J Neurophysiol 65: 761–770. Segal, M.M., and Furshpan, E.J. 1990. Epileptiform activity in microcultures containing small numbers of hippocampal neurons. J Neurophysiol 64:1390–1399. Shinnar, S., Berg, A.T., Treiman, D.M., Hauser, W.A., Hesdorffer, D.C., Sackellares, J.C., Leppik, I. et al. 2001. Status epilepticus and tiagabine therapy: review of safety data and epidemiologic comparisons. Epilepsia 42: 372–379.
Skardoutsou, A., Voudris, K.A., and Vagiakou, E.A. 2003 Non-convulsive status epilepticus associated with tiagabine therapy in children. Seizure 12: 599–601. Skodda, S., Kramer, I., Spittler, J.F., and Gehlen, W. 2001. Non-convulsive status epilepticus in two patients receiving tiagabine add-on treatment. J Neurol 248: 109–112. Sloviter, R.S., Dichter, M.A., Rachinsky, T.L., Dean, E., Goodman, J.H., Sollas, A.L., and Martin, D.L. 1996. Basal expression and induction of glutamate decarboxylase and GABA in excitatory granule cells of the rat and monkey hippocampal dentate gyrus. J Comp Neurol 373: 593–618. Solomon, G.E., and Labar, D. 1998. Hypothesis that tiagabine-induced NCSE is associated with GABAergic hyperfunction, with GABA(B) receptors playing a critical role, is supported by a case of generalized NCSE induced by baclofen. Epilepsia 39: 1383. Sombati, S., and DeLorenzo, R.J. 1995. Recurrent spontaneous seizure activity in hippocampal neuronal networks in culture. J Neurophysical 73: 1706–1711. Sperk, G., Furtinger, S., Schwarzer, C., and Pirker, S. 2004. GABA and its receptors in epilepsy. Adv Exp Med Biol 548: 92–103. Steinhoff, B.J., and Eckardt, K.M. 1999. Clinical and EEG findings in complex partial status epilepticus with tiagabine. Seizure 8: 197. Sun, DA, Sombati, S, and DeLorenzo, R.J. 2001. Glutamate injury-induced epileptogenesis in hippocampal neurons: an in vitro model of strokeinduced “epilepsy.” Stroke 32: 2344–2350. Tang, C.M., Dichter, M., and Morad, M. 1989. Quisqualate activates a rapidly inactivating high conductance ionic channel in hippocampal neurons. Science 243: 1474–1477. Tang, C.M., Dichter, M., and Morad, M. 1990. Modulation of the N-methyld-aspartate channel by extracellular H+. Proc Natl Acad Sci U S A 87: 6445–6449. Trussell, L.O., Thio, L.L., Zorumski, C.F., and Fischbach, G.D. 1988. Rapid desensitization of glutamate receptors in vertebrate central neurons. Proc Natl Acad Sci U S A 85: 2834–2838. Westbrook, G.L. 1994. Glutamate receptor update. Curr Opin Neurobiol 4: 337–346. White, H.S., Brown, S.D., Woodhead, J.H., Skeen, G.A., and Wolf, H.H. 1997. Topiramate enhances GABA-mediated chloride flux and GABAevoked chloride currents in murine brain neurons and increases seizure threshold. Epilepsy Res 28: 167–179. White, H.S., Brown, S.D., Woodhead, J.H., Skeen, G.A., and Wolf, H.H. 2000. Topiramate modulates GABA-evoked currents in murine cortical neurons by a nonbenzodiazepine mechanism. Epilepsia 41(Suppl 1): S17–S20. White, W.F., Snodgrass, S.R., and Dichter, M. 1980. Identification of GABA neurons in rat cortical cultures by GABA uptake autoradiography. Brain Res 190: 139–152. Wilcox, K.S., and Dichter, M.A. 1994. Paired pulse depression in cultured hippocampal neurons is due to a presynaptic mechanism independent of GABAB autoreceptor activation. J Neurosci 14: 1775–1788. Wilcox, K.S., Buchhalter, J., and Dichter, M.A. 1994. Properties of inhibitory and excitatory synapses between hippocampal neurons in very low density cultures. Synapse 18: 128–151. Wong, R.K., and Prince, D.A. 1978. Participation of calcium spikes during intrinsic burst firing in hippocampal neurons. Brain Res 159: 385–390. Zhang, G., Raol, Y.H., Hsu, F.C., Coulter, D.A., and Brooks-Kayal, A.R. 2004. Effects of status epilepticus on hippocampal GABAA receptors are age-dependent. Neuroscience 125: 299–303.
C
H
A
P
T
E
R
4 An Overview of In Vitro Seizure Models in Acute and Organotypic Slices UWE HEINEMANN, OLIVER KANN, AND SEBASTIAN SCHUCHMANN
Following a seizure-like event, there is usually a postictal depression period. Interictal discharges then reappear, eventually leading to the next seizure-like event. Interictal discharges can be “proictogenic,” but there are also examples where the frequent occurrence of interictal discharges prevents seizure generation. Criteria to discriminate between proepileptic and antiepileptic interictal discharges in the clinical environment have not yet been worked out and can only be experimentally determined. For example, reduction of magnesium concentration in the artificial cerebrospinal fluid (ACSF) bathing rat hippocampal slices (the low-Mg2+ model) induces recurrent short discharges that fulfill the criteria of paroxysmal depolarization shifts. When baclofen, a g-aminobutyric acid (GABA)B agonist, is added to the bathing medium, these short, recurrent discharges are reduced in frequency and seizure-like events emerge (Anderson et al., 1986). Seizure-like events are typically accompanied by rises in extracellular potassium concentration ([K+]o) to levels near 12 mM (with an undershoot to below baseline following the seizure-like event), decreases in extracellular calcium concentration ([Ca2+]o) by up to 0.6 mM, decreases in sodium and chloride concentrations ([Na+]o and [Cl-]o), and changes in the size of the extracellular space (Lux et al., 1986). Changes in pH are also characteristic, with an initial alkalotic shift followed by acidosis. Intracellular recordings from neurons reveal transient depolarizations superimposed by bursts of action potentials during the initial phase; a sustained depolarization by about 30 mV during the tonic phase; and depolarization shifts, which again evoke bursts of action potentials superimposed on a slowly declining membrane potential (Schmitz et al., 1997). During the tonic phase, intrasomatic recordings show frequently aborted spikes or
INTRODUCTION Characteristic Features of Seizures to Be Modeled In Vitro In vitro preparations offer a variety of options for studying the mechanisms of the generation, spread, and termination of seizures using methods that are difficult to employ under in vivo conditions. Particularly, in vitro preparations permit precise control of temperature and extracellular environment. However, in vitro seizure models lack the behavioral and motor components of clinical seizures. They must therefore rely on “equivalents” of seizures that have been observed in vivo. Such equivalents are characteristic changes of electrical activity and in the ionic environment as measured using either intracellular or extracellular recording techniques. Seizure models—in vivo or in vitro— should also share with human patients a similar sensitivity to antiepileptic drugs. Because about 30% of epileptic patients do not become seizure-free with classic anticonvulsants, there is a need for models that mimic drugresistant epilepsy. In vitro criteria for seizure models include electrographic features and changes in ionic concentrations that are comparable to features observed in human and animal studies. A seizure-like event (SLE) in most cortical structures lasts more than 10 seconds. In extracellular field potential recordings, a negative shift accompanies the SLE; superimposed on the negative potential shift are tonic-like or clonic-like electrographic features. Tonic-like discharges are characterized by relatively fast, small transients with a frequency range above 8 Hz; clonic-like discharges consist of relatively large-field potential transients of 50- to 200-ms duration.
Models of Seizures and Epilepsy
35
Copyright © 2006, Elsevier Inc. All rights of reproduction in any form reserved.
36
Chapter 4/An Overview of In Vitro Seizure Models in Acute and Organotypic Slices
no action potentials at all as a result of depolarizing inactivation of sodium currents. However, as the depolarization propagates electrotonically into the axon, axonal action potentials will occur where there is insufficient depolarization to cause inactivation of sodium currents; hence, high-frequency axonal firing can be observed during the tonic phase of seizure-like events. In some cases ectopic action potential generation in presynaptic terminals, resulting from changes in the ionic environment and heterosynaptic or homosynaptic effects of released transmitters, can also be involved in ictogenesis (Gutnick and Prince, 1972). Following a SLE, a long-lasting (~30 seconds) afterhyperpolarization is often observed, with reduced synaptic noise and initial suppression of interictal discharges. Occurrence and spread of SLEs can be monitored using extracellular recording techniques with multiple electrodes, with voltage-sensitive dyes (Demir et al., 1998), or by using intrinsic optical signals (Buchheim et al., 1999).
raise the possibility that adaptive homeostatic plastic changes develop in chronically epileptic tissue, which prevents frequent occurrence of seizures. Understanding such mechanisms might open new strategies for the cure of epilepsies.
IN VITRO PREPARATIONS We address two types of in vitro preparations that can be used for studies on seizure generation: acute slices and organotypic slice cultures. More intact preparations of early postnatal neocortex or hippocampus offer advantages for studying epilepsy features in preparations that correspond to perinatal human tissue (Khalilov et al., 1999) (see Chapter 6). An isolated brain preparation offers additional research options (Paré et al., 1992) (see Chapter 9). More “reduced” in vitro preparations also offer advantages for specific applications (e.g., see Chapters 2 and 3).
SPECIAL FEATURES OF IN VITRO MODELS
EPILEPTIFORM ACTIVITY IN ACUTE SLICES
Treatments that induce seizures in animals and humans often induce only relatively short recurrent discharges in slice preparations. This important “discrepancy” is most notably the case with agents that interfere with GABAergic or glycinergic synaptic transmission, such as strychnine, bicuculline, penicillin, etc. By contrast, agents that block potassium currents, such as 4-aminopyridine (4-AP), barium, and cesium, are more likely to induce seizure-like events, as is the case in vivo (Avoli and Perreault, 1987). Conditions where changes in Mg and Ca bathing medium concentrations are used to induce seizure-like events bear some relationship to eclamptic seizures. In such cases, opening the blood-brain barrier as a consequence of sudden surges in blood pressure leads to a hypomagnesaemia and a hypocalcaemia in the interstitial space of the central nervous system (CNS), which in turn may contribute to ictogenesis (Thomas, 1998). Delayed inactivation of sodium currents, as observed with veratridine, can induce ictal events both in vivo and in vitro (Alkadhi and Tian, 1996). Based on these observations, it appears that interference with intrinsic neuronal excitability is more likely to result in seizure-like generation in vitro than is interference with synaptic transmission. It should also be noted that most seizure models are used in otherwise healthy tissue. Little information is yet available about seizure characteristics in chronically epileptic tissue. For example, it remains unclear why we were unable to induce seizure-like events in slices from human epileptic tissue with low-Mg2+ bathing medium, bicuculline, 4-AP, and other agents, but potassium-evoked seizure-like events were generated (Gabriel et al., 2004). Such observations
The most popular in vitro preparations are acute brain slices, consisting of 200- to 600-mm thin sections of living brain tissue, which can be obtained from any species (including nonmammalian species) with a complex brain. Although there is much literature on burst discharges from invertebrate preparations, there is a current bias that invertebrate systems show too many differences from mammalian brain to make them useful tools to study epileptic activity (however, see Chapter 15). Many areas of the brain have been used for acute slices. Complex slice preparations, which partially preserve inter-area connectivity, for example, between the entorhinal cortex and the hippocampus (Dreier and Heinemann, 1991; Walther et al., 1986), between the amygdala and the entorhinal cortex-hippocampal formation (von Bohlen et al., 1998), or between the neocortex and the thalamus (Coulter and Lee, 1993), have been used for studies in experimental epilepsy. Acute slice preparations exploiting brainstem tissue, involving regions often involved in generation of myoclonic seizures and in secondary generalization of seizures, have been much less studied. Numerous problems must be taken into account by investigators using acute slice preparations. Inevitably such preparations have undergone a period of ischemia. Further, many fiber projections entering and leaving the brain slice are severed. Therefore all studies on ictogenesis in such brain slices are performed in tissue which has, per se, undergone an acute lesion. Moreover the thickness of the preparation requires a supply of nutrients that is dependent on exchange by diffusion from the ACSF. The average distance between capillaries is only 50 mm in brain tissue, providing
Epileptiform Activity in Organotypic Slice Cultures
efficient exchange of oxygen and nutrients to the neural tissue. In acute slices, diffusion processes are much less efficient. Exchange of the extracellular solution in acute brain slices takes about 60 minutes when investigations are performed under interface conditions and about 20 minutes when investigations are performed under submerged conditions. As a result of the acute lesion, and in analogy to in vitro observations after acute transection of the spinal cord, there is a drastic reduction in spontaneous synaptic activity. This reduction is particularly important in neocortical preparations where synaptic input from extrinsic sources provides a major source of excitatory drive, and is less important where physiologic synaptic activity can be maintained by intraslice circuitry (e.g., in the hippocampal formation). Because of limitations of diffusion and to provide a sufficient oxygen and glucose supply, solutions saturated with 95% of oxygen and high glucose content are typically used for maintaining acute slices. This approach results in cells on the slice surface being exposed to nonphysiologic, highoxygen tensions (which might cause cell alterations), whereas cells in the center of the slice see oxygen tensions that might be too low. It is worth noting that all early measurements on oxygen tension in acute brain slice preparations were performed with electrodes that, by themselves, consumed significant amounts of oxygen; other, as yet unpublished, observations with less oxygen-consuming electrodes suggest that this potential problem is overstated (Jiang et al., 1991). Although slice preparations permit investigators to study the mechanisms underlying different forms of epileptiform activity, they are not suited for studying mechanisms of cell death (for example, during status epilepticus). Even given the fact that diffusion and equilibration are faster in thinner slices, no attempts have been made to adjust oxygen tension and glucose concentrations to the real needs of neurons in such preparations. Another diffusion-related issue arises when considering the use of patch-clamp recording techniques. Patch-clamp recordings have become a very valuable tool in neuroscience research. In brain slice preparations, visual identification of individual neurons to be patched is facilitated using submerged bathing conditions. Although diffusional exchange is faster under submerged conditions than under interface conditions, the objective that is inserted into the fluid covering the slice might cause a zone of slowed perfusion. Indeed we have found that, for submerged conditions, care must be taken to prevent acidosis in the tissue. A high perfusion rate of 4 ml/min solves this problem in submerged chambers (compared with a perfusion rate of 1.3 to 2 ml/min in interface chambers to keep the slice preparation in good condition). Unfortunately many groups using patch-clamp recordings work at room temperature. Because seizure generation is usually blocked when the temperature in the preparation falls below 32° C (Schuchmann et al., 2002),
37
conclusions based on room temperature recordings must be interpreted with care. Finally, in using slices from different species, it is important to consider that different brain regions, particularly limbic regions, serve different functions in different animals. Thus in mice the hippocampus is the predominant association cortex, and many more functions are likely to involve the hippocampal formation for neuronal computation than in humans. Because of the small size of the mouse brain, a slice from a mouse may contain more of the functional connectivity of the structure of interest; in larger brains, less connectivity is likely to be preserved. Indeed it is much easier to induce seizure-like events in hippocampal slices from mice than from rats or cats.
EPILEPTIFORM ACTIVITY IN ORGANOTYPIC SLICE CULTURES Potentially the best suited preparations for studies on seizure generation and seizure-induced cell death are organotypic slice cultures. Organotypic cultures maintain some of the intrinsic properties of the tissue, including the most important aspects of connectivity. However, the preparations are usually made from pups (P6–P10) and then studied after 7 to 30 days in vitro; therefore these preparations do not necessarily represent adult tissue. The preparations are usually maintained in an artificial growth medium, which may include serum, so at least some of their properties are probably not comparable to those of adult tissue. Finally, as the preparations are more or less deafferentate and deefferented, abnormal connectivity may develop (Gutierrez and Heinemann, 1999). The degree of abnormal connectivity depends on the age of the animal at preparation, the brain area that is prepared (with or without adjacent tissue), and the culture medium. Unfortunately, no systematic studies have yet been performed to control for such alterations. In isolated organotypic hippocampal slice cultures in which the entorhinal cortex has been removed, the development of the dentate gyrus (DG) is usually incomplete. There is evidence for some mossy fiber sprouting, even when the entorhinal cortex is left attached to the hippocampus (Routbort et al., 1999). Aberrant connectivity between area CA1 and the DG has also been reported (Gutierrez and Heinemann, 1999). Because some of this abnormal connectivity mimics aberrant connectivity in epileptic brain, organotypic slice cultures may be viewed as good models of chronically epileptic tissue, where abnormal connectivity is one of the hallmarks of tissue reorganization. In spite of the limitations mentioned here, organotypic slice cultures offer some advantages over dissociated cultures and acute slices. First, they possess a limited extracellular space and contain many, if not all, of the neuron types present in the comparable area in vivo (i.e., they are
38
Chapter 4/An Overview of In Vitro Seizure Models in Acute and Organotypic Slices
“organotypic”). Second, they are not acutely damaged. Third, they are thinner (150–200 mm) than acute slice preparations (350–500 mm) and therefore do not require abnormally high oxygen and glucose levels for maintenance of excitability. In fact, high oxygen levels may damage the slices (Pomper et al., 2000; 2001). Finally, they can be put back in the incubator after a series of seizures, a manipulation that gives the investigator an opportunity to explore long-term effects of seizure-like events.
PREPARATIONS AND MAINTENANCE OF SLICES Acute Slices There are multiple variations of preparation techniques for acute slices. The precise method should depend on the purpose of the study and the area of interest. Initially most laboratories used a tissue chopper for cutting the tissue into thin slices; later, vibratomes were adopted in many laboratories because they appeared to make slices with less mechanical damage. Efforts have been made to determine which cutting parameters (with the vibratome) are most important for preservation of fine tissue details (preservation is essential, for example, for carrying out recordings from subcellular compartments such as presynaptic terminals (Geiger et al., 2002)). Likewise the storage of slices is an important issue. In our laboratory, for experiments under submerged conditions, slices are placed on a nylon grid, which is fixed at the surface of ACSF in a homemade Perspex incubation chamber (at room temperature). The incubation chamber contains 50 ml of gassed (95% O2/5% CO2) ACSF (static bath). For recordings, slices are individually transferred to a submersion-style recording chamber. For interface chamber experiments, we have found the best tissue preservation when slices are maintained in an interface chamber on a piece of lens paper, which facilitates transfer of the slice to the recording chamber. A period of 2 hours allows recovery of swollen neurons and mitochondria. Slice recordings can be performed in an interface chamber or in a submerged chamber. Alternatively a grease gap chamber can be used in which slices set over a separation sealed with Vaseline (Avsar and Empson, 2004), and recordings can be performed by measuring the potential difference between the two chambers. This procedure permits recording of different types of epileptiform activity and easy analysis of drug effects on such activity. Interface chambers are available in two basic variations: (1) the Oslotype chamber, developed in Per Andersen’s laboratory from the original design of McIllwain, who used slices to study brain metabolism (Andersen, 1975); and (2) The Haas-type chamber (Haas et al., 1979). We prefer the Haas chamber, where the slices set on the floor of the chamber, providing
mechanical stability. An always-important issue is the temperature at which the tissue is maintained because seizurelike events are difficult to induce at temperatures below 33° C. Another important issue is the composition of the ACSF, which is used to perfuse the in vitro preparations. Our laboratory uses ACSF containing (in mM): NaCl 124, KCl 3, MgSO2 1.8, CaCl2 1.6, NaH2PO4 1.25, NaHCO3 26, and glucose 10. The solution is equilibrated with carbogen gas (95% O2/5% CO2) to maintain a pH of 7.4; the osmolarity of the solution should be about 290 mOsm. Ca2+, Mg2, and K+ concentrations must be carefully adjusted because small variations in concentrations of these ions have marked effects on neuronal activity. The extracellular Ca2+ concentration ([Ca2+]o) in vivo is about 1.2 mM which is mimicked in slices by 1.6 mM. The reason for this difference is the chelating effect of HCO3- on Ca2+, which precipitates about 25% of the free [Ca2+]o. The potassium concentration in the brain is 3 mM (Lux et al., 1986), but many researchers use higher baseline concentrations following the original recipes of McIllwain. The Mg2+ concentration in CSF, as measured from the ventricles, is somewhere between 0.9 and 1.2 mM; it may be higher in the interstitial space. We use a baseline Mg2+ concentration of 1.6 mM in our experiments. Reduction of extracellular Mg2+ concentration from 1.6 to 1.2 mM has facilitating effects on synaptic transmission (Hamon et al., 1987), and further lowering to 0.9 mM is sufficient to induce epileptiform activity in slices from rat pups (Gloveli et al., 1995). An issue in preparing slices is the choice of anesthesia (and depth of anesthesia chosen before the brain is removed). Pups are frequently anesthetized by putting them on dry ice. This procedure exploits the anesthetic effect of high carbon dioxide levels combined with hypothermia. Many laboratories use gas anesthetics, such as ether or halothane. This choice gives reliable anesthesia with a reasonable therapeutic gap between deep and irreversible levels. It should be noted that very deep anesthesia leads to circulation arrest and hypoxia and causes cessation of protein synthesis (slices prepared in this way often do not exhibit long-term plasticity). Gas anesthesia works well in both sexes. Barbiturate anesthesia has the drawback that females often require more anesthetic to obtain an adequately deep state, but frequently they are put down so deeply that they die before decapitation. Ketamine anesthesia interferes with N-methyl-d-aspartate (NMDA) receptors, an effect not always desirable in studies on seizures. Some laboratories perfuse the animal with a low calcium medium in which sucrose is substituted for sodium to reduce cell death. We have not found that this modification normally enhances tissue viability. However, in cases where preparation time may be prolonged, as in chronically epileptic animals and human tissue, we have found that immersing the slices in sucrose ACSF together with alpha-tocopherol improves tissue preservation (Gabriel et al., 2004).
Imaging In Vitro Preparations
The following procedures are employed to prepare entorhinal cortex–hippocampal slices (Dreier and Heinemann, 1991). Rats (150–200 g) are anesthetized with ether and decapitated. The skull is opened, the dura cut, and the whole brain rapidly (within less than a minute) removed. The brain is submerged in cold (4° C) ACSF. The cerebellum is removed, and the brain is divided into two hemispheres. Each hemisphere is placed on its medial surface and divided into rostral and caudal sections by a transverse cut in a plane approximately parallel to the main axis of the hippocampus. The cut plane of the caudal piece is fixed to the plate of a vibratome (using cyanoacrylate glue), and five to eight horizontal slices are cut at a thickness of 400 mm. These slices contain the temporal cortex area, the perirhinal cortex, the entorhinal cortex, the subiculum, the DG, and the ventral hippocampus. Slices are placed separately on lens paper and stored in oxygenated ACSF in either an incubation chamber (experiments under submerged conditions) at room temperature or in an interface chamber (experiments under interface conditions) at 35° C. Slices are allowed to recover under these conditions for at least 60 to 90 minutes before starting the experiments. To test the viability of our slices, we monitor the extracellular field potential in the medial entorhinal cortex layer III/IV or hippocampal area CA1 following electrical stimulation (single pulse duration of 100 ms, pulse amplitude of 5–15 V) using bipolar platinum wires placed in the lateral entorhinal cortex or in stratum radiatum of area CA1, respectively. Slices are accepted for investigation if the extracellular field potential is at least 2 mV in amplitude. To validate epileptiform activity, we use standard ion-sensitive microelectrodes to measure changes in the extracellular field potential and the extracellular potassium concentration simultaneously. Ion-selective microelectrodes are prepared using double-barreled theta glass (Lux and Neher, 1973). One barrel is filled with 154 mM NaCl and serves as the reference. The other barrel is silanized (5% trimethyl-1chlorosilane in 95% CCl4) and filled with a potassium ionophore cocktail (A60031, Fluka). To compute the molar extracellular potassium concentrations from the recorded potential values, a modified Nernst equation is utilized (Heinemann and Arens, 1992).
Organotypic Slice Cultures We have found the Stoppini method for preparing slice cultures (Stoppini et al., 1991) to be the most simple and reliable. Animal age at time of preparation is an important variable. In both rats and mice, slice cultures can be prepared from tissue starting at embryonic states up to postnatal day 16. Attempts have been made to prepare cultures also from older animals, with some success up to an age of P28 (Leutgeb et al., 2003). Published protocols yield reproducible organotypic cultures in only about 20% of
39
experiments. Hence further methodologic developments are required before such organotypic slice cultures can be used for long-term investigations. The advantage of slice cultures for epilepsy research is that the effects of seizure activity (e.g., status epilepticus)—with respect to cell death, changes in neuronal excitability, neuronal interaction, and morphologic rearrangement of networks—can be followed for extended periods. However, because such changes occur on a background of developmental alterations in the tissue (and under nonphysiologic conditions), a large number of controls are required before drawing conclusions about seizurespecific effects. For maintaining slice cultures in vitro for the purpose of electrophysiologic recordings, it is important that the cultures are superfused with an ACSF that contains physiologic oxygen because ACSF with 95% oxygen can induce hyperoxic cell damage (Pomper et al., 2001; 2004). Ionic composition of bathing medium for these recordings is similar to that used for acute slices. At the time when organotypic hippocampal slice cultures are used for experimental studies (>7 days in vitro), there has been considerable reorganization which depends on two parameters: whether the entorhinal cortex is included in the preparation and which medium is used for maintaining the slices in culture. Some of the reorganizational processes observed in tissue from chronic epileptic rats and humans are also seen in slice cultures; examples include: mossy fiber sprouting; reorganization in area CA1 with extended interconnectivity between CA1 hippocampal pyramidal cells; and interconnections between CA1, subiculum and DG. Such reorganizational changes are less pronounced, or almost absent, in acute slices. As a result of such changes in slice cultures, application of bicuculline and other GABA antagonists can induce seizure-like events in this preparation (Gutierrez and Heinemann, 1999). Our procedures for preparing hippocampal slice cultures follow published protocols (Kann et al., 2003a, b; Stoppini et al., 1991). In brief, hippocampal slices (400 mm) are cut using a tissue chopper from 7- to 9-day-old Wistar rats under sterile conditions. Slices are immediately transferred to icecold, oxygenated (95%) minimal essential medium (MEM) at pH 7.3. Slices with intact anatomic structure are maintained on a biomembrane surface (0.4 mm, Millicell-CM, Millipore, Eschborn, Germany) at an interface between culture medium (1 ml, containing: 50% MEM, 25% Hank’s balanced salt solution, 25% horse serum (Gibco, Invitrogen, Karlsruhe, Germany), and 2 mM l-glutamine (pH 7.4)) and humidified atmosphere (5% CO2, 36.5° C) in an incubator. Half the culture medium is replaced every second day. Slices cultures are used after 7 days in vitro.
IMAGING IN VITRO PREPARATIONS An increasing number of fluorescent dyes have become available that permit measurements of voltage changes and
40
Chapter 4/An Overview of In Vitro Seizure Models in Acute and Organotypic Slices
intracellular ionic concentration changes, permit insight into second-messenger cascades, and allow specific studies on mitochondrial function. Generally both acute slices and slice cultures (as well as dissociated cultures) can be bulk stained by exposing the preparation to a given dye. The dye must be membrane permeable, which is often achieved by using an ester form of the dye that makes the substances lipophilic. One complicating factor is that drug transporters expressed in astrocytes can take up such dyes specifically into glial compartments; unless the staining procedure is prolonged or the transport activity is blocked by inhibitors of drug transporters, this glial uptake may make visualization of neuron changes quite difficult. Hence, for any dye, a specific protocol must be developed that permits neuronal loading. Dyes can also be applied focally or via the perfusate. Because these dyes are often expensive, many groups stain the tissue in stagnant chambers and then transfer slices or cultures to the recording chamber. This procedure may result in tissue damage from hypoxia, so dye application via perfusion is preferable. To reduce costs the perfusate can be recycled. Staining in organotypic slice cultures is simpler because the dye can simply be added to the culture medium. Electrophysiologic measurements can then be combined with microfluorimetric (photomultiplier) and imaging techniques (charge-coupled device (CCD) camera, confocal laser scanning microscopy, two-photon confocal microscopy) to monitor cytosolic or mitochondrial calcium concentrations (e.g., with indicators such as calcium green and Rhod-2), mitochondrial membrane potential (rhodamine123 and JC-1) as well as the energy status of the tissue (as reflected in the fluorescence of nicotinamide adenine dinucleotides [NADH and NADPH] and flavin adenine dinucleotide [FAD]). Measurements can be done in the interface mode or under submerged conditions. Some intracellular metabolites, such as NADH, NADPH, and FAD, are fluorescent. NADH and NADPH produce an overlapping fluorescence signal and therefore cannot be readily discriminated. Moreover, cytosolic processes influence the level of NADPH and NADH (Kann, et al., 2003; Kovacs et al., 2002). By contrast, FAD is dependent only on mitochondrial metabolic activity and therefore provides a direct indicator of mitochondrial function. Fluorescent dyes can also be used to obtain insight into such processes as mitochondrial production of radical oxygen species and nitrous oxide (NO) synthesis during seizure-like activities. Finally, dyes that indicate cell loss (e.g., propidium iodide, ethidium bromide) and cell viability (e.g., acridin orange) can also be used for studying consequences of seizures (Pomper et al., 2004). Monitoring NAD(P)H autofluorescence on-line in brain slices is an easy and stable method. Electrical and chemical stimuli elicit NAD(P)H autofluorescence signals with high reproducibility (Kann et al., 2003 a, b; Schuchmann et al., 2001). This stability allows the identification of mitochon-
drial metabolism or activity-induced changes of the NAD(P)H signal. A further advantage of the method is the ubiquity of NAD(P)H in biological tissue; therefore, NAD(P)H autofluorescence can be excited in nearly every region without any pretreatment of the slices. The main disadvantage of using NAD(P)H autofluorescence results from its excitation wavelength (350 ± 20 nm, near ultraviolet). Light with such a short wavelength involves the transfer of relatively high amounts of energy to tissue (photon energy 3.55 ± 0.2 eV) and may therefore induce phototoxicity. To minimize phototoxic effects, excitation time and intensity should be optimized with respect to the experimental conditions. Generally, continuous excitation requires reduced excitation intensity, whereas highexcitation intensity requires short excitation periods. Phototoxic effects are indicated by a rapid rundown in the NAD(P)H autofluorescence signal as well as by electrophysiologic (reduction in extracellular field potential amplitude) or morphologic (light-colored “burn” spots on the slice) changes. When slices are damaged by hypoxia, ischemia, or a mechanical lesion, the NAD(P)H autofluorescence signal is reduced especially in regions of densely packed neurons (CA1, CA3, area dentata). Thin slices (<200 mm) exhibit a significantly lower NAD(P)H autofluorescence baseline signal (compared with standard 400-mm-thick slices) under identical optical conditions, again because of the reduced number of cells in these slices. Additionally, thin slices and organotypic slice cultures (and cellular monolayers) undergo significantly increased rates of phototoxic effects compared with 400 mm slices.
IN VITRO SEIZURE MODELS Generally, before studying seizure induction, the viability of the tissue should be tested; experiments should be carried out only on preparations with “normal” physiologic responses, that is, those that show no signs of epileptiform alterations such as multiple population spikes. A good test of viability (in addition to that described previously) is whether long-term potential (LTP) or long-term depression (LTD) can be maintained beyond 20 minutes. Slices exposed to prolonged ischemia lose the capability for protein synthesis and therefore cannot maintain long-lasting changes in synaptic plasticity. Induction of seizure-like events in such preparations yields atypical discharge patterns, disturbances in ionic homeostasis, and rapid decline of the preparation once SLEs are induced. Often it is impossible to induce spontaneous activity.
Low Calcium-lnduced Epileptiform Activity Recordings in vivo have shown that extracellular Ca2+ concentration can drop to levels as low as 0.2 mM (Pumain et al., 1985). Studies initiated in vitro (Jefferys and Haas,
In Vitro Seizure Models
1982; Yaari et al., 1983) showed that lowering extracellular Ca2+ (i.e., in the bathing medium) could induce regular seizure-like events that lasted for about 30 seconds and recurred in a clock-like fashion. Similar events can also be induced when the hippocampus is treated with Ca2+chelating agents in vivo (Feng and Durand, 2003). This pattern of activity depends on low (zero mM) Ca2+ treatment and simultaneous elevation of [K+]o to 5.5 mM. The induction of seizure-like events coincides with the blockade of evoked synaptic transmission. It is a result of reduced surface charge screening (which increases neuronal excitability) and reduced Ca2+-dependent K2+ currents. Electrographically the events appear to mimic tonic-like discharges with slow negative shifts on which a series of population spikes are superimposed. The appearance of population spike activity is somewhat delayed with respect to onset of the negative field potential shift. Clonic-like afterdischarges are not apparent. Intracellular measurements reveal a membrane depolarization of about 30 mV (corresponding to the negative shift in the field), with superimposed action potentials. When normal Ca2+ levels are restored in the bathing medium, the tissue behaves normally, with little sign of neuronal deterioration. Interestingly, the low Ca2+ activity spreads with a low speed (Konnerth et al., 1984), similar to that observed for seizure-like events in the entorhinal cortex induced by low Mg and 4-AP (Weissinger et al., 2000) in which synaptic transmission is maintained, suggesting that nonsynaptic mechanisms—likely potassium diffusion—are involved in seizure spread (Shuai et al., 2003). As evoked transmitter and peptide release is blocked under conditions of low Ca2+, this model is particularly well suited for studies on mechanisms of nonsynaptic seizure spread and also for studies of whether and how anticonvulsants directly modify neuronal excitability (Heinemann et al., 1985). The low-Ca2+ model works well in rat hippocampal area CA1 where neurons are densely packed. The threshold for induction is lower in tissue from juvenile animals. The low-Ca2+ model does not work in human tissue or in other brain areas with low cell packing density, unless the size of the extracellular space (ES) is reduced by treatment with hypoosmolar solutions (which, however, also affect transmembrane Cl- concentration gradients). For example, low-Ca2+-induced seizure-like events in the DG have required simultaneous application of augmented potassium concentration (ª10 mM) or modification of extracellular osmolarity (Schweitzer et al., 1992). Under submerged conditions, induction of low-Ca2+ seizure-like events appears to be facilitated by lowering the recorded temperature (for still little-understood reasons), but in interface chambers lowering of temperature blocks this activity (Schuchmann et al., 2002). Pharmacologically, low-Ca2+ seizure-like activity responds to carbamazepine (CBZ), phenytoin (PHT), and valproate (VPA) in clinically relevant concentrations. The activity can also be blocked by application of DC fields.
41
Low Magnesium Induced Seizure-Like Events Epileptiform activity can be induced in virtually all epilepsy-sensitive regions of the brain by omitting Mg2+ from the ACSF. Induction of this activity depends on increased neuronal excitability resulting from reduced surface charge screening, facilitated transmitter release, and activation of NMDA receptors due to removal of the Mg2+ block of NMDA receptor-operated ion channels. Initially these events are always sensitive to application of NMDA receptor antagonists, which is consistent with the idea that activation of NMDA receptors is critical for induction of such events (Stanton et al., 1987). However, NMDA receptor antagonists may lose their efficacy with increasing time after application of low Mg2+. In such cases, a form of long-lasting synaptic potentiation is observed. In the isolated rat hippocampal slice, lowering Mg2+ induces recurrent, short-duration discharges that share the properties of interictal discharges. They are initiated in area CA3 and propagate to area CA1. The DG does normally not participate in this activity, although these recurrent epileptiform discharges do involve the hilus. These interictal-like discharges last for 60 to 150 ms, are characterized by positive-going field potential transients in stratum pyramidale of area CA1 and CA3, and are superimposed by bursts of population spikes (Mody et al., 1987). Low-Mg2+ seizure-like events can be induced in rat hippocampus by simultaneously applying baclofen and elevating potassium (Anderson et al., 1986). In mice, omitting Mg2+ from the ACSF can cause seizure-like events (Velisek et al., 1996) which are similar to those observed with low Mg2+ in rat limbic structures such as temporal neocortex, entorhinal cortex, and subiculum (Avoli et al., 1991; Dreier and Heinemann, 1991). Each of these regions can produce seizure-like events when isolated from the remaining structures of the hippocampal formation. The seizurelike events in subiculum, EC, and temporal neocortex are characterized by negative potential shifts superimposed by high-frequency, small-amplitude oscillations, followed by clonic-like afterdischarges. Intracellular recordings reveal depolarization shifts of up to 30 mV, on which are superimposed prolonged bursts of action potentials. During cloniclike after discharges, depolarization shifts that trigger series of action potential discharges are observed. In combined hippocampal–entorhinal cortex slices, the seizure-like events most frequently start in medial entorhinal cortex but can also begin in temporal neocortex, lateral entorhinal cortex, or the subiculum (Dreier and Heinemann, 1991). The seizures spread from site of origin slowly to neighboring areas. Speed of spread is slightly slower than the speed of spread for lowCa2+-induced seizure-like events (Buchheim et al., 2000). Spread of activity can be monitored by field recordings at multiple sites or by use of intrinsic optical signals. Low-Mg2+ seizure-like events possess the same pharmacologic properties as seizures induced in vivo, that is, they are sensitive to
42
Chapter 4/An Overview of In Vitro Seizure Models in Acute and Organotypic Slices
CBZ, PHT, and VPA and also to benzodiazepines and barbiturates in clinically relevant concentrations (Zhang et al., 1995). Interestingly, seizure-like events induced by low Mg2+ show different properties in frontal cortex slices. In this brain region, the epileptiform pattern does not include afterdischarges. Further, the activity spreads more rapidly than in temporal and limbic structures (Armand et al., 1998), and the episodes are much shorter than in the entorhinal cortex, amygdale, and hippocampus. This feature of low Mg2+ activity suggests that the relatively short, frequent, seizure episodes often observed in clinical frontal lobe epilepsies are dependent on intrinsic properties of frontal cortical tissue. Low-Mg2+-induced seizure-like events show different characteristics of spread when induced in chronic epileptic tissue. In both pilocarpine-treated animals and kindled animals, seizure spread is facilitated (Behr et al., 1998). Two routes of low-Mg2+ seizure spread have been described in pilocarpine treated animals: one through the subiculum and one through the DG. In contrast, seizure spread in kindled animals is preferentially through the DG, suggesting that the DG has lost some of its filtering properties (Wozny et al., unpublished observations). Low-Mg2+ seizure spread is also facilitated in preparations from rat pups, where the hippocampus is variably involved (Weissinger et al., 1998). Seizure-like events disappear sometime after induction by low Mg2+ and are replaced by shorter events, which most frequently represent tonic-like discharges. These events can be mistaken for interictal discharges. However, because the ionic change and the intracellularly recorded signals accompanying these activities differ from the properties of interictal discharges in duration and amplitude, we believe these events correspond to activity patterns observed during prolonged status epilepticus. Because application of GABA and GABA-uptake inhibitors reverse these events to seizurelike patterns, a loss of GABAergic functions seems to be involved in this activity. Muscimol blocks this activity at low concentrations; the change is likely not due to alterations in GABA-receptor affinity, but more likely to consumption of GABA in the GABA shunt of the tricarboxic acid cycle (Pfeiffer et al., 1996).These late recurrent discharges are of particular interest because they are not blocked by standard anticonvulsants even when high concentrations of these agents are applied (Dreier et al., 1998). Induction of low Mg2+ activity involves omission of magnesium sulfate from the perfusate. The first epileptiform discharges appear after 40 minutes under interface recording conditions and after 20 minutes under submerged conditions. Transition to the late recurrent, pharmacoresistant discharges occurs between 30 and 90 minutes after onset of epileptiform activity.
4-Aminopyridine-Induced Seizure-like Events 4-aminopyridne (4-AP) is a blocker of transient potassium currents. At low concentrations it affects transient currents containing Kv1.3 and 1.4 subunits in low concentrations and affects other transient potassium currents only in the millimolar range. In rat hippocampus, 4-AP usually induces recurrent discharges. In parahippocampal structures such as the entorhinal cortex, subiculum, and temporal neocortex (Avoli et al., 1996) and also in the amygdala (Klueva et al., 2003), it elicits seizure-like events. The seizure-like events start with an initial bursting period and give rise to a tonic-like episode and clonic afterdischarges superimposed on slow negative-potential shifts; these electrographic events are associated with ionic changes characteristic of seizure-like events. In interface recordings, the activity commences about 40 minutes after application of 50 or 100 mm 4-AP (Brückner and Heinemann, 2000). Transition to late recurrent discharges may or may not occur after more than 1.5 hours of ongoing seizure-like activity. These seizure-like events respond to all standard anticonvulsants (Brückner and Heinemann, 2000). Late pharmacoresistant activity can be evoked by combining bicuculline with 4-AP (Brückner, et al., 1999).
Seizure-like Events Induced by Elevating Potassium Concentration Early in vivo studies in different species suggested that elevating potassium concentration can induce seizure-like events in hippocampus. This effect is readily mimicked in vitro (Jensen and Yaari, 1988) by raising extracellular potassium in ACSF from 3/3.5 mM (standard in most laboratories) to 7.5 mM. This activity also responds to standard anticonvulsant drugs. When [K+]o is elevated to 11 mM and Ca2+ is lowered at the same time, seizure-like events can be induced in the DG of Sprague-Dawley rats (Schweitzer et al., 1992). In Wistar rats, the induction of seizure-like events with high K+ and moderately lowered Ca2+ and Mg2+ is difficult to reproduce.
Stimulation-Induced Seizures Short trains of repeated high-frequency electrical stimuli have also been used to induce ictaform activity in the form of afterdischarges. In combined hippocampal–entorhinal cortex slices from young Sprague-Dawley rats (P21–P30), repeated trains (100 Hz, 0.1-ms pulses, 1- or 2-second train duration) in the presence of 0.5 mM magnesium eventually results in self-sustained status epilepticus (Rafiq et al., 1995). In slices from older Sprague-Dawley rats, ictaform afterdischarges have been induced by stimulus trains when
References
slices were bathed in low Mg and low Ca concentrations and elevated K (Stelzer et al., 1987) or with 1.3 Mg and 5 mm 4AP bathing media (Higashima et al., 2000; Ohno and Higashima, 2002). Trains of repetitive stimulation in organotypic slice cultures also, in some cases, induce afterdischarges and spreading depressions.
Focal Induction of Seizure-like Events Although most in vitro models for seizures are thought to mimic aspects of focal or partial epilepsies, few attempts have been made to induce seizure-like events by focal manipulations. Seizure-like events in the models described herein usually have focal onset, most frequently in the entorhinal cortex, sometimes in area CA3, and more rarely in area CA1. An interesting alternative approach involves focal application of bicuculline (50 mm) and high K (10 mM) to the EC (Behr et al., 1998). These investigators studied spread patterns of epileptiform activity from the EC to the hippocampus in normal and kindled rats and later in pilocarpine-treated rats. Another method of focal induction involves discrete application of carbachol (10 mM) from a pipette with short pressure pulses (10–200 ms) (Gloveli, et al., 1998).
References Alkadhi, K.A., and Tian, L.-M. 1996. Veratridine-enhanced persistent sodium current induces bursting in CA1 pyramidal neurons. Neuroscience 71: 625–632. Andersen, P. 1975. Organization of hippocampal neurons and their interconnections. In The Hippocampus. Eds. R.L. Isaacson and K.H. Pribram. pp. 155–175. New York: Plenum Press. Anderson, W.W., Lewis, D.V., Swartzwelder, H.S., and Wilson, W.A. 1986. Magnesium-free medium activates seizure-like events in the rat hippocampal slice. Brain Res 398: 215–219. Armand, V., Gabriel, S., Hoffmann, P., Heinemann, U., and Vergnes, M. 1998. Epileptiform activity and changes in field potential responses induced by low [Mg2+]oin a genetic rat model of absence epilepsy. Brain Res 803: 19–26. Avoli, M., Barbarosie, M., Lücke, A., Nagao, T., Lopantsev, V., and Köhling, R. 1996. Synchronous GABA-mediated potentials and epileptiform discharges in the rat limbic system in vitro. J Neurosci 16: 3912–3924. Avoli, M., Drapeau, C., Louvel, J., Pumain, R., Olivier, A., and Villemure, J.-G. 1991. Epileptiform activity induced by low extracellular magnesium in the human cortex maintained in vitro. Ann Neurol 30: 589–596. Avoli, M., and Perreault, P. 1987. A GABAergic depolarizing potential in the hippocampus disclosed by the convulsant 4-aminopyridine. Brain Res 400: 191–195. Avsar, E., and Empson, R.M. 2004. Adenosine acting via A1 receptors, controls the transition to status epilepticus-like behaviour in an in vitro model of epilepsy. Neuropharmacology 47: 427–437. Behr, J., Lyson, K.J., and Mody, I. 1998. Enhanced propagation of epileptiform activity through the kindled dentate gyrus. J Neurophysiol 79: 1726–1732. Brückner, C., and Heinemann, U. 2000. Effects of standard anticonvulsant drugs on differnt patterns of epileptiform discharges induced by 4aminopyridine in combined entorhinal cortex-hippocampal slices. Brain Res 859: 15–20.
43
Brückner, C., Stenkamp, K., Meierkord, H., and Heinemann, U. 1999. Epileptiform discharges induced by combined application of bicucculline and 4-aminopyridine are resistant to standard anticonvulsants in slices of rats. Neurosci Lett 268: 163–165. Buchheim, K., Schuchmann, S., Siegmund, H., Gabriel, H.-J., Heinemann, U., and Meierkord, H. 1999. Intrinsic optical signal measurement reveal characteristic features during different forms of spontaneous neuronal hyperactivity associated with ECS shrinkage in vitro. Eur J Neurosci 11: 1877–1882. Buchheim, K., Schuchmann, S., Siegmund, H., Weissinger, F., Heinemann, U., and Meierkord, H. 2000. Comparison of intrinsic optical signals associated with low Mg2+ and 4-aminopyridine induced seizure-like events reveals characteristic features in adult rat limbic system. Epilepsia 41: 635–641. Coulter, D.A., and Lee, C.-J. 1993. Thalamocortical rhythm generation in vitro: Extra- and intracellular recordings in mouse thalamocortical slices perfused with low Mg2+ medium. Brain Res 631: 137– 142. Demir, R., Haberly, L.B., and Jackson, M.B. 1998. Voltage imaging of epileptiform activity in slices from rat piriform cortex: onset and propagation. J Neurophysiol 80: 2727–2742. Dreier, J.P., and Heinemann, U. 1991. Regional and time dependent variations of low magnesium induced epileptiform activity in rat temporal cortex. Exp Brain Res 87: 581–596. Dreier, J.P., Zhang, C.L., and Heinemann, U. 1998. Phenytoin, phenobarbital, and midazolam fail to stop status epilepticus-like activity induced by low magnesium in rat entorhinal slices, but can prevent its development. Acta Neurol Scand 98: 154–160. Feng, Z., and Durand, D.M. 2003. Low-calcium epileptiform activity in the hippocampus in vivo. J Neurophysiol 90: 2253–2260. Gabriel, S., Njunting, M., Pomper, J.K., Merschhemke, M., Sanabria, E.R., Eilers, A., Kivi, A. et al. 2004. Stimulus and potassiuminduced epileptiform activity in the human dentate gyrus from patients with and without hippocampal sclerosis. J Neurosci 24: 10416–10430. Geiger, J.R., Bischofberger, J., Vida, I., Frobe, U., Pfitzinger, S., Weber, H.J., Haverkampf K. et al. 2002. Patch-clamp recording in brain slices with improved slicer technology. Pflugers Arch 443: 491–501. Gloveli, T., Albrecht, D., and Heinemann, U. 1995. Properties of low Mg2+ induced epileptiform activity in rat hippocampal and entorhinal cortex slices during adolescence. Dev Brain Res 87: 145–152. Gloveli, T., Egorov, A.V., Schmitz, D., Heinemann, U., and Müller, W. 1998. Muscarinic control of excitability and [Ca2+]i signaling in layer II and III projection neurons of the medial entorhinal cortex. Soc Neurosci Abstr 24(2): 1583. Gutierrez, R., and Heinemann, U. 1999. Synaptic reorganization in explanted cultures of rat hippocampus. Brain Res 815: 304–316. Gutnick, M.J., and Prince, D.A. 1972. Thalamocortical relay neurons: antidromic invasion of spikes from a cortical epileptogenic focus. Science 176: 424–426. Haas, H.L., Schaerer, B., and Vosmansky, M. 1979. A simple perfusion chamber for the study of nervous tissue slices in vitro. J Neurosci Methods 1: 323–325. Hamon, B., Stanton, P.K., and Heinemann, U. 1987. An N-methyl-d-aspartate receptor-independent excitatory action of partial reduction of extracellular [Mg2+] in CA1-region of rat hippocampal slices. Neurosci Lett 75: 240–245. Heinemann, U., and Arens, J. 1992. Production and calibration of ionsensitive microelectrodes. In Practical Electrophysiological Methods: A Guide for In Vitro Studies in Vertebrate Neurobiology. Ed. R. Grantyn and H. Kettenmann. pp. 206–212. New York: Wiley-Liss. Heinemann, U., Franceschetti, S., Hamon, B., Konnerth, A., and Yaari, Y. 1985. Effects of anticonvulsants on spontaneous epileptiform activity which develops in the absence of chemical synaptic transmission in hippocampal slices. Brain Res 325: 349–352.
44
Chapter 4/An Overview of In Vitro Seizure Models in Acute and Organotypic Slices
Higashima, M., Ohno, K., Kinoshita, H., and Koshino, Y. 2000. Involvement of GABAA and GABAB receptors in afterdischarge generation in rat hippocampal slices. Brain Res 865: 186–193. Jefferys, J.G.R., and Haas, H.L. 1982. Synchronized bursting of CA1 hippocampal pyramidal cells in the absence of synaptic transmission. Nature 300: 448–450. Jensen, M.S., and Yaari, Y. 1988. The relationship between interictal and ictal paroxysms in an in vitro model of focal hippocampal epilepsy. Ann Neurol 24: 591–598. Jiang, C., Agulian, S., and Haddad, G.G. 1991. O2 tension in adult and neonatal brain slices under several experimental conditions. Brain Res 568: 159–164. Kann, O., Kovacs, R., and Heinemann, U. 2003a. Metabotropic receptormediated Ca2+ signaling elevates mitochondrial Ca2+ and stimulates oxidative metabolism in rat hippocampal slice cultures. J Neurophysiol 90: 613–622. Kann, O., Schuchmann, S., Buchheim, K., and Heinemann, U. 2003b. Coupling of neuronal activity and mitochondrial metabolism as revealed by NAD(P)H fluorescence signals in organotypic hippocampal slice cultures of the rat. Neuroscience 119: 87–100. Klueva, J., Munsch, T., Albrecht, D., and Pape, H.C. 2003. Synaptic and non-synaptic mechanisms of amygdala recruitment into temporolimbic epileptiform activities. Eur J Neurosci 18: 2779–2791. Konnerth, A., Heinemann, U., and Yaari, Y. 1984. Slow transmission of neural activity in hippocampal area CA1 in the absence of active chemical synapses. Nature 307: 69–71. Kovacs, R., Schuchmann, S., Gabriel, S., Kann, O., Kardos, J., and Heinemann, U. 2002. Free radical-mediated cell damage after experimental status epilepticus in hippocampal slice cultures. J Neurophysiol 88: 2909–2918. Leutgeb, J.K., Frey, J.U., and Behnisch, T. 2003. LTP in cultured hippocampal-entorhinal cortex slices from young adult (P25–30) rats. J Neurosci Methods 130: 19–32. Lux, H.D., Heinemann, U., and Dietzel, I. 1986. Ionic changes and alterations in the size of the extracellular space during epileptic activity. In Advances in Neurology, vol 44. Eds. A.V. Delgado-Escueta, A.A. Ward, D.M. Woodbury, and R.J. Porter. Basic Mechanisms of the Epilepsies: Molecular and Cellular Approaches. pp. 619–639. New York: Raven Press. Lux, H.D., and Neher, E. 1973. The equilibration time course of [K+]oin cat cortex. Exp Brain Res 17: 190–205. Mody, I., Lambert, J.D.C., and Heinemann, U. 1987. Low extracellular magnesium induces epileptiform activity and spreading depression in rat hippocampal slices. J Neurophysiol 57(3): 869–888. Ohno, K., and Higashima, M. 2002. Effects of antiepileptic drugs on afterdischarge generation in rat hippocampal slices. Brain Res 924: 39–45. Paré, D., DeCurtis, M., and Llinás, R.R. 1992. Role of the hippocampalentorhinal loop in temporal lobe epilepsy: Extra- and intracellular study in the isolated guinea pig brain in vitro. J Neurosci 12: 1867–1881. Pfeiffer, M., Draguhn, A., Meierkord, H., and Heinemann, U. 1996. Effects of t-aminobutyric acid (GABA) agonists and GABA uptake inhibitors on pharmacosensitive and pharmacoresistant epileptiform activity in vitro. Br J Pharmacol 119: 569–577. Pomper, J.K., Graulich, J., Kovács, R., Gabriel, S., Hoffmann, U., and Heinemann, U. Increased oxygen tension leads to cell damage in organotypic hippocampal slice cultures. 2000. International Conference Neuroprotection and Neurorepair. Cellular and molecular mechanisms in stroke ischemia and trauma. Technical Workshop, 01.03.-02.03.2000, Magdeburg, Germany. Pomper, J.K., Graulich, J., Kovacs, R, Hoffmann, U., Gabriel, S., and Heinemann, U. 2001. High oxygen tension leads to acute cell death in organotypic hippocampal slice cultures. Brain Res Dev Brain Res 126: 109–116. Pomper, J.K., Hoffmann, U., Kovacs, R., Gabriel, S., and Heinemann, U. 2004. Hyperoxia is not an essential condition for status epilepticus
induced cell death in organotypic hippocampal slice cultures. Epilepsy Res 59: 61–65. Pumain, R., Menini, C., Heinemann, U., Silva-Barrat, C, and Louvel, J. 1985. Chemical synaptic transmission is not necessary for epileptic activity to persist in the neocortex of the photosensitive baboon. Exp Neurol 89: 250–258. Rafiq, A., Zhang, Y.F., DeLorenzo, R.J., and Coulter, D.A. 1995. Long-duration self-sustained epileptiform activity in the hippocampal-parahippocampal slice: a model of status epilepticus. J Neurophysiol 74: 2028–2042. Routbort, M.J., Bausch, S.B., and McNamara, J.O. 1999. Seizures, cell death, and mossy fiber sprouting in kainic acid-treated organotypic hippocampal cultures. Neuroscience 94: 755–765. Schmitz, D., Empson, R.M., Gloveli, T., and Heinemann, U. 1997. Serotonin blocks different pattern of low Mg2+-induced epileptiform activity in rat entorhinal cortex, but not hippocampus. Neuroscience 76: 449–458. Schuchmann, S., Kovacs, R., Kann, O., Heinemann, U., and Buchheim, K. 2001. Monitoring NAD(P)H autofluorescence to assess mitochondrial metabolic functions in rat hippocampal-entorhinal cortex slices. Brain Res Brain Res Protoc 7: 267–276. Schuchmann, S., Meierkord, H., Stenkamp, K., Breustedt, J., Windmuller, O., Heinemann, U., and Buchheim, K. 2002. Synaptic and nonsynaptic ictogenesis occurs at different temperatures in submerged and interface rat brain slices. J Neurophysiol 87: 2929–2935. Schweitzer, J.S., Patrylo, P.R., and Dudek, F.E. 1992. Prolonged field bursts in the dentate gyrus: Dependence on low calcium, high potassium, and nonsynaptic mechanisms. J Neurophysiol 68: 2016–2025. Shuai, J., Bikson, M., Hahn, P.J., Lian, J., and Durand, D.M. 2003. Ionic mechanisms underlying spontaneous CA1 neuronal firing in Ca2+-free solution. Biophys J 84: 2099–2111. Stanton, P.K., Jones, R.S.G., Mody, I., and Heinemann, U. 1987. Epileptiform activity induced by lowering extracellular [Mg2+] in combined hippocampal-entorhinal cortex slices: modulation by receptors for norepinephrine and N-methyl-d-aspartate. Epilepsy Res 1: 53–62. Stelzer, A., Slater, N.T., and ten Bruggencate, G. 1987. Activation of NMDA receptors blocks GABAergic inhibition in an in vitro model of epilepsy. Nature 326: 698–701. Stoppini, L., Buchs, P.-A., and Muller, D. 1991. A simple method for organotypic cultures of nervous tissue. J Neurosci Methods 37: 173–182. Thomas, S.V. 1998. Neurological aspects of eclampsia. J Neurol Sci 155: 37–43. Velisek, L., Moshe S.L., and Stanton, P.K. 1996. Increased susceptibility of brain slices from carbonic anhydrase II-deficient mice to low [Mg2+]O-induced seizures. Neurosci Lett 207: 143–146. von Bohlen und Halbach, O., and Albrecht, D. (1998). Tracing of axonal connectivities in a combined slice preparation of rat brains—a study by rhodamine-dextran-amine-application in the lateral nucleus of the amygdala. J Neurosci Methods 81: 169–175. Walther, H., Lambert, J.D.C., Jones, R.S.G., Heinemann, U., and Hamon, B. 1986. Epileptiform activity in combined slices of the hippocampus, subiculum and entorhinal cortex during perfusion with low magnesium medium. Neurosci Lett 69: 156–161. Weissinger, F., Buchheim, K., Schuchmann, S., Siegmund, H., Gabriel, H.-J., Heinemann, U., and Meierkord, H. 1998. Optical imaging of epileptiform activity demonstrates age specific features in entorhinal cortex-hippocampus slices. Eur J Neurosci 10(Suppl 10): 44. Weissinger, F., Buchheim, K., Siegmund, H., Heinemann, U., and Meierkord, H. 2000. Optical imaging reveals characteristic seizure onsets, spread patterns and propagation velocities in hippocampalentorhinal cortex slices of juvenile rats. Neurobiol Dis 7: 286–298. Yaari, Y., Konnerth, A., and Heinemann, U. 1983. Spontaneous epileptiform activity of CA1 hippocampal neurons in low extracellular calcium solutions. Exp Brain Res 51: 153–156. Zhang, C.L., Dreier, J.P., and Heinemann, U. 1995. Paroxysmal epileptiform discharges in temporal lobe slices after prolonged exposure to low magnesium are resistant to clinically used anticonvulsants. Epilepsy Res 20: 105–111.
C
H
A
P
T
E
R
5 The Use of Brain Slice Cultures for the Study of Epilepsy SCOTT M. THOMPSON, XIANG CAI, CÉLINE DINOCOURT, AND MICHAEL W. NESTOR
ability to induce conventional long-term potentiation (e.g., Debanne et al., 1994; Stoppini et al., 1991).
Organotypic brain slices are becoming increasingly useful and advantageous for a variety of neurobiological questions, including the study of epilepsy. In this chapter, we provide a brief review of some of the defining characteristics of this technique. We also review some recent studies in which these cultures have been used to examine various issues pertaining to the causes and consequences of epilepsy to illustrate the kinds of experimental questions that are amenable to study with this methodology. Thin sections of brain tissue can be prepared from neonatal animals and cultured as intact slices of tissue rather than as dissociated cells. These brain slice cultures offer most of the same advantages as conventional cell cultures, including (1) long-term survival in vitro; (2) precise control of experimental conditions; (3) excellent accessibility for viral vectors, biolistic transfection, and other means of gene transfection; (4) survival of tissue from neonatal–lethal transgenic animals; and (5) excellent visibility of cells and subcellular structures for morphologic and electrophysiologic studies. In addition, slice cultures offer several advantages compared with conventional dissociated cell cultures. Most notably, they retain many features of their native organotypic organization, as described extensively elsewhere (e.g., Caeser et al., 1989; Gähwiler, 1984; Gähwiler et al., 1997; Zimmer and Gähwiler, 1984). This permits the identification of defined cell groups, stimulation or lesioning of specific axonal pathways, and study of synaptic connections that more closely approximate their normal in situ patterns (Debanne et al., 1995). Finally, the slice culture technique offers the investigator the opportunity to coculture slices from different brain regions, thus facilitating the experimental manipulation and study of long-distance connections in vitro (e.g., Gähwiler et al., 1987) as well as the
Models of Seizures and Epilepsy
ORGANOTYPIC BRAIN SLICE CULTURES Preparation Two methods are currently used to prepare slice cultures. In the roller-tube technique, pioneered by Gähwiler (1981), the slices are attached to glass coverslips and placed in sealed test tubes on a roller drum in a dry-air incubator. In the membrane or interface technique, pioneered by Stoppini et al. (1991), the slices are placed on semipermeable membranes and grown statically in CO2 incubators. The primary differences between the two techniques are that the rollertube cultures generally become thinner than the membrane cultures but are somewhat more demanding and time consuming to prepare. Detailed culturing procedures can be found elsewhere (e.g., Gähwiler et al., 1998; Thompson and Mason, 2004). In both methods (Figure 1), brain slices are cut from neonatal animals. The exact age depends on the region of the brain to be cultured. The hippocampus and cortex are typically taken from 5- to 7-day-old pups, whereas the thalamus is reported to survive in culture only when taken from embryonic animals (Molnar and Blakemore, 1991). Slices are cut at a thickness of about 350 mm, as one would for an ordinary acute brain slice experiment. Because of the need to maintain sterility, it is typically easier to use a tissue chopper for the preparation of the slices; however, a vibratome preserves tissue health and integrity better for larger brain sections.
45
Copyright © 2006, Elsevier Inc. All rights of reproduction in any form reserved.
46
Chapter 5/Use of Brain Slice Cultures for Study of Epilepsy
rostral tiss ue c
septum
hop per
Multiwell dish and membrane inserts
hippocampus
B
hippocampal fissure
caudal dorsal surface down
A Incubator
coverslip and fibrin clot
culture medium
semipermeable membrane
dry air
Incubator CO2 culture medium
roller drum
e e tub r u t l cu
FIGURE 1 Preparation of organotypic brain slice cultures. The tissue of interest is first dissected free from the neonatal brain, as illustrated for the hippocampus, and thin sections are cut under aseptic conditions using either a tissue chopper or a vibratome. A: In the roller-tube method, the slices are attached to cleaned glass coverslips in a film of clotted fibrin or chicken plasma; the slices are then placed in sealed test tubes and placed on a roller drum in a dry-air incubator. B: In the membrane method, the slices are placed on semipermeable membranes in multiwell plates so that they are at the gas–air interface and then maintained in a CO2 incubator.
In the roller-tube method, brain slices can be attached to glass coverslips using various substances, including chicken plasma clotted with thrombin, collagen, or synthetic fibrin solutions (e.g., Tisseal, Baxter International, Deerfield, IL), either alone or in combination. These substances serve as effective, tissue-friendly “glues” for holding the tissue down firmly in the roller drum. Coverslips containing the slices are placed in sealed test tubes containing culture medium, and the tubes are placed on a roller drum in an incubator at 36°C. The drum rotates at about 10 revolutions per hour. For the membrane cultures, the slices are placed directly on semipermeable membrane inserts (Millicell, Millipore, Billerica, MA) and need no adhesive substance because they remain static in the CO2 incubator. The inserts are placed in culture wells filled with medium so that the slices are at the interface between the medium and the air; this interface allows oxygen to diffuse into the slice at a sufficiently high concentration to maintain tissue viability. Similarly, in the
roller-drum method, the slices are only submerged in medium for part of each cycle so that adequate oxygenation is maintained. In both methods, the slices are typically grown in a semisynthetic medium containing bovine or horse serum. Serum-free medium can also be used (Annis et al., 1990), most effectively after the cultures have become established.
Properties The defining feature of slice cultures is that they retain the characteristic anatomic organization of the tissue of origin. Because slice cultures are derived from neonatal brain slices, the tissue has not yet achieved its final degree of maturation and development at the time it is explanted. In neonatal brain tissue, neurons are still elaborating their dendritic trees, axons are growing, synaptogenesis is under way, cells may be migrating, and (in some brain regions) cells may still be undergoing mitosis. The degree to which
47
Organotypic Brain Slice Cultures
the culture retains its organotypic organization is therefore determined primarily by the age and maturity of the tissue at the time of explantation; older slices generally attain a more “organotypic” state. In the hippocampus, for example, many granule cells are born postnatally, and the granule cell layer is thus sometimes less well-formed than the pyramidal cell layer in slice cultures. Nevertheless, the relative proportions, transmitter phenotypes, and dendritic and axonal morphologies of most neurons in slice cultures are well preserved, even though many of these properties develop after explantation. Because of the inevitable severing of axons during the preparation of acutely prepared ex vivo brain slices, many projection pathways may be more intact in cultured slices than in ex vivo slices. It is nevertheless important to consider which extrinsic inputs are likely to be lost as the result of the tissue isolation. For example, loss of perforant path inputs to the dentate gyrus from the entorhinal cortex is likely to lead to some reorganization of mossy fibers (Laurberg and Zimmer, 1981). Likewise, there are likely to be reorganizational consequences of the loss of contralateral inputs in neocortical cultures, but this feature of cortical slice cultures has not been examined rigorously. Even removal of all extrinsic cholinergic afferents to the hippocampus does not prevent pyramidal cells in slice cultures from responding appropriately to cholinergic agonists (Gähwiler and Brown, 1985). It must be noted, however, that cultures from relatively unstudied brain regions will need to be characterized in detail to establish the degree to which they remain organotypic. One particular advantage of using cultured brain slices is that they can be maintained in vitro for prolonged periods. With hippocampal roller-tube cultures, for example, survival in vitro for 4 weeks is routine, and cultures can often survive for 6 weeks or longer. This property is particularly useful for studying the effects produced by chronic drug or toxin treatment; modifications of activity levels; or lesions, where the changes might be expected to occur slowly as gene expression is modified and proteins turn over. We have examined several aspects of synaptic structure, such as dendritic spine density, the distribution of spine morphologies, and axonal growth associated protein expression, to assess the maturity of the cultures (e.g., McKinney et al., 1999b). Our results with roller-tube hippocampal slice cultures indicate that synaptogenesis goes on during the first 2 weeks in vitro but remains stable in healthy cultures thereafter. Another defining feature of the slice culture technique is that the tissue becomes flattened during its development in vitro. This flattening, together with disappearance of the tissue that is inevitably damaged during the slicing procedure, endows cultured tissue slices with far superior optical properties than acutely prepared brain slices. The final thickness of the culture depends on the thickness of the original slice, the brain region cultured, the age of the neonatal animals used, and the type of culturing method. Hippocam-
pal brain slices prepared with the roller-tube method attain a final thickness of about 50 mm at the cell body layer (i.e., roughly three to five cells thick) and are somewhat thinner in the dendritic layers. Cerebellar cultures prepared from 1day-old rat pups, in contrast, become a true monolayer of cells (Gähwiler, 1981). In practice, this thinness allows investigators to attain high spatial resolution using standard wide-field fluorescence microscopy for many experimental applications without resorting to confocal or multiphoton microscopy. For example, we routinely perform fluorescence-based analysis of dendritic spine morphology and intracellular Ca2+ levels in single dye-loaded pyramidal cells in hippocampal slice cultures or carry out live-cell imaging of axonal growth and growth cones using wide-field fluorescence excitation and charge-coupled device (CCD) video imaging (Figure 2). Electrophysiologic recordings made over the last two decades from cultured brain slices have established that many types of neurons display the same repertoire of intrinsic ionic currents as neurons in acutely isolated ex vivo brain slices and that they express receptors for many of the same neurotransmitters. There are exceptions (Perrier et al., 2000), however, and investigators should be aware of the possibility that channel expression has changed as a result of changes in the level of ongoing synaptic activity. The synaptic physiology of cultured hippocampal slices has also been shown to closely resemble that described in ex vivo slices, indicating that much of the neuronal circuitry develops in vitro as it would in situ. Connections between CA1 pyramidal cells, for example, are rare in both ex vivo and cultured slices (Debanne et al., 1995; Thomson and Radpour, 1991). Furthermore, unitary excitatory postsynaptic responses, obtained via recordings from monosynaptically coupled pairs of CA3 pyramidal cells in hippocampal slice cultures, have amplitudes of about 1 mV or 15 pA (Debanne et al., 1995), values that are essentially identical to unitary excitatory postsynaptic potential/current (EPSP/ EPSC) amplitudes in ex vivo hippocampal slices (Miles and Wong, 1986) and quite unlike the amplitudes (of several nanoamperes) reported for dissociated cell cultures (Rothman and Samaie, 1985). In our experience, overall network excitability is also normal in healthy cultures. In designing electrophysiologic experiments in slice cultures, however, it is important to keep in mind that the circuitry is “more intact” than in ex vivo slices. The extracellular saline should therefore contain a more physiological K+ concentration (2–3 mM) and Ca2+ : Mg2+ ratio (1 : 1) than the salines typically used in ex vivo slice experiments (5 mM and 2 : 1, respectively).
Cocultures The physiology of long-range neural pathways in the brain is not amenable to study under well-controlled in vitro
48
Chapter 5/Use of Brain Slice Cultures for Study of Epilepsy
FIGURE 2 Fluorescence imaging in hippocampal slice cultures. A: Low-power charge-coupled device (CCD) video image of two CA1 cells biolistically transfected with DNA for green fluorescent protein in a hippocampal slice culture prepared using the roller tube method. Higher-power CCD images of dendritic spines along apical dendritic segments are shown below. Scale bars: 50 mm upper image, 2 mm lower images. B: CCD images of an axonal growth cone of a sprouting CA3 cell axon 5 days after Schaffer collateral transection. The pair of images was captured 15 minutes apart and illustrate the dynamic processes occurring at the growth cone during axonal growth. Scale bars: 1 mm. C: CCD images of an apical terminal dendrite injected intracellularly with a red fluorescent dye (Alexa 568)(left) and an image of the fluorescence emission of the Ca2+-sensitive dye fluo-4 in the same dendrite as the result of a glutamate-induced dendritic plateau potential (see Cai et al., 2004). Scale bars: 2 mm. These results illustrate the excellent optical properties of hippocampal slice cultures prepared with the roller-tube method.
conditions because it is difficult or impossible to maintain these contacts during the preparation of ex vivo slices. In slice cultures, however, slices from two brain regions that are normally connected in vivo can be cocultured adjacent to one another, and they will form connections in vitro. This approach has been taken for septo-hippocampal (Gähwiler and Brown, 1985), thalamocortical (Molnar and Blakemore, 1991), corticostriatal (Ostergaard et al., 1991), entorhinal cortex-hippocampal (Li et al., 1994), and locus coeruleus–hippocampal connections (Knöpfel et al., 1989). Some specificity is also maintained in the growth of these
fiber pathways, as illustrated by the observation that cholinergic fibers from medial septal cells will not grow into cerebellar tissue slices, just as they do not normally innervate the cerebellum in vivo unless they are “tricked” by the addition of nerve growth factor (Gähwiler and Hefti, 1987; Gähwiler et al., 1991).
Transgenics and Gene Transfection Many transgenic animals, as a consequence of their expression of a transgene or lack of an essential gene, fail
What Aspects of Epilepsy Can be Modeled with Cultured Brain Slices?
to survive more than a few hours or days after birth due to developmental defects (often not involving the nervous system) or to behavioral defects (such as failure to suckle). This problem obviously renders it difficult or impossible to characterize the transgene-mediated central nervous system (CNS) phenotype. Obtaining brain slices from these animals at a very young age and growing them as slice cultures provide a convenient means for circumventing this problem. We have used this approach with mice lacking the growth associated protein of 43 kD (GAP-43), for example (Capogna et al., 1999), which die within 24 to 48 hours of birth as a result of axonal growth defects (Strittmater et al., 1995). Organotypic brain slices also lend themselves well to acute transfection with recombinant DNA using a variety of methods, including viral vectors, biolistic transfection, and electroporation. Viral vectors used successfully to transfect cells in slice cultures include Semiliki Forest virus, Sindbis virus (Ehrengruber et al., 1999; Jeromin et al., 2003), adenovirus (Keir et al., 1999; Ridoux et al., 1995), herpes simplex virus (Bergold et al., 1993), vaccinia virus (Pettit et al., 1995), and lentivirus (Ehrengruber et al., 2001). A particular advantage of this approach is the possibility of injecting virus into subpopulations of neurons or into one part of a coculture so that the virally delivered gene product affects only presynaptic axonal or postsynaptic dendritic compartments (e.g., Wilkemeyer and Angelides, 1995). Biolistic transfection, in which gold microparticles coated with plasmid DNA are propelled into the tissue and cells by a brief blast of N2 gas from a “gene gun” (McAllister, 2000), is a particularly simple and efficacious method of transfection. Even though the transfection efficiency is exceedingly low (<10 neurons per culture), the level of expression is high, making it suitable for morphologic and electrophysiologic studies (e.g., Cai et al., 2004; Kolleker et al., 2003). Finally, electroporation, in which a strong pulsed electrical field is used to increase membrane permeability and to allow extracellular plasmid DNA to enter cells, has been reported to produce high levels of transfection. Two methods have been described: Cells in freshly cut slices can be electroporated by bathing them in a cDNA containing saline and then applying the field across the slice (Murphy and Messer, 2001; Stühmer et al., 2002). Alternatively electroporation can be performed in neonatal animals in vivo, followed by the explantation of the slices hours or days later (Miyasaka et al., 1999). For all methods, cell type–specific promoters can lead to expression in defined cell types, even when the cDNA cannot be targeted to those cells only (Stühmer et al., 2002). Finally, slices derived from knockout animals and acute transfection can be combined to allow powerful rescue and acute “knock-in” approaches, which are considerably simpler and quicker than the generation of transgenic animals (e.g., Kolleker et al., 2003).
49
Plasticity All types of cultured neurons seem to be useful for studying long-term depression (LTD) of excitatory synaptic responses. For reasons that remain unknown, however, conventional dissociated cell cultures are almost universally found not to support the induction of conventional long-term potentiation (LTP) (but see Fitzsimonds et al., 1997). In contrast, LTP is reliably induced in slice cultures in response to either tetanization of afferent inputs or pairing of lowfrequency stimulation and directly induced postsynaptic depolarization (Debanne et al., 1994; Stoppini et al., 1991). Further, the high probability of obtaining pairs of monosynaptically coupled cells in these cultures has allowed the plasticity of unitary synaptic responses to be studied in great detail (Debanne et al., 1996; Montgomery et al., 2001). Likewise, the excellent optical properties of slice cultures has facilitated the study of the morphologic correlates of synaptic plasticity (Engert and Bonhoeffer, 1999; Toni et al., 1999). Finally, the ease of transfection and the use of slices from transgenic animals have made slice cultures an accessible preparation in which to study the molecular basis of long-term potentiation expression in great detail (Kolleker et al., 2003).
WHAT ASPECTS OF EPILEPSY CAN BE MODELED WITH CULTURED BRAIN SLICES? The following are the key questions for any model system: What patterns of epileptiform activity can it generate? What epilepsy syndromes can be mimicked in the model? As with any preparation made from normal animals, no epileptiform activity is apparent in healthy cultures under control conditions. Applications of convulsants, including bicuculline, picrotoxin, tetraethylammonium (TEA), or low Mg2+- or high K+-containing saline, can trigger both interictaland ictal-like burst discharges that are synchronized throughout large cell populations in hippocampal slice cultures (e.g., Scanziani et al., 1994). These bursts appear essentially identical to those evoked in vivo or in acutely prepared hippocampal slices. Activity-dependent depression of g-aminobutyric acid (GABA)ergic synaptic inhibition, triggered by tetanic stimulation, also results in self-sustaining epileptiform discharge (Thompson and Gähwiler, 1989). It thus appears that sufficient circuitry is present within these cultures to support synchronized network activity and that the cellular network develops in such a way that synaptic inhibition and excitation are balanced appropriately. In the following sections, we describe experiments in which application of convulsants to slice cultures has been used to study the cellular basis of the neuropathology
50
Chapter 5/Use of Brain Slice Cultures for Study of Epilepsy
associated with human epilepsy, including cell death and loss of dendritic spines as well as other consequences of chronic epileptiform activity. We also describe studies in which slice cultures have been used to study the consequences of brain injury, including changes in excitability resulting from axonal injury and from denervation. Slice cultures are a valuable preparation for such studies because of the excellent experimental control afforded by the in vitro conditions. For example, inadequate blood supply during intense epileptiform discharge may result in local hypoxia, rendering it difficult to dissect the relative contribution of excitotoxicity to the neuropathology of epilepsy from that of metabolic insufficiency. Similarly, brain injuries in vivo include not only neuronal damage but also blood extravasation and clotting, inflammation and infiltration of cells from the immune system, and interruption of blood vessels. In vitro experimentation provides the means to distinguish among these possibilities. Of course it is essential to keep the potential limitations of such reduced preparations clearly in mind. The complicating factors mentioned above do, in fact, occur in the clinical setting and are undoubtedly important. Furthermore, cultured cells and tissue slices have been isolated from some of their normal inputs and have developed under in vitro conditions that are less than physiologic, but to an unknown degree. Investigators must remain aware that cell and tissue cultures may therefore have experienced some unknown plastic changes that alter the starting conditions and confound comparisons with other preparations. It is thus important that results from all in vitro preparations, including slice cultures, be replicated and compared with results from other “more intact” preparations and models.
Epilepsy-Associated Neuropathology Cell Death Ammon’s horn (or hippocampal) sclerosis, consisting of neuronal loss, gliosis, and atrophy of neuronal dendrites, is a common feature of the human epilepsies involving the temporal lobe (Meldrum and Corsellis, 1984; Scheibel et al., 1974). It is widely assumed that the death and injury of neurons is a direct consequence of the excessive glutamatergic excitation that characterizes epileptiform discharge. The mechanisms of excitotoxic neuronal death have been extensively studied in hippocampal slice cultures. Glutamate and virtually all of its receptor subtype-specific analogues can cause cell death in all principal cell groups in hippocampal slice cultures (Vornov et al., 1991). Nevertheless, because of their Ca2+ permeability, N-methyl-d-aspartate (NMDA) receptor-gated channels are prime suspects in excitotoxicity. Indeed there is evidence that NMDA receptor antagonists offer considerable neuroprotection against the consequences of ischemic/anoxic insults in slice cultures (Pringle et al., 1997; Tasker et al., 1992; Vornov et al., 1994).
NMDA receptors are also strongly activated during epileptiform activity, in both ex vivo and cultured slices (Scanziani et al., 1994). Not surprisingly, chronic epileptiform activity induced with a variety of convulsants leads to considerable cell death in hippocampal slice cultures (Kovacs et al., 1999; Thompson et al., 1996). The neuropathological changes associated with 3 days of convulsant treatment were eliminated by simultaneous application of NMDA and non-NMDA receptor antagonists, whereas neither MK-801 nor 6-Cyano-7-nitroquihoxaline-2,3-dione (CNQX) alone reduced convulsant-induced neurodegeneration significantly (Thompson et al., 1996). We concluded that only a small part of the convulsant-induced neuropathology in hippocampal slice cultures occurs as a result of the NMDA receptor–mediated excitotoxicity that has been described in response to exogenous glutamate. Presumably other mechanisms contribute to cell death associated with ongoing epileptiform discharge in slice cultures, such as free radical generation (Kovacs et al., 2002), excessive release of Zn2+ from the mossy fiber axons of dentate granule cells, Ca2+ influx via voltage-dependent Ca2+ channels, deficits in glutamate uptake (Simantov et al., 1999), metabolic insufficiency (Kovacs et al., 2001), or non-NMDA receptor– mediated excitotoxicity. Loss of Dendritic Spines The highly branched dendrites of hippocampal pyramidal cells are covered with dendritic spines, the small protrusions that form the postsynaptic side of excitatory synapses. Healthy pyramidal cells in situ, like those in slice cultures, have about one spine per micrometer of dendrite, for a total of 5000 to 10,000 spines per neuron. In addition to hippocampal sclerosis, dendritic deformities are also prominent in human hippocampal tissue taken at autopsy (Scheibel et al., 1974). These deformities include swollen and beaded dendrites and complete or partial loss of dendritic spines. Experiments in which hippocampal slice cultures were treated with convulsants have established that these changes are a direct result of epileptiform activity (Müller et al., 1993). After allowing cultures to mature for 14 days in vitro, 3 days of treatment with the convulsants bicuculline or picrotoxin caused pathological changes in dendritic morphology in cells that were not grossly swollen or vacuolated (i.e., they did not appear to be dying). Many cells had dendrites with numerous nodules that appeared to be swollen dendritic spines, resembling the “string-ofbeads” deformity described in pyramidal cells from sclerotic human hippocampi. In addition, the dendrites of most labeled cells in treated cultures displayed a significant reduction in the density of their dendritic spines. The reduction in spine density could vary between cells, even in the same culture, but was generally correlated with the number of degenerating cells. Similar results have been obtained in models of chronic focal epilepsy in situ (e.g., Jiang et al.,
What Aspects of Epilepsy Can Be Modeled with Cultured Brain Slices?
1998). Quantitative light and electron microscopic analysis (Drakew et al., 1996) indicated that the surviving spines undergo a significant decrease in their area. It was also observed that when cultures are returned to control saline for one week (after 3 days of treatment with convulsants), there is a significant recovery of dendritic spine density (Müller et al., 1993), providing a remarkable example of their capacity for structural plasticity. Many changes in the morphology of dendritic spines have been ascribed to Ca2+dependent changes in intracellular enzymatic activity, but NMDA receptor antagonists offered only partial protection of dendritic spines in convulsant-treated cultures (Thompson et al., 1996).
Consequences of Chronic Epileptiform Activity The severity of hippocampal sclerosis in human autopsy specimens is positively correlated with the number and severity of the patient’s seizures. This relationship has engendered considerable discussion about whether hippocampal sclerosis is a cause or consequence of epilepsy. We have used cultured hippocampal slices to test the hypothesis that seizure-induced neuronal injury is itself epileptogenic. We established that chronic epileptiform activity, produced by applying the convulsants picrotoxin or bicuculline for 3 days, mimics many of the pathological changes associated with epilepsy in humans, including neuronal degeneration (Müller et al., 1993). This neuropathology did not result in an increase in neuronal excitability, as might be expected if such pathological changes were causing epilepsy but was rather accompanied by a reduction in excitability and a reduction in evoked EPSP amplitudes. We concluded that hippocampal sclerosis does not necessarily cause epilepsy. Several hypotheses can be formulated to account for the decrease in EPSP amplitude in convulsant-treated cultures, including a decreased number of excitatory synapses, a decreased release of glutamate from each synapse, or a decreased number of glutamate receptors at each synapse. The loss of dendritic spines discussed previously suggests that there may be fewer excitatory synapses present in the treated cultures, although synaptic contacts between axon terminals and dendritic shafts may persist in these cultures after retraction of the spines. Evidence was obtained using in situ hybridization to support the hypothesis of a downregulation of postsynaptic glutamate receptors (GerfinMoser et al., 1995). Cultures were examined after only 2 days of convulsant treatment to avoid the neuronal degeneration observed after 3 days of epileptic activity. Significant reductions in mRNA levels for two non-NMDA, (alpha)-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA)-preferring glutamate receptor subunits (GluR-1 and GluR-2) were observed. These changes were found to
51
be specific, not the result of a general decrease in gene expression; the mRNA levels for other receptor subunits, such as several subtypes of GABAA or NMDA receptors, were unchanged (Gerfin-Moser et al., 1995). This observation also rules out a general decrease in gene expression attributable to cell death. Despite the lack of hyperexcitability immediately after convulsant treatment, it is possible that chronic epileptiform activity might, with longer survival times, become epileptogenic. One hypothesis suggests that axonal sprouting and a reorganization of excitatory synaptic circuitry occurs with some delay after a loss of neurons. A second hypothesis is that periods of epileptiform activity lead to a potentiation of excitatory synaptic transmission. There is excellent evidence that seizures can lead to axonal sprouting in vivo and in-slice cultures. Mossy fiber sprouting has been observed by Bausch and colleagues in hippocampal slice cultures treated with kaininc acid for 48 hours (Bausch and McNamara, 2004; Routbort et al., 1999). As in human temporal lobe epilepsy (Houser, 1999; Sutula et al., 1988), large numbers of mossy fibers were detected in the supragranular dendritic regions of the dentate gyrus, where there are normally very few mossy fibers. As in ex vivo slices taken from animals with supragranular mossy fibers, dentate granule cells in cultures with supragranular mossy fibers were hyperexcitable, responding to afferent and antidromic activation with prolonged excitatory postsynaptic currents and epileptiform bursts (Bausch and McNamara, 2004). At least some of this enhanced excitability was due to growth of CA1 pyramidal cell axons into the dentate gyrus (a lesion between the two regions reduced the abnormal activity). Whether axonal sprouting by CA1 cells into the dentate gyrus also occurs in vivo is not yet known. What triggers the mossy fibers to sprout in this model? Because deafferentation of granule cells or loss of hilar mossy cells are also associated with mossy fiber sprouting, it remains unclear whether this sprouting is compensatory and due to the induction of cell death (e.g., Benedikz et al., 1993) or rather whether sprouting is induced specifically by the increased activity. For example, the sprouting of mossy fibers and CA1 cell axons may be driven by the well-documented up-regulation of neurotrophins and neurotrophin receptors that is seen after seizures in vivo and in slice cultures (Poulsen et al., 2002, 2004). Although brain-derived neurotrophic factor (BDNF) is not essential for mossy fibers to sprout in slice cultures (Bender et al., 1998), it appears likely that some tyrosine receptor kinase B (trkB) neurotrophin receptor ligand may play a critical role. First, there is biochemical and immunocytochemical evidence of trkB activation at the time when the mossy fibers are sprouting (Binder et al., 1999a, b). Second, seizure-induced mossy fiber sprouting in hippocampal slice cultures is reduced or eliminated by functionally blocking anti-BDNF antibodies or pharmacological antagonists of trkB tyrosine kinase activity (Koyama et al., 2004).
52
Chapter 5/Use of Brain Slice Cultures for Study of Epilepsy
In addition to a delayed sprouting response, there is excellent evidence of a potentiation of excitatory synaptic transmission after a period epileptiform activity (Abegg et al., 2004), potentiation that could contribute to persistent hyperexcitability (Figure 3). After a 12-hour exposure of hippocampal slice cultures to convulsants, the frequency of spontaneous miniature EPSCs was increased, and there was an increase in the ratio of the AMPA- to NMDA-receptor mediated components of the evoked EPSC. This latter effect could be attributed to the insertion of postsynaptic AMPA receptors into previously “silent” synapses, as demonstrated directly using viral transfection with fluorescently tagged AMPA receptors. Such compelling data offer a biological basis at last for Gowers’ famous dictum: seizures beget seizures.
Miniature excitatory postsynaptic currents control
20 pA 500 ms
after epileptiform discharge
Evoked excitatory postsynaptic currents control
after epileptiform discharge NMDA
AMPA
FIGURE 3 Potentiation of excitatory synaptic transmission after chronic epileptiform discharge. Epileptiform activity was induced by convulsant application in hippocampal slice cultures maintained in vitro for more than 14 days. After 12 hours, electrophysiologic recordings were made from CA1 pyramidal cells. Cultures experiencing chronic epileptiform discharge displayed higher amplitudes and frequencies of miniature excitatory postsynaptic currents than untreated sister cultures (upper panels). In addition, the ratio of the AMPA- and N-methyl-d-aspartate (NMDA)-receptor mediated components of evoked excitatory postsynaptic currents, as determined at negative and positive holding potentials, respectively, was considerably higher after epileptiform activity. This can be seen most clearly by scaling the currents so that the NMDA components were of equal amplitude (lower panels), thus controlling for differences in stimulation intensity in the two sets of cultures. These data are consistent with an epilepsy-induced potentiation of excitatory synaptic transmission mediated via the insertion of postsynaptic AMPA receptors. Data taken and adapted from Abegg et al. (2004).
Consequences of Brain Injury Head trauma and brain injury are significant factors in the etiology of some epilepsies, but the underlying mechanisms have received little attention. The percentage of all victims of a serious head injury that go on to develop posttraumatic epilepsy has been estimated at 10 to 34%, depending on the severity of the injury. One of the strongest predictors of the likelihood of posttraumatic epilepsy is a penetration of the dura (Willmore, 1990). A striking characteristic of posttraumatic epilepsy is the variable delay between the trauma itself and the development of seizures, which can last from weeks to years. Following head trauma, some relatively slow processes must be triggered, ultimately building to a permanently epileptic state. We have used organotypic hippocampal slice cultures to develop an in vitro model of posttraumatic epilepsy that allows the mechanisms underlying the development of hyperexcitability to be investigated under carefully controlled in vitro conditions (McKinney et al., 1997). Lesions of the Schaffer collateral axons of CA3 pyramidal cells in hippocampal slice cultures were made using a razor blade shard after the cultures had been allowed to develop in vitro for more than 14 days. Although the hippocampus is almost never involved in human posttraumatic epilepsy, its beautiful organization allows the presynaptic and postsynaptic consequences of injury to be studied in isolation: CA3 cells undergo a selective axonal injury, whereas CA1 cells undergo a selective partial denervation. Presynaptic Changes after Injury An important clue about the nature of the lasting changes underlying the genesis of posttraumatic epilepsy was the discovery that considerable axonal reorganization can occur in the adult brain in response to neuronal injury. For CNS neurons, this process has been studied almost exclusively for the mossy fiber axons of dentate granule cells because of the ease and specificity with which they are labeled using the Timm’s stain (Danscher and Zimmer, 1978). The mossy fiber axons of dentate granule cells have been shown to develop supragranular collaterals in the dendritic region of the dentate gyrus in various rodent models of epilepsy as well as in the hippocampi removed from patients undergoing anterior lobectomy for drug refractory, partial complex epilepsy (Houser, 1999; Sutula et al., 1988, 1989). Physiologic studies indicate that the net effect of this sprouting is to increase the excitability of the tissue (e.g., Buckmaster and Dudek, 1999). Our study of injury after Schaffer collateral transection in slice cultures indicates that pyramidal cells may also regenerate after axonal injury (McKinney et al., 1997). We first filled living CA3 pyramidal cells with biocytin to visualize the morphology of individual cells. Axons extending away from the lesion toward the dentate gyrus were largely
53
What Aspects of Epilepsy Can Be Modeled with Cultured Brain Slices?
straight and unbranched, as were axons in unlesioned cultures. Collaterals of the axons growing toward the lesion, in contrast, were highly branched, had clear growth cones, and extended in circuitous, meandering trajectories. In addition, the number of presynaptic boutons per unit length along the meandering axons near the lesion was increased twofold compared with axons extending away from the lesion or axons in control cultures. We demonstrated that these collaterals were not merely preexisting axons that had become rearranged because of the proximity to the lesion but were in fact sprouted de novo by using an antibody directed against the growth-associated protein GAP-43. This protein is highly expressed early in development in vivo, when axons elongate, but is down-regulated to very low levels after synaptogenesis is complete (Skene, 1989). Consistent with these observations, GAP-43 immunoreactive fibers are numerous in hippocampal slice cultures after 3 days in vitro but are never seen by 14 days in vitro. In cultures in which the Schaffer collaterals were transected after 14 days in vitro, in contrast, there were numerous immunoreactive fibers with readily identifiable growth cones, beginning 3 days post lesion. By 14 days post lesion, large numbers of immunoreactive fibers crossed the lesion cavity itself and entered area CA1 (Figure 4). We showed that these regenerated axons form functional synapses with CA1 pyramidal cells and restore synaptic transmission across the lesion (McKinney et al., 1999a). By 21 days post lesion, there were no more GAP-43 immunoreactive fibers, suggesting that sprouting had ceased. However, transmission across the lesion persisted, indicating that the newly generated axons remained and were functional. These data thus provided direct evidence that hippocampal pyramidal cells can sprout new axon collaterals after injury (see also Perez et al., 1996). The slow time course of this growth is interesting in the context of delayed development of posttraumatic epilepsy. The functional consequences of this injury-induced axonal sprouting were examined electrophysiologically (McKinney et al., 1997). High frequencies of spontaneous EPSPs were observed in most intracellular recordings made from CA3 pyramidal cells 14 days post lesion. In addition, local stimulation within area CA3 elicited unusual polysynaptic EPSPs that were often suprathreshold for action potential initiation. Similar pathological synaptic responses have been observed in ex vivo slices taken from the vicinity of neocortical lesions (Prince and Tseng, 1993). There was a strong positive correlation between the levels of GAP-43 immunoreactivity and the frequency of spontaneous EPSPs in individual lesioned cultures. Lesioned and unlesioned cultures were indistinguishable in the amount of GABA immunoreactivity and in the amplitude of pharmacologically isolated GABAergic inhibitory postsynaptic potentials (IPSPs). Finally, most lesioned cultures responded to a challenge with a subconvulsive concentration of the GABAA
A
Five days after transection CA3 1
lesion
2
CA1
1
2 CA3
B Unlesioned CA3 CA1
FIGURE 4 Axonal sprouting after Schaffer collateral transection. Images of hippocampal slice cultures stained with an antibody against the growth associated protein, GAP-43, a marker for growing axons. A: Low-power charge-coupled device (CCD) image of the lesion site in a culture in which the Schaffer collateral pathway was transected 5 days earlier. Two higherpower confocal images from the labeled regions are shown below. Note the large number of immunoreactive fibers leaving the CA3 side of the lesion and growing toward area CA1. Numerous growth cones are visible at the tips of the growing axons. B: Confocal image of area CA3 in an unlesioned culture maintained in vitro for 14 days. Scale bars = 100 mm in upper panel of A, 25 mm in A1, A2, and B. These results illustrate the lack of growing axons in cultures at the time the lesion is made, and the strong upregulation of GAP-43 in newly sprouted axons originating in area CA3 and growing toward area CA1 after axonal injury.
receptor antagonist, bicuculline, by producing pronounced epileptiform discharges, whereas unlesioned cultures never did. Dual intracellular recordings made 14 to 21 days after the lesion revealed that the probability that any two CA3 pyramidal cells were connected by a monosynaptic excitatory synapse was increased by 50% (compared with unlesioned sister cultures). In addition, complex polysynaptic unitary EPSPs were readily elicited in lesioned cultures in response to pairs of presynaptic action potentials. This hyperexcitability outlasted the presence of immunoreactive sprouting axons, suggesting that the newly generated axons remain
54
Chapter 5/Use of Brain Slice Cultures for Study of Epilepsy
after GAP-43 expression has returned to undetectable levels. We concluded that the connectivity of the CA3 pyramidal cell population had increased after the axonal injury as a result of the sprouting of new axonal collaterals. Excitation was able to spread more readily among the population of CA3 pyramidal cells along these numerous, newly sprouted connections. Is this axonal sprouting a “culture artifact,” or is it relevant to “real” brains in situ? There are two reasons to believe that hippocampal slice cultures do indeed provide a useful model of hyperexcitability after brain injury. First, the low level of GAP-43 expression at 14 days in vitro indicates that the normal developmental phase of axonal elongation and synaptogenesis is complete at the time we make the lesion; the induced axonal sprouting thus represents plasticity of a mature system. Second, there is electron microscopic evidence of a reinnervation of area CA1 following Schaffer collateral transection in vivo (Goldowitz et al., 1979). Although the source of the regenerated presynaptic terminals in this study was not identified, it is reasonable to suspect that the presynaptic terminals were formed by regenerated Schaffer collaterals of ipsilateral CA3 pyramidal cells. We are currently taking advantage of the ability to control the extracellular environment of these cultures to explore the role of injury-induced neurotrophin secretion as trigger of axonal sprouting. We have shown that exogenous neurotrophins acting at trkB neurotrophin receptors promote axonal sprouting by pyramidal cells (Schwyzer et al., 2002) and are now examining injury-induced axonal sprouting in slice cultures from transgenic mice with reduced levels of trkB and in injured wild-type cultures exposed to immunoadhesion molecules that bind to and inactivate endogenously secreted neurotrophins. Postsynaptic Changes after Injury Although much of the current focus is on changes in synaptic circuitry and function as the cause of epilepsy, changes in intrinsic postsynaptic excitability or receptor expression are attracting increased attention (Bernard et al., 2004; Chen et al., 2001; Shah et al., 2004). There are several examples of injury-induced hyperexcitability in which amplification of intrinsic excitability has been implicated. First, axotomy increases the excitability of several cell types through alterations in the number and properties of intrinsic voltage-dependent ion channels (e.g., Abdullah and Smith, 2001). Second, denervation supersensitivity to acetylcholine is observed in denervated muscle as the result of an increased expression of receptors at both extrajunctional (Axelsson and Thesleff, 1959) and junctional sites (Davis and Goodman, 1998). A similar phenomenon also occurs in neurons. Decreasing postsynaptic activity in cultured cortical neurons with tetrodotoxin (TTX) results in increased postsynaptic receptor expression (Rutherford et al., 1998).
Finally, intrinsic excitability can also be increased following periods of low levels of cell discharge. Desai and colleagues (1999a) demonstrated that inactivation of cortical cell cultures with TTX leads to a very selective downregulation of voltage-dependent Na+ and K+ currents, perhaps including Ca2+-activated K+ current. It is noteworthy that the effects of TTX on the expression of both glutamate receptors and intrinsic conductances have been attributed to decreases in the activation of postsynaptic trkB receptors by endogenously released BDNF (Desai et al., 1996b; Rutherford et al., 1998). The possibility that injuries to brain regions susceptible to epilepsy induce similar changes in postsynaptic excitability via axonal damage, partial denervation, and decreased neuronal discharge has not yet been tested. How is the sensitivity of postsynaptic cells to synaptically released glutamate affected by axonal transection? Is there “denervation suprasensitivity”? We have taken advantage of the excellent optical properties of slice cultures to use laser microphotolysis, in which a brief pulse of ultraviolet light is focused within the preparation to cause release of chemically “caged” neurotransmitters, to study postsynaptic changes in cells in injured tissue. These experiments have yielded two exciting observations. First, we found that distal CA1 cell dendrites in control hippocampal cultures display all-or-none spike-like responses, called plateau potentials (Wei et al., 2001). Distal, terminal dendritic branches of CA1 cells responded to weak photolysis of glutamate with passive subthreshold depolarizations. Stronger glutamate applications, however, triggered all-or-none Cd2+sensitive responses. Calcium imaging revealed that the subthreshold responses generated only small local Ca2+ transients, whereas all-or-none responses resulted in Ca2+ signals throughout the stimulated dendritic segment. Intracellular 1,2-bis(o-amino-5-bromophenoxy) ethane-N,N. N’, N’-tetraacetic acid (BAPTA), apamin, and high concentrations of TEA prolonged the responses twofold to fourfold, suggesting that Ca2+-activated K+ conductance, mediated by the small conductance (SK) channel subtype, is responsible for their termination (Cai et al., 2004). We concluded that terminal dendrites respond to strong stimuli with an active spike, mediated by voltage-gated Ca2+ channels, that is confined to a single dendritic compartment. Such binary behavior could enable distal dendritic segments to perform parallel nonlinear processing of synaptic inputs. Second, we discovered that 7 days after Schaffer collateral transaction, CA1 cells display pathologically prolonged plateau potentials and an abnormal ability to produce action potentials in response to dendritic glutamate photolysis or synaptic stimulation. When we compared the effectiveness of photolysis of caged glutamate in the distal dendrites of CA1 cells in control unlesioned cultures with CA1 cells that had been deafferented 7 days earlier, we found no change in the amplitude or kinetics of the responses to the smallest
55
Conclusion
Control
Denervated
+ TTX 5 mV 200 ms
Glutamate photolysis
no TTX 20 mV 200 ms
FIGURE 5 Dendritic hyperexcitability in denervated CA1 cells. Membrane potential changes elicited with microphotolysis of caged glutamate to single distal apical dendrites of control cells (left column) and cells that were denervated 7 days earlier as the result of a Schaffer collateral transaction (right column). The responses in the upper row were obtained in the presence of tetrodotoxin (TTX) to block fast-action potentials, whereas the responses in the bottom row were obtained in the absence of TTX. In each panel a series of responses was elicited using a series of photolysis steps of increasing duration (see Wei et al., 2001). Note that dendritic plateau potentials are greatly prolonged after denervation and that this facilitates the triggering of fast-action potentials.
glutamate pulses, indicating that transmitter supersensitivity does not occur in this model. We did observe a striking prolongation of the responses in the deafferented cells, however. In deafferented cells, the duration of the plateau potentials was increased sevenfold compared with control cultures (Figure 5). We also observed a marked increase in the ability of dendritic excitation to trigger action potential discharge after Schaffer collateral transaction; whereas photolysis of caged glutamate on terminal dendrites never elicited action potential discharge in control cells, the prolonged plateau potentials always elicited prolonged trains of action potentials in denervated cells. We also asked whether this prolongation of plateau potentials might contribute to the hyperexcitability seen with synaptic stimulation after Schaffer collateral transection. Indeed, unusual evoked synaptic responses were recorded from CA1 cells in the vicinity of a lesion made 7 to 21 days earlier. These data suggest that increased postsynaptic excitation may contribute to lesion-induced hyperexcitability.
CONCLUSION In summary, cultured brain slices are an advantageous experimental preparation. Their use has facilitated important contributions to our understanding of the causes and consequences of epilepsy. These studies have provided support for
the hypothesis that epileptiform activity can damage brain tissue, both in terms of inducing irreversible cell death and also triggering the retraction of dendritic spines. These results are in good agreement with results from other in vitro and in vivo studies. Current advances in neuroimaging on human subjects are facilitating clinical investigations of the relationship between the onset of epilepsy and the detection of hippocampal sclerosis; such studies will provide the ultimate test of this hypothesis. Investigation of the consequences of injury in hippocampal slice cultures has led to the novel hypothesis that deafferented cells “downstream” from a traumatic CNS injury have an increased sensitivity to glutamate and exhibit increased excitability. Together with other studies that also point to the association of altered dendritic integration and epilepsy (e.g., Bernard et al., 2004), these findings suggest novel therapeutic targets for antiepileptic drugs and offer new explanations for the anticonvulsant actions of others (Poolos et al., 2002). In addition, the description of axonal sprouting by CA3 pyramidal cells in slice cultures after Schaffer collateral transection is consistent with in vitro and in vivo observations of mossy fiber sprouting in various epilepsy models and thus supports the hypothesis that reorganization of synaptic networks is an important causative factor in some acquired epilepsies. These findings indicate further that this sprouting phenomenon is not limited to dentate granule cells but may be more widespread than has previously been appreciated. Taken together, these studies further suggest that newly sprouted axons may be forming synaptic contacts with intrinsically hyperexcitable cells, a potentially explosive situation strongly favoring the occurrence of epileptiform activity. It is our hope that the descriptions provided here will stimulate other investigators to take advantage of the unique features of these organotypic slice cultures to advance our understanding of epilepsy. The bulk of the work done to date has been on hippocampal slice cultures. We hope that future studies will also focus on other brain regions, particularly the neocortex. Similarly, most studies have been performed on tissue from normal wild-type animals. The use of slice cultures from genetically modified animals with seizure phenotypes might aid in the understanding of how single gene mutations affect network properties. Finally, models of simplified injuries in cultured slices have been used for gene array screens (Long et al., 2003; Matzilevich et al., 2002; Morrison et al., 2000), and this approach is likely to become increasingly useful to help identify genes and gene pathways that contribute to the genesis of posttraumatic and other acquired epilepsies.
Acknowledgments Supported by a grant from the National Institutes of Neurological Disorders and Stroke to SMT.
56
Chapter 5/Use of Brain Slice Cultures for Study of Epilepsy
References Abdulla, F.A., and Smith, P.A. 2001. Axotomy- and autotomy-induced changes in the excitability of rat dorsal root ganglion neurons. J Neurophysiol 85: 630–643. Abegg, M.H., Savic, N., Ehrengruber, M.U., McKinney, R.A., and Gähwiler, B.H. 2004. Epileptiform activity in rat hippocampus strengthens excitatory synapses. J Physiol 554: 439–448. Annis, C.M., Edmond, J., and Robertson, R.T. 1990. A chemically-defined medium for organotypic slice cultures. J Neurosci Methods 32: 63–70. Axelsson, J., and Thesleff, S. 1959. A study of supersensitivity in denervated mammalian skeletal muscle. J Physiol 147: 178–193. Bausch, S.B., and McNamara, J.O. 2004. Contributions of mossy fiber and CA1 pyramidal cell sprouting to dentate granule cell hyperexcitability in kainic acid-treated hippocampal slice cultures. J Neurophysiol 92: 3575–3588. Bender, R., Heimrich, B., Meyer, M., and Frotscher, M. 1998. Hippocampal mossy fiber sprouting is not impaired in brain-derived neurotrophic factor-deficient mice. Exp Brain Res 120: 399–402. Benedikz, E., Casaccia-Bonnefil, P., Stelzer, A., and Bergold, P.J. 1993. Hyperexcitability and cell loss in kainate-treated hippocampal slice cultures. Neuroreport 5: 90–92. Bergold, P.J., Casaccia-Bonnefil, P., Zeng, X.L., and Federoff, H.J. 1993. Transsynaptic neuronal loss induced in hippocampal slice cultures by a herpes simplex virus vector expressing the GluR6 subunit of the kainate receptor. Proc Natl Acad Sci U S A 90: 6165–6169. Bernard, C., Anderson, A., Becker, A., Poolos, N.P., Beck, H., and Johnston, D. 2004. Acquired dendritic channelopathy in temporal lobe epilepsy. Science 305: 532–535. Binder, D.K., Routbort, M.J., and McNamara, J.O. 1999a. Immunohistochemical evidence of seizure-induced activation of trk receptors in the mossy fiber pathway of adult rat hippocampus. J Neurosci 19: 4616–4626. Binder, D.K., Routbort, M.J., Ryan, T.E., Yancopoulos, G.D., and McNamara, J.O. 1999b. Selective inhibition of kindling development by intraventricular administration of TrkB receptor body. J Neurosci 19: 1424–1436. Buckmaster, P.S., and Dudek, F.E. 1999. In vivo intracellular analysis of granule cell axon reorganization in epileptic rats. J Neurophysiol 81: 712–721. Caeser, M., Bonhoeffer, T., and Bolz, J. 1989. Cellular organization and development of slice cultures from rat visual cortex. Exp Brain Res 77: 234–244. Cai, X., Liang, C.W., Muralidharan, S., Kao, J.P., Tang, C.M., and Thompson, S.M. 2004. Unique roles of SK and Kv4.2 potassium channels in dendritic integration. Neuron 44: 351–364. Capogna, M., Fankhauser, C., Gagliardini, V., Gähwiler, B.H., and Thompson, S.M. 1999. Excitatory synaptic transmission and its modulation by PKC is unchanged in the hippocampus of GAP-43-deficient mice. Eur J Neurosci 11: 433–440. Chen, K., Aradi, I., Thon, N., Eghbal-Ahmadi, M., Baram, T.Z., and Soltesz, I. 2001. Persistently modified h-channels after complex febrile seizures convert the seizure-induced enhancement of inhibition to hyperexcitability. Nat Med 7: 331–337. Danscher, G., and Zimmer, J. 1978. An improved Timm sulphide silver method for light and electron microscopic localization of heavy metals in biological tissues. Histochemistry 55: 27–40. Davis, G.W., and Goodman, C.S. 1998. Synapse-specific control of synaptic efficacy at the terminals of a single neuron. Nature 392: 82–86. Debanne, D., Gähwiler, B.H., and Thompson, S.M. 1994. Asynchronous pre- and postsynaptic activity induces associative long-term depression in area CA1 of the rat hippocampus in vitro. Proc Natl Acad Sci U S A 91: 1148–1152.
Debanne, D., Gähwiler, B.H., and Thompson, S.M. 1996. Cooperative interactions in the induction of long-term potentiation and depression of synaptic excitation between hippocampal CA3-CA1 cell pairs in vitro. Proc Natl Acad Sci U S A 93: 11225–11230. Debanne, D., Guérineau, N.C., Gähwiler, B.H., and Thompson, S.M. 1995. Physiology and pharmacology of unitary synaptic connections between pairs of cells in areas CA3 and CA1 of rat hippocampal slice cultures. J Neurophysiol 3: 1282–1294. Desai, N.S., Rutherford, L.C., and Turrigiano, G.G. 1999a. Plasticity in the intrinsic excitability of cortical pyramidal neurons. Nat Neurosci 2: 515–520. Desai, N.S., Rutherford, L.C., and Turrigiano, G.G. 1999b. BDNF regulates the intrinsic excitability of cortical neurons. Learn Mem 6: 284–291. Drakew, A., Müller, M., Gähwiler, B.H., Thompson, S.M., and Frotscher, M. 1996. Spine loss in experimental epilepsy: quantitative light and electron microscopic analysis of intracellularly stained CA3 pyramidal cells in hippocampal slice cultures. Neuroscience 70: 31–45. Ehrengruber, M.U., Hennou, S., Bueler, H., Naim, H.Y., Deglon, N., and Lundstrom, K. 2001. Gene transfer into neurons from hippocampal slices: comparison of recombinant Semliki Forest Virus, adenovirus, adeno-associated virus, lentivirus, and measles virus. Mol Cell Neurosci 17: 855–871. Ehrengruber, M.U., Lundstrom, K., Schweitzer, C., Heuss, C., Schlesinger, S., and Gähwiler, B.H. 1999. Recombinant Semliki Forest virus and Sindbis virus efficiently infect neurons in hippocampal slice cultures. Proc Natl Acad Sci U S A 96: 7041–7046. Engert, F., and Bonhoeffer, T. 1999. Dendritic spine changes associated with hippocampal long-term synaptic plasticity. Nature 399: 66–70. Fitzsimonds, R.M., Song, H.J., and Poo, M.M. 1997. Propagation of activity-dependent synaptic depression in simple neural networks. Nature 388: 439–448. Gähwiler, B.H. 1981. Organotypic monolayer cultures of nervous tissue. J Neurosci Methods 4: 329–342. Gähwiler, B.H. 1984. Development of the hippocampus in vitro: cell types, synapses, and receptors. Neuroscience 11: 751–760. Gähwiler, B.H., and Brown, D.A. 1985. Functional innervation of cultured hippocampal neurones by cholinergic afferents from co-cultured septal explants. Nature 313: 577–579. Gähwiler, B.H., Capogna, M., Debanne, D., McKinney, R.A., and Thompson, S.M. 1997. Organotypic slice cultures: a technique has come of age. Trends Neurosci 20: 471–477. Gähwiler, B.H., Enz, A., and Hefti, F. 1987. Nerve growth factor promotes development of the rat septo-hippocampal cholinergic projection in vitro. Neurosci Lett 75: 6–10. Gähwiler, B.H., and Hefti, F. 1984. Guidance of acetylcholinesterasecontaining fibres by target tissue in co-cultured brain slices. Neuroscience 13: 681–689. Gähwiler, B.H., Rietschin, L., and Gerber, U. 1991. Cholinergic fiber growth in co-cultures of CNS tissue. J Physiol Paris 85: 154–157. Gähwiler, B.H., Thompson, S.M., McKinney, R.A., Debanne, D., and Robertson, R.T. 1998. Organotypic slice cultures of neural tissue. In Culturing Nerve Cells, 2nd ed. Eds. G. Banker and K. Goslin. pp. 461–498. Cambridge, MA: MIT Press. Gerfin-Moser, A., F. Grogg, L. Rietschin, S.M. Thompson, and P. Streit. 1995. Alterations in glutamate but not GABAA receptor subunit expression as a consequence of epileptiform activity in vitro. Neuroscience 67: 849–865. Goldowitz, D., Scheff, S.W., and Cotman, C.W. 1979. The specificity of reactive synaptogenesis: a comparative study in the adult rat hippocampal formation. Brain Res 170: 427–441. Houser, C.R. 1999. Neuronal loss and synaptic reorganization in temporal lobe epilepsy. Adv Neurol 79: 743–761.
References Jeromin, A., Yuan, L.L., Frick, A., Pfaffinger, P., and Johnston, D. 2003. A modified Sindbis vector for prolonged gene expression in neurons. J Neurophysiol 90: 2741–2745. Jiang, M., Lee, C.L., Smith, K.L., and Swann, J.W. 1998. Spine loss and other persistent alterations of hippocampal pyramidal cell dendrites in a model of early-onset epilepsy. J Neurosci 18: 8356–8368. Keir, S.D., House, S.B., Li, J., Xiao, X., and Gainer, H. 1999. Gene transfer into hypothalamic organotypic cultures using an adeno-associated virus vector. Exp Neurol 160: 313–316. Knöpfel, T., Rietschin, L., and Gähwiler, B.H. 1989. Organotypic cocultures of rat locus coeruleus and hippocampus. Eur J Neurosci 1: 678–689. Kolleker, A., Zhu, J.J., Schupp, B.J., Qin, Y., Mack, V., Borchardt, T., Köhr, G., et al. 2003. Glutamatergic plasticity by synaptic delivery of GluRBlong-containing AMPA receptors. Neuron 40: 1199–1212. Kovacs, R., Gutierrez, R., Kivi, A., Schuchmann, S., Gabriel, S., and Heinemann, U. 1999. Acute cell damage after low Mg2+-induced epileptiform activity in organotypic hippocampal slice cultures. Neuroreport 10: 207–213. Kovacs, R., Schuchmann, S., Gabriel, S., Kardos, J., and Heinemann, U. 2001. Ca2+ signalling and changes of mitochondrial function during low-Mg2+-induced epileptiform activity in organotypic hippocampal slice cultures. Eur J Neurosci 13: 1311–1319. Kovacs, R., Schuchmann, S., Gabriel, S., Kann, O., Kardos, J., and Heinemann, U. 2002. Free radical-mediated cell damage after experimental status epilepticus in hippocampal slice cultures. J Neurophysiol 88: 2909–2918. Koyama, R., Yamada, M.K., Fujisawa, S., Katoh-Semba, R., Matsuki, N., and Ikegaya, Y. 2004. Brain-derived neurotrophic factor induces hyperexcitable reentrant circuits in the dentate gyrus. J Neurosci 24: 7215–7224. Laurberg, S., and Zimmer, J. 1981. Lesion-induced sprouting of hippocampal mossy fiber collaterals to the fascia dentata in developing and adult rats. J Comp Neurol 200: 433–459. Li, D., Field, P.M., Yoshioka, N., and Raisman, G. 1994. Axons regenerate with correct specificity in horizontal slice culture of the postnatal rat entorhino-hippocampal system. Eur J Neurosci 6: 1026–1037. Long, Y., Zou, L., Liu, H., Lu, H., Yuan, X., Robertson, C.S., and Yang, K. 2003. Altered expression of randomly selected genes in mouse hippocampus after traumatic brain injury. J Neurosci Res 71: 710–720. Matzilevich, D.A., Rall, J.M., Moore, A.N., Grill, R.J., and Dash, P.K. 2002. High-density microarray analysis of hippocampal gene expression following experimental brain injury. J Neurosci Res 67: 646–663. McAllister, A.K. 2000. Biolistic transfection of neurons. http://stke. sciencemag.org/cgi/content/full/OC_sigtrans;2000/51/pl1. McKinney, R.A., Bandtlow, C., Gähwiler, B.H., and Thompson, S.M. 1999a. Selective glutamate receptor antagonists can induce or prevent axonal sprouting in rat hippocampal slice cultures. Proc Natl Acad. Sci U S A 96: 11631–11636. McKinney, R.A., Capogna, M., Dürr, R., Gähwiler, B.H, and Thompson, S.M. 1999b. Miniature synaptic events maintain dendritic spines via AMPA receptor activation. Nat Neurosci 2: 44–49. McKinney, R.A., Debanne, D., Gähwiler, B.H., and Thompson, S.M. 1997. Lesion-induced axonal sprouting and hyperexcitability in the hippocampus in vitro: implications for the genesis of posttraumatic epilepsy. Nat Med 3: 990–996. Meldrum, B.S., and Corsellis, J.A.N. 1984. Epilepsy. In Greenfield’s Neuropathology Eds. J.H. Adams, J.A.N. Corsellis, and L.W. Duchen. pp. 921–950. New York: Wiley Medical. Miles, R., and Wong, R.K. 1986. Excitatory synaptic interactions between CA3 neurones in the guinea-pig hippocampus. J Physiol 373: 397–418. Miyasaka, N., Arimatsu, Y., and Takiguchihayashi, K. 1999. Foreign gene expression in an organotypic culture of cortical anlage after in vivo electroporation. Neuroreport 10: 2319–2323.
57
Molnar, Z., and Blakemore, C. 1991. Lack of regional specificity for connections formed between thalamus and cortex in coculture. Nature 351: 475–747. Montgomery, J.M., Pavlidis, P., and Madison, D.V. 2001. Pair recordings reveal all-silent synaptic connections and the postsynaptic expression of long-term potentiation. Neuron 29: 691–701. Morrison, B., Eberwine, J.H., Meaney, D.F., and McIntosh, T.K. 2000. Traumatic injury induces differential expression of cell death genes in organotypic brain slice cultures determined by complementary DNA array hybridization. Neuroscience 96: 131–139. Müller, M., Gähwiler, B.H., Rietschin, L., and Thompson, S.M. 1993. Reversible loss of dendritic spines and altered excitability after chronic epilepsy in hippocampal slice cultures. Proc Natl Acad Sci U S A 90: 257–261. Murphy, R.C., and Messer, A. 2001. Gene transfer methods for CNS organotypic cultures: a comparison of three nonviral methods. Mol Ther 3: 113–121. Ostergaard, K., Schou, J.P., Gähwiler, B.H., and Zimmer, J. 1991. Tyrosine hydroxylase immunoreactive neurons in organotypic slice cultures of the rat striatum and neocortex. Exp Brain Res 83: 357–365. Perez, Y., Morin, F., Beaulieu, C., and Lacaille, J.C. 1996. Axonal sprouting of CA1 pyramidal cells in hyperexcitable hippocampal slices of kainate-treated rats. Eur J Neurosci 8: 736–748. Perrier, J.F., Noraberg, J., Simon, M., and Hounsgaard, J. 2000. Dedifferentiation of intrinsic response properties of motoneurons in organotypic cultures of the spinal cord of the adult turtle. Eur J Neurosci 12: 2397–2404. Pettit, D.L., Koothan, T., Liao, D., and Malinow, R. 1995. Vaccinia virus transfection of hippocampal slice neurons. Neuron 14: 685–688. Poolos, N.P., Migliore, M., and Johnston, D. 2002. Pharmacological upregulation of h-channels reduces the excitability of pyramidal neuron dendrites. Nat Neurosci 5: 767–774. Poulsen, F.R., Jahnsen, H., Blaabjerg, M., and Zimmer, J. 2002. Pilocarpine-induced seizure-like activity with increased BNDF and neuropeptide Y expression in organotypic hippocampal slice cultures. Brain Res 950: 103–118. Poulsen, F.R., Lauterborn, J., Zimmer, J., and Gall, C.M. 2004. Differential expression of brain-derived neurotrophic factor transcripts after pilocarpine-induced seizure-like activity is related to mode of Ca2+ entry. Neuroscience 126: 665–676. Prince, D.A., and Tseng, G.F. 1993. Epileptogenesis in chronically injured cortex: in vitro studies. J Neurophysiol 69: 1276–1291. Pringle, A.K., Iannotti, F., Wilde, G.J., Chad, J.E., Seeley, P.J., and Sundstrom, L.E. 1997. Neuroprotection by both NMDA and non-NMDA receptor antagonists in in vitro ischemia. Brain Res 755: 36–46. Ridoux, V., Robert, J., Perricaudet, M., Mallet, J., Le Gal La Salle, G. 1995. Adenovirus mediated gene transfer in organotypic brain slices. Neurobiol Dis 2: 49–54. Rothman, S.M., and Samaie, M. 1985. Physiology of excitatory synaptic transmission in cultures of dissociated rat hippocampus. J Neurophysiol 54: 701–713. Routbort, M.J., Bausch, S.B., and McNamara, J.O. 1999. Seizures, cell death, and mossy fiber sprouting in kainic acid-treated organotypic hippocampal cultures. Neuroscience 94: 755–765. Rutherford, L.C., Nelson, S.B., and Turrigiano, G.G. 1998. BDNF has opposite effects on the quantal amplitude of pyramidal neuron and interneuron excitatory synapses. Neuron 21: 521–530. Scanziani, M., Debanne, D., Müller, M., Gähwiler, B.H., and Thompson, S.M. 1994. Role of excitatory amino acid and GABAB receptors in the generation of epileptiform activity in disinhibited hippocampal slice cultures. Neuroscience 61: 823–832. Scheibel, M.E., Crandall, P.H., and Scheibel, A.B. 1974. The hippocampaldentate complex in temporal lobe epilepsy. Epilepsia 15: 55–80.
58
Chapter 5/Use of Brain Slice Cultures for Study of Epilepsy
Schwyzer, L., Mateos, J.M., Abegg, M., Rietschin, L., Heeb, L., Thompson, S.M., Lüthi, A. et al. 2002. Physiological and morphological plasticity induced by chronic treatment with NT-3 or NT-4/5 in hippocampal slice cultures. Eur J Neurosci 16: 1939–1948. Shah, M.M., Anderson, A.E., Leung, V., Lin, X., and Johnston, D. 2004. Seizure-induced plasticity of h channels in entorhinal cortical layer III pyramidal neurons. Neuron 44: 495–508. Simantov, R., Crispino, M., Hoe, W., Broutman, G., Tocco, G., Rothstein, J.D., and Baudry M. 1999. Changes in expression of neuronal and glial glutamate transporters in rat hippocampus following kainate-induced seizure activity. Brain Res Mol Brain Res 65: 112–123. Skene, J.H.P. 1989. Axonal growth-associated proteins. Ann Rev Neurosci 12: 127–156. Stoppini, L., Buchs, P.A., and Muller, D. 1991. A simple method for organotypic cultures of nervous tissue. J Neurosci Methods 37: 173–182. Strittmatter, S.M., Fankhauser, C., Huang, P.L., Mashimo, H., and Fishman, M.C. 1995. Neuronal pathfinding is abnormal in mice lacking the neuronal growth cone protein GAP-43. Cell 80: 445–452. Stühmer, T., Anderson, S.A., Ekker, M., and Rubenstein, J.L. 2002. Ectopic expression of the Dlx genes induces glutamic acid decarboxylase and Dlx expression. Development 129: 245–252. Sutula, T., Cascino, G., Cavazos, J., Parada, I., and Ramirez, L. 1989 Mossy fiber synaptic reorganization in the epileptic human temporal lobe. Ann Neurol 26: 321–330. Sutula, T., He, X.X., Cavazos, J., and Scott, G. 1988. Synaptic reorganization in the hippocampus induced by abnormal functional activity. Science 239: 1147–1150. Tasker, R.C., Coyle, J.T., and Vornov, J.J. 1992. The regional vulnerability to hypoglycemia-induced neurotoxicity in organotypic hippocampal culture: protection by early tetrodotoxin or delayed MK-801. J Neurosci 12: 4298–4308.
Thomson, A.M., and Radpour, S. 1991. Excitatory connections between ca1 pyramidal cells revealed by spike triggered averaging in slices of rat hippocampus are partially NMDA receptor mediated. Eur J Neurosci 3: 587–601. Thompson, S.M., Fortunato, C., McKinney, R.A., Müller, M., and Gähwiler, B.H. 1996. Mechanisms underlying the neuropathological consequences of epileptiform activity in the rat hippocampus in vitro. J Comp Neurol 372: 515–528. Thompson, S.M., and Mason, S.E. 2004. Preparation of organotypic hippocampal slice cultures. In Cell Biology: A Laboratory Handbook, 3rd ed. Ed. J. E. Celis. Amsterdam: Elsevier. Toni, N., Buchs, P.A., Nikonenko, I., Bron, C.R., and Muller, D. 1999. LTP promotes formation of multiple spine synapses between a single axon terminal and a dendrite. Nature 402: 421–425. Vornov, J.J., Tasker, R.C., and Coyle, J.T. 1991. Direct observation of the agonist-specific regional vulnerability to glutamate, NMDA, and kainate neurotoxicity in organotypic hippocampal cultures. Exp Neurol 114: 11–22. Vornov, J.J., Tasker, R.C., and Coyle, J.T. 1994. Delayed protection by MK801 and tetrodotoxin in a rat organotypic hippocampal culture model of ischemia. Stroke 25: 457–464. Wei, D.S., Mai, Y.A., Bagal, A., Kao, J.P., Thompson, S.M., and Tang, Y.A. 2001. Compartmentalized and binary behavior of terminal dendrites in hippocampal pyramidal cells. Science 293: 2272–2275. Wilkemeyer, M.F., and Angelides, K.J. 1995. Adenovirus-mediated expression of a reporter gene in thalamocortical cocultures. Brain Res 703: 29–38. Willmore, J.L. 1990. Post-traumatic epilepsy: cellular mechanisms and implications for treatment. Epilepsia 31: S67–S73. Zimmer, J., and Gähwiler, B.H. 1984. Cellular and connective organization of slice cultures of the rat hippocampus and fascia dentate. J Comp Neurol 228: 432–446.
C
H
A
P
T
E
R
6 Hippocampal Slices: Designing and Interpreting Studies in Epilepsy Research CHRISTOPHE BERNARD
possible to identify it and correlate its morphologic properties (e.g., dendritic and axonal arbors) with its electrophysiologic characteristics. The intracellular constituents of the cell can also be retrieved and its mRNA contents determined. The development of imaging techniques, in particular multiphoton microscopy, now allows investigators to assess cellular and network function using such measures as [Ca2+]i variations in specific cell compartments (dendrites, spines) or the behavior of large populations of cells (and even neuronal networks) with voltage-sensitive fluorescent dyes. The slice preparation is thus versatile and well suited for multidisciplinary research strategies.
INTRODUCTION: DESCRIPTION OF THE HIPPOCAMPAL SLICE PREPARATION General Features of Acute Slice Preparations The development of the brain slice preparation by Yamamoto and McIlwain (Yamamoto and McIlwain, 1966) allowed major breakthroughs in the understanding of basic neurobiological processes. All fields of neuroscience benefited from this development, including anatomy, physiology, pharmacology, molecular biology, biochemistry, biophysics, and computer modeling. Brain slices, usually thin sections about 400 mm thick, can be maintained in viable condition for extended periods (>12 hours) in vitro. The slice preparation allows for easy access to many features of the tissue that would be very difficult to measure otherwise (i.e., in vivo), but at the same time it preserves much of the complex organization of the tissue. Most in vitro studies involve electrophysiologic recordings that may take different forms. Extracellular recordings are used to study population properties, including synaptic responses and neuronal firing. These parameters can be measured before and after an experimental manipulation. Within the slice, the investigator can apply a variety of stimuli, such as electrical activation of axons (e.g., to trigger synaptic plasticity) or pharmacologic treatment. In addition to the direct consequences of such stimuli on the electrophysiologic responses of the tissue, a variety of other correlated parameters can be measured (e.g., changes in gene expressions, phosphorylation levels etc.). Intracellular recordings (with sharp or patch electrodes) allow a more microscopic approach to the characterization of synaptic responses, properties of ionic channels, etc. If the recorded cell is filled with a dye, it is
Models of Seizures and Epilepsy
Specific Features of Hippocampal Slices: Comparison with Intact Preparations The advantages of the slice preparation can be summarized as follows: (1) Slices are thick enough to preserve some circuitry of a given brain area. This advantage is particularly marked in hippocampal slices, where the regular orientation and approximately lamellar organization of the structure is amenable to slices within which multisynaptic connections are maintained. (2) At the same time, the slice and its in vitro character significantly simplify much of the complexity associated with experimental protocols on intact animal preparations. This feature is also striking in hippocampal slices, which offer a window to a complex cortical structure that is integrated in widespread networks with the rest of the brain and has been implicated in complex cognitive function. (3) Stimulating and recording electrodes can be visually guided to desired positions. Because of the regular hippocampal structure, major cell types (composing densely packed cell body-containing layers) are easily
59
Copyright © 2006, Elsevier Inc. All rights of reproduction in any form reserved.
60
Chapter 6/Hippocampal Slices: Designing and Interpreting Studies in Epilepsy Research
identified. Different interneuron cell bodies reside in wellstudied locations relative to these primary cell bands, and dendritic trees and axon arbors can be targeted for both stimulation and recording, based on detailed knowledge of their trajectories, features that are maintained in the slice. Thus the investigator can use a simple binocular microscope to position electrodes for population or “blind” cellular recordings (or stimulation). In addition, electrodes can be very precisely manipulated using infrared/differential interference contrast (DIC) or epifluorescence video microscopy to target specific cell types. (4) Intracellular recordings are more stable in slices than in vivo because there is no mechanical movement resulting from heartbeat or respiration (a recurrent problem of in vivo recordings). (5) Other technical approaches can be easily combined with slice electrophysiology. Despite these technical advantages, several drawbacks must be taken into account, especially when extrapolating the results of in vitro studies to the “real” in vivo situation. Brain function relies on oxygen and energy delivery, which normally occurs via exchanges at the level of blood capillaries. The relationships between oxygen delivery and energy supply and demand are complex. Indeed, studies have shown that there is a direct spatiotemporal coupling between neuronal activity and cerebral blood flow in microcircuits (Chaigneau et al., 2003). These relationships are not reproduced in hippocampal slices. Similarly, the slice “ignores” the immune signaling system; this system cannot be separated from neuronal function because immune proteins play an important role in neuronal development, synaptic plasticity, and neurologic disorders (Boulanger and Shatz, 2004). Hormones also influence neuron behavior and the construction of networks (Gahr, 2004). These reciprocal “blood-immuno-endocrino-neuronal” interactions are lost in the slice preparation. Glucose is provided at a fixed level, O2 is saturated, and no hormone is present in the artificial cerebrospinal fluid (aCSF). The composition of aCSF itself is an important issue. The CSF contains many metabolites, including amino acids, sometimes in large concentrations (such as glutamate, g-aminobutyric acid [GABA], glutamine, taurine, glutathione, etc.) These metabolites are not usually included in aCSF, and the functional consequences of such omission remain to be determined. Finally, when one is investigating a given brain structure in vitro, many of its intrinsic and most of its extrinsic connections are severed. The hippocampus is a typical example. In adult rats, a 400-mm-thick transverse slice represents less than one tenth the whole hippocampal structure. Because axonal arbors of hippocampal neurons usually have a large extension along the longitudinal axis (Freund and Buzsáki, 1996), many intrinsic connections are lost. Extrinsic connections from the contralateral hippocampus and extrahippocampal structures (septum, entorhinal cortex, parahippocampus, thalamus, etc.) are also severed. Although
many of the primary glutamatergic and GABAergic synaptic pathways are preserved within a slice, inputs that provide important modulatory function (dopaminergic, serotonergic, cholinergic, etc.) are cut. Even at the single-cell level, the slicing procedure leads to significant losses. For example, the neurons that are contained within a given slice usually have a significant portion of their own axonal and dendritic arbors severed. As a result many cells die (e.g., at least 50% of somatostatinergic interneurons in the CA1 region of the hippocampus, unpublished observation). The surviving circuitry is thus highly truncated and only approximately represents the original hippocampal network. Despite these limitations, the hippocampal slice preparation remains a useful system in which to investigate numerous neurobiological issues, such as basic properties of synapses, receptors, etc. Indeed, the hippocampal slice preparation has provided the basis for much of today’s insight into the cellular and molecular biology of neurons. The investigator simply must be cautious in interpretation and extrapolation of results, particularly those dealing with network properties. For example, the hippocampus in vivo is known to spend most of its time oscillating at various frequencies (Buzsaki, 2002; Klausberger et al., 2003). Spontaneous oscillations do occur in vitro, in the in toto (i.e., the “intact” hippocampus) preparation (Khalilov et al., 1997) prepared from animals at early developmental stages. Apart from slices from the ventral hippocampus (Colgin et al., 2004; Kubota et al., 2003), they do not occur spontaneously in adult structures in vitro, and they must be induced by pharmacologic manipulations or electrical stimulation (Whittington and Traub, 2003). How these in vitro oscillations relate to the in vivo oscillatory behavior is not known. In summary, hippocampal slices are particularly suited to studying the details of microcircuitry. Caution should be used, however, when interpreting network properties.
WHAT TYPES OF EPILEPTIC ACTIVITY CAN BE MODELLED IN HIPPOCAMPAL SLICES? The organization, generation, and propagation of seizures in temporal lobe epilepsy (TLE) can be understood via the concept of the epileptic zone (Talairach et al., 1974). TLE is indeed a disease (or perhaps a set of disorders) involving neuronal networks within the temporal lobe. In TLE, seizures engage different structures, not only at their onset (ictogenesis) but also during their course of propagation. Most past studies of TLE have concentrated on the hippocampus as the key structure in seizure generation and spread, and thus studies of hippocampal slices may provide insight into seizure activity associated with TLE. It should be noted, however, that several reports have proposed that various cortical structures participate in ictogenesis (Bartolomei et al.,
Methods of Generation (Preparing Good Slices)
1999; Munari et al., 1994; Spencer and Spencer, 1994; Talairach et al., 1974; Wieser, 1983), with particular attention focused on the critical involvement of the entorhinal cortex (EC) in ictogenesis. The EC has extensive reciprocal connections with the hippocampus and neocortical and paralimbic regions (perirhinal cortex, temporal pole). Neuropathological (Du et al., 1995) and neuroradiologic (Bernasconi et al., 1999, 2000, 2001) data have revealed anomalies within the rhinal cortex of patients with mesial TLE, but the relationship between those observations and electrophysiologic data remains hypothetical. If extrahippocampal structures are involved in the type of epilepsy under consideration, the isolated hippocampal slice might not be the best preparation for elucidating more complex seizure networks associated with TLE (e.g., see chapter 4 for consideration of the combined hippocampal-entorhinal slice). Nevertheless, hippocampal slices are useful for studying the propagation of seizures. With this preparation, one can examine some of the relationships associated with TLElike discharges (e.g., the relationships between ictal and interictal activity). Most of the extrinsic—and many of the intrinsic—connections are severed in the hippocampal slice, so it is hardly surprising that ictal-like discharges do not occur spontaneously in slices obtained from human resections or animal models. The same connectivity issues may be relevant to the paucity of spontaneous interictal-like activities in these preparations, although they can occasionally be recorded in human tissue (Cohen et al., 2002). As a consequence, ictalor interictal-like discharges must, in most hippocampal slice experiments, be artificially induced. Several different protocols can be used, as described in the section Studying Epilepsy Using the Slice Preparation. One major drawback with artificially induced epileptiform activity in vitro is the absence of behavioral and clinical seizure correlates. To address this obvious problem, experimenters have generally tried to produce electrographic seizure equivalents in vitro. An in vitro equivalent of an in vivo TLE-like seizure should satisfy several conditions. Before its occurrence, interictal activity can (should?) be present; that is, large-amplitude field potential “spikes” (in the clinical electroencephalographic [EEG] sense). Individual spikes last up to 100 ms and may occur in bursts. Just before seizure onset, these spikes may increase in amplitude, become more rhythmic (~1 Hz), and display striking synchrony when recorded across different hippocampal subregions and limbic structures. There is then a flattening of the EEG (field potential) signal, and the seizure starts with a high frequency (~20 Hz) discharge. The electrographic seizure then typically consists of tonic rhythmic discharge and clonic bursting phases (rhythmic spikes that increase in amplitude and then decrease in frequency). Alternatively TLE-like seizures may start independently of interictal activity; such seizures usually have the same electrographic signature with seizures
61
lasting 30 to 60 seconds. These general descriptions, based on EEG recordings from intact animals (or humans) with TLE-associated seizures, provide the general target for experiments using slices that focus on seizure activity involving hippocampus. Can we match that description in hippocampal slices?
METHODS OF GENERATION (PREPARING GOOD SLICES) The method and care of slice preparation will determine the tissue’s viability and in large part the validity and applicability of the experimental results obtained in the preparation. Every laboratory uses its own “magical” tricks to prepare good slices. Variations include the type of anesthetic used before decapitating the animal. Some laboratories find that slice quality is improved when animals (before decapitation) are intracardially perfused cold (~ 4° C) oxygenated aCSF in which NaCl is replaced by an equimolar concentration of sucrose or choline (Hirsch et al., 1996; Hoffman and Johnston, 1998). Other tricks include the use of glutamatergic antagonists or low Ca2+/high Mg2+ (0.5/6.0 mM) concentrations in the modified aCSF to prevent glutamate excitotoxicity and to reduce synaptic transmission. The use of prior brain perfusion becomes a critical issue when juvenile or adult brains are used (>21 days postnatal). A pump can be used for these perfusions, although a simple gravity system is sufficient. The temperature should be controlled, as a too-cold (0° C) aCSF is deleterious. The next step is to remove the brain from the skull as quickly as possible. The detail of this manipulation depends somewhat on the animal species. In rats the difficulty of this process increases with age because the bone becomes thicker and harder. Once the bone covering the cerebellum is removed, it is possible to make a cut along the midline with sharp scissors. Rongeurs or pliers can be used to remove the top part of the skull in one rotating movement. The dura should then be carefully cut so that the brain can be safely extracted using a scoop. The intact brain is then placed into a beaker of ice-cold oxygenated, modified aCSF. This procedure should not take more than 15 to 20 seconds (from time of decapitation). Although it will be more cumbersome, the whole extraction procedure can be performed with the animal’s head submerged in ice-cold oxygenated, modified aCSF. The extracted brain is then prepared for the slicing procedure. Standard procedures for cutting hippocampal slices in rats include removing the cerebellum and the most frontal regions of cortex. The hemispheres are then typically separated. If a “chopper” is used, the hippocampus is removed from the brain and placed on a cutting stage. Caution must
62
Chapter 6/Hippocampal Slices: Designing and Interpreting Studies in Epilepsy Research
be used to limit the mechanical stresses and stretches. Most hippocampal slice studies use transverse sections, that is, slices cut perpendicular to the longitudinal axis of the hippocampus. Because of the curvature of the hippocampus (Figure 1A), it is not possible to obtain transverse slices from the whole hippocampus without artificially stretching the structure. When a vibroslicer is used to cut slices (Figure 1B), the investigator may leave the hippocampus embedded within the whole brain hemisphere and glue the hemisphere onto a support block. Although leaving the hippocampus protected inside the hemisphere reduces the number of slices that can be made in the “transverse” orientation, this procedure offers the advantage of lesser manipulation of the hippocampal structure before slicing. Further, by cutting the brain surface (to be glued to the support block) at an appropriate angle, the experimenter can manipulate the orientation of the slice with respect to the longitudinal axis of the hippocampus and thus “expose” hippocampal substructures of particular interest (e.g., for recording from pyramidal cell dendrites) (Hoffman et al., 1997).
A
The slicing procedure itself is a critical step. A vibroslicer with minimal Z-deflection and a glass or sapphire blade should be used for best results. Optimal slicing parameters (e.g., cut speed, amplitude, frequency of oscillation of the blade) depend on the preparation. Tissue from adult animals cut differently from tissue from immature animals because of the presence of choroid tissue, myelin, etc. Tissue from rats and mice cut somewhat differently from, for example, primate hippocampus, not least of all because of the different size of the structure in these different species. The issue of cutting parameters becomes particularly important when preparing slices from the human brain (following extraction of an epileptic hippocampus during surgery for medically intractable TLE), as the density and rigidity of the tissue may be very different according to the underlying reorganizations (sclerosis, gliosis, etc.). Cutting slices from immature brain presents the investigator with other types of challenges. Because the immature rat hippocampus easily “falls apart” when sliced, it is preferable to keep it embedded within the rest of the hemisphere during cutting, and to
B
C Longitudinal axis
FIGURE 1 A: Schematic showing the three-dimensional organization of the hippocampus within a rodent brain. B: Schematic showing key features of the slice-cutting procedure. The cortex (not shown) containing the hippocampus is glued on an agar block. Transverse slices are limited to the ventral part of the hippocampus. C: Typical transverse hippocampal slice showing the major cell regions within a slice. The hippocampal slices typically consist of the dentate gyrus (with granule cells), the CA3 and CA1 pyramidal cell regions, and the subiculum. Thick lines represent the distribution of the somata of the principal neurons (granule cells in the dentate gyrus and pyramidal cells in the CA3 and CA1 regions).
Studying Epilepsy Using the Slice Preparation
use a very slow forward speed and a high-frequency oscillation. Whatever the type of tissue, a general “rule of thumb” is to use a slow forward speed and large lateral amplitude and high frequency oscillation. However, it is important to invest the necessary time in establishing the appropriate set of parameters for a given preparation (and slicing equipment). As stressed already, all the experimental procedures and data depend on the quality of the slices. Slice thickness is another critical parameter, and it usually represents a compromise between the desired amount of intrinsic connectivity and the experimenter’s ability to provide adequate oxygenation to the core of the slice. Slices from adult tissue are rarely thicker than 400 mm. In the immature brain, this limit is less critical; the whole hippocampus can survive for 48 hours in vitro (Khalilov et al., 1997). Not all the slices made from a given hippocampus are useful for a given set of experiments. Which slices are chosen depends on the goals of the study. For example, the connectivity patterns in the ventral, dorsal, and midhippocampus are very different (Moser and Moser, 1998; Witter and Groenewegen, 1984). Physiologic features may also vary according to the slice location (along the longitudinal axis) and orientation (Ferbinteanu and McDonald, 2001). Slices are normally cut into cold aCSF and then transferred (for “storage”) into a holding chamber at room temperature. Slices needed for study are transferred to the recording chamber. The choice of interface versus submerged chamber system is another critical issue, and each offers its own advantages. For example, extracellular space (ES) is reduced when an interface chamber is used, thus increasing the ephaptic interactions, a potentially important issue in epilepsy studies (Schuchmann et al., 2002). Ictallike discharges are more easily obtained in interface versus submerged chambers. All perfusion systems should allow for a continuous flow of aCSF into the recording chamber. The perfusion speed appears to be a critical parameter because biologically relevant hippocampal rhythms can be recorded only when high flow rates (i.e., >4 ml/min vs. the usual 1.5 ml/min) are used (Hajos et al., 2004; Wu et al., 2002). Differences in such apparently subtle parameters may explain interlaboratory discrepancies, for example, when using interface versus submerged chambers (Bracci et al., 1999). A higher flow rate (with O2-saturated aCSF) is usually needed for submerged chambers in which all oxygenation is derived from the medium. In contrast, much of the oxygen supply to slices in interface chambers is derived from the O2-saturated gas environment above the tissue. A typical aCSF formulation consists of (in millimolar): NaCl 125, KCl 2.5, CaCl2 2, MgCl2 2, NaH2PO4 1.25, NaHCO3 25, and dextrose 10. The aCSF is equilibrated with 5% CO2/95% O2 gas which is bubbled through the solution. The concentrations of K+, Ca2+, and Mg2+ are particularly variable (within 1 mM or so) from laboratory to laboratory.
63
These concentrations are important because even minor changes in these ionic concentrations will alter cell and network excitability, synaptic transmission, and intracellular processes. As pointed out earlier, typical slice aCSF does not contain many metabolites that are usually contained in the CSF of intact animals. To be “more relevant” to physiologic conditions, slice experiments should be performed close to physiologic temperature (~35° C). Below 30° C, transporters, ionic channels, etc., have different biophysical properties. Working close to physiologic temperature, however, raises a number of challenges. First, there is often a “dead space” between the system that warms aCSF (e.g., a temperature-regulated water bath) and the recording chamber. Therefore, aCSF will have to be warmed to a higher temperature than the target, raising the risk of precipitation (e.g., Ca2+) and driving out needed oxygen. One can reduce the dead space by using a system close to the recording chamber. However, such a system is normally of smaller capacity and must also be set to a high level because the time that the aCSF spends in the warming apparatus is so short. The best technical solution is to use two warming systems: a temperature-regulated bath to prewarm aCSF and a small system close to the chamber for final adjustment. These temperature control issues are particularly difficult when high flow rates are used. There are two good tests to check the condition of a slice. The first one involves a visual inspection with infrared microscopy. The surface of the slice should be planar, and the neurons at the surface should be healthy, that is, having no “balloon-like” somata (with a clearly visible nucleus) and no dying neurons (with a strong black-and-white contrast soma contour). The second test involves determining whether oscillations can be induced (Hajos et al., 2004). This latter assessment can be performed even when “blind” cellular or field recording techniques are used.
STUDYING EPILEPSY USING THE SLICE PREPARATION Many different types of epilepsy exist. Hence multiple models have been developed, for example, partial or generalized epilepsies and convulsive or nonconvulsive epilepsies. A similar diversity of “models” has been reported using the hippocampal slice preparation (and variations thereon), most focusing on generating activity relevant to TLE. Many different issues can be addressed in the slice preparation. A major area of investigation has been the issue of ictogenesis, including where ictal discharges are generated, how they propagate, how they stop (or how we can stop them), and what underlying mechanisms might be involved. Another important theme involves studies of epileptogenesis, that is, what processes lead to an epileptic state following an initial insult. In pursuit of these and related questions, two general
64
Chapter 6/Hippocampal Slices: Designing and Interpreting Studies in Epilepsy Research
types of preparations have been used for the past three decades: (1) brain slices obtained from “normal” animals, in which in vitro manipulations have been used to generate epileptiform activities; and (2) brain slices obtained from human patients or chronically epileptic animals. Slices from human patients are difficult to obtain and study (see chapter 8), and generating epileptic animals is time consuming (as described elsewhere in this volume). Many investigators thus turned to normal brain slices to study ictogenesis. In addition to easy accessibility, the extensive (but far from complete) knowledge of the underlying network architecture of hippocampus, and of its physiological properties, has facilitated the design of such experiments and the interpretation of their results. The main drawback of these “acute” models is that little structural pathological change is apparent in these normal circuits. In contrast, most investigators believe that in temporal lobe epilepsy, the network architecture has been considerably modified (cell loss, sprouting, protein modifications etc.). The “rules” and insights derived from acute studies must therefore be reviewed with caution in trying to understand the mechanisms of chronic epilepsies. In the following sections, I describe a number of the acute models generated in hippocampal slices and briefly comment on the use of slices to study chronic models. Before doing so, however, it is important to consider the issue of the age of the animal from which the slice is made. Rats 5 to 6 weeks old are considered adults. Before this age, the rat’s neuronal networks in the hippocampus are still developing and undergo considerable modifications. During the first postnatal week in the rat, GABA acts as an excitatory neurotransmitter (Ben Ari, 2002), GABAergic interneurons are the source and targets of the first synapses (Gozlan and Ben Ari, 2003), and neuronal network activity results from the synergistic excitatory actions of GABA and glutamate (Ben Ari et al., 1989; Leinekugel et al., 2002). At these young ages, many connections are lacking, and neurons continue to proliferate and migrate to their proper target regions. The state of such a developing network and its functioning mode are quite different from the adult brain. This early period of rodent development corresponds roughly to the last trimester of gestation in infrahuman primates (Khazipov et al., 2001) and (perhaps) in humans (Clancy et al., 2001). Because GABA switches from a depolarizing to a hyperpolarizing mode well before birth in infrahuman primates (Khazipov et al., 2001), studies performed in rodents during the first 2 postnatal weeks may be relevant primarily to in utero epilepsy in human. The following weeks are characterized by a refinement of connections, myelination, changes in receptor subunit composition, channel expression, etc. (Fritschy et al., 1994; Katz & Shatz, 1996; Meier et al., 2004; Ritter et al., 2002; Stellwagen and Shatz, 2002; Tansey et al., 2002). How the time points of these changes correspond to human developmental stages is unknown.
This issue of age relevance is important for many slice studies because recordings are typically carried out on slices from animals between postnatal days 14 and 21. This timing choice is dictated largely by technical considerations, an empirical consensus that it is easiest to prepare slices from these young animals and that slice viability is superior (e.g., compared with slices from more mature animals). As suggested, it is possible to argue that experiments performed on 6-week-old rodents are relevant to human (adult?) epilepsy because the hippocampal neuronal networks have been stabilized in their mature forms. However, in slice studies on rats (or mice) between the second and the sixth postnatal week, it is particularly difficult to extrapolate the data to human epileptic phenomena. Not only is “matching” ages difficult, but the situation is also complicated by the fact that maturation of different cells, different systems, and different molecular controls occur at different speeds (and span different periods) in rodents and in humans. While there is no “solution” to this problem, it is important to keep these issues in mind while designing experiments and interpreting in vitro results.
Acute Models of Epilepsy Several in vivo models of ictal-like and inter-ictal-like activity have been developed in hippocampal slices, including slices challenged with high-frequency electrical stimulation (Somjen et al., 1985), GABAA-receptor antagonists (Schwartzkroin and Prince, 1978; Swann and Brady, 1984), kainic acid (KA) (Fisher and Alger, 1984; Westbrook and Lothman, 1983), K+ channel blockers (Galvan et al., 1982), low [Ca2+]o (Jefferys and Haas, 1982; Taylor and Dudek, 1982), no [Mg2+]o (Anderson et al., 1986) or high [K+]o (Traynelis and Dingledine, 1988). As detailed later, some models reproduce some features of interictal activity and others produce tonic-clonic discharges. These models have several advantages. They are easy to implement, and pathological discharges emerge with high reproducibility. The slice preparation allows easy access to numerous parameters, including activity patterns of neuronal populations, propagation of signals from one subregion to the next, synaptic inputs in individually recorded cells, and pharmacologic responsiveness of different patterns of paroxysmal discharges. Electrical Stimulation-Induced Afterdischarge Ictal-like afterdischarges displaying tonic- and cloniclike phases can be evoked following tetanic stimulation (40–50 pulses at 100 Hz) applied in CA1 stratum radiatum (Figure 2A). The tonic-clonic phase appears after several stimulations, suggesting a long-term potentiation-like effect (Rafiq et al., 1993). The afterdischarge is composed of several epochs, with a sequence of slow and fast oscillations
Studying Epilepsy Using the Slice Preparation
65
A
B
C
D
FIGURE 2 A: Progression of afterdischarge waveform and duration, recorded in the CA1 region in response to stimulation of the Schaffer collaterals. (Adapted from Rafiq et al., 1993.) The graph at the right shows the gradual increase in afterdischarge duration with repeated stimuli. B: Interictal-like and ictal-like activities recorded in the disinhibited CA1 minislice. Left panel: Simultaneous intracellular recordings of a pyramidal cell soma (top) and dendrite (bottom), showing an interictal discharge (shown at a faster time scale below) followed by an ictal-like discharge (duration, 7 seconds). Upper right panel: Experimental design showing the cuts performed to isolate the CA1 region and the positions of the recording electrodes. Lower right panel: Bar graph showing the duration of ictal-like activity as a function of the g-aminobutyric acid (GABA) antagonist used. Bic, bicuculline; PTX, picrotoxin; GBZ, gabazine 100 mm. (Adapted from Karnup and Stelzer, 2001.) C: Simultaneous field and intracellular recordings in the CA1 region showing interictal-like activity induced by 1 mm kainic acid. (Adapted from Fisher and Alger, 1984.) D: Simultaneous field and whole-cell patch-clamp recordings in the CA3 region, showing ictal-like activity induced by 100 mm 4-AP in toto. (Adapted from Luhmann et al., 2000.)
followed by a silent postictal depression and a secondary discharge. This pattern is similar to that found in afterdischarges evoked in vivo (Bragin et al., 1997). The mechanisms underlying physiologic oscillations often involve interneurons (Freund and Buzsáki, 1996), and so afterdischarges constitute a good model for studying synchronization via local circuits (including the role of N-methyl-d-aspartate [NMDA] receptors) (Stasheff et al., 1985, 1993), interneurons and depolarizing GABA (Bracci
et al., 1999; Fujiwara-Tsukamoto et al., 2003, 2004; Kaila et al., 1997; Staley et al., 1995; Velazquez and Carlen, 1999; Whittington et al., 1997) as well as ephaptic interactions (Bracci et al., 1999). Combining electrophysiology (intracellular recording) and morphology (intracellular labeling) allows the investigator to dissect out key features of specific hippocampal sub-networks (Fujiwara-Tsukamoto et al., 2004). This model of electrically induced afterdischarge has been discussed as potentially relevant to ictal discharges in
66
Chapter 6/Hippocampal Slices: Designing and Interpreting Studies in Epilepsy Research
human temporal lobe epilepsy (Stasheff et al., 1985). As mentioned previously, these experiments are performed on hippocampal slices from normal animals, and translating the results to chronic epilepsy is somewhat dangerous. For example, CA1 stratum oriens interneurons are directly involved in the synchronization process during the afterdischarge (Fujiwara-Tsukamoto et al., 2004); yet a large number of these interneurons are lost in chronic epilepsy (Cossart et al., 2001; Dinocourt et al., 2003). Nevertheless, it is intriguing to note that NMDA receptors and depolarizing GABA play an important role in evoked afterdischarges (Staley et al., 1995; Stasheff et al., 1985). In chronic epilepsy, the NMDA receptor-dependent component of synaptic transmission is considerably increased (Turner and Wheal, 1991) and fast GABAergic neurotransmission becomes, in part, excitatory (Cohen et al., 2002).
as CA3 pyramidal cells (Westbrook and Lothman, 1983) and interneurons (Cossart et al., 1998; Frerking et al., 1998), leading them to generate action potentials. KA also has a multiplicity of presynaptic effects on glutamatergic and GABAergic terminals (Huettner, 2003) as well as on ionic channels (Melyan et al., 2002). Despite its epileptogenicity in vivo (Ben Ari and Cossart, 2000) and its ability to generate g-oscillations (40 Hz) at nanomolar concentration in vitro (Buhl et al., 1998; Fisahn et al., 1998), KA has not been extensively used to study the initiation and propagation of interictal-like discharges in the hippocampal slice preparation. A study performed in the intact (in toto) hippocampus (in vitro) described the development of a “mirror focus” in contralateral (naïve) hippocampus when the ipsilateral hippocampus was challenged with KA (Khalilov et al., 2003). Blocking K+ Channels
GABAergic Disinhibition Pharmacologic blockade of GABAA receptors has been used extensively to study epileptiform activity in vitro. In the absence of fast GABAergic neurotransmission, synchronized inter-ictal-like bursts can occur (Miles and Wong, 1986, 1987; Schwartzkroin and Prince, 1978; Wong et al., 1986). Not surprisingly, these bursts depend on fast glutamatergic neurotransmission to activate (alpha) amino-3hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/KA and NMDA receptors (Simpson et al., 1991; Williamson and Wheal, 1992). In general, the generation of ictal-like events in vitro requires additional pharmacologic manipulations (at least in mature tissue), such as elevating [K+]o (Traub et al., 1996). However, ictal-like events can be recorded in slices from the immature brain (Khalilov et al., 1997; Swann and Brady, 1984). Further, ictal-like activity is present in the disinhibited CA1 minislice of adult guinea pigs (Figure 2B) (Karnup and Stelzer, 2001). The usefulness of the disinhibited hippocampal slice model, at least for studying ictogenesis, is questionable because GABAergic neurotransmission appears to be quite robust (even increased) in chronic temporal lobe epilepsy (Bernard et al., 2000; Cossart et al., 2001; Esclapez et al., 1997). However, blocking fast GABAergic neurotransmission may be a useful approach to unravel changes in excitatory circuits in chronic epilepsy (Esclapez et al., 1999; Meier and Dudek, 1996; Patrylo and Dudek, 1998). Kainic Acid-Induced Epileptiform Activity Bath application of kainic acid KA induces spontaneous interictal-like activity in hippocampal slices (Figure 2C). KA has multiple presynaptic and postsynaptic effects, and so the underlying bases for this KA effect remains unclear (Ben Ari and Cossart, 2000; Huettner, 2003). KA can directly depolarize neurons that express KA receptors, such
Blocking K+ channels with 10 to 30 mm 4-aminopyridine (4-AP) produces ictal-like discharges in the olfactory cortex (Galvan et al., 1982). In the hippocampus, 50 mm 4-AP depolarizes neurons (Perreault and Avoli, 1989) and induces interictal-like (Voskuyl and Albus, 1985) or ictal-like (Chesnut and Swann, 1988) discharges (Figure 2D). This model can be used to study the propagation of paroxysmal discharges between different regions (Luhmann et al., 2000), the role of GABAergic neurotransmission in such discharges (Perreault and Avoli, 1992), the transition between interictal- and ictal-like discharges (Dzhala and Staley, 2003b), and synchronization mechanisms (Netoff and Schiff, 2002). However, it appears particularly useful in combined hippocampus—EC slices (see chapter 4). Low Extracellular Ca2+ Lowering [Ca2+]o (nominally to 0 mM) abolishes neurotransmission and results in spontaneous paroxysmal discharges (Figure 3A) (Jefferys and Haas, 1982; Taylor and Dudek, 1982). These events arise focally and spread through the CA1 region (Konnerth et al., 1984). This model may be particularly valuable for the study of synchronization mechanisms (Bikson et al., 2003) and for investigating interventions to abort/stop these discharges (Ghai et al., 2000). Epileptiform Discharges in the Absence of [Mg2+]o Removing Mg2+ from aCSF results in the appearance of spontaneous interictal-like discharges in slices from juvenile/adult animals (Anderson et al., 1986). This model could be clinically relevant because low levels of Mg2+ have been associated with human epilepsy (Durlach, 1967). Removing [Mg2+]o allows NMDA receptors to respond directly and robustly to glutamate excitation (Figure 3B) (Mody et al., 1987). This model allows for the study of propagation of
Studying Epilepsy Using the Slice Preparation
A
67
B
D C
FIGURE 3 A: Ictal-like discharges recorded in low [Ca2+]o in the CA1 region. Traces are shown at different time scales (expanded time frame in middle trace, slower time frame below). (Adapted from Konnerth et al., 1986.) B: Spontaneous epileptiform discharges recorded in Mg2+-free artificial cerebrospinal fluid (aCSF). These discharges were modulated by application of the N-methyl-d-aspartate (NMDA) receptor antagonist APV. (Adapted from Mody et al., 1987.) C: Spontaneous ictal-like discharge recorded in the CA1 region in toto, in Mg2+-free aCSF. (Adapted from Quilichini et al., 2002.) D: Spontaneous ictal-like discharges recorded in the CA1 region in slices exposed to elevated extracellular [K+]. Different portions of the discharge are displayed at different time scales. (Adapted from Traynelis and Dingledine, 1988.)
epileptiform activity and the role of interneurons in those discharges (Perez Velazquez, 2003). Interestingly, although not present in acute hippocampal slices, ictal-like discharges can be recorded in Mg2+-free aCSF in the in toto immature hippocampal preparation (Figure 3C) (Quilichini et al., 2002). This preparation is useful for testing antiepileptic drugs (Quilichini et al., 2003). The electrographical signature of the discharge is very similar to that recorded in patients. Elevated K+ Model of Epilepsy
complex network questions such as the mechanisms of fast ripples at seizure onset (Dzhala and Staley, 2004) and the transition from interictal to ictal activity (Dzhala & Staley, 2003b). This model is particularly useful because it causes an elevation of the general excitability of all neural networks; it is noteworthy that elevations of [K+]o comparable in magnitude to the K+ changes imposed on hippocampal slices occur during seizures in vivo (Fisher and Alger, 1984; Lothman, 1976; Moody, 1974).
Chronic Models of Epilepsy
Bathing slices with 8.5 mM K results in the occurrence of spontaneous tonic-clonic discharges (Figure 3D) (Traynelis and Dingledine, 1988). Under these conditions, it is possible to investigate the role of GABAergic neurotransmission (Dzhala and Staley, 2003a), the behavior of the different hippocampal cell types (McBain, 1994), and +
Hippocampal slices can be obtained from chronic animal models of epilepsy. The technical advantages of the slice to investigate detailed cellular and synaptic phenomena has been particularly important in studying models of TLE and epileptogenesis, such as the kindling, kainate, and pilocarpine models. Two epochs following an epileptogenic
68
Chapter 6/Hippocampal Slices: Designing and Interpreting Studies in Epilepsy Research
event or stimulus have been investigated: the chronic phase of epilepsy, during which the animals display spontaneous recurrent seizures (epilepsy), and the latent period, the interval between the initial insult and the first spontaneous seizure (epileptogenesis). The hippocampus undergoes considerable modifications during epileptogenesis as well as during the chronic phase. In designing experiments focused on these issues, the investigator must consider this “reactive plasticity” to be a dynamic process and assume that results may vary, depending on what parameters are measured and when. An obvious advantage of studying hippocampal slices from chronic animal models (as opposed to studying epileptiform phenomena in “normal” tissue) is the fact that these animals are epileptic. This fact allows the investigator to analyze parameters that are correlated with the epileptic state or may be causally related to ictogenesis. Unfortunately, as suggested already, interictal-like or ictal-like discharges have not been reported to occur—under physiologic conditions—in slices obtained from epileptic animals. However, slices from the ventral hippocampus, in which spontaneous waves can be recorded, remain to be tested (Colgin et al., 2004; Kubota et al., 2003). Further, the epileptogenic challenges described in the previous section (e.g., GABAA receptor blockade, high K+, low Mg2+, etc.) can be used to unveil the epileptic propensity of slices from chronic models. Comparing the pattern and properties of interictallike or ictal-like activity between control and epileptic slices may reveal important information about functional reorganizations (e.g., sprouting of excitatory axons) that take place during epileptogenesis or during the chronic phase of epilepsy (Cronin et al., 1992; Hardison et al., 2000; Lynch and Sutula, 2000; Patrylo and Dudek, 1998; Patrylo et al., 1999; Wuarin and Dudek, 1996). Another use of these slices is to investigate the details of modifications of hippocampal circuitry associated with the epileptic state. Questions are usually related to the fate of glutamatergic and GABAergic pathways as well as of ionic channels. Many studies are based on a multidisciplinary approach that combines electrophysiology, functional morphology, or molecular biology (Bernard et al., 2004; Brooks-Kayal et al., 1998; Buhl et al., 1996; Chen et al., 2001, 2003; Cossart et al., 2001; Esclapez et al., 1997, 1999; Nusser et al., 1998; Ratzliff et al., 2004; Scharfman et al., 2000; Su et al., 2002). As indicated already, the main difficulty in applying slice approaches to studying chronic animal models lies in interpretation of the data. Seizures in temporal lobe epilepsy usually involve several limibic regions. The exact anatomic location(s) of seizure initiation and of the propagation patterns remain unknown, and there is high variability from one patient to another. Thus it is still unclear where the investigator should look in the hippocampal slice for TLE-related abnormalities. It is perhaps more useful to focus on epilepsyinduced plasticity and to use the slice preparation to eluci-
date the details of these changes. Even here, however, much of the connectivity is lost in the slice preparation—even from normal animals—and so correlating slice abnormalities with epilepsy-related pathology may be hazardous. Nevertheless using the hippocampal slice preparation to identify parameters in which alterations could be potentially “proepileptic” may provide new therapeutic targets (Bernard et al., 2004; Su et al., 2002).
FUTURE DIRECTIONS Seizures recruit several regions and thousands of neurons. Thus, ideally one should use a model system that maintains those regions and their connections, that is, an in vivo approach. Historically many investigators lost interest in such complex preparations because in vitro slices were developed to offer more powerful technical approaches. However, advances have suggested that cellular electrophysiologic techniques, for example, patch-clamp recordings (Khazipov and Holmes, 2003), can now be applied to intact model systems (although here the use of anaesthetics is an important issue to consider). The in toto hippocampal in vitro preparation represents an interesting “compromise” between in vitro slice and intact approaches. Most experiments performed in the slice can be done in toto, where network properties can be more effectively investigated (Khalilov et al., 1997, 2003). This preparation is limited, however, to the first postnatal week in rats (Khalilov et al., 1997) and (with some adaptation) to adult mice (Wu et al., 2002). The slice preparation allows high throughput in terms of data generation, but it has been limited to the fine analysis of single cells (with intracellular recordings) or the gross behavior of small populations of neurons (with extracellular recordings). Recent technical advances, particularly with imaging methods, now allow for the study of network properties in the slice preparation. For example, it is possible to record the activity of thousands of neurons simultaneously with high-speed two-photon calcium imaging systems (Figure 4A) and then to record from individual neurons to obtain access to more microscopic properties (Cossart et al., 2003). Another technical approach is to apply voltagesensitive dyes to the preparation. Their use is still limited because of their deleterious effects and low signal-to-noise ratio, but they can provide useful information about the mechanisms underlying the initiation and propagation of ictal and interictal discharges (Figure 4B) (Otsu et al., 2000).
CONCLUSION In summary, the main limitation of the slice preparation is the massive loss of intrinsic and extrinsic connectivity.
69
References
FIGURE 4 A: Two-photon imaging of the CA1 region of a hippocampal slice from a mouse. Pyramidal cell somata are clearly visible in the pyramidal cell layer (P); interneurons are visible in stratum oriens (O) and stratum radiatum (R). Neurons are filled with a Ca2+ indicator, and variations in [Ca2+]i are measured. Electrophysiologic properties of any individual neuron can also be recorded. For example, the inset shows the spontaneous activity recorded in a stratum oriens interneuron (Rosa Cossart, personal communication). B: Spatiotemporal patterns of neuronal activity evoked in the dentate gyrus in control and kainic acid (KA)-treated rat hippocampal slices. Level of neuronal activity is displayed according to the pseudocolor code (from background gray to highly activated red). (Adapted from Otsu et al., 2000.) (See color insert.)
Hence the main pitfall lies in the interpretation of the results and their applicability to epileptogenic conditions in intact systems. Slice preparations, however, can provide some insight into the connectivity and the transfer of information from one hippocampal subregion to another. Despite the issues of interpretation and applicability, comparing control and “epileptic” hippocampal slices has proven very useful for unraveling seizure-related modifications in network properties. Arguably the best use of the hippocampal slice preparation is for analysis of the reorganizations that take place within the various hippocampal networks during the latent period and the chronic phase of epilepsy as established within intact animal models. Such modifications give profound insights into epilepsy-associated brain plasticity. The future of this research focus lies, at least in part, in the simultaneous analysis of group and individual cell properties (e.g., with fluorescent dyes and patch-clamp recordings) in relevant models (e.g., a transgenic animal carrying the same mutation found in patients and displaying the same type of epilepsy). In this way the hippocampal slice constitutes an adjunctive approach to studying many of the models that are presented in other chapters in this volume.
References Anderson, W.W., Lewis, D.V., Swartzwelder, H.S., and Wilson, W.A. 1986. Magnesium-free medium activates seizure-like events in the rat hippocampal slice. Brain Res 398: 215–219. Bartolomei, F., Wendling, F., Vignal, J.P., Kochen, S., Bellanger, J.J., Badier, J.M., Bouquin-Jeannes, R. et al. 1999. Seizures of temporal lobe epilepsy: identification of subtypes by coherence analysis using stereoelectro-encephalography. Clin Neurophysiol 110: 1741–1754. Ben Ari, Y. 2002. Excitatory actions of GABA during development: the nature of the nurture. Nat Rev Neurosci 3: 728–739. Ben Ari, Y., Cherubini, E., Corradetti, R., and Gaiarsa, J.L. 1989. Giant synaptic potentials in immature rat CA3 hippocampal neurones. J Physiol 416: 303–325. Ben Ari, Y., and Cossart, R. 2000. Kainate, a double agent that generates seizures: two decades of progress. Trends Neurosci 23: 580–587. Bernard, C., Anderson, A., Becker, A., Poolos, N.P., Beck, H., and Johnston, D. 2004. Acquired dendritic channelopathy in temporal lobe epilepsy. Science 305: 532–535. Bernard, C., Cossart, R., Hirsch, J.C., Esclapez, M., and Ben Ari, Y. 2000. What is GABAergic inhibition? How is it modified in epilepsy? Epilepsia 41(Suppl 6): S90–S95. Bernasconi, N., Bernasconi, A., Andermann, F., Dubeau, F., Feindel, W., and Reutens, D.C. 1999. Entorhinal cortex in temporal lobe epilepsy: a quantitative MRI study. Neurology 52: 1870–1876. Bernasconi, N., Bernasconi, A., Caramanos, Z., Andermann, F., Dubeau, F., and Arnold, D.L. 2000. Morphometric MRI analysis of the parahip-
70
Chapter 6/Hippocampal Slices: Designing and Interpreting Studies in Epilepsy Research
pocampal region in temporal lobe epilepsy. Ann NY Acad Sci 911: 495–500. Bernasconi, N., Bernasconi, A., Caramanos, Z., Dubeau, F., Richardson, J., Andermann, F., and Arnold, D.L. 2001. Entorhinal cortex atrophy in epilepsy patients exhibiting normal hippocampal volumes. Neurology 56: 1335–1339. Bikson, M., Fox, J.E., and Jefferys, J.G. 2003. Neuronal aggregate formation underlies spatiotemporal dynamics of nonsynaptic seizure initiation. J Neurophysiol 89: 2330–2333. Boulanger, L.M., and Shatz, C.J. 2004. Immune signalling in neural development, synaptic plasticity and disease. Nat Rev Neurosci 5: 521–531. Bracci, E., Vreugdenhil, M., Hack, S.P., and Jefferys, J.G. 1999. On the synchronizing mechanisms of tetanically induced hippocampal oscillations. J Neurosci 19: 8104–8113. Bragin, A., Penttonen, M., Buzs, and Ki, G. 1997. Termination of epileptic afterdischarge in the hippocampus. J Neurosci 17: 2567–2579. Brooks-Kayal, A.R., Shumate, M.D., Jin, H., Rikhter, T.Y., and Coulter, D.A. 1998. Selective changes in single cell GABA(A) receptor subunit expression and function in temporal lobe epilepsy. Nat Med 4: 1166–1172. Buhl, E., Otis, T., and Mody, I. 1996. Zinc-induced collapse of augmented inhibition by GABA in a temporal lobe epilepsy model. Science 271: 369–373. Buhl, E.H., Tamas, G., and Fisahn, A. 1998. Cholinergic activation and tonic excitation induce persistent gamma oscillations in mouse somatosensory cortex in vitro. J Physiol 513(Part 1): 117–126. Buzsaki, G. 2002. Theta oscillations in the hippocampus. Neuron 33: 325–340. Chaigneau, E., Oheim, M., Audinat, E., and Charpak, S. 2003. Two-photon imaging of capillary blood flow in olfactory bulb glomeruli. Proc Natl Acad Sci U S A 100: 13081–13086. Chen, K., Aradi, I., Thon, N., Eghbal-Ahmadi, M., Baram, T.Z., and Soltesz, I. 2001. Persistently modified h-channels after complex febrile seizures convert the seizure-induced enhancement of inhibition to hyperexcitability. Nat Med 7: 331–337. Chen, K., Ratzliff, A., Hilgenberg, L., Gulyas, A., Freund, T.F., Smith, M., Dinh, T.P. et al. 2003. Long-term plasticity of endocannabinoid signaling induced by developmental febrile seizures. Neuron 39: 599–611. Chesnut, T.J., and Swann, J.W. 1988. Epileptiform activity induced by 4aminopyridine in immature hippocampus. Epilepsy Res 2: 187–195. Clancy, B., Darlington, R.B., and Finlay, B.L. 2001. Translating developmental time across mammalian species. Neuroscience 105: 7–17. Cohen, I., Navarro, V., Clemenceau, S., Baulac, M., and Miles, R. 2002. On the origin of interictal activity in human temporal lobe epilepsy in vitro. Science 298: 1418–1421. Colgin, L.L., Kubota, D., Brucher, F.A., Jia, Y., Branyan, E., Gall, C.M., and Lynch, G. 2004. Spontaneous waves in the dentate gyrus of slices from the ventral hippocampus. J Neurophysiol. 92: 3385–3398. Cossart, R., Aronov, D., and Yuste, R. 2003. Attractor dynamics of network UP states in the neocortex. Nature 423: 283–288. Cossart, R., Dinocourt, C., Hirsch, J.C., Merchan-Perez, A., De Felipe, J., Ben Ari, Y., Esclapez, M. et al. 2001. Dendritic but not somatic GABAergic inhibition is decreased in experimental epilepsy. Nat Neurosci 4: 52–62. Cossart, R., Esclapez, M., Hirsch, J.C., Bernard, C., and Ben-Ari, Y. 1998. GluR5 kainate receptor activation of interneurons increases tonic GABAergic inhibition in pyramidal cells. Nat Neurosci 1: 470–478. Cronin, J., Obenaus, A., Houser, C.R., and Dudek, F.E. 1992. Electrophysiology of dentate granule cells after kainate-induced synaptic reorganization of the mossy fibers. Brain Res 573: 305–310. Dinocourt, C., Petanjek, Z., Freund, T.F., Ben Ari, Y., and Esclapez, M. 2003. Loss of interneurons innervating pyramidal cell dendrites and axon initial segments in the CA1 region of the hippocampus following pilocarpine-induced seizures. J Comp Neurol 459: 407–425.
Du, F., Schwarcz, R., and Tamminga, C.A. 1995. Entorhinal cortex in temporal lobe epilepsy. Am J Psychiatry 152: 826. Durlach, J. 1967. [Apropos of a case of the “epileptic” form of latent tetany due to a magnesium deficiency]. Rev Neurol (Paris) 117: 189–196. Dzhala, V.I., and Staley, K.J. 2003a. Excitatory actions of endogenously released GABA contribute to initiation of ictal epileptiform activity in the developing hippocampus. J Neurosci 23: 1840–1846. Dzhala, V.I., and Staley, K.J. 2003b. Transition from interictal to ictal activity in limbic networks in vitro. J Neurosci 23: 7873–7880. Dzhala, V.I., and Staley, K.J. 2004. Mechanisms of fast ripples in the hippocampus. J Neurosci 24: 8896–8906. Esclapez, M., Hirsch, J.C., Ben-Ari, Y., and Bernard, C. 1999. Newly formed excitatory pathways provide a substrate for hyperexcitability in experimental temporal lobe epilepsy. J Comp Neurol 408: 449–460. Esclapez, M., Hirsch, J.C., Khazipov, R., Ben-Ari, Y., and Bernard, C. 1997. Operative GABAergic inhibition in hippocampal CA1 pyramidal neurons in experimental epilepsy. Proc Natl Acad Sci U S A 94: 12151–12156. Ferbinteanu, J., and McDonald, R.J. 2001. Dorsal/ventral hippocampus, fornix, and conditioned place preference. Hippocampus 11: 187–200. Fisahn, A., Pike, F.G., Buhl, E.H., and Paulsen, O. 1998. Cholinergic induction of network oscillations at 40 Hz in the hippocampus in vitro. Nature 394: 186–189. Fisher, R.S., and Alger, B.E. 1984. Electrophysiological mechanisms of kainic acid-induced epileptiform activity in the rat hippocampal slice. J Neurosci 4: 1312–1323. Frerking, M., Malenka, R.C., and Nicoll, R.A. 1998. Synaptic activation of kainate receptors on hippocampal interneurons. Neuroscience 1: 479–486. Freund, T.F., and Buzsáki, G. 1996. Interneurons of the hippocampus. Hippocampus 6: 347–470. Fritschy, J.M., Paysan, J., Enna, A., and Mohler, H. 1994. Switch in the expression of rat GABAA-receptor subtypes during postnatal development: an immunohistochemical study. J Neurosci 14: 5302–5324. Fujiwara-Tsukamoto, Y., Isomura, Y., Kaneda, K., and Takada, M. 2004. Synaptic interactions between pyramidal cells and interneurone subtypes during seizure-like activity in the rat hippocampus. J Physiol 557: 961–979. Fujiwara-Tsukamoto, Y., Isomura, Y., Nambu, A., and Takada, M. 2003. Excitatory GABA input directly drives seizure-like rhythmic synchronization in mature hippocampal CA1 pyramidal cells. Neuroscience 119: 265–275. Gahr, M. 2004. Hormone-dependent neural plasticity in the juvenile and adult song system: what makes a successful male? Ann NY Acad Sci 1016: 684–703. Galvan, M., Grafe, P., and Ten Bruggencate, G. 1982. Convulsant actions of 4-aminopyridine on the guinea-pig olfactory cortex slice. Brain Res 241: 75–86. Ghai, R.S., Bikson, M., and Durand, D.M. 2000. Effects of applied electric fields on low-calcium epileptiform activity in the CA1 region of rat hippocampal slices. J Neurophysiol 84: 274–280. Gozlan, H., and Ben Ari, Y. 2003. Interneurons are the source and the targets of the first synapses formed in the rat developing hippocampal circuit. Cereb Cortex 13: 684–692. Hajos, N., Palhalmi, J., Mann, E.O., Nemeth, B., Paulsen, O., and Freund, T.F. 2004. Spike timing of distinct types of GABAergic interneuron during hippocampal gamma oscillations in vitro. J Neurosci 24: 9127–9137. Hardison, J.L., Okazaki, M.M., and Nadler, J.V. 2000. Modest increase in extracellular potassium unmasks effect of recurrent mossy fiber growth. J Neurophysiol 84: 2380–2389. Hirsch, J.C., Quesada, O., Esclapez, M., Gozlan, H., Ben-Ari, Y., and Bernard, C. 1996. Enhanced NMDAR-dependent epileptiform activity
References is controlled by oxidizing agents in a chronic model of temporal lobe epilepsy. J Neurophysiol 76: 4185–4189. Hoffman, D.A., and Johnston, D. 1998. Downregulation of transient K+ channels in dendrites of hippocampal CA1 pyramidal neurons by activation of PKA and PKC. J Neurosci 18: 3521–3528. Hoffman, D.A., Magee, J.C., Colbert, C.M., and Johnston, D. 1997. K+ channel regulation of signal propagation in dendrites of hippocampal pyramidal neurons. Nature 387: 869–875. Huettner, J.E. 2003. Kainate receptors and synaptic transmission. Prog Neurobiol 70: 387–407. Jefferys, J.G., and Haas, H.L. 1982. Synchronized bursting of CA1 hippocampal pyramidal cells in the absence of synaptic transmission. Nature 300: 448–450. Kaila, K., Lamsa, K., Smirnov, S., Taira, T., and Voipio, J. 1997. Longlasting GABA-mediated depolarization evoked by high-frequency stimulation in pyramidal neurons of rat hippocampal slice is attributable to a network-driven, bicarbonate-dependent K+ transient. J Neurosci 17: 7662–7672. Karnup, S., and Stelzer, A. 2001. Seizure-like activity in the disinhibited CA1 minislice of adult guinea-pigs. J Physiol 532: 713–730. Katz, L.C., and Shatz, C.J. 1996. Synaptic activity and the construction of cortical circuits. Science 274: 1133–1138. Khalilov, I., Esclapez, M., Medina, I., Aggoun, D., Lamsa, K., Leinekugel, X., Khazipov, R. et al. 1997. A novel in vitro preparation: the intact hippocampal formation. Neuron 19: 743–749. Khalilov, I., Holmes, G.L., and Ben Ari, Y. 2003. In vitro formation of a secondary epileptogenic mirror focus by interhippocampal propagation of seizures. Nat Neurosci 6: 1079–1085. Khazipov, R., Esclapez, M., Caillard, O., Bernard, C., Khalilov, I., Tyzio, R., Hirsch, J. et al. 2001. Early development of neuronal activity in the primate hippocampus in utero. J Neurosci 21: 9770–9781. Khazipov, R., and Holmes, G.L. 2003. Synchronization of kainate-induced epileptic activity via GABAergic inhibition in the superfused rat hippocampus in vivo. J Neurosci 23: 5337–5341. Klausberger, T., Magill, P.J., Marton, L.F., Roberts, J.D., Cobden, P.M., Buzsaki, G., and Somogyi, P. 2003. Brain-state- and cell-type-specific firing of hippocampal interneurons in vivo. Nature 421: 844–848. Konnerth, A., Heinemann, U., and Yaari, Y. 1984. Slow transmission of neural activity in hippocampal area CA1 in absence of active chemical synapses. Nature 307: 69–71. Konnerth, A., Heinemann, U., and Yaari, Y. 1986. Nonsynaptic epileptogenesis in the mammalian hippocampus in vitro. I. Development of seizurelike activity in low extracellular calcium. J Neurophysiol 56: 409–423. Kubota, D., Colgin, L.L., Casale, M., Brucher, F.A., and Lynch, G. 2003. Endogenous waves in hippocampal slices. J Neurophysiol 89: 81–89. Leinekugel, X., Khazipov, R., Cannon, R., Hirase, H., Ben Ari, Y., & Buzsaki, G. 2002. Correlated bursts of activity in the neonatal hippocampus in vivo. Science 296: 2049–2052. Luhmann, H.J., Dzhala, V.I., and Ben Ari, Y. 2000. Generation and propagation of 4-AP-induced epileptiform activity in neonatal intact limbic structures in vitro. Eur J Neurosci 12: 2757–2768. Lynch, M., and Sutula, T. 2000. Recurrent excitatory connectivity in the dentate gyrus of kindled and kainic acid-treated rats. J Neurophysiol 83: 693–704. McBain, C.J. 1994. Hippocampal inhibitory neuron activity in the elevated potassium model of epilepsy [corrected and republished in J Neurophysiol 1995; 73(2): 2853–2863]. J Neurophysiol 72: 2853–2863. Meier, C.L., and Dudek, F.E. 1996. Spontaneous and stimulation-induced synchronized burst afterdischarges in the isolated CA1 of kainatetreated rats. J Neurophysiol 76: 2231–2239. Meier, S., Brauer, A.U., Heimrich, B., Nitsch, R., and Savaskan, N.E. 2004. Myelination in the hippocampus during development and following lesion. Cell Mol Life Sci 61: 1082–1094.
71
Melyan, Z., Wheal, H.V., and Lancaster, B. 2002. Metabotropic-mediated kainate receptor regulation of IsAHP and excitability in pyramidal cells. Neuron 34: 107–114. Miles, R., and Wong, R. 1987. Inhibitory control of local excitatory circuits in the guinea-pig hippocampus. ZZI 388: 611–629. Miles, R., and Wong, R.K. 1986. Excitatory synaptic interactions between CA3 neurones in the guinea-pig hippocampus. J Physiol 373: 397– 418. Mody, I., Lambert, J.D., and Heinemann, U. 1987. Low extracellular magnesium induces epileptiform activity and spreading depression in rat hippocampal slices. J Neurophysiol 57: 869–888. Moser, M.B., and Moser, E.I. 1998. Functional differentiation in the hippocampus. Hippocampus 8: 608–619. Munari, C., Hoffmann, D., Francione, S., Kahane, P., Tassi, L., Lo, R.G., and Benabid, A.L. 1994. Stereo-electroencephalography methodology: advantages and limits. Acta Neurol Scand Suppl 152: 56–67. Netoff, T.I., and Schiff, S.J. 2002. Decreased neuronal synchronization during experimental seizures. J Neurosci 22: 7297–7307. Nusser, Z., Hajos, N., Somogyi, P., and Mody, I. 1998. Increased number of synaptic GABA(A) receptors underlies potentiation at hippocampal inhibitory synapses. Nature 395: 172–177. Otsu, Y., Maru, E., Ohata, H., Takashima, I., Kajiwara, R., and Iijima, T. 2000. Optical recording study of granule cell activities in the hippocampal dentate gyrus of kainate-treated rats. J Neurophysiol 83: 2421–2430. Patrylo, P.R., and Dudek, F.E. 1998. Physiological unmasking of new glutamatergic pathways in the dentate gyrus of hippocampal slices from kainate-induced epileptic rats. J Neurophysiol 79: 418–429. Patrylo, P.R., Schweitzer, J.S., and Dudek, F.E. 1999. Abnormal responses to perforant path stimulation in the dentate gyrus of slices from rats with kainate-induced epilepsy and mossy fiber reorganization. Epilepsy Res 36: 31–42. Perez Velazquez, J.L. 2003. Bicarbonate-dependent depolarizing potentials in pyramidal cells and interneurons during epileptiform activity. Eur J Neurosci 18: 1337–1342. Perreault, P., and Avoli, M. 1989. Effects of low concentrations of 4aminopyridine on CA1 pyramidal cells of the hippocampus. J Neurophysiol 61: 953–970. Perreault, P., and Avoli, M. 1992. 4-aminopyridine-induced epileptiform activity and a GABA-mediated long-lasting depolarization in the rat hippocampus. J Neurosci 12: 104–115. Quilichini, P.P., Diabira, D., Chiron, C., Ben Ari, Y., and Gozlan, H. 2002. Persistent epileptiform activity induced by low Mg2+ in intact immature brain structures. Eur J Neurosci 16: 850–860. Quilichini, P.P., Diabira, D., Chiron, C., Milh, M., Ben Ari, Y., and Gozlan, H. 2003. Effects of antiepileptic drugs on refractory seizures in the intact immature corticohippocampal formation in vitro. Epilepsia 44: 1365–1374. Rafiq, A., DeLorenzo, R.J., and Coulter, D.A. 1993. Generation and propagation of epileptiform discharges in a combined entorhinal cortex/hippocampal slice. J Neurophysiol 70: 1962–1974. Ratzliff, A.H., Howard, A.L., Santhakumar, V., Osapay, I., and Soltesz, I. 2004. Rapid deletion of mossy cells does not result in a hyperexcitable dentate gyrus: Implications for epileptogenesis. J Neurosci 24: 2259–2269. Ritter, L.M., Vazquez, D.M., and Meador-Woodruff, J.H. 2002. Ontogeny of ionotropic glutamate receptor subunit expression in the rat hippocampus. Brain Res Dev Brain Res 139: 227–236. Scharfman, H.E., Goodman, J.H., and Sollas, A.L. 2000. Granule-like neurons at the hilar/CA3 border after status epilepticus and their synchrony with area CA3 pyramidal cells: Functional implications of seizure-induced neurogenesis. J Neurosci 20: 6144–6158. Schuchmann, S., Meierkord, H., Stenkamp, K., Breustedt, J., Windmuller, O., Heinemann, U., and Buchheim, K. 2002. Synaptic and nonsynaptic
72
Chapter 6/Hippocampal Slices: Designing and Interpreting Studies in Epilepsy Research
ictogenesis occurs at different temperatures in submerged and interface rat brain slices. J Neurophysiol 87: 2929–2935. Schwartzkroin, P.A., and Prince, D.A. 1978. Cellular and field potential properties of epileptogenic hippocampal slices. Brain Res 147: 117–130. Simpson, L., Wheal, H., and Williamson, R. 1991. The contribution of nonNMDA and NMDA receptor to graded bursting activity in the CA1 region of the hippocampus in a chronic model of epilepsy. Can J Physiol Pharmacol 69: 1091–1098. Somjen, G.G., Aitken, P.G., Giacchino, J.L., and McNamara, J.O. 1985. Sustained potential shifts and paroxysmal discharges in hippocampal formation. J Neurophysiol 53: 1079–1097. Spencer, S.S., and Spencer, D.D. 1994. Entorhinal-hippocampal interactions in medial temporal lobe epilepsy. Epilepsia 35: 721– 727. Staley, K.J., Soldo, B.L., and Proctor, W.R. 1995. Ionic mechanisms of neuronal excitation by inhibitory GABAA receptors. Science 269: 977–981. Stasheff, S.F., Bragdon, A.C., and Wilson, W.A. 1985. Induction of epileptiform activity in hippocampal slices by trains of electrical stimuli. Brain Res 344: 296–302. Stasheff, S.F., Mott, D.D., and Wilson, W.A. 1993. Axon terminal hyperexcitability associated with epileptogenesis in vitro. II. Pharmacological regulation by NMDA and GABAA receptors. J Neurophysiol 70: 976–984. Stellwagen, D., and Shatz, C.J. 2002. An instructive role for retinal waves in the development of retinogeniculate connectivity. Neuron 33: 357–367. Su, H., Sochivko, D., Becker, A., Chen, J., Jiang, Y., Yaari, Y., and Beck, H. 2002. Upregulation of a T-type Ca2+ channel causes a long-lasting modification of neuronal firing mode after status epilepticus. J Neurosci 22: 3645–3655. Swann, J.W., and Brady, R.J. 1984. Penicillin-induced epileptogenesis in immature rat CA3 hippocampal pyramidal cells. Brain Res 314: 243–254. Talairach, J., Bancaud, J., Szikla, G., Bonis, A., Geier, S., and Vedrenne, C. 1974. [New approach to the neurosurgery of epilepsy. Stereotaxic methodology and therapeutic results. 1. Introduction and history]. Neurochirurgie 20: 1–240. Tansey, E.P., Chow, A., Rudy, B., and McBain, C.J. 2002. Developmental expression of potassium-channel subunit Kv3.2 within subpopulations of mouse hippocampal inhibitory interneurons. Hippocampus 12: 137–148.
Taylor, C.P., and Dudek, F.E. 1982. Synchronous neural afterdischarges in rat hippocampal slices without active chemical synapses. Science 218: 810–812. Traub, R.D., Borck, C., Colling, S.B., and Jefferys, J.G. 1996. On the structure of ictal events in vitro. Epilepsia 37: 879–891. Traynelis, S.F., and Dingledine, R. 1988. Potassium-induced spontaneous electrographic seizures in the rat hippocampal slice. J Neurophysiol 59: 259–276. Turner, D., and Wheal, H. 1991. Excitatory synaptic potentials in kainic acid-denervated rat CA1 pyramidal neurons. J Neurosci 11: 2786–2794. Velazquez, J.L., and Carlen, P.L. 1999. Synchronization of GABAergic interneuronal networks during seizure-like activity in the rat horizontal hippocampal slice. Eur J Neurosci 11: 4110–4118. Voskuyl, R.A. and Albus, H. 1985. Spontaneous epileptiform discharges in hippocampal slices induced by 4-aminopyridine. Brain Res 342: 54–66. Westbrook, G.L., and Lothman, E.W. 1983. Cellular and synaptic basis of kainic acid-induced hippocampal epileptiform activity. Brain Res 273: 97–109. Whittington, M.A., Stanford, I.M., Colling, S.B., Jefferys, J.G., and Traub, R.D. 1997. Spatiotemporal patterns of gamma frequency oscillations tetanically induced in the rat hippocampal slice. J Physiol (Lond) 502: 591–607. Whittington, M.A., and Traub, R.D. 2003. Interneuron diversity series: inhibitory interneurons and network oscillations in vitro. Trends Neurosci 26: 676–682. Wieser, H. G. (1983). Depth recorded limbic seizures and psychopathology. Neu Neurosci. Biobehav. Rev. 7: 427–440. Williamson, R., and Wheal, H.V. 1992. The contribution of AMPA and NMDA receptors to graded bursting activity in the hippocampal CA1 region in an acute in vitro model of epilepsy. Epilepsy Res 12: 179–188. Witter, M.P., and Groenewegen, H.J. 1984. Laminar origin and septotemporal distribution of entorhinal and perirhinal projections to the hippocampus in the cat. J Comp Neurol 224: 371–385. Wong, R.K., Traub, R.D., and Miles, R. 1986. Cellular basis of neuronal synchrony in epilepsy. Adv Neurol 44: 583–592. Wu, C., Shen, H., Luk, W.P., and Zhang, L. 2002. A fundamental oscillatory state of isolated rodent hippocampus. J Physiol 540: 509–527. Wuarin, J.P., and Dudek, F.E. 1996. Electrographic seizures and new recurrent excitatory circuits in the dentate gyrus of hippocampal slices from kainate-treated epileptic rats. J Neurosci 16: 4438–4448. Yamamoto, C., and McIlwain, H. 1966. Electrical activities in thin sections from the mammalian brain maintained in chemically-defined media in vitro. J Neurochem 13: 1333–1343.
A
]~ Controlrat 1
Normal
0 ms Calcium free
3 ms
2
0 ms
3 ms
I
2
6ms
20ms
N
6rns
20 ms
KArat Normal
B 0ms Calcium free
0m~
~
t
~ 3rns
FIGURE 6--4 A: Two-photon imaging of the CAI region of a hippocampal slice from a mouse. Pyramidal cell somata are clearly visible in the pyramidal cell layer (P); interneurons are visible in stratum oriens (0) and stratum radiatum (R). Neurons are filled with a Ca 2+ indicator, and variations in [Ca2+]~ are measured. Electrophysiologic properties of any individual neuron can also be recorded. For example, the inset shows the spontaneous activity recorded in a stratum oriens interneuron (Rosa Cossart, personal communication). B: Spatiotemporal patterns of neuronal activity evoked in the dentate gyms in control and kainic acid (KA)-treated rat hippocampal slices. Level of neuronal activity is displayed according to the pseudocolor code (from background gray to highly activated red). (Adapted from Otsu et al., 2000.)
rO.06
C
H
A
P
T
E
R
7 Thalamic, Thalamocortical, and Corticocortical Models of Epilepsy with an Emphasis on Absence Seizures THOMAS BUDDE, HANS-CHRISTIAN PAPE, SANJAY S. KUMAR, AND JOHN R. HUGUENARD
dominant inheritance of the “spike-wave discharge” (SWD) trait (Engel, 2001). Seizures start at 3 to 8 years of age, may occur several hundred times per day, and remit near the onset of adolescence in roughly 70% of the patients. Major neuropathologic deficits have not been found. Linkage studies in absence epilepsy patients have led to the identification of two gene mutations localized to the voltage-gated Ca2+ channel a1A-subunit gene (CACNA1A, chromosome 19p) (Jouvenceau et al., 2001) and the GABAA receptor g subunit gene (GABRG2, chromosome 5q) (Baulac et al., 2001; Wallace et al., 2001). A number of susceptibility loci and polymorphisms in various types of ion channels, transmitter receptors, and other proteins have also been described, although the linkage to CAE is not always clear (see Crunelli and Leresche, 2002).
Absence epilepsy is an idiopathic, generalized, and nonconvulsive form of epilepsy with an as yet unknown polygenic background (for review, see Crunelli and Leresche, 2002). A typical absence episode consists of a sudden epileptic seizure with severe impairment of consciousness. Although the interictal electroencephalogram (EEG) appears normal, the ictal EEG is characterized by phases of bilateral, synchronous 2.5- to 4.0-Hz spike and slow-wave discharges (SWDs). As defined by the current International League against Epilepsy (ILAE) classification (Engel, 2001), typical absence seizures are an integral part of several types of idiopathic generalized epilepsies, including childhood absence epilepsy (CAE), juvenile absence epilepsy (JAE), juvenile myoclonic epilepsy (JME), and generalized tonic-clonic seizures (GTCS), all of which display complex partially overlapping phenotypes. A single-model pharmacologic manipulation or genetic alteration can hardly account for the integral nature of various types of absence epilepsies, their polygenic background, and the pathophysiologies of the underlying interacting synaptic networks. In fact, different experimental approaches have been used to investigate various aspects of absence epilepsy. Following a brief outline of genetic models and the pathophysiology of absence epilepsy, we review here thalamic, thalamocortical, and corticocortical models (with particular reference to CAE) and discuss their usefulness and limitations. For details on the epidemiology, the genetic etiology, and the pathophysiologic mechanisms of CAE, the reader is referred to a number of excellent recent reviews (Crunelli and Leresche, 2002; Destexhe and Sejnowski, 2003; McCormick and Contreras, 2001; Snead, 1995; Steriade et al., 1997). In brief, CAE is genetically determined, with incomplete penetrance and complex autosomal-
Models of Seizures and Epilepsy
MODELS OF ABSENCE EPILEPSY IN INTACT RATS Genetic Models Spontaneous point mutations have resulted in mutant mice that develop SWDs on the EEG accompanied with behavioral arrest. These mutant mice (see Chapter 17) are considered suitable models of CAE. The best studied of these mutant mice, their genotype, and their phenotype are listed in Table 1. Single-locus abnormalities have been identified in these mutants; the mutant genes and the pathways in which the aberrant gene products are involved provide important insights into the underlying bases for human absence epilepsy. A number of different mutations involving the genes encoding four separate subunits of the
73
Copyright © 2006, Elsevier Inc. All rights of reproduction in any form reserved.
74
Chapter 7/Thalamic, Thalamocortical, and Corticocortical Models of Epilepsy
TABLE 1 Comparison of Features of Pharmacologically Induced and Genetic Animal Models of Absence Epilepsy with Human Childhood Absence Epilepsy Pharmacologic models
Model
Species
Seizure characteristics
Penicillin
Cat
GHB
Rat, cat, monkey
Onset of seizures 1 h after injection of antibiotic (300,000 IU/kg, IM); duration of seizures 6–8 h SWDs appear within 2–5 min of administration of the prodrug GBL to rats; maximum sensitivity for rats at P28
SWD frequency (Hz)
Attenuation by ETX
3
Yes
7–9
Yes
Genetic mouse models (single gene mutation)
Model Leaner Rocker Tottering Ducky Lethargic
Chromosome gene product
Phenotype
Chromosome 8/Ca2+ channel a1A-subunit Chromosome 8/Ca2+ channel a1A-subunit Chromosome 8/Ca2+ channel a1A-subunit Chromosome 9/Ca2+ channel a2 b2-subunit Chromosome 2/Ca2+ channel b4-subunit
Stargazer
Chromosome 15/Ca2+ channel g2-subunit
Coloboma Mocha
Chromosome 2/SNAP25 Chromosome 10/adaptorlike protein complex (AP-3) b-subunit Chromosome 4/Na+/H+ exchanger (Nhe1)
Slow-wave epilepsy mouse
SWD frequency (Hz)
Attenuation by ETX
Severe ataxia; SWDs
5–7
Yes
Ataxia; SWDs
6–7
Not determined
Ataxia and motor seizures at 3 wk; SWDs Ataxia and dyskinesia; SWDs
6–7
Yes
6
Yes
Lethargy, ataxia and loss of motor coordination at P15; focal motor seizures and SWDs Ataxia and impaired vestibular function; frequent and prolonged SWDs Hyperactivity; SWDs Hyperactivity; SWDs
5–6
Yes
6
Yes
5–6 6
Yes Yes
Ataxia; tonic-clonic seizures; SWDs
3–4
Yes
Inbred rat models (polygenetic)
Model GAERS WAG/Rij
Onset of seizures
Remission with age
At P30–40; all animals reveal seizures at 13 wk Seizures in all animals at 4 mo
SWD frequency (Hz)
Attenuation by ETX
No
7–10
Yes
No
7–11
Yes
Remission with age
Ictal EEG
Attenuation by ETX
CAE
Clinical symptoms Severe impairment of consciousness; no response to commands or recollection of ictal events; eyes are open; automatisms
Onset of seizures 4–10 yr
Seizures will remit in the majority of patients (~70 %) by adolescence; some might go on to develop myoclonic jerks and generalized tonic-clonic seizures
Spike (mostly 1, max. 3) and slow-wave discharge is generalized, bilateral and synchrnous; frequency is 3 Hz (range 2.5–4 Hz); duration is ~10 s (range 4–20 s); abrupt onset and cessation
Yes
CAE, childhood absence epilepsy; EEG, electroencephalogram; ETX, ethosuximide; GHB, g-hydroxybutyrate; IM, intrasmuscularly; SWD, spike-wave discharge.
Pathophysiologic Mechanisms of Childhood Absence Epilepsy
multimeric neuronal Ca2+ channel complex (tottering, leaner, rocker, lethargic, ducky, stargazer), the Na+/H+ exchanger (slow-wave epilepsy mouse), adapter-like proteins (Mocha), and SNAP25 (coloboma) have been described (for reviews see Pietrobon, 2002; Felix, 2002). In most mouse mutant strains, SWDs occur at slightly higher frequencies (5–7 Hz) compared with SWD in humans and are abolished by treatment with the antiabsence drug ethosuximide. It is important to note that these mouse mutants display neurologic deficits in addition to the SWD trait, the most obvious being a dysfunction of the motor system (e.g., ataxia) (Table 1). Given that the identified genes have potentially multiple functions, it is important to consider the broad implications of alterations in protein functions when interpreting the causative role of these gene mutations with respect to the absence phenotype. Two genetic rat models, termed Genetic Absence Epilepsy Rats from Strasbourg (GAERS) (for review, see Danober et al., 1998; Marescaux et al., 1992) and Wistar Albino Glaxo Rats from Rijswik, WAG/Rij (for review, see Coenen et al., 1992; Renier and Coenen, 2000; van Luijtelaar et al., 2002), were independently derived from inbreeding of the Wistar strain (see also Chapter 18). Their genotypes are not known, although there is some evidence of an autosomal-dominant inheritance of the SWD trait and a polygenic background that may modify seizure characteristics (Danober et al., 1998; Renier and Coenen, 2000). The absence phenotype is similar in both strains (although subtle differences have been reported for the developmental and electrophysiologic profile of the seizures) and largely resembles that in human CAE. The SWDs occur spontaneously on a normal EEG (mostly during quiet wakefulness) and are associated with a severe reduction in sensory responsiveness and a mild facial myoclonus; there are no major neuropathological abnormalities (Danober et al., 1998; Renier and Coenen, 2000). Furthermore, classic absence antiepileptic drugs (ethosuximide, valproate, benzodiazepines) suppress SWDs, whereas drugs specific for convulsive or focal seizures (carbamazepine, phenytoin) are ineffective or aggravate SWDs in these rats (Danober et al., 1998; Renier and Coenen, 2000). Differences from human CAE relate to the higher frequency of the SWDs (7–11 Hz), the relatively late appearance of absence seizure activity during development, and the persistence of SWDs through rat “adolescence” (Danober et al., 1998; Renier and Coenen, 2000). The g-Hydroxybutyrate Model One established thalamic model of absence epilepsy is the administration of g-hydroxybutyrate (GHB) or the prodrug g-butyrolactone (GBA) to thalamic nuclei, like the ventrobasal (VB) nucleus (Snead, 1991) (see also Chapter 10). GHB is a short-chain fatty acid that is synthesized from
75
GABA and occurs naturally in the mammalian brain. This compound has the ability to induce absence-like seizures in a number of species (for review, see Snead, 1995). GHBtreated animals show an arrest of activity with staring associated with bilaterally synchronous SWDs, ranging in frequency from 2.5 Hz in monkeys to 6–7 Hz in rats. The cellular mechanisms underlying the actions of GHB are not fully understood but are currently emerging from experimental data; the activity of GHB is thought to be mediated through a GHB receptor, which may be distinct from the GABAB receptor (Gervasi et al., 2003; Wong et al., 2004). The experimental procedures for the injection of GHB and GBA in the VB of young (200–300 g) male Sprague-Dawley rats have been detailed by Snead and colleagues (Snead, 1991) (see also Chapter 10). Intrathalamic injections are made in awake animals; recording of the electrocorticogram (ECoG) are carried out in freely moving animals. About 25 seconds after intrathalamic administration of GHB, the ECoG reveals brief bursts of SWDs (duration ~60 s). The drug threshold for this effect is about 25 mg per side. GHB-treated animals represent a reproducible, consistent, and pharmacologically specific model for the study of generalized absence seizures and allow the investigator to assess the effect of pharmacologic and transgenic manipulations of neuronal channels or receptors on the expression of this epileptic activity (Kim et al., 2001; Snead et al., 2000). GHB administration to horizontal thalamic slices (see later) induces self-sustained intrathalamic oscillations at a frequency of ~3 Hz, resembling SWDs (Gervasi et al., 2003).
PATHOPHYSIOLOGIC MECHANISMS OF CHILDHOOD ABSENCE EPILEPSY Clinical evidence indicates that absence seizures are associated with states of decreased vigilance, such as drowsiness (Crunelli and Leresche, 2002). In an early model of generalized epilepsy that used systemic or focal cortical application of penicillin (penicillin-generalized epilepsy model; for review, see Gloor and Fariello, 1988), investigators observed that SWDs on the EEG (e.g., Figure 1A) developed gradually from sleep spindles during early stages of slow-wave sleep (Kostopoulos et al., 1981). From those and subsequent studies in the mutant mice and the genetic rat models mentioned previously, an overall scenario evolved that can be summarized along two lines: (1) The neurons and synaptic interconnections of the thalamocortical system (Figure 1B) that normally sustain rhythmic activities during slow-wave sleep are also critically involved in the generation of SWDs. (2) Seizure activity arises from a concerted interaction within this network, with initial sites most likely residing in the cortex; the corticothalamocortical loop plays a pivotal role in the generation and synchronization of SWD at an extended spatiotemporal scale.
76
Chapter 7/Thalamic, Thalamocortical, and Corticocortical Models of Epilepsy
A
EEG
B
cortex +
+
thalamocortical network
+
+
-
TC
-
dorsal thalamus 20 mV
RT nucleus
C 0.5 s
20 mV
-60 mV
D 1s
20 mV
10 mV
-60 mV
100 ms LTS
E
20 ms
EPSPs -71 mV
20 mV
-66 mV
EPSP
0.5 s
-50 mV
10 mV
-60 mV IPSPs 20 ms
FIGURE 1 Intracellular counterparts of spike-wave discharges (SWDs) in GAERS model of absence epilepsy. A: Electroencephalographic (EEG) recording of spontaneous SWDs. B: Schematic diagram of the thalamocortical network. C: Layer V cortical neurons reveal rhythmic depolarizations, which elicit one to three action potentials, superimposed on a long-lasting hyperpolarization. D: In reticular thalamic (RT) neurons, SWD-associated activity starts with a hyperpolarization (see expanded trace bottom left), followed by rhythmic generation of low-threshold Ca2+ spikes (LTSs) associated with bursts of action potentials (see expanded trace bottom right). Note that excitatory postsynaptic potentials (EPSPs) lead to the generation of a LTS. E: Thalamocortical (TC) neurons of the ventrobasal thalamus show rhythmic sequences of EPSP and inhibitory postsynaptic potentials (IPSPs), with occasional firing of action potentials. An EPSP/IPSP sequence is expanded in the bottom panel. (C–E adapted, with permission, from Crunelli and Leresche, 2002.) (See color insert.)
It should be stressed that neither cortical nor thalamic networks alone can generate or sustain SWDs (Steriade and Contreras, 1995, 1998) and that influences exerted by brain structures other than the thalamocortical system can modulate SWD generation (Danober et al., 1998). Of additional interest is the notion that the hippocampal formation is exempt from SWDs in models of pure absence (Snead, 1995). Studies in various models, including GAERS and WAG/Rij, have indicated that spontaneous SWDs occur first in the somatosensory cortex and then invade other cortical and thalamic areas (Inoue et al., 1993; Manning et al., 2004; Meeren et al., 2002; Richards et al., 2003; Seidenbecher et al., 1998; Steriade and Contreras, 1995, 1998). Pathophysiologic mechanisms in the cortex may relate to an increase in excitatory synaptic transmission mediated via N-methyl-d-aspartate (NMDA) receptors (Pumain et al., 1992), a decrease in GABAergic inhibition (Luhmann et al., 1995) and an altered expression of the hyperpolarizationactivated cyclic-nucelotide-gated cation channels (HCN) (Strauss et al., 2004). Cortical SWDs (Figure 1C) reach the reticular thalamic (RT) nucleus via corticofugal fibers (Figure 1B). The response of RT neurons consists of bursts of excitatory postsynaptic potentials (EPSPs) and a regenerative low-threshold Ca2+ spike (LTS; Figure 1D) crowned by a burst of fast spikes (Slaght et al., 2002; Steriade, 1997; Steriade et al., 1993a; Timofeev et al., 1998). The Ca2+ potential is produced by activation of a Ca2+ current with low threshold of activation, termed IT, which requires membrane hyperpolarization for de-inactivation (Huguenard, 1996). The overall response is synchronized burst activity in RT neurons coinciding with the SWDs on the EEG. Pathophysiologic alterations that have been reported with respect to SWD generation include an increase in strength of corticofugal inputs (Blumenfeld and McCormick, 2000), an increase in T-current amplitude associated with an increased expression of the Cav3.2 subunit in RT neurons (Tsakiridou et al., 1995; Talley et al., 2000), and an imbalance of GABAA receptor- and gap junction-mediated synaptic interactions involved in synchronization of local synaptic networks (Bal et al., 1995a, 1995b; Huntsman et al., 1999). Circuitry within the thalamus promotes recurrent network activity. RT neurons are GABAergic in nature and are reciprocally connected with excitatory thalamocortical (TC) neurons of the corresponding sensory relay nuclei (Figure 1B), for instance, the VB thalamic complex of the somatosensory system (for review, see Steriade et al., 1993b, 1997). In response to the incoming RT volleys, TC neurons produce inhibitory postsynaptic potentials (IPSPs; Figure 1E) mediated via GABAA and GABAB receptors, which result in de-inactivation of the T-type Ca2+ current (Crunelli and Leresche, 2002; Steriade et al., 1993b, 1997). The
In Vitro Models of Absence Epilepsy
current is activated on repolarization of the membrane potential during IPSP decay, resulting in a regenerative lowthreshold calcium spike triggering a burst of fast spikes, which is then relayed to the RT nucleus and cortex. As a corollary of this activity, the cortico-thalamo-cortical network produces synchronized burst discharges that are temporally locked to the spike component of the SWDs on the EEG (Crunelli and Leresche, 2002; Steriade et al., 1993b, 1997). The pivotal role of the T-type Ca2+ conductance in thalamic neurons is supported by the findings that knockout of the Cav3.1 subunit results in resistance to gbutyrolactone-induced SWDs (Kim et al., 2001). Further, an imbalance of GABAB over GABAA receptor-mediated inhibition has been reported to shift activity in TC neurons toward SWD-like discharges (Bal et al., 1995a, b; Crunelli and Leresche, 1991; Lui et al., 1992; Snead, 1992; Snead et al., 1992), although GABAA receptor-mediated influences dominate during spontaneous SWDs in rat genetic models (Staak and Pape, 2001), and the balance between GABAA and GABAB seems to relate to the prevailing frequency of the SWDs (3–5 Hz in humans versus 7–11 Hz in most animal models) (Destexhe, 1998). It also should be noted that slightly different conclusions have been reached in various models with respect to the relative contribution of lowthreshold burst firing and of GABA potentials to the SWDs in TC neurons (Pinault et al., 1998). Furthermore, there is evidence for an involvement of neurons in intralaminar thalamic nuclei to the SWDs (Figure 2), although their exact role remains to be delineated (Seidenbecher and Pape, 2001). Because the relative roles played by the different components of the thalamocortical system in the generation of SWDs are still a matter of debate, experimental models with different network connectivity (i.e., thalamic, cortical, and thalamocortical models) have been developed, thereby helping to assess their specific contributions.
IN VITRO MODELS OF ABSENCE EPILEPSY The Ferret Dorsal Lateral Geniculate Nucleus Slice: A Model for the Transformation of Spindle Waves into Spike-Wave Discharges A number of thalamic in vitro models have been developed to investigate the mechanisms underlying the generation and spread of spike wave (SW)-like discharges in this brain structure. The ferret primary visual thalamic relay nucleus (dorsal part of the lateral geniculate nucleus, LGNd) and the associated section in the RT nucleus (termed the perigeniculate nucleus, PGN) have proven particularly useful. A sufficient part of the synaptic network is preserved in a slice preparation in vitro to generate spontaneous recur-
77
rent, spindle-like activity (Figure 3A), and this pattern of activity can be acutely transformed into SW-like discharges (Figure 3B) on pharmacologic manipulation (Bal et al., 1995a, b; von Krosigk et al., 1993). Ferret thalamic slices can be obtained and studied using standard brain slicing and electrophysiologic recording techniques. Preparation includes decapitation of deeply anaesthetized (pentobarbital, 30–40 mg/kg intraperitoneally) male or female animals 3 months to 3 years old. Sagittal slices (400-mm thickness) from the forebrain of one hemisphere are prepared using a vibratome or vibroslicer. During preparation, tissue should be placed in a chilled solution in which NaCl is replaced with sucrose while maintaining an osmolarity of ~305 mOsm. After preparation, slices are placed in an interface style recording chamber and allowed at least 2 hours to recover. The bathing solution contains (in mM): NaCl, 126; KCl, 2.5; MgSO4, 1.2; NaH2PO4, 1.25; CaCl2, 2; NaHCO3, 26; dextrose, 10. A pH of 7.4 is achieved by gassing the solution with 95% O2 and 5% CO2. Bathing of the slices in an equal mixture of normal NaCl and the sucrose-substituted solutions for the first 20 minutes in the recording chamber may be beneficial. Intraspindle and particularly interspindle frequencies as well as the duration of each spindle wave are temperature sensitive; a bath temperature of 34 to 35° C is optimal for studying the cellular basis of spindle waves and SWDs in vitro. Typically each hemisphere of the ferret LGNd yields two or three slices that exhibit robust spontaneous spindling activity in more than 95% of experiments. Extracellular multiunit recordings from ferret LGNd slices, using standard electrophysiologic techniques, revealed the occurrence of spontaneous spindle waves that were remarkably similar to those recorded in vivo in anaesthetized ferrets (interspindle period of 3–30 s, intraspindle frequency 6–10 Hz, spindle duration 2–5 s). Intracellular recordings obtained with bevelled micropipettes pulled from medium-walled borosilicate glass and filled with 4 M potassium acetate allowed the identification of the cellular mechanisms underlying spindling in TC neurons of the LGNd. It was shown that spindle waves are associated with barrages of IPSPs occurring at a frequency of 6 to 10 Hz, occasionally resulting in the generation of low-threshold Ca2+ spikes (Figure 3A). Most important, the bath application of 20 mM (—)-bicuculline methiodide resulted in a prolongation and an increase in amplitude of these IPSPs, leading to a highly synchronized 2- to 4-Hz oscillation in which each TC cell generated action potential bursts on every cycle, thus forming a paroxysmal event resembling SWDs (Figure 3B). Bath application of the GABAB antagonist 2-OH-saclofen (250 mM) abolished synchronized 2- to 4-Hz oscillations in ferret LGNd slices (Bal et al., 1995a); the effect of the classic antiabsence drug ethosuximide (ETX) has not been reported.
A
C
B
D
E
FIGURE 2 Correlated cellular activities in thalamus and neocortex during spike-wave discharges (SWDs). A: Simultaneous recording of multiunit activities in ventrobasal nucleus (VPM), rostral reticular thalamic nucleus (rRT), and somatosensory cortical sites. Epidural recordings of the bilateral electroencephalogram (EEG) (r, right; l, left hemisphere) from frontoparietal cortical areas. Calibration bars indicate 500 mV for EEG recording, 100 mV for unit activity. B: Inset demonstrates the temporal relationship of SWDs and burst-like activity at a faster time scale. C–E: Multisite unit recordings were simultaneously obtained from deep layers of the somatosensory cortex, rRT and caudal reticular thalamic (cRT) nucleus (C), cortex, rRT, ventroposterolateral thalamic (VPL) nucleus (D), and cortex, ventroposteromedial (VPM) and ventrolateral (VL) thalamic nucleus (E). Peristimulus-time histograms of unit activity (1-ms bins) triggered by the spike component on the EEG (upper traces in C—E show averaged SWDs) demonstrate phase locked unit activity. Stimulus-time histograms were averaged from 40 trials; n indicates number of animals. (Reprinted, with permission, from Seidenbecher et al., 1998.)
In Vitro Models of Absence Epilepsy ferret LGNd slice
A control -71 mV
B 20 µM bicuculline -70 mV
20 mV 1s
FIGURE 3 Block of g-amino-butyric acid (GABA)A receptors leads to spike-wave discharge (SWD)-like synchronized oscillations in ferret dorsal part of the lateral geniculate nucleus (LGNd) slices. Intracellular recording from a thalamocortical (TC) neuron during the generation of a normal spindle wave. B: Bath application of (-)- bicuculline methiodide (20 mM) results in a slowing of the frequency of oscillations from 5 to 2.4 Hz and to a marked enhancement of low-threshold spike (LTS)-associated burst firing. (Adapted from Bal et al., 1995.)
The Horizontal Thalamic Slice: A Model for Intrathalamic Rhythmicity A rodent in vitro thalamic slice preparation has been developed that contains interconnected VB and RT neurons and that is capable of generating sustained low-frequency (2–4 Hz) oscillations (Huguenard and Prince, 1994b). The horizontal thalamic slice provides a preparation that can be obtained easily and that allows straightforward analyses of genetic mutations or pharmacologic interventions on intrathalamic rhythmicity. Horizontal thalamic slices are taken through the middle portion of the RT nucleus (stereotaxic levels 2.1–4.1 mm posterior from bregma), which contains the adjacent ventral posterior lateral nucleus (see Paxinos and Watson, 1997). Rat pups P8–P26 are anesthetized (50 mg/kg pentobarbital) and decapitated. Brains are rapidly removed and placed in chilled (4° C) low-Ca2+/low-Na+ slicing solution consisting of (in mM): sucrose, 234; glucose, 11; NaHCO3, 24; KCl, 2.5; NaH2PO4, 1.25; MgSO4; CaCl2, 0.5; equilibrated with a mixture of 95% O2, 5% CO2. Thereafter a block of brain containing the thalamus is transferred to a vibratome, and 400-mm slices are obtained in the horizontal plane, hemisected and submerged in preheated (33° C), oxygenated physiological saline containing (in mM): NaCl, 126; glucose, 11; NaHCO3, 26; KCl, 2.5; NaH2PO4, 1.25; MgSO4, 0.63; CaCl2, 2; equilibrated with a mixture of 95% O2, 5% CO2. After 1 hour the heat is turned off and slices are allowed to cool to room temperature. For electrophysiologic recordings, slices are placed in an interface-type recording chamber with continuous perfusion (2 ml/min) of physiologic saline at 33° C. Multiunit extracellular recordings can be obtained from thalamic relay neurons in VB and from GABAergic neurons from the RT
79
nucleus using sharpened tungsten electrodes (0.1 MW resistance). Recordings are amplified and filtered above 100 Hz. Intrathalamic network oscillations driven by synaptic interactions between RT and VB neurons can be evoked by stimulation of the internal capsule. Bicuculline methiodide (1–10 mM) added to the bathing medium results in a prolongation and increase in synchronization of oscillatory activity. On the other hand, application of the classic antiabsence drug ETX has a robust anti-oscillatory effect. Typical responses evoked by stimulating the internal capsule (40 ms shocks of 40-V intensity) consist of one to five repetitive bursts, at a frequency of 2 to 4 Hz, that last for 2 to 8 seconds. Recordings are typically stable for more than an hour. The horizontal thalamic slice preparation represents a simple experimental setup that is ideal for screening of antiepileptic drugs and the effects of gene knockout (Huguenard and Prince, 1994a, b; Huntsman et al., 1999; Yue and Huguenard, 2001). Besides the extracellular recordings described previously, the horizontal thalamic slice can be used in conjunction with conventional sharp intracellular (Sohal et al., 2003) or patch-clamp recording techniques (use of a submerged rather than an interface-type chamber is highly recommended for the latter). Whereas blind patchrecordings were described originally (Huguenard and Prince, 1994b), the use of a standard upright microscope equipped with infrared differential interference contrast optics (Dodt and Zieglgänsberger, 1990) allows for the visual identification of single neurons.
The Thalamocortical Slice: A Model for Synchronous Thalamocortical Activity To account for the joint contribution of both thalamus and cortex to the generation of SWDs, in vitro preparations including both regions of the brain have been developed. Originally the mouse thalamocortical slice was introduced as a suitable system for studying the physiology and pharmacology of the thalamocortical synapse and for exploring the synaptic circuitry of the somatosensory cortex (Agmon and Connors, 1991). Later a similar preparation was introduced for rats (Tancredi et al., 2000; Zhang et al., 1996). This thalamocortical slice preparation is a reproducible model that enables investigators to analyze thalamocortical synchronization and to understand the pathogenesis of absence epilepsy (D’Arcangelo et al., 2002; Tancredi et al. 2000). To achieve thalamocortical slices Wistar rats (P15–P28) are decapitated under halothane anesthesia, and their brains are quickly removed and placed in cold, oxygenated artificial cerebrospinal fluid (ACSF) containing (mM): NaCl, 124; KCl, 2; KH2PO4, 1.25; MgSO4, 0.5; CaCl2, 2; NaHCO3, 26; glucose, 10; a pH of 7.4 is achieved by bubbling
80
Chapter 7/Thalamic, Thalamocortical, and Corticocortical Models of Epilepsy
with 95% O2/5% CO2. Combined thalamocortical slices (550–650 mm), involving a hybrid coronal plane forming a 45-degree angle with the sagittal plane, can be obtained on a vibratome (Figure 4). Typically two slices are obtained from each hemisphere at the level of the VB. After cutting, slices are transferred to an interface tissue chamber perfused with ACSF (32–35° C). Extracellular field potentials are recorded with ACSF-filled electrodes (2–8 MW) positioned under visual control in cortex and thalamus (VB or RT nucleus). Signals are fed to high-impedance amplifiers and processed through second-stage amplifiers with filtering capability. Bipolar stainless steel electrodes can be used to deliver extracellular stimuli (50–150 ms; <200 mA) to selected areas of the thalamocortical slice. Single-shock stimuli delivered in VB, the internal capsule, or the white matter are able to elicit a complex series of field potential waves in layers IV to V of the cortex, resulting from antidromic activation of corticothalamic axions and synaptic activation of thalamocortical afferents. An additional short latency (12–18 ms) response, resulting from reactivation of thalamocortical neurons in VB, can be observed. Spontaneous synchronous field potentials do not occur in thalamocortical slices bathed in normal ACSF. However, the use of low concentrations of the K+ channel blocker 4-aminopyridine (4-AP, ~1 mM) increases transmitter release at both excitatory and inhibitory synapses and
B
A
45-55° Th
10∞
C
D Cx
thus enhances the background activity of cortical and thalamic neurons. Indeed, with 4-AP, rhythmic oscillatory field potential activity occurs either spontaneously or following electrical stimulation of either thalamus or cortex. These oscillations can be recorded at both cortical (500–1200 mm from the pia) locations and thalamic sites (VB or RT nucleus) and are characterized by bursts of field potential waves of negative-positive polarity at frequencies ranging from 9 to 16 Hz (0.4–3.5 s duration; recurrence of the bursts every 6–24 s). Furthermore, other experimental procedures known to increase neuronal excitability (nominal Mg2+-free ACSF; elevation of the total extracellular K+ concentration to 8.25 mM) are able to induce synchronous oscillatory activity in thalamocortical slices of epileptic WAG/Rij and nonepileptic control rats (with different characteristic features) (D’Arcangelo et al., 2002). Although the effects of different glutamate receptor antagonists on 4-AP-induced oscillatory activity in thalamocortical slices has been described, no data are available for the classic anti-absence drug ETX in this preparation. Epileptiform discharge induced by nominal Mg2+ free ACSF was reduced by ETX (Zhang et al., 1996).
IN VITRO MODELS OF CORTICOCORTICAL CIRCUITRY IN EPILEPSY Whereas thalamocortical involvement is implicated in most forms of typical absence seizures, in some pharmacologic feline epilepsy models, SWDs have been observed in isolated cortical circuits (Marcus and Watson, 1966; Steriade and Contreras, 1998), suggesting that the cortical circuitry itself is capable of generating bilaterally synchronous 3- to 5-Hz electrographic activity. As a preliminary step in testing the involvement of long-range intracortical connections in widespread neocortical synchronization, Kumar and Huguenard (2001) refined a callosal slice preparation based on earlier work of Vogt and Gorman (1982).
3.0 mm 600 µm VB Hip
FIGURE 4 Preparation of rat thalamocortical slices. A: The brain is placed on a ramp with the caudal end elevated above the rostral end at an angle of 10 degrees. Th, approximate location of the thalamus. B: Dorsal view showing angle of initial vertical cut made with a razor blade. C: The cut surface of the brain is then glued to the vibratome stage. Horizontal lines indicate the approximate position of collected slices. Typically two or three slices (550–650 mm in thickness) retain full thalamocortical connectivity. D: Typical positions of recording (left, in cortical barrel field) and stimulating (right, in the external part of the ventrobasal (VB) near the border with the reticular thalamic nucleus (RTN) electrodes in a schematic thalamocortical slice. Cx, cortex; Hip, hippocampus; RTN, reticular thalamic nucleus; VB, ventrobasal thalamus. (After Agmon and Connors, 1991; and Tancredi et al., 2000.)
What Does the Corticocortical Preparation Model? The mammalian neocortex is characterized by extensive recurrent excitatory circuitry. Roughly 85% of synapses are excitatory, and an almost equal percentage of synapses made by excitatory neurons are onto other excitatory neurons (Braitenberg and Schüz, 1991). Such neural networks with prominent positive feedback are prone to become hyperexcitable and seizure generating following disruption of inhibition. The study of epilepsy necessitates model systems in which excitatory corticocortical synapses can be studied in isolation so that response properties of individual neurons and their contribution to the overall excitability of the
In Vitro Models of Corticocortical Circuitry in Epilepsy
network can be characterized. Not only are such model systems useful in assessing pathophysiology, but they are also essential in characterizing normal physiologic properties of excitatory-to-excitatory synapses and in elucidating their receptor compositions. This background is essential for understanding the changes in synaptic connectivity during epileptogenesis, changes that are difficult to detect given the complexity of the underlying circuitry. Attempts to isolate and study synaptic excitatory responses in brain tissue have been frustrating in many models of experimental epilepsy because attempts to block inhibition invariably lead to conditions of “runaway” excitation or hyperexcitability. By contrast, studies of inhibition are more readily accomplished because excitatory receptors can be readily blocked (using glutamatergic receptor antagonists), yielding “residual” synaptic responses that are (for the most part) inhibitory responses mediated by GABA receptors. In the following sections we provide an overview of the development of a callosal slice model that lends itself quite well to the study of long-range cortical excitatory connectivity.
Importance of the Corpus Callosum in a Model for the Study of Intracortical Excitability The corpus callosum is the principal commissural pathway in the forebrain linking the two cerebral hemispheres. The cells of origin of neocortical callosal projections are almost entirely pyramidal neurons, located mainly in layers III and V; the projection terminates exclusively with excitatory asymmetric synapses on spines of pyramidal neurons in homotopic and heterotopic regions of the contralateral cortex (Akers and Killackey, 1978; Jacobson, 1965; Jacobson and Trojanowski, 1974; Seggie and Berry, 1972; Wise and Jones, 1976). Callosal projections can be reliably stimulated (Vogt and Gorman, 1982); because they are purely excitatory, activation of this pathways aids greatly in the study of excitatory-to-excitatory cortical synapses (Aram and Lodge, 1988) and intracortical excitation. Furthermore, the callosum is itself considered a primary substrate for intrahemispheric spread of discharges in generalized epileptic seizures (Gazzaniga et al., 1975; Reeves and O’Leary, 1985; Wilson et al., 1975). Clinical studies have shown that cutting of this pathway (callosotomy) can eliminate seizure activity or decrease its severity and frequency, suggesting that transcortical excitation can initiate or perpetuate epileptiform activity. Excitatory corticocortical projections may play a crucial role in determining the strength and extent of seizure generalization, especially during critical periods in early maturation when neocortical tissue is vulnerable to epileptiform activity (Luhmann and Prince, 1990; Moshe et al., 1983; Swann et al., 1993). However, despite the long history of callosal
81
studies in epilepsy, and a wealth of anatomic information on callosal organization, a neocortical preparation involving hemispheric connection via the corpus callosum has only recently been recognized as a viable model for studying intracortical excitation. This delay is due in part to limitations in our knowledge of the functional properties and receptor composition of the synapses made by callosal fibers and the mechanisms that control their efficacy. To overcome this deficiency, Kumar and colleagues (2001) undertook a study to assay the usefulness of callosal activation in a model system for studying intracortical excitability by (1) investigating the receptor composition of the callosal synapse; (2) characterizing the voltage dependence of the pharmacologically isolated components of excitatory postsynaptic currents (EPSCs) evoked by minimal stimulation of the callosum; (3) determining whether kinetic properties of spontaneous and evoked EPSCs recorded in these neurons can reveal differences in function of the underlying receptor populations at callosal and noncallosal synapses; and (4) identifying changes in the physiologic properties of these receptors as a function of early postnatal age (Kumar and Huguenard, 2001). Kumar and colleagues (2001) found that midline stimulation of the corpus callosum in callosally connected acute brain sections of the rat neocortex (Figure 5) could evoke inward EPSCs in whole-cell voltage-clamped (-70 mV) pyramidal neurons in layer V of the agranular frontal cortex. In the presence of the GABAA receptor antagonist picrotoxin (to isolate the EPSCs) and a low concentration of 1,2,3,4-tetrahydro-6-nitro-2,3-dioxo-benzo [f] quinoxaline7-sulfonamid (NBQX) (0.1 mM) (to block partially a-amino3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors and thereby prevent epileptiform activity), purely glutamatergic EPSCs were obtained. These isolated EPSCs had fixed latencies from stimulus onset, could follow stimulus trains (1–20 Hz) without changes in kinetic properties, and were completely antagonized with high concentrations of NBQX (10 mM), indicating that they were mediated by AMPA receptors. Depolarization of the recorded neurons revealed a late, slowly decaying component that reversed at ~0 mV and that could be blocked by D-2 amino-5-phosphonovaeric acid (D-APV). These studies showed clearly that callosal synapses involve both AMPA and NMDA receptors. Analysis of the callosal EPSCs revealed age-dependent changes in the composition of the underlying AMPA receptors. In particular, AMPA receptor-mediated responses in immature cortex (tissue from younger than 15 day old rats) were characterized by inward rectification—the hallmark of GluR2-deficient AMPA receptors. Direct measurement of Ca2+ permeability, another characteristic of GluR2 deficiency, confirmed this finding (Kumar et al., 2002). An interesting finding was that the functional properties of AMPA receptors were similar at callosal and noncallosal excitatory connections. By contrast, NMDA receptor-mediated
82
Chapter 7/Thalamic, Thalamocortical, and Corticocortical Models of Epilepsy
response properties were pathway-specific, suggesting differences in subunit composition of the underlying receptors (Kumar and Huguenard, 2003).
Corticocortical Slice Preparation General Considerations
FIGURE 5 The callosal slice preparation and schematic. A1–A5: lowpowered images of a coronal cortical section, obtained with a 10¥ objective, depicting placement of a bipolar stimulating electrode (S in A1) at different locations (•) along the dorsal—ventral extent of the callosum. The corresponding whole-cell responses of a layer V pyramidal neuron (R in A1), evoked by stimulation of the callosum at these locations, are shown as insets. Traces are averaged responses evoked at a holding potential of -70 mV; stimulus intensity was constant throughout. Patch pipette in A1 is visible during whole-cell recording from pyramidal neuron on the right (R, scale bar is 40 mm). Note that responses were especially robust for one nearmidline stimulus location (* in A2). Postsynaptic currents (PSCs) with longer latency and similar kinetic properties could also be evoked from the contralateral hemisphere (A5). Typically the recording region was closer to midline, in the frontal-cortex areas 1 and 2 (Fr1 and Fr2, A1). B: schematic of the slice preparation, showing typical placement of the stimulating (S) and recording (R) electrodes (S1 and S2 for callosal and local intracortical stimulation, respectively) on the slice. Anatomic structures that can be easily recognized are labeled: CC, corpus callosum; CA1 and CA3 regions of the hippocampus; neocortical laminae indicated by Roman numerals. (Reprinted with permission from the American Physiological Society, 2001.)
The primary consideration in making acute callosal slices for studying corticocorticol synapses is to retain and optimize intrahemispheric connectivity. All experiments were carried out in coronal sections of rat (Sprague-Dawley) brains, retaining both hemispheres and the callosal tract. Preserving callosal connectivity in brain slices is complicated owing to the curvature of the corpus callosum. We recommend using straightforward coronal sections (300– 350 mm thick) obtained on a vibratome. We have found that during slicing the presentation angle of the sectioning blade is a critical factor for optimal slice health and connectivity; an angle of 18 degrees relative to the plane of the section is optimal. Using coronal slices prepared in this manner, we have been able to evoke responses in neurons located as lateral as the somatosensory cortex via midline stimulation of the callosum. In general, however, we prefer recording closer to the midline—from the agranular frontal cortex— to maximize callosal connectivity (Figure 6). The thickness of the slice is also a critical factor in determining connectivity; the range of slice thickness we recommend is chosen as a compromise so that we can maintain connectivity but still record from visually identified neurons deep in the tissue. Another important parameter that affects connectivity is the age of the experimental animals. We have used animals in three different developmental age groups for studying the ontogeny of callosally evoked responses: neonates (P6–7), in which callosal fibers just approach their final cortical target lamina; juveniles (P12–16), in which neocortical synaptogenesis approaches adult levels of maturity; and young adults (P20–28), in which synaptogenesis is almost complete and myelination has begun to develop. It is worth noting that these demarcations of age groups overlap a period of early postnatal maturation between P11–20, during which there is transient but well-defined temporal manifestation of strong excitatory polysynaptic activity (NMDA receptor-mediated) leading to an enhanced sensitivity for epileptogenesis. Although the callosal model represents long-range intrahemispheric connections, layer V pyramidal neurons also receive a diverse set of short-range intracortical excitatory afferents that arise locally from neurons in close vicinity to the cells of interest (Burkhalter and Charles, 1990). These latter fibers can also be activated concomitantly with the callosal afferents by using stimulating electrodes placed intracortically in close proximity to the recorded neurons (either off- or on-column), to study any pathway-specific differences
In Vitro Models of Corticocortical Circuitry in Epilepsy
83
FIGURE 6 Orthograde transport of biocytin reveals callosal projection in coronal slices. A: A biocytin crystal (~0.5 mm diameter) was placed in layer V of the contralateral cingulate cortex (right side, crystal placement not shown in this figure). The slice was incubated for 3 hours in an interface chamber and then processed to obtain a final horseradish peroxidase reaction product. The arrows in A indicate labeling of the callosal fibers. The square area marked in A is expanded in B. B: A dark-field image showing the callosal fibers coursing upward through the ipsilateral layer V. (See color insert.)
in synaptic properties. Previous work suggests that although functional attributes of AMPA receptors are uniform among synaptic connections onto layer V pyramidal neurons (i.e., callosal and noncallosal excitatory inputs onto these cells are indistinguishable), properties of NMDA receptors at these inputs can be functionally distinct (Kumar and Huguenard, 2003). How Sections Are Prepared Standard techniques for preparing and maintaining neocortical slices are employed (reviewed in Kumar and Huguenard, 2001). Briefly, Sprague-Dawley rats of the desired age are anesthetized (50 mg/kg pentobarbital), decapitated, and the brain rapidly removed and transferred to a chilled (4° C) low Ca2+, low Na+ slicing solution equilibrated with a 95% : 5% mixture of O2 and CO2. The brain is subsequently blocked and coronal slices, 350mm thick, are prepared on a vibratome with the blade set at the appropriate cutting angle. All slices are incubated at 32° C in oxygenated artificial cerebrospinal fluid (ACSF) for 1 hour before being transferred to the recording chamber. Generally, four to six slices are obtained per animal; slices remain viable for up to 6 hours. Electrophysiologic Techniques, Data Collection, and Analysis Recordings are obtained at 32 ± 1° C from layer V pyramidal neurons in the agranular frontal cortex (Paxinos and
Watson, 1997). Patch recording electrodes (1.2–2 mm tip diameters; 3–6 MW) typically contained the following electrolyte (in mM): for voltage-clamp experiments, 120 cesium gluconate, 1 MgCl2, 1 CaCl2, 11 KCl, 10 HEPES, 2 NaATP, 0.3 NaGTP, 1 QX-314, and 11 EGTA (pH 7.3 was corrected with Cs-OH, 290 mOsm); for current-clamp experiments, 105 potassium gluconate, 30 KCl, 10 HEPES, 10 phosphocreatine, 4 MgATP, and 0.3 GTP (adjusted to pH 7.3 with KOH). Slices are maintained in oxygenated (95% O2-5% CO2) ACSF, and drugs and chemicals are applied via the perfusate (2 ml/min) or through a local perfusion system that allows fast exchange of media at the level of the synapse (Kumar et al., 2002). Concentric bipolar electrodes (e.g., CB-XRC75 from Frederick Haer Company, Bowdoinham, ME), with 75-mm-tip diameters, are positioned on the callosal tract or intracortically in close proximity to the recorded neuron; constant current pulses (50–300 ms in duration and 100–500 mA in amplitude) are applied at low frequencies (0.1–0.3 Hz). Callosal stimulation activates fibers potentially in both orthodromic and antidromic directions, each of which in turn activates monosynaptic excitatory connections onto the recorded pyramidal neuron (Kumar and Huguenard, 2001). Thus this model consists of activating a well-defined, relatively homogeneous population of intracortical excitatory connections. Stimulation parameters are determined by increasing current strength until postsynaptic responses can be evoked (minimal stimulation); stimulus intensity is held constant at about 1.2 times the threshold for obtaining a detectable response throughout the duration of the experiment (thresholds are characterized by
84
Chapter 7/Thalamic, Thalamocortical, and Corticocortical Models of Epilepsy
a large proportion of failures). Characterization of synaptic currents mediated by AMPA and NMDA receptors requires the isolation of purely excitatory monosynaptic responses with minimal contribution from polysynaptic events, such as those arising from feed-forward excitation. Toward this end, the minimal stimulation paradigm outlined previously can be used in conjunction with a pharmacologically controlled blockade of inhibition. Callosally evoked responses can be compared with EPSCs evoked during stimulation of local excitatory circuitry in the vicinity of the recorded neuron to determine differences in the biophysical properties of the underlying receptor subtypes and the input specificity of their responses. Evoked responses are recorded with a patch amplifier filtered at 2 to 5 kHz and digitized at 10 kHz. Solutions The low-Ca2+, low Na+ slicing solution consists of (in mM): 234 sucrose, 11 glucose, 24 NaHCO3, 2.5 KCl, 1.25 NaH2PO4, 10 MgSO4, and 0.5 CaCl2. The composition of the ACSF used in the incubation and perfusion (bathing medium) of the slices during recording is as follows: 126 NaCl, 26 NaHCO3, 2.5 KCl, 1.25 NaH2PO4, 2 MgCl2, 2 CaCl2, and 10 glucose, pH 7.4. The following are bath-applied as required for specific protocols: APV, 40 mM; NBQX, 0.05–0.1 mM; picrotoxin (PTX), 50 mM. Biocytin (0.1%) can be included in the patch solution in experiments in which histologic processing is required.
Using the Corticocortical Model: An Example Intrinsic excitatory connectivity is the primary mediator for the generation and spread of epileptiform activity within the neocortex. During maturation, there is a critical period during which normal cortical tissue appears to be most epileptogenic (Luhmann and Prince, 1990; Moshe et al., 1983; Swann et al., 1993). This maturational dynamic presents an opportunity to study changes in the functional properties of intrinsic excitatory connections and the cellular mechanisms that lead to epileptiform activity. To this end, we have used the callosal model to determine how the ontogeny of excitatory connections compares with the development of intrinsic neuronal excitability and epileptogenicity within the frontal cortex. Given that the incidence of seizure generalization is critically dependent on the maturation of corticocortical connections, we used animals from developmentally distinct age groups to assay the ontogeny of synaptic responses in visually identified layer II/III and V pyramidal neurons. We then determined whether changes in the postsynaptic properties of these excitatory connec-
tions lead to alterations in synaptic efficacy, thereby making the tissue more likely to engage in epileptiform activity. The goals of these studies included the hope that our findings would aid in the identification of candidate cellular mechanisms that produce changes in synaptic efficacy, thereby providing useful information about the role of excitation in the developmental regulation of epileptiform events. We also anticipated that these studies would help address two critical basic neurobiological questions: (1) Do maturational changes in corticocortical synaptic efficacy parallel the transient manifestation of the period of hyperexcitability in the neocortex? (2) Do the functional properties and relative contribution of the different excitatory receptors (AMPA vs. NMDA) change during this critical period? Using the callosal-connected cortical model, we discovered that synaptic AMPA receptors of excitatory layer 5 pyramidal neurons in the rat neocortex were deficient in GluR2 in early development (before P16), as evidenced by their inwardly rectifying current-voltage relationship, blockade of AMPA receptor-mediated EPSCs by external and internal polyamines, permeability to Ca2+, and GluR2 immunoreactivity. Our results indicated that neocortical pyramidal neurons underwent a developmental switch in the Ca2+ permeability of their AMPA receptors through an alteration of the AMPA subunit composition (Kumar et al., 2002). This finding led us to explore the general question of whether all cortical glutamatergic receptors change their subunit composition during maturation? If that were so, we could begin to understand how these alterations influence the development of intrinsic neuronal excitability and epileptogenicity. Early low expression of GluR2 subunits or the failure to incorporate the GluR2 subunit into AMPA receptors during the developmental critical period might underlie increased seizure susceptibility of the immature brain (Moshe et al., 1983; Schwartzkroin and Prince, 1980; Sensi et al., 1999). Indeed, one study (Sanchez et al., 2001) demonstrated that hypoxia-induced seizures in neonatal rats (P10–12) are linked with maturational and seizure-induced changes in AMPA receptor composition and function, particularly involving the GluR2 subunit (see Chapter 25). These results indicated that seizures induce an increased expression of Ca2+-permeable AMPA receptors and an increased capacity for AMPA receptor-mediated epileptogenesis. The AMPA receptor switch described in our study occurs approximately midway through the period of maximum synaptogenesis in rats (P11–20) (Sutor and Luhmann, 1995) and results in changes in the functional properties of AMPA receptors that depend on the presence or absence of GluR2. Failure to switch the subunit composition of these receptors to incorporate GluR2 at this juncture might indeed have deleterious consequences for neocortical excitability (Feldmeyer et al., 1999; PellegriniGiampietro et al., 1997).
85
Conclusions
FURTHER DEVELOPMENT OF THE MODEL Insights into Human Conditions Callosal projections (i.e., excitatory synapses onto excitatory cells) have long been known to provide a primary pathway for intrahemispheric generalization of seizure activity. Callosotomy has emerged as one of the only surgical treatment for patients with medically intractable seizures who are not eligible for resective surgery. A variety of seizure types have been considered as appropriate for callosotomy surgery, including complex partial seizures and frontal lobe epilepsies (Reeves and O’Leary, 1985). The reported efficacy of such intervention for epilepsy (such as a reduced frequency of generalized seizures) varies from one study to another. Currently there are no good models available to address precisely how seizures propagate and generalize. What are the underlying cellular events? In vitro models such as the ones considered in this chapter constitute an invaluable resource for studying such questions that are directly related to the human condition. For instance, it is possible, using the corticocortical model, to generate an epileptic focus in one hemisphere of the brain section (e.g., by disrupting inhibition focally) to explore the precise features of its spread to the other hemisphere; this model allows the investigator to elucidate synaptic changes at the single cell level (intracellular recording), to detail the mechanisms underlying seizure propagation, and to describe “global” changes at the level of the network (field recordings). The callosal model is also amenable to exploration of therapeutic approaches, pharmacologic or otherwise, for preventing intrahemispheric spread of epileptic discharges. In addition to pathophysiology, structural changes following callosotomy can also be investigated using a combined in vivo and in vitro approach in which the effects of callosotomy in vivo can be followed both anatomically (for neuropathology) and physiologically in vitro using brain sections obtained from such animals.
LIMITATIONS OF THE THALAMIC, THALAMOCORTICAL, AND CORTICOCORTICAL MODEL Several technical and methodological difficulties can be expected in the course of using the thalamic, thalamocortical, and corticocortical models: (1) Perhaps most critically, it is sometimes difficult to obtain intrathalamic, thalamocortical, or callosal connectivity, despite the intact appearance of VB-RT, thalamocortical, or callosal axons. In such instances it may not be possible to evoke any responses in the recorded neurons, despite the presence of normal spontaneously occurring postsynaptic currents. (2) Neurons that contribute axons to the corpus callosum (or internernal
capsule) may not be uniformly distributed throughout the neocortex, and different cortical areas may have different distribution profiles that might be subject to change during development (Ivy and Killackey, 1981; Olavarria and van Sluyters, 1986). This limitation therefore restricts the number of anatomically distinct regions that can be studied using coronal sections. (3) As is the case for many preparations, it may not be possible to adequately voltage-clamp— from a single point source—neurons with extensive dendritic arborizations. Recordings of PSCs may be contaminated by errors resulting from the extended electrotonic structure of the recorded neurons. (4) As is commonly found for slice studies, whole-cell recording from neurons in tissue from older animals can be technically more challenging than those in younger animals; obtaining long-term, high-quality recordings is simply more difficult in mature tissue. (5) Finally, one must acknowledge the in vitro nature of the preparation and exercise all necessary precautions that go into interpreting results and extending them to situations in vivo. One potentially effective means of improving connectivity and extending the number of areas that can be studied using these models is to increase the thickness of the brain sections. However, there is a tradeoff between connectivity and visualization. Clear visualization of neurons, especially those located deep within the sections (usually the ones with the best intrahemispheric connectivity in callosal slices), is generally difficult in thicker sections (despite the use of infrared video microscopy). This limitation is particularly problematic in thalamic areas, such as RT and lateral VB, which contain densely packed myelinated axons. Another potentially powerful approach to improving the extent of callosal connectivity in brain sections is to take into account the global curvature of the corpus callosum and design sectioning techniques that follow curved trajectories. For instance, the callosal projections to areas OC1 and OC2 of the rat visual cortex are generally inaccessible to studies using brain slices on account of their curved pathway. However, Berry et al. (1990) developed a slice preparation in which curved cutting blades were used to circumvent this problem; they have obtained slices in which callosal fibers projecting to OC1 or OC2 are preserved.
CONCLUSIONS We have described various in vitro model systems that allow for careful dissection of cellular, synaptic, and network interactions that occur during seizure genesis. Each of these has advantages and disadvantages; as pointed out by in a review of absence epilepsy by Crunelli and Leresche (2002): “There is no established in vitro model that is capable of fully reproducing human SWDs.” Some models may accurately reproduce the types of neural networks that
86
Chapter 7/Thalamic, Thalamocortical, and Corticocortical Models of Epilepsy
become activated during seizures, but insights regarding the mechanisms of initiation of seizures have remained quite elusive. In the intact brain, absence seizures arise spontaneously, often from a normal EEG background. This type of sudden transition is rarely seen in vitro, likely because of the disconnected (deafferented) state of brain slices. It is hoped that future models will incorporate more complete circuitry that will approximate the intact brain and yet still allow the quantitative intracellular recordings that are required for elucidation of epileptic mechanisms. For example, a preparation retaining the entire cerebral cortex has recently been developed by Kilb and Luhmann (2003).
References Agmon, A., and Connors, B.W. 1991 Thalamocortical responses of mouse somatosensory (barrel) cortex in vitro. Neuroscience 41: 365–379. Akers, R.M., and Killackey, H.P. 1978. Organization of corticocortical connections in the parietal cortex of the rat. J Comp Neurol 181: 513–537. Aram, J.A., and Lodge, D. 1988. Validation of a neocortical slice preparation for the study of epileptiform activity. J Neurosci Methods 23: 211–224. Bal, T., von Krosigk, M., and McCormick, D.A. 1995a. Role of the ferret perigeniculatate nucleus in the generation of synchronized oscillations in vitro. J Physiol (Lond) 483(3): 665–685. Bal, T., von Krosigk, M., and McCormick, D.A. 1995b. Synaptic and membrane mechanisms underlying synchronized oscillations in the ferret lateral geniculate nucleus in vitro. J Physiol (Lond) 483(3): 641–663. Baulac, S., Huberfeld, G., Gourfinkel-An, I., Mitropoulou, G., Beranger, A., Prud’homme J.F., Baulac, M. et al. 2001. First genetic evidence of GABA(A) receptor dysfunction in epilepsy: a mutation in the gamma2subunit gene. Nat Genet 28: 46–48. Berry, R.L., Nowicky, A., and Teyler, T.J. 1990. A slice preparation preserving the callosal projection to contralateral visual cortex. J Neurosci Methods 33: 171–178. Blumenfeld, H., and McCormick, D.A. 2000. Corticothalamic inputs control the pattern of activity generated in thalamocortical networks. J Neurosci 20: 5153–5162. Braitenberg, V., and Schüz, A. 1991. Anatomy of the Cortex. Berlin: Springer-Verlag. Burkhalter, A., and Charles, V. 1990. Organization of local axon collaterals of efferent projection neurons in rat visual cortex. J Comp Neurol 302: 920–934. Coenen, A.M., Drinkenburg, W.H., Inoue, M., and van Luijtelaar, E.L. 1992. Genetic models of absence epilepsy, with emphasis on the WAG/Rij strain of rats. Epilepsy Res 12: 75–86. Crunelli, V., and Leresche, N. 1991. A role for GABAB receptors in excitation and inhibition of thalamocortical cells. TINS 14: 16–21. Crunelli, V., and Leresche, N. 2002. Childhood absence epilepsy: genes, channels, neurons and networks. Nat Rev Neurosci 3: 371–382. D’Arcangelo, G., D’Antuono, M., Biagini, G., Warren, R., Tancredi, V., and Avoli, M. 2002. Thalamocortical oscillations in a genetic model of absence seizures. Eur J Neurosci 16: 2383–2393. Danober, L., Deransart, C., Depaulis, A., Vergnes, M., and Marescaux, C. 1998. Pathophysiological mechanisms of genetic absence epilepsy in the rat. Prog Neurobiol 55: 27–57. Destexhe, A. 1998. Spike-and-wave oscillations based on the properties of GABAB receptors. J Neurosci 18: 9099–9111. Destexhe, A., and Sejnowski, T.J. 2003. Interactions between membrane conductances underlying thalamocortical slow-wave oscillations. Physiol Rev 83: 1401–1453.
Dodt, H.U., and Zieglgänsberger, W. 1990. Visualizing unstained neurons in living brain slices by infrared DIC-videomicroscopy. Brain Res 537: 333–336. Engel, J. 2001. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia 42: 796–803. Feldmeyer, D., Kask, K., Brusa, R., Kornau, H.C., Kolhekar, R., Rozov, A., Burnashev, N., et al. 1999. Neurological dysfunctions in mice expressing different levels of the Q/R site-unedited AMPAR subunit GluR-B. Nat Neurosci 2: 57–64. Felix, R. 2002. Insights from mouse models of absence epilepsy into Ca2+ channel physiology and disease etiology. Cell Mol Neurobiol 22: 103–120. Gazzaniga, M.S., Risse, G.L., Springer, S.P., Clark, D.E., and Wilson, D.H. 1975. Psychologic and neurologic consequences of partial and complete cerebral commissurotomy. Neurology 25: 10–15. Gervasi, N., Monnier, Z., Vincent, P., Paupardin-Tritsch, D., Hughes, S.W., Crunelli, V., and Leresche, N. 2003. Pathway-specific action of gammahydroxybutyric acid in sensory thalamus and its relevance to absence seizures. J Neurosci 23: 11469–11478. Gloor, P., and Fariello, R.G. 1988. Generalized epilepsy: some of its cellular mechanisms differ from those of focal epilepsy. TINS 11: 63–68. Huguenard, J.R. 1996. Low-threshold calcium currents in central nervous system neurons. Annu Rev Physiol 58: 329–3248. Huguenard, J.R., and Prince, D.A. 1994a. Clonazepam suppresses GABAB-mediated inhibition in thalamic relay neurons through effects in nucleus reticularis. J Neurophysiol 71: 2576–2581. Huguenard, J.R., and Prince, D.A. 1994b. Intrathalamic rhythmicity studied in vitro: nominal T-current modulation causes robust antioscillatory effects. J Neurosci 14: 5485–5502. Huntsman, M.M., Porcello, D.M., Homanics, G.E., DeLorey, T.M., and Huguenard, J.R. 1999. Reciprocal inhibitory connections and network synchrony in the mammalian thalamus. Science 283: 541–543. Inoue, M., Duysens, J., Vossen, J.M., and Coenen, A.M. 1993. Thalamic multiple-unit activity underlying spike-wave discharges in anesthetized rats. Brain Res 612: 35–40. Ivy, G.O., and Killackey, H.P. 1981. The ontogeny of the distribution of callosal projection neurons in the rat parietal cortex. J Comp Neurol 195: 367–389. Jacobson, S. 1965. Intralaminar, interlaminar, Callosal and thalamocortical Connections in frontal and parietal areas of the albino rat cerebral cortex. J Comp Neurol 124: 131–145. Jacobson, S., and Trojanowski, J.Q. 1974. The cells of origin of the corpus callosum in rat, cat and rhesus monkey. Brain Res 74: 149–155. Jouvenceau, A., Eunson, L.H., Spauschus, A., Ramesh, V., Zuberi, S.M., Kullmann, D.M., and Hanna, M.G. 2001. Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel. Lancet 358: 801–807. Kilb, W., and Luhmann, H.J. 2003. Carbachol-induced network oscillations in the intact cerebral cortex of the newborn rat. Cereb Cortex 13: 409–421. Kim, D., Song, I., Keum, S., Lee, T., Jeong, M.J., Kim, S.S., McEnery, M.W. et al. 2001. Lack of the burst firing of thalamocortical relay neurons and resistance to absence seizures in mice lacking alpha(1G) T-type Ca(2+) channels. Neuron 31: 35–45. Kostopoulos, G., Gloor, P., Pellegrini, A., and Siatitsas, I. 1981. A study of the transition from spindles to spike and wave discharge in feline generalized penicillin epilepsy: EEG features. Exp Neurol 73: 43–54. Kumar, S.S., Bacci, A., Kharazia, V., and Huguenard, J.R. 2002. A developmental switch of AMPA receptor subunits in neocortical pyramidal neurons. J Neurosci 22: 3005–3015. Kumar, S.S., and Huguenard, J.R. 2001. Properties of excitatory synaptic connections mediated by the corpus callosum in the developing rat neocortex. J Neurophysiol 86: 2973–2985.
References Kumar, S.S., and Huguenard, J.R. 2003. Pathway-specific differences in subunit composition of synaptic NMDA receptors on pyramidal neurons in neocortex. J Neurosci 23: 10074–10083. Luhmann, H.J., Mittmann, T., van Luijtelaar, G., and Heinemann, U. 1995. Impairment of intracortical GABAergic inhibition in a rat model of absence epilepsy. Epilepsy Res 22: 43–51. Luhmann, H.J., and Prince, D.A. 1990. Transient expression of polysynaptic NMDA receptor-mediated activity during neocortical development. Neurosci Lett 111: 109–115. Lui, Z., Vergnes, M., Depaulis, A., and Marescaux, C. 1992. Involvment of intrathalmic GABAB neurotransmission in the control of absence seizures in the rat. Neuroscience 48: 87–93. Manning, J.P., Richards, D.A., Leresche, N., Crunelli, V., and Bowery, N.G. 2004. Cortical-area specific block of genetically determined absence seizures by ethosuximide. Neuroscience 123: 5–9. Marcus, E.M., and Watson, C.W. 1966. Studies of the bilateral cortical callosal preparation. Trans Am Neurol Assoc 91: 291–293. Marescaux, C., Vergnes, M., and Depaulis, A. 1992. Genetic absence epilepsy in rats from Strasbourg–A review. J Neural Transm 35: 37–69. McCormick, D.A., and Contreras, D. 2001. On the cellular and network bases of epileptic seizures. Annu Rev Physiol 63: 815–46. Meeren, H.K., Pijn, J.P., van Luijtelaar E.L., Coenen, A.M., and Lopes da Silva, F.H. 2002. Cortical focus drives widespread corticothalamic networks during spontaneous absence seizures in rats. J Neurosci 22: 1480–1495. Moshe, S.L., Albala B.J., Ackermann, R.F., and Engel, J. Jr. 1983. Increased seizure susceptibility of the immature brain. Brain Res 283: 81–85. Olavarria, J., and van Sluyters, R.C. 1986. Axons from restricted regions of the cortex pass through restricted portions of the corpus callosum in adult and neonatal rats. Brain Res 390: 309–313. Paxinos, G., and Watson, C. 1997. The Rat Brain in Stereotaxic Coordinates. San Diego: Academic Press. Pellegrini-Giampietro, D.E., Gorter, J.A., Bennett, M.V., and Zukin, R.S. 1997. The GluR2 (GluR-B) hypothesis: Ca(2+)-permeable AMPA receptors in neurological disorders. Trends Neurosci 20: 464– 470. Pietrobon, D. 2002. Calcium channels and channelopathies of the central nervous system. Mol Neurobiol 25: 31–50. Pinault, D., Leresche, N., Charpier, S., Deniau, J.M., Marescaux, C., Vergnes, M., and Crunelli, V. 1998. Intracellular recordings in thalamic neurones during spontaneous spike and wave discharges in rats with absence epilepsy. J Physiol (Lond) 509: 449–456. Pumain, R., Louvel, J., Gastard, M., Kurcewicz, I., and Vergnes, M. 1992. Responses to N-methyl-D-aspartate are enhanced in rats with petit mallike seizures. J Neural Transm Suppl 35: 97–108. Reeves, A., and O’Leary, P. 1985. Total corpus callosotomy for control of medically intractable epilepsy. In Epilepsy and the Corpus Callosum. Ed. A. Reeves. pp. 269–280. New York: Plenum Press. Renier, W.O., and Coenen, A.M.L. 2000. Human absence epilepsy: The WAG/Rij rat as a model. Neurosci Res Commun 26: 181–191. Richards, D.A., Manning, J.P., Barnes, D., Rombola, L., Bowery, N.G., Caccia, S., Leresche, N. et al. 2003. Targeting thalamic nuclei is not sufficient for the full anti-absence action of ethosuximide in a rat model of absence epilepsy. Epilepsy Res 54: 97–107. Sanchez, R.M., Koh, S., Rio, C., Wang, C., Lamperti, E.D., Sharma, D., Corfas, G. et al. 2001. Decreased glutamate receptor 2 expression and enhanced epileptogenesis in immature rat hippocampus after perinatal hypoxia-induced seizures. J Neurosci 21: 8154–8163. Schwartzkroin, P.A., and Prince, D.A. 1980. Changes in excitatory and inhibitory synaptic potentials leading to epileptogenic activity. Brain Res 183: 61–76. Seggie, J., and Berry, M. 1972. Ontogeny of interhemispheric evoked potentials in the rat: significance of myelination of the corpus callosum. Exp Neurol 35: 215–232.
87
Seidenbecher, T., and Pape, H.C. 2001. Contribution of intralaminar thalamic nuclei to spike-and-wave-discharges during spontaneous seizures in a genetic rat model of absence epilepsy. Eur J Neurosci 13: 1537–1546. Seidenbecher, T., Staak, R., and Pape, H.-C. 1998. Relations between cortical and thalamic cellular activities during absence seizures in rats. Eur J Neurosci 10: 1103–1112. Sensi, S.L., Yin, H.Z., Carriedo, S.G., Rao, S.S., and Weiss, J.H. 1999. Preferential Zn2+ influx through Ca2+-permeable AMPA/kainate channels triggers prolonged mitochondrial superoxide production. Proc Natl Acad Sci USA 96: 2414–2419. Slaght, S.J., Leresche, N., Deniau, J.M., Crunelli, V., and Charpier, S. 2002. Activity of thalamic reticular neurons during spontaneous genetically determined spike and wave discharges. J Neurosci 22: 2323–2234. Snead, O.C.3. 1991 The gamma-hydroxybutyrate model of absence seizures: correlation of regional brain levels of gamma-hydroxybutyric acid and gamma-butyrolactone with spike wave discharges. Neuropharmacology 30: 161–167. Snead, O.C. III 1992. Evidence for GABAB-mediated mechanisms in experimental generalized absence seizures. Eur J Pharmacol 213: 343–349. Snead, O.C. III 1995. Basic mechanisms of generalized absence seizures. Ann Neurol 37: 146–157. Snead, O.C. III, Banerjee, P.K., Burnham, M., and Hampson, D. 2000. Modulation of absence seizures by the GABA(A) receptor: a critical role for metabotropic glutamate receptor 4 (mGluR4). J Neurosci 20: 6218–6224. Snead, O.C. III, Depaulis, A., Banerjee, P.K., Hechler, V., and Vergnes, M. 1992. The GABAA receptor complex in experimental absence seizures in rat: an autoradiographic study. Neurosci Lett 140: 9–12. Sohal, V.S., Keist, R., Rudolph, U., and Huguenard, J.R. 2003. Dynamic GABA(A) receptor subtype-specific modulation of the synchrony and duration of thalamic oscillations. J Neurosci 23: 3649–3657. Staak, R., and Pape, H.C. 2001. Contribution of GABA(A) and GABA(B) receptors to thalamic neuronal activity during spontaneous absence seizures in rats. J Neurosci 21: 1378–1384. Steriade, M. 1997. Synchronized activities of coupled oscillators in the cerebral cortex and thalamus at different levels of vigilance. Cereb Cortex 7: 583–604. Steriade, M., and Contreras, D. 1995. Relations between cortical and thalamic cellular events during transition from sleep patterns to paroxysmal activity. J Neurosci 15: 623–642. Steriade, M., and Contreras, D. 1998. Spike-wave complexes and fast components of cortically generated seizures. I. Role of neocortex and thalamus. J Neurophysiol 80: 1439–1455. Steriade, M., Contreras, D., Curro Dossi, R.C., and Nunez, A. 1993a. The slow (<1 Hz) oscillation in reticular thalamic and thalamocotical neurons: Scenario of sleep rhythm generation in interacting thalamic and neocortical networks. J Neurosci 13: 3284–3299. Steriade, M., Jones, E.G., and McCormick, D.A. 1997. Thalamus. Amsterdam: Elsevier. Steriade, M., McCormick, D.A., and Sejnowski, T.J. 1993b. Thalamocortical oscillations in the sleeping and aroused brain. Science 262: 679–685. Strauss, U., Kole, M.H., Brauer, A.U., Pahnke, J., Bajorat, R., Rolfs, A., Nitsch, R. et al. 2004. An impaired neocortical Ih is associated with enhanced excitability and absence epilepsy. Eur J Neurosci 19: 3048–3058. Sutor, B., and Luhmann, H.J. 1995. Development of excitatory and inhibitory postsynaptic potentials in the rat neocortex. Perspect Dev Neurobiol 2: 409–419. Swann, J., Smith, K., Brady, R., and Pierson, M. 1993. Epilepsy: Models, Mechanisms, and Concepts. Cambridge: Cambridge University Press.
88
Chapter 7/Thalamic, Thalamocortical, and Corticocortical Models of Epilepsy
Talley, E.M., Solorzano, G., Depaulis, A., Perez-Reyes, E., and Bayliss, D.A. 2000. Low-voltage-activated calcium channel subunit expression in a genetic model of absence epilepsy in the rat. Brain Res Mol Brain Res 75: 159–165. Tancredi, V., Biagini, G., D’Antuono, M., Louvel, J., Pumain, R., and Avoli, M. 2000. Spindle-like thalamocortical synchronization in a rat brain slice preparation. J Neurophysiol 84: 1093–1097. Timofeev, I., Grenier, F., and Steriade, M. 1998. Spike-wave complexes and fast components of cortically generated seizures. IV. Paroxysmal fast runs in cortical and thalamic neurons. J Neurophysiol 80: 1495–513. Tsakiridou, E., Bertollini, L., De Curtis, M., Avanzini, G., and Pape, H.C. 1995. Selective increase in T-Type calcium conductance of reticular thalamic neurons in a rat model of absence epilepsy. J Neurosci 15: 3110–3117.
van Luijtelaar, E.L., Drinkenburg W.H., van Rijn, C.M., and Coenen, A.M. 2002. Rat models of genetic absence epilepsy: what do EEG spike-wave discharges tell us about drug effects? Methods Find Exp Clin Pharmacol 24(Suppl D): 65–70. Vogt, B.A., and Gorman, A.L. 1982. Responses of cortical neurons to stimulation of corpus callosum in vitro. J Neurophysiol 48: 1257– 1273. von Krosigk, M., Bal, T., and McCormick, D.A. 1993. Cellular mechanisms of a synchronized oscillation in the thalamus. Science 261: 361– 364. Wallace, R.H., Marini, C., Petrou, S., Harkin, L.A., Bowser, D.N., Panchal, R.G., Williams, D.A. et al. 2001. Mutant GABAA receptor g2-subunit in childhood absence epilepsy and febrile seizures. Nat Genet 28: 49–52.
A
EEG
B thalamocortical network
>
E
0.5s
Dm.v..
04
ls
>
E
-6
ms
~
>
E
EPSPs/fl~r¢~~
20 ms
-71 mV J~ E
E r;2J EPSP
0.5s
-60 mV
I=
20 ms
FIGURE 7 - 1 Intracellular counterparts of spike-wave discharges (SWDs) in GAERS model of absence epilepsy. A: Electroencephalographic (EEG) recording of spontaneous SWDs. B: Schematic diagram of the thalamocortical network. The different colors of neuronal cell types also apply to the intracellular in vivo traces recorded during SWDs in C-E: Green, neurons of reticular thalamic (RT) nucleus; blue, thalamocortical (TC) neuron of the ventrobasal thalamus; red, neuron of the cortical layer V. C: Layer V cortical neurons reveal rhythmic depolarizations, which elicit one to three action potentials, superimposed on a long-lasting hyperpolarization. D: In reticular thalamic (RT) neurons, SWDassociated activity starts with a hyperpolarization (see expanded trace bottom left), followed by rhythmic generation of low-threshold Ca 2+ spikes (LTSs) associated with bursts of action potentials (see expanded trace bottom right). Note that excitatory postsynaptic potentials (EPSPs) lead to the generation of a LTS. E: Thalamocortical (TC) neurons of the ventrobasal thalamus show rhythmic sequences of EPSP and inhibitory postsynaptic potentials (IPSPs), with occasional firing of action potentials. An EPSP/IPSP sequence is expanded in the bottom panel. (C-E adapted, with permission, from Crunelli and Leresche, 2002.)
B
FIGURE 7 - 6 Orthograde transport of biocytin reveals callosal projection in coronal slices. A: A biocytin crystal (-0.5 mm diameter) was placed in layer V of the contralateral cingulate cortex (right side, crystal placement not shown in this figure). The slice was incubated for 3 hours in an interface chamber and then processed to obtain a final horseradish peroxidase reaction product. The arrows in A indicate labeling of the callosal fibers. The square area marked in A is expanded in B. B: A dark-field image showing the callosal fibers coursing upward through the ipsilateral layer V.
Outflow (Ethanolvapor) Ethanol (via pump)
Inflow (Air) vaporizing chamber
Water bath37 °C
Metering
~
'\
pump
~Water
Air pump
r--Urine Ethanol
Experimental
collection
chamber
FIGURE 1 3--1 Schematic representation of a system for administration of ethanol by inhalation modified after Ruwe et al. (1986). Ethanol (95%) is delivered by a solvent metering pump into a 250-ml vaporization chambers. The airtight vaporization chamber is maintained at 37 ° C by a water bath. Air is delivered into the vaporization chamber with an air pump to provide a flow rate of 2.5 to 4 liters per minute. Animals are exposed to ethanol-vapor concentrations of 7 to 35 mg/liter of air in a Plexiglas experimental chamber. A food tray and water bottle are securely affixed to the experimental chamber, giving the animals free access to food and water. The sample port allows air within the experimental chamber to be sampled for determination of ethanol concentrations.
C
H
A
P
T
E
R
8 Studying Epilepsy in the Human Brain In Vitro RÜDIGER KÖHLING, PHILIP A. SCHWARTZKROIN, AND MASSIMO AVOLI
ments on human epileptic brain can be carried out only in vitro (or to a rather limited extent, in the operating room in situ on tissue due to be resected), and so the phenomena available for study reflect the activity of a “reduced” system that does not reveal the overall properties and capabilities of the intact epileptic brain. These limitations are addressed in more detail below. In this chapter we concentrate mainly on electrophysiologic methods for studying resected human epileptic tissue and review much of the work carried out over the past 30 years. Although most of these studies have focused on the question of functional alterations associated with epileptic activity, these studies also illustrate how general principles of neuronal function can be derived from such studies. In this respect, investigations in human epileptic tissue, despite their limitations, offer an exciting possibility to explore many aspects of both normal and pathological human brain function.
OVERVIEW The goal of this chapter is to provide an overview of the methods employed, useful experimental goals, and limitations of investigating human chronically epileptic brain tissue in vitro. Such tissue is often available in the course of epilepsy surgery, particularly for temporal lobe resection associated with intractable mesial temporal lobe epilepsy (MTLE) but also for lesionectomies and other types of epileptogenic “foci.” Human specimens can be maintained in vitro in a slice preparation, and thus they can be studied with many of the technical advantages applied to tissue from animal models. Because human brain slices do not really model epileptic phenomena in the human epileptic brain (i.e., this tissue cannot serve as a model of itself), the format of this chapter departs somewhat from that of the other chapters in this book. In particular we spend little time drawing comparisons to clinical seizure types, elaborating on the challenge of establishing an epilepsy model, or discussing peculiarities of a model in different species. However, we focus not only on the technical aspects of human slice experiments but also on the conceptual issues involved in evaluating the advantages of this particular approach to elucidating basic mechanisms of epilepsy or for advancing drug discovery. Research on human tissue faces specific problems that are not evident in animal experiments. First, for obvious reasons, experiments can be carried out exclusively on tissue that is therapeutically resected and thus per se abnormal. This means that human brain samples are chronically affected by seizures, exposed to wide variations in pharmacologic treatment, and (in almost all cases) resistant to pharmacotherapy. Second, studies on human tissue slices lack proper controls. Third, for obvious ethical reasons, experi-
Models of Seizures and Epilepsy
RELATIONSHIP OF IN VITRO ACTIVITY TO CLINICAL SEIZURE PATTERNS Discussion of seizure types and their relationship to the International League Against Epilepsy (ILAE) classification is not particularly useful within the context of in vitro human slice preparations. It is, to start, important to note that no ictal-like events are observed spontaneously in such preparations (a general property of slices from animals as well as from humans). In contrast, brief interictal-like discharges have been reported (see section on Spontaneous Epileptiform Activity) by several laboratories. However, questions remain regarding the significance of these discharges, especially because we have no “normal” human tissue for
89
Copyright © 2006, Elsevier Inc. All rights of reproduction in any form reserved.
90
Chapter 8/Studying Epilepsy in the Human Brain
comparison (see section on Limitations). Although such events could reflect tissue epileptogenicity, they may also reflect (1) normal discharge properties of the tissue of origin, (2) aberrant discharge resulting from presurgical treatment (e.g., drug washout), or even (3) tissue pathology resulting from slice preparation and maintenance. These spontaneous events appear to be quite variable from patient to patient and even across slices within the tissue sample from a given patient. It is notable that there has been no careful attempt to relate such discharges to the activity of that tissue region before resection (i.e., relationship to regional interictal discharge or seizure initiation in the intact brain). A variety of interictal-like and ictal-like electrographic phenomena can be elicited from human tissue samples with experimental manipulations (see section on Evoked Epileptiform Discharges as Models of Epileptiform Synchronization). Similar patterns can, however, also be elicited from “normal” animal tissue. Thus these patterns may not be useful in characterizing the tissue with respect to a particular epilepsy type or manifestation. What may be more significant, in human slices as in slices from animal models, are the sensitivity and threshold of such tissue to epileptogenic manipulations. Unfortunately, here too the absence of appropriate normal controls makes interpretation of threshold data very difficult.
METHODOLOGIC APPROACHES In this section we discuss general aspects of obtaining, slicing, and maintaining the human tissue for both neocortical and hippocampal specimens. In addition, we will consider some of the ethical and health-hazard issues involved in handling human tissue.
resections, this is most easily accomplished with a diagram or photograph showing the resection site. When tissue is removed from deeper structures (e.g., hippocampus), it is useful to get a verbal description from the surgeon regarding the location and extent of the resection. If the tissue is to be divided (e.g., with some going to the clinical pathologist), it is important to maintain a record of which part of the tissue is retained for the slice experiment. In all cases a key piece of information is how the resected tissue is related to the epileptogenic zone. When electrocorticography has been carried out as part of the surgery, electrode positions should be documented relative to the cortical surface so that spiking and nonspiking areas can be identified (Avoli and Olivier, 1989; Colder et al., 1996; Williamson et al., 1995; Schwartzkroin et al., 1983). If electroencephalographic (EEG) monitoring has been carried out before the surgery (e.g., with implanted strips or grids), an attempt should be made to relate the resected tissue to the site(s) of seizure initiation. Clinical, Imaging, and Pathology Background Data A record of presurgical clinical workup is also helpful. The investigator must know patient age and sex, the onset of seizure activity (at what age and for how many years), the clinical seizure diagnosis (seizure type, frequency), and current and past medications. Also useful is information from magnetic resonance imaging (MRI) or other imaging procedures (especially if that helps to localize the resection with respect to abnormal structure and/or function). The pathology report based on the resected tissue is also important and may complement the investigator’s own histology efforts. Relating Tissue Features to Surgical Outcome
Obtaining Human Brain Tissue from Epilepsy Surgery Resections Human tissue samples in most cases result from surgical procedures aimed at treating focal, pharmacoresistant epileptic disorders. These samples derive from partial temporal or extratemporal lobectomy, excision of lesions, or selective hippocampectomy. Rarely, complete lobectomies or functional or anatomic hemispherectomies are undertaken, during which tissue for experimental purposes can be obtained. In some studies, specimens from tumor resections have been investigated (Lücke et al., 1995; Patt et al., 1996; Straub et al., 1992; Williamson et al., 2003). Location and Source of the Tissue and Its Relationship to the Epileptogenic Zone It is critical to obtain a detailed record of precisely where the resected tissue comes from. In the case of neocortical
Although surgical outcome is not necessarily a determinant of whether the resected tissue is actually “epileptogenic,” it is helpful to learn whether the surgical procedure led to cessation of seizures. Presumably, if the answer to this question is yes, the investigator can conclude that the resected tissue contributed to the patient’s epileptic state. Tissue Procurement and Handling The general approach to obtain the tissue is similar across laboratories. As the patient is undergoing surgery, the investigator sets up a tissue-processing station in or adjacent to the operating room. It is useful for the experimenter and the surgeon to have conferred about the nature of the resection beforehand so that the surgeon can deliver the requested samples without the need for discussion at the time of surgery. Tissue samples (often more than one) are excised and immediately placed in a beaker filled with ice-cold
91
Methodologic Approaches
(4° C) artificial cerebrospinal fluid (ACSF) saturated with a 95% O2/5% CO2 gas mixture (pH 7.4). The composition of the ACSF, as with animal slice experiments (Dingledine, 1984), varies slightly from group to group. A basic ACSF solution consists of (in mM): NaCl, 124–129; KCl, 2–4; CaCl2, 1.6–2.4; MgSO4 1.3–2, NaH2PO4 1.24–1.25, NaHCO3 21–26 and glucose, 10 (e.g., Schwartzkroin et al., 1983). Instead of NaH2PO4, KH2PO4 can be used; in this instance, the KCl concentration should be 2 mM. Some groups (e.g., Kivi et al., 2000; Köhling et al., 1998b) have used one or more of the following variations as protective solution for transport and slicing procedures of the tissue: (1) 0.1 mM atocopherol as radical scavenger; (2) high-Mg2+ concentration (addition of 2 mM MgCl2) to reduce excitability; (3) low Na+ concentrations (omitting NaCl completely and replacing it with 200 mM sucrose) to reduce neuronal toxicity; and (4) low (1 mM) CaCl2 levels to protect against hypoxia-induced depolarization and Ca2+-mediated cytotoxicity. Tissue handling, from its removal from the patient through all experimental manipulations, must be carried out in accordance with the institutional review board policies for experiments with humans (or human materials). In addition, appropriate precautions should be taken to protect the experimenters from human pathogen exposure. Although rare, the danger of exposure to tissue containing pathogens (e.g., prions associated with Jacob-Creutzfeldt disease) warrants special precautions. Thus it is important not only to adhere to common-sense laboratory practices (e.g., use of gloves, eye shields, etc) but also to clean and disinfect all surfaces exposed to the tissue. It is also highly recommended to have a separate set of instruments (and a separate slice chamber) devoted to human studies.
Slicing Procedures and Tissue Maintenance Tissue samples may come from the neurosurgeon in small blocks (of approximately 1 cm3) or as larger resections (e.g., en bloc hippocampus). If the tissue is to be used for functional (e.g., electrophysiologic or imaging) studies, it should be rapidly sliced into thinner sections (maximally 600 mm in thickness) to ensure proper oxygen supply by diffusion from the surrounding ACSF. In all cases, special care should be taken to slice the block of resected tissue as quickly as possible, maximally within 5 minutes after excision. Preferably this tissue preparation is carried out at a site adjacent to the operating room. Coronal slices are cut with a conventional chopper (e.g., McIllwain type) or with a vibratome (e.g., Campden, Leica, TSE, WPI, etc.), using the same procedures as used for making slices from animal tissue. If network activity is to be investigated, thicker (450–600 mm) slices should be obtained to maintain a maximum degree of connectivity within the slices; for isolated neurones (see later), slices can
be made thinner. In some cases, intense gliotic reaction will render the tissue hard and rubbery and make it difficult to cut through the tissue to make thin, even slices. In such cases, the experimenter is left to his or her own devices. It is usually the case, however, that such tissue will yield little useful electrophysiologic data because it will be difficult to penetrate with microelectrodes. After slicing, the tissue can be transferred directly to the recording chamber, or it can be maintained viable at room temperature in carbogenated ACSF (placing slices on a nylon mesh immersed in a fluid-filled beaker). Good viability, particularly for longer transport of the tissue slices from the operating room to the laboratory, can be achieved by using a portable chamber with ACSF at 28° C (Köhling et al., 1996a). Such a chamber, illustrated in Figure 1, consists of multiple wells (with nylon-mesh bottoms) and a central funnel through which the carbogen-bubbled ACSF can rise. The fluid circulation stabilizes the slices on the nylon mesh. Recording chambers are identical to those used for animal tissue slices and may be of either a submerged type, with slices resting on the bottom of an ACSF; a perfused flow chamber; or a standard interface-type chamber with the tissue resting on a nylon mesh at the interface of humidified carbogen and ACSF. Recognition of slice orientation within the tissue chamber is essential for carrying out interpretable experiments. If hippocampal slices are used, identification of the different hippocampal subregions is often visually possible, although the convoluted nature of the very anterior tip of hippocampus may make such identification difficult. In many cases, the hippocampus may show severe atrophy of areas CA3 and CA1 (Ammon’s horn sclerosis, or AHS), it may be damaged from surgical procedures, or it may be intensely gliotic. These factors can determine which areas are accessible and appropriate for further investigation. In studying neocortical samples, it is useful to not only identify pial and white matter edges but also to estimate cortical layers.
Electrophysiologic Monitoring Field Potential Recordings Extracellular recording of network activity can be performed in human tissue very much the same way as it is done in animal preparations. To obtain field potential recordings, low impedance (1–2 MW) glass microelectrodes filled with ACSF usually are used. For special purposes (e.g., current-source-density analyses, which necessitate multiple electrode recordings at short equidistant positions), insulated, etched tungsten or platinum-nickel wire (diameter, 30–40 mm) or carbon fibers can be used (Cohen et al., 2002; Köhling et al., 1999; Louvel et al., 2001). The disadvantage of such electrodes is that that high-frequency signal components (>50 Hz) are not detected because of the impedance
92
Chapter 8/Studying Epilepsy in the Human Brain
FIGURE 1 Schematic diagram of slice maintenance chamber. (Modified from Köhling et al., 1996a, with permission.)
properties, and direct coupled (DC) recordings are not possible because of the polarizing properties of metal or carbon. Field potential recordings have been used to address several experimental issues in human tissue slices (see section on Characteristics of the Activity Generated by Human Epileptic Neurons). Intracellular Recordings The first intracellular studies in human tissue were performed with sharp-electrode recordings. For impalements of both neocortical and hippocampal cells, sharp microelectrodes with a resistance of 30 to 150 MW and filled with 2 to 4 M of K-acetate or K-methylsulphate were used. Several experimental issues can be addressed with this technique: 1. Resting and passive properties of neurons. Most investigators have concluded that resting membrane potential, input resistance, and time constants of human neurons are not different from corresponding cells in animal preparations. Most laboratories failed to observe any conspicuous increase in intrinsic bursting; firing properties on current injection generally did not differ from region—specific
“controls” from rodents (or monkeys) (Avoli and Olivier, 1989; Foehring et al., 1991; McCormick and Williamson, 1989; Schwartzkroin, 1987; Schwartzkroin and Prince, 1976; Tasker et al., 1996). One exception to this generality is that Dietrich et al. (1999a) found that some dentate granule cells in AHS tissue appeared to display properties of hilar interneurones. 2. Spontaneous synaptic activity. Spontaneous activity was demonstrated to occur regularly in human slices, apparently without sufficient network synchronization to generate field potential discharges. Such activity, particularly in mesial structures, was found to be dependent on glutamatergic and g-aminobutyric acid (GABA)ergic transmission (Knowles et al., 1992; Schwartzkroin and Haglund, 1986; Schwartzkroin and Knowles, 1984). An interesting finding was that in mesial temporal tissue where such network synchronization was seen, this spontaneous activity reflected bursting-discharging neurones in which there was a positively-shifted GABA reversal potential (and hence a depolarizing GABA response) (Cohen et al., 2002). 3. Synaptic activation by focal stimulation. For such studies, a stimulating electrode (monopolar or bipolar) is placed into pathways afferent to the recorded cell. In the
93
Methodologic Approaches
hippocampus, these investigations have focused mainly on perforant path activation of granule cells (Dietrich et al., 1999a; Isokawa et al., 1991). In neocortical tissue, stimulation of underlying white matter or focal activation of tangential association fibers have been used (Avoli and Olivier, 1989; Avoli et al., 1994a; Schwartzkroin et al., 1983; Strowbridge et al., 1992). These studies revealed graded evoked bursts and, in rare cases, paroxysmal depolarization shifts or very prolonged excitatory postsynaptic potentials with relatively weak inhibitory activity. For further analysis of both synaptic responses and modulation of voltage-gated channels, voltage-clamp experiments have been performed in human tissue slices, either using switch-clamp amplifiers and sharp electrodes (McCormick and Williamson, 1989, Wuarin et al., 1992), or patch-clamp electrodes (2–4 MW, with Lucifer yellow filling for cell identification (Isokawa et al., 1997, Isokawa, 1998). These studies revealed the existence of pharmacologically isolated NMDA-receptor mediated currents and the existence of Mg2+-block, as known from animal experiments (Wuarin et al., 1992) and modulation of different K+ currents via acetylcholine, adenosine, and other modulators (McCormick and Williamson, 1989). Perhaps more importantly, NMDA-receptor mediated responses were particularly variable in amplitude, whereas GABA-mediated inhibitory potentials were reduced after high-frequency activation (Isokawa, 1998; Isokawa et al., 1997). These results underscore an increased excitability of the human epileptic hippocampus. Also, human astrocytes have altered properties (i.e., a larger proportion of AMPA-receptor flip variant, enhanced inward-rectifying K+ currents similar to juvenile rodent astrocytes, and even generation of slow action potentials) in sclerotic hippocampus (Bordey and Sontheimer, 2004; Hinterkeuser et al., 2000; Schröder et al., 2000). Measuring Extracellular Ionic Concentrations As an extension of field potential recordings, the concentrations of ions in the extracellular space can be monitored using modified, double-barrelled micropipettes. The methods used to manufacture these electrodes have been described in detail in studies on animal tissue, where this technique has been in use for many years (Heinemann et al., 1977). Briefly, double-barrelled theta-glass capillaries are pulled (tip diameter, 2–6 mm), and one channel is backfilled with of NaCl solution equimolar to the ACSF to be used as field potential and reference channel. The tip of the other barrel channel’s tip is silanized, filled with ion exchanger (typically Fluka 60398, 60031, or Corning 477317 for K+ and Fluka 21196, 21048, or 21191 for Ca2+) and backfilled with corresponding KCl or CaCl2 solutions (100 mM). Recordings with these electrodes have shown that although basal levels of K+ are relatively normal in human neocorti-
cal or hippocampal tissue (Kivi et al., 2000; Köhling et al., 1998b), K+ spatial buffering can be disturbed, particularly in sclerotic hippocampus (Kivi et al., 2000a). High levels of K+ are also reached in human neocortical tissue when the tissue exhibits pathological function, such as spreading depression (Avoli et al., 1991; Gorji et al., 2001); however, these levels do not substantially differ from those seen in animal preparations undergoing similar treatments. Isolated Neurons Another technique, again adapted from animal experiments, is the use of acutely isolated neurons from neocortex or hippocampal tissue. This approach has been used to investigate voltage-gated currents, which are difficult to be analyze in situ because of space-clamp problems. The methods of cell isolation are essentially the same as in animal tissue (see Chapter 2). First, slices are cut from the resected block and then microdissected to yield the areas of interest. These slabs are then incubated with proteases, for example, trypsin (type XI, 0.5 mg/ml for 1–2 hours in ACSF at 29° C) or pronase (2–3 mg/ml, 25 minutes, 28° C, in piperazine diethanesulfonic acid (PIPES)-buffered ACSF) and then washed with PIPES- or 4-(2-hydroxyethyl)-1piperazine-ethanesulfonic acid (HEPES)-buffered solution. To isolate neurons, the predigested tissue slabs are triturated through fire-polished pipettes and then incubated in appropriate solutions (Beck et al., 1996, 1997a, b, 1998; Cummins et al., 1994; Remy et al., 2003; Rüschenschmidt et al., 2004; Vreugdenhil et al., 1998, 2004). These studies have characterized current properties in human cells and studied the mechanism of action of antiepileptic drugs. Although K+, Na+ and Ca2+ currents are essentially similar to those described in animal tissue, some peculiarities have been identified. For instance, human subicular cells possess a large, persistent Na+ current that may predispose them to bursting (Vreugdenhil et al., 2004); moreover, effects of carbamazepine on Na+ currents are reduced in cells from sclerotic, but not from nonsclerotic tissue (Remy et al., 2003, Vreugdenhil et al., 1998).
Other Methodologic Approaches Optical Imaging Optical imaging techniques can be employed in human tissue in vitro very much the same way as in animal preparations. Both voltage-sensitive dyes and intrinsic optical imaging can be used to monitor spatiotemporal patterns of network activity. For voltage-sensitive imaging, the styryl dye RH795 has already been employed (1 hour incubation in 12.5 mg/ml, 450-mm- thick slices; (Köhling et al., 2000, 2002)); other fast dyes of the ANEP-type should also be informative. This method has the advantage of yielding high
94
Chapter 8/Studying Epilepsy in the Human Brain
temporal resolution, but it allows for limited recording times because of phototoxicity effects. Studies using this technique have shown that spontaneous network activity goes along with heterogeneously distributed excitation within the neuronal network which it can be initiated in minimal foci up to 50 ms before activation of the rest of the network (Köhling et al., 2000, 2002). Furthermore, about 30% of the slices tested displayed epileptic responses after focal stimulation (Straub et al., 2003). Intrinsic optical imaging makes use of alterations in reflectance and absorbance properties of brain tissue as a consequence of neuronal activity. These changes, as recorded in in vitro slices, presumably reflect modifications in the extracellular space, for example, as a function of K+ accumulation and cell swelling (Andrew et al., 1996, Holthoff and Witte, 1996; MacVicar and Hochman, 1991). To date the temporal resolution of this method appears to be somewhat limited; however, it does not necessitate any tissue manipulation other than illumination. Hence, it can be used to monitor spread of activity not only in vitro but also in the patient’s brain in the operating room (as a diagnostic tool for guidance of tissue resection) (Haglund et al., 1992, Haglund and Hochman, 2004). Histologic Analysis A large number of histochemical and immunochemical techniques have been used to characterize resected human tissue. It is beyond the scope of this chapter to describe such analyses, but they are a critical part of the study of human tissue and provide information that can help to interpret the electrophysiologic data (see chapter 50). The importance of identifying individual neurons from which intracellular data have been obtained is noteworthy. A number of dye injection techniques for cellular labeling have been used, including fluorescent dyes (e.g., Lucifer yellow) and tracers to be detected histologically (e.g., biocytin, neurobiotin). These dyes are added to the intracellular recording solution both in sharp and patch pipettes.
iments with antibodies directed against specific GABA and metabotropic glutamate receptor (mGluR) subtypes have shown up-regulation of specific GABA and mGluR subunits (Lie et al., 2000; Loup et al., 2000). Finally, by employing a similar approach, Lie et al. (1999) discovered that Ca2+ channel b1 and b2 subunits are increased in sclerotic hippocampus. Molecular methods can also provide information on the mRNA expression of receptors and channels in the human tissue. These studies involve the use of reverse transcription reaction followed by polymerase chain reaction (PCR) and by restriction enzyme assays. Such experiments have shown that the relative amount of edited RNA of the AMPA receptor GluR2 was significantly increased in the hippocampal tissue, whereas no changes were found in neocortical tissues from epilepsy patients (Musshoff et al., 2000) and that NMDA-receptor mRNA splicing was unchanged compared with autopsy control material (Vollmar et al., 2004). Similar changes have been found in neurones and in hippocampal astocytes, where real-time PCR has revealed an increase in flip-to-flop ratio of the GluR1 AMPA-receptor mRNA matching functional results (Seifert et al., 2004). An alternative approach involves expresson monitoring by microarrays (Becker et al., 2002, 2003). Using this method, investigators have found some genes are up-regulated in human epileptic hippocampus (ataxin-3 and glial acidic fibrillary protein), whereas some are down-regulated (e.g., calmodulin) (Becker et al., 2002). In these studies, the findings were pinpointed to cell populations by using single-cell real-time PCR. Another application of molecular techniques to the analysis of ligand-gated currents in human tissue consists of injecting mRNA or cell membranes extracted from epileptic patients into frog oocytes (Palma et al., 2002, 2004). This procedure led to the expression of ionotropic receptors for GABAA, kainate, and AMPA. These investigators have reported that GABAA receptor-mediated currents in oocytes injected with “epileptic” mRNA or cell membranes are characterized by a strong run-down after repetitive ligand applications; this phenomenon can be abolished by phosphatase inhibitors (Palma et al., 2004).
Analysis of Channel and Receptors A number of nonelectrophysiologic techniques can be used to address changes of intrinsic excitability or synaptic physiology in human tissue. Although these methods do not directly show functional effects, they are nevertheless valuable for identifying the density of receptors or the abundance and localization of channel proteins. In many cases, and in contrast to functional studies, control tissue is available (e.g., from autopsy), so that direct comparisons between epileptic and nonepileptic tissue can be drawn. Receptor autoradiography using [3H]-tagged ligands have revealed up-regulation of AMPA-receptors in human epileptogenic neocortex (Zilles et al., 1999). Immunohistochemical exper-
CHARACTERISTIC OF THE ACTIVITY GENERATED BY HUMAN EPILEPTIC NEURONS Spontaneous Epileptiform Activity One important topic in studying human epileptic tissue is whether spontaneous epileptiform network activity is maintained in vitro after tissue excision. Field potential recordings have demonstrated network synchronization as reflected in population spikes (Figure 2). These spontaneous discharges, which resemble epileptiform spikes seen with
Characteristic of the Activity Generated by Human Epileptic Neurons
95
FIGURE 2 Spontaneous field potential discharges and associated intracellular responses in human neocortical (A) and subicular (B) tissue in vitro are sensitive to GABAA receptor blockade by bicuculline (bic). A: Field potential discharges (FP) at condensed (bottom) and expanded time scale (top inset) before (control), during (Bic), and after (washout) bicuculline application. Inset demonstrates that, generally, hyperpolarizing membrane potential (MP) fluctuations of single neurons accompany field discharges. B: FP discharges at condensed time scale (bottom) before (control), during (Bic), and after (washout) bicuculline application. Top insets show two different responses of single pyramidal cells (top recording of each inset) related to field discharges (bottom recording of each inset): Most responses (as in A) are hyperpolarizing (inhibited pyramidal), but a fraction of neurons shows depolarizing (excited pyramidal) potentials, at times leading to bursts. (Modified from Köhling et al., 1998b (A), and Cohen et al., 2002 (B), with permission.)
intracranial EEG recordings, have been found in neocortical (Köhling et al., 1998b, 1999, 2000) and hippocampal preparations (Cohen et al., 2002). Because in the latter study spontaneous events appeared to be triggered by pacemaker neurons, they indeed might reflect intrinsic epileptogenicity of the tissue.
Evoked Epileptiform Discharges as Models of Epileptiform Synchronization As in animal studies, electrical stimulation, pharmacologic manipulations, or changes in the ionic microenviron-
ment disclose epileptiform activity in human tissue maintained in vitro. For example, Masukawa et al. (1989, 1996) reported that 1-Hz repetitive stimulation of the perforant path induces epileptiform afterdischarges in the dentate gyrus. Pharmacologic manipulations such as bath application of the GABAA receptor antagonist bicuculline (10 mM) also lead to short-lasting epileptiform discharges that resemble interictal events, correspond to intracellular bursts of action potentials, and are accompanied by afterdischarges (Avoli and Olivier, 1989; Franck et al., 1995; Hwa et al., 1991; McCormick, 1989; Tasker et al., 1992). Apart from constituting a model of epileptiform activity, these findings
96
Chapter 8/Studying Epilepsy in the Human Brain
FIGURE 3 Spontaneous synchronous activity induced by 4-aminopyridine (4-AP) in neocortical slices obtained from patients with mesial temporal lobe epilepsy (MTLE) (A) and focal cortical dysplasia (FCD) (B and C). A: Isolated field potentials occur spontaneously in a MTLE slice analyzed with field potential and [K+]o recordings at 1000 mm from the pia. Note that each field potential event is associated with a transient increase in [K+]o. B: Spontaneous field potential discharges recorded in two slices (a and c panels) obtained from two FCD patients; in both cases the activity is characterized by isolated interictal field potentials (asterisks) and sustained epileptiform events resembling ictal discharges (continuous lines). Note also that the onset of the ictal event is associated with the occurrence of a negative field potential (arrow) followed by a slow negative event (arrowhead) leading to ictal discharge oscillations. The different characteristics of the isolated negative field events (1) and of the ictal discharge onset (2) are shown in (b) for three or four graphically superimposed samples obtained from the experiment in (a); note that the isolated interictal events are of lower amplitude compared with those leading to ictogenesis. C: Temporal relation between slow interictal events and ictal discharge onset during 4-AP application to slices from FCD cortex. In (a), histogram of the probability of occurrence of the interictal activity over a period of 50 seconds before ictal onset normalized to epoch 5 seconds before ictal event; data were obtained from 64 epochs recorded in 11 FCD slices. One of these epochs is shown in (b). Arrow points to time zero (i.e., ictal on set); asterisks identify slow interictal events.
Characteristic of the Activity Generated by Human Epileptic Neurons
suggest the presence of GABAA receptor-mediated inhibition within the human neocortical network, along with its ability to control epileptiform synchronization. However, one study using this technique suggested an impaired GABAergic inhibitory system in some hippocampi with dentate abnormalities; in these experiments, bicucullineinduced bursting occurred at a lower drug concentration in epileptic hippocampal tissue with mossy fiber sprouting than
97
in tissue with a relatively “normal” dentate (Franck et al., 1995). Another important pharmacologic manipulation has involved the application of the K+ channel blocker 4aminopyridine (4-AP). As in normal animal tissue, 4-AP produces recurrent interictal events in human neocortical slices removed from temporal lobe epilepsy patients (Figure 3A) (Avoli et al., 1994); this tissue is characterized by no
FIGURE 4 Field potential and intracellular characteristics of the synchronous epileptiform activity and of the spreading depression (SD)-like episodes generated by human neocortical slices superfused with Mg2+-free medium. A: Field potential of spontaneous and stimulus-induced (arrow) epileptiform discharges. B: Typical intracellular and field potential activity associated with an ictal-like event. Note that a long-lasting hyperpolarization follows the end of the epileptiform discharge. C: intracellular (top trace) and [K+]o (bottom trace) recordings during an epileptiform discharge (a, left portion of the trace) and two SD-like episodes (a, right portion of the trace and b). The SD in (a) was induced by a train of low-frequency (5 Hz) stimuli (continuous line).
98
Chapter 8/Studying Epilepsy in the Human Brain
obvious structural aberration, including abnormal lamination. In contrast, a similar dose of 4-AP elicits NMDA receptor-mediated ictal discharges in neocortical tissue obtained from patients with Taylor’s type, focal cortical dysplasia (FCD) (Figure 3B). FCD corresponds to a localized disruption of the normal cortical lamination with an excess of large, dysmorphic neurons (Spreafico et al., 1998; Taylor et al., 1971). These studies (Avoli et al., 1999; D’Antuono et al., 2004) have shown that epileptiform synchronization leading to in vitro ictal activity in the human FCD tissue is initiated by a synchronizing mechanism that paradoxically relies on GABAA receptor activation, causing sizeable increases in [K+]o. Moreover, this mechanism may be facilitated by the decreased ability of GABAB receptors to control GABA release from interneuron terminals. In addition to the bicuculline and 4-AP, epileptiform discharges are also recorded with field potential and intracellular techniques in human neocortical (Avoli et al., 1991, 1995; Köhling et al., 1998b, 1999) and hippocampal slices (Remy et al., 2003) during the application of Mg2+-free bathing medium. These events are often characterized by similarities in duration and waveform to the electrographic seizures recorded in vivo (Figure 4A and B). Moreover, human neocortical slices superfused with Mg2+-free medium generate spreading depression (SD)-like episodes (Figure 4C). SDs have also been recorded during hypoxia (Köhling et al., 1996b, 1998a) and following local local pressure ejection of 3 M KCl (Gorji et al., 2001). As reported to occur in animal experiments, Mg2+-free epileptiform events recorded in human tissue are readily blocked by NMDA receptor antagonists. Because Mg2+-freeinduced epileptiform activity has been considered as a model of therapy-resistant discharges in vitro (Heinemann et al., 1994; Zhang et al., 1995), Mg2+-free-induced discharges have been used to test the efficacy of standard and new antiepileptic drugs in human tissue. These experiments demonstrated that carbamazepine exerts only a moderate antiepileptic action on Mg2+-free-induced epileptiform activity, whereas vigabatrin is highly effective (Musshoff et al., 2000b); retigabine and melatonin also displayed a suppressive action in this model (Fauteck et al., 1995; Straub et al., 2001).
Synaptic Plasticity Using field potential recordings, several groups have revealed that in epileptic hippocampus, repetitive stimulation leads to disproportionately large responses and afterdischarges. Moreover, synaptic depression mediated via group III (but not group II) metabotropic glutamate receptor (mGluR) is impeded in sclerotic but not in nonsclerotic human epileptic hippocampus (Dietrich et al., 1999b, 2002; Masukawa et al., 1989, 1996). Further, studies using paired stimuli in the dentate gyrus to test the strength of recurrent
inhibition or presynaptic modulation confirmed that inhibition in epileptic tissue is presumably intact and dependent on presynaptic group II metabotropic glutamate receptors (as in animal tissue; Dietrich et al., 2002; Masukawa et al., 1996; Swanson et al., 1998; Uruno et al., 1995). In these studies, as in other investigations, a distinction between sclerotic and nonsclerotic hippocampus may help to circumvent the problem of lacking appropriate control tissue. As proposed by Dietrich et al. (1999, 2002), sclerotically altered hippocampus can differ from nonsclerotic tissue; for the purpose of comparison, the latter specimens may be viewed as “control” tissue. Lastly, perforant path long-term potentiation elicited by high-frequency stimulus trains was also lost in sclerotic but not in nonsclerotic hippocampus (Beck et al., 2000).
LIMITATIONS A general limitation of all slice preparation models of epileptiform activity is their isolation from the distributed system that is presumably involved in seizure generation. This is an especially important consideration in dealing with human tissue because we ignore which brain region is actually responsible for seizure generation or even if there is a localized epileptogenic zone. At the clinical level, surgical procedures have been justified by their effective ends. However, it is not the case that if seizure activity is interrupted by removal of, for example, hippocampus, that result “proves” that the hippocampus is responsible for the seizure activity. That may be the case, or the hippocampus simply may have been a part (perhaps a normal part) of a larger seizure circuit. Thus when we remove a piece of tissue from the human brain, we do not know that tissue is “epileptic.” A major problem in interpreting data from human slice experiments is the absence of “normal” controls. Obviously, for ethical reasons, we are not able to remove apparently normal tissue. In some cases, it may be possible to obtain “nonepileptic” cortical samples, for example, when the surgeon must remove a deep-lying brain tumor. However, even in such cases, it seems unlikely that this tissue is “normal.” Investigators have adopted a variety of strategies to deal with the control issue, but none is entirely adequate. For instance, a relatively easy approach is to compare the human epileptic tissue to “comparable” animal tissue. Thus, resected tissue from MTLE cases may be compared with chronically epileptic animal models such as kainate- or pilocarpine-treated rodents. However, this approach ignores what are likely to be significant species differences as well as the difficulty of determining what rat brain region corresponds to a given region of the human brain. Another approach is to compare human tissue that is electrographically very active (“hot”) on presurgical electrocorticography with human tissue that is relatively inactive (e.g., spiking vs.
References
nonspiking cortex). It is unclear what is being compared in this analysis because it is highly likely that even “nonspiking” tissue is abnormal. Further, this comparison ignores the likelihood that different regions of the same brain—even normal brain—may have quite different functional characteristics. Ideally, regional differences should be recognized and characterized. A further strategy is to make comparisons on the same area of resection across patients and to use as a basis for comparison some identifiable epilepsy marker, for example, sclerotic versus nonsclerotic hippocampus (or lesional vs. nonlesional cortex). Unfortunately, it is often unclear if and how tissue epileptogenicity is connected to such markers (e.g., both sclerotic and nonsclerotic hippocampus may be “epileptic”; both lesional and nonlesional neocortex may be “epileptic”). A third significant area of concern revolves around the variability of phenomenology from patient to patient. Whereas variables in animal models can be controlled, the clinical variability is often overwhelming, and it prevents most investigators from collecting tissue samples from a significant number of patients with similar clinical disorders. Age, sex, age of seizure onset, duration of the seizure disorder, history of medication, location and clinical characteristics of the epilepsy, etc., all contribute to making each clinical case “unique.” Finally, given our inability to “see” spontaneous seizure events in resected tissue, it may be unclear to what extent the human tissue slice provides advantages over slices from well-characterized animal models. To say that we can produce similar patterns of epileptiform activity in human tissue (“epileptic” human tissue) and in tissue from animal models does not constitute, in itself, a rationale for the human slice studies.
INSIGHTS INTO CLINICAL DISORDERS Given the limitations discussed herein, it is extremely important that investigators who choose to carry out studies on human epileptic tissue identify and justify their experiments carefully. Certainly most experimental manipulations used for animal preparations in vitro can also be adapted to investigations on human tissue. Thus few technical problems arise when electrophysiologic or other techniques are employed. Technology is not the obstacle. The real challenge is to design experiments so that the data we obtain are useful and interpretable.
References Andrew, R.D., Adams, J.R., and Polischuk, T.M. 1996. Imaging kainate and NMDA-induced intrinsic optical signals from the hippocampal slice. J Neurophysiol 76: 2707–2717. Avoli, M., and Olivier, A. 1989. Electrophysiological properties and synaptic responses in the deep layers of the human epileptogenic neocortex in vitro. J Neurophysiol 61: 589–606.
99
Avoli, M., Drapeau, C., Louvel, J., Pumain, R., Olivier, A., and Villemure J.-G. 1991. Epileptiform activity induced by low extracellular magnesium in the human cortex maintained in vitro. Ann Neurol 30(4): 589–596. Avoli, M., Bernasconi, A., Mattia, D., Olivier, A., and Hwa, G.G.C. 1999. Epileptiform discharges in the human dysplastic neocortex: In vitro physiology and pharmacology. Ann Neurol 46: 816–826. Avoli, M., Hwa, G.G.C., Lacaille, J.C., Olivier, A., Villemure, J.G., and Granger, G. 1994a. Electrophysiological and repetitive firing properties of neurons in the superficial/middle layers of the human neocortex maintained in vitro. Exp Brain Res 98: 135–144. Avoli, M., Mattia, D., Siniscalchi, A., Perreault, P., and Tomaiuolo, F. 1994b. Pharmacology and electrophysiology of a synchronous GABAmediated potential in the human neocortex. Neuroscience 62: 655–666. Avoli, M., Louvel, J., Drapeau, C., Pumain, R., and Kurcewicz, I. 1995. GABAA-mediated inhibition and in vitro epileptogenesis in the human neocortex. J Neurophysiol 73: 468–484. Beck, H., Clusmann, H., Kral, T., Schramm, J., Heinemann, U., and Elger, C.E. 1997a. Potassium currents in acutely isolated human hippocampal dentate granule cells. J Physiol 498: 73–85. Beck, H., Steffens, R., Heinemann, U., and Elger, C.E. 1997b. Properties of voltage-activated Ca2+ currents in acutely isolated human hippocampal granule cells. J Neurophysiol 77: 1526–1537. Beck, H., Steffens, R., Elger, C.E., and Heinemann, U. 1998. Voltagedependent Ca2+ currents in epilepsy . Epilepsy Res 32: 321–332. Beck, H., Goussakov, I.V., Lie, A., Helmstädter, C., and Elger, C.E. 2000. Synaptic plasticity in the human dentate gyrus. J Neurosci 20: 7080–7086. Becker, A.J., Chen, J., Paus, S., Normann, S., Beck, H., Elger, C.E., et al. 2002. Transcriptional profiling in human epilepsy: expression array and single cell real-time qRT-PCR analysis reveal distinct cellular gene regulation. Neuroreport 13: 1327–1333. Becker, A.J., Chen, J., Zien, A., Sochivko, D., Normann, S., Schramm, J., Elger, C.E. et al. 2003. Correlated stage- and subfield-associated hippocampal gene expression patterns in experimental and human temporal lobe epilepsy. Eur J Neurosci 18: 2792–2802. Bordey, A., and Sontheimer, H. 2004. Properties of human glial cells associated with epileptic seizure foci. Epilepsy Res 32: 286–303. Cohen, I., Navarro, V., Clemenceau, S., Baulac, M., and Miles, R. 2002. On the origin of interictal activity in human temporal lobe epilepsy in vitro. Science 298: 1418–1421. Colder, B.W., Frysinger, R.C., Wilson, C.L., Harper, R.M., and Engel, J. 1996. Decreased neuronal burst discharge near site of seizure onset in epileptic human temporal lobes. Epilepsia 37: 113–121. Cummins, T.R., Xia, Y., and Haddad, G.G. 1994. Functional properties of rat and human neocortical voltage-sensitive sodium currents. J Neurophysiol 71: 1052–1064. D’Antuono, M., Louvel, J., Kohling, R., Mattia, D., Bernasconi, A., Olivier, A., Turak, B. et al. 2004. GABAA receptor-dependent synchronization leads to ictogenesis in the human dysplastic cortex. Brain 127: 1626–1640. Dietrich, D., Clusmann, H., Kral, T., Steinhäuser, C., Blümcke, I., Heinemann, U., and Schramm, J. 1999a. Two electrophysiologically distinct types of granule cells in epileptic human hippocampus. Neuroscience 90: 1197–1206. Dietrich, D., Kral, T., Clusmann, H., Friedl, M., and Schramm, J. 1999b. Reduced function of L-AP4-sensitive metabotropic glutamate receptors in human epileptic sclerotic hippocampus. Eur J Neurosci 11: 1109–1113. Dietrich, D., Kral, T., Clusmann, H., Friedl, M., and Schramm, J. 2002. Presynaptic group II metabotropic glutamate receptors reduce stimulated and spontaneous transmitter release in human dentate gyrus. Neuropharmacology 42: 297–305. Dingledine, R., Ed. 1984. Brain Slices. Dordrecht-London-New York: Kluwer Academic Publishing.
100
Chapter 8/Studying Epilepsy in the Human Brain
Fauteck, J.-D., Bockmann, J., Böckers, T.M., Wittkowski, W., Köhling, R., Lücke, A., Straub, H. et al. 1995. Melatonin reduces low-Mg2+ epileptiform activity in human temporal slices. Exp Brain Res 107: 321–325. Foehring, R.C., Lorenzon, N.M., Herron, P., and Wilson, C.J. 1991. Correlation of physiologically and morphologically identified neuronal types in human association cortex in vitro. J Neurophysiol 66: 1825–1837. Franck, J.E., Pokorny, J., Kunkel, D.D., and Schwartzkroin, P.A. 1995. Physiologic and morphologic characteristics of granule cell circuitry in human epileptic hippocampus. Epilepsia 36: 543–558. Gorji, A., Scheller, D., Straub, H., Tegtmeier, F., Köhling, R., Höhling, J.M., Tuxhorn, I. et al. 2001. Spreading depression in human neocortical slices. Brain Res 906: 74–83. Haglund, M.M., and Hochman, D.W. 2004. Optical imaging of epileptiform activity in human neocortex. Epilepsia 45(Suppl 4): 43–47. Haglund, M.M., Ojemann, G.A., and Hochman, D.W. 1992. Optical imaging of epileptiform and functional activity in human cerebral cortex. Nature 358: 668–671. Heinemann, U., Lux, H.D., and Gutnick, M.J. 1977. Extracellular free calcium and potassium during paroxysmal activity in the cerebral cortex of the cat. Exp Brain Res 27: 237–243. Heinemann, U., Draguhn, A., Ficker, E., Stabel, J., and Zhang, C.L. 1994. Strategies for the development of drugs for pharmacoresistant epilepsies. Epilepsia 35(suppl 5): S10–21. Hinterkeuser, S., Schröder, W., Hager, G., Seifert, G., Blümcke, I., Elger, C.E., Schramm, J. et al. 2000. Astrocytes in the hippocampus of patients with temporal lobe epilepsy display changes in potassium conductances. Eur J Neurosci 12: 2087–2096. Holthoff, K., and Witte, O.W. 1996. Intrinsic optical signal in rat neocortical slices measured with near-infrared dark-field microscopy reveal changes in extracellular space. J Neurosci 16: 2740–2749. Hwa, G.G.C., Avoli, M., Olivier, A., and Villemure, J.G. 1991. Bicucullineinduced epileptogenesis in the human neocortex maintained in vitro. Exp Brain Res 83: 329–339. Isokawa, M. (1998) Modulation of GABAA receptor-mediated inhibition by postsynaptic calcium in epileptic hippocampal neurons. Brain Res 810: 241–250. Isokawa, M., Avanzini, G., Finch, D.M., Babb, T.L., and Levesque, M.F. 1991. Physiologic properties of human dentate granule cells in slices prepared from epileptic patients. Epilepsy Res 9: 242–250. Isokawa, M., Levesque, M.F., Babb, T.L., and Engel, J. Jr. 1993. Single mossy fiber axonal systems of human dentate granule cells studied in hippocampal slices from patients with temporal lobe epilepsy. J Neurosci. 13: 1511–1522. Isokawa, M., Levesque, M., Fried, I., and Engel, J. 1997. Glutamate currents in morphologically identified human dentate granule cells in temporal lobe epilepsy. J Neurophysiol 77: 3355–3369. Kivi, A., Lehmann, T.N., Kovács, R., Eilers, A., Jauch, R., Meencke, H.J., Von Deimling, A., et al. 2000. Effects of barium on stimulus-induced rises of [K+]o in human epileptic non-sclerotic and sclerotic hippocampal area CA1. Eur J Neurosci 12: 2039–2048. Knowles, W.D., Awad, I.A., and Nayel, M.H. 1992. Differences of in vitro electrophysiology of hippocampal neurons from epileptic patients with mesiotemporal sclerosis versus structural lesions. Epilepsia 33: 601–609. Köhling, R., Lücke, A., Straub, H., and Speckmann, E.J. 1996a. A portable chamber for long-distance transport of surviving human brain slice preparations. J Neurosci Methods 67: 233–236. Köhling, R., Schmidinger, A., Hülsmann, S., Vanhatalo, S., Lücke, A., Straub, H., Speckmann, E.-J. et al. 1996b. Anoxic terminal negative DC-shift in human neocortical slices in vitro. Brain Res 741: 174–179. Köhling, R., Greiner, C., Wölfer, J., and Speckmann, E.-J. 1998a. Optical monotoring of PO2 changes and simultaneous recording of bioelectric activity in human and animal brain slices. J Neurosci Methods 85: 181–186.
Köhling, R., Lücke, A., Straub, H., Speckmann, E.-J., Tuxhorn, I., Wolf, P., Pannek, H. et al. 1998b. Spontaneous sharp waves in human neocortical slices excised from epileptic patients. Brain 121: 1073–1087. Köhling, R., Qu, M., Zilles, K., and Speckmann, E.J. 1999. Current-sourcedensity profiles associated with sharp waves in human epileptic neocortical tissue. Neuroscience 94: 1039–1050. Köhling, R., Höhling, H.-J., Straub, H., Kuhlmann, D., Kuhnt, U., Tuxhorn, I., Ebner, A. et al. 2000. Optical monitoring of neuronal activity during spontaneous sharp waves in chronically epileptic human neocortical tissue. J Neurophysiol 84: 2161–2165. Köhling, R., Reinel, J., Vahrenhold, J., Hinrichs, K., and Speckmann, E.J. 2002. Spatio-temporal patterns of neuronal activity: analysis of optical imaging data using geometric shape matching. J Neurosci Methods 15: 114: 17–23. Lie, A.A., Blümcke, I., Volsen, S.G., Wiestler, O.D., Elger, C.E., and Beck, H. 1999. Distribution of voltage-dependent calcium channel beta subunits in the hippocampus of patients with temporal lobe epilepsy. Neuroscience 93: 449–456. Lie, A.A., Becker, A., Behle, K., Beck, H., Malitschek, B., Conn, P.J., Kuhn, R. et al. 2000. Up-regulation of the metabotropic glutamate receptor mGluR4 in hippocampal neurons with reduced seizure vulnerability. Ann Neurol 47: 26–35. Loup, F., Wieser, H.G., Yonekawa, Y., Aguzzi, A., and Fritschy, J.-M. 2000. Selective alterations in GABAA receptor subtypes in human temporal lobe epilepsy. J Neurosci 20: 5401–5419. Louvel, J., Papatheodoropoulos, C., Siniscalchi, A., Kurciewicz, I., Pumain, R., Devaux, B., Turak, B. et al. 2001. GABA-Mediated synchronization in the human cortex: Elevations in extracellular potassium and presynaptic mechanisms. Neuroscience 105: 803–813. Lücke, A., Köhling, R., Straub, H., Moskopp, D., Wassmann, H., and Speckmann, E.J. 1995. Changes of extracellular calcium concentration induced by application of excitatory amino acids in the human neocortex in vitro. Brain Res 671: 222–226. MacVicar, B., and Hochman, D. 1991. Imaging of synaptically evoked intrinsic optical signals in hippocampal slices. J Neurosci 11: 1458–1469. Masukawa, L.M., Wang, H.W., O’Connor, M.J., and Uruno, K. 1996. Prolonged field potentials evoked by 1 Hz stimulation in the dentate gyrus of temporal lobe epileptic human brain slices. Brain Res 721: 132–139. Masukawa, L.M., Higashima, M., Kim, J.H., and Spencer, D.D. 1989. Epileptiform discharges evoked in hippocampal brain slices from epileptic patients. Brain Res 493: 168–174. McCormick, D.A. 1989. GABA as an Inhibitory neurotransmitter in human cerebral Cortex. J Neurophysiol 62: 1018–1027. McCormick, D.A., and Williamson, A. 1989. Convergence and divergence of neurotransmitter action in human cerebral cortex. Proc Natl Acad Sci USA 86: 8098–8102. Musshoff, U., Schünke, U., Köhling, R., and Speckmann, E.-J. 2000a. Alternative splicing of the NMDAR1 glutamate receptor subunit in human temporal lobe epilepsy. Mol Brain Res 76: 377–384. Musshoff, U., Lücke, A., Köhling, R., Speckmann, E.-J., Tuxhorn, I., Wolf, P., Pannek, H. et al. 2000b. Vigabatrin reduces epileptiform activity in brain slices from pharmacoresistant epilepsy patients. Eur J Pharmacol 401: 167–172. Palma, E., Esposito, V., Mileo, A.M., Di Gennaro, G., Quarato, P., Giangaspero, F., Scoppetta, C. et al. 2002. Expression of human epileptic temporal lobe neurotransmitter receptors in Xenopus oocytes: An innovative approach to study epilepsy. Proc Natl Acad Sci U S A 99: 15078–15083. Palma, E., Ragozzino, D.A., Di Angelantonio, S., Spinelli, G., Trettel, F., Martinez-Torres A., Torchia, G. et al. 2004. Phosphatase inhibitors remove the run-down of gamma-aminobutyric acid type A receptors in the human epileptic brain. Proc Natl Acad Sci U S A 101: 10183–10188. Patt, S., Labrakakis, C., Bernstein, M., Weydt, P., Cervòs-Navarro, J., Nisch, G., and Kettenmann, H. 1996. Neuron-like physiological prop-
References erties of cells from human oligodendroglial tumors. J Neurosci 71: 601–611. Remy, S., Gabriel, S., Urban, B.W., Dietrich, D., Lehmann, T.N., Elger, C.E., Heinemann, U. et al. 2003. A novel mechanism underlying drug resistance in chronic epilepsy. Ann Neurol 53: 469–479. Rüschenschmidt, C., Köhling, R., Schwarz, M., Straub, H., Gorji, A., Siep, E., Ebner, A. et al. 2004. Characterization of a fast transient outward current in neocortical neurons from epilepsy patients. J Neurosci Res 75: 807–816. Schröder, W., Hinterkeuser, S., Seifert, G., Schramm, J., Jabs, R., Wilkin, G.P., and Steinhäuser, C. 2000. Functional and molecular properties of human astrocytes in acute hippocampal slices obtained from patients with temporal lobe epilepsy. Epilepsia 41: S181–S184. Schwartzkroin, P.A. 1987. The electrophysiology of human brain slices resected from “epileptic” brain tissue. In: Fundamental mechanisms of human brain function. Ed. J. Engel. pp. 145–154. New York: Raven Press. Schwartzkroin, P.A., and Haglund, M.M. 1986. Spontaneous rhythmic synchronous acivity in epileptic human and normal monkey temporal lobe. Epilepsia 27: 523–533. Schwartzkroin, P.A., and Knowles, W.D. 1984. Intracellular study of human epiieptic cortex: in vitro maintenance of epileptiform activity? Science 223: 709–712. Schwartzkroin, P.A., and Prince, D.A. 1976. Microphysiology of human cerebral cortex studied in vitro. Brain Res 115: 497–500. Schwartzkroin, P.A., Turner, D.A., Knowles, W.D., and Wyler, A.R. 1983. Studies of human and monkey “epileptic” neocortex in the in vitro slice preparation. Ann Neurol 13: 249–257. Seifert, G., Hüttmann, K., Schramm, J., and Steinhäuser, C. 2004. Enhanced relative expression of glutamate receptor 1 flip AMPA receptor subunits in hippocampal astrocytes of epilepsy patients with Ammon’s horn sclerosis. J Neurosci 24: 1996–2003. Spreafico, R., Battaglia, G., Arcelli, P., Andermann, F., Dubeau, F., Palmini, A., Olivier, A. et al. 1998. Cortical dysplasia: an immunocytochemical study of three patients. Neurology 50: 27–36. Straub, H., Lücke, A., Köhling, R., Moskopp, D., Pohl, M., Wassmann, H., and Speckmann E.J. 1992. Low-magnesium-induced epileptiform activity in the human neocortex maintained in vitro: Suppression by the organic calcium antagonist verapamil. J Epilepsy 2: 166–170. Straub, H., Köhling, R., Höhling, J.M., Rundfeldt, C., Tuxhorn, I., Ebner, A., Wolf, P. et al. 2001. Effects of retigabine on rhythmic synchronous activity of human neocortical slices. Epilepsy Res 44: 155–165. Straub, H., Kuhnt, U., Höhling, J.-M., Köhling, R., Gorji, A., Kuhlmann, D., Tuxhorn, I. et al. 2003. Stimulus-induced patterns of bioelectric activity in human neocortical tissue recorded by a voltage sensitive dye. Neuroscience 121: 587–604.
101
Strowbridge, B.W., Masukawa, L.M., Spencer, D.D., and Shepherd, G.M. 1992. Hyperexcitability associated with localizable lesions in epileptic patients. Brain Res 587: 158–163. Swanson, T.H., Sperling, M.R., and O’Connor, M.J. 1998. Strong paired pulse depression of dentate granule cells in slices from patients with temporal lobe epilepsy. J Neural Transm 105: 613–625. Taylor, D.C., Falconer, M.A., Bruton, C.J., and Corsellis, J.A.N. 1971. Focal dysplasia of the cerebral cortex in epilepsy. J Neurol Neurosurg Psychiatry 34: 369–387. Tasker, J.G., Peacock, W.J., and Dudek, F.E. 1992. Local synaptic circuits and epileptiform activity in slices of neocortex from children with intractable epilepsy. J Neurophysiol 67: 496–507. Tasker, J.G., Hofman, N.W., Kim, Y.I., Fisher, R.S., Peacock, W.J., and Dudek, F.E. 1996. Electrical properties of neocortical neurons in slices from children with intractable epilepsy. J Neurophysiol 75: 931–939. Uruno, K., O’Connor, M.J., and Masukawa, L.M. 1995. Effects of bicuculline and baclofen on paired-pulse depression in the dentate gyrus of epileptic patients. Brain Res 695: 163–172. Vollmar, W., Gloger, J., Berger, E., Kortenbruck, G., Köhling, R., Speckmann. E.-J., and Musshoff, U. 2004. RNA editing (R/G site) and flipflop splicing of the AMPA receptor subunit GluR2 in nervous tissue of epilepsy patients. Neurobiol Dis 15: 371–379. Vreugdenhil, M., van Veelen, C.W.M., van Rijen, P.C., Da Silva, F.H.L., and Wadman, W.J. 1998. Effect of valproic acid on sodium currents in cortical neurons from patients with pharmaco-resistant temporal lobe epilepsy. Epilepsy Res 32: 309–320. Vreugdenhil, M., Hoogland, G., van Veelen, C.W., and Wadman, W.J. 2004. Persistent sodium current in subicular neurons isolated from patients with temporal lobe epilepsy. Eur J Neurosci 19: 2769–2778. Williamson, A., Patrylo, P.R., Lee, S., and Spencer, D.D. (2003) Physiology of human neurons adjacent to cavernous malformations and tumors. Epilepsia 44: 1413–1419. Williamson, A., Spencer, S.S., and Spencer, D.D. 1995. Depth electrode studies and intracellular dentate granule cell recordings in temporallobe epilepsy. Ann Neurol 38: 778–787. Wuarin, J.-P., Peacock, W.J., and Dudek, F.E. 1992. Single-electrode voltage-clamp analysis of the N-methyl-d-aspartate component of synaptic responses in neocortical slices from children with intractable epilepsy. J Neurophysiol 67: 84–92. Zhang, C.L., Dreier, J.P., and Heinemann, U. 1995. Paroxysmal epileptiform discharges in temporal lobe slices after prolonged exposure to low magnesium are resistant to clinically used anticonvulsants. Epilepsy Res 20: 105–111. Zilles, K., Qü, M.S., Köhling, R., and Speckmann, E.-J. 1999. Ionotropic glutamate and GABA receptors in human epileptic neocortical tissue: quantitative in vitro receptor autoradiography. Neuroscience 94: 1051–1061.
C
H
A
P
T
E
R
9 In Vitro Isolated Guinea Pig Brain MARCO DE CURTIS, LAURA LIBRIZZI, AND LAURA UVA
The isolated guinea pig brain preparation maintained in vitro by arterial perfusion has been utilized to develop a model of acute epileptogenesis in the temporal lobe. The technique is ideal for performing high-resolution electrophysiologic and optical imaging studies of the generation and the propagation patterns of interictal and ictal epileptiform discharges induced by different acute pharmacologic treatments in vitro. The preparation potentially could be used to study long-range network interactions, also in brains isolated from guinea pigs, in which a chronic model of epilepsy has been developed. Preservation of the neuronal and vascular compartments in this preparation allows investigation of the role of neurovascular interactions in the control of epileptiform discharges.
mental conditions: the isolated guinea pig brain preparation maintained in vitro by arterial perfusion. The preparation was introduced and originally developed by Rodolfo Llinas in collaboration with Yosef Yarom, Matsuyuki Sugimori, Kerry Walton, and Michael Muhlethaler at the New York University (Llinás et al., 1981, 1989; Muhlethaler et al., 1993). In 1991 the preparation was set up at the Istituto Nazionale Neurologico in Milano, Italy, where it was further developed and characterized (de Curtis et al., 1994, 1996, 1998a, 1998b; Forti et al., 1997; Librizzi and de Curtis, 2003). Multisite eletrophysiologic recordings combined with intracellular recordings (Biella et al., 2001; Forti et al., 1997; Pare et al., 1992), optical imaging of both intrinsic signals (Federico and MacVicar, 1996; Federico et al., 1994), and voltage-generated fluorescent signals (Biella et al., 2003; de Curtis et al., 1999b) have been performed since in the isolated guinea pig brain in conditions of normal excitability and after diverse epileptogenic challenges. In addition, given that the whole brain is perfused in vitro via the arterial system integrally preserved in situ during the isolation procedure, it is feasible to utilize this preparation to evaluate the reciprocal interactions between the vascular and neuronal compartments during the generation of epileptiform discharges (Librizzi and de Curtis, 1999). With this purpose in mind, the functional and structural preservation of the cerebral vascular system, in particular of the blood-brain barrier, has been extensively characterized in the isolated guinea pig brain during the last few years (Librizzi and de Curtis, 1999; Librizzi et al., 2000, 2001; Mazzetti et al., 2004).
GENERAL DESCRIPTION OF THE MODEL The identification of neuronal circuits involved in the generation and propagation of interictal and ictal epileptiform discharges is central to understanding the dynamic process of epileptogenesis. The analysis of network interactions in epileptogenesis has been approached in various in vivo and in vitro experimental conditions that allow exploration of brain activity with different degrees of detail and complexity. For instance, in vivo experimental conditions allow performance of electrophysiologic studies of population activities sampled from a restricted number of recording sites over a wide cortical area. On the other hand, in vitro studies performed on sliced cerebral tissue allow a finer cellular analysis of epileptiform activity, but these studies are spatially restricted to the network interactions spared by the slicing procedure. This chapter describes a preparation that has been used in the last 15 years to study epileptogenesis in different experi-
Models of Seizures and Epilepsy
WHAT DOES IT MODEL? The in vitro isolated guinea pig brain has been used to analyze propagation of epileptiform discharges induced in
103
Copyright © 2006, Elsevier Inc. All rights of reproduction in any form reserved.
104
Chapter 9/In Vitro Isolated Guinea Pig Brain
the olfactory-limbic cortices either by tetanic cortical stimulation (Pare et al., 1992) or by acute pharmacologic application of epileptogenic agents, such as the g-aminobutyric acid (GABA) receptor antagonists bicuculline, penicilline, and picrotoxin (de Curtis et al., 1994, 1999b, 1998; Forti et al., 1997) and the muscarinic agonists carbachol and pilocarpine. These drugs were applied either locally in the brain parenchyma or by arterial perfusion. In both conditions epileptiform discharges with a focal onset were observed. Therefore the preparation has been largely used as a model of acute, focal epileptogenesis. As for studies conducted on in vitro slices, whole brains could be acutely isolated ex vivo from animals in which a chronic epileptic condition has been established. These experiments would allow study of complex interactions that occur between remote areas in a chronically epileptic brain. Preliminary studies in this direction are in progress in our laboratory (Librizzi et al., 2005).
METHODS OF PREPARATION AND GENERATION OF EPILEPTIFORM DISCHARGES The methods used to isolate and maintain in vitro a guinea pig brain have been extensively described (de Curtis et al., 1991, 1998; Llinás et al., 1981, 1989; Muhlethaler et al., 1993). Young adult guinea pigs weighing 150 to 250 g are anesthetized with 70 mg/kg tiopenthal, administered intraperioneally. A study of the time course of barbiturate washout in this preparation demonstrated that within 1 hour from the in vitro isolation, the brain concentration of the anesthetic measured by high-performance liquid chromatography (HPLC) is reduced to values close to zero (Librizzi et al., unpublished observations), which exclude possible pharmacologic interference with the recorded activity. After exposing the heart, intracardiac perfusion with a cold saline solution (see later discussion) at 14° C is performed to reduce brain metabolism and to preserve the brain tissue during the dissection. The animal is decapitated after 3 minutes, and the brain is carefully isolated and transferred to the incubation chamber. The surgical maneuver to isolate the brain does not differ substantially from the technique used to prepare brain slices, but it must be performed rapidly (i.e., in 6 to 8 minutes). The details are reported in Muhlethaler et al. (1993). After dissection the isolated brain is positioned in the incubation chamber with its ventral surface upward to visualize the base of the brain and the vascular system formed by the basilar artery and the circle of Willis that is removed en bloc with the brain. The isolated brain is held down by two silk threads secured to the bottom of the incubation chamber to improve mechanical stability. The dura that enfolds the basilar artery is removed, a cannula (PE 60 tubing tapered to about 300-mm-tip diameter) is
inserted into the basilar artery, and the cannula is secured by tying a thin silk thread around the artery. Arterial perfusion at a rate of 5.5 ml per minute is restored with the following solution: NaCl 126 mM, KCl 2.3 mM, NaHCO3 26 mM, MgSO4 1.3 mM, CaCl2 2.4 mM, KH2PO4 1.2 mM, glucose 15 mM, 4(2-hydroxyethyl)-1-piperazine-ethanesulfonic acid (HEPES) 5 mM, and 3% dextran 70.000 (pH 7.3) saturated with a 95 to 5% O2-CO2 gas mixture. The same solution is used for the intracardiac perfusion with a slightly acidic pH (7.1) to enhance protection of the tissue during dissection. In the perfusion chamber, the hypophyseal and carotid arteries are ligated with silk knots. The temperature of the incubation chamber is slowly increased to 32° C (0.2°C per minute). The arterial pressure of the isolated brain, as measured by a pressure transducer interposed along the perfusion line, ranges between 45 and 65 mm Hg. Brains are commonly isolated from young adult guinea pigs, 15 days to 4 months of age. No attempts have been performed to date to isolate the brains of younger and older animals. Viable isolated guinea pig brains can be reliably reproduced by expert experimenters. Since setting up the method at the Department of Experimental Neurophysiology of the Istituto Nazionale Neurologico, more than 10 young scientists have been trained to isolate guinea pig brains; all have mastered the isolation technique within 2 to 3 months. Brains can be isolated in vitro from species such as guinea pigs that show a peculiar arrangement of the communication between the posterior (vertebrobasilar) and the anterior (carotid) arterial systems that form the circle of Willis. The basilar artery in the guinea pig divides into two large-diameter posterior communicating arteries (Figure 1), from which the posterior cerebral arteries originate. The guinea pig is the only animal analyzed so far in which the presence of these large-capacity posterior communicating arteries and the arrangement of the circle of Willis are compatible with perfusion of the entire brain via the basilar artery. In other animal species, such as the rat and the mouse (see Figure 1A), the small diameter of the posterior communicating arteries does not allow good brain perfusion in vitro when the basilar artery is cannulated. No attempts have been made to evaluate the feasibility of the brain isolation technique in animal species other than the rat, the mouse, and the guinea pig. An acute epileptogenic condition can be easily and reliably established in the isolated guinea pig brain preparation. Interictal and ictal discharges can be consistently reproduced by brief arterial applications of proconvulsive compounds that are permeable to the blood-brain barrier. Three-minute applications of bicuculline (50 mM), penicillin (1000 units/ml), or picrotoxin (1 mM) diluted in the perfusion solution induce interictal spikes in the piriform-entorhinal cortex; these applications are followed, within 5 to 10 minutes, by ictal discharges that typically originate in the
Methods of Preparation and Generation of Epileptiform Discharges
105
FIGURE 1 A: Schematic representation of the circle of Willis of the rat (left) and the guinea pig (right). 1, Anterior communicating artery; 2, anterior cerebral artery; 3, middle cerebral artery; 4, carotid artery; 5, hypophyseal artery; 6, posterior communicating artery; 7, posterior cerebral artery; 8, Superior cerebellar artery; 9, basilar artery. B: Arteriographic image obtained by perfusing an isolated guinea pig brain with 0.2 ml iodine contrast medium in the basilar artery. Large arteries of the circle of Willis are shown during an early perfusion time of the contrast medium.
hippocampus-entorhinal cortex and secondarily invade the perirhinal cortex (Figure 2). Unlike results reported for cats in vivo (Avoli and Gloor, 1982; Gloor et al., 1977), GABAergic antagonists in the isolated guinea pig brain preparation induce epileptiform discharges that demonstrate a clear focal onset in the mesial temporal lobe. Typical ictal events are characterized by fast activity (around 20 to 25 Hz) that originates from the hippocampus-entorhinal cortex and builds up in 2 or 3 seconds (Figure 2b) superimposed on a slow extracellular voltage shift. The fast activity is followed by phasic runs of high-amplitude afterdischarges (0.5 to 1 second in duration) widely distributed in the hippocampus and parahippocampal regions (Figure 2c) that progressively become more regular and increase in amplitude. Afterdischarge can propagate to regions in which the early part of the seizure was never observed, such as the piriform cortex or the neocortex. After 2 to 4 minutes, afterdischarges decrease in duration and periodicity and ultimately disappear. A postictal depression of several tenths of minutes follows, during which epileptiform discharges could not be induced, but afferent stimulation can evoke responses in the limbic region. Ictal epileptiform discharges repeat for several minutes or hours after a single arterial perfusion with GABA-receptor antagonists. A normal excitability condition resumes within 2 to 3 hours after bicuculline application. Ictal activity generated in the temporolimbic region does not propagate diffusely into the brain; for instance, ictal epileptiform discharges were never observed in the neocortex and seldom occurred in the piriform cortex (Librizzi and de Curtis, 2003; Uva et al., unpublished observations). For this reason the experimental procedure can be proposed as
a model of acute focal epileptogenesis of the temporal lobe. The ictal pattern generated in the isolated brain preparation is similar to that commonly observed during stereo electroencephalographic (EEG) recordings from human epileptogenic areas (Francione et al., 1994, 2003; Lieb et al., 1976; Pacia and Ebersole, 1999; Spencer and Spencer 1994; Tassi et al., 2002; Towsend and Engel, 1991; Wendling et al., 2002; Young Jung et al., 1999) characterized by the appearance of fast activity at the onset, followed by afterdischarges. Such an ictal onset differs from the pattern usually induced by the application of epileptogenic drugs in slices. In most acute pharmacologic models developed in slices of hippocampus or cortex, ictal-like events are formed by large-amplitude afterdischarges characterized by repeated, fast-onset paroxysmal depolarizing shifts (PDSs) that gradually decline in frequency to about 2 to 10 Hz, interpreted as a preictal event or subclinical “embryo seizure” (Ralston, 1958). The differences between the pattern observed in the isolated guinea pig brain and that observed in slices probably depends on the restricted connectivity preservation in brain tissue slices. Muscarinic receptor agonists (carbachol, pilocarpine) do not induce epileptiform activity unless they are co-perfused with a GABA-receptor antagonist. Unlike the case for cortical slices (Nagao et al., 1996), arterial perfusion with pilocarpine alone at concentrations between 10 and 100 mM, for periods up to 2 hours, never resulted in epileptiform discharges, even though intraperitoneal application of pilocarpine in the guinea pig in vivo induced a prolonged status epilepticus.
106
Chapter 9/In Vitro Isolated Guinea Pig Brain
FIGURE 2 Representative ictal discharge recorded in the olfactory and limbic cortices of the isolated guinea pig brain preparation after arterial perfusion of 50 mM bicuculline. Recordings were performed in the piriform cortex (PC), in the entorhinal cortex (EC), in the CA1 region of the hippocampus (hip), and in the perirhinal cortex (PRC), as illustrated on the ventral view of the guinea pig brain on top. Expanded traces in a, b, c, and d are sampled from the upper traces. The ictal onset of the discharge features fast activity that originates in the hippocampus. For details see text.
Focal hypersynchronous potentials can be reliably induced by local application of proconvulsive compounds. Intraparenchymal injection of bicuculline (1 to 2 mM) or picrotoxin (10 mM) in the piriform cortex induces largeamplitude interictal spikes that repeat with a 5- to 10-second periodicity and propagate to synaptically connected regions, such as the amygdala, the periamygdaloid cortex, and the lateral entorhinal cortex (Biella et al., 1996, 2003). Unlike systemic applications, local drug treatment in the piriform cortex did not induce ictal discharges but could promote the generation of brief afterdischarges. To date no attempts have been performed to trigger epileptiform activity by local applications of drugs in structures other than the piriform region. An alternative procedure that has been used to generate epileptiform discharges in the hippocampal-parahippocampal area is represented by direct application of tetanic stimulation to the cerebral tissue at 100 Hz for 1 second, as
reported by Paré and colleagues (1992). When such prolonged tetanic stimuli are repeated for three to five cycles at 0.5 Hz, self-sustained epileptiform afterdischarges of brief duration are generated that only occasionally develop into seizure-like activity with features similar to those described above for the pharmacologic model.
ADVANTAGES, LIMITATIONS, AND FUTURE DEVELOPMENTS The advantages of the isolated guinea pig brain with respect to other in vitro and the in vivo conditions and preparations have been discussed extensively in previous articles (de Curtis et al., 1991; Llinás et al., 1981; Muhlethaler et al., 1993). The most obvious advantage is preservation of the tridimensional connections between close and remote brain areas, which allows evaluation of the unrestricted expres-
107
Advantages, Limitations, and Future Developments
sion of network interactions during epileptiform discharges. Moreover, use of the in vitro brain preparation allows (1) approaching brain regions that are otherwise difficult to access in vivo; (2) evaluating the tangential propagation of activity across the surface of the brain with a more direct and facilitated approach than in vivo by means of electrophysiologic recordings and optical imaging; (3) performing multisite recordings at extracellular and intracellular levels; (4) performing pharmacologic tests by perfusing drugs via the arterial system in a close-to-in vivo situation in which the blood-brain barrier is functionally active; (5) applying drugs that cannot be used in vivo because of their severe, if not lethal, systemic effects. Finally, because of the in situ preservation of the vascular system in the isolated guinea pig brain, the mechanisms of interactions between neuronal activity and the vascular compartment can be analyzed. It is well known that bidirectional neurovascular-neuronal interactions regulate brain excitability. Neuronal and glial activities are coupled to localized changes in cerebral blood flow that rely on several mechanisms, such as changes in local concentration of ions and the release of classic neurotransmitters or neuromodulators (e.g., nitric oxide or adenosine). Further changes in blood flow and in blood-brain barrier permeability influence metabolism and activity of the brain, which result in dramatic excitability changes (Akgoren et al., 1996; Gaillard et al., 1995; Logothetis et al., 2001; Magistretti et al., 1999; Iadecola et al., 1997; Malonek and Grinvald, 1996; Villringer and Dirnagl, 1995; Zonta et al., 2003). The neuronal and vascular compartments during epileptiform activation have been studied simultaneously in the past during pioneer studies in vivo (Caspers and Speckmann, 1972; Jasper and Erickson, 1941; Paulson and Sharbrough, 1974; Penfield et al., 1940) that have been largely overlooked for several decades in epilepsy research field in favor of the study of intrinsic excitability properties and synaptic interactions between neurons. With the spread of diagnostic imaging technology, such as single-photon emission computed tomography (SPECT), positron emission tomography (PET), and functional magnetic resonance imaging (MRI), the interactions between blood flow, brain metabolism, and neuronal activity have been reconsidered (Arthurs and Boniface, 2002; Duncan, 1992; Logothetis et al., 2001). Very preliminary attempts to correlate brain activity with changes in blood flow during an ictal epileptiform discharge have been carried out on the isolated brain preparation (de Curtis et al., 1998). As illustrated in Figure 3, the time course of seizure-like events induced by arterial application of bicuculline can be correlated with the simultaneous changes in extracellular ion concentrations (potassium and protons/pH) and changes in resistance to blood flow, measured with a pressure transducer positioned along the perfusion line. These studies could be further detailed by measuring changes in the size of pial vessels with a video microscopy
FP
1 mV
[K ]o
+
2 mM
pH
0.05 pH
VT
5 mmHg 1 min
FIGURE 3 Simultaneous recording of ictal discharges elicited by arterial application of penicillin (1000 units/ml). Two-barrel electrodes recorded field potentials (FP) simultaneously with extracellular potassium ([K+]o) and proton (pH) concentration in the extracellular space by means of ion-selective electrodes. The changes in brain blood flow associated with seizure activity were simultaneously measured as changes in the resistance to flow by a pressure transducer inserted along the perfusion line just upstream of the insertion of the polyethylene cannula in the basilar artery. VT, vascular tone. Downward deflections represent vasodilation associated with an increase in blood flow.
system to evaluate changes in local cerebral blood flow during brain activity. Even though a detailed neuropathologic study of isolated brains after the induction of repetitive seizures has never been performed, no obvious damage was observed in the ictal onset region (hippocampus and entorhinal cortex) after thionine staining of the tissue (performed to identify the position of the recording and stimulating electrodes at the end of the electrophysiologic experiment). Histochemical studies of the isolated brains after induction of epileptiform discharges could be performed, in principle, to analyze acute changes in brain tissue, such as induction of immediate early genes, inflammatory molecules, edema, etc. In addition, MRI scans of in vitro isolated or postfixed guinea pig brains (Figure 4) can be performed with a spatial resolution that allows identification of an altered signal in the gray and white matter, such as postepileptic brain edema or alterations associated with sclerosis or gliosis (not shown). The main limitation of the currently available technique is that it models an acute epileptogenic condition. Future developments include the possibility of isolating brains from animals in which a chronic epileptic condition has been established. Preliminary experiments on the pilocarpine model have been performed (Turski et al., 1989). Intraperitoneal injection of 380 mM of pilocarpine induces in guinea pigs subcontinuous partial and secondary generalized seizures lasting several hours this activity can be effectivey terminated by intraperitoneal injection of benzodiazepines. Brains isolated just after the epileptic status produce
108
Chapter 9/In Vitro Isolated Guinea Pig Brain
FIGURE 4 High-definition magnetic resonance T2-weighted images of the isolated brain of the guinea pig performed with a 1.5 Tesla Philips instrument (courtesy of Dr. Maria Grisoli and Dr. Maria Grazia Bruzzone).
spontaneous epileptiform activity without further pharmacologic or stimulation procedures. Ideally brain isolation could be performed at different times during the “latent period” as well as before and after establishment of a chronic epileptic condition. The use of an in vitro isolated brain for such a study would allow precise reconstruction of the patterns of generation and propagation of epileptiform discharges using microphysiologic and imaging techniques, under conditions that preserve the tridimensional connectivity among brain structures.
References Akgoren, N., Dalgaard, P., and Lauritzen, M. 1996. Cerebral blood flow increases evoked by electrical stimulation of rat. Brain Res 710(1–2): 204–214. Arthurs, O., and Boniface, S. 2002. How well do we understand the neural origins of the fMRI BOLD signal? Trends Neurosci 25: 27–31. Avoli, M., and Gloor, P. 1982. Interaction of cortex and thalamus in spike and wave discharges of feline generalized penicillin epilepsy. Exp Neurol 76: 196–217.
Biella, G., Forti, M., and de Curtis, M. 1996. Propagation of epileptiform potentials in the guinea-pig piriform cortex is sustained by associative fibres. Epilepsy Res 24: 137–146. Biella, G., Uva, L., and de Curtis, M. 2001. Network activity evoked by neocortical stimulation in area 36 of the guinea pig perirhinal cortex. J Neurophysiol 86: 164–172. Biella, G.R., Gnatkovsky, V., Takashima, I., Kajiwara, R., Iijima, T., and De Curtis, M. 2003. Olfactory input to the parahippocampal region of the isolated guinea pig brain reveals weak entorhinal-to-perirhinal interactions. Eur J Neurosci 18: 95–101. Caspers, H., and Speckmann, E.J. 1972. Cerebral pO2, pCO2, and pH changes during convulsive activity and their significance for spontaneoous arrest of seizures. Epilepsia 13: 699–725. de Curtis, M., Biella, G., Buccellati, C., and Folco, G. 1998. Simultaneous investigation of the neuronal and vascular compartments in the guinea pig brain isolated in vitro. Brain Res Protocols 3: 221–228. de Curtis, M., Biella, G., and Forti, M. 1996. Epileptiform activity in the piriform cortex of the in vitro isolated guinea pig brain preparation. Epilepsy Res 26: 75–80, 1996. de Curtis, M., Biella, G., Forti, M., and Panzica, F. 1994. Multifocal spontaneous epileptic activity induced by restricted bicuculline ejection in the piriform cortex of the isolated guinea pig brain. J Neurophysiol 71: 2463–2475. de Curtis, M., Manfridi, A., and Biella, G. 1998. Activity-dependent pH shifts and periodic recurrence of spontaneous interictal spikes in a model of focal epileptogenesis. J Neurosci 18: 7543–7551. de Curtis, M., Pare, D., and Llinás, R.R. 1991. The electrophysiology of the olfactory-hippocampal circuit in the isolated and perfused adult mammalian brain in vitro. Hippocampus 1: 341–354. de Curtis, M., Radici, C., and Forti, M. 1999a. Cellular mechanisms underlying spontaneous interictal spikes in an acute model of focal cortical epileptogenesis. Neuroscience 88: 107–117. de Curtis, M., Takashima, I., and Iijima, T. 1999b. Optical imaging of cortical activity after in vitro perfusion of cerebral arteries with a voltagesensitive dye. Brain Res 837: 314–319. Duncan, R. 1992. Epilepsy, cerebral blood flow, and cerebral metabolic rate. Cerebrovasc Brain Metab Rev 4: 105–121. Federico, P., Borg, S.G., Salkauskus, A.G., and MacVicar, B.A. 1994. Mapping patterns of neuronal activity and seizure propagation by imaging intrinsic optical signals in the isolated whole brain of the guinea pig preparation. Neuroscience 58: 461–480. Federico, P., and MacVicar, B.A. 1996. Imaging the induction and spread of seizure activity in the isolated brain of the guinea pig: the roles of GABA and glutamate receptors. J Neurophysiol 76: 3471–3492. Forti, M., Biella, G., Caccia, S., and de Curtis, M. 1997. Persistent excitability changes in the piriform cortex of the isolated guinea-pig brain after transient exposure to bicuculline. Eur J Neurosci 9: 435–451. Francione, S., Kahane, P., Tassi, L., Hoffmann, D., Durisotti, C., Pasquier, B., and Munari, C. 1994. Stereo-EEG of interictal and ictal electrical activity of a histologically proved heterotopic gray matter associated with partial epilepsy. Electroencephalogr Clin Neuropjysiol 90: 284–290. Francione, S., Nobili, L., Cardinale, F., Citterio, A., Galli, C., and Tassi, L. 2003. Intra-lesional stereo-EEG activity in Taylor’s focal cortical dysplasia. Epileptic Disord 5(Suppl 2): S105—S114. Gaillard, W.D., Fazilat, S., White, S., Malow, B., Sato, S., Reeves, P., Herscovitch, P. et al. 1995. Interictal metabolism and blood flow are uncoupled in temporal lobe cortex of patients with complex partial epilepsy. Neurology 45: 1841–1847. Gloor, P., Quesney, L.F., and Zumstein, H. 1977. Pathophysiology of generalized penicillin epilepsy in the cat: the role of cortical and subcortical structures. II. Topical application of penicillin to the cerebral cortex and to subcortical structures. Electroencephalogr Clin Neurophysiol 43: 79–94.
References Iadecola, C., Yang, G., and Ebner, T. 1997. Local and propagated vascular responses evoked by focal synaptic activity in cerebellar cortex. J Neurophysiol 78: 651–659. Jasper, H., and Erickson, T.E. 1941. Cerebral blood flow and pH in excessive cortical discharge induced by metrazol and electrical stimulation. J Neurophysiol 4: 333–347. Librizzi, L., and de Curtis, M. 1999. Simultaneous recording of changes in pH, K+, and vasular tone during epileptiform activity in the olfactorylimbic cortex. Soc Neurosci Abst 25: 842. Librizzi, L., and de Curtis, M. 2003. Epileptiform ictal discharges are prevented by periodic interictal spiking in the olfactory cortex. Ann Neurol 53: 382–389. Librizzi, L., Folco, G., and and de Curtis, M. 2000. NO-synthase inhibitors block acetylcholine-mediated dilation of cerebral arteries in the in vitro isolated guinea pig brain. Neuroscience 101: 283–287. Librizzi, L., Janigro, D., De Biasi, S., and de Curtis, M. 2001. Blood brain barrier preservation in the in vitro isolated guinea-pig brain preparation. J Neurosc Res 66: 289–297. Lieb, J.P., Walsh, G.O., and Babb, T.L. 1976. A comparison of EEG seizure patterns recorded with surface and depth electrodes in patients with temporal lobe epilepsy. Epilepsia 17: 137–160. Llinás, R., Muhlethaler, M., and Walton, K. 1989. Electrophysiology of the isolated adult guinea pig in vitro. J Physiol (Lond) 414: 16P. Llinás, R., Yarom, Y., and Sugimori, M. 1981. Isolated mammalian brain in vitro: new technique for analysis of electrical activity of neuronal circuit function. Fed Proc 40: 2240–2245. Logothetis, N.K., Pauls, J., Augath, M., Trinath, T., and Oeltermann, A. 2001. Neurophysiological investigation of the basis of the fMRI signal. Nature 412: 150–157. Magistretti, P.J., Pellerin, L., and Rothman, D. 1999. Energy on demand. Science 283: 496–497. Malonek, D., and Grinvald, A. 1996. Interactions between electrical activity and cortical microcirculation revealed by imaging spectroscopy: implications for functional brain mapping. Science 272: 551–444. Mazzetti, S., Librizzi, L., Frigerio, S., de Curtis, M., and Vitellaro-Zuccarello, L. 2004. Molecular anatomy of the cerebral microvessels in the isolated guinea-pig brain. Brain Res 999: 81–90. Muhlethaler, M., de Curtis, M., Walton, K., and Llinas, R. 1993. The isolated and perfused brain of the guinea-pig in vitro. Eur J Neurosci 5: 915–926. Nagao, T., Alonso, A., and Avoli, M. 1996. Epileptiform activity induced by pilocarpine in the rat hippocampal-entorhinal slice preparation. Neuroscience 72: 399–408.
109
Pacia, S.V., and Ebersole, J.S. 1999. Intracranial EEG in temporal lobe epilepsy. J Clin Neurophysiol 16: 399–407. Pare, D., de Curtis, M., and Llinas, R. 1992. Role of the hippocampalentorhinal loop in temporal lobe epilepsy: extra- and intracellular study in the isolated guinea pig brain in vitro. J Neurosci 12: 1867–1881. Paulson, O.B., and Sharbrough, F.W. 1974. Physiologic and pathophysiologic relationship between the electroencephalogram and the regional cerebral blood flow. Acta Neurol Scand 50: 194–220. Penfield, W., von Santha, K., and Cipriani, A. 1940. Cerebral blood flow during induced epileptiform seizures in animals and man. J Neurophysiol 3: 257–267. Ralston, B.L. 1958. The mechanism of transition of interictal spiking foci into ictal seizure discharges. Electroencephalogr Clin Neurophysiol Suppl 10: 217–232. Spencer, S.S., and Spencer, D.D. Entorhinal-hippocampal interactions in medial temporal lobe epilepsy. Epilepsia 35: 721–727, 1994. Tassi, L., Colombo, N., Garbelli, R., Francione, S., Lo Russo, G., Mai, R., Cardinale, F. et al. 2002. Focal cortical dysplasia: neuropathological subtypes, EEG, neuroimaging and surgical outcome. Brain 125: 1719–1732. Towsend, J.B., and Engel, J. 1991. Clinico-pathological correlations of low voltage fast and high amplitude spike and wave medial temporal stereoencephalographic ictal onset [abstract]. Epilepsia 32: 21. Turski, L., Ikonomidou, C., Turski, W.A., Bortolotto, Z.A., and Cavalheiro, E.A. 1989. Review: cholinergic mechanisms and epileptogenesis. The seizures induced by pilocarpine: a novel experimental model of intractable epilepsy. Synapse 3: 154–171. Villringer, A., and Dirnagl, U. 1995.Coupling of brain activity and cerebral blood flow: basis of functional neuroimaging. Cerebrovascular Brain Metab 7: 240–276. Wendling, F., Bartolomei, F., Bellanger, J.J., and Chauvel, P. 2002. Epileptic fast activity can be explained by a model of impaired GABAergic dendritic inhibition. Eur J Neurosci 15: 1499–508. Young Jung, W., Pacia, S.V., and Devinsky, O. 1999. Neocortical temporal lobe epilepsy:intracranial EEG features and surgical outcome. J Clin Neurophysiol 16: 419–425. Zonta, M., Angulo, M.C., Gobbo, S., Rosengarten, B., Hossmann, K.A., Pozzan, T., and Carmignoto, G. 2003. Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation. Nat Neurosci 6: 43–50.
C
H
A
P
T
E
R
10 Pharmacologic Models of Generalized Absence Seizures in Rodents MIGUEL A. CORTEZ AND O. CARTER SNEAD III
in Table 2, criteria designed to mirror accurately human absence seizures (see Table 1). Pharmacologic animal models of absence seizures are defined by the electrobehavioral characteristics produced by acute administration of a specific compound to an animal, usually a rat or a mouse. Data from these pharmacologic models typically have a limited time frame for collection that is dependent on the half-life of the compound administered. Most of the pharmacologic models of absence, such as the 4,5,6,7 tetrahydroxyisoxazolo (4,5,c) pyridine 3-ol (THIP) model (Fariello and Golden, 1987), the penicillin model (Fisher and Prince, 1977; Gloor, 1984), the low-dose pentylenetetrazole (PTZ) model (Marescaux et al., 1984; Snead, 1988), and the GHB model (which utilizes the biologically inactive prodrug of GHB, g-butyrolactone [GBL]) (Snead, 1988, 2002, 1996; Hu et al., 2000, 2001a) are selflimited and resolve within a defined period of administration of the respective drugs. The exceptions to this rule are the AY-9944 (Cortez et al., 2001) and the methylazoxymethanol acetate (MAM)-AY-9944 models (Serbanescu et al., 2004), in which the atypical absence seizures induced by AY 9944 persist long after administration of the compound. Acute pharmacologic models of absence seizures have expanded our understanding of thalamocortical mechanisms (Banerjee et al., 1993; Cortez et al., 2001; Gloor, 1984; Gloor and Fariello, 1988; McCormick and Bal, 1997; Steriade and Llinas, 1988), absence-seizure ontogeny (Schickerova et al., 1984; Snead, 1984 b, 1994, 2002), GABAergic mechanisms (Smith and Biercamper, 1990; Snead, 1984a, 1990), and the molecular changes that may participate in the generation and maintenance of absence seizures (Banerjee et al., 1998a, b; Hu et al., 2001a, b; Kim et al., 2001). The pharmacologic animal models of general-
GENERAL DESCRIPTION OF MODEL Generalized absence seizures are defined as a paroxysmal loss of consciousness of abrupt and sudden onset and offset that is associated with bursts of bilaterally synchronous three cycles per second or 3 Hz spike-wave discharge (SWD) recorded on the electroencephalogram (EEG). There is no aura or postictal state. This particular type of seizure usually occurs in children between the ages of 4 years and adolescence, although they can occur at either ends of that age spectrum (Snead, 1995; Snead et al., 1999). Generalized absence seizures are pharmacologically unique, responding only to ethosuximide, trimethadione, valproic acid, or benzodiazepines and being resistant to or worsened by phenytoin, barbiturates, or carbamazepine (Snead et al., 1999) (Table 1). The unpredictable occurrence of absence seizures and the limitations of the clinical investigation on mechanisms of seizure generation constitute two fundamental challenges that led to the development of animal models of absence seizures. Since the development of the pentylenetetrazole animal model of acutely induced seizure and the evolution of this model as a standard tool for the screening and development of antiepileptic drugs (AEDs) with antiabsence properties, a number of additional pharmacologic models of absence seizures have been developed, along with considerable debate over their relevance to human absence epilepsy. As with all other epilepsy syndromes, there is no perfect animal model of epilepsy (for reviews see Mody and Schwartzkroin, 1997; Snead et al., 1999). Rather, the investigation of the determinants of both the subtlety and the complexity of human absence seizure phenomenology can be approached only by the rational use of multiple animal models that have in common the basic requirements outlined
Models of Seizures and Epilepsy
111
Copyright © 2006, Elsevier Inc. All rights of reproduction in any form reserved.
112
Chapter 10/Pharmacologic Models of Generalized Absence Seizures in Rodents
TABLE 1 Characteristics of Generalize Absence Seizures in Humans Occur in children with onset between 4 and 15 yr of age EEG findings of bilaterally synchronous 3 Hz SWDs Clinical findings of staring, behavioral arrest, occasional myoclonus, eye movements, automatisms Brief, no aura, no postictal state Treated with ethosuximide, trimethadione, or valproic acid Aggravated by carbamazepine and phenytoin Aggravated by GABA agonists (progabide, vigabatrin, tiagabine, baclofen) c/s, cycles per second; EEG, electroencephalographic; GABA, gaminobutyric acid; SWD, spike-and-wave discharges.
TABLE 2 Criteria for Experimental Generalized Absence Seizures EEG and behavior similar to the human condition
International League Against Epilepsy (ILAE). Both clinicians and basic scientists have contributed to the dynamic evolution of the classifications of epileptic seizures (ILAE, 1981) and epileptic syndromes (ILAE, 1989). For a more detailed account of the rationale of these changes and for the terminology we use in this chapter, we refer you to the work of the Task Force on Classification and Terminology (ILAE, 2001). This chapter focuses on the pharmacologic models of absence seizures. All the pharmacologic models of typical absence seizures are acute and self-limited. The models of atypical absence seizures are chronic models. The epilepsy syndromes discussed in the context of the animal models reviewed are childhood and juvenile absence epilepsy and Lennox Gastaut syndrome. The latter is included because atypical absence seizures are an integral part of the symptom complex of this syndrome.
METHODS OF GENERATION
Reproducibility and predictability Quantifiable Appropriate pharmacology Unique developmental profile Exacerbated by GABAergic drugs Involvement of thalamocortical mechanisms Blocked by GABAB receptor antagonists EEG, electroencephalographic; GABA, g-aminobutyric acid.
ized bilaterally synchronous SWDs in rats are reproducible and have been standardized across models for the quantification of SWDs (Depaulis et al., 1989). Chronic animal models of absence epilepsy represent the semiology EEG correlates and pharmacologic profile of human typical (Snead 1995; 1996) and atypical absence seizures (Nolan et al., 2004). The former group includes the Genetic Absence Epilepsy Rats from Strasbourg (GAERS) (Marescaux et al., 1984) and Waj/Rij (Wistar Albino Glaxo strain bred in Rijswijk, the Netherlands) (Coenen and Van Luijtelaar, 1987) rat models of typical absence epilepsy; the latter consists of the AY-9944 and AY9944/MAM (Cortez et al., 2004) rat models of atypical absence seizures (Cortez et al., 2001; Serbanescu et al., 2004; Wu et al., 2004).
WHAT DOES IT MODEL? To facilitate communication among clinicians and basic scientists and to enable the development of animal models relevant to human epilepsy, an agreement on the terminology to designate clinical seizures was required. This standardization was perhaps the major contribution of the
Acute pharmacologic models of typical absence seizures are derived from systemic administration of a single pharmacologic compound (THIP, GHB, PTZ, or penicillin) that results in bilaterally synchronous SWD associated with behavioral arrest, facial myoclonus, and vibrissal twitching. In the animal models of typical absence, there is a precise correlation between the onset and offset of the behavioral manifestations of the experimental absence seizure and that of the SWD. The seizure ends abruptly, and the animal resumes its preictal activity with no impairment in consciousness (Snead et al., 1999). In the models under review, the onset of absence seizures occurs reliably within 5 minutes of administration of drug. The acquired chronic models of atypical absence seizures are derived from a timely prenatal administration (MAM) and postnatal systemic administration of an inhibitor of cholesterol, AY-9944. As with all animal models of absence seizures, both acute and chronic pharmacologic models of absence seizures require EEG, and preferably EEG-video, recordings to measure accurately seizure duration, frequency, and severity (Depaulis et al., 1989). The methods of generation for the pharmacologic models, acute or chronic, are illustrated in Table 3, where the pharmacologic models of absence seizures are compared with standard genetic models of absence epilepsy, such as the GAERS and the WAG/Rij rats.
The THIP Model THIP is a GABA agonist that induces bilaterally synchronous SWDs in rats (Fariello and Golden, 1987). THIP is administered intraperitoneally (IP) in a dose of 5 to 10 mg per kilogram of weight and leads to bilaterally synchronous SWDs lasting 7 to 9 seconds that occur in bursts lasting 1
113
Methods of Generation
TABLE 3 Acute Seizure Models and Chronic Epilepsy Models Dose (mg/kg)
Species
Strain
Acute PCL THIP LD-PTZ GHB
600Ta 10 20 100 (GBL)
Cat Rat Rat Rat
?
Genetic GAERS WAG/Rij
-
Chronic AY-9944 MAM-AY
7.5 100/7.5
Model
Age Specificity
Procedure
Monitoring
Effort (%)
Reliability
Seizures
Remission
SD, W SD, W
Adult Adult Adult Adult
IM IP IP IP
EEG EEG EEG EEG/VEEG
++ + + +
100 100 100 100
TAS ?TAS TAS TAS
Yes Yes Yes Yes
Rat Rat
W W
Adult Adult
Genetic Genetic
EEG/VEEG EEG/VEEG
+++ +++
100 100
TAS TAS
No No
Rat Rat
LEH LEH
Prepuberty Prepuberty
SC IP/SC
EEG/VEEG EEG/VEEG
++ +++
100 100
CAAS CRAAS
No No
AY-9944, AY; BCC, bicuculline; CAAS, chronic atypical absence seizures; CRAAS, chronic refractory atypical absence seizures; EEG, electroencephalography; GAERS, Genetic Absence Epilepsy in Rats from Strasbourg; GBL, gamma butyrolactone; GHB, gamma-hydroxybutyrate; HD, high dose; LD, low dose; MAM, methylazoxymethanol acetate; PCL, penicillin; PTZ, pentylenetetrazole; SD, Sprague-Dawley; TAS, typical absence seizures; VEEG, video electroencephalography; W, Wistar. a 600.000 units per kilogram.
to 7 seconds. The dose of THIP to elicit SWDs is 7.5 mg/kg of THIP given IP in a volume of normal saline of 1 ml/kg. The model is quantitated in the same manner as described later herein for the GHB model (Depaulis et al., 1989) (see Table 3).
The GHB Model GHB is a GABA metabolite that occurs naturally in the mammalian brain (Roth and Giarman, 1969). After IP administration of GHB, a predictable sequence of electrographic and behavioral events occurs, mirroring generalized absence seizures. This phenomenon has been well described in cats, rats, and monkeys (Bearden et al., 1980; Godschalk et al., 1977; Snead et al., 1976, 1978a–c, 1980, 1988). Use of the prodrug of GHB (i.e., GBL) enhances the reproducibility and predictability of the GHB model of absence seizures. GBL has been shown to be biologically inactive (Roth et al., 1966; Snead, 1991). An active lactonase that rapidly converts GBL to GHB is present in serum and liver but not brain or cerebrospinal fluid (Roth and Giarman, 1966; Roth et al., 1967). GBL is used because of the consistency and rapidity of onset of its effect (Bearden et al., 1980) and has been shown to produce exactly the same EEG and behavioral effect as that of GHB (Snead, 1991; Snead et al., 1980). The regional brain concentration of both GHB and GBL has been determined in time-course and dose-response studies after IP administration of GBL as well as at the onset of EEG changes induced by both GHB and GBL. Also, EEG and behavior were assessed following bilateral intrathalamic microinjection of either GHB or GBL in the rat. IP administration of GBL resulted in rapid onset of bilaterally synchronous SWDs in rat that correlated with an almost immediate appearance of GHB in the brain. In
animals that received IP GHB, the EEG changes did not occur until 20 minutes after GHB administration, when GHB levels in brain were peaking. The threshold brain concentration of GHB for EEG changes in both GHB- and GBL-treated animals was 240mM. GBL concentration in brain peaked 1 minute after GBL administration and fell rapidly to undetectable levels within 5 minutes. Bilateral microinjection of GHB into thalamus resulted in brief bursts of SWD, whereas GBL administered into the thalamus had no effect. These data confirm the hypothesis that GBL is biologically inactive in brain and support the validity of the use of GBL as a prodrug for GHB in this model of absence seizures (Snead, 1991). The GHB model of generalized absence seizures meets all criteria outlined in Table 2 (Snead, 2002; Snead et al., 1999). The model is quantitated similar to other electrographic models of generalized absence seizures (Depaulis et al., 1989). GBL-induced SWDs can be quantitated in terms of cumulative duration (in seconds) per 20-minute epoch of time or as a percent of control SWD duration. In this way the GHB model of absence can be compared with any other rodent model of generalized absence seizures using the same pharmacologic paradigm (Depaulis et al., 1989). The GHB rat model of generalized absence seizures is a useful experimental model for the study of the mechanisms of bilaterally synchronous SWD production and can be used to screen for antiabsence activity of potential antiepileptic drugs (Tables 1–3).
The PTZ Model PTZ is the most commonly used GABAA receptor (GABAAR) antagonist used to induce absence-like seizures with low doses. However, all GABAAR antagonists have this
114
Chapter 10/Pharmacologic Models of Generalized Absence Seizures in Rodents
property (Snead et al., 2000). Low doses (20–30 mg/kg) of PTZ induce absence-like seizures that meet all the criteria for experimental absence set forth in Table 2, and the PTZ model is indistinguishable from the GHB model in this regard. The dose-response curves of GABAAR antagonists indicate that the EEG and behavior changes induced by GABAAR antagonists in mice represent a highly dose-specific continuum. Low doses induce absence-like seizures that meet the criteria for absence seizure models (see Table 2) (Marescaux et al., 1984; Snead, 1988; Snead et al., 2000). The dose-response curves for GABAAR antagonist-induced absence seizures indicate that the CD100 is 30 mg/kg for PTZ, 3 mg/kg for bicuculline, and 1.5 mg/kg for picrotoxin. As the dosage of GABAAR antagonists is increased, clonic seizures appear. In fact, even though the seizures do not meet the criteria outlined in Table 2 for experimental absence seizures, these clonic seizures are used to screen for antiabsence activity of putative anticonvulsant drugs in the PTZ screening model. With a further increase in dosage, tonic seizures emerge. The CD95 for the induction of clonic seizures with PTZ, bicuculline, and picrotoxin in the mGluR4+/+ mice is 45, 4.5, and 1.8 mg/kg, respectively (Snead et al., 2000). The clonic component observed with intermediate doses of PTZ (40–60 mg/kg) may be correlated with the work of Browning and Nelson (1986), who showed that clonus restricted to the face and forelimbs depends on seizure discharge emanating from structures within the forebrain for expression. Facial clonus mirrors the forebrain involvement and is typical of all rat models of generalized absence seizures (Table 3). The tonic seizures manifested in the face of high doses of GABAAR antagonists represent brainstem seizures (Browning and Nelson, 1986).
The Penicillin Model Intramuscular (IM) administration of penicillin (300,000–600,000 units/kg) to the cat consistently produces generalized, bilaterally synchronous SWD discharges associated with blinking, myoclonus, and staring (Fisher and Prince, 1977; Gloor, 1984; Guberman et al., 1975; TaylorCourval and Gloor, 1984). This model shows pharmacologic specificity for antiabsence drugs (Guberman et al., 1975) and is exacerbated by PTZ (Gloor and Testa, 1974), photic stimulation (Quesney, 1984), and GABAergic agonists (Fariello, 1979) (Table 3). When given IM to rodents, penicillin does not consistently produce bilaterally synchronous SWDs similar to that seen in cats. Rather, this drug produces multifocal spikes with only occasional bursts of bilaterally synchronous SWDs associated with a decrease in vigilance (Avoli, 1980). The penicillin model in rodents has not been as well characterized as the GHB and PTZ models and is of limited usefulness because of inconstant penetration of penicillin into the brain through the blood-brain barrier. This model,
however, has been shown to be exacerbated by GHB. Conversely, pretreatment with penicillin prolongs GHB-induced SWDs (Snead, l988). When using this model of absence, the same general experimental design as described previously is used. The dose of penicillin is from 300,000 to 600,000 units/kg given IM. There are no antiabsence, antiepileptic drugs or ontogeny data for the penicillin model in rat, but there is some evidence of involvement of thalamocortical mechanisms in penicillin-induced SWDs in rats (Avoli, 1980). Because of the limited usefulness of the penicillin model in rat and the fact that this chapter focuses on pharmacologic models in rodents, the penicillin model in rat will not be considered further in this review.
The AY-9944 Model Subcutaneous administration AY-9944 (7.5 mg/kg), a compound that inhibits the reduction of 7-dehydrocholesterol to cholesterol (Cenedella, 1980; Dvornik and Hill, 1968), to suckling rats every 6 days at postnatal days 2, 6, 8, 14, and 20 leads to absence-like seizures during the adult period (Cortez et al., 2001) (see Table 3). Seizures in this model represent human atypical absence seizures and are associated with an abnormal cognitive outcome (Chan et al., 2004; Nolan et al., 2004), with a prepubescent seizure onset (Persad et al., 2002) and maximum peak in the adult period (Cortez et al., 2002). These seizures are reduced by antiabsence drugs and exacerbated by phenytoin and GABA agonists (Cortez et al., 2001; Smith and Bierkamper, 1990). Developmentally the seizures in this model emerge at postnatal day (P) 21 (Persad et al., 2002; Snead and Cortez, 1999). The role of cholesterol inhibition in epileptogenesis is still under investigation (Serbanescu et al., 2004) (see Table 3). The AY-treated rat represents a predictable, reproducible, and clinically relevant animal model of atypical absence seizures that can be used to investigate the pathogenesis and treatment of this malignant disorder.
The MAM-AY Model (Double-Hit Model) Rats exposed to the antimitotic agent MAM on gestational day (G) 15 develop a neuronal migration disorder similar to the cortical dysplasias seen in the human brain. MAM-exposed suckling rats then undergo the AY model protocol as described previously. The result is that the animal presents with spontaneous, recurrent, atypical absence seizures that are characterized by bilaterally synchronous slow spike-wave discharges (SSWDs) with a frequency of 4 to 6 Hz (see Table 3). The MAM-AY-induced atypical absence seizures are refractory to ethosuximide and sodium valproate. Histologic examination of brains from MAM-treated rats showed hippocampal heterotopias in addition to atrophy and abnormalities of cortical lamination. The MAM-AY-treated rat represents a reproducible model
Characteristics and Defining Features
of refractory atypical absence seizures in children with brain dysgenesis (Serbanescu et al., 2004) (see Table 3).
CHARACTERISTICS AND DEFINING FEATURES Behavioral and Clinical Features 1. The THIP model. Animals demonstrate immobility and some vibrissal twitching. This model appears to be a generalized absence model based on electroclinical correlation; however, to date no pharmacologic data support this hypothesis, nor are there ontogeny data or data concerning possible thalamocortical mechanisms in the generation of these discharges. This model differs from others described in this review because THIP-induced absence-like seizures in rats are exacerbated by valproate (Vergnes et al., 1985). 2. The GHB model. The behavioral correlate of SWD is complete behavioral arrest with facial myoclonus and vibrissal twitching. GHB-induced SWDs most similar to those seen in humans are produced by intravenous (IV) administration of GHB to prepubescent monkeys. In this animal, an IV dose of 200 mg/kg of GHB results in 2.5 Hz SWDs associated with behavioral immobility, head drops, staring, pupillary dilation, eyelid fluttering, rhythmic eye movements, and stereotypical automatisms (Snead, 1978a). In the
115
rat, a standard dose of 0.09 ml (100 mg) of GBL per kilogram given IP reliably produces onset of bilaterally synchronous SWDs within 2 to 5 minutes of GBL administration (Figure 1). The frequency of the SWD is 7 to 9 Hz. Associated with these hypersynchronous electrographic changes are behavioral arrest, facial myoclonus, and vibrissal twitching. Therefore this model meets the criteria outlined in Table 2 in that it is predictable, reproducible, and produces electrographic and behavioral events similar to the human condition. The GHB meets all the pharmacologic criteria (Snead, 1988) and involves thalamocortical circuitry (Banerjee et al., 1993). An additional advantage of the GHB model is that it affords control of pharmacokinetic variables in any pharmacologic study in that the concentration of GBL and GHB can be determined in the brain and the kinetics is known (Snead, 1991). 3. The low-dose PTZ model. This model would seem to meet all the criteria set forth in Table 2. A dose of 20 mg/kg of PTZ results in bursts of bilaterally synchronous SWDs with a frequency of about 7 to 9 Hz. The behavior seen in the PTZ animal is exactly the same as that described for GHB-treated animals, and it too meets pharmacologic criteria (Snead, 1988). 4. The AY-9944 model. This is a model of spontaneous, recurrent, atypical absence seizures. Clinically, atypical absence seizures are more complex than typical absence seizures. They present with a clinical behavioral change that
FIGURE 1 A: Baseline electrocorticogram (ECoG) recordings in controls are characterized by 35 to 50 uV, 7 to 11 Hz intermingled 6 to 9 Hz oscillations in awake resting conditions. B: The ECoG recording 5 minutes following 100 mg/kg GBL illustrates two consecutive high-amplitude 7 to 9 Hz bilaterally synchronous SWDs. The ictal behavior during SWD consisted of frozen stare, vibrissal twitching, and facial myoclonus with complete behavioral arrest. GBL, g-butyrolactone; LF-P, left frontal-parietal; RF-P, right frontal-parietal; SWDs, spike-and-wave discharges.
116
Chapter 10/Pharmacologic Models of Generalized Absence Seizures in Rodents
is gradual in both onset and offset. During atypical absence seizures children retain some ability for purposeful movement and speech but with fogging of consciousness. The ictal EEG discharge in atypical absence seizures is slower than the 3 Hz that characterizes typical absence seizures, and it is not time-locked with the ictal behavior (Figure 2). Similarly, the AY9944 model shows a gradual onset and offset of ictal behavior and the ability to move purposefully during the seizures. Also reminiscent of the human condition, the ictal EEG discharge in the AY 9944 model is not time-locked with the ictal behavior, and it is slower in frequency than the epileptiform activity that characterizes typical absence seizures (Cortez et al., 2001). The phenotypic expression of atypical absence seizures in the AY 9944 model is highly significant because there is a major difference in outcome in children with typical compared with atypical absence seizures. Children with typical absence seizures have a good outcome and are spared any cognitive deficit, perhaps because of the limitation of the SWDs to the thalamocortical circuitry. In distinct contrast, atypical absence seizures are associated with a severely abnormal cognitive and neurodevelopmental outcome in children (Nolan et al., 2004). Therefore, whether absence seizures are typical or atypical is a critical predictor of outcome in children with absence epilepsy. The AY 9944 model also shows evidence of cognitive impairment (Chan et al., 2004) and thus represents a well-characterized model of atypical absence seizures that can be used to investigate mechanistic reasons for why atypical absence seizures confer such a poor long-term outcome on children afflicted by this disorder. 5. The MAM-AY model. The behavioral and EEG features of the MAM-AY model are exactly the same as the AY
model. The difference is that the MAM-AY treated rat is a model of medically refractory atypical absence seizures, whereas the AY model responds to ethosuximide and valproic acid (Serbanescu et al., 2004). Seizure Severity (Racine or Modified Racine Scale) The original rating scale of convulsive seizures presented by Racine in (1972a, b) was based on amygdala kindling and may not be applicable to kindling from other sites (McIntyre et al., 2002). Status Epilepticus (SE): Defining the Type of SE There are few data concerning animal models of generalized nonconvulsive status epilepticus (NCSE) (Hosford, 1999). Experimentally, PTZ-induced generalized NCSE leads to a subtle deficit-in-place learning in rats, with no demonstrable long-term behavioral effects on spatial learning or sensorimotor function. However, at 1 week followup, these animals showed an increase in absence seizures in response to a repeat dose of PTZ compared with controls. There was no detectable brain damage, but rats continued to show neuronal functional changes characterized by alteration of electrical excitability of neural circuits after generalized NCSE (Erdogan et al., 2004; Wong et al., 2003). This finding is consistent with our previous report on repeated induction of GHB absence seizures (Hu et al., 2001a) and is distinct from the pilocarpine-induced NCSE, which is associated with attendant seizure-related brain damage (Krsek et al., 2001).
FIGURE 2 Baseline electrocorticogram (ECoG) recordings at postnatal day 60 AY-9944-treated rat illustrates the spontaneous bilaterally synchronous and high-amplitude 5- to 6-Hz SSWDs from cortex, thalamus, and hippocampal monopolar electrodes. The ictal behavior during SSWDs consisted of frozen stare, vibrissal twitching, and facial myoclonus with the ability to move during seizures. L, left; R, right; Ctx, cortex; Th, thalamus; Hi, hippocampus. SSWD, slow spike-and-wave discharges.
117
Characteristics and Defining Features
Forebrain Versus Hindbrain Seizures Experimental absence seizures are constrained within thalamocortical circuitry and therefore are exclusively forebrain seizures (Banerjee et al., 1993; Crunelli and Leresche, 2002; McCormick and Bal, 1997; Snead et al., 1999, 2000; Vergnes et al., 1990). As mentioned, increasing doses of the GABAAR antagonists bicuculline, picrotoxin, or pentylenetetrazole results in a dose-dependent phenomenon in which the lower doses first involve thalamocortical circuitry and produce absence-like seizures. Intermediate doses involve more widely distributed forebrain structures and produce forelimb clonus. Higher doses result in recruitment of brainstem circuitry with resultant tonic seizures. One could postulate that the same progression is present in Lennox-Gastaut syndrome, which is characterized by atypical absence (thalamocortical-hippocampal circuitry), clonic and myoclonic seizures (widespread neocortical circuitry), and tonic seizures (brainstem circuitry).
Electrographic and Electroencephalogric Features McQueen and Woodbury (1975) attempted to produce bilaterally synchronous SWDs in the electrocorticogram of rats by using several experimental paradigms, including administration of pentylenetetrazole, picrotoxin, conjugated estrogens, and bilateral intracerebral cobalt implants. In their hands, no pharmacologic modality produced consistent bilaterally synchronous SWDs. The authors concluded, therefore, that the rodent was not suitable for any detailed study of the pathophysiology of SWD. However, that same year, spontaneous SWDs were first reported in rodent (Vanderwolf, 1975) and have been described in a number of strains of rats since that time (Buzsaki et al., 1988; Kaplan, 1985, 1990; Kleinlogel, 1985). With a few notable excep-
tions (Cox et al., 1997), rats do not usually generate 3 Hz SWDs; rather, the usual frequency of SWDs in the THIP, PTZ, and GHB models range from 7 to 9 Hz, whereas the SSWD frequency in the AY-9944 and MAM-AY models is 4 to 6 Hz (Table 4).
Neuropathology Cell Loss There are no reports on cell loss in pharmacologic models of generalized absence seizures comparable to those reported in the other models of status that are associated with severe hippocampal damage. The reason for this is probably related to the fact that absence seizures are constrained within thalamocortical circuitry. Reactive Gliosis To date, there are no reports on reactive gliosis following experimental absence seizures of any kind except for the recently described two-hit MAM-AY9944 model of refractory atypical absence epilepsy (Serbanescu et al., 2004). However, further pathological and molecular investigation of the morphologic changes observed in animal models of limbic epilepsy may provide further understanding of the chronicity and refractoriness observed in MAM-atypical absence seizure model because atypical absence seizures appear to involve limbic as well as thalamocortical circuitry (Chan et al., 2004; Cortez et al., 2001). Plasticity Cognitive abnormalities are reported to occur in patients with atypical absence seizures (Nolan et al., 2004) and in the AY model (Chan et al., 2004). In typical absence seizures
TABLE 4 Electrographic features pharmacological models Models
Latency (minutes)
Frequency (Hz)
Seizure Duration (Sec/Hour)
8–9 2–4 3–5 4–5
7–9 7–9 7–9 7–9
300 400 400 300
TAS TAS TAS AAS
Prince, 1978 De Deyn, 1992 Snead, 2002 Depaulis et al; 1989
Genetic GAERS WAG/Rij
Spontaneous Spontaneous
9–11 7–9
450 560
CTAS CTAS
Marescaux, 1992 van Luijtelaar, 2001
Acquired AY-9944 MAM-AY
Spontaneous Spontaneous
4–6 4–6
600 560
CAAS CRAAS
Cortez et al; 2001 Serbanescu et al; 2004
Acute PCL LDPTZ GHB THIP
Human Seizure Type
References
Chronic
AS, Absence Seizures; AY-9944, AY; CAAS, Chronic Atypical Absence Seizures; CRAAS, Chronic Refractory Atypical Absence Seizures, CTAS, Chronic Typical Absence Seizures; GAERS, Genetic Absence Epilepsy Rat from Strasbourg; LD, Low Dose; PCL, Penicillin; PTZ, Pentylenetetrazole; TAS, Typical Absence Seizures; WAG/Rij, rat strain.
118
Chapter 10/Pharmacologic Models of Generalized Absence Seizures in Rodents
and the experimental models of typical absence, there is no cognitive deficit. One of the great conundrums in clinical and basic epilepsy research, particularly in regard to children, in whom neurodevelopment is critical, is whether there is a cause and effect relationship between seizure frequency and severity and cognitive deficits. In the AY model the hypothesis was tested that ongoing AY-induced atypical absence seizures are wholly or partially responsible for the observed learning and memory by determining the effect of treating the seizures with ethosuximide on cognitive outcome. These data indicate that the cognitive deficits in this model of atypical absence seizures are largely seizure dependent, but seizure-independent mechanisms also may be at play in the genesis of the perturbation of cognition in this model. The most definitive way to test this hypothesis would be to accomplish complete, long-term seizure control in the AY model to tease out the effect of seizure versus intrinsic brain dysfunction on cognition (Chan et al., 2004).
Imaging and Metabolic Changes Electrophysiologic studies in WAG/Rij rats, have shown SWDs over the perioral somatosensory cortex but not over the visual cortex. Functional magnetic resonance imaging (fMRI) studies showed localized increases in fMRI signals in the perioral somatosensory cortex and thalamus during SWD. Furthermore, there was a parallel increase in neuronal activity and cerebral blood flow (CBF) during SWD in the whisker somatosensory (barrel) cortex, whereas the visual cortex showed no significant changes. These measurements were repeated during somatosensory (whisker) stimulation and bicuculline-induced GTCS in the same animals. These findings suggest that even in regions with intense neuronal activity during epileptic seizures, oxygen delivery exceeds metabolic needs, enabling fMRI to be used for investigation of dynamic cortical and subcortical network involvement in this disorder (Abo et al., 2004; Mueggler et al., 2001; Nersesyan et al., 2004). EEG-triggered blood oxygen level dependant (BOLD) fMRI has confirmed an anatomic correlation between areas in which an increased BOLD signal is found and those in which SWDs have been recorded and no negative BOLD signal was associated with these spontaneous SWDs (Tenney et al., 2004). In GAERS, the early studies using [C]2-deoxyglucose (2DG) autoradiographic method demonstrated a lack of correlation between the occurrence of SWDs and local cerebral metabolic rates for glucose (LCMRglcs) and favor normal or decreased ictal metabolism and increased interictal glucose utilization by the brain in rats with absence epilepsy (Nehlig et al., 1993). The diffuse increase in cerebral energy metabolism was not directly related the occurrence of SWDs (Nehlig et al., 1991). The generalized increase in cerebral glucose metabolism occurs in both at the glycolytic and at
the oxidative step. It is unclear how the ubiquitous mutation(s) generates SWDs only in the thalamocortical circuit (Dufour et al., 2003). During development and prior seizure onset by P21, the basal local cerebral metabolic rates for glucose (LCMRglcs) indicate that the genetic mutation(s) underlying the cellular and molecular events responsible for the expression of SWDs in adult GAERS is(are) able to increase metabolic activity in limbic structures and in the nigral inhibitory system before the occurrence of absence seizures. Conversely, the full electrocortical maturation seems necessary for the expression of SWDs with the concurrent increase in CMRglcs in adult GAERS (Nehlig et al., 1998 a, b). A recent study suggested the mediodorsal nucleus of the thalamus to be involved in absence seizures modulation and that this nucleus could participate in the control of the basal ganglia over generalized epileptic seizures (Riban et al., 2004). Rates of glucose utilization, measured by the quantitative autoradiographic 2-DG in rats at 10, 14, 17, and 21 days of postnatal life, indicate that maturation of connections, of metabolic activity, and of neurotransmitter interaction within the brain, occurs mainly during the third week of postnatal life (el Hamdi et al., 1992). 2-DG studies in the PTZ model (systemic administration of PTZ, first 40 mg/kg, followed 10 minutes later by 20 mg/kg, and later every 10 minutes, additional injections of PTZ 10 mg/kg until the onset of SE) have shown changes over the cerebral cortex, hippocampus, sensory regions, as well as scattered thalamic and hypothalamic nuclei; and they occur in the absence of visible neuronal death, most likely related to changes in the final arborization and synaptic organization of the developing brain (Nehlig et al., 1996). Brain extraction of (18)Flabeled 2-fluoro-2-deoxy-d-glucose (FDG) was significantly higher in (PTZ)-treated rats, and the transporter V(max) and blood brain barrier (BBB) glucose permeability increased by 30 to 40% (Cornford et al., 2000). In the THIP model, the magnitudes and distribution of in vivo cerebral metabolic responses were not correlated simply with markers for GABAergic synapses, suggesting that additional factors, such as neural circuitry, regulate the local cerebral glucose utilization (LCGU) responses to GABAergic drugs (Kelly et al., 1982; Palacios et al., 1982). Genetic and Molecular Changes Reciprocal thalamocortical projections play a critical role in the generation of SWDs in GAERS. The epileptic phenotype apparent in adult GAERS may result in part from elevations in T-type calcium channel mRNA levels (Rogawski and Loscher, 2004; Talley et al., 2000; Tsakiaridou et al., 1995). Similarly, quantification of channel expression indicates that the development of SWDs in WAG/Rij rats is concomitant with an increase of Ca(v)2.1 channels in the rhomboid thalamic nucleus (RhTN). These channels are
Characteristics and Defining Features
mainly presynaptic, as revealed by double immunofluorescence involving the presynaptic marker syntaxin (van de Bovenkamp-Janssen et al., 2004). Conversely, animals made deficient in T-type calcium channels are resistant to GHBinduced absence seizures (Kim et al., 2001). Some early immediate gene studies were done with the PTZ model. At 15 minutes following PTZ injection, only transcription for c-fos was increased. By 6 hours following PTZ treatment, transcription for all immediate early genes and for dynorphin and neuropeptide Y was increased; however, this increase was transient in that transcription of all genes returned to control values by 48 hours after PTZ treatment, which suggests that additional posttranscriptional regulation of gene expression occurs in hippocampal neurons (Yount et al., 1994). When the expression profiles of N-methyl-daspartate (NMDA) receptor subunits in rats were examined, the expression of NMDA receptors was found to undergo subunit- and region-related changes in the developmental and kindled seizure of rats induced by PTZ (Zhu et al., 2004). The ability of the rodent brain to support plasticityrelated phenomena declines with increasing age. Old rats retain the capacity to initiate transcription for immediate early genes, particularly as it relates to brain plasticity, in response to a strong stimulus such as PTZ. Although the aging brain retains the capacity to respond to chemically induced seizures, the induction of tissue plasminogen activator (TPA) mRNA is temporarily delayed and the levels are diminished with increasing age. Because TPA has been implicated in neuronal plasticity, this finding suggests that immediate early genes are important factors in the limited plasticity of the aging brain (Popa-Wagner et al., 2000). Transient changes in transcription of the GABA(A)receptor delta-subunit gene occur after acute PTZ-induced seizures, but not after kindling. (Penschuck et al., 1997). Zhang et al. (1991) examined fos oncoprotein expression in the rat thalamus with fos antibody immunohistochemistry after GHB-induced absence-like seizure activity. There was a progressive involvement of the bilateral thalamic paraventricular nuclei (PV), the lateral habenular nucleus (LHb), the PV, the rhomboid thalamic nucleus, and the intralaminar nuclei of the thalamus, which suggest that the LHb and the midline and intralaminar thalamic nuclei are very likely involved in the pathophysiology of absence seizures in the GHB model. GHB-induced absence seizures interact in a number of ways with GABAAR-mediated activity in brain, although GHB itself has no affinity for the GABAAR (Snead and Liu, 1993). The two synthetic neuroactive steroids, alphaxalone (5a-pregnane 3a-ol-11,20-dione) and tetrahydrodeoxycorticosterone both exacerbate GHB-induced absence seizures when given intrathalamically (Banerjee and Snead, 1998). These same neuroactive steroids inhibit [3H]GHB binding in a dose-dependent fashion. This inhibition is limited to the thalamus and increases after the onset of GHB-induced
119
absence seizures, suggesting that the enhancement of inhibition of GHB binding was absence seizure induced (Banerjee et al., 1998a). GHB-induced absence seizures also regulate GABAA receptor a1 and a4 gene expression in thalamic relay nuclei (Banerjee et al., 1998b) and decrease steroid modulation of the binding of ligands to the GABAAR in thalamus (Banerjee et al., 1998c). Also, there is decreased release of GABA in thalamus in the GHB model of absence seizures (Banerjee and Snead, 1995). There also are perturbations of glutamate-mediated excitation in the GHB model of absence. GluR2 protein expression significantly decreases after onset of absence seizures in the GHB model, and this alteration of GluR2 was accompanied by a redistribution of GluR2 expression from laminae V to IV in the cerebral cortex (Hu et al., 2001b). The duration of SWDs was also significantly decreased in GluR2 knockout mice compared with wild-type controls (Hu et al., 2001a). Systemic administration of GBL has been associated with a decrease in K+-evoked glutamate release in thalamus, the onset and duration of which correlates with that of GHB-induced absence seizures. However, basal release of glutamate was unaltered in these experiments (Banerjee and Snead, 1995). Using the same experimental design, no alteration in basal and in K+-evoked glutamate release was observed in superficial laminae of cerebral cortex, that region of cortex from which SWDs emanate in the GHB model of absence seizures (Hu et al., 2000). There is reduction of sonic hedgehog (Shh) signaling in AY9944-treated embryos, resulting in the definition of a narrower ventral domain. Later in development, this reduction of Shh signaling led to a complete interruption of the pathway in the rostral hindbrain and caudal midbrain. Other regions, such as the forebrain and the spinal cord, appeared less sensitive to the reduction of Shh signaling, and interruption of the pathway was observed only in a subset of embryos (Gofflot et al., 2001). The steroidal analogue GW707, the oxidosqualene cyclase inhibitor U18666A, the 3-b-hydroxysterol delta(7)-reductase inhibitor AY-9944, and the vacuolar-type adenosine triphosphatase (ATPase) inhibitor bafilomycin A1 induced sequestration of free cholesterol in the endosomal-lysosomal compartment, leading to a positive filipin staining pattern and a complete inhibition of cholesterol ester synthesis (Issandou et al., 2004). It is unclear whether these mechanisms are involved in the AY model. MAM-induced apoptosis in the external granule cell layer of the rat is associated with strong c-Jun expression, which is restricted to apoptotic cells, and with the formation of high-molecular-weight c-Jun. c-Jun may participate in the genetic cascade of events leading to apoptotic cell death in the developing cerebellum (Ferrer et al., 1997). Molecular analysis revealed that MAM-induced heterotopic cells do not express mRNA markers normally found in hippocampal pyramidal cells or dentate granule cells (SCIP, Math-2, Prox-1, neuropilin-2). In contrast, Id-2 mRNA, normally
120
Chapter 10/Pharmacologic Models of Generalized Absence Seizures in Rodents
abundant in layer II and III supragranular neocortical neurons but not in CA1 pyramidal neurons, was prominently expressed in hippocampal heterotopia (Castro et al., 2002).
Response to Antiepileptic Drugs and Usefulness in Screening Drugs Historically, the classic screening tests, such as maximal electroshock (MES) and PTZ, have used nonepileptic rodents to identify AEDs and their mechanisms of action and side effects. Clearly no single model can be used to identify potential compounds adequately for development, provided the full pharmacologic profile is demonstrated (Kupferberg, 2001). Optimal screening of novel AEDs, both for efficacy and side effects, requires models with receptor and ion channel changes similar to those in the target human syndrome (Meldrum, 2002); however, all the pharmacologic models, with the exception of the THIP model, have a predicted pharmacologic profile for absence seizures; that is, the seizures are blocked or attenuated by ethosuximide, trimethadione, benzodiazepines, and valproic acid and worsened by phenytoin or carbamazepine. Therefore the pharmacologic models are useful in screening putative antiepileptic drugs for antiabsence seizure activity.
LIMITATIONS How Easy to Develop Are They? The acute pharmacologic models of absence seizures are relatively easy to reproduce. The major obstacle for an investigator inexperienced in these models is the EEG monitoring required for the identification and quantitation of the experimental absence seizure. The chronic pharmacologic models that represent the human (AY and MAM-AY models) entail more demanding and labor intensive laboratory work. In both cases, acute or chronic systemic administration of the proabsence compounds leads to an epileptic phenomenon amenable to EEG or vigilance-controlled electroencephalogram (VEEG) monitoring and further circuitry and molecular investigations. The genetic models of absence continue to be the standard reference by which comparisons are made, but the AY and MAM-AY models compare quite favorably to the genetic models in terms of reliability, spontaneity, recurrence of seizures, and chronicity of the epilepsy induced. The AY and AY-MAM models have the additional advantage of representing a unique seizure type for which there is no genetic model, atypical absence seizures.
Mortality There is virtually no mortality involved in the administration of proabsence compounds at the recommended
doses. Mortality becomes an issue rather in the postoperative condition of rodents with chronically implanted electrodes. To minimize mortality in developing rodents, halothane anesthesia is recommended. Pentobarbital or ketamine anesthesias at the recommended doses also minimize mortality in adult rodents.
Reproducibility Acute pharmacologic models of generalized absence seizures are user friendly and quite reproducible. These acute models are particularly useful for illustrating the EEG correlates of absence to young scientists newly interested in epilepsy. Also, these models can be used to formulate hypotheses of mechanisms of epileptogenesis in absence seizures. The chronic models are also highly reproducible, although they require careful and timely administrations of either MAM at G 15 or AY at P2, P8, P14, and P20 to obtain 100% reproducibility of an accurate experimental representation of refractory atypical absence seizures with neuronal heterotopias (MAM-AY) or atypical absence seizures alone AY). The spontaneous occurrence of chronic SSWDs in these models is remarkably constant and age dependent, as described already. SSWD onset as early as P21, with maximum peak of atypical absence seizures during adulthood, is followed by severe exacerbation of SSWDs associated with similar seizure type and head clonus at the frequency of SSWDs, which is at 4 to 6 Hz. The reproducibility of the acquired chronic models is comparable only to that of the genetic models of absence epilepsy (Table 5).
Age-Related Effects The AEDs must be tested during development because it may not be possible to extrapolate age-specific anticonvulsant effects from studies in adult animals (Veliskova et al., 1996). Chronic postnatal administration of 1-phenylcyclohexylpiperidine (phencyclidine, or PCP), a NMDA channel blocker, alters PTZ-induced seizure susceptibility in an agedependent manner, leading to long-term changes that persist into adulthood (Sircar et al., 1994). GHB in threshold doses of 100 mg/kg was observed to produce bilaterally synchronous SWDs in rats initially at P18. Earlier than that, GHB produces varying degrees of slowing and, in very young animals, a profound burst suppression seen only at doses greater than 200 mg/kg in adult animals (Snead, 1984b, 1994). This ontogeny is similar to the developmental profile of the low-dose PTZ model of typical absence seizures (Schickerova et al., 1984) and the AY 9944 model of atypical absence epilepsy (Cortez et al., 2001). Seizure onset in the AY model occurs at postnatal day 21 (Cortez et al., 2001; Persad et al., 2002).
121
Limitations
TABLE 5 Experimental Rat Models of Absence Seizures Compared with Those of Clinical Absence Seizures Typical
Atypical
Experimental Features General Reproducibility Standardized, quantitative Appropriate ontogeny Strain/Ethnic differences Gender differences Other seizure typesa Associated cognitive deficitsa Neurophysiologic Bilaterally synchronous SWD SWD frequencya, Hz SWD from thalamus and cortex SWD from hippocampusa Spontaneous, recurrent SWD Recurrent spontaneous absences
Experimental
GAERS
GHB
Clinical CTAE
AY-9944
MAM-AY
Clinical CAAS
+ + + -
+ + + ND ND -
NA NA NA NA -
+ + + + + + +
+ + + ND ND + +
NA NA NA + + +
+ 7–11 + -
+ 7–9 + -
+ 3 + ND
+ 4–6 + +
+ 4–6 + +
+ 1.5 ND +
+
Behavioral Immobility, staring and myoclonus Precise EEG/behavioral correlationa Movement during SWDa SWD and myoclonus during sleep
+ + -
+ + -
+ + + -
+ + + +
+ + + +
+ + +
Pharmacologic Blocked by ETX, VPA, TMD Exacerbated by GABAA, B R agonists Blocked by GABABR antagonists
+ + +
+ + +
+ + +
+ + +
+ +
+ + ND
a Characteristics that separate atypical absence seizures from typical absence seizures. These are also the features that define the AY-9944 and the MAM-AY treated rats as models of atypical absence epilepsy. AY-9944, AY; CAAS, Chronic Atypical Absence Seizures; CTAE, Clinical typical absence epilepsy; ETX, ethosuximide; GABAA, B R, Receptors; GAERS, Genetic Absence Epilepsy in Rats from Strasbourg; GHB, gamma-hydroxybutyrate model; MAM, methylazoxymethanol acetate; NA, non applicable; ND, no clinical data; SWD, spike-and-wave discharge; TMD, trimethadione; VPA, valproic acid. Modified from Cortez et al; 2001.
Need for Future Development to Improve the Model or Characterize its Features Common strategies used currently for both the development of antiepileptic drugs and the investigation of the basic pathogenesis of epilepsy entail the use of animal models of seizures that are known to respond to currently marketed antiepileptic drugs (White, 2002). Numerous problems have emerged with this approach (Serbanescu et al., 2004). First, the question arises about the utility of existing models in discovering novel and efficacious antiepileptic drugs. The use of standard animal models of seizures in adult rodents (e.g., electroshock, pentylenetetrazole, kindling, strychnine) to screen for anticonvulsant efficacy and a spectrum of seizures against which the potential AED is effective has become a self fulfilling prophecy. Putative AEDs shown to be efficacious against seizures in these animal-model screens have proven to be possessed of a clinical efficacy similar to other drugs that have been predicted to be effective by the animal
models. The data to support this supposition are that the rates of remission in patients who receive an established AED are similar to those who are treated with a new AED (Kwan and Brodie, 2000). Therefore the likelihood is remote that new drugs developed with existing strategies utilizing standard animal models will be beneficial for the 30% of patients with medically refractory epilepsy. The second problem with current strategies of AED development is the unlikelihood that the use of the standard models will give rise to new insights into clinically relevant pathogenic processes involved in epileptogenesis. There are at least three reasons for this concern. First, acute animal models of seizures lend themselves to hypothesis testing that addresses the underlying seizure events and not epileptogenesis, the latter requiring an animal to have spontaneous, recurrent seizures over a long period. Second, the fundamental question of what makes epilepsy refractory cannot be addressed with an animal model that responds to known AEDs. Finally, existing models that utilize adult animals do
122
Chapter 10/Pharmacologic Models of Generalized Absence Seizures in Rodents
not address the unique problems of medically refractory epilepsy in children, in whom it is highly likely that the refractoriness of the epilepsy is related to a perturbation in brain development. Selection criteria for laboratory models of intractable epilepsy have been proposed (Löscher, 1997), including similarity to the clinical condition, paroxysmal EEG abnormalities associated with the behavioral ictal event in the animal, resistance of the seizures to standard AEDs, and the ability to use the putative model for long-term studies on anticonvulsant drug efficacy. The MAM-AY model meets all these criteria (Serbanescu et al., 2004). An additional advantage is that the MAM-AY model is uniquely applicable to the investigation of refractory epilepsy in children. Specifically, the MAM-AY model of medically refractory epilepsy is particularly relevant to the Lennox-Gastaut syndrome in children. The ictal event in the MAM-AY model consists of spontaneous recurrent, medically refractory atypical absence seizures that occur in the presence of a congenitally dysplastic brain, a finding observed in 75% of patients with the Lennox-Gastaut syndrome (Sillinpää, 1995; Zifkin, 1990).
INSIGHTS INTO HUMAN DISORDERS Underlying Mechanisms Primary Generalized Epilepsies In both rodent and feline models of absence seizures, the evidence suggests that the mechanisms that underlie the SWD bursts that characterize this seizure type may be related to the thalamocortical mechanism that mediates spindles and recruiting responses (Crunelli and Leresche, 2002). Seizures with SWD complexes preferentially evolve from sleep oscillations. They are initiated in the neocortex and spread to the thalamus after a few seconds (Sitnikova and Van Luijtelaaar, 2004; Steriade and Amzica, 2003; Timofeev et al., 2004). Because human (Williams, 1953) and animal data both strongly suggest that generalized absence seizures arise from aberrant thalamocortical rhythms, it may prove helpful to consider the functional aspects of thalamocortical circuitry. The EEG is state dependent because the electrical activity of mammalian forebrain as recorded on the EEG varies with the state of consciousness. When the animal is alert, the EEG is characterized by desynchronization or a replacement of synchronized rhythms by lower amplitude and faster wave forms. Alternatively, certain altered states of consciousness (e.g., slow-wave sleep) are associated with synchronous EEG activity, such as high-amplitude oscillations with relatively slow frequencies (Avoli et al., 1993; Steriade et al., 1990). These state related alterations in EEG are a reflection of fundamental and dynamic underlying changes
in the activity of forebrain neurons in response to interplay between the intrinsic activity of thalamocortical circuitry with ascending neurotransmitter systems that project on thalamocortical structures (Steriade et al., 1990). The regional distribution of GHB-induced SWD has been determined by the use of EEG mapping and lesional studies. To carry out the EEG mapping studies, bipolar depth electrodes were implanted in discrete regions of thalamus, cortex, and hippocampus in rat. With the advent of GHBinduced absence seizures, the ventroposterolateral (VPL), ventroposteromedial (VPM), medial, and reticular nuclei (RT) of the thalamus discharged synchronously with layers I through IV of cerebral cortex. No SWDs were recorded from deeper layers (V–VI) of cerebral cortex. Hippocampal structures were completely silent during the GHB-induced SWDs (Banerjee et al., 1993). The effect of bilateral electrolytic lesions of various thalamic nuclei on the GHB-induced absence seizures also has been determined. Bilateral lesions in mediodorsal (MD) and intralaminar thalamic nuclei abolished GHB-induced SWDs from both the cortex and the thalamus. Bilateral lesions of the VPL and RT suppressed but did not eliminate GHBinduced SWDs. The emanation of SWD from superficial layers of cortex during GHB-induced absence suggests that the projections from mediodorsal thalamic nuclei to those superficial cortical laminae rich in [3H]GHB binding sites form an integral part of thalamocortical circuitry involved in GHB-induced absence seizures (Banerjee and Snead, 1994; Banerjee et al., 1993). Other subcortical structures such as the mamillary bodies and their projections (Mirski and Ferrendelli, 1986; Mirski et al., 1986), the superior colliculus (Depaulis et al., 1990), and the substania nigra (Depaulis et al., 1988a, b, 1989) may also have an important role in generalized absence seizures experimentally, but their involvement in human absence has yet to be established. Symptomatic Generalized Epilepsies Recent experimental observations involving the chronic model of atypical absence seizures led us to revisit the clinical spectrum of atypical absence seizures. We concluded that differentiation between children with only atypical absence seizures and children with multiple seizure types may be useful with respect to potential academic ability (Nolan et al., 2004). Human atypical absence seizures produce a 1 to 2-Hz SSWD that is concomitant with other abnormal background activity. Although patients with atypical absence do not have an aura or postictal state, the behavioral arrest is not sudden. The gradual entrance into ictal state prevents the patient from losing complete consciousness; thus some mobility and interaction with others can occur. During the seizure, the patient may become atonic or have other seizure types, such as tonic or clonic activity.
References
Atypical absence seizures are not as easily controlled by AEDs and frequently become intractable to drug treatment. The prognosis is usually poor, and patients are usually developmentally delayed, often displaying neurologic and cognitive deficits. Both clinical and experimental data indicate that the hippocampus may play a substantial role in epileptogenesis and cognitive outcome (Chan et al., 2004; Nolan et al., 2004). A great dead of work on the chronic models will be required to determine the molecular perturbations that lead to the SSWD and cognitive impairment associated with atypical absence seizures. Loss of selective types of interneurons, alteration of GABA receptor configuration, or a decrease in dendritic inhibition could contribute to the development of spontaneous seizures (Morimoto et al., 2004).
Usefulness for Treatment Assessment, Development, and Screening Animal and human data suggest that generalized seizures involve selective thalamocortical networks. We are confident that a greater understanding of these molecular and network mechanisms will ultimately lead to improved targeted therapies for generalized epilepsy (Blumenfeld, 2003). For example, the findings that mGluR4 knockout mice are resistant to absence seizures induced by low doses of GABAAR antagonists and that this phenotype is reproduced by the intra-nRT administration of an mGluR4 antagonist suggest that mGluR4 antagonists may potentially be useful in the treatment of absence epilepsy.
References Abo, M., Suzuki, M., Senoo, A., Miyano, S., Yamauchi, H., Yonemoto, K., Watanabe, S. et al. 2004. Influence of isoflurane concentration and hypoxia on functional magnetic resonance imaging for the detection of bicuculline-induced neuronal activation. Neurosignals 13: 144–149. Avoli, M. l980. Electroencephalographic and pathophysiological features of rat parenteral penicillin epilepsy. Exp Neurol 69: 373–382. Avoli, M., Gloor, P., Kostopoulos, G., and Gotman, J. 1993. An analysis of penicillin-induced generalized spike and wave discharges using simultaneous recordings of cortical and thalamic single neurons. J Neurophysiol 50: 819–837. Banerjee, P.K., and Snead, O.C. III. 1994. Thalamic mediodorsal and intralaminar nuclear lesions disrupt the generation of experimentally induced generalized absence-like seizures in rats. Epilepsy Res 17: 193–205. Banerjee, P.K., and Snead, O.C. III. 1995. Presynaptic g-hydroxybutyric acid (GHB) and g aminobutyric acid b(GABAB) receptor-mediated release of GABA and glutamate (GLU) in rat thalamic ventrobasal nucleus (VB): a possible mechanism for the generation of absence-like seizures induced by GHB. J Pharmacol Exp Ther 273: 1534–1543. Banerjee, P.K., and Snead, O.C. III. 1998. Neuroactive steroids exacerbate g-hydroxybutyric acid-induced absence seizures in rats. Eur J Pharmacol 359: 41–48. Banerjee, P.K., Hirsch, E., and Snead, O.C. III. 1993. g-Hydroxybutyric acid induced spike and wave discharges in rats: relation to high affin-
123
ity [3H]-g-hydroxybutyric acid binding sites in the thalamus and cortex. Neuroscience 56: 11–21. Banerjee, P.K., Liu, C.C., and Snead, O.C. III. 1998a. Steroid inhibition of [3H]g-hyddroxybutyric acid (GHB) binding in thalamic relay nuclei increase during absence seizures. Brain Res 813: 343–350. Banerjee, P.K., Olsen, R.W., Tillakaratne, N.J., Brailowsky, S., Tobin, A.J., and Snead, O.C. III. 1998c. Absence seizures decrease steroid modulation of t-[35S]butylbicyclophosphorothionate binding in thalamic relay nuclei. J Pharmacol Exp Ther 287: 766–772. Banerjee, P.K., Tillakaratne, N.J., Brailowsky, S., Olsen, R.W., Tobin, A.J., and Snead, O.C. III. 1998b. Alterations in GABAA receptor alpha 1 and alpha 4 subunit mRNA levels in thalamic relay nuclei following absence-like seizures in rats. Exp Neurol 154: 213–223. Bearden, L.J., Snead, O.C. III, Healy, C.T., and Pegram, G.V. l980. Antagonism of gamma hydroxybutyrate-induced frequency shifts in the cortical EEG of rats by dipropylacetate. Electroencephalogr Clin Neurophysiol 49: 181–183. Blumenfeld, H. 2003. From molecules to networks: cortical/subcortical interactions in the pathophysiology of idiopathic generalized epilepsy. Epilepsia 44(Suppl 2): Suppl 2, 7–15. Browning, R.A., and Nelson, D.K. l986. Modification of electroshock and pentylenetetrazol seizure patterns in rats after pericollicular transections. Exp Neurol 93: 546–556. Buzsaki, G., Bickford, R.G., Ponomareff, G., Thal, L.J, Mandel, R., and Gage, F.H. 1988. Nucleus basalis and thalamic control of neocortical activity in the freely moving rat. J Neurosci 8: 4007–4026. Buzsaki, G., Laszlovszky, I., Lajtha, A., and Vadasz, C. 1990. Spike-andwave neocortical patterns in rats: Genetic and aminergic control. Neuroscience 38: 323–333. Castro, P.A., Pleasure, S.J., and Baraban, S.C. 2002. Hippocampal heterotopia with molecular and electrophysiological properties of neocortical neurons. Neuroscience 114: 961–972. Cenedella, R.J. l980. Concentration dependent effects of AY-9944 and U18666A on sterol synthesis in brain. Variable sensitivities of metabolic steps. Biochem Pharmacol 29: 2751–2574. Chan, K.F.Y., Jia, Z., Murphy, P.A., Burnham, W.M., Cortez, M.A., and Snead, O.C. III. 2004. Learning and memory impairment in rats with chronic atypical absence seizures. Exp Neurol 190: 327–335. Coenen, A.M., and Van Luijtelaar, E.L. 1987. The WAG/Rij rat model for absence epilepsy: age and sex factors. Epilepsy Res 1: 297–301. Commission on Classification and Terminology of the International League Against Epilepsy. 1981. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 22: 489–501. Commission on Classification and Terminology of the International League Against Epilepsy. 1989. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30: 389–399. Cornford, E.M., Nguyen, E.V., and Landaw, E.M. 2000. Acute upregulation of blood-brain barrier glucose transporter activity in seizures. Am J Physiol 279: 1346–1354. Cortez, M.A., McKerlie, C., and Snead, O.C. III. 2001. A model of atypical absence seizures: EEG, pharmacology and developmental characterization. Neurology 56: 341–349. Cortez, M.A., Cunnane, S.C., and Snead, O.C. III. 2002. Brain sterols in the AY-9944 rat model of atypical absence seizures. Epilepsia 43: 3–8. Cortez, M.A., Gibson, M.K., and Snead, O.C. III. 2004. SSADH deficient mice: EEG, pharmacology and developmental characterization. Epilepsia 45(Suppl 7): 41. Cox, G.A., Lutz, C.M., Yang, C.L., Biemesderfer, D., Bronson, R.T., Fu, A., Aronson, P.S., et al. 1997. Sodium/hydrogen exchanger gene defectin slow-wave epilepsy mutant mice. Cell 91: 139–148. Crunelli, V., and Leresche, N. 2002. Childhood absence epilepsy: genes channels, neurons, and networks. Nat Rev Neurosci 3: 371–382.
124
Chapter 10/Pharmacologic Models of Generalized Absence Seizures in Rodents
Depaulis, A., Bourguignon, J., Marescaux, C., Vergnes, M., Schmitt, M., Micheletti, G., and Warter, J.M. 1988a. Effect of gamma-hydroxybutyrate and gamma-butyrolactone derivatives on spontaneous generalized non-convulsive seizures in the rat. Neuropharmacology 27: 683–689. Depaulis, A., Vergnes, M., Marescaux, C., Lannes, B., and Warter, J.M. 1988b. Evidence that activation of GABA receptors in the substantia nigra suppresses spontaneous spike-and-wave discharges in the rat. Brain Res 448: 20–29. Depaulis, A., Snead, O.C. III, Marescaux, C., and Vergnes, M. 1989. Suppressive effects of intranigral injection of muscimol in three models of generalized non-convulsive epilepsy induced by chemical agents. Brain Res 498: 64–72. Depaulis, A., Liu, Z., Vergnes, M., Marescaux, C., Micheletti, G., and Warter, J.M. 1990. Suppression of spontaneous generalized non-convulsive seizures in the rat by microinjection of GABA antagonists into the superior colliculus. Epilepsy Res 5: 192–198. Dufour, F., Koning, E., and Nehlig, A. 2003. Basal levels of metabolic activity are elevated in Genetic Absence Epilepsy Rats from Strasbourg (GAERS): measurement of regional activity of cytochrome oxidase and lactate dehydrogenase by histochemistry. Exp Neurol 182: 346– 352. Dvornik, D., and Hill, P. 1968. Effects of long term administration of AY9944, an inhibitor of 7-dehydrocholesterol delta 7-reductase on serum and tissue lipids in the rat. J Lipid Res 9: 587–595. el Hamdi, G., Boutroy, M.J., and Nehlig, A. 1992. Effects of pentylenetetrazol-induced seizures on dopamine and norepinephrine levels and on glucose utilization in various brain regions of the developing rat. Int J Dev Neurosci 10: 301–311. Erdogan, F., Golgeli, A., Arman, F., and Ersoy, A.O. 2004. The effects of pentylenetetrazole-induced status epilepticus on behavior, emotional memory, and learning in rats. Epilepsy Behav 5: 388–393. Fariello, R.G. 1979. Action of inhibitory amino acids on acute epileptic foci: an electrographic study. Exp Neurol 66: 55–63. Fariello, R.G., and Golden, G.T. 1987. The THIP induced model of bilateral synchronous spike and wave in rodents. Neuropharmacology 26: 161–165. Ferrer, I., Pozas, E., Marti, M., Blanco, R., and Planas, A.M. 1997. Methylazoxymethanol acetate-induced apoptosis in the external granule cell layer of the developing cerebellum of the rat is associated with strong c-Jun expression and formation of high molecular weight c-Jun complexes. J Neuropathol Exp Neurol 156: 1–9. Fisher, R.S., and Prince, D.A. 1977. Spike-wave rhythms in cat cortex induced by parenteral penicillin. II. Cellular features. Elecrtoencephalogr Clin Neurophysiol 42: 625–639. Gloor, P. 1984. Electrophysiology of generalized epilepsy. In Electrophysiology of Epilepsy. Eds. P.A. Schwartzkroin and H.V. Wheal. pp. 107–136. London: Academic Press. Gloor, P., and Testa, G. 1974. Generalized penicillin epilepsy in the cat: effects of intracarotid and intravertebral pentylenetetrazol and amobarbital injections. Electroencephalogr Clin Neurophysiol 36: 499–515. Gloor, P., and Fariello, R.G. 1988. Generalized epilepsy: some of its cellular mechanisms differ from those of focal epilepsy. Trends Neurosci 11: 63–68. Godschalk, M., Dzoljic, M.R., and Bonta, I.L. 1977. Slow wave sleep and a state resembling absence epilepsy induced in the rat by gammahydroxybutyrate. Eur J Pharmacol 44: 105–111. Gofflot, F., Gaoua, W., Bourguignon, L., Roux, C., and Ricard, J.J. 2001. Expression of Sonic Hedgehog downstream genes is modified in rat embryos exposed in to a distal inhibitor of cholesterol biosynthesis. Dev Dyn 220: 99–111. Guberman, A., Gloor, P., and Sherwin, A.L. 1975. Response of generalized penicillin epilepsy in the cat to ethosuximide and diphenylhydantoin. Neurology 25: 758–764.
Hosford, D.A. 1999. Animal models of nonconvulsive status epilepticus. J Clin Neurophysiol 16: 306–313. Hu, R.Q., Banerjee, P.K., and Snead, O.C. III. 2000. Regulation of gammaaminobutyric acid (GABA) release in cerebral cortex in the gammahydroxybutyric acid (GHB) model of absence seizures in rat. Neuropharmacology 39: 427–439. Hu, R.Q., Cortez, M.A., Man, H.Y., Roder, J., Jia, Z., Wang, Y.T., and Snead, O.C. III. 2001a. Gamma-hydroxybutyric acid-induced absence seizures in GluR2 null mutant mice. Brain Res 897: 27–35. Hu, R.Q., Cortez, M.A., Man, H.Y., Wang, Y.T., and Snead, O.C. III. 2001b. Alteration of GluR2 expressoin in the rat brain following absence seizures induced by gamma-hydroxybutyric acid. Epilepsy Res 44: 41–51. International League Against Epilepsy Commission Report. 2001. A proposed diagnostic schema for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia 42: 796–803. Issandou, M., Guillard, R., Boullay, A.B., Linhart, V., and Lopez-Perez, E. 2004. Up-regulation of low-density lipoprotein receptor in human hepatocytes is induced by sequestration of free cholesterol in the endosomal/lysosomal compartment. Biochem Pharmacol 67: 2281– 2289. Kaplan, B.J. 1985. The epileptic nature of rodent electrocortical polyspiking is still unproven. Exp Neurol 88: 425–436. Kelly, P.A., and McCulloch, J. 1982. Effects of the putative GABAergic agonists, muscimol and THIP, upon local cerebral glucose utilisation. J Neurochem 39: 613–624. Kim, D., Song, I., Keum, S., Lee, T., Jeong, M.J., Kim, S.S., McEnery, M.W., et al. 2001. Lack of the burst firing of thalamocortical relay neurons and resistance to absence seizures in mice lacking a1G T-type Ca-2+channels. Neuron 31: 35–45. Kleinlogel, H. 1985. Spontaneous EEG paroxysms in the rat: effects of psychotropic and alpha-adrenergic agents. Neuropsychobiology 13: 206–213. Krsek, P., Mikulecka, A., Druga, R., Hlinak, Z., Kubova, H., and Mares, P. 2001. An animal model of nonconvulsive status epilepticus: a contribution to clinical controversies. Epilepsia 42: 171–180. Kupferberg, H. 2001. Animal models used in the screening of antiepileptic drugs. Epilepsia 42(Suppl 4): 7–12. Kwan, P., and Brodie, M.J. 2000. Early identification of refractory epilepsy. N Engl J Med 342: 314–319. Librizzi, L., DeGrazia, U., Corci, D., and de Curtis, M. 2005. Barbiturate washout in an isolated guinea-pig brain preparation. Neurosci Lett 380: 66–69. Löscher, W. 1997. Animal models of intractable epilepsy. Prog Neurobiol 53: 239–258. Marescaux, C., Micheletti, G., Vergnes, M., Depaulis, A., Rumbach, L., and Warter, J.M. 1984. A model of chronic spontaneous petit mal-like seizures in the rat: comparison with pentylenetetrazole-induced seizures. Epilepsia 25: 326–331. McCormick, D.A., and Bal, T. 1997. Sleep and arousal: thalamocortical mechanisms. Annu Rev Neurosci 20: 185–215. McQueen, J.K., and Woodbury, D.M. 1975. Attempts to produce spike wave complexes in the electrocorticogram of the rat. Epilepsia 16: 295–299. McIntyre, D.C., Poulter, M.O., and Gilby, K. 2002. Kindling: some old and some new. Epilepsy Res 50: 79–92. Meldrum, B. 2002. Do preclinical seizure models preselect certain adverse effects of antiepileptic drugs. Epilepsy Res 50: 33–40. Mirski, M.A., and Ferrendelli, J.A. 1986. Anterior thalamic mediation of generalized pentylenetetrazol seizures. Brain Res 399: 212–223. Mirski, M.A., McKeon, A.C., and Ferrendelli, J.A. 1986. Anterior thalamus and substantia nigra: two distinct structures mediating experimental generalized seizures. Brain Res 397: 377–380.
References Mody, I., and Schwartzkroin, P.A. 1997. Acute seizure models (intact animals). In Epilepsy A Comprehensive Textbook, vol I. Eds. J. Engel, Jr., and T.A. Pedley. pp. 397–404. Philadelphia: Lippincott-Raven. Morimoto, K., Fahnestock, M., and Racine, R.J. 2004. Kindling and status epilepticus models of epilepsy: rewiring the brain. Prog Neurobiol 73: 1–60. Mueggler, T., Baumann, D., Rausch, M., and Rudin, M. 2001. Bicucullineinduced brain activation in mice detected by functional magnetic resonance imaging. Magn Reson Med 46: 292–298. Nehlig, A., and Pereira de Vasconcelos, A. 1996. The model of pentylenetetrazol-induced status epilepticus in the immature rat: short-and longterm effects. Epilepsy Res 26: 93–103. Nehlig, A., Vergnes, M., Marescaux, C., Boyet, S., and Lannes, B. 1991. Local cerebral glucose utilization in rats with petit mal-like seizures. Ann Neurol 29: 72–77. Nehlig, A., Vergnes, M., Marescaux, C., and Boyet, S. 1993. Cerebral energy metabolism in rats with genetic absence epilepsy is not correlated with he pharmacologic increase or suppression of spike-wave discharges. Brain Res 618: 1–8. Nehlig, A., Vergnes, M., Boyet, S., and Marescaux, C. 1998a. Local cerebral glucose utilization in adult and immature GAERS. Epilepsy Res 32: 206–212. Nehlig, A., Vergnes, M., Boyet, S., and Marescaux, C. 1998b. Metabolic activity is increased in discrete brain regions before the occurrence of spike-and-wave discharges in weanling rats with genetic absence epilepsy. Brain Res Dev Brain Res 108: 69–75. Nersesyan, H., Hyder, F., Rothman, D.L., and Blumenfeld, H. 2004. Dynamic fMRI and EEG recordings during spike-wave seizures and generalized tonic-clonic seizures in WAG/Rij rats. J Cereb Blood Flow Metab 24: 589–599. Nolan, M., Bergazar, M., Chu, B., Cortez, M.A., and Snead, O.C. III. 2004. The clinical and neurophysiological spectrum associated with atypical absence seizures. J Child Neurol 20(5): 404–410. Palacios, J.M., Kuhar, M.J., Rapoport, S.I., and London, E.D. 1982. Effects of gamma-aminobutyric acid agonist and antagonist drugs on local cerebral glucose utilization. J Neurosci 2: 853–860. Penschuck, S., Luscher, B., Fritschy, J.M., and Crestani, F. 1997. Activation of the GABA(A)-receptor delta-subunit gene promoter following pentylenetetrazole-induced seizures in transgenic mice. Brain Res Mol Brain Res 51: 212–219. Persad, V., Cortez, M.A., and Snead, O.C. III. 2002. A chronic model of atypical absence seizures: studies of developmental and gender sensitivity. Epilepsy Res 48: 111–119. Popa-Wagner, A., Fischer, B., Platt, D., Schmoll, H., and Kessler, C. 2000. Delayed and blunted induction of mRNA for tissue plasminogen activator in the brain of old rats following pentylenetetrazole-induced seizure activity. J Gerontol A Biol Sci Med Sci 55: 242–248. Quesney, L.F. 1984. Pathophysiology of generalized photosensitive epilepsy in the cat. Epilepsia 25: 61–69. Racine, R. 1972a. Modification of seizure activity by electrical stimulation. I. After-discharge thresholds. Electroencephalogr Clin Neurophysiol 32: 269–279. Racine, R. 1972b. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 32: 281–294. Riban,V., Pereira de Vasconcelos, A., Pham-Le, B.T., Ferrandon, A., Marescaux, C., Nehlig, A., and Depaulis, A. 2004. Modifications of local cerebral glucose utilization in thalamic structures following injection of a dopaminergic agonist in the nucleus accumbens–involvement in antiepileptic effects? Exp Neurol 188: 452–460. Rogawski, M.A., and Loscher, W. 2004. The neurobiology of antiepileptic drugs. Nat Rev Neurosci 5: 553–564. Roth, R.H., and Giarman, N.J. 1966. g-butyrolactone and g-hydroxybutyric acid. I. Distribution and metabolism. Biochem Pharmacol 15: 1331–1348.
125
Roth, R.H., and Giarman, N.J. 1969. Conversion in vivo of gammaaminobutyric acid to gamma-hydroxybutyrate in the rat. Biochem Pharmacol 18: 247–250. Roth, R.H., Delgado, J.M.R., and Giarman, N.J. 1966. g-Hydroxybutyric acid and g-butyrolactone. The metabolically active form. Int J Neuropharmacol 5: 421–428. Roth, R.H., Levy, R., and Giarman, N.J. 1967. Dependence of rat serum lactonase upon calcium. Biochem Pharmacol 16: 596–598. Schickerova, R., Mares, P., and Trojan, S. 1984. Correlation between electrocorticographic and motor phenomena induced by pentylenetetrazol during ontogenesis in rats. Exp Neurol 84: 153–164. Serbanescu, I., Cortez, M.A., McKerlie, C., and Snead, O.C. III. 2004. Refractory atypical absence seizures in rat: a two hit model. Epilepsia Res. 62(1): 53–63. Sillinpää, M. 1995. Epidemiology of intractable epilepsy in children. In Intractable Epilepsy. Eds. S.I. Johannessen, L. Gram, M. Sillinpää, and T. Tomson. pp.13–25. Petersfield, UK: Wrightson Biomedical Publishing. Sircar, R., Veliskova, J., and Moshe, S.L. 1994. Chronic neonatal phencyclidine treatment produces age-related changes in pentylenetetrazolinduced seizures. Brain Res Dev Brain Res 81: 185–191. Sitnikova, E., and van Luijtelaar, G. 2004. Cortical control of generalized absence seizures: effect of lidocaine applied to the somatosensory cortex in WAG/Rij rats. Brain Res 1012: 127–137. Smith, K.A., and Bierkamper, G.G. 1990. Paradoxical role of GABA in a chronic model of petit mal (absence)-like epilepsy in the rat. Eur J Pharmacol 176: 45–55. Snead, O.C. III. 1978a. Gammahydroxybutyrate in the monkey. I. Electroencephalographic, behavioral, and pharmacokinetic studies. Neurology 28: 636–642. Snead, O.C. III. 1978b. Gammahydroxybutyrate in the monkey. II. Effect of chronic oral anticonvulsant drugs. Neurology 28: 643–648. Snead, O.C. III. 1978c. Gammahydroxybutyrate in the monkey. III. Effect of intravenous anticonvulsant drugs. Neurology 28: 1173–1178. Snead, O.C. III. 1984a. Gamma-hydroxybutyric acid, gamma-aminobutyric acid and petit mal epilepsy. In Neurotransmitters, Seizures, and Epilepsy, vol II. Eds. R.G. Fariello, P.L. Morselli, K.G. Lloyd, L.F. Quesney, and J. Engel. pp. 37–38. New York: Raven Press. Snead, O.C. III. 1984b. Ontogeny of gamma-hydroxybutyric acid. II. Electroencephalographic effects. Brain Res 317: 89–96. Snead, O.C. III. 1988. The g-hydroxybutyrate model of generalized absence seizures: further characterization and comparison to other absence models. Epilepsia 29: 361–368. Snead, O.C. III. 1990. The ontogeny of GABAergic enhancement of the gamma-hydroxybutyrate model of generalized absence seizures. Epilepsia 31: 363–368. Snead, O.C. III. 1991. The g-hydroxybutyrate model of absence seizures: correlation of regional brain levels of g-hydroxybutyric acid and gbutyrolactone with spike-wave discharges. Neuropharmacology 30: 161–167. Snead, O.C. III. 1994. The ontogeny of [3H]gamma-hydroxybutyrate and [3H]GABAB binding sites: relation to the development of experimental absence seizures. Brain Res 659: 147–156. Snead, O.C. III. 1995. Basic mechanisms of generalized absence seizures. Ann Neurol 37: 146–147. Snead, O.C. III. 1996. Antiabsence seizure activity of specific GABAB and g-hydroxybutyric acid receptor antagonists. Pharmacol Biochem Behav 53: 73–79. Snead, O.C. III. 2002. g-Hydroxybutyric acid and absence seizure activity. In Gamma Hydroxybutyrate. Eds. G. Tunnicliff, C.D. Cash. pp. 132–141. New York: Taylor and Francis. Snead, O.C., III, and Liu, C.C. 1993. GABAA receptor function in the ghydroxybutyrate model of generalized absence seizures. Neuropharmacology 32: 401–409.
126
Chapter 10/Pharmacologic Models of Generalized Absence Seizures in Rodents
Snead, O.C. III, and Cortez, M.A. 1999. Ontogeny of spike and wave discharge (SWD) in the chronic model of atypical absence seizures. Neurology 52: A49. Snead, O.C. III, Yu, R.K., and Huttenlocher, P.R. 1976. Gamma-hydroxybutyrate. Correlation of serum and cerebrospinal fluid levels with electroencephalographic and behavioral effects. Neurology 26: 51–56. Snead, O.C. III, Bearden, L.J., and Pegram, V. 1980. Effect of acute and chronic anticonvulsant administration on endogenous gamma-hydroxybutyrate in rat brain. Neuropharmacology 19: 47–52. Snead, O.C. III, Depaulis, A., Vergnes, M., and Marescaux, C. 1999. Absence epilepsy: advances in experimental animal models. Adv Neurol 79: 253–278. Snead, O.C. III, Banerjee, P.K., Burnham, M., and Hampson, D. 2000. Modulation of absence seizures by the GABA(A) receptor: a critical role for metabotropic glutamate receptor 4 (mGluR4). J Neurosci 20: 6218–6224. Steriade, M., Amzica, F. 2003. Sleep oscillations developing into seizures in corticothalamic systems. Epilepsia 44(Suppl 12): 9–20. Steriade, M., and Llinas, R.R. 1988. The functional states of the thalamus and the associated neuronal interplay. Physiol Rev 68: 649–742. Steriade, M., Gloor, P., Llinas, R.R., Lopes da Silva, F.H., and Mesulam, M.M. 1990. Basic mechanisms of cerebral rhythmic activities. Electroencephalogr Clin Neurophysiol 76: 481–508. Talley, E.M., Solorzano, G., Depaulis, A., Perez-Reyes, E., and Bayliss, D.A. 2000. Low-voltage-activated calcium channel subunit expression in a genetic model of absence epilepsy in the rat. Brain Res Mol Brain Res 175: 159–165. Taylor-Courval, D., and Gloor, P. 1984. Behavioral alterations associated with generalized spike and wave discharges in the EEG of the cat. Exp Neurol 83: 167–186. Tenney, J.R., Duong, T.Q., King, J.A., and Ferris, C.F. 2004. FMRI of brain activation in a genetic rat model of absence seizures. Epilepsia 45: 576–582. Timofeev, I., Grenier, F., and Steriade, M. 2004. Contribution of intrinsic neuronal factors in the generation of cortically driven electrographic seizures. J Neurophysiol 92: 1133–1143. Tsakiridou, E., Bertolini, L., DeCurtis, M., Avanzini, G., and Pape, H.C. 1995. Selective increasein T-type calcium conductance of reticular thalamic neurons in a rat model of absence epilepsy. J Neurosci 153: 3110–3117. van de Bovenkamp-Janssen, M.C., Scheenen, W.J., Kuijpers-Kwant, F.J., Kozicz, T., Veening, J.G., van Luijtelaar, E.L., McEnery, M.W. et al.
2004. Differential expression of high voltage-activated Ca2+ channel types in the rostral reticular thalamic nucleus of the absence epileptic WAG/Rij rat. J Neurobiol 58: 467–478. Vanderwolf, C.H. 1975. Neocortical and hippocampal activation in relation to behavior effects of atropine, eserine, phenothiazines, and amphetamine. J Comp Physiol Psychol 88: 300–323. Veliskova, J., Velisek, L., and Moshe, S.L. 1996. Age-specific effects of baclofen on pentylenetetrazol-induced seizures in developing rats. Epilepsia 37: 718–722. Vergnes, M., Marescaux, C., Micheletti, G., Rumbach, L., and Warter, J.M. 1985. Blockade of “antiabsence” activity of sodium valproate by THIP in rat model of genetic petit mal-like seizures. Comparison with ethosuximide. J Neural Transm 63: 133–141. Vergnes, M., Marescaux, C., Depaulis, A., Micheletti, G., and Warter, J.M. 1990. The spontaneous spike and wave discharges in Wistar Rats: a model of genetic generalized nonconvulsive epilepsy. In Generalized Epilepsy: Neurobiological Approaches. Eds. M. Avoli, P. Gloor, G. Kostopoulos, and R. Naquet. pp. 238–253. Boston: Birkhauser. White, H.S. 2002. Animal models of epileptogenesis. Neurology 59(Suppl 5): S7–S14. Williams, D. 1953. A study of thalamic and cortical rhythms in petit mal. Brain 76: 50–69. Wong, M., Wozniak, D.F., and Yamada, K.A. 2003. An animal model of generalized nonconvulsive status epilepticus: immediate characteristics and long-term effects. Exp Neurol 183: 87–99. Wu, J., Ellsworth, K., Ellsworth, M., Schroeder, K.M., Smith, K., and Fisher, R.S. 2004. Abnormal benzodiazepine and zinc modulation of GABAA receptors in an acquired absence epilepsy model. Brain Res 1013: 230–240. Yount, G.L., Ponsalle, P., and White, J.D. 1994. Pentylenetetrazole-induced seizures stimulate transcription of early and late response genes. Brain Res Mol Brain Res 21: 219–224. Zhang, X., Ju, G., and Le Gal La Salle, G. 1991. Fos expression in GHBinduced generalized absence epilepsy in the thalamus of the rat. Neuroreport 2: 469–472. Zhu, L.J., Chen, Z., Zhang, L.S., Xu, S.J, Xu, A.J., and Luo, J.H. 2004. Spatiotemporal changes of the N-methyl-d-aspartate receptor subunit levels in rats with pentylenetetrazole-induced seizures. Neurosci Lett 356: 53–56. Zifkin, B.G. 1990. The Lennox-Gastaut syndrome. In Comprehensive Epileptology. Eds. M. Dam and L. Gram. pp. 123–131. New York: Raven Press.
C
H
A
P
T
E
R
11 Models of Chemically-Induced Acute Seizures ˇEK LIBOR VELÍS
This chapter reviews models of generalized seizures induced by systemic administration or focal application of chemical agents. For some substances, there is an unavoidable overlap with the preceding chapter on absence models or with subsequent chapters on exploring status epilepticus (SE) or the effects of repeated seizures. This chapter intends to help the investigator develop and use a particular model. Chemical agents are organized by the route of administration and then by the prevailing mechanism of action or a major feature. This chapter is not an all-exhaustive review of available convulsive chemicals, however, so references to appropriate reviews are provided (Fisher, 1989; Sarkisian, 2001). Whenever possible, a reference to a general neurotoxicology text that summarizes the neurotoxic effects in the experimental models and in humans is linked (Spencer and Schaumburg, 2000). Because seizures in humans most frequently occur during childhood and I have extensively studied developmental issues of seizure models, special emphasis is placed on developing animals, if such information is available. Significant material for this chapter was retrieved from the lifetime studies of Pavel Maresˇ and his co-workers, whose contributions to the field of developmental seizure models should be acknowledged irrespective of the fact that I worked on my Ph.D. thesis in Pavel Maresˇ’s laboratory.
is the most widely used route to create models of seizures. The procedure is convenient, straightforward, and simple. Sub-Q injection is commonly applied in the skin fold on the back of the neck. A syringe with a small, 25- to 26-gauge, needle is usually sufficient. The onset of action after sub-Q administration of the bolus of the drug is usually slow compared with the same bolus administered IP or IV. The doses producing seizures in 50% of subjects (CD50) usually follow the same order, from highest to the lowest: sub-Q, IP, and IV administration (Petersen, 1983). For IP injection, a larger needle (22- to 23-gauge) is more convenient for its capability to penetrate all involved layers: skin, muscle wall, and peritoneum. After inserting the needle, gentle aspiration will verify whether the inferior vena cava or abdominal aorta has not been hit. If this is the case and the drug is administered, seizures develop within seconds. Some drugs (such as bicuculline) are heavily metabolized in liver and, if the liver enzymatic system is developed, IP doses for the same effect to occur may be substantially higher than sub-Q doses (firstpass effect). For IV administration of the drug, the tail vein is usually used. Administration requires complete restraint of the rat. Effects of the bolus dose will occur faster than after a similar dose administered IP. Sometimes a catheter in the tail is implanted for continuous convulsant drug delivery. This arrangement allows for determining the seizure threshold based on the amount of delivered drug (Orlof et al., 1949). For basic experiments, only experimental animals, a syringe with a needle, a convulsant substance in a solution, and a stopwatch are required. However, stress resulting from the systemic drug administration (e.g., handling, potentially painful injection, etc.) may interfere with the model expression.
SYSTEMIC INJECTION OF CONVULSANT SUBSTANCES Systemic administration (subcutaneous [sub-Q], intraperitoneal [IP], or intravenous [IV]) of convulsant agents
Models of Seizures and Epilepsy
127
Copyright © 2006, Elsevier Inc. All rights of reproduction in any form reserved.
128
Chapter 11/Models of Chemically-Induced Acute Seizures
GABA-Related Substances The g-aminobutyric acid (GABA) drugs are probably the most commonly used. The group of chemicals includes GABAA receptor antagonists, chloride channel blockers, inhibitors of GABA synthesis, convulsant benzodiazepines and drugs with prevailing or suspected effects on the GABAA receptor, including flurothyl, which is commonly administered by inhalation (although IP and IV administrations are also possible) and has certain GABA-related effects. Figure 1 provides a simplified view of a GABAA receptor and the convulsant drugs described here. For a brief overview of the models, see Table 1.
GABA site Bicuculline
Barbiturate site
Cl-
Benzodiazepine site b-Carbolines
Steroid site
Picrotoxin site Picrotoxin Ro 5-3663 TBPS site PTZ
FIGURE 1 Simplified scheme of the g-aminobutyric acid (GABA)A receptor with its binding sites and identified sites of action for some convulsant drugs. PTZ, pentylenetetrazol; TBPS, t-butyl-bicyclo-phosphorothionate.
Behaviorally all these drugs induce different phenomena, depending on the dose, delay after administration, and developmental stage of the experimental animal (for detailed analysis, see Chapter 48). Behavioral phenomena usually occur in the following sequence: (1) freezing behavior, (2) myoclonic twitches, (3) clonic seizures, and (4) tonic-clonic seizures. After high doses of convulsant drugs, the rats usually die. In the electroencephalogram (EEG), four different patterns appear: 1. Isolated spikes. These spikes may be initially focal and eventually may generalize. Sometimes they are associated with mycolonic twitches, but the association is loose. Developing animals are unable to generate spikes. During the first 2 to 3 postnatal weeks, slow and sharp waves are seen instead. 2. Spindles of spike and wave activity. In the rat, this crescendo-decrescendo EEG pattern usually runs with a frequency around 5 to 6 Hz, and it is associated with freezing (motionless stare) behavior. Occurrence of these spindles is developmentally regulated and also depends on the drug used. 3. Decrescendo spike and wave. This pattern is commonly associated with clonic seizures and thus may also be regulated developmentally and depend on the drug. Dissociation of this EEG pattern from behavioral seizures is frequent. 4. Polyspike, polyspike, and wave. This EEG pattern frequently occurs at the beginning of tonic-clonic seizures and is followed by regular spike and wave discharges (SWDs). Early in development, only sharp waves may be present.
TABLE 1 Acute Seizure Models Induced by GABA-Related Drugs in Adult and Immature Rats Administration route
Bolus doses adult rats (mg/kg)a
Bolus doses PN12–18 rats (mg/kg)a
Saline
Sub-Q IP
40–120 40–100
40–100 30–100
0.1 N HCl
IP IV
6–8 1–2
2–4 1–2
Picrotoxin
Saline
IP, IV, sub-Q
4–6
3–4
Isonicotinehydrazide
Saline
IP
300–400
200–400
Drug Pentylenetetrazol (PTZ) Bicuculline
3-Mercaptopropionic acid (3-MPA)
Solubility
Already liquid
IP
30–60
20–60
Allylglycine
Saline
IP
100–250
100–250
b-carbolines
Acetic acid
IP Sub-Q
1–2 1–5
N/A N/A
Ro 5-3663
0.1 N HCl
IP
5–15
5–15
GABA, g-aminobutyric acid; IP, intraperitoneally; IV, intravenously; N/A, information not available; PN, postnatal day; sub-Q, subcutaneously. a See the text for additional information about the correlation of convulsant drug doses and elicited seizure types. Doses for younger ages are available in the text.
Systemic Injection of Convulsant Substances
129
Neuropathology is usually negligible. These drugs are commonly used to produce acute seizures without long-term survival. Although high doses may lead to prolonged tonicclonic seizures, adult animals usually die during these seizures. Minor changes in the cerebellum have been described after convulsions induced by pentylenetetrazol and bicuculline (Ben-Ari et al., 1981b). In adult rats, induction of SE as a prerequisite for occurrence of neuropathologic changes is difficult when using these drugs. However, in immature rats it is possible to sustain SE using repeated administrations of subconvulsive doses (Nehlig and de Vasconselos, 1996; Pereira de Vasconcelos et al., 1995). Resulting neuronal injury is only transient and does not lead to neuronal death (Pineau et al., 1999). Relationship to Human Seizure Disorders Differential features of seizures induced by GABArelated substances can be related to different seizures in humans (Engel, 2001). Thus motionless stare accompanied by rhythmic EEG spindles, which involves thalamocortical circuits, is considered a model of generalized seizures— typical absence seizures (Depaulis et al., 1989). Clonic seizures are considered a model of generalized seizures— myoclonic seizures (Loscher and Schmidt, 1988). Finally, tonic-clonic seizures are believed to represent generalized seizures—tonic-clonic seizures (Sarkisian, 2001).
FIGURE 2 CD50 for clonic and tonic-clonic seizures induced by the subcutaneous administration of pentylenetetrazol (PTZ) during postnatal development of Wistar rats (according to Velísˇek et al., 1992). Mean (M) ± standard error of the mean (SEM) (in mg/kg) are displayed. Clonic seizures were regularly induced by PTZ from the third postnatal week; tonic-clonic seizures occurred throughout development.
Pentylenetetrazol Methods of Generation Originally a cardiostimulant, pentylenetetrazol (Cardiazol, Leptazol, Metrazol, pentamethylenetetrazol, pentetrazol, pentazol), or PTZ, has significant convulsant potency in mice, rats, monkeys, and humans (Reinhard and Reinhard, 1977; Swinyard et al., 1989; Vernadakis and Woodbury, 1969a, b). PTZ-induced clonic seizures represent a routine test for screening anticonvulsants (Swinyard et al., 1989). PTZ freely dissolves in saline or water and can be administered sub-Q, IP (most commonly), or IV (less commonly, usually via the tail vein). Repeated low doses of PTZ administered IP may be used to induce SE in immature rats (Nehlig and de Vasconselos, 1996; Pereira de Vasconcelos et al., 1995). Developmental CD50 levels for clonic and tonicclonic seizures in male Wistar rats are shown in Figure 2 (according to (Velísˇek et al., 1992). CD50 levels for IP and IV administration are lower compared with those of sub-Q doses (Fisher, 1989). For practical purposes, doses around 100 mg/kg IP or sub-Q are usually used. With these doses, seizures develop within 20 minutes after application. Defining Features PTZ induces all four behavioral phenomena: freezing, myclonic twitches, clonic seizures, and tonic-clonic sei-
FIGURE 3 Rhythmic, spindle-shaped discharges induced by a low systemic dose of pentylenetetrazol (PTZ) in a Wistar rat. These discharges with a crescendo-decrescendo pattern were associated with freezing behavior (motionless stare). Electrocorticograms from RF, right frontal (sensorimotor) cortex; RO, right occipital (visual) cortex; LF, left frontal cortex; LO, left occipital cortex.
zures. Twitches and tonic-clonic seizures are recorded throughout development. However, there is limited occurrence of freezing behavior and clonic seizures during the first 2 postnatal weeks of the rat. PTZ-induced seizures can be easily scored according to the appropriate scoring table (see Chapter 48). Graded doses of PTZ in adult rats will induce specific seizures. Thus low doses can be titrated to induce only freezing with underlying EEG spindles (Figure 3), somewhat higher doses for kindling, even higher doses for clonic seizures, and finally doses over 100 mg/kg for tonic-clonic seizures. Using a constant PTZ dose, latency to onset of seizures is also age specific (de Casrilevitz et al., 1971; Velísˇek et al., 1992; Vernadakis and Woodbury, 1969a; Weller and Mostofsky, 1995). The whole spectrum of EEG changes can be observed after PTZ
130
Chapter 11/Models of Chemically-Induced Acute Seizures
administration (Schickerová et al., 1984; Zouhar et al., 1980); however these changes are developmentally regulated: EEG spindles occur from the third postnatal week and beyond (Marescaux et al., 1984; Ono et al., 1990; Schickerová et al., 1984). Metabolic [14C]2-deoxyglucose (2DG) studies demonstrate that there is an increased uptake (ergo metabolic activation) in the motor and limbic cortex after PTZ-induced status epilepticus during the first postnatal week and in the brainstem areas at postnatal day (PN)10. In PN17, PN21, and adult rats, there is a redistribution of glucose uptake from the cortex and hippocampus to the midbrain, brainstem, hypothalamus, and septum (Ben-Ari et al., 1981a; Nehlig et al., 1992; Pereira de Vasconcelos et al., 1992). In young rats (
as a solvent, followed by careful titration using a weak base (0.1 N NaOH) up to the resulting pH of approximately 5.6 (de Feo et al., 1985; Velísˇek et al., 1995). Because of the low final pH, it is recommended that bicuculline solution be administered IP because the sub-Q injection is very painful and stressful. However, IP injection of bicuculline in mature rats may require significantly higher doses than young rats require because of the “first-pass” effect. This disadvantage can be avoided by using IV administration of bicuculline (Zouhar et al., 1989). For IP administration, 2- to 4-mg/kg doses are used for developing rats; 6- to 8-mg/kg doses are used for prepubertal and adult rats (Velísˇková et al., 1990). However, if administered IV, a dose of 2 mg/kg is sufficient for the adult rats (Zouhar et al., 1989). After these doses, seizures occur within 20 minutes. An additional bicuculline model is worth mentioning. A derivative, bicuculline methiodide, is almost freely soluble in saline. However, this compound does not cross the blood-brain barrier. Nevertheless, in developing rats, in which the blood-brain barrier is still imperfect, systemic administration of bicuculline methiodide induces seizures. Required doses are between 2 and 20 mg/kg IP for rats up to PN18 (Maresˇ et al., 2000). Defining Features Bicuculline produces all behavioral phenomena described previously. The EEG pattern also fits the description (Figure 4). The only difference compared with other drugs is that clonic seizures induced by bicuculline begin to occur during the second postnatal week of the rat. Metabolic studies with 2DG identified changes after bicuculline seizures similar to those seen after PTZ seizures (Ben-Ari et al., 1981a). A study using 2DG in paralyzed, ventilated rats, however, did not show any increases in cerebral glucose metabolic rate (Evans and Meldrum, 1984).
FIGURE 4 Example of several episodes of rhythmic, spindle-shaped discharges induced by intraperitoneal administration of bicuculline in a Wistar rat. Discharges were generalized over all cortical recording. Arrows mark these discharges in RF cortical area recording. Electrocorticograms from the RF, right frontal (sensorimotor) cortex; RO, right occipital (visual) cortex; LF, left frontal cortex; LO, left occipital cortex.
Systemic Injection of Convulsant Substances
Limitations The difficulties in dissolving and the acidic pH of the solution, along with the significant first-pass effect somewhat limit the usefulness of systemically administered bicuculline for seizure models. EEG spindles can vary not only as a function of age but also as a function of sex (Mateˇ jovská et al., 1998). Insights into Human Disorders The mechanisms of action of bicuculine are well understood (competitive antagonism at GABA binding site of the GABAA receptor), although additional effects of bicuculline, such as prolongation of Ca2+ action potential and blockade of K+ channels, have been reported (Seutin and Johnson, 1999). Classic anticonvulsant drugs have good effects against bicuculline-induced seizures with superb activity of GABAA receptor-acting drugs, such as benzodiazepines (De Deyn et al., 1992). Except for the well-known mechanism of action, there is no other advantage to using bicuculline over PTZ for screening for anticonvulsant drugs. Picrotoxin Methods of Generation In contrast to bicuculline, picrotoxin (Ludolph and Spencer, 2000) can be dissolved in saline (Velísˇková et al., 1990, 1993), although some groups prefer dissolving in 10% dimethylsulfoxide (Hiscock et al., 1996). Route of administration can be sub-Q, IP, or IV. Doses for IP bolus administration range between 3 and 6 mg/kg through all developmental stages of the rat. Development of seizures is slower than in PTZ and bicuculline. Seizures usually occur within 30 to 40 minutes. Continuous infusion of picrotoxin solution in the jugular vein has been used to characterize regional EEG patterns and the EEG power spectra (Mackenzie et al., 2002). The addition of a small dose of picrotoxin to pilocarpine has been used to intensify development of pilocarpine-induced SE, thus helping to decrease the pilocarpine dose (Hamani and Mello, 1997, 2002). Defining Features Behavioral and EEG patterns after picrotoxin resemble to those found after PTZ and bicuculline administration (Mackenzie et al., 2002). After a single picrotoxin seizure, early gene c-fos expression was found in the frontal and parietal cortex as well as in the piriform and entorhinal cortex. Neurons with c-fos expression were mostly calbindin D28K-positive cells and many of the calcium-binding, protein-unlabeled neurons, which were spiny and presumed excitatory, (Hiscock et al., 1996). Limitations Picrotoxin seizures develop at a slower pace than PTZ and bicuculline seizures, and they also occur less reliably
131
(Velísˇek et al., 1995). However, the very specific mechanism of action (even compared with bicuculline) and the very good solubility provide a small advantage over bicucullineinduced seizures. Insights into Human Disorders Picrotoxin seizures are well defined mechanistically. They arise from GABAA receptor chloride channel blockade. Available data on anticonvulsant drugs suggest a similar efficacy as against bicuculline-induced seizures (Velísˇková et al., 1990; De Deyn et al., 1992; Velísˇková et al., 1993). The usefulness for screening of putative antiepileptic drugs is similar as in bicuculline-induced seizures. Glutamic Acid Decarboxylase (GAD) Inhibitors Methods of Generation The GAD inhibitors (isonicotinehydrazide, 3-mercaptopropionic acid, and allylglycine), which inhibit GABA synthesis, can be potent convulsants. Isonicotinehydrazide can be dissolved in saline in the concentration of 100 mg/ml. Doses used for IP induction of seizures range between 150 and 400 mg/kg throughout development in the rat (Maresˇ and Trojan, 1991). Seizures usually occur within 40 to 60 minutes. 3-Mercaptopropionic acid is a liquid and doses between 30 and 60 mg/kg can be used for IP seizure induction throughout development (Maresˇ et al., 1993). In this model, seizures occur within 10 to 15 minutes at all developmental stages except for the first postnatal week (within 25 to 40 minutes). Finally, allyglycine can be dissolved in saline; and 100 to 250 mg/kg can produce seizures. The solution should be used within 2 hours, though (Horton and Meldrum, 1973; Ashton and Wauquier, 1979, 1981; de Feo et al., 1985; Thomas and Yang, 1991). After this dose, seizures develop between 60 and 80 minutes after administration. Defining Features All drugs invariably induce a sequence of myoclonic twitches as well as clonic and tonic-clonic seizures. In the isonicotinehydrazide model, in younger rats, tonic-clonic seizures continuously follow after clonic seizures (Maresˇ and Trojan, 1991). In the EEG, all drugs induce spikes (sharp waves in immature animals), polyspikes, and spike and wave patterns. In the 3-mercaptopropionic acid model, the correlation between behavioral seizures and EEG (recorded in the neocortex) is poor even in adult rats (Maresˇ et al., 1993). Tonic extension may be pronounced in seizures induced with allylglycine (Thomas and Yang, 1991). During l-allylglycine seizures, there is significantly increased glucose cerebral metabolic rate determined by the 2DG method in the cortex, caudate/putamen, amygdala, hippocampus, thalamus, and inferior colliculus (Evans and
132
Chapter 11/Models of Chemically-Induced Acute Seizures
Meldrum, 1984); however, this study was carried out on paralyzed and ventilated rats.
Beta-carbolines and convulsant benzodiazepine Ro 5-3663 Methods of Generation
Limitations The slow development of isonicotinehydrazide and allylglycine-induced seizures may become inconvenient. Reliability of seizure production is very good for all three drugs. Insights into Human Disorders Figure 5 shows a simplified scheme of GABA synthesis and the effects of main GAD inhibitors. Isonicotinehydrazide (Schröder, 2000) acts most likely via inhibition of the GAD coenzyme pyridoxine (Williams and Bain, 1961; Woodbury, 1980b). 3-Mercaptopropionic acid (Spencer, 2000b) and allylglycine (Ludolph, 2000a) are direct inhibitors of GAD (Lamar, 1970; Horton and Meldrum, 1973; Loscher, 1979; Meldrum et al., 1987). As a result, GABA production is decreased and both GABAA and GABAB receptors are less activated. Use of these models for screening purposes does not provide advantages other than the known mechanisms of action at a particular stage of GABA synthesis.
Isonicotinehydrazide
pyridoxine glutamate
GAD
GABA
3-Mercaptopropionic acid Allylglycine FIGURE 5 Simplified diagram of biosynthesis pathway for g-aminobutyric acid (GABA) with sites of action of some convulsant drugs. X marks a blockade of the enzyme. GAD, glutamic acid decarboxylase.
Among beta-carbolines (Collins and Neafsey, 2000), methyl-b-carboline-3-carboxylate (b-CCM) and methyl6,7-dimethoxyl-4-ethyl-b-carboline (DMCM) were shown to induce convulsions (Braestrup and Nielsen, 1982; Braestrup et al., 1980, 1982; Jensen et al., 1983; Prado de Carvalho et al., 1984). Effective doses of b-CCM are 1 to 10 mg/kg administered IP in mice. CD50 for b-CCM for clonic seizures in mice was calculated at about 1 mg/kg IP (Chapman et al., 1985) and 5 mg/kg sub-Q (Prado de Carvalho et al., 1984). DMCM can be dissolved in minimal amounts of acetic acid and diluted with saline (Chapman et al., 1985). Effective doses of DMCM to elicit clonic seizures in rats are about 1 mg/kg IV (Ableitner and Herz, 1987) and up to 15 mg/kg IP to elicit tonic-clonic seizures in mice (Chapman et al., 1985).The CD50 for clonic seizures in mice is 1.5 mg/kg IP (Chapman et al., 1985). Petersen’s study (Petersen, 1983) demonstrates the differences of CD50 levels for clonic and tonic-clonic seizures as well as LD50 after IP, SC, IV, and oral (PO) administration in NMR1 mice strain. Ro 5-3663 can be dissolved in 0.1 N HCl. Effective doses range between 5 and 15 mg/kg IP with seizures occurring within 30 minutes (Maresˇ et al., 1987). b-CCM can be also used as an add-on convulsant with picrotoxin and strychnine (for details, see Zhao et al., 1996). Defining Features Both beta-carbolines and Ro 5-3663 induce clonic and tonic-clonic seizures. EEG analysis of Ro 5-3663 effects determined that this drug also produces EEG spindles associated with behavioral arrest. A functional (2DG) study demonstrated an increase in local glucose utilization in the hippocampus, dentate gyrus, and basal ganglia, including the substantia nigra reticulate, and in the ventral and lateral thalamic nuclei (Ableitner and Herz, 1987). Limitations These drugs represent less commonly used GABArelated agents for production of seizures. Additional information on the effects of these drugs can be found in the following studies (Chapman et al., 1987; Croucher et al., 1984; Meldrum, 1984; Meldrum and Chapman, 1986; Petersen 1983). Insights into Human Disorders Beta-carbolines have a high affinity to benzodiazepine receptors and act as inverse agonists (Braestrup et al., 1982, 1983). The result is seizures resulting from attenuated GABAA inhibition. A benzodiazepine derivative, Ro 5-3663 is also a potent convulsant; however, it acts via a picrotoxin-
133
Systemic Injection of Convulsant Substances
binding site in the chloride channel of the GABAA receptor (Harrison and Simmonds, 1983; Maresˇ et al., 1987).
Excitatory Amino Acid–Related Substances Excitatory features of some of the excitatory amino acid (EEA) drugs were described more than 50 years ago (Hayashi, 1952). EAAs are very popular for the induction of SE and studies of neuropathologic changes. However, these features are described in detail elsewhere in this book (see Chapter 34). In addition to the systemic administration (Collins et al., 1980), microamounts of these drugs are frequently administered (microinfused) in the lateral ventricles for central, intracerebroventricular (ICV) administration (Ben-Ari et al., 1980). The advantage is that only a very small amount of the drug is required for a convulsant response and the lethal effects associated with systemic administration are diminished. Early studies showed feasibility of seizure induction by systemically administered EAA in the adult and infant rats (Albala et al., 1984; BenAri et al., 1981b; Fagg et al., 1986; Nitecka et al., 1984; Schoepp et al., 1990; Zaczek and Coyle, 1982; Zaczek et al., 1981). For an overview of these models, see Table 2. Behaviorally, these drugs produce various automatisms and clonic and tonic-clonic seizures. The occurrence of all these behavioral features is drug and age specific. Additionally, special seizure patterns may be recorded. The EEG patterns are also very similar to EEGs already described, with spikes, spike and waves, polyspikes, and wave complexes. However, an extra feature can be observed after the administration of all principal EAA agonists: largeamplitude slow waves with superimposed spikes (“serrated waves”) frequently recorded from the hippocampus. Sometimes periods of EEG suppression occur. There is no special timing for the occurrence of the discharges and EEG suppression; frequently they are observed during motor convulsions but they can be also recorded when the rat is motionlessness.
The neuropathology is very complicated and still is subjected to extensive studies. In general, all drugs can produce neuronal damage resulting from neurotoxic features (BenAri, 1985). In addition, all these drugs can produce SE (prolonged continuous seizures longer than 30 minutes), which has an additional capability to produce seizure-induced damage (Albala et al., 1984; Pitkanen and Sutula, 2002; Sutula et al., 1988). Current data indicate that the neuronal damage resulting from EAA-related drug-induced convulsions has age- and brain-region specific features (Haut et al., 2004). Relationship to human seizure disorders (Engel, 2001): Undoubtedly, automatisms, which may reflect very focal activation of the limbic system (entorhinal cortex, dentate gyrus, hippocampus proper) may serve as a model of focal motor seizure with typical automatisms. The occurrence of clonic or tonic-clonic seizures may be considered the secondary generalization from a focus. Special seizure types may become a useful model for intractable epilepsy syndromes, as described later.
Kainic Acid Methods of Generation Kainic acid (KA) is the most common neurotoxin (McGeer et al., 1978) used to produce SE and related neuro-pathologic changes (Baran, 1985; Ben-Ari et al., 1981b; Fariello et al., 1980; Fuller and Olney, 1979; Heggli and Malthe-Sorenssen, 1982; Lothman and Collins, 1981; Sperk, 1985; Sperk et al., 1983; Worms et al., 1981; Zaczek et al., 1981). KA can be dissolved in normal saline; however, the resulting pH is on the acidic side. Therefore phosphatebuffered saline, pH 7.4, and the IP route of administration are preferred. Doses depend on the maturational state of the animal because there is somewhat limited penetration of KA to the brain. Usually for adult rats doses of 10 to 14 mg/kg are sufficient to produce seizures and SE. In young rats,
TABLE 2 Acute Seizure Models Induced by Excitatory Amino Acid (EAA)-Related Drugs in Immature and Adult Rats Drug
Solubility
Kainic acid (KA)
PBS buffer
Quisqualic acid
TRIS buffer, water
N-methyl-D-aspartic acid (NMDA)
Saline up to 50 mg/ml
Homocystein Homocysteic acid
Administration route
Bolus doses: adult rats (mg/kg)a
Bolus doses: PN12–18 rats (mg/kg)a
IP
10–14
2–8
ICV, IP
10 mg/min ICV infusion
2–12 mg/kg IP
IP
150–250
10–60
Saline
IP
6–16 mmol/kg
6–16 mmol/kg
Saline, adjust pH
IP
>13 mmol/kg
3–13 mmol/kg
ICV, intracerebroventricularly; IP, intraperitoneally; IV, intravenously; N/A, information not available; PBS, phosphate-buffered saline; PN, postnatal day. a See text for additional information about the correlation of convulsant drug doses and elicited seizure types. Doses for younger ages are available in the text.
134
Chapter 11/Models of Chemically-Induced Acute Seizures
doses of 1 to 4 mg/kg may be sufficient. For doses in developing rats, see Table 3. It should be noted that mice generally require higher doses of KA; doses of 20 to 60 mg/kg are usual. For additional information on KA, see Chapter 34. Defining Features Systemically administered KA produces hypoactivity for about 20 to 30 minutes (Ben-Ari et al., 1981b). Then agespecific automatisms occur. In rats, during the first 2 weeks, profuse scratching prevails (Albala et al., 1984; Cherubini et al., 1983; Tremblay et al., 1984; Velísˇková et al., 1988).
TABLE 3 Developmental Doses of Kainic Acid (KA): Rat Strain Differences
Age (postnatal days; PN)
KA dose mg/kg IP 90–100% status epilepticus Sprague-Dawley ratsa
KA dose mg/kg IP (age in parentheses) 50–100% status epilepticus Wistar ratsb
PN5 (7)
1–2
4–8
PN10 (12)
2–3
4–8
PN20 (18)
8
8–10
PN30 (25)
10–11
8–14
PN60 (90)
10–12
10–16
“adult” a b
From Stafstrom et al., 1992. From Velísˇková et al., 1988.
During the third postnatal week, “wet-dog shakes” (WDS) begin to emerge; their frequency increases with aging. Clonic seizures can be induced only exceptionally during first 2 postnatal weeks, regularly appear during the third and fourth postnatal week, and are the exclusive pattern in the adult rats. Profound salivation frequently occurs. Tonicclonic seizures decrease in incidence with increasing age. They represent the only seizure type in 2-week-old and younger rats and become extremely rare even after high doses of KA (60 mg/kg; unpublished observation) in adult rats. Seizures usually occur within the first 60 minutes after KA administration. EEG patterns consist of spikes, spike and waves, and polyspikes and waves (Figure 6). Hippocampal recordings may show serrated waves. There is very poor correlation between KA-induced motor and EEG activity. EEG activity significantly prevails (Figure 7). Electrographic seizures may last many hours after the behavioral seizures have stopped (Giorgi et al., 2005). Metabolic studies in the adult rats revealed an increase in 2DG uptake in the hippocampal formation and lateral septum during early stages (<1 hour) of KA seizures (Ben-Ari et al., 1981a, 1984). Substantia nigra part reticulata also displayed increased 2DG uptake (Albala et al., 1984). Later putamen, anterolateral thalamic nuclei, nucleus accumbens, rostral limbic complex, perirhinal and piriform cortex, and amygdala also display 2DG uptake increases (Ben-Ari et al., 1981a, 1984). Additionally, there is a decrease in 2DG uptake in the neocortex, forebrain, mesencephalon, and brainstem. In immature, PN15 to 18 rats, KA seizures increase 2DG uptake in the hippocampus and lateral septum, deep cortical layers, and
FIGURE 6 Discharges induced by i.p. administration of kainic acid (KA; 6–14 mg/kg) in a Wistar rat. Arrow indicates the onset of clonic motor seizures. There were many more discharges than motor seizure activity. For quantification, see Figure 7. Electrocorticogram and stereo electroencephalogram (EEG) from RO, right occipital (visual) cortex; LF, left frontal (sensorimotor) cortex; LO, left occipital cortex; RHi, right hippocampus; LHi, left hippocampus.
Systemic Injection of Convulsant Substances
135
been described in adult rats of different strains: Thus hippocampal CA1 damage prevails in Wistar rats and either CA1 or CA3 damage prevails in Sprague-Dawley rats (Albala et al., 1984; Sperber, 1996b; Brandt et al., 2003). Additionally, the damage may be sex specific (Brandt et al., 2003). Immature 2-week-old rats are very resistant to a classic KA seizure-induced damage seen in adult rats (hilus of the dentate gyrus, CA3 pyramidal cells (Albala et al., 1984; Nitecka et al., 1984; Sperber, 1996a; Sperber et al., 1999b; Haas et al., 2001; Sperber and Moshé, 2001). Insights into Human Disorders
FIGURE 7 Quantification of the occurrence of discharges in the hippocampus and neocortex along with behavioral activity and motor seizures after intraperitoneal administration of 14 mg/kg of kainic acid (KA). Duration of phenomena in seconds was recorded within each 5-minute interval and plotted as a histogram (means from eight rats are shown, standard error of the means were omitted for clarity). Occurrence of discharges prevailed over the occurrence of behavioral activity, especially motor seizures. This indicates significant dissociation of electroencephalographic and motor seizures after systemic KA.
KA is an agonist for the KA subtype of ionotropic glutamate receptor with highest density in the hippocampus, especially in the CA3 region, also in the amygdala, perirhinal and entorhinal cortex (Miller et al., 1990). These areas are preferentially affected after systemic administration of KA. Therefore KA serves as a valuable model of partial (focal) seizures with complex symptomatology and secondary generalization from the limbic focus (Ben-Ari, 1985; Engel, 2001) as well as a model of epileptogenesis after status epilepticus (Cavalheiro et al., 1982; Stafstrom et al., 1993). For these features, KA-induced seizures may be a valuable tool in assessment of the antiepileptic drug efficacy in complex partial seizures. Another glutamate analogue structurally related to KA, domoic acid, produced temporal lobe seizures in humans after ingestion of infested mussels (Cendes et al., 1995), providing an additional support for use of KA in modeling limbic seizures. Quisqualic Acid/a-Amino-3-Hydroxy-5-Methyl-4Isoxasole Propionic Acid Methods of Generation
ventromedial thalamic nuclei. There are no changes in the 2DG uptake in the substantia nigra pars reticulata (Albala et al., 1984). A study in paralyzed, ventilated rats showed significant increases in glucose metabolism only throughout the hippocampus (Evans and Meldrum, 1984). Neuropathology is age specific. After PN18 to 21, there is a significant cell loss after KA in the hippocampus associated with synaptic remodeling (Albala et al., 1984; Sperber et al., 1999b). Other areas of neuronal damage include pyriform and entorhinal cortex, medial, cortical, and lateral posterior nuclei of amygdala and thalamic nuclei (mediodorsal, paraventricular and parafascicular) (Ben-Ari et al., 1981b). In younger animals, only minimal nonspecific changes in limbic structures can be observed (Albala et al., 1984; Nitecka et al., 1984). For additional details, see Chapter 34. Limitations Doses of KA may be quite specific for the rat strain (see Table 3). Similarly, significant differences in the prevailing location and extent of KA seizure–induced damage have
Quisqualic acid (QA) and amino-3-hydroxy-5-methyl-4isoxasole propionic acid (AMPA) are almost exclusively used for ICV administrations in minute amounts. QA can be dissolved easily in tris(hydroxyymethyl)-aminomethane (TRIS) buffer and pH balanced to 7.4 (Thurber et al., 1994). The ICV dose for QA is 10 mg per minute of 2.94 mg/ml solution. Schoepp and colleagues (1990) described convulsant effects of QA after systemic administration in PN7 and PN11 rats. QA seizures can also be induced in mice (Jurson and Freed, 1990; Schwarz and Freed, 1986). The ICV dose for AMPA is 1 to 5 mg (Turski et al., 1981). Defining Features After a period of either hypoactivity (PN23) or agitation (older rats), QA administered unilaterally ICV produces contraversive circling throughout development (PN23 adult). Later the rats display facial clonus, salivation, and tail tonus. In the EEG, spikes, spikes and waves, and serrated waves can be recorded (Thurber et al., 1994). Histologic evaluation after 2 weeks revealed that QA caused
136
Chapter 11/Models of Chemically-Induced Acute Seizures
massive neuronal loss in hippocampal CA2 and CA3 regions. There was also a cell loss in the hilus and CA1 region of both the injected and contralateral side, which indicates seizure-induced damage. Limitations Blood-brain barrier permeability is an obstacle for systemic use of QA/AMPA in older animals. Insights into Human Disorders QA and AMPA act as agonists at the AMPA subtype of ionotropic glutamate receptors expressed especially in the hippocampal CA3 region and in the amygdala (Insel et al., 1990). Thus seizures after systemic administration may arise from these structures. However, the usefulness of these two drugs administered systemically for screening purposes is limited by their cost and very poor penetration to the brain. N-methyl-d-aspartic acid (NMDA) Methods of Generation NMDA dissolves well in normal saline up to 50 mg/ml. Seizures are usually induced intracerebrally administered, 2 to 10 nmol (Ishimoto et al., 2000; Lees, 1995) administered NMDA because of poor blood-brain barrier permeability. However, appropriate doses of NMDA (>100 mg/kg) administered systemically will induce seizures even in mature animals with a fully developed blood-brain barrier. In mice, CD50 is around 110 mg/kg administered IP (Budziszewska et al., 1998), whereas in rats, it is estimated between 150 to 200 mg/kg IP (Maresˇ and Velísˇek, 1992). In immature rats, doses required for seizure induction are much lower than in adults (Schoepp et al., 1990; Maresˇ and Velísˇek, 1992) (for developmental CD50, see Figure 8). Seizures occur within 15 to 45 minutes, depending on the dose. Defining Features The first symptom is increased locomotor activity, especially in prepubertal and adult rats. Wild running is the most prominent feature. If rats are allowed enough space, they run the “8”-shaped trajectory. After the period of hyperactivity, automatisms occur at all developmental stages. These usually start with tail flicking beginning at the tip and continuing sigmoidally to the trunk. Sometimes biting of forelimbs or hindlimbs occurs. In rats younger than 3 weeks of age, NMDA induces a special seizure pattern consisting of hyperflexion of the head, body, and tail while the rat is lying on its side. These seizures are termed emprosthotonic. Additionally, NMDA induces tonic-clonic but not clonic seizures throughout development. The tonic phase of tonic-clonic seizures may not be developed. However, in this model, clonus regularly precedes tonus, which is indicative of imminent death (Maresˇ and Velísˇek, 1992). (For further
FIGURE 8 CD50 values for tonic-clonic seizures induced by i.p. administration of N-methyl-d-aspartic acid (NMDA) during postnatal development in Wistar rats (according to Maresˇ and Velísˇek, 1992). Tonic-clonic seizures were the only seizure occurring throughout development after systemic administration of NMDA. CD50 for postnal day 60 (PN60: young adult) rats was estimated due to few experimental groups used for this age.
details, see Chapter 48.) The EEG pattern is nonspecific. Long periods of EEG suppression occur in cortical and hippocampal recordings (Figure 9). During these almost isoelectric recordings, various behaviors can be observed, including hyperactivity and tonic-clonic seizures. Later, serrated EEG waves may occur (Kábová et al., 1999). Frequently, chaotic activity in the EEG appears between motor seizures. Although intracerebrally administered NMDA induces severe neuronal damage (Lees, 1995; McDonald et al., 1988) in adult rats, no overt neuronal damage is found after seizures induced by systemic NMDA in young rats (Kábová et al., 1999; Stafstrom and Sasaki-Adams, 2003). Systemic administration of NMDA in rats induces c-fos expression, especially in the piriform cortex and dentate gyrus of the hippocampus, irrespective of seizure occurrence (Morgan and Linnoila, 1991). Limitations Follow-up studies after NMDA-induced emprosthotonus are quite restricted by the very low survival rates. Administration of the NMDA receptor antagonist ketamine (50 mg/kg IP) after a defined (15–30 minutes) period of seizure duration may help to increase survival. Insights into Human Disorders NMDA is a prototype agonist at the NMDA subtype of the ionotropic glutamate receptor. These receptors are prominently expressed in the hippocampal CA1, dentate gyrus, and striatum (Insel et al., 1990). Based on the specific motor pattern of hyperflexion, significant age specificity (Maresˇ and Velísˇek, 1992), resistance to pharmacotherapy (Kábová et al., 1999; Velísˇek and Maresˇ, 1995), and long-term learning impairments (Stafstrom and
Systemic Injection of Convulsant Substances
137
normal saline and effective dose ranges between 6 and 16 mmol/kg in rats (Kubová et al., 1995). D,l-homocysteic acid can be also dissolved in saline; however, the pH needs to be adjusted by alkalinization. CD50 for PN7–25 rats are between 1.5 and 12.5 mmol/kg (Folbergrová et al., 2000; Maresˇ et al., 1997). Defining Features
FIGURE 9 Electrocorticogram and stereo electroencephalographic (EEG) recording in a postnatal day 18 (PN18) Wistar rat before and after intraperitoneal administration of N-methyl-d-aspartate (NMDA). Top traces: baseline recordings before NMDA administration. Bottom traces: EEG suppression, which developed after systemic NMDA administration. During these periods of EEG suppression, different associated motor behaviors or seizures were recorded from motionlessness to emprosthotonus and tonic-clonic seizures. RF, right frontal (sensorimotor) cortex; RO, right occipital (visual) cortex; LF, left frontal cortex; LO, left occipital cortex; RHi, right hippocampus.
Sasaki-Adams, 2003), we believe that NMDA-induced emprosthotonic seizures in the immature rats are one of the closest models currently available for the West syndrome, although with some reservations (Lado and Moshé, 2002; Stafstrom and Holmes, 2002). NMDA seizures have been previously proposed as a model of refractory seizures (Loscher, 1997). NMDA induces only a tonic-clonic seizure pattern, and this seizure type in various chemically induced models is significantly suppressed by NMDA receptor antagonists; therefore we further propose that the tonicclonic seizure pattern uses NMDA receptor neurotransmission for its expression (Velísˇek and Maresˇ, 1990, 1992; Velísˇek et al., 1989, 1990 1991, 1997). Other Drugs (Homocysteine, Homocysteic Acid) Methods of Generation Homocysteine seizures can be induced in rats and in mice (Blennow et al., 1979). Homocysteine can be dissolved in
D,l-homocysteic acid induces seizures similar to NMDA during development. A special feature of D,l-homocysteic acid and both its stereoisomers is the occurrence of barrel rotations in PN12 rats (Maresˇ et al., 1997). Homocysteine induces different seizures. The first sign is decreased locomotion; then clonic seizures may occur. Younger rats may display a status of clonic seizures. Flexion (emprostohotonic) seizures develop later but regularly in rats younger than PN15 and only rarely in older age groups. Tonic-clonic seizures can be observed in all age groups. The efficacy of homocysteine increases with age (Kubová et al., 1995). In the EEG, slow waves (young rats), spikes, and spike and wave patterns occur (in prepubertal and older rats). All these phenomena have very poor electroclinical correlation, which slightly improves with age. Metabolic studies show early (1 hour after ICV infusion) decreases in glucose and glycogen and increases in lactate in the cerebral cortex and late (24 hours after administration) increases in glucose and glycogen (Folbergrová et al., 2000). Limitations The profile of action is practically the same as with NMDA seizures, including EEG patterns (Maresˇ et al., 2004). All the mechanisms of action of homocysteine remain to be elucidated. Because of high mortality after systemic homocysteic acid administration in developing rats (similar to NMDA), investigators may use ICV administration, which induces long-lasting but not lethal tonic-clonic seizures (Folbergrová et al., 2000). Insights into Human Disorders Both homocysteine and homocysteic acid are related to the EAA system. Although l-homocysteic acid is an agonist at the NMDA subtype of the ionotropic glutamate receptor, homocysteine has broader nonspecific agonistic features on the EAA receptors. Homocysteic acid can be used instead of NMDA for flexion (emprosthotonic) seizures.
Acetylcholine (ACh)-Related Substances The cholinergic system has been practically explored for seizure induction far before the experimental approach was used. Organophosphorus-based nerve gasses tabun, sarin, soman, cyclosarine, VX, and VR produce seizures on their way to lethal effects and mechanistically block acetylcholine (ACh) degradation in the synaptic cleft by inhibiting
138
Chapter 11/Models of Chemically-Induced Acute Seizures
acetycholinesterase (Shih and McDonough, 1999). Experimentally, in addition to the use of nerve gasses, muscarinic receptor agonists are widely employed for induction of clonic seizures, especially of the long-lasting SE with neuropathologic consequences (Turski et al., 1989b). Issues of pilocarpine-induced seizures and SE are analyzed in detail in Chapter 35. Behaviorally all these drugs induce akinesia, tremor, olfactory automatisms, wet-dog shakes, and clonic seizures, culminating in SE (Turski et al., 1983). These symptoms can be clearly observed only with pilocarpine because nerve gasses have extremely fast onset of seizures, consistent with their intended effects: Only in animals that do not develop seizures and thus do not die is it possible to record automatisms (Shih et al., 2003). In the EEG, the hippocampus is activated before the amygdala and cortex are, with prevailing high-voltage spiking. Neuropathologically, pilocarpineinduced SE produces an extensive and age-specific injury.
cortex, septum, and neocortex (Cavalheiro et al., 1987). However, in immature rats at the lower limit of this developmental interval (PN12), neuronal damage is found in thalamic nuclei (Kubová et al., 2001). Limitations Pilocarpine seizures are very persistent and long-lasting, and they result in severe neuropathologic damage that far exceeds the damage seen in human mesial temporal lobe sclerosis. The pilocarpine or Li-pilocaprine model has become very popular during the period of very limited (practically nonexistent) availability of KA, which until then had been a drug of choice for models of temporal lobe seizures with SE, resulting in spontaneous seizures and brain damage. The administration of a peripheral cholinergic antagonist further complicates the use of high doses of pilocarpine for acute seizure induction. On the other hand, the low cost of pilocarpine compared with KA represents a significant advantage.
Pilocarpine
Insights into Human Disorders
Methods of Generation
Pilocarpine is an agonist of muscarinic ACh receptors expressed especially in the hippocampus, striatum, and cortex (Kuhar and Yamamura, 1976). Therefore its seizureproducing effect arises from the increased activation of these receptors. The pilocarpine model may be useful for testing of the drugs potentially effective against complex partial seizures.
Systemic (IP) injection of pilocarpine, 300 to 400 mg/kg, produces seizures in rats and mice (Turski et al., 1983). However, this very high dose has significant peripheral effects. Therefore concomitant treatment with a peripheral muscarinic antagonist (not crossing the blood-brain barrier), such as scopolamine methylbromide (1 mg/kg sub-Q), is necessary. To decrease pilocarpine doses (and thus peripheral effects), pretreatment with lithium chloride (LiCl, 3 mEq) may be used 24 hours before the pilocarpine dose of 30 to 60 mg/kg. This paradigm significantly limits peripheral side effects (Jope et al., 1986). For detailed information on all aspects of pilocarpine-induced seizures, see Chapter 35. Defining Features Pilocarpine induces automatisms, WDS, and clonic seizures developing into SE as described previously. In the EEG, fast spikes occur in the hippocampus and spread to the cortex at all studied ages PN3 through adulthood (Cavalheiro et al., 1987). Metabolic studies determined the involvement of the hippocampus, dentate gyrus, globus pallidus, substantia nigra, ventrobasal and mediodorsal thalamus, pyriform, and visual and frontal cortex (Clifford et al., 1987). Features of the Li-pilocarpine model are very similar to those of pilocarpine (Turski et al., 1989a). Neuropathologic changes are age specific. In adult rats, the hippocampus is predominantly damaged (Turski et al., 1989a), but other areas (e.g., amygdala, pyridorm cortex, thalamic nuclei, and the substantia nigra pars reticulate) are also affected. In immature animals at PN11–21, some damage can be found in the hippocampus, thalamus, olfactory
Weapon-Grade Organophosphorus Compounds Methods of Generation All nerve agents (organophosphates) (Lotti, 2000; Spencer et al., 2000) can be dissolved in saline. Seizures were described after administration in rats and guinea pigs. All the drugs are extremely toxic (Lotti, 2000; Spencer et al., 2000); the median lethal dose (LD)50 ranges from 8 mg /kg to 300 mg/kg, depending on the potency (from the lowest to the highest: tabun, cyclosarin, sarin, soman, VR, and VX; see Table 4) and on the experimental animals used. Administration is usually sub-Q (Shih et al., 1999). No data for immature rats are available. Features Convulsions begin as a tremor, twitching, and shivering, continuing to strong convulsions (Tuovinen, 2004) associated with loss of righting reflex (Shih et al., 1999). Cortical EEG displays fast spiking (Shih et al., 2003). Limitations These drugs are extremely toxic and dangerous for humans even in minimal doses. The popularity of this model is limited. There is no available detailed description of seizures and associated EEG.
Systemic Injection of Convulsant Substances
TABLE 4 LD50 of Weapon-Grade Organophosphates Nerve agent
LD50 rats (mg/kg sub-Q)a
LD50 guinea pigs (mg/kg sub-Q)b
300 110 125 210 16 N/A N/A
120 42 28 72 8 52 11
Tabun Soman Sarin GF VX Cyclosarin VR a
From Shih et al., 1999; Shih and McDonough, 1999. From Shih and McDonough, 1999; Shih et al., 2003. N/A, information not available; sub-Q, subcutaneous.
b
139
be seen from PN7 onward. Tonic-clonic seizure pattern either fully developed or without the tonic phase can be recorded in all age groups, including adults. Sharp waves and spikes are the predominant features in the EEG of PN12–25 rats. In younger rats, slow waves with very poor electroclinical correlation occur (Kubová and Maresˇ, 1994; Pylkkö and Woodbury, 1961). Limitations Seizures induced by strychnine are considered by some investigators as a model of therapy-resistant seizures (Löscher, 1997). However, it is difficult to fit these seizures into the classification of human seizures and epilepsy (Engel, 2001).
Insights into Human Disorders
Insights into Human Disorders
Organophosphates are potent and irreversible inhibitors of acetylcholine esterase (AChE), the ACh degrading enzyme. Therefore their administration increases the availability of ACh for general activation of all subtypes of the ACh receptors.
The mechanism of the convulsant action of strychnine has been defined as a blockade of chloride channel associated with glycine receptors (Curtis et al., 1971). These inhibitory receptors can be found mostly in the spinal cord and brainstem (Young and Snyder, 1973; Zarbin et al., 1981). Therefore strychnine can serve as a model of therapyresistant seizures arising from the lower brainstem and spinal cord.
Other Drugs This section combines several other drugs, the administration of which is associated with seizures. Although these drugs are unrelated to one another, they are worth mentioning either for their mechanisms of convulsive action or because of relevant occurrence in humans. Some of these drugs induce conditions with epileptic seizures that do not require a diagnosis of epilepsy: drug or other chemically induced seizures (Engel, 2001). However, hypoglycemia is not included in the current classification (Engel, 2001), although one might argue that this condition associated with seizures is commonly caused by excessive insulin (i.e., a drug) of exogenous or endogenous origin.
Aminophylline Methods of Generation Both aminophylline (theophylline and ethylenediamine) and caffeine can induce convulsions (Chu, 1981; Stone and Javid, 1980; Walker, 1981a, b). Aminophylline can be dissolved in normal saline. Doses from 150 to 350 mg/kg IP induce seizures in rats from PN7 to adulthood with CD50 values ranging between 180 and 280 mg/kg IP throughout development (Maresˇ et al., 1994). Defining Features
Strychnine Methods of Generation Strychnine (Allen, 2000) has been used for practical human toxicology for centuries. Victims of strychnine poisoning die in convulsions. Strychnine sulfate can be dissolved in normal saline (1 mg/ml). Doses between 1 and 4 mg/kg IP are used for 3- to 25-day-old rats. CD50 values for the same ages are between 1.8 and 0.5 mg/kg and decrease with age (Kubová and Maresˇ, 1995). Doses for adult rats are around 2 to 3 mg/kg administered sub-Q (Kubová et al., 1990). Defining Features In very young rats at PN3–5, circling and barrel rotations are observed. A higher incidence of myoclonic twitches can
Aminophylline induces dose-dependent clonic seizures, tonic-clonic seizures, and lethality throughout development. Limitations This is an unusual model of symptomatic seizures. Theophylline-induced seizures have been described in humans (Jensen et al., 1984). Insights into Human Disorders Theophylline acts as an antagonist of adenosine receptors. According to the classification published in 2001 (Engel, 2001), aminophylline-induced seizures are a model of conditions with epileptic seizures that do not require a diagnosis of epilepsy (drug or other chemically induced seizures).
140
Chapter 11/Models of Chemically-Induced Acute Seizures
Insulin-induced Hypoglycemia Methods of Generation In experimental animals, seizures can be induced by administration of insulin, leading to hypoglycemia (Urion et al., 1979). Insulin can be dissolved in distilled water at a concentration of 15 international units (IU) per milliliter. The usual dose for seizure production is 5 to 30 IU/kg IP (Urion et al., 1979; Vannucci and Vannucci, 1978). After this dose, rats develop seizures within 4 hours. Our unpublished data show that the prior fasting (for 24 hours) improves the incidence and decreases the latency to onset of insulininduced seizures. Thus, in overnight fasted rats, hypoglycemic seizures usually fully develop within 2 to 3 hours, and their incidence is close to 100%. In our experience, it is very difficult to produce hypoglycemic seizures in the immature rats. We were able to induce seizures in PN21 and older rats (post weaning) but only extremely rarely in suckling rats (Vannucci and Vannucci, 1978), even during observation periods as long as 10 hours after insulin administration. Defining Features During severe hypoglycemia, a sequence of events occurs. Onset of seizures usually correlates with a peripheral glucose drop down to 20 mg/100 ml (1.1 mM). First, with decreasing systemic glucose, rats are hypoactive and flaccid. Individual twitches then occur. Jumps, usually restricted to the hindlimbs, are also observed. Barrel rotations are a very typical expression of hypoglycemic seizures
(see Chapter 48). Sometimes clonic and tonic seizures occur, including an opisthotonic position. All these seizures are associated with a loss of posture. EEG shows generalized spike and spike and wave activity (Figure 10). Metabolic studies demonstrate significant changes in the 2DG uptake in hypothalamic nuclei (belonging to food-intake control group) and also in the midbrain and brainstem structures, such as subthalamic nucleus, substantia nigra pars reticulata, pedunculopontine tegmental nucleus, and vestibular nuclei. The c-fos immunopositivity is especially prominent in the substantia nigra reticulata and subthalamic nucleus in rats experiencing hypoglycemic seizures. Neuronal injury has been studied in rats with 10 to 30 minutes of isoelectric EEG during severe hypoglycemia. The injury involves the neocortex, hippocampal CA1, and amygdala regions as well as cerebellar Purkinje cells (Auer and Siesjo, 1993; Auer et al., 1984). Limitations This model is not important for the studies of the mechanisms of anticonvulsant drug action. However, the mechanisms underlying hypoglycemic seizures and the brain structures responsible for excessive and synchronized firing during conditions of general metabolic shutdown of neuronal activity are still worth further exploration (Lewis et al., 1974). Insights into Human Disorders Hypoglycemia is frequently associated with neurologic side effects (Davis et al., 1997). From these side effects,
FIGURE 10 Discharges recorded during severe insulin-induced hypoglycemia (blood glucose <20 mg/100 ml) in a Sprague-Dawley rat. Arrow marks time of onset of barrel rotations. This pattern illustrates dissociation of electroencephalographic (EEG) discharges and motor seizures induced by insulin-induced hypoglycemia. Electrocorticograms and stereo EEG from sensorimotor cortex, hippocampus, and deep midbrain/brainstem structures: SNR, substantia nigra pars reticulate; PPTG, pedunculopontine tegmental nucleus.
Inhalation of Convulsant Substances
141
seizures occur most frequently (Kaufman, 1998; Pocecco and Ronfani, 1998). Hypoglycemic seizures represent a model of symptomatic seizures frequently occurring in humans, especially with type 1 diabetes mellitus or metabolic conditions affecting carbohydrate metabolism (Cornblath and Schwartz, 1991). Treatment for these seizures is correction of blood glucose; therefore no antiepileptic drugs are required (Auer and Siesjo, 1988).
INHALATION OF CONVULSANT SUBSTANCES Inhalation is a less usual route of delivery for a convulsant drug. For inhalation, the drug must have some special features, such as easy evaporation at room temperature. This is true for all ether-like substances. Indeed, ethers have excitatory features, reflected in the original classification of ether-induced anesthesia as stage II. However, in most of these drugs, stage III of surgical anesthesia develops quickly and covers the excitatory stage II. Although delivery of inhalatory convulsants requires some special equipment, it also has significant advantages over administration by injection. Minimum requirements for the equipment are an airtight glass cylinder, which serves as the inhalation chamber, and a fume hood for draining away excessive fumes of the convulsant. More sophisticated systems (and less hazardous for the laboratory worker) consist of an airtight chamber with sufficient inside volume (Figure 11). This chamber is attached to the vacuum exhaust system through the system of valves, which allows the chamber to be flushed after each experiment. Therefore the convulsant fumes do not escape to the surrounding atmosphere. The chamber is placed in the fume hood for additional protection. The convulsant drug is delivered using a constant infusion rate pump, and it evaporates at the filter paper with a standard size placed at the top of the chamber. Latency to onset of seizures from the beginning of the convulsant drug delivery is recorded. The major advantage of inhalation delivery is that no potentially painful injection and stressful restraint of the animal is involved, which results in minimal interference of stressors with the seizure model. Flurothyl (Indoklon) Methods of Generation Flurothyl (bis-2,2,2-trifluoroethyl ether) seizures have been described in mice, rats, gerbils, and humans. The procedure consists of placing the animal (rat or mouse) in an airtight cylinder of a sufficient volume and injecting a specific volume of flurothyl, which then evaporates and forms convulsant fumes (Prichard et al., 1969; Truitt et al., 1960). Our laboratory uses 9.34 l airtight chamber for the rat exper-
FIGURE 11 Scheme of the chamber for the induction of flurothyl seizures. Flurothyl is delivered by precision microinfusion pump onto a filter paper, where it evaporates. After the experiment, the chamber is flushed with vacuum. The entire chamber, including the microinfusion pump, is placed in the fume hood for increased protection of the crew because flurothyl vapors have the capability of inducing seizures in humans.
iments. Flurothyl is delivered using a microinfusion pump at a constant rate; for this size chamber, the usual rate is 20 ml/min. Latency to onset of seizures from the application of the convulsant is measured. In our paradigm, the exact amount of flurothyl required to produce a certain seizure type can be calculated (flurothyl seizure threshold). It is imperative to run the tests in control and experimental conditions back to back because atmospheric factors may affect evaporation of flurothyl. Mortality after acute flurothyl exposure is low. However, if the adult rats are subjected to long-term flurothyl exposure to induce SE, they regularly die, in contrast to immature PN14 rats (Huang et al., 1999; Sogawa et al., 2001; Sperber et al., 1999a). Defining Features Seizures induced by flurothyl are age specific (Sperber and Moshé, 1988). Flurothyl induces initial agitation and increased exploratory activity in rats throughout development (Gatt et al., 1993). In rats during the first postnatal week, swimming movement occurs, followed by a tonus. Clonic seizures develop after PN10. After this age, rats usually display several myoclonic twitches followed by a clonic seizure, which at between PN10 and 20 usually evolves into a tonic-clonic seizure with loss of posture. After
142
Chapter 11/Models of Chemically-Induced Acute Seizures
PN20, several separated episodes of clonic seizures appear before the development of tonic-clonic seizures. It should be noted that the sequence and seizure phenomena after flurothyl exposure are very similar to the seizures occurring after systemic administration of GABA-related drugs (especially PTZ and bicuculline). However, in contrast to these drugs, flurothyl induces seizures that are more violent: Clonic seizures often involve tonic components of axial muscles, which may cause a temporary loss of posture. Clonic seizure may involve all four limbs simultaneously, which also interferes with the upright posture. However, in all these cases, the rat struggles to get up. This is in contrast to the loss of posture in tonic-clonic seizure, in which no active effort is made to regain posture. During the tonic phase, cyanosis and acidosis may occur, with fast correction within 5 minutes after the end of the seizure (McCabe et al., 2001). EEG shows rhythmic discharges (Figure 12) associated with a motionless stare from the third postnatal week onward. Additionally, individual spikes (or sharp waves in immature animals) are recorded. In young rats, these discharges very loosely correlate with myoclonic twitches; the correlation improves with age. Bilateral forelimb clonus is associated with long periods of spikes or sharp waves (Figure 13). In adult rats, discharges are found in the cortex, whereas in immature rats the discharges occur in both the cortex and the hippocampus (Sperber et al., 1999a). Metabolic studies using 2DG in adult rats demonstrate complex involvement of basal ganglia structures, including the
substantia nigra reticulata. The pattern of metabolic involvement depends on the seizure type and whether in ictal or postictal state (Velísˇková et al., 2005, in press). In immature rats, mild seizures induce decreases in 2DG uptake while severe seizures produce increases in the brainstem and decreases in the cortex (Szot et al., 2001). In adult rats, c-fos immunoreactivity after flurothyl seizures was found throughout the cortex; PN10 rats had immunopositivity only in the deep neocortical layers (Jensen et al., 1993). Limitations A more sophisticated airtight chamber is required to produce flurothyl seizures by inhalation of flurothyl vapors. Atmospheric factors such as barometric pressure, air humidity, and temperature may affect the evaporation rate of flurothyl. Therefore the experiments should be carefully planned. Sometimes it is difficult to compare corresponding data collected over different periods. Insights into Human Disorders The mechanisms of action of flurothyl are uncertain. Increased opening of sodium channels has been suggested (Woodbury, 1980a). Antagonism at the GABAA receptor may also contribute to the convulsant potency of flurothyl (Araki et al., 2002). Additionally, activation of cholinergic system has been proposed (Eger et al., 2002). Because flurothyl induces a motionless stare with accompanying
FIGURE 12 Rhythmic, spindle-shaped discharge induced by inhalation of flurothyl in sensorimotor cortex of an adult Sprague-Dawley rat. This discharge was associated with freezing behavior. Bipolar recording from the sensorimotor cortex is shown.
FIGURE 13 Spike-and-wave and polyspike discharges induced by inhalation of flurothyl in sensorimotor cortex of an adult Sprague-Dawley rat. Arrow indicates onset of clonic seizure and rearing. The onset of this discharge significantly preceded the onset of motor seizures. However, the occurrence of high-frequency polyspike discharges was associated with the onset of clonic seizure.
Topical (Focal) Application of Substances
EEG spindles, this can be considered a model of generalized seizures—typical absence seizures (Engel, 2001). Clonic seizures can be a model of generalized myoclonic seizures. Finally, tonic-clonic flurothyl seizures are a model of generalized tonic-clonic seizures (Engel, 2001).
TOPICAL (FOCAL) APPLICATION OF SUBSTANCES This approach is frequently used to create an acute or chronic seizure focus in a particular brain area, usually in the cortex. Additional structures may be injected with a convulsant substance, such as the hippocampus, amygdala, substantia nigra, area tempestas, etc. Many of the convulsant drugs can be injected in a solution into the brain ventricular system. Some of these ICV administrations have already been mentioned herein. The advantage of this approach is that it produces seizures very reliably and only microamounts of the drug are required. However, there is no exact control of the focus of the seizure onset. All structures surrounding the injected ventricle are affected by the drug; thus seizure onset can be multifocal. For precise localization of the focus, intraparenchymal administration of a convulsant substance is preferred. Many different convulsant substances are used for production of seizure focus, and its major representatives are briefly mentioned as follow. Metals (Cobalt, Zinc, Antimony, Alumina Cream, Iron) Methods of Generation Cobalt can be implanted as a powder or rod, or it can be injected as a solution of CoCl2 (Cooper and Legare, 1997). ICV injection of cobalt chloride has the CD50 of 10 ml of 0.45 mM solution. Seizures develop very slowly in powdered or rod cobalt implants and vanish in about a month. After ICV injection of a soluble cobalt salt, seizures develop within an hour and last for about a week (Zhao et al., 1985). Other metals such as nickel and antimony have high epileptogenic potency; iron has a somewhat lower potency than cobalt (Colasanti and Craig, 1992; Craig and Colasanti, 1992; Dambinova et al., 1998; DeDeyn et al. 1992; Doi et al., 2000; Kabuto et al., 1998; Pei and Koyama, 1986; Ueda and Willmore, 2000a, b, c; see also Fisher, 1989). Additional technique of application includes positioning of a filter paper soaked with a soluble salt (e.g., saturated solution of NiCl2·6H2O) on the cortex (Cooper et al., 2001). Alumina cream (Kopeloff et al., 1942, 1954; Ward, 1969; Wyler et al., 1978), 4% AlOH3 (Spencer, 2000a), is a very potent and frequently used topical convulsant; however, its effects are limited to monkeys and rabbits (see Chapter 14). The latent period is several months and seizures may last for up to several years (Louis et al., 1987).
143
Defining Features In the rat, unilateral cobalt implant produces seizures within 5 days. Simple partial seizures develop first and consist of contralateral clonus associated with EEG spikes above the implant. Although very frequent (more than 20 per day), these seizures disappear within 9 days. Generalization is characterized by a bilateral clonus, occurring about 10 times a day, most frequently 1 week after cobalt implantation. Behavioral arrest may also occur and is associated with gradual buildup of EEG activity (Chang et al., 2004). ICV administration of soluble cobalt salt produces seizures resulting from irritation of the hippocampus. Therefore these seizures are similar to KA-induced seizures (Zhao et al., 1985). Nickel salt applied on the filter paper on the cortex produces contralateral myoclonic twitches within an hour; these twitches last about 2 hours (Cooper et al., 2001). After cobalt implantation in the posterior cortex, dark patches of increased 2DG uptake appear around the implant site and in the lateral geniculate nucleus of the thalamus. This is, however, not true for anterior cortex cobalt implants and for implants of other convulsogenic metals such as nickel and antimony (Cooper and Legare, 1997). Metal implants cause focal necrosis. Limitations These models are labor intensive and expensive to prepare, especially for the monkey alumina cream model. The difference of clinical seizure foci may be the direct irritation of the brain tissue by the metal deposit. Cobaltinduced seizures are more sensitive to antiepileptic drugs used against absence seizures in humans and thus cannot be a predictive model of refractory focal epilepsy (Loscher, 1997). Except for the alumina cream model in monkeys, foci spontaneously deactivate after several weeks. Insights into Human Disorders Mechanisms of action of these metal deposits are largely unclear. Metal deposition models depend on the localization of the deposit; these are good models of focal motor seizures with elementary clonic motor signs or focal motor seizures with typical (temporal lobe) automatisms (Engel, 2001). Except for cobalt, metal deposit models may have good predictive value for screening anticonvulsant drugs effective against focal onset seizures. Convulsant Drugs Methods of Generation All convulsant drugs mentioned previously in this section, plus cholinergics, anticholinergics, estrogens, and strychnine can act focally if applied on the cortex or in a particular seizure-prone structure, such as amygdala, hippocampus, substantia nigra, or area tempestas (Campbell
144
Chapter 11/Models of Chemically-Induced Acute Seizures
and Holmes, 1984). Older studies usually used focal administration of the drug on the surface of the neocortex of paralyzed and ventilated or anesthetized animals (Velísˇková et al., 1991). In that case, a filter paper of an exact geometry is used. Its area is either soaked with a water solution of a convulsant drug or a defined volume is delivered using a microsyringe to the filter paper positioned on the cortex. More recent studies use chronic cannulation with microinfusions of the drugs in freely moving animals (Gale, 1995; Halonen et al., 1994; Soukupová et al., 1993; Velísˇek et al., 1993).
initial automatisms followed by generalization of seizure activity and clonic seizures (Sierra-Paredes and SierraMarcuno, 1996b). Application of the drugs on the motor cortex will produce myoclonic twitches and, later, clonic seizures (Soukupová et al., 1993). Finally, drugs with high affinity for limbic structures will produce automatisms and clonic seizures even when the injection site is remote to the limbic system (such as the substantia nigra pars reticulata (Sawamura et al., 2001). EEG usually displays individual discharges (Figure 14), which may cumulate over time and develop into ictal activity.
Defining Features
Limitations
Behavioral features depend on the following: (1) the drug used and (2) the exact placement of the microinfusion. For doses of commonly used convulsant drugs, see Table 5. Microinfusions of any drug in the limbic system will induce
These models are used less frequently because they are relatively labor intensive. Further, the use of NMDA as a focal convulsant drug may be surprising in some brain structures because NMDA has a very high propensity to
TABLE 5 Concentrations of Some Focally Applied Convulsant Drugs Drug
Structure
Dose
Frequency
Reference
Bicuculline methiodide
Neocortex
5 ml of 1–2 mM solution
1–2 times
Soukupová et al., 1993
Pentylenetetrazol
Neocortex
2.5 ml of 200 mg/ml solution
Single
Velísˇek et al., 1993
Bicuculline methiodide
Neocortex
2.5 ml of 4 mM solution
Single
Velísˇ ková et al., 1991
Picrotoxin
Hippocampus
100–500 mM
Continuous
Sierra-Paredes and Sierra-Marcuno, 1996a, b
Kainic acid
Amygdala
0.4–2.0 mg in 0.1–0.4 ml
Single
Ben-Ari et al., 1980
Kainic acid
Substantia nigra
1 mg in 1 ml
Single
Sawamura et al., 2001
Bicuculline
Area tempestas
118 pmol
Single
(Wardas et al., 1990)
Carbachol
273 pmol
Kainic acid
117 pmol
FIGURE 14 Discharges induced by bilateral application of 2.5 ml of the 200 mg/ml pentylenetetrazol (PTZ) solution on the sensorimotor cortex in a freely moving adult Wistar rat. Individual discharges (sharp waves) are well synchronized between both frontal areas; transfer to the occipital areas (especially left one) is incomplete. RF, right frontal (sensorimotor) cortex; RO, right occipital (visual) cortex; LF, left frontal cortex; LO, left occipital cortex.
Topical (Focal) Application of Substances
145
induce spreading depression (for review, see Somjen, 2001). This feature may account for some of its paradoxical anticonvulsant effects when it is applied focally (Turski et al., 1987).
neurons in the epileptic focus (Matsumoto and Ajmonemarsan, 1964; Prince, 1968). Neurons around the focus exert substantial inhibitory activity in an attempt to limit the spread of the seizure (Prince and Wilder, 1967).
Insights into Human Disorders
Limitations
Mechanisms of action for these drugs were mentioned during the description of their systemic use (see preceding). All these models represent models of focal seizures with possible secondary generalization. According to the localization of the initial injection site or the preferential activity of the drug, the model can be of focal motor seizures with elementary clonic motor signs or focal seizures with typical automatisms (Engel, 2001). Focal administration of convulsant drugs may serve as a model for screening antiepileptic drugs potentially useful in treatment of focal-onset seizures.
If a high concentration of a potassium salt of the antibiotic drug is directly applied onto the cortex, spreading depression may develop (for review, see Somjen, 2001), masking thus the onset of discharges and interfering with the experiment. Therefore sodium salts are preferred, if they are available.
Antibiotics (Penicillins and Cephalosporins) Methods of Generation Epileptogenic effects of antibiotic drugs were first described in monkeys and later in humans (Johnson et al. 1946; Walker and Johnson, 1945; Walker et al., 1945). Locally administered penicillin (Velísˇek and Moshé, 2000a) produces an epileptic focus in many other species, including rats and cats. The potency of antibiotic drugs to induce epileptiform discharges has been studied repeatedly both in vivo (Gutnick et al., 1976) and in vitro (Grondahl and Langmoen, 1993). After application on the cortex, the convulsant potency is the following: benzyl penicillin (threshold concentration ~25 mmol/L), phenoxymethylpenicillin (~100 mmol/L), oxacilin (~150 mmol/L), methicillin (~150 mmol/L), and ampicillin (~175 mmol/L) (Gutnick et al., 1976). Sodium and potassium salts of penicillins are preferred for application because their solubility is superior to the antibiotic bases. Cephalosporins, especially the first generation, have also substantial epileptogenic potency if applied focally (Kamei et al., 1983); for review see (Velísˇek and Moshé, 2000b). Some epileptogenic antibiotic drugs the cross blood barrier, although in limited amounts. Therefore, it is possible to induce seizures by systemic injections of high doses of some penicillins or cephalosporins. Cats are more sensitive to systemic antibiotics than rats or mice (Chen et al., 1986; Eng et al., 1989; Gloor and Testa, 1974; Nistico et al., 1978; Yu et al., 1984).
Insights into Human Disorders Low doses of penicillin selectively block GABAA mediated inhibitory postsynaptic potentials as a result of their GABAA receptor antagonism (Dingledine and Gjerstad, 1980; Wong and Prince, 1979). Higher doses may have additional nonspecific effects (Ayala et al., 1970). Focally administered epileptogenic antibiotics produce a model of focal seizures with initial symptoms that depend on the exact localization (Engel, 2001). After generalization of the electrical seizure activity from the focus, clonic seizures may occur. Tetanus Toxin Methods of Generation Focal administration of tetanus toxin (Griffin and Oyler, 2000) introduced by Mellanby and colleagues (Mellanby et al., 1977) can induce seizures in both mice and rats. Hippocampal localization of tetanus toxin injection is used to produce recurrent seizures (see Fisher, 1989). After the infusion of 4 to 5 ng in 1 ml of phosphate buffer (Finnerty and Jefferys, 2002), the seizures occur within a day and recur chronically over weeks (see Chapter 33 for further details). Defining Features In rats a seizure usually begins with behavioral arrest, followed by myoclonic twitches of forelimbs and sometimes with tonic-clonic seizures. Seizures may be quite frequent (up to 100 per day, returning for a month). EEG shows fast spikes or spike and waves (3–20 Hz) (Jefferys and Williams, 1987).
Defining Features
Limitations
Seizures depend on the exact localization of the focus. Interictal focal activity is usually accompanied with isolated twitches, while the ictal discharges may be associated with a clonic seizure. The penicillin focus is very localized (Noebels and Pedley, 1977) and the neurons display the paroxysmal depolarizing shift, the hallmark of epileptic
There is limited neuropathology and temporal limitation for recurrent seizures. Insights into Human Disorders After focal administration, tetanus toxin is picked up by nerve endings and interferes with synaptic vesicular release.
146
Chapter 11/Models of Chemically-Induced Acute Seizures
As per localization of the focus in the hippocampus, this is a model of focal seizures with typical automatisms (Engel, 2001) with further generalization. This model is used with advantage in both immature (Anderson et al., 1999; Rashid et al., 1999; Smith et al., 1998) and adult rats (Jefferys and Williams, 1987) because epileptogenesis develops after initial seizures.
CONCLUSION Acute seizures can be induced by administration of chemoconvulsant drugs via different delivery routes (sub-Q, IP, IV, ICV, or inhalation). Main categories of convulsant drugs used for the production of acute seizures affect the inhibitory (GABA or glycine) transmission, affect excitatory amino acid transmission, or act on ACh receptors. The seizures are primarily or secondarily generalized, and some of their behavioral, EEG, metabolic, and neuropathologic features are age specific. An additional possibility for the induction of acute focal seizures is implantation of convulsant substances into the sensitive brain regions (e.g., neocortex, hippocampus, or area tempestas). For this purpose, convulsant metals, convulsant drugs, or antibiotics with convulsant features can be used. Acute behavioral seizures emanating from an altered GABAergic system represent models of myoclonic seizures and generalized tonic-clonic seizures; rhythmic EEG activity associated with behavioral arrest corresponds to absence seizures. Seizures that are due to hyperactivation of the EAA system may help with models of special seizure syndromes, especially catastrophic epilepsies of childhood. Some of the EAA-based models (such as NMDA seizures) are resistant to antiepileptic drug therapy; thus they may be useful for screening the drugs that are potentially effective in refractory epilepsy.
References Ableitner, A., and Herz, A. 1987. Changes in local cerebral glucose utilization induced by the beta-carbolines FG 7142 and DMCM reveal brain structures involved in the control of anxiety and seizure activity. J Neurosci 7: 1047–1055. Albala, B.J., Moshé, S.L., and Okada, R. 1984. Kainic-acid-induced seizures: a developmental study. Dev Brain Res 13: 139–148. Allen, C.N. 2000. Strychnine. In Experimental and Clinical Neurotoxicology. Eds. P.S. Spencer, and H.H. Schaumburg. pp. 1114–1115. New York: Oxford University Press. Anderson, A.E., Hrachovy, R.A., Antalffy, B.A., Armstrong, D.L., and Swann, J.W. 1999. A chronic focal epilepsy with mossy fiber sprouting follows recurrent seizures induced by intrahippocampal tetanus toxin injection in infant rats. Neuroscience 92: 73–82. Andre, V., Pineau, N., Motte, J. E., Marescaux, C., and Nehlig, A. 1998. Mapping of neuronal networks underlying generalized seizures induced by increasing doses of pentylenetetrazol in the immature and adult rat: a c-Fos immunohistochemical study. Eur J Neurosci 10: 2094– 2106.
Araki, H., Kobayashi, Y., Hashimoto, Y., Futagami, K., Kawasaki, H., and Gomita, Y. 2002. Characteristics of flurothyl-induced seizures and the effect of antiepileptic drugs on flurothyl-induced seizures in Mongolian gerbils. Pharmacol Biochem Behav 74: 141–147. Ashton, D., and Wauquier, A. 1979. Effects of some antiepileptic, neuroleptic and gabaminergic drugs on convulsions induced by D, L-allylglycine. Pharm Biochem Behav 11: 221–226. Ashton, D., and Wauquier, A. 1981. Alpha-noradrenaline modulation of D,l-allylglycine seizures. Eur J Pharmacol 75: 71–74. Auer, R.N., and Siesjo, B.K. 1988. Biological differences between ischemia, hypoglycemia and epilepsy. Ann Neurol 24: 699–707. Auer, R.N., and Siesjo, B.K. 1993. Hypoglycaemia: brain neurochemistry and neuropathology. Baillieres Clin Endocrinol Metab 7: 611–625. Auer, R.N., Wieloch, T., Olsson, Y., and Siesjo, B.K. 1984. The distribution of hypoglycemic brain damage. Acta Neuropathol (Berl) 64: 177–191. Ayala, G.F., Lin, S., and Vasconetto, C. 1970. Penicillin as epileptogenic agent: its effect on an isolated neuron. Science 167: 1257–1260. Ben-Ari, Y. 1985. Limbic seizure and brain damage produced by kainic acid: Mechanisms and relevance to human temporal lobe epilepsy. Neuroscience 14: 375–403. Ben-Ari, Y., Tremblay, E., and Ottersen, O.P. 1980. Injections of kainic acid into the amygdaloid complex of the rat: an electrographic, clinical and histological study in relation to the pathology of epilepsy. Neuroscience 5: 515–528. Ben-Ari, Y., Riche, D., Tremblay, E., and Charton, G. 1981a. Alterations in local glucose consumption following systemic administration of kainic acid, bicuculline or metrazol. Eur Neurol 20: 173–175. Ben-Ari, Y., Tremblay, E., Berger, M., and Nitecka, L. 1984. Kainic acid seizure syndrome and binding sites in developing rats. Dev Brain Res 14: 284–288. Ben-Ari, Y., Tremblay, E., Riche, D., Ghilini, G., and Naquet, R. 1981b. Electrographic, clinical and pathological alterations following systemic administration of kainic acid, bicuculline or pentetrazole: Metabolic mapping using the deoxyglucose method with special reference to the pathology of epilepsy. Neuroscience 6: 1361–1391. Blennow, G., Folbergrova, J., Nilsson, B., and Siesjo, B.K. 1979. Cerebral metabolic and circulatory changes in the rat during sustained seizures induced by DL-homocysteine. Brain Res 179: 129–146. Brabcová, R., Kubová, H., Velísˇek, L., and Maresˇ, P. 1993. Effects of benzodiazepine, bretazenil (Ro 16-6028), on rhythmic metrazol EEG activity: comparison with standart anticonvulsants. Epilepsia 34: 1135–1140. Braestrup, C., and Nielsen, M. 1982. Beta-carbolines and benzodiazepine receptors. Prog Clin Biol Res 90: 227–231. Braestrup, C., Nielsen, M., and Olsen, C.E. 1980. Urinary and brain betacarboline-3-carboxylates as potent inhibitors of brain benzodiazepine receptors. Proc Natl Acad Sci U S A 77: 2288–2292. Braestrup, C., Schmiechen, R., Neef, G., Nielsen, M., and Petersen, E.N. 1982. Interaction of convulsive ligands with benzodiazepine receptors. Science 216: 1241–1243. Braestrup, C., Nielsen, M., Honore, T., Jensen, L.H., and Petersen, E.N. 1983. Benzodiazepine receptor ligands with positive and negative efficacy. Neuropharmacology 22: 1451–1457. Brandt, C., Potschka, H., Loscher, W., and Ebert, U. 2003. N-methyl-daspartate receptor blockade after status epilepticus protects against limbic brain damage but not against epilepsy in the kainate model of temporal lobe epilepsy. Neuroscience 118: 727–740. Budziszewska, B., Siwanowicz, J., Leskiewicz, M., Jaworska-Feil, L., and Lason, W. 1998. Protective effects of neurosteroids against NMDAinduced seizures and lethality in mice. Eur Neuropsychopharmacol 8: 7–12. Campbell, A.M., and Holmes, O. 1984. Bicuculline epileptogenesis in the rat. Brain Res 323: 239–246.
References Cavalheiro, E.A., Silva, D.F., Turski, W.A., Calderazzo-Filho, L.S., Bortolotto, Z.A., and Turski, L. 1987. The susceptibility of rats to pilocarpine-induced seizures is age-dependent. Dev Brain Res 465: 43–58. Cavalheiro, L.A., Riche, D.A., and Le Gal La Salle, G. 1982. Long-term effects of intrahippocampal kainic acid injection in rats: a method for inducing spontaneous recurrent seizures. Electroencephalogr Clin Neurophysiol 53: 581–589. Cendes, F., Andermann, F., Carpenter, S., Zatorre, R.J., and Cashman, N.R. 1995. Temporal lobe epilepsy caused by domoic acid intoxication: evidence for glutamate receptor-mediated excitotoxicity in humans. Ann Neurol 37: 123–126. Chang, J.H., Yang, X.F., Zempel, J.M., and Rothman, S.M. 2004. The unilateral cobalt wire model of neocortical epilepsy: a method of producing subacute focal seizures in rodents. Epilepsy Res 61: 153–160. Chapman, A.G., Cheetham, S.C., Hart, G.P., Meldrum, B.S., and Westerberg, E. 1985. Effects of two convulsant beta-carboline derivatives, DMCM and beta-CCM, on regional neurotransmitter amino acid levels and on in vitro D-[3H]aspartate release in rodents. J Neurochem 45: 370–381. Chapman, A.G., De Sarro, G.B., Premachandra, M., and Meldrum, B.S. 1987. Bidirectional effects of beta-carbolines in reflex epilepsy. Brain Res Bull 19: 337–346. Chen, R.-C., Huang, Y.-H., and How, S.-W. 1986. Systemic penicillin as an experimental model of epilepsy. Exp Neurol 92: 533–540. Cherubini, E., DeFeo, M.R., Mecarelli, O., and Ricci, G.F. 1983. Behavioral and electrograhic patterns induced by systemic administration of kainic acid in developing rats. Dev Brain Res 9: 69–77. Chu, N.S. 1981. Caffeine- and aminophylline-induced seizures. Epilepsia 22: 85–94. Clifford, D.B., Olney, J.W., Maniotis, A., Collins, R.C., and Zorumski, C.F. 1987. The functional anatomy and pathology of lithium-pilocarpine and high- dose pilocarpine seizures. Neuroscience 23: 953–968. Colasanti, B.K., and Craig, C.R. 1992. Reduction of seizure frequency by clonazepam during cobalt experimental epilepsy. Brain Res Bull 28: 329–331. Collins, M.A., and Neafsey, E.J. 2000. Carbolines and Isoquinones. In Experimental and Clinical Neurotoxicology. Eds. P.S. Spencer, and H.H. Schaumburg. pp 304–314. New York: Oxford University Press. Collins, R.C., McLean, M., and Olney, J. 1980. Cerebral metabolic response to systemic kainic acid: 14-C-deoxyglucose studies. Life Sci 27: 855–862. Cooper, R.M., and Legare, C. 1997. Effects of neocortical implants of cobalt and other seizure-inducing metals on brain C-14 2-deoxyglucose uptake. Epilepsy Res 27: 13–28. Cooper, R.M., Legare, C.E., and Campbell Teskey, G. 2001. Changes in (14)C-labeled 2-deoxyglucose brain uptake from nickel-induced epileptic activity. Brain Res 923: 71–81. Cornblath, M., and Schwartz, R. 1991. Disorders of Carbohydrate Metabolism in Infancy. Boston: Blackwell Scientific Publications. Craig, C.R., and Colasanti, B.K. 1992. Reduction of frequency of seizures by carbamazepine during cobalt experimental epilepsy in the rat. Pharmacol Biochem Behav 41: 813–816. Croucher, M., De Sarro, G., Jensen, L., and Meldrum, B. 1984. Behavioural and convulsant actions of two methyl esters of beta-carboline-3carboxylic acid in photosensitive baboons and in DBA/2 mice. Eur J Pharmacol 104: 55–60. Curtis, D.R., Duggan, A.W., and Johnston, G.A. 1971. The specificity of strychnine as a glycine antagonist in the mammalian spinal cord. Exp Brain Res 12: 547–565. Dambinova, S.A., Granstrem, O.K., Tourov, A., Salluzzo, R., Castello, F., and Izykenova, G.A. 1998. Monitoring of brain spiking activity and autoantibodies to N-terminus domain of GluR1 subunit of AMPA receptors in blood serum of rats with cobalt-induced epilepsy. J Neurochem 71: 2088–2093.
147
Davis, E.A., Keating, B., Byrne, G.C., Russell, M., and Jones, T.W. 1997. Hypoglycemia: incidence and clinical predictors in a large populationbased sample of children and adolescents with IDDM. Diabetes Care 20: 22–25. de Casrilevitz, M., Engelhardt, E., and Esbérard, C. 1971. Maturation of convulsogenic activity induced by leptazol in the albino rat. Br J Pharmacol 42: 31–42. De Deyn, P.P., D’Hooge, R., Marescau, B., and Pei, Y.Q. 1992. Chemical models of epilepsy with some reference to their applicability in the development of anticonvulsants. Epilepsy Res 12: 87–110. de Feo, M., Mecarelli, O., and Ricci, G. 1985. Bicuculline-and allyglycineinduced epilepsy in developing rats. Exp Neurol 90: 411–421. Depaulis, A., Snead, O.C.I., Marescaux, C., and Vergnes, M. 1989. Suppressive effects of intranigral injection of muscimol in three models of generalized non-convulsive epilepsy induced by chemical agents. Brain Res 498: 64–72. Dingledine, R., and Gjerstad, L. 1980. Reduced inhibition during epileptiform activity in the in vitro hippocampal slice. J Physiol 305: 297–313. Doi, T., Ueda, Y., Tokumaru, J., Mitsuyama, Y., and Willmore, L.J. 2000. Sequential changes in glutamate transporter mRNA levels during Fe(3+)-induced epileptogenesis. Brain Res Mol Brain Res 75: 105–112. Eger, E. I. II, Gong, D., Xing, Y., Raines, D.E., and Flood, P. 2002. Acetylcholine receptors and thresholds for convulsions from flurothyl and 1,2dichlorohexafluorocyclobutane. Anesth Analg 95: 1611–1615. Eng, R.H.K., Munsif, A.N., Yangco, B.G., Smith, S.M., and Chmel, H. 1989. Seizure propensity with imipenenm. Arch Intern Med 149: 1881–1883. Engel, J., Jr. 2001. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia 42: 796–803. Evans, M.C., and Meldrum, B.S. 1984. Regional brain glucose metabolism in chemically-induced seizures in the rat. Brain Res 297: 235–245. Fagg, G., Foster, A., and Ganong, A. 1986. Excitatory amino acid synaptic mechanism and neurological function. Trends Pharmacol Sci 7: 357–363. Fariello, R.G., Golden, G.T., and Pisa, M. 1980. Homotaurine antagonizes the neurotoxic and convulsant action of systemically administered kainic acid (KA). Neurology 30: 386. Finnerty, G.T., and Jefferys, J.G. 2002. Investigation of the neuronal aggregate generating seizures in the rat tetanus toxin model of epilepsy. J Neurophysiol 88: 2919–2927. Fisher, R.S. 1989. Animal models of epilepsies. Brain Res Rev 14: 245–278. Folbergrová, J., Haugvicová, R., and Maresˇ, P. 2000. Behavioral and metabolic changes in immature rats during seizures induced by homocysteic acid: the protective effect of NMDA and non-NMDA receptor antagonists. Exp Neurol 161: 336–345. Fuller, T.A., and Olney, J.W. 1979. Effects of morphine and naloxone on kainic acid neurotoxicity. Life Sci 24: 1793–1798. Gale, K. 1995. Chemoconvulsant seizures: advantages of focally-evoked seizure models. Ital J Neurol Sci 16: 17–25. Gatt, A., Velísˇková, J., Liu, Z., Moshé, S.L., and Holmes, G.L. 1993. Ontogeny of flurothyl-induced seizures: A behavioral and EEG electroencephalogrpahic analysis. Epilepsia 34(Suppl 6): 63. Giorgi, F.S., Malhotra, S., Hasson, H., Velísˇková, J., Rosenbaum, D., and Moshé, S.L. 2005. Effects of status epilepticus early in life on susceptibility to ischemic injury in adulthood. Epilepsia. 46: 490–498. Gloor, P., and Testa, G. 1974. Generalized penicillin epilepsy in the cat: Effect of intracarotid and intravertebral pentylenetetrazol and amobarbital injections. Electroencephalogr Clin Neurophysiol 36: 499–515. Griffin, J.W., and Oyler, G. 2000. Tetanospasmin. In Experimental and Clinical Neurotoxicology. Eds. P.S. Spencer, and H.H. Schaumburg. pp 1143–1148. New York: Oxford University Press. Grondahl, T.O. and Langmoen, I.A. 1993. Epileptogenic effect of antibiotic drugs. J Neurosurg 78: 938–943.
148
Chapter 11/Models of Chemically-Induced Acute Seizures
Gutnick, M.J., Van Duijn, H., and Citri, N. 1976. Relative convulsant potencies of structural analogues of penicillin. Brain Res 114: 139–143. Haas, K.Z., Sperber, E.F., Opanashuk, L.A., Stanton, P.K., and Moshé, S.L. 2001. Resistance of the immature hippocampus to morphologic and physiologic alterations following status epilepticus or kindling. Hippocampus 11: 615–625. Halonen, T., Tortorella, A., Zrebeet, H., and Gale, K. 1994. Posterior piriform and perirhinal cortex relay seizures evoked from the area tempestas: role of excitatory and inhibitory amino acid receptors. Brain Res 652: 145–148. Hamani, C., and Mello, L.E. 1997. Status epilepticus induced by pilocarpine and picrotoxin. Epilepsy Res 28: 73–82. Hamani, C., and Mello, L.E. 2002. Spontaneous recurrent seizures and neuropathology in the chronic phase of the pilocarpine and picrotoxin model epilepsy. Neurol Res 24: 199–209. Harrison, N.L., and Simmonds, M.A. 1983. The picrotoxin-like action of a convulsant benzodiazepine, Ro5-3663. Eur J Pharmacol 87: 155–158. Haut, S.R., Velísˇková, J., and Moshé, S.L. 2004. Susceptibility of immature and adult brains to seizure effects. Lancet Neurol 3: 608–617. Hayashi, T. 1952. A physiological study of epileptic seizures following cortical stimulation in animals and its aplication to human clinics. Jap J Pharmacol 3: 46–64. Heggli, D.E., and Malthe-Sorenssen, D. 1982. Systemic injection of kainic acid: effect on neurotransmitter markers in piriform cortex, amygdaloid complex and hippocampus and protection by cortical lesioning and anticonvulsants. Neuroscience 7: 1257–1264. Hiscock, J.J., MacKenzie, L., and Willoughby, J.O. 1996. Fos induction in subtypes of cerebrocortical neurons following single picrotoxininduced seizures. Brain Res 738: 301–312. Horton, R.W., and Meldrum, B.S. 1973. Seizures induced by allylglycine, 3-mercaptopropionic acid and 4-deoxypyridoxine in mice and photosensitive baboons, and different modes of inhibition of cerebral glutamic acid decarboxylase. Br J Pharmacol 49: 52–63. Huang, L., Cilio, M.R., Silveira, D.C., McCabe, B.K., Sogawa, Y., Stafstrom, C.E., and Holmes, G.L. 1999. Long-term effects of neonatal seizures: a behavioral, electrophysiological, and histological study. Brain Res Dev Brain Res 118: 99–107. Insel, T.R., Miller, R.P., and Gelhard, R.E. 1990. The ontogeny of excitatory amino acid receptors in rat forebrain. I. N-methyl-D-aspartate receptors and quisqualate receptors. Neuroscience 35: 31–43. Ishimoto, T., Omori, N., Mutoh, F., and Chiba, S. 2000. Convulsive seizures induced by N-methyl-D-aspartate microinjection into the mesencephalic reticular formation in rats. Brain Res 881: 152–158. Jefferys, J.G., and Williams, S.F. 1987. Physiological and behavioural consequences of seizures induced in the rat by intrahippocampal tetanus toxin. Brain 110: 517–532. Jensen, F.E., Firkusny, I.R., and Mower, G.D. 1993. Differences in c-fos immunoreactivity due to age and mode of seizure induction. Mol Brain Res 17: 185–193. Jensen, M.H., Jorgensen, S., Nielsen, H., Sanchez, R., and Andersen, P.K. 1984. Is theophylline-induced seizures in man caused by inhibition of cerebral 5¢-nucleotidase activity? Acta Pharmacol Toxicol (Copenh) 55: 331–334. Jensen, L.H., Petersen, E.N., and Braestrup, C. 1983. Audiogenic seizures in DBA/2 mice discriminate sensitively between low efficacy benzodiazepine receptor agonists and inverse agonists. Life Sci 33: 393–399. Johnson, H.C., Walker, A.E., Case, T.J., and Kollros, J.J. 1946. Effects of antibiotic substances on the central nervous system. Arch Neurol Psychiatry 56: 184–197. Jope, R.S., Morrisett, R.A., and Snead III, O.C. 1986. Characterization of lithium potentiation of pilocarpine-induced status epilepticus in rats. Exp Neurol 67: 471–480. Jurson, P.A., and Freed, W.J. 1990. A slight anticonvulsant effect of CNQX and DNQX as measured by homocysteine- and quisqualate-induced seizures. Pharmacol Biochem Behav 36: 177–181.
Kábová, R., Liptáková, S., Sˇ lamberová, R., Pometlová, M., and Velísˇek, L. 1999. Age-specific N-methyl-d-aspartate-induced seizures: perspectives for the West syndrome model. Epilepsia 40: 1357–1369. Kabuto, H., Yokoi, I., and Ogawa, N. 1998. Melatonin inhibits iron-induced epileptic discharges in rats by suppressing peroxidation. Epilepsia 39: 237–243. Kamei, C., Sunami, A., and Tasaka, K. 1983. Epileptogenic activity of cephalosporins in rats and their structure activity relationship. Epilepsia 24: 431–439. Kaufman, F.R. 1998. Diabetes in children and adolescents. Areas of controversy. Med Clin North Am 82: 721–738. Kopeloff, L.M., Barrera, S.E., and Kopeloff, N. 1942. Recurrent convulsive seizures in animals produced by immunologic and chemical means. Am J Psychol 98: 881–902. Kopeloff, L.M., Chusid, J.G., and Kopeloff, N. 1954. Chronic experimental epilepsy in Macaca mulatta. Neurology 4: 218–227. Kubová, H., and Maresˇ, P. 1994. Effects of MK-801 (dizocilpine) and ketamine on strychnine-induced convulsions in rats: comparison with benzodiazepines and standard anticonvulsants. Physiol Res 43: 313–320. Kubová, H., and Maresˇ, P. 1995. Different postnatal development of convulsions and lethality induced by strychnine in rats. Pharmacol Toxicol 77: 219–224. Kubová, H., Bohuslav, T., and Maresˇ, P. 1990. Anticonvulsant effects of clonazepam on chemically induced convulsions. Physiol Bohemoslov 39: 459–469. Kubová, H., Folbergrová, J., and Maresˇ, P. 1995. Seizures induced by homocysteine in rats during ontogenesis. Epilepsia 36: 750–756. Kubová, H., Druga, R., Lukasiuk, K., Suchomelová, L., Haugvicová, R., Jirmanová, I., and Pitkanen, A. 2001. Status epilepticus causes necrotic damage in the mediodorsal nucleus of the thalamus in immature rats. J Neurosci 21: 3593–3599. Kuhar, M., and Yamamura, H.I. 1976. Localization of cholinergic muscarinic receptors in rat brain by light microscopic radioautography. Brain Res 110: 229–243. Lado, F., and Moshé, S.L. 2002. Role of subcortical structures in the pathogenesis of infantile spasms: What are possible subcortical mediators? 2002. In Epilepsy, Infantile Spasms and Developmental Encepahlopathy. Eds. P.A. Schwartzkroin and J. Rho. pp. 116–135. New York: Academic Press. Lamar, C., Jr. 1970. Mercaptopropionic acid: a convulsant that inhibits glutamate decarboxylase. J Neurochem 17: 165–170. Lees, G.J. 1995. Influence of ketamine on the neuronal death caused by NMDA in the rat hippocampus. Neuropharmacology 34: 411–417. Lewis, L.D., Ljunggren, B., Ratcheson, R.A., and Siesjo, B.K. 1974. Cerebral energy state in insulin-induced hypoglycemia, related to blood glucose and to EEG. J Neurochem 23: 673–679. Löscher, W. 1979. 3-Mercaptopropionic acid: convulsant properties, effects on enzymes of the gamma-aminobutyrate system in mouse brain and antagonism by certain anticonvulsant drugs, aminooxyacetic acid and gabaculine. Biochem Pharmacol 28: 1397–1407. Löscher, W. 1997. Animal models of intractable epilepsy. Prog Neurobiol 53: 239–258. Löscher, W., and Schmidt, D. 1988. Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res 2: 145–181. Lothman, E.W., and Collins, R.C. 1981. Kainic acid induced limbic seizures: Metabolic, behavioral, electroencephalographic and neuropathological correlates. Brain Res 218: 299–318. Lotti, M. 2000. Organophosphorus Compounds. In Experimental and Clinical Neurotoxicology. Eds. P.S. Spencer, and H.H. Schaumburg. pp. 897–925. New York: Oxford University Press. Louis, E.D., Williamson, P.D., and Darcey, T.M. 1987. Experimental models of chronic focal epilepsy: a critical review of four models. Yale J Biol Med 60: 255–272.
References Ludolph, A.C. 2000a. Allylglycine. In Experimental and Clinical Neurotoxicology. Eds. P.S. Spencer, and H.H. Schaumburg. pp. 140–141. New York: Oxford University Press. Ludolph, A.C. 2000b. Bicuculline. In Experimental and Clinical Neurotoxicology. Eds. P.S. Spencer, and H.H. Schaumburg. pp. 235–236. New York: Oxford University Press. Ludolph, A.C., and Spencer, P.S. 2000. Picrotoxin. Experimental and Clinical Neurotoxicology. Eds. P.S. Spencer, and H.H. Schaumburg. p. 1004. New York: Oxford University Press. Mackenzie, L., Medvedev, A., Hiscock, J.J., Pope, K.J., and Willoughby, J.O. 2002. Picrotoxin-induced generalised convulsive seizure in rat: changes in regional distribution and frequency of the power of electroencephalogram rhythms. Clin Neurophysiol 113: 586–596. Maresˇ, P., and Trojan, S. 1991. Ontogenetic development of isonicotinehydrazide-induced seizures in rats. Brain Dev 13: 121–125. Maresˇ, P., and Velísˇek, L. 1992. N-Methyl-D-aspartate (NMDA)-induced seizures in developing rats. Dev Brain Res 65: 185–189. Maresˇ, P., Chino, M., Kubová, H., Mathern, P., and Velik´y, M. 2000. Convulsant action of systemically administered glutamate and bicuculline methiodide in immature rats. Epilepsy Res 42: 183–189. Maresˇ, P., Folbergrová, J., and Kubová, H. 2004. Excitatory aminoacids and epileptic seizures in immature brain. Physiol Res 53(Suppl 1): S115–S124. Maresˇ, P., Folbergrová, J., Langmeier, M., Haugvicová, R., and Kubová, H. 1997. Convulsant action of D,L-homocysteic acid and its stereoisomers in immature rats. Epilepsia 38: 767–776. Maresˇ, P., Hlavatá, J., Lisˇková, K., and Mudrochová, M. 1983. Effects of carbamazepine and diphenylhydantoin on metrazol seizures during ontogenesis in rats. Physiol Bohemoslov 32: 92–96. Maresˇ, P., Kubová, H., and Czuczwar, S.J. 1994. Aminophylline exhibits convulsant action in rats during ontogenesis. Brain Dev 16: 296–300. Maresˇ, P., Kubová, H., Zouhar, A., Folbergrová, J., Koryntová, H., and Stanˇ ková, L. 1993. Motor and electrocorticographic activity induced by 3-mercaptopropionic acid in immature rats. Epilepsy Res 16: 11–18. Maresˇ, P., Lisˇkova-Bernásˇkova, K., and Mudrochová, M. 1987. Ontogenetic development of convulsant action of Ro 5-3663 in the rat. Life Sci 40: 1161–1170. Maresˇ, P., Maresˇová, D., and Schickerová, R. 1981. Effect of antiepileptic drugs on metrazol convulsions during ontogenesis in rats. Physiol Bohemoslov 30. Marescaux, C., Micheletti, G., Vergnes, M., Depaulis, A., Rumbach, L., and Warter, J.M. 1984. A model of chronic spontaneous petit mal-like seizures in the rat: comparison with pentylenetetrazol-induced seizures. Epilepsia 25: 326–331. Mateˇjovská, I., Velísˇková, J., and Velísˇek, L. 1998. Bicuculline-induced rhythmic EEG episodes: gender differences and the effects of ethosuximide- and baclofen-treatment. Epilepsia 39: 1243–1252. Matsumoto, H., and Ajmonemarsan, C. 1964. Cellular Mechanisms in Experimental Epileptic Seizures. Science 144: 193–194. McCabe, B.K., Silveira, D.C., Cilio, M.R., Cha, B.H., Liu, X., Sogawa, Y., and Holmes, G.L. 2001. Reduced neurogenesis after neonatal seizures. J Neurosci 21: 2094–2103. McDonald, J.W., Silverstein, F.S., and Johnston, M.V. 1988. Neurotoxicity of N-methyl-d-aspartate is markedly enhanced in developing rat central nervous system. Brain Res 459: 200–203. McGeer, E.G., Olney, J.W., and McGeer, P.L. 1978. Kainic acid as a tool in Neurobiology. New York: Raven Press. Meldrum, B. 1984. GABAergic agents as anticonvulsants in baboons with photosensitive epilepsy. Neurosci Lett 47: 345–349. Meldrum, B.S., and Chapman, A.G. 1986. Benzodiazepine receptors and their relationship to the treatment of epilepsy. Epilepsia 27(Suppl 1): S3–S13. Meldrum, B.S., Swan, J.H., Ottersen, O.P., and Storm-Mathisen, J. 1987. Redistribution of transmitter amino acids in rat hippocampus and cerebellum during seizures induced by l-allylglycine and bicuculline: an
149
immunocytochemical study with antisera against conjugated GABA, glutamate and aspartate. Neuroscience 22: 17–27. Mellanby, J., George, G., Robinson, A., and Thompson, P. 1977. Epileptiform syndrome in rats produced by injecting tetanus toxin into the hippocampus. J Neurol Neurosurg Psychiatry 40: 404–414. Miller, L.P., Johnson, A.E., Gelhard, R.E., and Insel, T.R. 1990. The ontogeny of excitatory amino acid receptors in the rat forebrain-II. Kainic acid receptors. Neuroscience 35: 45–51. Morgan, P.F., and Linnoila, M. 1991. Regional induction of c-fos mRNA by NMDA: a quantitative in-situ hybridization study. Neuroreport 2: 251–254. Nehlig, A., and de Vasconselos, A.P. 1996. The model of pentylenetetrazolinduced status epilepticus in the immature rat: short- and long-term effects. Epilepsy Res 26: 93–103. Nehlig, A., Vergnes, M., Marescaux, C., and Boyet, S. 1992. Mapping of cerebral energy metabolism in rats with genetic generalized nonconvulsive epilepsy. J Neural Transm 35: 141–153. Nistico, G., Musolino, R., Naccari, F., and Di Perri, R. 1978. Experimental epilepsy in chicks and rats after intravenous benzylpenicillin and cefazolin. Boll Soc Ital Biol Sper 54: 600–605. Nitecka, L., Tremblay, E., Charton, G., Bouillot, J.P., Berger, M.L., and Ben-Ari, Y. 1984. Maturation of kainic acid seizure-brain damage syndrome in the rat. II Histopathological sequelae. Neuroscience 13: 1073–1094. Noebels, J.L., and Pedley, T.A. 1977. Anatomic localization of topically applied [14C]penicillin during experimental focal epilepsy in cat neocortex. Brain Res 125: 293–303. Olsen, R.W. 1981. The GABA postsynaptic membrane receptor-ionophore complex. Site of action of convulsant and anticonvulsant drugs. Mol Cell Biochem 39: 261–279. Ono, J., Vieth, R., and Walson, P.D. 1990. Electrocorticographical observation of seizures induced by pentylenetetrazol (PTZ) injection in rats. Funct Neurol 5: 345–352. Orlof, M.J., Williams, H.L., and Pfeiffer, C.C. 1949. Timed intravenous infusion of metrazol and strychnine for testing anticonvulsant drugs. Proc Soc Exp Biol Med 70: 254–257. Pei, Y.Q., and Koyama, I. 1986. Features of seizures and behavioral changes induced by intrahippocampal injection of zinc sulfate in the rabbit: a new experimental model of epilepsy. Epilepsia 27: 183–188. Pereira de Vasconcelos, A., el Hamdi, G., Vert, P., and Nehlig, A. 1992. An experimental model of generalized seizures for the measurement of local cerebral glucose utilization in the immature rat. II mapping of the brain metabolism using quantitative [14C]-2-deoxyglucose technique. Dev Brain Res. 69: 243–259. Pereira de Vasconcelos, A., Boyet, S., Koziel, V., and Nehlig, A. 1995. Effects of pentylenetetrazol-induced status epilepticus on local cerebral blood flow in the developing rat. J Cereb Blood Flow Metab 15: 270–283. Petersen, E.N. 1983. DMCM: a potent convulsive benzodiazepine receptor ligand. Eur J Pharmacol 94: 117–124. Pineau, N., Charriaut–Marlangue, C., Motte, J., and Nehlig, A. 1999. Pentylenetetrazol seizures induce cell suffering but not death in the immature rat brain. Brain Res Dev Brain Res 112: 139–144. Pitkanen, A., and Sutula, T.P. 2002. Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy. Lancet Neurol 1: 173–181. Pocecco, M., and Ronfani, L. 1998. Transient focal neurologic deficits associated with hypoglycaemia in children with insulin-dependent diabetes mellitus. Italian Collaborative Paediatric Diabetologic Group. Acta Paediatr 87: 542–544. Prado de Carvalho, L., Grecksch, G., Cavalheiro, E.A., Dodd, R.H., Chapouthier, G., and Rossier, J. 1984. Characterization of convulsions induced by methyl beta-carboline-3-carboxylate in mice. Eur J Pharmacol 103: 287–293.
150
Chapter 11/Models of Chemically-Induced Acute Seizures
Prichard, J.W., Gallagher, B.B., and Glaser, G.H. 1969. Experimental seizure-threshold testing with flurothyl. J Pharmacol Exp Ther 166: 170–178. Prince, D.A. 1968. The depolarization shift in “epileptic” neurons. Exp Neurol 21: 467–485. Prince, D.A., and Wilder, B.J. 1967. Control mechanisms in cortical epileptogenic foci. Arch Neurol 16: 194–202. Pylkkö, O., and Woodbury, D. 1961. The effect of maturation on chemically induced seizures in rats. J Pharmacol Exp Therap 131: 185–190. Rashid, S., Lee, I., Anderson, A.E., Hrachovy, R.A., and Swann, J.W. 1999. Insights into the tetanus toxin model of early-onset epilepsy from longterm video monitoring during anticonvulsant therapy. Brain Res Dev Brain Res 118: 221–225. Reinhard, J.F., and Reinhard, J.F.J. 1977. Experimental evaluation of anticonvulsants. In Anticonvulsants. Eds. J.A. Vida. pp. 57–111. New York: Academic Press. Sarkisian, M.R. 2001. Overview of the Current Animal Models for Human Seizure and Epileptic Disorders. Epilepsy Behav 2: 201–216. Sawamura, A., Hashizume, K., Yoshida, K., and Tanaka, T. 2001. Kainic acid-induced substantia nigra seizure in rats: behavior, EEG and metabolism. Brain Res 911: 89–95. Schickerová, R., Maresˇ, P., and Trojan, S. 1984. Correlation between electrocorticographic and motor phenomena induced by pentamethylenetetrazol during ontogenesis in rats. Exp Neurol 84: 153–164. Schoepp, D.D., Gamble, A.Y., Salhoff, C.R., Johnson, B.G., and Ornstein, P.L. 1990. Excitatory amino acid-induced convulsions in neonatal rats mediated by distinct receptor subtypes. Eur J Pharmacol 182: 421–427. Schröder, J.M. 2000. Isoniazid. In Experimental and Clinical Neurotoxicology. Eds. P.S. Spencer, and H.H. Schaumburg. pp. 690–697. New York: Oxford University Press. Schwarz, S.S., and Freed, W.J. 1986. Inhibition of quisqualate-induced seizures by glutamic acid diethyl ester and anti-epileptic drugs. J Neural Transm 67: 191–203. Seutin, V., and Johnson, S.W. 1999. Recent advances in the pharmacology of quaternary salts of bicuculline. Trends Pharmacol Sci 20: 268–270. Shih, T., McDonough, J.H. Jr., and Koplovitz, I. 1999. Anticonvulsants for soman-induced seizure activity. J Biomed Sci 6: 86–96. Shih, T.M., and McDonough, J.H. Jr. 1999. Organophosphorus nerve agents-induced seizures and efficacy of atropine sulfate as anticonvulsant treatment. Pharmacol Biochem Behav 64: 147–153. Shih, T.M., Duniho, S.M., and McDonough, J.H. 2003. Control of nerve agent-induced seizures is critical for neuroprotection and survival. Toxicol Appl Pharmacol 188: 69–80. Sierra-Paredes, G., and Sierra-Marcuno, G. 1996a. Effects of NMDA antagonists on seizure thresholds induced by intrahippocampal microdialysis of picrotoxin in freely moving rats. Neurosci Lett 218: 62–66. Sierra-Paredes, G., and Sierra-Marcuno, G. 1996b. Microperfusion of picrotoxin in the hippocampus of chronic freely moving rats through microdialysis probes: a new method of induce partial and secondary generalized seizures. J Neurosci Methods 67: 113–120. Smith, K.L., Lee, C.L., and Swann, J.W. 1998. Local circuit abnormalities in chronically epileptic rats after intrahippocampal tetanus toxin injection in infancy. J Neurophysiol 79: 106–116. Sogawa, Y., Monokoshi, M., Silveira, D.C., Cha, B.H., Cilio, M.R., McCabe, B.K., Liu, X., et al. 2001. Timing of cognitive deficits following neonatal seizures: relationship to histological changes in the hippocampus. Brain Res Dev Brain Res 131: 73–83. Somjen, G.G. 2001. Mechanisms of spreading depression and hypoxic spreading depression-like depolarization. Physiol Rev 81: 1065–1096. Soukupová, S., Mikolásˇová, R., Kubová, H., and Maresˇ, P. 1993. New model of cortical foci in freely moving developing rats. Epilepsy Res 15: 27–34. Spencer, P.S. 2000a. Aluminum and its compounds. In Experimental and Clinical Neurotoxicology. Eds. P.S. Spencer, and H.H. Schaumburg. pp. 142–151. New York: Oxford University Press.
Spencer, P.S. 2000b. 3-Mercaptopropionic acid. In Experimental and Clinical Neurotoxicology. Eds. P.S. Spencer, and H.H. Schaumburg. pp. 762–763. New York: Oxford University Press. Spencer, P.S., and Schaumburg, H.H. (Eds.) 2000. Experimental and Clinical Neurotoxicology. New York: Oxford University Press. Spencer, P.S., Wilson, B.W., and Albuquerque, E.X. 2000. Sarin, other “nerve agents” and their antidotes. In Experimental and Clinical Neurotoxicology. Eds. P.S. Spencer, and H.H. Schaumburg. pp. 1073–1093. New York: Oxford University Press. Sperber, E. 1996a. The relationship between seizures and damage in the maturing brain. In Progressive Nature of Epileptogenesis. Eds. U. Heinemann, J.J. Engel, G. Avanzini, B. Meldrum, A. Mouritzen-Dam, and C. Wasterlain. pp. 365–376. Amsterdam: Elsevier. Sperber, E.F. 1996b. The relationship between seizures and damage in the maturing brain. In Progressive Nature of Epileptogenesis. Eds. U. Heinemann, J. Engel Jr., G. Avanzini, B.S. Meldrum, A. MouritzenDam, and C. Wasterlain. pp. 365–376. Amsterdam: Elsevier. Sperber, E.F., and Moshé, S.L. 1988. Age-related differences in seizure susceptibility to flurothyl. Dev Brain Res 39: 295–297. Sperber, E.F., and Moshé, S.L. 2001. The effects of seizures on the hippocampus of the immature brain. In Brain Plasticity and Epilepsy: A Tribute to Frank Morrell. Eds. J.J. Engel, P.A. Schwartzkroin, S.L. Moshé, and D.H. Lowenstein. pp 119–139. San Diego: Academic Press. Sperber, E.F., Haas, K.Z., Romero, M.T., and Stanton, P.K. 1999a. Flurothyl status epilepticus in developing rats: behavioral, electrographic histological and electrophysiological studies. Brain Res Dev Brain Res 116: 59–68. Sperber, E.F., Germano, I.M., Friedman, L.K., Velísˇková, J., and Romero, M.T. 1999b. The resiliency of the immature brain to seizure-induced damage. In Childhood Epilepsies and Brain Development. Eds. A. Nehlig, J. Motte, S.L. Moshé, and P. Plouin. pp 255–262. London: John Libbey. Sperk, G., Lassmann, H., Baran, H., Kish, S.J., Seitelberger, F., and Hornykiewicz, O. 1983. Kainic acid induced seizures: neurochemical and histopathological changes. Neuroscience 10: 1301–1315. Stafstrom, C.E., and Holmes, G.L. 2002. Infantile spasms: criteria for an animal model. Int Rev Neurobiol 49: 391–411. Stafstrom, C.E., and Sasaki-Adams, D.M. 2003. NMDA-induced seizures in developing rats cause long-term learning impairment and increased seizure susceptibility. Epilepsy Res 53: 129–137. Stafstrom, C.E., Thompson, J.L., and Holmes, G.L. 1992. Kainic acid seizures in the developing brain: status epilepticus and spontaneous recurrent seizures. Brain Res Dev Brain Res 65: 227–236. Stafstrom, C.E., Chronopoulos, A., Thurber, S., Thompson, J.L., and Holmes, G.L. 1993. Age-dependent cognitive and behavioral deficits after kainic acid seizures. Epilepsia 34: 420–432. Stone, W.E., and Javid, M.J. 1980. Aminophylline and imidazole as convulsants. Arch Int Pharmacodyn Ther 248: 120–131. Sutula, T., Zhang, P., Lynch, M., Sayin, U., Golarai, G., and Rod, R. 1998. Synaptic and axonal remodeling of mossy fibers in the hilus and supragranular region of the dentate gyrus in kainate-treated rats. J Comp Neurol 390: 578–594. Swinyard, E.A., Woodhead, J.H., White, H.S., and Franklin, M.R. 1989. Experimental selection, quantification, and evaluation of anticonvulsants. In Antiepileptic Drugs. Eds. R.H. Levy, F.E. Dreifuss, R.H. Mattson, B.S. Meldrum, and J.K. Penry. pp 85–102. New York: Raven Press. Szot, P., White, S.S., McCarthy, E.B., Turella, A., Rejniak, S.X., and Schwartzkroin, P.A. 2001. Behavioral and metabolic features of repetitive seizures in immature and mature rats. Epilepsy Res 46: 191–203. Thomas, J., and Yang, Y.C. 1991. Allyglycine-induced seizures in male and female rats. Physiol Behav 49: 1181–1183. Thurber, S.J., Mikati, M.A., Stafstrom, C.E., Jensen, F.E., and Holmes, G.L. 1994. Quisqualic acid-induced seizures during development: a behavioral and EEG study. Epilepsia 35: 868–875.
References Tremblay, E., Nitecka, L., Berger, M., and Ben-Ari, Y. 1984. Maturation of kainic acid seizure-brain damage syndrome in the rat. I. Clinical, electrographic and metabolic observations. Neuroscience 13: 1051–1072. Truitt, E.B., Ebesberg, E.M., and Ling, A.S.G. 1960. Measurement of brain excitability by use of hexaflurodiethyl ether (Indoclon). J Pharm Exp Ther 129: 445–453. Tuovinen, K. 2004. Organophosphate-induced convulsions and prevention of neuropathological damages. Toxicology 196: 31–39. Turski, L., Ikonomidou, C., Turski, W.A., Bortolotto, Z.A., and Cavalheiro, E.A. 1989a. Cholinergic mechanisms and epileptogenesis: the seizures induced by pilocarpine: a novel experimental model of intractable epilepsy. Synapse 3: 154–171. Turski, L., Ikonomidou, C., Turski, W.A., Bortolotto, Z.A., and Cavalheiro, E.A. 1989b. Review: cholinergic mechanisms and epileptogenesis. The seizures induced by pilocarpine: a novel experimental model of intractable epilepsy. Synapse 3: 154–171. Turski, L., Meldrum, B.S., Cavalheiro, E.A., Calderazzo-Filho, L.S., Bortolotto, Z.A., Ikonomidou-Turski, C., and Turski, W.A. 1987. Paradoxical anticonvulsant activity of the excitatory amino acid N-methyl-D-aspartate in the rat caudate-putamen. Proc Natl Acad Sci U S A 84: 1689–1693. Turski, W., Turski, L., Czuczwar, S.J., and Kleinrok, Z. 1981. (RS)-alphaAmino-3-hydroxy-5-methyl-4-isoxazolepropionic acid: wet dog shakes, catalepsy and body temperature changes in rats. Pharmacol Biochem Behav 15: 545–549. Turski, W.A., Cavalheiro, E.A., Schwarz, M., Czuczwar, S.J., Kleinrok, Z., and Turski, L. 1983. Limbic seizures produced by pilocarpine in rats: behavioural, electroencephalographic and neuropathological study. Behav Brain Res 9: 315–335. Ueda, Y., and Willmore, L.J. 2000a. Molecular regulation of glutamate and GABA transporter proteins by valproic acid in rat hippocampus during epileptogenesis. Exp Brain Res 133: 334–339. Ueda, Y., and Willmore, L.J. 2000b. Hippocampal gamma-aminobutyric acid transporter alterations following focal epileptogenesis induced in rat amygdala. Brain Res Bull 52: 357–361. Ueda, Y., and Willmore, L.J. 2000c. Sequential changes in glutamate transporter protein levels during Fe(3+)-induced epileptogenesis. Epilepsy Res 39: 201–209. Urion, D., Vreman, H.J., and Weiner, M.W. 1979. Effect of acetate on hypoglycemic seizures in mice. Diabetes 28: 1022–1026. Vannucci, R.C., and Vannucci, S.J. 1978. Cerebral carbohydrate metabolism during hypoglycemia and anoxia in newborn rats. Ann Neurol 4: 73–79. Velísˇek, L., and Maresˇ, P. 1990. Anticonvulsant action of ketamine in laboratory animals. In Status of Ketamine in Anesthesiology. Ed. E.F. Domino. pp 541–549. Ann Arbor, Mich.: NPP Books. Velísˇek, L., and Maresˇ, P. 1992. Developmental aspects of the anticonvulsant action of MK-801. In Multiple Sigma and PCP Receptor Ligands: Mechanisms for Neuromodulation and Neuroprotection? Eds. J.M. Kamenka, and E.F. Domino. pp. 779–795. Ann Arbor, Mich.: NPP Books. Velísˇek, L., and Maresˇ, P. 1995. Age-dependent anticonvulsant action of clonazepam in the N-methyl-D-aspartate model of seizures. Pharmacol Biochem Behav 52: 291–296. Velísˇek, L., and Moshé, S.L. 2000a. Penicillins. In Experimental and Clinical Neurotoxicology. Eds. P.S. Spencer, and H.H. Schaumburg. pp. 948–951. New York: Oxford University Press. Velísˇek, L., and Moshé, S.L. 2000b. Cephalosporins. In Experimental and Clinical Neurotoxicology. Eds. P.S. Spencer, and H.H. Schaumburg. pp. 345–348. New York, Oxford University Press. Velísˇek, L., Mikolásˇová, R., and Maresˇ, P. 1989. Effects of ketamine on metrazol-induced seizures during ontogenesis in rats. Pharmacol Biochem Behav 32: 405–410. Velísˇek, L., Vondrˇicˇková, R., and Maresˇ, P. 1993. Models of simple partial and absence seizures in freely moving rats: Action of ketamine. Pharmacol Biochem Behav 45: 889–896.
151
Velísˇek, L., Velísˇková, J., and Moshé, S.L. 1995. Developmental seizure models. Ital J Neurol Sci 16: 127–133. Velísˇek, L., Vachová, D., and Maresˇ, P. 1997. Excitatory amino acid antagonists and pentylenetetrazol-induced seizures during ontogenesis. IV. Effects of CGP 39551. Pharmacol Biochem Behavi 56: 493–498. Velísˇek, L., Kusá, R., Kulovaná, M., and Maresˇ, P. 1990. Excitatory amino acid antagonists and pentylenetetrazol-induced seizures during ontogenesis: I. The effects of 2-amino-7-phosphonoheptanoate. Life Sci 46: 1349–1357. Velísˇek, L., Veresˇová, S., Pôbisˇová, H., and Maresˇ, P. 1991. Excitatory amino acid antagonists and pentylenetetrazol-induced seizures during ontogenesis: II. The effects of MK-801. Psychopharmacology 104: 510–514. Velísˇek, L., Kubová, H., Pohl, M., Stanˇ ková, L., Maresˇ, P., and Schickerová, R. 1992. Pentylenetetrazol-induced seizures in rats: An ontogenetic study. Naunyn Schmiedebergs Arch Pharmacol 346: 588–591. Velísˇková, J., Velísˇek, L., and Maresˇ, P. 1988. Epileptic phenomena produced by kainic acid in laboratory rats during ontogenesis. Physiol Bohemoslov 37: 395–405. Velísˇková, J., Velísˇek, L., Maresˇ, P., and Rokyta, R. 1990. Ketamine suppresses both bicuculline- and picrotoxin-induced generalized tonicclonic seizures during ontogenesis. Pharmacol Biochem Behav 37: 667–674. Velísˇková, J., Velísˇek, L., Maresˇ, P., Rokyta, R., and Budko, K.P. 1991. Bicuculline-induced neocortical epileptiform foci and the effects of 6-hydroxydopamine in developing rats. Brain Res Bull 26: 693– 698. Velísˇková, J., Velísˇek, L., Maresˇ, P., Rokyta, R., and Micˇianiková, D. 1993. Ethosuximide suppresses seizures and lethality induced by picrotoxin in developing rats. Pharmacol Biochem Behav 44: 975–979. Vernadakis, A., and Woodbury, D.M. 1969a. The developing animal as a model. Epilepsia 10: 163–178. Vernadakis, A., and Woodbury, D. 1969b. Maturational factors in development of seizures. In Mechanisms of the Epilepsies. Eds. H. Jasper, A. Ward, and A. Pope. pp. 535–541. Boston: Little, Brown. Walker, A.E., and Johnson, H.C. 1945. Convulsive factor in commercial penicillin. Arch Surg 50: 69–73. Walker, A.E., Johnson, H.C., and Kollros, J.J. 1945. Penicillin convulsions: the convulsive effects of penicillin applied to the cerebral cortex of monkey and man. Surg Gynecol Obstet 81: 692–701. Walker, J.E. 1981a. Effect of aminophylline on seizure thresholds and brain regional cyclic nucleotides in the rat. Exp Neurol 74: 299–304. Walker, J.E. 1981b. Aminophylline seizures in the rat. J Pharm Pharmacol 33: 479–480. Ward, A. 1969. The epileptic neuron: chronic foci in animals and man. In Basic Mechanisms of the Epilepsies. Eds. H. Jasper, A. Ward, and A. Pope. pp. 263–288. Boston: Little, Brown. Wardas, J., Graham, J., and Gale, K. 1990. Evidence for a role of glycine in area tempestas for triggering convulsive seizures. Eur J Pharmacol 187: 59–66. Weller, A., and Mostofsky, D.I. 1995. Ontogenetic development and pentylenetetrazol seizure thresholds in rats. Physiol Behav 57: 629– 631. Williams, H.L., and Bain, J.A. 1961. Convulsive effects of hydrazides: relationship to pyridoxine. Int Rev Neurobiol 3: 319–348. Wong, R.K., and Prince, D.A. 1979. Dendritic mechanisms underlying penicillin-induced epileptiform activity. Science 204: 1228–1231. Woodbury, D.M. 1980a. Convulsant drugs; mechanism of drug action. Adv Neurol 27: 249–303. Woodbury, D.M. 1980b. Convulsants. In Antiepileptic Drugs: Mechanisms of Action. Eds. G.H. Glaser, J.K. Penry, and D.M. Woodbury. New York: Raven Press. Worms, P., Willigens, M.T., and Lloyd, K.G. 1981. The behavioral effects of systemically administered kainic acid: a pharmacological analysis. Life Sci 29: 2215–2225.
152
Chapter 11/Models of Chemically-Induced Acute Seizures
Wyler, A.R., Burchiel, K.J., and Ward, A.A., Jr. 1978. Chronic epileptic foci in monkeys: correlation between seizure frequency and proportion of pacemaker epileptic neurons. Epilepsia 19: 475–483. Young, A.B., and Snyder, S.H. 1973. Strychnine binding associated with glycine receptors of the central nervous system. Proc Natl Acad Sci U S A 70: 2832–2836. Yu, Q.H., Kitazumi, K., Kamei, C., and Tasaka, K. 1984. Epileptogenic activity induced by intravenous injection of certain cephalalosporins in rats. J Pharmacobio Dynam 7: 586–592. Zaczek, R., and Coyle, J.T. 1982. Excitatory amino acid analogues: Neurotoxicity and seizures. Neuropharmacology 21: 15–26. Zaczek, R., Nelson, M., and Coyle, J.T. 1981. Kainic acid neurotoxicity and seizures. Neuropharmacology 20: 183–189. Zarbin, M.A., Wamsley, J.K., and Kuhar, M.J. 1981. Glycine receptor: light microscopic autoradiographic localization with [3H]strychnine. J Neurosci 1: 532–547.
Zhao, D.Y., Feng, G.J., Wu, X.R., and Zuo, Q.H. 1985. Seizures induced by intraventricular microinjection of ionized cobalt in the rat—a new experimental model of epilepsy. Brain Res 342: 323–329. Zhao, T.J., Rosenberg, H.C., and Chiu, T.H. 1996. Treatment with an antisense oligodeoxynucleotide to the GABAA receptor gamma 2 subunit increases convulsive threshold for beta-CCM, a benzodiazepine “inverse agonist’, in rats. Eur J Pharmacol 306: 61–66. Zouhar, A., Maresˇ, P., and Brozˇek, G. 1980. Electrocorticographic activity elicited by metrazol during ontogenesis in rats. Arch Int Pharmacodyn 248: 280–288. Zouhar, A., Maresˇ, P., Lisˇková-Bernásˇková, K., and Mudrochová, M. 1989. Motor and electrocorticographic epileptic activity induced by bicuculline in developing rats. Epilepsia 30: 501–510.
C
H
A
P
T
E
R
12 Electrical Stimulation-Induced Models of Seizures PAVEL MARESˇ AND HANA KUBOVÁ
Seizures induced by electrical stimulation exhibit one advantage: The epileptogenic agent is acting only during application of current and epileptic activity is no longer contaminated by this agent. On the other hand, electrical current stimulates all neuronal and nonneuronal elements in the stimulated nervous tissue. Electrically induced seizures may be divided according to the mode of stimulation into two main types: (1) those elicited by stimulation of the whole brain (electroshock seizures) and (2) those induced by local stimulation of a defined brain structure (epileptic afterdischarges).
induced by threshold and slightly suprathreshold stimulation through corneal electrodes. With increasing intensity of stimulation, generalized tonic-clonic seizures are elicited. Maximal electroshock seizures (MESs) are a model of generalized tonic-clonic seizures. They represent hindbrain seizures; using auricular stimulation, even the threshold current evokes this type of seizures (Browning and Nelson, 1985).
Animals Mostly mice or rats are used. Other species are used only exceptionally. There are no data indicating differences among mouse or rat strains. This may be due to extremely high intensity of stimulation current; a difference might be expected at threshold or slightly suprathreshold intensities. Screening of anticonvulsant drugs is usually done in mice; their body weight is approximately 10 times less than that of rats.
ELECTROSHOCK SEIZURES Methods of Generation There are various modifications of this model (Swinyard, 1972), but only two are commonly used: (1) stimulation with an alternating current of 60- or 50-Hz (according to the local current) frequency and (2) low-frequency stimulation (usually 6 Hz). Two types of seizures might be induced in relation to the localization of stimulation electrodes and intensity of stimulation current (Figure 1): (1) minimal clonic seizures involving muscles of head and forelimbs (righting ability is preserved) and (2) maximal (i.e., generalized tonic-clonic) seizures with a loss of righting reflexes. Both stimulation frequencies may be used for estimation of seizure threshold as well as for elicitation of maximal seizures. Minimal seizures probably represent a model of myoclonic seizures (Löscher and Schmidt, 1988). Minimal clonic seizures are generated in the forebrain; they are
Models of Seizures and Epilepsy
Procedures Mainly corneal electrodes are used; eyes must be moistened with a drop of physiologic saline after previous local anesthesia with 0.5% tetracaine. Less common are transcranial electrodes or ear clips. Low impedance, that is, good contact of stimulation electrodes, is of primary importance; therefore formulas used for electroencephalographic (EEG) electrodes in human patients are recommended for transcranial as well as ear stimulation. The classic MES test is performed with 0.2-second series of alternating current with 60-Hz frequency and an intensity of 50 mA for mice and 150 mA for rats applied through
153
Copyright © 2006, Elsevier Inc. All rights of reproduction in any form reserved.
154
Chapter 12/Electrical Stimulation-Induced Models of Seizures
FIGURE 1 Motor seizures elicited by electroshock stimulation. A–F: Minimal seizures induced by corneal suprathreshold stimulation in an 18-day-old rat. Righting ability is preserved, and the animal exhibits clonic movements of forelimbs. A, F: Classified as stage 2 (only head movements, both forelimbs on the floor). C–E: Stage 3 (forelimb clonus). B: Stage 4 (forelimb clonus with rearing; not yet perfect at this age). G: Tonic extension of forelimbs and hindlimbs in an adult rat. H: Tonic flexion of the forelimbs in 7-day-old rat pup (hindlimbs are not involved).
corneal electrodes. The animal is restrained in hand during stimulation. It is necessary to release the animal immediately after the end of stimulation to see all phases of the seizures. Monitoring these tests is visual; the presence or absence of individual components of seizures and their duration may be measured. In the most common MES test, only the presence of tonic hindlimb extension is taken as a criterion. Threshold estimation may be performed using the staircase method (Finney, 1952). Statistical evaluation, that is, estimation of a current eliciting seizures in 50% of animals (CD50) as well as 50% effective doses (ED50) of anticonvulsants can be performed using the Lichtfield and Wilcoxon graphic method (1953) or the Finney’s probit analysis (1952). These tests are very easy to perform. It is necessary to have a good stimulator with a constant current output allowing application of high current intensities (up to 150 mA). Reliability of data is high. It can be affected by the experience of the observer, and video recording could be used if more than tonic hindlimb extension is measured.
TABLE 1 Stages of seizures 1
Mouth and facial movements
2
Head nodding
3
Forelimb clonus
4
Rearing
5
Rearing and falling From Racine, 1972.
Characteristics Behavioral Features Minimal threshold electroshock seizures consist of clonic seizures of the head and the forelimb muscles (Figure 1A–F). To quantify these seizures, the 5-point scale of Racine (1972) can be used (Table 1). Maximal electroshock seizures consist of tonic flexion followed by tonic extension and clonus accompanied by a loss of posture. The endpoint is tonic extension of hindlimb
155
Local Electrical Stimulation
with the limbs extended 180 degrees at the plane of the body (Figure 1G). The duration of hindlimb tonic extension is in the range of seconds (tens of seconds at maximum). It is possible but not common to include a 5-second duration as the limit for a positive result. MESs are followed by a period of postictal depression when the same stimulation cannot induce MES (Velísˇek and Maresˇ, 1992). This depression lasts longer in rats than in mice, and its duration depends on the intensity of stimulation (Swinyard, 1972). There are no consistent data on EEG during MES because of the high intensity of stimulation current and violent movements during the clonic phase. Morphologic studies have not found any significant neuropathological changes after single MES (Meldrum, 1986). To induce neuronal death, repeated electroshocks must be applied, but single electroshock seizures are sufficient to induce immediate early gene expression (French et al., 2001). Inducing and evaluating MESs are easy tasks that are not time consuming. They thus represent an ideal screening tool and are used as a routine testing method for potential antiepileptic drugs (AEDs). The AEDs that block voltagegated sodium channels (phenytoin, carbamazepine, valproate, lamotrigine, topiramate, zonisamide, and others) are effective (Swinyard and Woodhead, 1982). There are data not only for all clinically used and potential AEDs but also for many other drugs. The 6-Hz stimulation inducing minimal seizures was also extensively studied pharmacologically (Barton et al., 2001). There are two limitations of the MES test: (1) animals are to be used only once; and (2) evaluation of hindlimb tonic extension only is a restriction of possibilities of this model. Low-frequency electroshock seizures may be repeated, especially if high-stimulation currents are avoided. Electroshock seizures (usually repeated) may serve as a tool in studies of brain chemistry (e.g., Wasterlain and Plum, 1973) or molecular biology (e.g., expression of genes; see French et al., 2001; Altar et al., 2004). Ontogeny Developmental data were published by Millichap (1958) and Vernadakis and Woodbury (1969). The maturation patterns are not the same using the two basic stimulation frequencies. A mature pattern of MES induced by 60-Hz stimulation appears at the age of 16 days in rats; younger animals exhibited only forelimb flexion (10–12 days or earlier) (Figure 1H) or forelimb flexion, followed by forelimb extension and hindlimb flexion (13–15 days). The lowest threshold for elicitation of seizures with the 60-Hz stimulation is around postnatal day 16 in both rats and mice. Low-frequency electroshock threshold with minimal seizures as an endpoint decreases steeply up to the end of
the third postnatal week, and then a moderate decrease continues up to postnatal day 40 (Vernadakis and Woodbury, 1969).
LOCAL ELECTRICAL STIMULATION Methods of Generation Electroencephalographic afterdischarges (ADs) elicited by local electrical stimulation have different electrographic patterns and behavioral correlates according to the structure stimulated. The experiments can be aimed at two different phenomena: (1) measurement of threshold intensities of electrical current necessary for elicitation of ADs or (2) repeated stimulations with the same intensity but with short intervals not leading to kindling. This second type of arrangement can be used for studies of acute anticonvulsant effects. Epileptic ADs represent a model of complex partial seizures (stimulation of limbic structures) or myoclonic seizures (stimulation of sensorimotor cortex). Animals used in these experiments are mostly rats; mice, rabbits, and cats are nowadays rarely used.
Procedures The experiment starts with surgical preparation. Volatile anesthetics (diethylether, halothane, isoflurane) or barbiturates with a short to middle duration of action (e.g., pentobarbitone) are recommended. Dissociative anesthesia (ketamine 100 mg/kg IP [administered intraperitoneally] and xylazine 20 mg/kg IM [administered intramuscularly]) is also possible. Postsurgical recovery takes at least 1 week in adult animals with chronically implanted electrodes. Electrodes can be placed epidurally (flat or ball electrodes; higher stimulation intensities are then needed). If the electrodes are introduced into the cerebral cortex (the same type of electrodes as for subcortical stimulation), a stereotaxic apparatus must be used. Stimulation of subcortical structures can be performed using concentric electrodes or twisted twin electrodes. Care must be given to isolating the electrodes up to the tips. Different frequencies of stimulation can be used similarly to the electroshock model: high frequency (60 or 50 Hz, less frequently higher frequencies) or low frequency (from 3 to 12 Hz). Rectangular pulses are more common, but sinusoid waves may also be used. Biphasic pulses (i.e., those with the same duration of both phases) are preferable to avoid excessive polarization of electrodes. Duration of stimulation series is in an inverse relation to frequency: High-frequency stimulation is usually applied only for 1 to 2 seconds, whereas low-frequency stimulation has to be applied for longer time (up to tens of seconds). Stimulation sessions might be repeated if very high intensities of stimulation are
156
Chapter 12/Electrical Stimulation-Induced Models of Seizures
not used. It is necessary to avoid initial kindling because progressive lengthening of ADs (see Chapter 28) might interfere with the action of AEDs. Long-lasting stimulation can lead to status epilepticus (see Chapter 36). In the case of pharmacologic experiments, the half-life of the administered drug has to be taken into account. Monitoring requires EEG apparatus; a sample rate of 200 Hz might not be sufficient, or the sharp EEG discharges can be distorted. Digitization at a rate of 500 Hz is recommended. The evaluation focuses on the presence or absence of epileptic ADs (a duration of 5 seconds is sometimes taken as a criterion), their pattern, and accompanying behavioral phenomena. This method is not difficult to develop, but it is reliable only with experience in the field (anesthesia of animals, stereotaxic implantation of electrodes, and concomitant registration of EEG and behavior).
Characteristics Behavioral Features Behavior depends on the stimulated structure and age (see below). Spread of epileptic activity (especially if high stimulation intensities are used) modifies behavioral pattern of seizures (see Chapters 28 and 30). Electroencephalographic Features Afterdischarges may be of different types in relation to the stimulated structure: cortical or thalamic low-frequency stimulation elicits spike-and-wave rhythm, whereas limbic ADs are characterized by trains of fast spikes, large delta waves (sometimes with superimposed low-amplitude spikes), or sharp theta waves. Again the spread of epileptic activity can modify the EEG pattern of ADs (e.g., highintensity neocortical stimulation; see later). The duration of ADs also depends on the stimulated structure: spike-andwave type lasts usually only a few seconds; limbic ADs are substantially longer: from tens of seconds to few minutes. Even a single AD results in plastic changes. Immediately after the end of the Ads, postictal depression (postictal refractoriness) appears (Dyer et al., 1979); its duration may change with stimulated structure and age (see later discussion). Postictal depression prevents elicitation of the second seizure for a maximum of few minutes, with a progressive return to the prestimulation level (i.e., there is an absolute and relative refractory phase). This refractoriness is probably due to prolonged activation of inhibitory systems responsible for termination of seizures. Depression is followed by potentiation; if stimulation is repeated with long intervals, kindling may be induced (see Chapters 28–30). Possible changes in the range of tens of minutes to a few hours were studied only exceptionally, and repeated poten-
tiation and suppression phases cannot be excluded Neuropathology was not studied after a single or a few seizures. Investigators should be aware that even the insertion of electrodes may lead to focal changes (focal hemorrhage, neuronal damage, activation of glia). Penetration of electrodes into the hippocampus (i.e., a mechanical insult) may induce a short-lasting seizure. Response to AEDs was repeatedly studied. There are many studies, but they are far from being comparable and complete because of differences in stimulated structure, stimulation paradigm, methods of evaluation, and selection of AEDs to be studied. Limitations Electrically induced ADs require good equipment and operator experience to be reproducible. In addition, they are time consuming. On the other hand, they provide much more information than electroshock seizures do. Mortality of animals depends mostly on surgical technique and postsurgical care. Afterdischarges can be elicited if a certain level of maturation is achieved. The exact age depends on the structure stimulated (see later discussion). Standardization is necessary in evaluation of behavioral phenomena accompanying ADs. Most common is a scale published by Racine (1972), originally for limbic stimulation (see Table 1); but with slight modification it can be used for ADs elicited from various structures (e.g., cortical ADs) (Maresˇ et al., 2002). Afterdischarges Elicited by Stimulation of Individual Brain Structures Neocortex Two experimental arrangements using rats have been published ( Kubová et al., 1996; Voskuyl et al., 1989, 1992). Voskuyl’s method uses electrodes over right and left motor cortical areas; that is, stimulation of both hemispheres is performed. The intensity of current is progressively increased during the stimulation series. Originally they estimated only the threshold intensity of current necessary to induce clonic movements during stimulation (threshold for localized seizure activity); later this method was extended to the second parameter: spread of convulsions (threshold for generalized seizure activity) (Hoogerkamp et al., 1994; Krupp and Löscher, 1998). An advantage of this method is the possibility of performing repeated measurements. Using daily stimulation, the threshold values initially decreased, but after 10 days they stabilized and did not change further (Della Paschoa et al., 1998). Thus animals can be used for repeated measurements of drug effects. This has been done (with parallel measurement of pharmacokinetic parameters) with oxazepam, midazolam, phenytoin, valproate, lamotrigine, tiagabine, and loreclezole (see Jonker et al., 2003).
Local Electrical Stimulation
The method developed in our laboratory applies both electrodes over the sensorimotor area of the same hemisphere; that is, only one hemisphere is stimulated, but the cortical area is more extensive than in the Voskuyl’s model. Low-frequency stimulation (8 Hz for 15 seconds) is used; it allows evaluation of motor phenomena during stimulation (i.e., induced by direct excitation of the motor cortex) and epileptic ADs appearing after the end of stimulation. High-
157
frequency stimulation (50 Hz for 2 seconds) resulted in a similar pattern of ADs, but it cannot be used for studies of the direct effects of stimuli on the motor system (Maresˇ et al., 2002). Repeated stimulations with a stepwise increase of current intensity make it possible to measure four different phenomena: (1) movements during stimulation, (2) spikeand-wave EEG ADs (Figure 2); (3) clonic seizures as a motor correlate of spike-and-wave ADs; (4) transition into
FIGURE 2 Electroencephalographic (EEG) recording of cortical aferdischarges (ADs) in an adult rat. Upper part: Spike-and-wave type of ADs accompanied by stage 4 with a transition into stage 3. Lower part: mixed type of ADs elicited in the same rat by higher stimulation intensity. The right sensorimotor cortical area was stimulated. Individual leads from top to bottom: LF, left sensorimotor (frontal); LP, left parietal; LO, left visual (occipital); and RO, right visual cortical regions. The last second of the 15-second stimulation series is in the frame at the beginning of the recordings. Full arrows mark the end of the spike-and-wave type of ADs; empty arrow denotes the end of the mixed type. Time mark is 2 seconds; amplitude calibration is 0.5 mV.
158
Chapter 12/Electrical Stimulation-Induced Models of Seizures
another type of AD (Figure 2) similar to that induced by stimulation of limbic structures accompanied by automatisms, mostly wet-dog shakes. Repeated elicitation of spikeand-wave ADs with unchanged stimulation intensity can be used for testing of antiepileptic drugs (Kubová et al., 1996). Ontogeny Ontogenetic study demonstrated reliable elicitation of cortical ADs in rats from the age of 12 days and older if low-frequency stimulation is used or from postnatal day 9 and older if 50-Hz stimulation is applied. Twelve-dayold rat pups are not able to generate spike-and-wave rhythm; the AD is formed by rhythmic sharp delta waves (Maresˇ et al., 2002). The maximal sensitivity to cortical stimulation is around the end of the third postnatal week of life in rats (Maresˇ et al., 2002). In addition, repetition of stimulation in 12-day-old rats with 10- or 20-minute intervals leads to a progressive increase of duration of ADs; postictal depression, which is observed in adult rats, is absent in this age group. Hippocampus Electrodes can be introduced into the dorsal or ventral hippocampus. The pattern of ADs is variable: low-amplitude spikes, delta waves, and delta waves with superimposed low-amplitude spikes. The first AD is followed by a period of EEG depression, and then the secondary (recurrent) AD appears (Dyer et al., 1979; Leung, 1987). The most common behavioral pattern is wet-dog shakes (Le Gal la Salle et al., 1983; Velísˇek and Maresˇ, 2004). Ontogeny It is possible to evoke hippocampal ADs in rats at the age of 7 days (Velísˇek and Maresˇ, 1991). In rat pups 12 to 15 days old, postictal depression is absent; 7-dayold rat pups exhibit postictal refractoriness, probably because of the fatigability of the system, not to a presence of active inhibition (Velísˇek and Maresˇ, 1991). Amygdala There are differences among individual nuclei studied in detail in the kindling model. Epileptic automatisms form a behavioral pattern of these seizures: arrest at the beginning, followed by chewing movements that continue for several seconds after the end of stimulation (Goddard et al., 1969). Ontogeny Ontogenetic studies demonstrated the possibility of eliciting these ADs at the end of the second postnatal week in rats (Moshe, 1981). In contrast to the results in older animals, amygdala ADs are not followed by a period of postictal depression in 2-week-old rats (Moshe and Albala, 1983). Baram et al. (1993) was able to elicit epileptic ADs by amygdala stimulation in 7-day-old rats. Entorhinal Cortex Electrodes can be introduced either into the entorhinal cortex or into the perforant path. It is possible to perform a
preoperative electrophysiologic control using single stimuli and recording responses in the dentate gyrus. The pattern of ADs may be variable: low-amplitude spikes, large delta waves, and delta waves with superimposed low-amplitude spikes. Behavioral concomitants are represented by an intense orienting reaction in a cage where the animal spent tens of minutes and include locomotion, sniffing, and rearing. Such behavior is appropriate for the first 2 to 3 minutes in a new environment. This automatism appears toward the end of the AD and continues even after the EEG epileptic activity is over. Wet-dog shakes are observed less frequently. Ontogeny Afterdischarges can be induced by stimulation of angular bundle in rat pups 10 to 11 days old, and adult characteristics are attained at the age of 21 days (Stringer and Lothman, 1992). Piriform Cortex Afterdischarges and their behavioral correlates elicited by stimulation of this structure do not differ from those induced by amygdala stimulation (Goddard et al., 1969; Honack et al., 1991). A disadvantage of piriform cortex is its anatomy: a very thin, rather long structure difficult for an exact placement of electrodes.
CONCLUSIONS The aforementioned seizures in rodents model different types of human seizures: MES is generally accepted as a model of generalized tonic-clonic seizures and stimulation of limbic structures as models of human complex partial seizures. Seizures elicited by stimulation of the sensorimotor cortex represent a model of focal motor or myoclonic seizures. Changes with repeated stimulations or increasing intensity can be used for studies of seizure spread as well as of secondary generalization (see Chapters 28–30). The MES screening tool is useful because it can provide data for many doses of the tested drug with minimal investment and experience. The other models discussed in this chapter are more time and money consuming, and both recording and evaluation of the data require experience. It is necessary to take into account that we discuss here models of epileptic seizures, not epilepsies, and that these experimental seizures are usually elicited in a healthy brain.
References Altar, C.A., Laeng, P., Jurata L.W., Brockman, J.A., Lemire, A., Bullard, J., Bukhman et al. 2004. Electroconvulsive seizures regulate gene expression of distinct neurotrophic signaling pathways. J Neurosci 24: 2667–2677. Baram, T.Z., Hirsch, E., and Schultz, L. 1993. Short-interval amygdala kindling in neonatal rats. Dev Brain Res 73: 79–83.
References Barton, M.E., Klein, B.D., Wolf, H.H., and White, H.S. 2001. Pharmacological characterization of the 6 Hz psychomotor seizures model of partial epilepsy. Epilepsy Res 47: 217–227. Browning, R.A., and Nelson, D.K. 1985. Variation in threshold and pattern of electroshock-induced seizures in rats depending on site of stimulation. Life Sci 37: 2205–2211. Della Paschoa, O.E., Kruk, M.R., Voskuyl, R.A., and Danhof, M. 1998. Effects of repeated seizure induction on seizure activity, postictal and interictal behavior. Brain Res 814: 199–208. Dyer, R.S., Swartzwelder, H.S., Eccles, C.U., and Annau, Z. 1979. Hippocampal afterdischarges and their post-ictal sequelae in rats: a potential tool for assessment of CNS toxicity. Neurobehav Toxicol 1: 5–19. Finney, D.J. 1952. Probit Analysis. Cambridge: Cambridge University Press. French, P.J., O’Connor, V., Jones, M.W., Davis, S., Errington, M.L., Voss, K., Truchet, B., et al. 2001. Subfield specific immediate early gene expression associated with hippocampal long-term potentiation in vivo. Eur J Neurosci 13: 968–976. Goddard, G.V., McIntyre, D.C., and Leech, C.K. 1969. A permanent change in brain function resulting from daily electrical stimulation. Exp Neurol 25: 295–330. Honack, D., Wahnschaffe, U., and Loscher, W. 1991. Kindling from stimulation of a highly sensitive locus in the posterior part of the piriform cortex. Comparison with amygdala kindling and effects of antiepileptic drugs. Brain Res 538: 196–202. Hoogerkamp, A., Vis, P.W., Danhof, M., and Voskuyl, R.A. 1994. Characterization of the pharmacodynamics of several antiepileptic drugs in a direct cortical stimulation model of anticonvulsant effect in the rat. J Pharmacol Exp Ther 269: 521–528. Jonker, D.M., van de Mheen, C., Eilers, P.H., Kruk, M.R., Voskuyl, R.A., and Danhof, M. 2003. Anticonvulsant drugs differentially suppress individual ictal signs: a pharmacokinetic/pharmacodynamic analysis in the cortical stimulation model in the rat. Behav Neurosci 117: 1076–1085. Krupp, E., and Löscher, W. 1998. Anticonvulsant drug effects in the direct cortical ramp-stimulation model in rats: Comparison with conventional seizure models. J Pharmacol Exp Ther 285: 1137–1149. Kubová, H., Lansˇtiaková, M., Mocková, M., Maresˇ, P., and Vorlícˇek, J. 1996. Pharmacology of cortical epileptic afterdischarges in rats. Epilepsia 37: 336–341. Le Gal La Salle, G., Cavalheiro, E.A., Feldblum, S., and Maresova, D. 1983. Studies of wet-dog shake behavior induced by septohippocampal stimulation in the rat. Can J Physiol Pharmacol 61: 1299–1304. Leung, L.W. 1987. Hippocampal electrical activity following local tetanization. I. Afterdischarges. Brain Res 419: 173–187.
159
Lichtfield, J.T. Jr., and Wilcoxon, F. 1953. The reliability of graphic estimates of relative potency from dose-per cent effect curves. J Pharmacol Exp Ther 108: 18–25. Löscher, W., and Schmidt, D. 1988. Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res 2: 95–134. Maresˇ, P., Haugvicová, R., and Kubová, H. 2002. Unequal development of thresholds for various phenomena induced by cortical stimulation in rats. Epilepsy Res 49: 35–43. Meldrum, B.S. 1986. Neuropathological consequences of chemically and electrically induced seizures. Ann N Y Acad Sci 462: 186–193. Millichap, J.G. 1958. Seizure patterns in young animals. II. Significance of brain carbonic anhydrase. Proc Soc Exp Biol Med 97: 606–611. Moshe, S.L. 1981. The effects of age on the kindling phenomenon. Dev Psychobiol 14: 75–81. Moshe, S.L., and Albala, B.J. 1983. Maturational changes in postictal refractoriness and seizure susceptibility in developing rats. Ann Neurol 13: 552–557. Racine, R.J. 1972. Modification of seizure activity by electrical stimulation: II. Motor seizures. Electroencephalogr Clin Neurophysiol 32: 269–279. Stringer, J.L., and Lothman, E.W. 1992. Ontogeny of hippocampal afterdischarges in the urethane-anesthetized rat. Dev Brain Res 70: 223–229. Swinyard, E.A. 1972. Electrically induced convulsions. In Experimental Models of Epilepsy. Eds. D.P. Purpura, J.K. Penry, D. Tower, D.M. Woodbury, and R. Walter. pp. 433–458. New York: Raven Press. Swinyard, E.A., and Woodhead, J. 1982. Experimental detection, quantification and evaluation of anticonvulsants. In Antiepileptic Drugs, 2nd ed. Eds. D.M. Woodburt, J.K. Penry, C.E. Pippenger. pp. 111–126. New York: Raven Press. Velísˇek, L., and Maresˇ, P. 1991. Increased epileptogenesis in the immature hippocampus. Exp Brain Res 20: 183–185. Velísˇek, L., and Maresˇ, P. 1992. Differential effects of naloxone on postictal depression. Epilepsy Res 12: 37–43. Velísˇek, L., and Maresˇ, P. 2004. Hippocampal afterdischarges in rats. I. Effects of antiepileptics. Physiol Res 53: 453–461. Vernadakis, A., and Woodbury, D.M. 1969. The developing animal as a model. Epilepsia 10: 163–178. Voskuyl, R.A., Dingmanse, J., and Danhof, M. 1989. Determination of the threshold for convulsions by direct cortical stimulation. Epilepsy Res 3: 120–129. Voskuyl, R.A., Hoogerkamp, A., and Danhof, M. 1992. Properties of the convulsive threshold determined by direct cortical stimulation in rats. Epilepsy Res 12: 111–120. Wasterlain, C.G., and Plum, F. 1973. Vulnerability of developing brain to electroconvulsive seizures. Arch Neurol 29: 38–45.
C
H
A
P
T
E
R
13 Alcohol Withdrawal Seizures PROSPER N’GOUEMO AND MICHAEL A. ROGAWSKI
to generalized tonic seizures (Freedland and McMicken, 1993a). Alcohol withdrawal seizure has been included in the International League Against Epilepsy Classification of Epilepsies and Epileptic Syndromes as a condition with epileptic seizures that does not require a diagnosis of epilepsy (Engel, 2001). These seizures typically occur 6 to 48 hours after discontinuation of alcohol consumption, but they may also occur up to 7 days after the last drink, particularly if the patient has been abusing other psychoactive agents, such as benzodiazepines or barbiturates. Generalized tonic-clonic seizures are the most severe type of alcohol withdrawal seizures in humans. Convenient rodent models that mimic human alcohol withdrawal-related tonic-clonic seizures have been developed, thus providing a substrate to study the underlying seizure mechanisms and for the development of treatment approaches. In these models, the following tonic-clonic seizure types can be observed during a finite period (typically 1 to 3 days) after the cessation of alcohol intake: (1) spontaneous seizures, (2) auditory-evoked seizures (“audiogenic seizures,” or AGS), and (3) handling-induced convulsions (HIC). This chapter describes procedures for inducing alcohol dependence, precipitating withdrawal, and eliciting and scoring the resultant alcohol withdrawal seizures. In these models rats or mice are exposed to alcohol by intragastric intubation, inhalation, or feeding in a nutritionally complete liquid diet for periods of 2 to 21 days. (The use of a seizuresensitive mouse strain that exhibits an increase in seizure severity after a single dose of alcohol is briefly discussed in the section entitled Selection of a Model.) Each of the models is associated with highly reproducible alterations in seizure susceptibility so that they are suitable for basic neurobiological, pharmacologic, and genetic studies. In
Ethyl alcohol (ethanol) is a central nervous system (CNS) depressant that exerts diverse behavioral actions. At low blood concentrations, alcohol produces euphoria and behavioral excitation, and at concentrations greater than 0.08 g/dl (17 mM), it significantly impairs motor skills. Concentrations of 0.15 to 0.30 g/dl induce acute intoxication, which manifests as drowsiness, ataxia, slurred speech, stupor, and coma. The acute effects of alcohol on brain function are believed to result largely from its actions on ligand-gated and voltage-gated ion channels, resulting in alterations in neuronal signaling (Crews et al., 1996; Deitrich and Erwin, 1996; Nevo and Hamon, 1995). Chronic alcohol consumption leads to the development of tolerance and physical dependence, which may result from compensatory changes in neuronal signaling that balance the acute effects of alcohol. Abrupt cessation of chronic alcohol consumption unmasks the compensatory physiologic change, leading to a cluster of neurologic signs and symptoms known as alcohol withdrawal syndrome. In humans alcohol withdrawal syndrome includes blackouts, tremors, muscular rigidity, delirium tremens, and seizures (Hillbom et al., 2003; Kosten and O’Connor, 2003). These various manifestations of alcohol withdrawal may reflect an involvement of different neuronal networks and cellular mechanisms (Schmidt and Sander, 2000). The most prominent and dramatic aspects of alcohol withdrawal syndrome in humans are alcohol withdrawal seizures, which can be life threatening (Hillbom et al., 2003; Mattson, 1983; Peininkeroinen et al., 1992; Ripley, 1990). Alcohol withdrawal seizures are usually generalized tonic-clonic (“grand mal”) seizures, although 60% of subjects experience multiple seizure types (Victor and Brausch, 1967). These additional seizure types include partial seizures and partial seizures progressing
Models of Seizures and Epilepsy
161
Copyright © 2006, Elsevier Inc. All rights of reproduction in any form reserved.
162
Chapter 13/Alchol Withdrawal Seizures
addition, the models can be of value in evaluating potential therapies for alcohol withdrawal seizures. This chapter also reviews the present understanding of the brain mechanisms underlying withdrawal seizures and considers briefly seizures related to withdrawal of other CNS depressants.
METHODS FOR INDUCTION OF ALCOHOL DEPENDENCE AND FOR MONITORING WITHDRAWAL SEIZURES Species, Strain, Gender, and Age Considerations As in humans, an alcohol withdrawal syndrome that includes generalized tonic-clonic seizures has been observed in the mouse, rat, cat, dog, monkey, and chimpanzee (Ellis and Pick, 1970; Essig et al., 1969; Freund, 1969; Guerrero-Figueroa et al., 1970; Majchrowicz, 1975; Pieper et al., 1972). In all species, the signs of alcohol withdrawal last for 1 to 3 days, after which behavior returns to normal and there is no enhanced seizure susceptibility. Rodents are the most common species used in laboratory studies of alcohol withdrawal seizures. Here we describe methods for the induction of alcohol dependence and for inducing and scoring withdrawal seizures in the rodent species that are most frequently used in laboratory experiments. The intragastric intubation method was originally developed in studies with rats and is mainly applied in this species. In contrast, inhalation methods are most commonly used in mice. The liquid diet procedure is applied in both mice and rats. The experimental methods can be adapted for use with other species. Among rodents, there are substantial differences among strains in the severity of withdrawal seizures (Crabbe, 2002; Metten and Crabbe, 1994). For example, DBA/2 inbred mice exhibit more severe acute alcohol withdrawal seizures than do C57BL/6 mice (Roberts et al., 1992). As discussed in the section entitled Metabolic Changes Following Alcohol Withdrawal, there has been an extensive effort to identify the specific genes that influence alcohol withdrawal seizure severity and other behavioral components of alcohol dependence and withdrawal. Consideration of strain differences is critical when selecting animals for experimental studies, and in the future, as specific susceptibility loci are identified, the specific genotype will also likely be a factor of relevance. There are significant sex differences in the incidence of ethanol abuse and alcoholism, with nearly 20% of adult men affected, in contrast to only about 5 to 6% of adult women (Devaud et al., 1999). Alcohol withdrawal seizures seem to affect predominantly men (Essardas Daryanani et al., 1994; Pilke et al., 1984). These differences have been attributed mainly to societal influences, although neurobiological
factors could also play a role. Both male and female rodents exhibit withdrawal seizures in alcohol-dependence models. However, there may be small sex differences in susceptibility. For example, male mice may experience more severe seizures than females do (Buck et al., 2002). Adult animals are typically used in studies of alcohol withdrawal seizures. Interestingly, however, mice that have been bred for susceptibility to ethanol withdrawal seizures may also show enhanced susceptibility to AGS, but only at young ages (Feller et al., 1994) corresponding with the developmental sensitivity of mouse strains such as DBA/2, which are only susceptible to audiogenic seizures from postnatal days 20 to 80.
Procedures Methods for Alcohol Administration Intragastric Intubation Induction of alcohol dependence in rats by intragastric intubation was first described by Majchrowicz (1975). A key advantage of this approach over other methods of alcohol administration is that dosing is highly reliable, so when the treatment is discontinued, all animals exhibit the major signs of withdrawal. In addition, this method allows physical dependence to be produced in a relatively short time. In the model, 50 mM ethanol (95%) is administered in ISOMIL Soy Infant Formula Concentrate diluted 1 : 1 with water (Riaz and Faingold, 1994). A priming dose of 5 g/kg of ethanol is administered to each animal, and subsequent doses are determined by the degree of intoxication exhibited. Dosing occurs at 8-hour intervals for 4 days, with total daily doses in the range of 9 to 15 g/kg/day. The dosages are adjusted so that the animals exhibit mild to moderate ataxia (Table 1). Ethanol is withdrawn after the second dose on the
TABLE 1 Behavioral Rating Scale for Alcohol Intoxication Stage
Signs
Neutral
No signs of alcohol intoxication or withdrawal
Sedation
Reduced muscle tone; slow locomotor activity
Ataxia 1
Slight impairment of gait and motor coordination
Ataxia 2
Impaired gait and motor coordination; considerable elevation of abdomen and pelvis
Ataxia 3
Sedation; lethargy; impaired motor coordination
Loss of righting reflex
Inability to right after 5 s when placed on back
Coma
No movements; no response to pain stimuli; no eye blink; palpebral closure
Adapted from Majchrowicz (1975).
Methods for Induction of Alcohol Dependence and for Monitoring Withdrawal Seizures
fourth day. Control animals are maintained under similar conditions but are fed the ISOMIL diet without ethanol. This method can be associated with significant mortality (9–23%; N’Gouemo et al., 1996). Inhalation Alcohol intoxication is initiated by administration of a loading dose of ethanol (1.6 g/kg; 8%, wt/vol). Some investigators administer the alcohol dehydrogenase inhibitor pyrazole to enhance and stabilize the blood ethanol concentrations (Goldstein and Pal, 1971). Animals are then placed in a closed inhalation chamber as illustrated in Figure 1, and alcohol dependence is induced by continuous exposure to alcohol vapors for 2 to 7 days. Air is continuously delivered to the chamber at a rate of 10 liters per minute to provide for the respiratory need of the animals. Ethanol (95%) is evaporated into the air so that the experimental chamber holding the animal receives air with an ethanol concentra-
163
tion of 7 to 35 mg/liter. Control chambers are similarly configured, but with the absence of ethanol vapor. Liquid Diet Alcohol can also be chronically administered in a liquid diet. Rats have an aversion to alcohol. However, high alcohol intake can be induced with a nutritionally complete liquid diet used as the only food source, such as the LieberDeCarli diet (Dyets, Inc., Bethlehem, PA) (Lieber and DeCarli, 1982). Control animals receive a similar diet in which an isocaloric amount of maltose is substituted for ethanol. The ethanol concentration is typically 6 to 7% (vol/vol) and is administered for 4 to 21 days. At the end of the alcohol exposure period, animals are switched to a regular diet. Mice can be treated with a similar diet, but the ethanol concentration may be lower (4.5 to 6.5%) and the exposure period is typically 2 to 6 days. Mice can also be “kindled” by repeated withdrawal (periods of 1 to 2 days of
FIGURE 1 Schematic representation of a system for administration of ethanol by inhalation modified after Ruwe et al. (1986). Ethanol (95%) is delivered by a solvent metering pump into a 250-ml vaporization chamber. The airtight vaporization chamber is maintained at 37° C by a water bath. Air is delivered into the vaporization chamber with an air pump to provide a flow rate of 2.5 to 4 liters per minute. Animals are exposed to ethanol-vapor concentrations of 7 to 35 mg/liter of air in a Plexiglas experimental chamber. A food tray and water bottle are securely affixed to the experimental chamber, giving the animal free access to food and water. The sample port allows air within the experimental chamber to be sampled for determination of ethanol concentrations. (See color insert.)
164
Chapter 13/Alchol Withdrawal Seizures
abstinence during the chronic ethanol feeding), which potentiates the severity of withdrawal seizures (Becker and Hale, 1993; Pinel, 1980; Ripley et al., 2002). Blood Sampling and Measurement of Blood Alcohol Concentrations Blood alcohol concentrations are typically measured during intoxication, at the onset of withdrawal symptoms, and during the fully developed withdrawal syndrome. Blood samples are usually collected from the tail vein in mice or by intracardiac sampling in deeply anesthetized rats using large-bore (21-gauge) needles to prevent hemolysis. Blood samples are stored in tubes containing heparin or the anticoagulant potassium oxalate and sodium fluoride (Becton Dickinson Vacutainer Systems, Rutherford, NJ). Blood ethyl alcohol concentrations are measured using gas chromatography (Brown and Long, 1988) or determined in the plasma using the alcohol dehydrogenase method, which requires a spectrophotometer to measure the absorbance at 340 nm (Pointe Scientific, Canton, MI). Seizure Monitoring Following Alcohol Withdrawal
The animal’s behavior is recorded on videotape for subsequent review. The incidence and type of seizures (wild running, bouncing clonus, tonic) are noted, and the overall severity is scored according to the scale of Jobe et al. (1973) (Table 2) and also Chapter 20). Audiogenic seizures can be measured repeatedly in the same animal with high interrater reliability. Handling-Induced Convulsions Mice are observed for seizure activity in response to various degrees of stimulation. Animals that exhibit spontaneous seizures or a tonic-clonic seizure within seconds of being handled during removal from their home cages receive the highest seizure scores. If no seizure occurs immediately with routine handling, animals are picked up by the tail and observed for an additional 2 seconds. If they still fail to exhibit a seizure, they are gently spun by the tail through a 180- to 360-degree arc. A score is assigned as defined in Table 3 based on the degree of stimulation required to elicit the seizure (handling alone, tail lift, or spinning) and the type of seizure (clonic, tonic, tonic-clonic) (Becker et al., 1997; Crabbe and Kosobud, 1990; Goldstein and Pal, 1971). HIC can be measured repeatedly in the same animal with high interrater reliability.
Spontaneous Seizures On administration of the last dose of ethanol, the animals are placed in a Plexiglas observation chamber located in a sound-attenuated room (Gonzalez et al., 1989). The behavior of each animal is recorded on videotape at 30 frames per second for about 84 hours from the time of ethanol discontinuation. The videotapes are scanned at high speed to identify segments with evidence of seizure-like behavior and then at slower speeds for scoring. The incidence and severity of the following behaviors are recorded: (1) myoclonic jerks of the head or trunk; (2) jumping episodes; (3) generalized tonic-clonic seizures consisting of loss of upright posture and repetitive extension and retraction of the limbs and trunk; and (4) rigid, tonic extension of the limbs. Myoclonic jerks occur most frequently during the first 6 hours following alcohol withdrawal. The incidence of generalized tonic-clonic seizures is maximal between 24 and 60 hours after alcohol withdrawal; tonic seizures are most frequent at 60 to 84 hours following withdrawal.
TABLE 2 Behavioral Rating Scale for Audiogenic Seizures Score 0
No response
1
Running only; no convulsion
2
Two running phases separated by a refractory period; generalized clonus involving forelimbs and hindlimbs
3
One running phase; generalized clonus involving forelimbs and hindlimbs
4
Two running phases separated by a refractory period; tonic flexion of neck, trunk and forelimbs with clonus of hindlimbs
5
One running phase and no refractory period; tonic flexion of neck, trunk and forelimbs with clonus of hindlimbs
6
Two running phases separated by a refractory period; tonic flexion of neck, trunk and forelimbs with hindlimbs in partial tonic extension (i.e., tonic extension of thighs and legs with clonus of feet)
7
One running phase and no refractory period; tonic flexion of neck, trunk and forelimbs with hindlimbs in partial tonic extension (i.e., tonic extension of thighs and legs with clonus of feet)
8
Two running phases separated by a refractory period; tonic flexion of neck, trunk and forelimbs with hindlimbs in complete tonic extension (maximal convulsion)
9
One running phase and no refractory period; tonic flexion of neck, trunk and forelimbs with hindlimbs in complete tonic extension (maximal convulsion)
Audiogenic Seizures Mice and rats subjected to alcohol withdrawal are susceptible to AGS between 10 and 26 hours following the last doses of alcohol (Freund, 1969; Riaz and Faingold, 1994). AGSs are induced in a sound-attenuating chamber using an electric bell that produces a sound volume of about 122 dB at the middle of the acoustic chamber. The bell tone is presented either until a seizure is triggered or for 60 seconds.
Description of Behavior
From Jobe et al. (1973).
165
Selection of an Experimental Model
TABLE 3 Behavioral Rating Scale for Handling-Induced Convulsion Score
Description of Behavior
0
No convulsion or facial grimace on tail lift, or after gentle 180to 360-degree spin
1
Facial grimace after 180- to 360-degree spin
2
Tonic convulsion after 180- to 360-degree spin
3
Tonic-clonic convulsion after 180- to 360-degree spin
4
Tonic convulsion on tail lift
5
Tonic-clonic convulsion on tail lift, onset delayed by 1–2 s
6
Severe tonic-clonic convulsion on tail lift, no delay in onset
7
Severe tonic-clonic convulsion before tail lift Adapted from Becker et al. (1997) and Crabbe and Kosobud (1990).
BEHAVIORAL FEATURES AND BRAIN MECHANISMS Spontaneous Seizures Spontaneous seizures are observed between 24 to 60 hours following cessation of alcohol consumption, and their incidence reaches a peak between hour 36 and 48 of the withdrawal period (Clemmesen et al., 1988; Gonzalez et al., 1989). The behaviors observed include myoclonic jerks, facial and forelimb clonic seizures, rearing, falling, tonicclonic seizures, and tonic seizures. The neuronal networks that generate these behaviors are as yet unknown. However, the similarity to amygdala kindled seizures suggests that they may originate in the limbic system. Interestingly, studies with 2-deoxyglucose autoradiography have implicated amygdala neurons in the generation of spontaneous seizures associated with alcohol withdrawal (Clemmesen et al., 1988).
Handling-Induced Convulsions Handling-induced convulsions are characterized by the occurrence of tonic-clonic seizures with routine handling as well as tonic or tonic-clonic seizures on tail lift or after spinning. The network for HIC is still poorly understood. Seizures elicited after spinning suggest an initial involvement of the vestibular system. The pontine reticular formation and periaqueductal gray are thought to play important roles in the expression of alcohol withdrawal-related clonic and tonic audiogenic seizures (see subsequent discussion). It is likely that these brainstem loci may also play a similar role in HIC.
Audiogenic Seizures The behavioral features of AGS following alcohol withdrawal consist of wild running, bouncing clonus, and tonic
seizures. Wild running is considered a model of partial seizures, whereas bouncing clonus represents generalized tonic-clonic seizures. The neuronal networks for AGS associated with alcohol withdrawal appear to be located in the brainstem, and a large body of evidence suggests that inferior colliculus (IC) neurons are critical in the initiation of these seizures (Faingold et al., 1998). Bilateral lesions of the IC, but not of the medial geniculate body, the first efferent synaptic target of IC neurons, block AGS susceptibility following alcohol withdrawal (Frey et al., 1986). These findings suggest that alcohol withdrawal seizure activity diverges from the classic auditory pathway at the levels of the IC and that these seizures are not of auditory nature per se. Consistent with this idea, epileptic activity was observed in hippocampal neurons, but with significant delay after the onset of auditory-evoked tonic-clonic seizures following alcohol withdrawal, suggesting an involvement of limbic structures in the network for AGS (Hunter et al., 1973). The IC plays an important role in the processing of auditory information and is the gateway to sensorimotor integration for the auditory system (Atkin, 1986). The IC can be subdivided into three main subnuclei: the central nucleus, dorsal cortex, and external cortex. All three subnuclei of the IC have been implicated in alcohol withdrawal seizures, and the IC external cortex appears to be important for the convergence of the outflow from the IC to the neuronal network responsible for producing motor seizures, which include the superior colliculus, periaqueductal gray and reticular formation (Faingold et al., 1998).
SELECTION OF AN EXPERIMENTAL MODEL There are various tradeoffs in the choice between spontaneous seizures or seizures elicited by audiogenic or handling stimulation as the endpoint in studies of alcohol withdrawal seizures. Spontaneous seizures may have greater face validity to human alcohol withdrawal seizures because human alcohol withdrawal seizures occur paroxysmally without an apparent eliciting stimulus. Spontaneous alcohol withdrawal seizures in rodents are observed over a time course similar to that in humans. However, spontaneous seizures in experimental animals are mainly myoclonic seizures, whereas alcohol withdrawal seizures in humans are mostly generalized tonic-clonic seizures, as are vestibular or auditory-evoked seizures in animals. Such reflex seizures may have significantly different underlying pathophysiologic mechanisms from alcohol withdrawal seizures in humans, which are not elicited by audiogenic or vestibular stimulation. (It is notable that some features of the alcohol withdrawal syndrome in humans are, in fact, triggered by external stimuli, including visual, auditory, or tactile
166
Chapter 13/Alchol Withdrawal Seizures
hallucinations.) From a practical point of view, monitoring spontaneous seizures following alcohol withdrawal is technically more difficult than assessing seizures that are induced under the control of the experimenter; so reflex seizures are used more often in pharmacologic and physiologic studies. In some mouse strains, mild HIC scores are elicited in some animals, even in the absence of alcohol. In these sensitive mouse strains, it may be possible to obtain potentiation of HIC scores after a single dose of alcohol. Withdrawal from alcohol in these strains is associated with higher HIC scores. A test paradigm using a single dose of ethanol has been used extensively in genetic studies to select for mice that are more or less withdrawal-seizure prone (Metten and Crabbe, 1994; 1999). Figure 2 schematically illustrates the results of a typical experiment with mice that are withdrawal-seizure prone (WSP) or withdrawal-seizure resistant (WSR). At baseline, WSP mice exhibit slightly greater HIC scores than WSR mice. A single hypnotic dose of ethanol
(4 g/kg) is administered at zero time, and HIC susceptibility is monitored for the subsequent 12 hours. Both strains show a reduction in HIC score at 2 hours because of the anticonvulsant effects of alcohol. As blood alcohol levels fall and the animals are in a state of alcohol withdrawal, there is an increase in HIC score, which peaks at about 6 hours; WSP mice exhibit greater HIC scores than do WSR mice.
SINGLE-NEURON FIRING DURING CELLULAR ELECTROPHYSIOLOGY OF ALCOHOL WITHDRAWAL SEIZURES Audiogenic Seizures Forebrain During alcohol withdrawal-related AGS, the cortical electroencephalogram typically shows no sign of paroxysmal activity compatible with the idea that the seizures are mediated largely in the brainstem (Hunter et al., 1973; Maxson and Sze, 1976). Nevertheless, epileptiform activity has been observed in the hippocampus, but with a significant delay after the onset of AGS, suggesting a role in the propagation rather than in the initial generation of the seizures (Hunter et al., 1973). Inferior Colliculus
FIGURE 2 Schematic illustration of the time course of handling-induced convulsion (HIC) scores after withdrawal from a single dose of ethanol in withdrawal-seizure prone (WSP) and withdrawal-seizure resistant (WSR) mouse strains, according to the protocol of Metten et al. (1998). A baseline HIC assessment is recorded (see Table 3). Mice are then injected intraperitoneally with a sedating dose of ethanol (4 g/kg, 20% vol/vol in 0.9% saline) at time 0. HIC scores are initially suppressed by the ethanol injection, but a rebound of the HIC response occurs by about 3 to 4 hours after injection as the ethanol is eliminated. Withdrawal is evidenced by exacerbation of HIC severity, typically peaking at around 6 to 7 hours and returning to control levels at about 12 hours after the ethanol injection. Baseline seizure scores and withdrawal responses of WSR mice are reduced in comparison with WSP mice.
Acute alcohol intoxication suppresses spontaneously and acoustically evoked neuronal firing in the IC central nucleus, whereas alcohol withdrawal is accompanied by significant increases of these responses (Faingold and Riaz, 1995). Electrophysiologic studies have revealed that, at the transition to seizure, the IC central nucleus exhibits sustained increases in firing that persist during wild running, the initial phase of AGS (Chakravarty and Faingold, 1998). It has therefore been suggested that the IC central nucleus plays a role in the initiation of these seizures. The IC external nucleus is also a target of alcohol. Indeed IC external nucleus responses were suppressed during both acute alcohol intoxication and alcohol withdrawal (Chakravarty and Faingold, 1998). However, during alcohol withdrawal, IC external cortex neuronal firing is increased before the onset of AGS and persists during the wild running phase. The IC external cortex is believed to amplify and propagate neuronal activity originating in the IC central nucleus. Increased neuronal activity in these systems is then transmitted to nuclei responsible for the generation of convulsive motor behaviors. Superior Colliculus Spontaneous and acoustically evoked responses are suppressed during acute alcohol intoxication and alcohol
Neuropathological Effects of Alcohol Withdrawal
withdrawal in the deep layers of the superior colliculus (SC) (Yang et al., 2001a). However, these neurons exhibit tonic neuronal firing before the onset and during wild running in alcohol withdrawal-related AGS. The tonic firing preceding the onset of wild running suggests that SC neurons may play a role in the generation of this component of AGS. Periaqueductal Gray Acute alcohol intoxication suppresses spontaneous and acoustically evoked periaqueductal gray (PAG) neuronal responses (Yang et al., 2003). During alcohol withdrawal, a significant increase in spontaneous and acoustically evoked PAG responses is observed. PAG neurons exhibit burst firing during wild running and tonic repetitive firing during the tonic-clonic phase of alcohol withdrawal-related AGS. The bursting activity preceding tonic-clonic seizures suggests that PAG may play a role in the generation of these seizures. Pontine Reticular Formation Spontaneous and acoustically-evoked pontine reticular formation (PRF) neuronal firing is suppressed by acute alcohol intoxication, whereas alcohol withdrawal associated with enhanced seizure susceptibility is accompanied by a significant increase in spontaneous and acoustically evoked PRF responses (Faingold and Riaz, 1994). The neuronal firing during alcohol withdrawal-related sound induced seizures has not yet been characterized. Nevertheless, studies using the genetically epilepsy-prone rat, which exhibits an inherited susceptibility to AGS, have found that PRF neurons exhibit tonic firing during the tonic phase of AGS and this pattern of neuronal activity persists during the postictal depression following the seizures (Faingold and Randall, 1995). Such a pattern of neuronal firing could also occur in PRF neurons during alcohol withdrawal seizures. Synaptic Pathways Generating Audiogenic Seizures The evidence to date indicates that IC neurons are critical in the initiation of alcohol withdrawal-related AGS. It is hypothesized that seizure activity propagates from the IC to deep layers of the SC, a major output of the IC, to trigger the wild running phase of the AGS. The deep layers of the SC send projections directly to the spinal cord via the PRF and the periaqueductal gray, which is thought to trigger clonic seizures, and the PRF is implicated in generation of the tonic phase of AGS activity (Faingold, 2004).
Handling-Induced Convulsions The cellular electrophysiologic correlates of alcohol withdrawal-related HIC have not yet been described. Nevertheless, brief spindle episodes (BSEs) are observed
167
in hippocampal neurons in animals that exhibit such HIC (Veatch and Becker, 2002). Although the incidence of BSE peaks earlier than HIC in these animals, the discharges could play a role in the seizures. The electrographic patterns of alcohol withdrawal-related BSEs resemble those observed in models of generalized absence seizures (Danober et al., 1998; Snead, 1995). However, because alcohol withdrawal-related HIC are tonic-clonic seizures, there are likely important differences in the underlying mechanisms.
NEUROPATHOLOGICAL EFFECTS OF ALCOHOL WITHDRAWAL In humans, alcohol withdrawal seizures have been associated with ventricular and sulcal enlargement as well as significantly smaller volume of temporal lobe white matter and hippocampal sclerosis (Essardas-Daryanani et al., 1994). In animal models, there is evidence that alcohol intoxication can lead to selective damage to specific brain regions, including the hippocampus (Ikonomidou et al., 2000; Walker et al., 1980). Withdrawal from long-term alcohol consumption can aggravate alcohol-induced neurodegeneration. Indeed alcohol withdrawal is associated with augmented loss of CA1 and CA3 pyramidal neurons, mossy fiber-CA3 synapses, and dentate gyrus granule cells (Cadete-Leite et al., 1989; Paula-Barbosa et al., 1993; Scorza et al., 2003). The mechanisms underlying alcohol withdrawal-induced neurodegeneration are not completely understood. However, alcohol withdrawal, but not alcohol intoxication, is thought to be associated with significant increases in free intracellular calcium in hippocampal neurons (Prendergast et al., 2004). Thus alcohol withdrawal–induced neurotoxicity may result, in part, from enhanced calcium signaling. Indeed there is evidence for increased synaptic activation of calcium channels in alcohol withdrawal seizures (Whittington et al., 1993, 1995). Another key mediator of calcium entry into neurons is the N-methyl-d-aspartate (NMDA) receptor. There is an increasing body of data supporting the view that NMDA receptor function is enhanced in alcohol withdrawal (Krystal et al., 2003). This may result from enhanced activity in glutamatergic systems (Hoffman and Tabakoff, 1996), and, in fact, there is evidence of increased brain extracellular glutamate concentrations following ethanol withdrawal (Rossetti and Carboni, 1995). Moreover, whereas acute ethanol inhibits NMDA receptors, prolonged ethanol exposure may result in a compensatory upregulation of NMDA receptor function (Carpenter-Hyland et al., 2004; Floyd et al., 2003; Gulya et al., 1991; Snell et al., 1996). Overall the excessive activation of NMDA receptors could be a major contributor to the neuropathology of alcohol withdrawal.
168
Chapter 13/Alchol Withdrawal Seizures
METABOLIC CHANGES FOLLOWING ALCOHOL WITHDRAWAL Alcohol intoxication decreases local cerebral glucose utilization (LCGU) in many areas of the brain, including the limbic system, cerebellum, and motor system (Eckardt et al., 1992). The most striking effects on LCGU are observed in the IC (Grunwald et al., 1993), in accordance with other evidence indicating that this brain site is a major target of alcohol. Alcohol withdrawal is associated with increased brain glucose uptake, oxygen consumption, and blood flow (Eckardt et al., 1992; Hemmingsen et al., 1979; Newman et al., 1985). Significant increases in LCGU with alcohol withdrawal have been reported in motor systems, the auditory system (including IC), and the mammillary bodies-anterior thalamus-cingulate cortex pathway (Eckard et al., 1992), although one study reported decreases with acute withdrawal in most limbic regions and no changes in cerebellum and subcortical structures (Clemmesen et al., 1988). Animals that had experienced spontaneous withdrawal seizures exhibited relatively greater reductions in glucose utilization in the amygdala, whereas those with previous withdrawal-related audiogenic seizures had greater reductions in the auditory system, including the IC.
GENETICS OF ALCOHOL WITHDRAWAL SEIZURES Alcohol-associated seizures tend to run in families. For example, it has been reported that the incidence of seizures in first-degree relatives of individuals who experienced alcohol associated seizures is 2.45-fold that of unaffected individuals, whereas no excess incidence was observed in family members of persons experiencing posttraumatic seizures (Schaumann et al., 1994). An increased incidence of seizures in relatives was found whether the proband had alcohol-related seizures (spontaneously occurring seizures in association with chronic alcohol abuse) or alcohol withdrawal seizures. Thus some people without a history of epilepsy may have inherited genetic susceptibilities that make seizures more likely to occur in the setting of alcohol abuse. One gene implicated in susceptibility to alcohol withdrawal seizures is the dopamine transporter (DAT) gene (SLC6A3), which has a variable-number tandem repeat (VNTR) in exon 15 encoding the 3¢ untranslated region of its messenger RNA (mRNA) (Gorwood et al., 2003; Vandenbergh et al., 1992). In a study of alcoholics who reported histories of withdrawal seizures or delirium, Sander et al. (1997) found an increased prevalence of the nine-repeat (A9) allele compared with nonalcoholic controls. Two issues must be considered in assessing the significance of this
finding. First, the presence of the marker does not influence coding of the DAT protein and is therefore unlikely to have functional relevance itself. However, it has been noted that the repeat is close to the coding region and could be in linkage disequilibrium with a vulnerability-causing mutation that alters gene expression or protein structure. Precisely how alterations in DAT would influence seizure susceptibility is unknown. Alternatively the marker could be linked to other susceptibility alleles within a haplotype. The second issue is that the candidate gene approach, such as used in the Sander et al. study, is inherently susceptible to false positives. False associations can occur because of the large number of potential candidates and the low a priori probability that any particular candidate is a true susceptibility gene. Moreover, there is evidence of ethnic stratification of the DAT VNTR alleles so that uncontrolled differences in ethnicity between the affected and control populations could increase the risk of false positives, particularly in a study with a small sample size as was the case in Sander and colleagues (Uhl, 2004). Although the association of the DAT A9 allele with susceptibility to alcohol withdrawal seizures in humans requires confirmation, studies in animals do indicate the existence of inherited factors that predispose to the symptoms of alcohol withdrawal, including seizures. GoraMaslak et al. (1991) concluded that an aggregate set of genetic markers accounts for up to 62% of the variability in withdrawal syndrome severity. However, candidate gene studies have been disappointing, with no consistent results linking genes for serotonin, g-aminobutyric acid (GABA), endorphin, and dopamine receptors and the serotonin transporter with susceptibility to the withdrawal syndrome (Schmidt and Sander, 2000). The available evidence suggests that multiple genes are involved in various components of the syndrome, each of them contributing only modestly to withdrawal vulnerability. Nevertheless, in the mouse, there is good evidence that allelic variation in Mpdz influences the liability of alcohol withdrawal seizures (Fehr et al., 2004). Mpdz encodes the multiple PDZ domain protein (MPDZ). Mpdz haplotypes in standard mouse strains encode the three distinct protein variants MPDZ1–3. Recently it was reported that MPDZ status cosegregates with withdrawal convulsion severity in lines of mice selectively bred for phenotypic differences in severity of acute withdrawal from alcohol. MPDZ1 strains have significantly less severe acute alcohol withdrawal seizures than strains that express MPDZ2 or the closely related MPDZ3. Severity of pentobarbital withdrawal seizures is similarly correlated with MPDZ status (Fehr et al., 2002). Many ion channels and transporters possess PDZ-binding domains that are important in their trafficking and targeting to synapses. Although the MPDZ allelic variants could participate in such targeting, their precise functional roles are poorly understood and the differences among the variants that
Cellular and Molecular Mechanisms
would confer differences in seizure susceptibility have not yet been defined.
CELLULAR AND MOLECULAR MECHANISMS Although alcohol is the most widely used psychoactive agent, the pharmacologic basis of its intoxicating effects is incompletely understood. Similarly the molecular mechanisms underlying alcohol dependence and withdrawal are obscure. Nevertheless, it is well recognized that alcohol affects the functional activity of many receptors and ion channels, including NMDA (Lovinger et al., 1989, 1990), kainate (Carta et al., 2003), serotonin (Lovinger and White, 1991), GABAA (Davies, 2003) and glycine (Mihic et al., 1997) receptors, and G protein–coupled inwardly rectifying potassium channels (Kobayashi et al., 1999) and calcium channels (Walter and Messing, 1999). In most cases, the effects of alcohol on these targets occur at high concentrations. However, the effects of alcohol on certain GABAA receptor isoforms occur with concentrations within the intoxicating range. Acute alcohol potentiates these GABAA receptor isoforms and therefore enhances GABA-mediated inhibition through allosteric modulation of the receptors. Recent evidence indicates that GABAA receptors containing d-subunits are preferentially affected (Wei et al., 2004). Such d-subunit-containing receptors appear to be located extrasynaptically, where they sense ambient GABA in the extrasynaptic environment and mediate tonic inhibition. The role of GABAA receptor-mediated tonic inhibition is not fully defined. However, the extrasynaptic d-containing receptors that are responsible for tonic inhibition appear to be an important target of alcohol at intoxicating concentrations (Hanchar et al., 2004). It is interesting to speculate that these extrasynaptic receptors may be activated by spillover of GABA when GABAergic interneurons are intensely activated, such as occurs during a seizure discharge. The ability of alcohol to potentiate extrasynaptic GABA receptors could therefore contribute to the anticonvulsant activity of ethanol, including its protective activity against alcohol withdrawal seizures. Alcohol tolerance and dependence have been linked to changes in the function of GABAA receptors that are possibly related to alterations in subunit assembly (Devaud et al., 1997; Kang et al., 1996, 1998; Mahmoudi et al., 1997; Matthews et al., 1998; Mhatre et al., 1993; Morrow et al., 1990). In addition to effects on GABAA receptor isoforms that are located postsynaptically, there is emerging evidence that alcohol also enhances GABA-mediated inhibition via a presynaptic mechanism that involves GABA release from interneurons (Carta et al., 2004). It is hypothesized that there is a compensatory downregulation of GABAA receptors during chronic exposure to alcohol. When alcohol is with-
169
drawn and its potentiating effects are no longer present, the reduced functional activity of GABAA receptors would predispose to seizures. Indeed a loss of GABA-mediated inhibition has been associated with enhanced susceptibility to alcohol withdrawal seizures (Faingold et al., 2000; N’Gouemo et al., 1996). Alcohol exposure can also influence excitatory neurotransmission (Dodd et al., 2000). Acute alcohol exposure inhibits NMDA and kainate receptors, whereas chronic alcohol exposure results in upregulation of these receptors (Carta et al., 2002; Costa et al., 2000; Lovinger et al., 1990; Peoples et al., 1997). The ability of ethanol to inhibit NMDA responses appears to be dependent on NR1/NR2A and NR1/NR2B NMDA receptor isoforms (Wirkner et al., 1999). Abrupt cessation of alcohol exposure may result in brain hyperexcitability because inhibition of the upregulated NMDA and kainate receptors is uncovered (Whittington et al., 1995). There is evidence of upregulation of the NR1 and NR2A subunits of the NMDA receptor (Gulya et al., 1991; Snell et al., 1996; Trevisan et al., 1994) and the GluR6/7 kainate receptors (Carta et al., 2002). Alcohol also produces important effects on ion channels mediating intrinsic neuronal excitability, particularly calcium channels. Electrophysiologic studies suggest that increased neuronal firing is critically important for alcohol withdrawal seizures (Chakravarty and Faingold, 1998). However, the shape of action potentials is not significantly altered in brain neurons following alcohol withdrawal (Evans et al., 2000; Yang et al., 2002), indicating that there are not likely to be changes in the voltage-gated sodium and potassium channels that are responsible for action potentials. On the other hand, there is some evidence that ethanol selectively inhibits N-, P-, and Q-type calcium channels that mediate neurotransmitter release (Maldve et al., 2004; Newton et al., 2004). Moreover, increased L- and P-type calcium channel-current density has been observed following alcohol withdrawal associated with enhanced seizure susceptibility (N’Gouemo and Morad, 2003; PerezVelazquez et al., 1994). As previously noted, neurons within the central nucleus of the IC represent an important target of alcohol and seem to play a critical role in the initiation of alcohol withdrawalrelated AGS. Although it is plausible that alcohol withdrawal could be associated with changes in synaptic function and intrinsic excitability within this subnucleus (Evans et al., 2000; Yang et al., 2002), experimental support is not yet available.
TESTING PHARMACOLOGICAL AGENTS IN ANIMAL MODELS OF ALCOHOL WITHDRAWAL SEIZURES Because alcohol withdrawal-related AGS and HIC can be elicited at the will of the experimenter during a defined
170
Chapter 13/Alchol Withdrawal Seizures
period after cessation of alcohol intake, the anticonvulsant properties of pharmacologic agents can be easily studied (unlike the situation with spontaneous seizure models, where seizures occur unpredictably, requiring sophisticated monitoring systems and less robust trial designs). A limitation of these models is that AGS or HIC do not occur in every animal. However, the incidence (and severity) of AGS can be increased with intermittent ethanol administration (C.L. Faingold, personal communication). The peak incidence of AGS occurs at about 24 hours following alcohol withdrawal. Thus pharmacologic agents are typically tested between hour 20 and 28 following alcohol withdrawal, which encompasses a period of high seizure likelihood. Pharmacologic substances are typically administered 30 to 60 minutes before the time at which the AGS is elicited, but the choice of interval for any specific substance must be based on its pharmacokinetic characteristics. If the time of peak blood-brain levels is not known, a time course study should be carried out. Table 4 compares the potencies of various anticonvulsant substances for protection against alcohol withdrawal seizures (AGS in rats and HIC in mice) and in conventional seizure models used for the evaluation of antiepileptic drugs (White et al., 2002). The values in the diverse models are not directly comparable because of significant experimental differences. However, it is apparent that there is a rough concordance in the effectiveness of substances for protection against seizures in the alcohol withdrawal and nonalcohol–related models, with the possible exception of
the sodium channel–blocking anticonvulsant drugs carbamazepine and phenytoin (Rogawski and Löscher, 2004), which may be less effective against alcohol withdrawal seizures than in conventional seizure models. This corresponds with the lack of effectiveness of these drugs for many forms of generalized seizures (although the drugs are generally believed to be useful for generalized tonic-clonic seizures).
SEIZURES RELATED TO WITHDRAWAL OF OTHER CENTRAL NERVOUS SYSTEM DEPRESSANTS Drugs that increase GABAA-mediated inhibition (e.g., benzodiazepines, barbiturates) are commonly prescribed for their anxiolytic, sedative, hypnotic, muscle relaxant, and anticonvulsant properties. Prolonged administration of benzodiazepines and barbiturates can result in tolerance and physical dependence. The spectrum of behavioral signs and symptoms that occur following withdrawal from barbiturates and benzodiazepines—including hyperexcitability, tremors, and seizures—is similar to that occurring following alcohol withdrawal (Busto et al., 1986; Hillbom et al., 2003). In addition, genetic characteristics that influence susceptibility to alcohol withdrawal also affect susceptibility to barbiturate and benzodiazepine withdrawal (Metten and Crabbe, 1994, 1999). Furthermore, there is cross-tolerance among benzodiazepines, ethanol, and barbiturates, and ben-
TABLE 4 Comparison of the Potencies of Anticonvulsant Substances for Protection Against Alcohol Withdrawal Seizures and in Conventional Seizure Models ED50 (mg/kg) Alcohol withdrawal Substance Carbamazepine Chlormethiazole Diazepam Dizocilpine (MK-801) Gabapentin Phenytoin Valproic acid
Conventional seizure models
AGS (rat)
HIC (mice)
AGS (mice)
150a
NEb ~100d 20h 0.1l
11.2c
NEg 0.33k ~50 (mice)o 50p
NEq 300r
0.04–0.12i 0.047m 91.1c 3.9c 55–300c,i
PTZ (mice) >50c 36e 0.27j 1.17n 47.5c >50c 220c
MES (mice) 7.8c 137.6f 18.7j 0.95n 78.2c 5.6c 263c
ED50, median effective dose; HIC, handling-induced convulsions; PTZ, pentylenetetrazol seizure test; MES, maximal electroshock seizure test; NE, not effective. Conventional AGS testing is performed in strains of mice that are genetically susceptible to AGS, mainly DBA/2 but also Frings. a Chu, 1979; bGrant et al., 1992; cWhite et al., 2002; dGreen et al., 1990; eOgren, 1986; fPilip et al., 1998; gLittle et al., 1986; hCrabbe, 1992; iChapman et al., 1984; jSwinyard and Castellion, 1996; kMorrissett et al., 1990; lGrant et al., 1982; mChapman et al., 1989; nRogawski et al., 1991; oWatson et al., 1997; pChu et al., 1981; qGessner, 1974; rGoldstein, 1979.
Relevance of Alcohol Withdrawal Seizures in Rodents to the Human Condition
zodiazepines and barbiturates can protect against ethanol withdrawal convulsions in humans and rodents (see section on Relevance of Alcohol Withdrawal Seizures in Rodents to the Human Condition for further discussion of benzodiazepines in alcohol withdrawal). These various factors suggest that similar underlying mechanisms mediate the withdrawal syndromes that occur with the different CNS depressants (Kliethermes et al., 2000). Handling-induced convulsions have been used extensively to study the relationship between seizures that occur on withdrawal of alcohol and other CNS depressants such as benzodiazepines, barbiturates, and also inhalation anesthetics. However, pharmacokinetic factors may require alterations in the specific procedures that are used with certain agents. For example, because of its long half-life, diazepam does not produce the waxing and waning pattern of HIC exacerbation after injection that occurs with alcohol withdrawal as discussed previously and illustrated in Figure 2 (Crabbe, 1992). However, injection of the benzodiazepine receptor antagonist flumazanil precipitates a brief, relatively intense withdrawal reaction that lasts several minutes after the injection (Metten and Crabbe, 1994, 1999). In genetic studies in mice, a single dose of diazepam (20 mg/kg) is administered, followed by flumazenil (10 mg/kg) at an interval of 60 minutes. Withdrawal HICs are scored 1, 3, 5, 8, and 12 minutes later. In contrast to diazepam, zolpidem, a benzodiazepine that is selective for GABAA receptors containing a1 subunits, does not require precipitation by an antagonist (Metten et al., 1998). Withdrawal from barbiturates, such as pentobarbital, is also associated with potentiation of HICs. In studies of pentobarbital withdrawal for genetic studies, HICs are assessed at hourly intervals from 1 to 8 hours following injection (Metten and Crabbe, 1994). Nitrous oxide withdrawal is similarly associated with potentiation of HICs (Belknap et al., 1993). In a typical paradigm used for genetic studies, mice are exposed to a mixture of 75% nitrous oxide and 25% oxygen for 1 hour in an inhalation chamber and then returned to room air. HICs are assessed at baseline; immediately on removal from the inhalation chamber; and 5, 10, 15, 20, 40, and 60 minutes later (Metten et al., 1998). In addition to withdrawal of alcohol and GABA-potentiating drugs, seizures can also be induced by withdrawal of GABA administered locally in susceptible brain regions, including the cerebral cortex, amygdala, hippocampus, or IC (Brailowsky et al., 1988; Yang et al., 2001b). GABA solutions have been delivered through an indwelling catheter using a subcutaneously implanted osmotic minipump. In experiments examining IC infusion in rats, 1 M GABA is delivered bilaterally at the rate of 0.25 mliters per hour for 7 days (Yang et al., 2001b). Thirty minutes following abrupt cessation of the GABA infusion, animals exhibited spontaneous seizures (17% of rats tested) and a susceptibility to
171
AGS (39% of rats) that persisted in some animals for as long as 6 months. The sound-induced behaviors following GABA withdrawal consisted of wild running and bouncing clonus, which resemble seizures observed after ethanol withdrawal.
RELEVANCE OF ALCOHOL WITHDRAWAL SEIZURES IN RODENTS TO THE HUMAN CONDITION Although alcohol withdrawal seizures in rodents do not represent a perfect model of human alcohol withdrawal seizures, the available evidence indicates that the animal models are valid in many respects. As noted, most alcohol withdrawal seizures in humans are generalized tonic-clonic seizures. Similarly, the various forms of alcohol withdrawal seizures in rodents represent generalized convulsions. In both humans and rodents, the peak incidence of alcohol withdrawal related generalized seizures occurs between 20 to 24 hours following cessation of alcohol intake. In addition to exhibiting shared behavioral features, the brain systems underlying alcohol withdrawal seizures in humans and rodents are likely to be similar across species. There is no cortical paroxysmal activity in the electroencephalogram during auditory-evoked tonic-clonic alcohol withdrawal seizures in rodents (Hunter et al., 1973; Maxson and Sze, 1976). Epileptiform activity is also rare in the electroencephalogram recorded between episodes of alcohol withdrawal tonic-clonic seizures in humans (Sand et al., 2002; Touchon et al., 1981). The lack of cortical epileptic activity interictally during alcohol withdrawal suggests that the withdrawal seizures may not be initiated by cortical hyperexcitability but instead result from the abnormal function of subcortical neuronal networks that eventually trigger seizure discharges in the cortex. One neuronal network of interest is the brainstem auditory pathway, which has been implicated in rodent AGS (see previous discussion). Indeed significant abnormalities in auditory-evoked potentials have been reported in humans suffering from alcohol withdrawal seizures, including increased latency to wave V, which is unique to individuals suffering from alcohol withdrawal seizures (Neiman et al., 1991; Touchon et al., 1984). IC neurons are the major source of wave V in brainstem auditory-evoked potentials (Hughes and Fino, 1985), suggesting that abnormalities in the function of IC neurons can contribute to the genesis of alcohol withdrawal seizures in humans, as is believed to be the case in rodents. Indeed IC neurons are not only a component of the neuronal network for alcohol withdrawal seizures, but they are also believed to play an important role in other models of epilepsy and are considered a critical site for the genesis of tonic-clonic seizures whatever the underlying etiology (Faingold, 1999).
172
Chapter 13/Alchol Withdrawal Seizures
Neuronal plasticity mechanisms may play a role in the susceptibility to alcohol withdrawal seizures in humans and rodents. In humans the number of detoxifications, not the absolute amount of alcohol intake, best predicts the likelihood of subsequent alcohol withdrawal seizures (Ballenger and Post, 1978). Similarly studies in rodents have shown that repeated alcohol withdrawal experiences increase the severity and duration of subsequent withdrawal seizures. For example, this was the case in the study of Becker and Hale (1993) in which adult male mice were chronically exposed to ethanol vapor by inhalation. Animals in a multiple withdrawal group experienced three 16-hour exposure periods separated by 8-hour periods of abstinence; a single withdrawal group received a single 16-hour bout of ethanol exposure. The severity of HIC was significantly greater in the multiple withdrawal group than in the single withdrawal group. In additional studies, mice experiencing multiple withdrawal episodes were found to have greater susceptibility to chemoconvulsant-induced seizures (Becker et al., 1998). Furthermore, in rats, multiple withdrawal episodes from chronic alcohol treatment facilitate the rate of the development of IC kindling while at the same time inhibiting the evolution of amygdala and hippocampal kindling (Gonzalez et al., 2001; McCown and Breese, 1990). This observation provides further support for the concept that brainstem systems encompassing the IC are critical to the initiation of alcohol withdrawal seizures, whereas the forebrain mechanisms mediating “limbic” seizures (the equivalent of complex partial seizures in humans) do not play a major role, at least in triggering these seizures. This conclusion is consistent with observations from studies of cerebral glucose metabolism (see previous section entitled Metabolic Changes Following Alcohol Withdrawal). In chronic alcohol abusers, it seems likely that kindling-like effects of multiple detoxifications leads to hyperexcitability in IC neurons, which further predisposes to withdrawal seizures (Duka et al., 2004). Overall the various lines of evidence discussed in this section support the view that the neural mechanisms mediating alcohol-withdrawal tonic-clonic seizures in humans and rodents are similar. Do the animal models represent appropriate test systems for the evaluation of agents useful in the treatment of alcohol withdrawal seizures in humans? The available data suggest that the models can be applied for identification of agents useful in preventing alcohol withdrawal seizures, but there could be limitations, as highlighted by what appears to be poor concordance between the efficacy of benzodiazepines in the models and their use in clinical practice. In the United States, benzodiazepines are considered the drugs of choice to treat alcohol withdrawal and to prevent the occurrence of seizures (D’Onofrio et al., 1999; Mayo-Smith, 1977). In Europe, carbamazepine, chlormethiazole, and valproate are often used. Benzodiazepines have been shown to be protective in some animal
models of alcohol withdrawal seizures (Becker and Veatch, 2002; Mhatre et al., 2001), although they may not exhibit high potency (see Table 4). In fact, benzodiazepines generally have low potency in models of tonic seizures, such as the maximal electroshock test (see Table 4). In animal models, benzodiazepines are modestly effective in preventing the increased withdrawal severity that occurs with repeated withdrawals (Ulrichsen et al., 1995), although the drugs can also produce a paradoxical worsening (Becker and Veatch, 2002), and not all studies have yielded positive results (Mhatre et al., 2001), indicating that caution is warranted in using benzodiazepines for alcohol detoxification. Alcohol withdrawal has been associated with alterations in the subunit composition of GABAA receptors, including an increase in the expression of the a4 subunit that confers benzodiazepine insensitivity (Cagetti et al., 2003; Devaud et al., 1997; Sanna et al., 2003). Clinical experience demonstrates that benzodiazepines do reduce the risk of recurrent seizures in patients who present with an alcohol withdrawal seizure (D’Onofrio et al., 1999), so that in practice there is not complete benzodiazepine resistance. However, GABAA receptor modulators other than benzodiazepines that would not be expected to lose activity might be superior therapeutic agents. In fact, chlormethiazole is a positive modulator of GABAA receptors, which, in contrast to benzodiazepines, has high efficacy in enhancing GABAA receptors containing a4 subunits (Usala et al., 2003). Chlormethiazole has been shown to protect transiently against alcohol withdrawal seizures in mice withdrawn from exposure to inhaled ethanol (Green et al., 1990) and, in Central Europe, the drug represents the standard of care for the acute treatment of alcohol withdrawal (Majumdar, 1990; Morgan, 1995). It is interesting to speculate that chlormethiazole might be superior to benzodiazepines in the treatment of alcohol withdrawal as a result of its activity as a modulator of benzodiazepine-insensitive GABAA receptor isoforms. Carbamazepine may decrease the craving for alcohol after withdrawal, but there is little evidence that it prevents seizures and delirium. In fact, carbamazepine was inactive in blocking alcohol withdrawal-related HIC in mice (Grant et al., 1992), and only very high doses were able to suppress withdrawal-related AGS in rats (Chu, 1979). Interestingly, in humans, phenytoin is not effective in protecting against the recurrence of alcohol withdrawal seizures (Rathlev et al., 1994). The animal model therefore shows a good correspondence with clinical experience. Valproate also has some protective activity against alcohol withdrawal-related HIC in mice (Goldstein, 1979), and topiramate may also protect against enhanced seizure susceptibility in ethanol-dependent rats (Cagetti et al., 2004). There is increasing interest in the potential of gabapentin as a treatment for alcohol withdrawal, inasmuch as encouraging results have been produced in several small clinical studies (Bonnet et al., 1999; Bozikas et al., 2002; Myrick et al., 1998; Rustembegovic et
References
al., 2004; Voris et al., 2003). Animal studies confirm that gabapentin has protective activity against ethanol withdrawal seizures. For example, in mice undergoing alcohol withdrawal, gabapentin at doses of 50 to 100 mg/kg decreased the incidence of AGS (Watson et al., 1997). Vigabatrin may also be of value in alcohol withdrawal, but data from animal studies are not available as yet (Stuppaeck et al., 1996).
CONCLUSIONS It is estimated that two million Americans experience the symptoms of alcohol withdrawal each year (Bayard et al., 2004). Generalized tonic-clonic seizures are the most dramatic and dangerous component of the syndrome. In this chapter we have reviewed rodent models of alcohol withdrawal seizures that are commonly used for mechanistic and genetic studies and that can also be applied in the identification of new treatment approaches. In each of these models, withdrawal from alcohol, administered either chronically or in some instances acutely, leads to enhanced seizure susceptibility and occasionally spontaneous seizures. Interestingly the brain substrates that trigger these seizures are largely distinct from those responsible for other clinically important seizure types, and it is likely that the pathophysiologic mechanisms are different. Therefore it is not surprising that pharmacologic agents effective in other seizure types may not be effective in the treatment of alcohol withdrawal seizures. The alcohol withdrawal models provide unique opportunities to gain insights into the specific cellular mechanisms underlying this distinctive seizure syndrome. They also provide opportunities to optimize the therapy of alcohol withdrawal seizures. Indeed newer agents such as chlormethiazole, gabapentin, or valproate, which are effective in the models, are gaining acceptance clinically. NMDA receptor antagonists are especially active in animal models of alcohol withdrawal seizures, in accordance with the substantial evidence that alterations in NMDA receptor function play a key pathophysiologic role; whether such agents will have a role in clinical practice will require further study. An important challenge is to develop strategies to interdict the development of enhanced seizure susceptibility that occurs with multiple episodes of detoxification. Determining whether NMDA receptor antagonists or other pharmacologic approaches have such antiepileptogenic actions in repeated episodes of withdrawal will represent an important future application of the animal models.
References Atkin, L. 1986. The Auditory Midbrain: Structure and Function in the Central Auditory Pathway. Clifton: Humana Press. Ballenger, J.C., and Post, R.M. 1978. Kindling as a model for alcohol withdrawal syndromes. Br J Psychiatry 133: 1–14.
173
Bayard, M., McIntyre, J., Hill, K.R., and Woodside, J. Jr. 2004. Alcohol withdrawal syndrome. Am Fam Physician 69: 1443–1450. Becker, H.C., and Hale, R.L. 1993. Repeated episodes of ethanol withdrawal potentiate the severity of subsequent withdrawal seizures—an animal model of alcohol withdrawal kindling. Alcohol Clin Exp Res 17: 94–98. Becker, H.C., Diaz-Granados, J.L., and Hale, R.L. 1997. Exacerbation of ethanol withdrawal seizures in mice with a history of multiple withdrawal experience. Pharmacol Biochem Behav 57: 179–183. Becker, H.C., Veatch, L.M., and Diaz-Granados, J.L. 1998. Repeated ethanol withdrawal experience selectively alters sensitivity to different chemoconvulsant drugs in mice. Psychopharmacology (Berl) 139: 145–153. Belknap, J.K., Metten, P., Helms, M.L., O’Toole, L.A., Angeli-Gade, S., Crabbe, J.C., and Phillips, T.J. 1993. Quantitative trait loci (QTL) applications to substances of abuse: physical dependence studies with nitrous oxide and ethanol in BXD mice. Behav Genet 23: 213–222. Bonnet, U., Banger, M., Leweke, F.M., Maschke, M., Kowalski, T., and Gastpar, M. 1999. Treatment of alcohol withdrawal syndrome with gabapentin. Pharmacopsychiatry 32: 107–109. Bozikas, V., Petrikis, P., Gamvrula, K., Savvidou, I., and Karavatos, A. 2002. Treatment of alcohol withdrawal with gabapentin. Prog Neuropsychopharmacol Biol Psychiatry 26: 197–199. Brailowsky, S., Kunimoto, M., Menini, C., Silva-Barrat, C., Riche, and Naquet, R. 1988. The GABA-withdrawal syndrome: a new model of focal epileptogenesis. Brain Res 442: 175–179. Brown, D.J., and Long, W.C. 1988. Quality control in blood alcohol analysis: simultaneous quantitation and confirmation. J Anal Toxicol 12: 279–283. Buck, K.J., Rademacher, B.S., Metten, P., and Crabbe, J.C. 2002. Mapping murine loci for physical dependence on ethanol. Psychopharmacology (Berl) 160: 398–407. Busto, U., Sellers, E.M., Naranjo, C.A., Cappell H., Sanchez-Craig, M., and Sykora, K. 1986. Withdrawal reaction after long-term therapeutic use of benzodiazepines. N Engl J Med 315: 854–859. Cadete-Leite, A., Tavares, M.A., Pacheco, M.M., Volk, B., and PaulaBarbosa, M.M. 1989. Hippocampal mossy fiber-CA3 synapses after chronic alcohol consumption and withdrawal. Alcohol 6: 303–310. Cagetti, E., Liang, J., Spigelman, I., and Olsen, R.W. 2003. Withdrawal from chronic intermittent ethanol treatment changes subunit composition, reduces synaptic function, and decreases behavioral responses to positive allosteric modulators of GABAA receptors. Mol Pharmacol 63: 53–64. Cagetti, E., Baicy, K.J., and Olsen, R.W. 2004. Topiramate attenuates withdrawal signs after chronic intermittent ethanol in rats. Neuroreport 15: 207–210. Carpenter-Hyland, E.P., Woodward, J.J., and Chandler L.J. 2004. Chronic ethanol induces synaptic but not extrasynaptic targeting of NMDA receptors. J Neurosci 24: 7859–7868. Carta, M., Ariwodola, O.J., Weiner, J.L., and Valenzuela, C.F. 2003. Alcohol potently inhibits the kainate receptor-dependent excitatory drive of hippocampal interneurons. Proc Natl Acad Sci USA 100: 6813–6818. Carta, M., Mameli, M., and Valenzuela, C.F. 2004. Alcohol enhances GABAergic transmission to cerebellar granule cells via an increase in Golgi cell excitability. J Neurosci 24: 3746–3751. Carta, M., Olivera, D.S., Dettmer, T.S., and Valenzuela, C.F. 2002. Ethanol withdrawal upregulates kainate receptors in cultured rat hippocampal neurons. Neurosci Lett 327: 128–132. Chakravarty, D.N., and Faingold, C.L. 1998. Comparison of neuronal response patterns in the external and central nuclei of inferior colliculus during ethanol administration and ethanol withdrawal. Brain Res 783: 102–108. Chapman, A.G., Croucher, M.J., and Meldrum, B.S. 1984. Evaluation of anticonvulsant drugs in DBA/2 mice with sound-induced seizures. Arzneimittelforschung 34: 1261–1264.
174
Chapter 13/Alchol Withdrawal Seizures
Chapman, A.G., and Meldrum, B.S. 1989. Non-competitive N-methyl-daspartate antagonists protect against sound-induced seizures in DBA/2 mice. Eur J Pharmacol 166: 201–211. Chu, N.S. 1979. Carbamazepine: prevention of alcohol withdrawal seizures. Neurology 29: 1397–1401. Chu, N.S. 1981. Prevention of alcohol withdrawal seizures with phenytoin in rats. Epilepsia 22: 179–184. Clemmesen, L., Ingvar, M., Hemmingsen, R., and Bolwig, T.G. 1988. Local cerebral glucose consumption during ethanol withdrawal in the rat: effects of single and multiple episodes and previous convulsive seizures. Brain Res 453: 204–214. Costa, E.T., Soto, E.E., Cardoso, R.A., Olivera, D.S., and Valenzuela, C.F. 2000. Acute effects of ethanol on kainate receptors in cultured hippocampal neurons. Alcohol Clin Exp Res 24: 220–225. Crabbe, J.C. 1992. Antagonism of ethanol withdrawal convulsions in withdrawal seizure prone mice by diazepam and abecarnil. Eur J Pharmacol 221: 85–90. Crabbe, JC. 2002. Alcohol and genetics: new models. Am J Med Genet 114: 969–974. Crabbe, J., and Kosobud, A. 1990 Alcohol withdrawal seizures: genetic animal models. In Alcohol and Seizures: Basic Mechanisms and Clinical Concepts. Eds. R.J. Porter, R.H. Mattson. pp. 126–139. Philadelphia: F.A. Davis. Crews, F.T., Morrow, A.L., Criswell, H., and Breese, G. 1996. Effects of ethanol on ion channels. Int Rev Neurobiol 39: 283–367. Danober, L., Deransart, C., Depaulis, A., Vergnes, M., and Marescaux, C. 1998. Pathophysiological mechanisms of genetic absence epilepsy in the rat. Prog Neurobiol 55: 27–57. Davies, M. 2003. The role of GABAA receptors in mediating the effects of alcohol in the central nervous system. J Psychiatry Neurosci 28: 263–274. Deitrich, R.A., and Erwin, V.G. 1996. Pharmacological Effects of Ethanol on the Nervous System. Boca Raton: CRC Press. Devaud, L.L., Matthews, D.B., and Morrow AL. 1999. Gender impacts behavioral and neurochemical adaptations in ethanol-dependent rats. Pharmacol Biochem Behav 64: 841–849. Devaud, L.L., Fritschy, J.M., Sieghart, W., and Morrow, A.L. 1997. Bidirectional alterations of GABAA receptor subunit peptide levels in rat cortex during chronic ethanol consumption and withdrawal. J Neurochem 69: 126–130. Dodd, P.R., Beckmann, A.M., Davidson, M.S., and Wilce, P.A. 2000. Glutamate-mediated transmission, alcohol, and alcoholism. Neurochem Int 37: 509–533. D’Onofrio, G., Rathlev, N.K., Ulrich, A.S., Fish, S.S., and Freedland, E.S. 1999. Lorazepam for the prevention of recurrent seizures related to alcohol. N Engl J Med 340: 915–919. Duka, T., Gentry, J., Malcolm, R., Ripley, T.L., Borlikova, G., Stephens, D.N., Veatch, L.M. et al. 2004. Consequences of multiple withdrawals from alcohol. Alcohol Clin Exp Res 28: 233–246. Eckardt, M.J., Campbell, G.A., Marietta, C.A., Majchrowicz, E., Rawlings, R.R., and Weight, F.F. 1992. Ethanol dependence and withdrawal selectively alter localized cerebral glucose utilization. Brain Res 584: 244–250. Ellis, F.W., and Pick, J.R. 1970. Experimentally induced ethanol dependence in rhesus monkeys. J Pharmacol Exp Ther 175: 88–93. Engel, J. Jr. 2001. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE task force on classification and terminology. Epilepsia 42: 796–803. Essardas-Daryanani, H., Santolaria, F.J., Gonzalex Reimers, E., Jorge, J.A., Batista Lopez, N., Martin Hernandez, F., Martinez Riera, A., et al. 1994. Alcoholic withdrawal syndrome and seizures. Alcohol Alcohol 29: 323–328. Essig, C.F., Jones, B.E., and Lam, R.C. 1969. The effects of pentobarbital on alcohol withdrawal in dogs. Arch Neurol 20: 554–558.
Evans, M.S., Li, Y., and Faingold, C.L. 2000. Inferior colliculus intracellular response abnormalities in vitro associated with susceptibility to ethanol withdrawal seizures. Alcoholism Clin Exp Res 24: 1180–1186. Faingold, C.L. 1999. Neuronal networks in the genetically epilepsy-prone rat. Adv Neurol 79: 311–321. Faingold, C.L. 2004. Emergent properties of CNS neuronal networks as targets for pharmacology: application to anticonvulsant drug action. Prog Neurobiol 72: 55–85. Faingold, C.L., and Riaz, A. 1995. Ethanol withdrawal induces increased firing in inferior colliculus neurons associated with audiogenic seizure susceptibility. Exp Neurol 132: 91–98. Faingold, C.L., and Riaz, A. 1994. Increased responsiveness of pontine reticular formation neurons associated with audiogenic seizures susceptibility during ethanol. Brain Res 663: 69–76. Faingold, C.L., and Randall, M.E. 1995. Pontine reticular formation neurons exhibit a premature and precipitous increase in acoustic responses prior to audiogenic seizures in genetically epilepsy-prone rats. Brain Res 704: 218–226. Faingold, C.L., Li, Y., and Evans, M.S. 2000. Decreased GABA and increased glutamate receptor-mediated activity on inferior colliculus neurons in vitro are associated with susceptibility to ethanol withdrawal seizures. Brain Res 868: 287–295. Faingold, C.L., N’Gouemo, P., and Riaz, A. 1998. Ethanol and neurotransmitter interaction. From molecular to integrative effects. Prog Neurobiol 55: 509–535. Fehr, C., Shirley, R.L., Metten, P., Kosobud, A.E., Belknap, J.K., Crabbe, J.C., and Buck, K.J. 2004. Potential pleiotropic effects of Mpdz on vulnerability to seizures. Genes Brain Behav 3: 8–19. Fehr, C., Shirley, R.L., Belknap, J.K., Crabbe, J.C., and Buck, K.J. 2002. Congenic mapping of alcohol and pentobarbital withdrawal liability loci to a <1 centimorgan interval of murine chromosome 4: identification of Mpdz as a candidate gene. J Neurosci. 22: 3730–3738. Feller, D.J., Bassir, J.M., Crabbe, J.C., and Le Fevre CA. 1994. Audiogenic seizure susceptibility in WSP and WSR mice. Epilepsia 35: 861–867. Floyd, D.W., Jung, K.Y., and McCool, B.A. 2003. Chronic ethanol ingestion facilitates N-methyl-d-aspartate receptor function and expression in rat lateral/basolateral amygdala neurons. J Pharmacol Exp Ther 307: 1020–1029. Freedland, E.S., and McMicken, D.B. 1993a. Alcohol-related seizures, Part I: pathology, differential diagnostic, and evaluation. J Emerg Med 11: 463–473. Freedland, E.S., and McMicken, D.B. 1993b. Alcohol-related seizures, Part II: clinical presentation and management. J Emerg Med 11: 605–618. Freund, G. 1969. Alcohol withdrawal syndrome in mice. Arch Neurol 21: 315–320. Frey, G.D., McCown, T.J., Breese, G.R., and Peterson, S.L. 1986. GABAergic modulation of inferior colliculus excitability: role in ethanol withdrawal seizures. J Pharmacol Exp Ther 227: 663–670. Gessner, P.K. 1974. Failure of diphenylhydantoin to prevent alcohol withdrawal convulsions in mice. Eur J Pharmacol 27: 120–129. Goldstein, D.B. 1979. Sodium bromide and sodium valproate: effective suppressants of ethanol withdrawal reactions in mice. J Pharmacol Exp Ther 208: 223–227. Goldstein, D.B., and Pal, N. 1971. Alcohol dependence produced in mice by inhalation of ethanol: grading the withdrawal reaction. Science 172: 288–290. Gonzalez, L.P., Czachura, J.F., and Brewer, K.W. 1989. Spontaneous versus elicited seizures following ethanol withdrawal: differential time course. Alcohol Alcohol 6: 481–487. Gonzalez, L.P., Veatch, L.M., Ticku, M.K., and Becker, H.C. 2001. Alcohol withdrawal kindling: mechanisms and implications for treatment. Alcohol Clin Exp Res 25(5 suppl ISBRA): 197S–201S. Gora-Maslak, G., McClearn, G.E., Crabbe, J.C., Phillips, T.J., Belknap, J.K., and Plomin R. 1991. Use of recombinant inbred strains to iden-
References tify quantitative trait loci in psychopharmacology. Psychopharmacology (Berl) 104: 413–424. Gorwood, P., Limosin, F., Batel, P., Hamon, M., Ades, J., and Boni, C. 2003. The A9 allele of the dopamine transporter gene is associated with delirium tremens and alcohol-withdrawal seizure. Biol Psychiatry 53: 85–92. Grant, K.A., Snell, L.D., Rogawski, M.A., Thurkauf, A., and Tabakoff, B. 1992. Comparison of the effects of the uncompetitive N-methyld-aspartate antagonist (±)-5-aminocarbonyl-10,11-dihydro-5Hdibenzo[a, d]cyclohepten-5,10-imine (ADCI) with its structural analogs dizocilpine (MK-801) and carbamazepine on ethanol withdrawal seizures. J Pharmacol Exp Ther 260: 1017–1022. Green, A.R., Davies, E.M., Little, H.J., Whittington, M.A., and Cross, A.J. 1990. Action of chlormethiazole in a model of ethanol withdrawal. Psychopharmacology (Berl) 102: 239–242. Grunwald, F., Schrock, H., Biersack, H.J., and Kuschinsky, W. 1993. Changes in local cerebral glucose utilization in the awake rat during acute and chronic administration of ethanol. J Nucl Med 34: 798–803. Guerrero-Figueroa, R., Rye, M.M., Gallant, D.M., and Bishop, M.P. 1970. Electrographic and behavioral effects of diazepam during alcohol withdrawal stage in cats. Neuropharmacology 9: 143–150. Gulya, K., Grant, K.A., Valverius, P., Hoffman, P.L., and Tabakoff, B. 1991. Brain regional specificity and time-course of changes in the NMDA receptor-ionophore complex during ethanol withdrawal. Brain Res 547: 129–134. Hanchar, H.J., Wallner, M., and Olsen, R.W. 2004. Alcohol effects on gaminobutyric acid type A receptors: are extrasynaptic receptors the answer? Life Sci 76: 1–8. Hemmingsen, R., Barry, D.I., Hertz, M.M., and Klinken, L. 1979. Cerebral flow and oxygen consumption during ethanol withdrawal in the rat. Brain Res 173: 259–269. Hillbom, M., Pieninkeroinen, I., and Leone, M. 2003. Seizures in alcoholdependent patients. CNS Drugs 17: 1013–1030. Hoffman, P.L., and Tabakoff, B. 1996. Alcohol dependence: a commentary on mechanisms. Alcohol Alcohol 31: 333–340. Hughes, J.R., and Fino, J.J. 1985. A review of generators of the brainstem auditory evoked potentials: contribution of an experimental study. J Clin Neurophysiol 2: 355–381. Hunter, B.E., Boast, C.A., Walker, D.W., and Zornetzer, S.F. 1973. Alcohol withdrawal syndrome in rats: neural and behavioral correlates. Pharmacol Biochem Behav 1: 719–725. Ikonomidou, C., Bittigau, P., Ishimaru, M.J., Wozniak, D.F., Koch, C., Genz, K., Price, M.T. et al. 2000. Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome. Science 287: 947–948. Jobe, P.C., Pichioni, A.L., and Chin, L. 1973 Role of brain norepinephrine in audiogenic seizures in the rat. J Pharmacol Exp Ther 184: 1–10. Kang, M., Spigelman, I., Sapp, D.W., and Olsen, R.W. 1996. Persistent reduction of GABAA receptor-mediated inhibition in rat hippocampus after chronic intermittent ethanol treatment. Brain Res 709: 221–228. Kang, M.H., Spigelman, I., and Olsen, R.W. 1998. Alteration in the sensitivity of GABAA receptors to allosteric modulatory drugs in rat hippocampus after chronic intermittent ethanol treatment. Alcohol Clin Exp Res 22: 2165–2173. Kliethermes, C.L., Metten, P., Belknap, J.K., Buck, K.J., and Crabbe, J.C. 2004. Selection for pentobarbiatal withdrawal severity: correlated differences in withdrawal from other sedative drugs. Brain Res 1009: 17–25. Kobayashi, T., Ikeda, K., Kojima, H., Niki, H., Yano, R., Yoshioka, T., and Kumanishi, T. 1999. Ethanol opens G-protein-activated inwardly rectifying K+ channels. Nat Neurosci 2: 1091–1097. Kosten, T.R., and O’Connor, P.G. 2003 Management of drug and alcohol withdrawal. N Engl J Med 348: 1786–1795. Krystal, J.H., Petrakis, I.L., Mason, G., Trevisan, L., and D’Souza, D.C. 2003. N-methyl-d-aspartate glutamate receptors and alcoholism:
175
reward, dependence, treatment, and vulnerability. Pharmacol Ther 99: 79–94. Lieber, C.S., and DeCarli, L.M. 1982. The feeding of alcohol in liquid diets: two decades of applications and 1982 update. Alcohol Clin Exp Res 6: 523–531. Little, H.J., Dolin, S.J., and Halsey, M.J. 1986. Calcium channel antagonists decrease the ethanol withdrawal syndrome. Life Sci 39: 2059–2065. Lovinger, D.M., and White, G. 1991. Ethanol potentiation of 5-hydroxytryptamine3 receptor-mediated ion current in neuroblastoma cells and isolated adult mammalian neurons. Mol Pharmacol 40: 263–270. Lovinger, D.M., White, G., and Weight, F.F. 1989. Ethanol inhibits NMDAactivated ion current in hippocampal neurons. Science 243: 1721–1724. Lovinger, D.M., White, G., and Weight, F.F. 1990. NMDA receptor-mediated synaptic excitation selectively inhibited by ethanol in hippocampal slice from adult rat. J Neurosci 10: 1372–1379. Mahmoudi, M., Kang, M.H., Taillakaratne, N., Tobin, A.J., and Olsen, R.W. 1997. Chronic intermittent ethanol treatment in rats increases GABAA receptor a4-subunit expression: possible relevance to alcohol dependence. J Neurochem 68: 2485–2492. Majchrowicz, E. 1975. Induction of physical dependence on ethanol and associated metabolic and behavioral changes in rats. Psychopharmacologia 43: 245–254. Majumdar, S.K. 1990. Chlormethiazole: current status in the treatment of the acute ethanol withdrawal syndrome. Drug Alcohol Depend 27: 201–207. Maldve, R.E., Chen, X., Zhang, T.A., and Morrisett, R.A. 2004. Ethanol selectively inhibits enhanced vesicular release at excitatory synapses: real-time visualization in intact hippocampal slices. Alcohol Clin Exp Res 28: 143–152. Matthews, D.B., Devaud, L.L., Fritschy, J.M., Sieghart, W., and Morrow, A.L. 1998. Differential regulation of GABAA receptor gene expression by ethanol in the rat hippocampus versus cerebral cortex. J Neurochem 70: 1160–1166. Mattson, R.H. 1983. Seizures associated with alcohol use and alcohol withdrawal. In Epilepsy—Diagnosis and Management Ed. B. Feldman. pp. 325–332. Boston: Little Brown. Maxson, S.C., and Sze, P.Y. 1976. Electroencephalographic correlates of audiogenic seizures during ethanol withdrawal in mice. Psychopharmacology 47: 17–20. Mayo-Smith, M.F. 1977. Pharmacological management of alcohol withdrawal: a meta-analysis and evidence-based practice guideline. JAMA 278: 144–151. McCown, T.J., and Breese, G.R. 1990. Multiple withdrawals from chronic ethanol “kindles” inferior collicular seizure activity: evidence for kindling of seizures associated with alcoholism. Alcohol Clin Exp Res 14: 394–399. Metten, P., Belknap, J.K., and Crabbe, J.C. 1998. Drug withdrawal convulsions and susceptibility to convulsions after short-term selective breeding for acute ethanol withdrawal. Behav Brain Res 95: 113– 122. Metten, P., and Crabbe, J.C. 1994. Common genetic determinants of severity of acute withdrawal from ethanol, pentobarbital and diazepam in inbred mice. Behav Pharmacol 5: 533–547. Metten, P., and Crabbe, J.C. 1999. Genetic determinants of severity of acute withdrawal from diazepam in mice: commonality with ethanol and pentobarbital. Pharmacol Biochem Behav 63: 473–479. Mhatre, M.C., McKenzie, S.E., and Gonzalez, L.P. 2001. Diazepam during prior ethanol withdrawals does not alter seizure susceptibility during a subsequent withdrawal. Pharmacol Biochem Behav 68: 339–346. Mhatre, M.C., Pena, G., Sieghart, W., and Ticku, M.K. 1993. Antibodies specific for GABAA receptor alpha subunits reveal that chronic alcohol treatment downregulates alpha-subunit expression in rat brain regions. J Neurochem 61: 1620–1625.
176
Chapter 13/Alchol Withdrawal Seizures
Mihic, S.J., Ye, Q., Wick, M.J., Koltchine, V.V., Krasowski, M.D., Finn, S.E., Mascia, M.P. et al. 1997. Sites of alcohol and volatile anaesthetic action on GABAA and glycine receptors. Nature 389: 385–389. Morgan, M.Y. 1995. The management of alcohol withdrawal using chlormethiazole. Alcohol Alcohol 30: 771–774. Morrisett, R.A., Rezvani, A.H., Overstreet, D., Janowsky, D.S., Wilson, W.A., and Swartzwelder, H.S. 1990. MK-801 potently inhibits alcohol withdrawal seizures in rats. Eur. J. Pharmacol. 176: 103–105. Morrow, A.L., Montpied, P., Lingford-Hughes, A., and Paul, S.M. 1990. Chronic ethanol and pentobarbital administration in the rat: effects on GABAA receptor function and expression in brain. Alcohol 7: 237–244. Myrick, H., Malcolm, R., and Brady, K.T. 1998. Gabapentin treatment of alcohol withdrawal. Am J Psychiatry 155: 1632. N’Gouemo, P., and Morad, M. 2003. Ethanol withdrawal seizure susceptibility is associated with upregulation of L-and P-type Ca2+ channel currents in inferior colliculus neurons. Neuropharmacology 45: 429–437. N’Gouemo, P., Caspary, D.M., and Faingold, C.L. 1996. Decreased GABA effectiveness in the inferior colliculus neurons during ethanol withdrawal in rats susceptibile to audiogenic seizures. Brain Res 724: 200–204. Neiman, J., Noldy, N.E., El-Nesr, B., McDonough, M., Carlen, P.L. 1991. Late auditory evoked potentials in alcoholics: identifying those with a history of epileptic seizures during withdrawal. Ann NY Acad Sci 620: 73–81. Nevo, I., and Hamon, M. 1995. Neurotransmitter and neuromodulatory mechanisms involved in alcohol abuse and alcoholism. Neurochem Int 26: 305–342. Newman, L.M., Hoffman, W.E., Miletich, D.J., Albrecht, R.F. 1985. Regional blood flow and cerebral metabolic changes during alcohol withdrawal and following midazolama therapy. Anesthesiology 63: 395–400. Newton, P.M., Orr, C.J., Wallace, M.J., Kim, C., Shin, H.S., and Messing, R.O. 2004. Deletion of N-type calcium channels alters ethanol reward and reduces ethanol consumption in mice. J Neurosci 24: 9862–9869. Ogren, S.O. 1986. Chlormethiazole–mode of action. Acta Psychiatr. Scand Suppl 329: 13–27. Paula-Barbosa, M.M., Brandao, F., Madeira, M.D., and Cadete-Leite, A. 1993. Structural changes in the hippocampal formation after long-term alcohol consumaption and withdrawal in the rat. Addiction 88: 237–247. Peininkeroinen, I.P., Telakivi, T.M., and Hillbom, M.E. 1992. Outcome in subject with alcohol-provoked seizures. Alcohol Clin Exp Res 16: 955–959. Peoples, R.W., White, G., Lovinger, D.M., and Weight, F.F. 1997. Ethanol inhibition of N-methyl-D-aspartate-activated current in mouse hippocampal neurones: whole-cell patch-clamp analysis. Br J Pharmacol 122: 1035–1042. Perez-Velazquez, J.L., Valiante, T.A., and Carlen, P.L. 1994. Changes in calcium currents during ethanol withdrawal in a genetic mouse model. Brain Res 649: 305–309. Pieper, W.A., Skeen, M.J., McClure, H.M., and Bourne, P.G. 1972. The chimpanzee as an animal model for investigating alcoholism. Science 176: 71–73. Pilke, A., Partinen, M., and Kovanen, J. 1984. Status epilepticus and alcohol abuse: an analysis of 82 status epilepticus admissions. Acta Neurol Scand 70: 443–450. Pilip, S., Urbanska, E.M., Czuczwar, S.J., Kleinrok, Z., and Turski, W.A. 1998. Chlormethiazole anticonvulsive efficacy diminished by Nmethyl-d-aspartate but not kainate in mice. Eur J Pharmacol 345: 257–260. Pinel, J.P. 1980. Alcohol withdrawal seizures: implications of kindling. Pharmacol Biochem Behav 13(suppl 1): 225–231. Prendergast, M.A., Harris, B.R., Mullholland, P.J., Blanchard, J.A., Gibson, D.A., Holley, R.C., and Littleton, J.M. 2004. Hippocampal CA1 region
neurodegeneration produced by ethanol withdrawal requires activation of intrinsic polysynaptic hippocampal pathways and function of Nmethyl-d-aspartate receptors. Neuroscience 124: 869–877. Rathlev, N.K., D’Onofrio, G., Fish, S.S., Harrison, P.M., Bernstein, E., Hossack, R.W., and Pickens, L. 1994. The lack of efficacy of phenytoin in the prevention of recurrent alcohol-related seizures. Ann Emerg Med 23: 513–518. Riaz, A., and Faingold, C.L. 1994. Seizures during ethanol withdrawal are blocked by focal microinjection of excitant amino acid antagonists into the inferior colliculus and pontine reticular formation. Alcohol Clin Exp Res 18: 1456–1462. Ripley, J.B. 1990. A 39-year-old man with fatal alcohol withdrawal seizures. J Emerg Nurs 16: 67—79. Ripley, T.L., Dunworth, S.J., and Stephens, D.N. 2002. Effects of CGP39551 administration on the kindling of ethanol-withdrawal seizures. Psychopharmacology 163: 157–165. Roberts, A.J., Crabbe, J.C., and Keith, L.D. 1992. Genetic differences in hypothalamic-pituitary-adrenal axis responsiveness to acute ethanol and acute ethanol withdrawal. Brain Res 579: 296–302. Rogawski, M.A., and Löscher, W. 2004. The neurobiology of antiepileptic drugs. Nat Rev Neurosci 5: 553–564. Rogawski, M.A., Yamaguchi, S., Jones, S.M., Rice, K.C., Thurkauf, A., and Monn, J.A. 1991. Anticonvulsant activity of the low-affinity uncompetitive N-methyl-D-aspartate antagonist (±)-5-aminocarbonyl-10,11dihydro-5H-dibenzo[a,da,d]cyclohepten-5,10-imine (ADCI): comparison with the structural analogs dizocilpine (MK-801) and carbamazepine. J Pharmacol Exp Ther 259: 30–37. Rossetti, Z.L., and Carboni, S. 1995. Ethanol withdrawal is associated with increased extracellular glutamate in the rat striatum. Eur J Pharmacol 283: 177–183. Rustembegovic, A., Sofic, E., Tahirovic, I., and Kundurovic, Z. 2004. A study of gabapentin in the treatment of tonic-clonic seizures of alcohol withdrawal syndrome. Med Arh 58: 5–6. Ruwe, W.D., Bauce, L., Flemons, W.W., Veale, W.L., and Pittman, Q.J. 1986. Alcohol dependence and withdrawal in the rat: an effective means of induction and assessment. J Pharmacol Meth 15: 225–234. Sand, T., Brathen, G., Michler, R., Brodtkorb, E., Helde, G., and Bovim, G. 2002. Clinical utility of EEG in alcohol-related seizures. Acta Neurol Scand 105: 18–24. Sander, T., Harms, H., Podschus, J., Finckh, U., Nickel, B., Rolfs, A., Rommelspacher, H. et al. 1997. Allelic association of a dopamine transporter gene polymorphism in alcohol dependence with withdrawal seizures or delirium. Biol Psychiatry 41: 299–304. Sanna, E., Mostallino, M.C., Busonero, F., Talani, G., Tranquilli, S., Mameli, M., Spiga, S., et al. 2003. Changes in GABAA receptor gene expression associated with selective alteration in receptor function and pharmacology after ethanol withdrawal. J Neurosci 23: 11711–11724. Schaumann, B.A., Annegers, J.F., Johnson, S.B., Moore, K.J., Lubozynski, M.F., and Salinsky, M.C. 1994. Family history of seizures in posttraumatic and alcohol-associated seizure disorders. Epilepsia 35: 48–52. Schmidt, L.G., and Sander, T. 2000. Genetics of alcohol withdrawal. Eur Psychiatry 15: 135–139. Scorza, F.A., Arida, R.M., Cysneiros, R.M., Priel, M.R., de Albuquerque, M., and Cavalheiro, E.A. 2003. The effects of alcohol intake and withdrawal on the seizures frequency and hippocampal morpphology in rats with epilepsy. Neurosci Res 47: 323–328. Snead, O.C. 1995. Basic mechanisms of generalized absence seizures. Ann Neurol 37: 146–157. Snell, L.D., Nunley, K.R., Lickteig, R.L., Browning, M.D., Tabakoff, B., and Hoffman, P.L. 1996. Regional and subunit specific changes in NMDA receptor mRNA and immunoreactivity in mouse brain following chronic ethanol ingestion. Mol Brain Res 40: 71–78. Stuppaeck, C.H., Deisenhammer, E.A., Kurz, M., Whitworth, A.B., and Hinterhuber, H. 1996. The irreversible g-aminobutyrate transaminase
References inhibitor vigabatrin in the treatment of the alcohol withdrawal syndrome. Alcohol Alcohol 31: 109–111. Swinyard, E.A., and Castellion, A.W. 1966. Anticonvulsant properties of some benzodiazepines. J Pharmacol Exp Ther 151: 369–375. Touchon, J., Besset, A., Baldy-Moulinier, M., Billiard, M., Uziel, A., and Passouant, P. 1981. Electrophysiological aspect of alcoholic epilepsy. Rev Electroencephalogr Neurophysiol 14: 133–137. Touchon, J., Rondouin, G., DeLustrac, C., Billiard, M., Baldy-Moulinier, M., and Cadilhac, M. 1984. Brainstem auditory evoked potential in “alcoholic epilepsy.” Rev Electroencephalogr Neurophysiol 14: 133–137. Trevisan, L., Fitzgerald, L.W., Brose, N., Gasic, G.P., Heinemann, S.F., Duman, R.S., and Nestler, E.J. 1994. Chronic ingestion of ethanol upregulates NMDAR1 receptor subunit immunoreactivity in hippocampus. J Neurochem 62: 1635–1638. Uhl, G.R. 2003. Dopamine transporter: basic science and human variation of a key molecule for dopaminergic function, locomotion, and parkinsonism. Mov Disord 18(suppl 7) S71–S80. Ulrichsen, J., Bech, B., Allerup, P., and Hemmingsen, R. 1995. Diazepam prevents progression of kindled alcohol withdrawal behaviour. Psychopharmacology (Berl) 121: 451–460. Usala, M., Thompson, S.A., Whiting, P.J., and Wafford, K.A. 2003. Activity of chlormethiazole at human recombinant GABAA and NMDA receptors. Br J Pharmacol 140: 1045–1050. Vandenbergh, D.J., Persico, A.M., and Uhl, G.R. 1992. A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetitive element and provides racially-dimorphic TaqI RFLPs. Brain Res Mol Brain Res 15: 161–166. Veatch, L.M., and Becker, H.C. 2002. Electrographic and behavioral indices of ethanol withdrawal sensitization. Brain Res 946: 272—282. Victor, M., and Brausch, C. 1967. The role of abstinence in the genesis of alcoholic epilepsy. Epilepsy 8: 1–20. Voris, J., Smith, N.L., Rao, S.M., Thorne, D.L., and Flowers, Q.J. 2003. Gabapentin for the treatment of ethanol withdrawal. Subst Abus 24: 129–132. Walker, D.W., Barnes, D.E., Hunter, B.E., Zornetzer, J.F., and Kubanis, P. 1980. Neuronal loss in hippocampus induced by prolonged ethanol consumption in rats. Science 209: 773–778. Walter, H., and Messing, R.O. 1999. Regulation of neuronal voltage-gated calcium channels by ethanol. Neurochem Int 35: 95–101.
177
Watson, W.P., Robinson, E., and Little, H.J. 1997. The novel anticonvulsant, gabapentin, protects against both convulsant and anxiogenic aspects of the ethanol withdrawal syndrome. Neuropharmacology 36: 1369–1375. Wei, W., Faria, L.C., and Mody, I. 2004. Low ethanol concentrations selectively augment the tonic inhibition mediated by d subunit-containing GABAA receptors in hippocampal neurons. J Neurosci 24: 8379– 8382. White, H.S., Woodhead, J.H., Wilcox, K.S., Stables, J.P., Kupferberg, H.J., and Wolf, H.H. 2002. General principles: discovery and preclinical development of antiepileptic drugs. In Antiepileptic Drugs, 5th ed. Eds. R.H. Levy, R.H. Mattson, B.S. Meldrum, and E. Perucca. Philadelphia: Lippincott Williams & Wilkins. Whittington, M.A., Lambert, J.D., and Little, H.J. 1993. Increases in synaptic activation of calcium current as a mechanism for generation of ethanol withdrawal seizures. Alcohol Alcohol 2: 391–394. Whittington, M.A., Lambert, J.D., and Little, H.J. 1995. Increased NMDA receptor and calcium channel activity underlying ethanol withdrawal hyperexcitability. Alcohol Alcohol 30: 105–114. Wirkner, K., Poelchen, W., Koles, L., Muhlberg, K., Scheibler, P., Allgaier, C., and Illes, P. 1999. Ethanol-induced inhibition of NMDA receptor channels. Neurochem Int 35: 153–162. Yang, L., Long, C., and Faingold, C.L. 2001a. Neurons in the deep layers of supperior colliculus are a requisite component of the neuronal network for seizures during ethanol withdrawal. Brain Res 920: 134–141. Yang, L., Long, C., and Faingold, C.L. 2001b. Audiogenic seizure susceptibility is induced by termination of continuous infusion of g-aminobutyric acid or an N-methyl-D-aspartic acid antagonist into the inferior colliculus. Exp Neurol 171: 147–152. Yang, L., Long, C., and Faingold, C.L. (2003). Neurons in the periaqueductal gray are critically involved in the neuronal network for audiogenic seizures during ethanol withdrawal. Neuropharmacology 44: 275–281. Yang, L., Long, C., Evans, M.S., and Faingold C.L. 2002. Ethanol withdrawal results in aberrant membrane properties and synaptic responses in periaqueductal gray neurons associated seizure susceptibility. Brain Res 957: 99–108.
B
FIGURE 7 - 6 Orthograde transport of biocytin reveals callosal projection in coronal slices. A: A biocytin crystal (-0.5 mm diameter) was placed in layer V of the contralateral cingulate cortex (right side, crystal placement not shown in this figure). The slice was incubated for 3 hours in an interface chamber and then processed to obtain a final horseradish peroxidase reaction product. The arrows in A indicate labeling of the callosal fibers. The square area marked in A is expanded in B. B: A dark-field image showing the callosal fibers coursing upward through the ipsilateral layer V.
Outflow (Ethanolvapor)
Ethanol (via pump)
Inflow (Air) vaporizing chamber
Water bath37 °C
Metering
~
'\
pump
~Water
Air pump
r--Urine Ethanol
Experimental
collection
chamber
FIGURE 1 3--1 Schematic representation of a system for administration of ethanol by inhalation modified after Ruwe et al. (1986). Ethanol (95%) is delivered by a solvent metering pump into a 250-ml vaporization chambers. The airtight vaporization chamber is maintained at 37 ° C by a water bath. Air is delivered into the vaporization chamber with an air pump to provide a flow rate of 2.5 to 4 liters per minute. Animals are exposed to ethanol-vapor concentrations of 7 to 35 mg/liter of air in a Plexiglas experimental chamber. A food tray and water bottle are securely affixed to the experimental chamber, giving the animals free access to food and water. The sample port allows air within the experimental chamber to be sampled for determination of ethanol concentrations.
C
H
A
P
T
E
R
14 Alumina Gel Injection Models of Epilepsy in Monkeys CHARLES E. RIBAK, LEE A. SHAPIRO, LASZLO SERESS, AND ROY A. BAKAY
culline, provides ample time to study these morphologic and electrophysiologic changes. Third, the initial injury caused by the injection of alumina gel into the sensorimotor cortex is well localized and provides the topographic focus for seizure initiation. Such localized foci are essential for analyzing different stages along the time line of seizure development using anatomic methods. Several studies have taken advantage of these features and are reviewed subsequently herein.
Epilepsy is a neurologic disorder that has been modeled in many animals, including the monkey. This chapter deals with two types of alumina gel injections that model two different human epileptic disorders. Where alumina gel is injected into the brain determines what type of epilepsy it models. For example, alumina gel injections into sensorimotor cortical regions produce seizures that have been used as a model for posttraumatic epilepsy. Alternatively, when alumina gel is injected into the temporal lobe of rhesus monkeys, complex partial seizures and neuropathologic changes occur which are analogous to those seen in human temporal lobe epilepsy. This chapter will examine each of these two models, beginning with the sensorimotor cortex model.
Methods of Generation The central sulcus of either adult or adolescent monkeys is exposed through a frontal craniotomy under general anesthetic, taking great care not to damage the cortex. After opening the dura, the hand-face region of the sensorimotor cortex is identified with cortical stimulation and injected with alumina gel. Although different injection patterns have been used, one of the most successful is the Ward modification of the Kopeloff technique (Bakay and Harrris, 1981). In this method, two injections are made 4 mm apart in the precentral gyrus and two injections in the postcentral gyrus, paralleling each other. A 27-gauge needle is used for the injection, which is placed into the cortex to a depth of approximately 4 mm. A volume of 0.1 ml of aluminum hydroxide (fully saturated solution) in the form of alumina gel is injected at each site. Each injection is made quite slowly to allow time for volume equilibrium to be reached before removing the needle. In general an injection under the pia is avoided because greater scarring will occur in this situation. The epidural space is covered with Gelfoam, and perioperative steroids are used to avoid brain swelling because a watertight dura closure is extremely difficult to
SENSORIMOTOR CORTEX MODEL The advantages of the alumina gel model of cortical focal epilepsy are several. First, it is a model that is focal in its initiation and then proceeds with time to produce spontaneous focal seizures that often become generalized. Focal motor seizures in the human are well characterized, and this model produces seizures that are extremely similar to those in regard to their behavior, electrophysiology, biochemistry, neuropathological, and pharmacologic responses (Lockard, 1980). The second advantage of this model is the time course of the development of seizures: They usually begin 4 to 8 weeks following the application of the alumina gel, allowing time to analyze electroencephalographic (EEG) and neuropathological changes that may underlie the cause of the seizures. This delay in seizure development, as opposed to the use of fast-acting convulsants like bicu-
Models of Seizures and Epilepsy
179
Copyright © 2006, Elsevier Inc. All rights of reproduction in any form reserved.
180
Chapter 14/Alumina Gel Injection Models of Epilepsy in Monkeys
perform and marked brain swelling could introduce injury to the cortex. Anticonvulsant drugs should be avoided. In general within 2 to 4 weeks sharp waves can be detected over the injection site. Within 1 to 2 months, epileptiform activity and clinical seizures will begin to be observed. These are initially focal and frequently progress to Jacksonian-type marches. Secondary generalized seizures are not uncommon.
Characteristics and Defining Features Behavioral and Clinical Features Monkeys that received alumina gel applications to the left cerebral hemispheres to produce seizure foci were analyzed for behavioral and EEG changes. Injections into the precentral and postcentral gyri did not cause any abnormalities in the EEG tracings initially. Within 4 to 8 weeks, however, abnormalities appeared on the EEG tracings and focal seizures began in the contralateral upper extremity corresponding to the alumina gel–injected area of the sensorimotor cortex that is the homologous region representing that extremity. Seizure activity was observed in most monkeys after 4 weeks, and the seizure frequency was two or three per day. The duration of each seizure ranged from a few seconds on electrocorticography (ECoG), up to 1 to 2 minutes behaviorally when the monkey’s focal seizure generalized. The epileptic animals demonstrated an ECoG consistent with spike-and-wave discharges in the area immediately adjacent to the alumina gel injection. As indicated by previous studies, the seizures begin with a tonicclonic movement of the hand contralateral to the cortical injection site, followed by tonic-clonic movements of the ipsilateral upper extremity. These tonic-clonic events often generalize to the lower extremity and the face, leading to the monkey’s falling in the cage and to unconsciousness. Although seizure activity spreads to both upper extremities, there is no evidence of a mirror focus in the contralateral homotopic cortex in monkeys; Harris and Lockard (1981) did not show this region as having independent seizure activity. Electroencephalographic Features The ECoG showed spike-and-wave activity around the electrodes overlying the injected sensorimotor cortex. This spike-and-wave activity corresponded to the behavioral manifestations described in the preceding section. Neuropathology Cell Loss Blocks of tissue from epileptic cortex and a homologous area in the contralateral nonepileptic cortex were analyzed in light and electron microscopic preparations. As a result of the injections into the sensorimotor cortex, the area
bordered by the injection site often shows a disruption in the laminar pattern in Nissl-stained sections. It is remarkable that adjacent to the injection site, normal-looking pyramidal neurons are seen throughout the cortical layers, suggesting that the amount of neuronal loss is minimal outside the injection site. In monkeys with chronic seizures a significant loss of neurons was observed that ranged from 11 to 61% at the focus compared with the normal side (Ribak et al., 1989). Details about the loss of g-aminobutyric acid (GABA)ergic neurons are provided later in a separate section of this chapter. Reactive Gliosis The glial changes consist of thick pial-glial membranes (Harris, 1980), hypertrophied neuroglial cell processes containing increased numbers of filaments, and increased numbers of intracellular glial connections of both the gap junction and desmosome type. In layers IV and V of cortex, hypertrophied astrocytes are seen in organized bands where high-potassium ion fluxes have been demonstrated to be associated with seizures (Harris, 1980). Furthermore, analysis of the surface of pyramidal cell bodies in layer V showed a statistically significant increase in apposition by astrocytic processes (Ribak et al., 1982) (Figure 1). For example, at the focus, 50% of the soma of pyramidal cells was apposed by glia, whereas 22% in the contralateral normal cortex were apposed by glia (see Figure 1). In addition, the area in the neuropil occupied by glial profiles showed a 50% increase at the focus relative to the normal cortex (Ribak et al., 1982). Therefore reactive gliosis is a well-documented neuropathological finding in this model of focal epilepsy. Loss of GABAergic Neurons To test the hypothesis that a decrease in the number of inhibitory GABAergic neurons could lead to seizure activity, several studies were performed in this model of epilepsy, beginning in the late 1970s (Ribak et al. 1979). Initially light microscopic analysis of glutamate decarboxylase (GAD) immunocytochemistry indicated a significant decrease in the number of GAD-positive terminals at the epileptic focus compared with the contralateral normal cortex. Because many of these terminals are apposed to the surfaces of layer V pyramidal cells, it was suggested that these pyramidal neurons were inhibited less and therefore were more likely to be engaged in excitatory circuitry and bursting (Ribak et al., 1979). Subsequently, Houser et al. (1986) analyzed GABAergic axon terminals in monkeys before seizure onset and reported a decrease in GABAergic terminals ranging from 14 to 22%, whereas the initial studies of chronic monkeys reported a loss of 58 to 62% (Ribak et al., 1979). The GABAergic somata were analyzed (Ribak et al. 1986) using an antibody that recognizes GAD within somata (Oertel et al., 1981). The results indicated a 35 to 52% significant loss of small GABAergic somata at the foci of
Senserimotor Cortex Model
181
FIGURE 1 Bar graphs showing the number of synapses per 10 mm-length of somal surface of 90 layer V pyramidal somata (left) and the amount of glial apposition to these layer V pyramidal somata (right). The number of axosomatic synapses was greatest in the nonepileptic cortex (N) and least at the focus (F). The parafocus (P) displayed an intermediate number. The opposite result was found for glial apposition. The error bars represent standard error of the mean (SEM). (Reprinted with permission from Ribak et al., 1982.)
chronic epileptic monkeys. These data suggested that the loss of GABAergic terminals at epileptic foci is due to the loss of neuronal somata that give rise to these axons. Similar to the study by Houser et al. (1986), Ribak et al. (1989) analyzed the cortex next to the alumina gel application for a loss of GABAergic somata before onset of epileptic activity in monkeys. They observed a 23 to 44% reduction in the number of GABAergic neurons at the site of the developing focus. Nissl preparations were also used to determine the selectivity of this loss, and statistical tests showed no differences in the number of total neurons between this and the other site. In contrast, chronically epileptic monkeys had a significant loss of neurons that ranged from 11 to 61% at the focus, compared with the normal side. To determine whether the loss of GABAergic terminals was due to an actual degeneration of these terminals or simply to a loss of GAD immunostaining within the terminals, electron microscopy was utilized. GABAergic axon terminals were identified in electron microscopic preparations by the fact they form symmetric synapses. In two studies (Ribak, 1985; Ribak et al., 1982), pyramidal neurons were analyzed for a loss of GABAergic synapses on both their cell bodies and axon initial segments (Figure 2). The results showed an 80% loss of such axon terminals on the cell body (see Figure 1) and a more severe loss of axon terminals forming symmetric synapses on the axon initial segment. These findings indicated that the previous reported loss of GAD-positive axon terminals was due to their degeneration and that two GABAergic cell types are particularly
affected at the epileptic focus: the basket and chandelier cells. Biochemical Findings The biochemical data for alumina gel–treated epileptic monkeys are consistent with the immunocytochemical results stated previously herein. Bakay and Harris (1981) reported decreased GABA receptor binding, GABA concentration, and GAD activity at the epileptic focus. They suggested that these alterations in presynaptic GABA indices were probably due to the degeneration of GABAergic axon terminals at the epileptic focus. Furthermore, they reported that seizure frequency was correlated with the loss of GAD activity. These results support the GABA hypothesis for focal epilepsy. Response to Antiepileptic Drugs Anticonvulsant drugs have been screened using the alumina gel–injected monkeys. Two of these drugs, phenytoin and phenobarbital, have been shown to protect alumina gel-injected monkeys from developing secondary generalized tonic clonic seizures. In addition both drugs decrease seizure frequency and severity relative to placebo-treated animals (Lockard et al., 1976a, b). However, if cessation of drug treatment occurs in the monkeys injected with alumina gel, seizure frequency and severity are increased relative to placebo-treated monkeys (Lockard et al., 1976b).
182
Chapter 14/Alumina Gel Injection Models of Epilepsy in Monkeys
FIGURE 2 Electron micrographs of axon initial segments from layer III pyramidal cells from normal cortex (a) and the epileptic focus (b). The normal axon initial segment in (a) displays two symmetrical synapses (arrows) formed with axon terminals. Two characteristic features of axon initial segments are shown: a fasciculation of microtubules (M) and a dense undercoating that is continuous with the coating over a pinocytotic vesicle (V). In the focus, reactive astrocytes (A) were seen where axon terminals were found in the normal cortex. The initial segment showed normal features including microtubules (M) and a dense undercoating (arrow). Bar = 1 mm. (Reprinted with permission from Ribak, 1985.)
Other drugs that have been screened in the alumina gel injected monkeys include valproic acid. Results from these studies indicate that the efficacy of valproic acid in decreasing seizure frequency and duration correlates with plasma levels and that plasma levels show drastic fluctuations. When plasma levels are high, relatively few EEG interictal spikes are seen, and when they are low, relatively high numbers of interictal spikes are observed (Lockard et al., 1977). Thus valproic acid plasma levels inversely correlate with EEG interictal spike activity. In these monkeys, there is a high correlation between the number of interictal spikes and occurence seizures (Lockard, 1980). Benzodiazepines and their derivatives are common antiepileptic treatments in humans. One of these, clonazepam, has been evaluated in the alumina gel–injected monkey. When administered to achieve plasma levels above
29.9 ng/ml and 59.9 ng/ml, clonazapam caused seizures to decrease in severity and frequency or disappear, respectively (Lockard et al., 1979). It is pertinent that while being treated with clonazapam, the monkeys exhibited improved performance on a lever-pressing behavioral task. However, if drug treatment was stopped, seizure activity increased and a deficit in lever pressing behavior was seen (Lockard et al., 1979).
Limitations In general the alumina gel model can be introduced into any nonhuman primate species, sex, or age. Seizures almost always develop when the appropriate injection technique is used, and in the rare incidences when they do not develop, repeat injections are usually successful. A properly prepared animal will produce stable spontaneous seizures for many
183
Temporal Lobe Model
years. However, in an occasional subject, status epilepticus will develop and anticonvulsants are needed to maintain viability. This is more likely to occur with large injections and subpial spread. There is a relatively high variability as to the seizure rates, with rates as low as one per month or as high as 10 to 20 per day, even though the same injection technique, species, age, and sex of monkey are used. To get an accurate seizure frequency, 24-hour video monitoring is required. A movement-detection device or ECoG monitoring technique allows for the videotape review to be streamlined (Lockard and Ward, 1980). Like the human condition, seizures in monkeys may cluster in relation to estrus and may increase with behavioral or physical stress. These features are particularly useful in a model of focal neocortical epilepsy. Although seizures can be generated in neocortical areas other than sensorimotor cortex, they are more difficult to document and far more variable in their development and maintenance. Such seizures may model a variety of epileptic activities, which might result from dysgenesis, vascular abnormality, or a lesion or tremor. The disadvantages of this method are that it is very expensive and the number of subjects that can be involved in any one project is relatively small; the monitoring techniques are complex and the studies require long-term commitment of resources. The advantages are that the model involves a nonhuman primate model with anatomic, biological, pharmacologic, and electrophysiologic properties much closer to the human than those found in rodent models.
Insights into Human Disorders The neuropathological and biochemical results from the analysis of the sensorimotor cortex of monkeys injected with alumina gel indicate a causal role for GABAergic neuronal loss. This model best replicates most of the features of human focal epilepsy. This model is also a chronic one and follows a time course in its development similar to posttraumatic epilepsy in humans (Wyler and Ward, 1984). That is, the EEG abnormalities and clinical seizures develop at a similar time in this model and in humans with posttraumatic epilepsy. Based on the data from this experimental model, we suggest that people with this type of epilepsy probably display a reduction in the number of GABAergic neurons and synapses at the epileptic focus. This hypothesis is supported by the pharmacologic data showing that GABAergic agonists are effective to varying degrees at limiting the frequency, duration, and severity of seizures in monkeys injected with alumina gel.
TEMPORAL LOBE MODEL Alumina gel injections into the temporal lobe of rhesus monkeys were used in an attempt to mimic complex partial
seizures associated with temporal lobe epilepsy in humans (Ribak et al., 1998). Our analysis is based on injections of alumina gel into several regions of the temporal lobe in rhesus monkeys. Thus structures that were injected include the hippocampus, entorhinal and perirhinal cortices, and the amygdala. In all cases, complex partial and secondarily generalized seizures were observed. They had many similarities to the ictal symptoms of human temporal lobe epilepsy.
Methods of Generation Adult or adolescent monkeys are placed under general anesthesia, and stereotactic injections are made into the mesial temporal structures. In the past these injections have been performed through an approach from above that enters the ventricle. The disadvantage of that approach is that the alumina gel can back-track into the ventricles and spread beyond the desired location. With an updated lateral approach, the tract is below the ventricle so the needle can approach the amygdala, hippocampus, or entorhinal cortex (Ribak et al., 1998). This approach requires a specially designed right-angle needle of approximately 23-gauge (higher gauges tend to deflect in variable directions as a result of the lack of rigidity). The musculus temporalis must be split and the zygoma removed along the path to the target. A small craniotomy is made in the temporal bone, and the dura opened along the needle trajectory. Targets have been selected in the past with stereotactic atlases. However, with current imaging technology, the monkey can be placed in a magnetic resonance imaging (MRI)-compatible stereotactic frame, and the needle directed to its target based on the anatomy of the individual animal. Injections consist of 0.1 to 0.2 ml of alumina gel. The most reliable seizure activity occurs with injections into the entorhinal cortex, 2 to 3 weeks after injection. With hippocampal or amygdala injections, sometimes the seizures evolve so rapidly that after the first several seizures a secondary generalization occurs. A high rate of seizure frequency can endanger the monkey’s health. A somewhat slower, more stable pattern is generally observed with entorhinal injections or mesial temporal cortical injections. Injected subjects develop electrophysiologic and behavioral characteristics of complex partial seizures. Chronic spontaneous seizures have been observed with this technique, and electrographic seizures can be recorded using epidural electrode strips (Figure 3).
Characteristics and Defining Features Behavioral and Clinical Features Alumina gel injections into the hippocampus result in clinical seizure activity that typically develops 12 to 14 days after the injections (Ribak et al., 1998). This seizure activity is characterized as complex partial seizures with secondary generalization. Alumina gel injections into the
184
Chapter 14/Alumina Gel Injection Models of Epilepsy in Monkeys
FIGURE 3 X-rays of the anterior-posterior (A) and lateral (B) views of a monkey implanted with epidural electrodes. Lead 1 is in the mesial-inferior temporal region, lead 2 is over the inferior temporal region, lead 3 is over the superior temporal region, and lead 4 is over the parietal cortex. The electrical connections are buried subcuticularly and emerge through a superior head plug (arrows). (Reprinted with permission from Ribak et al., 1998.)
amygdala develop more slowly, typically over a 3- to 6week period (Ribak et al., 1998). Complex partial seizures result from these injections, and they persist over a long period. Alumina gel injections into entorhinal and perirhinal cortices result in similarly characterized complex partial seizures within 2 to 3 weeks (Ribak et al., 1998). Overall, alumina gel injections into mesial temporal lobe structures of monkeys result in subclinical, complex partial and secondarily generalized seizures that have many similarities to the ictal symptoms of human temporal lobe epilepsy (Sharbrough, 1987). Injections of the inferior temporal gyrus showed no behavioral abnormalities and served as a control for the other injected regions of the temporal lobe that are responsible for causing complex partial seizures (Ribak et al., 1998). When complex partial seizures developed in these monkeys, the behavioral pattern was remarkably similar (Ribak et al., 1998). In all instances the seizures started with blank stares followed by head turning. In monkeys injected into the hippocampus, this behavior rapidly became secondarily generalized. Other symptoms included smelling of the fingers, followed by an arrest of movement with a motionless stare for up to a minute. As the seizure generalized, these behaviors evolved to include vocalization, drooling, open-mouth oral-facial automatisms, chewing motions, and head turning with extremity automatisms. Infrequently the secondary generalization would lead to tonic-clonic Jacksonian march.
Ammon’s horn and dentate gyrus all initially displayed focal pathological EEG slowing limited to the injection site. After clinical seizures developed, widespread pathological EEG slowing over both hemispheres followed. In addition, the monkeys displayed the cardinal ictal and interictal epileptiform EEG abnormalities limited to the mesial-inferior temporal lobe on the side ipsilateral to the injection site (Figure 4). Furthermore, other ipsilateral and contralateral structures were observed to have different degrees of spread. These electrophysiologic abnormalities are very similar to those observed in human temporal lobe epilepsy (Ribak et al., 1998).
Electrographic and Electroencephalographic Features
Reactive Gliosis
Electroencephalography can be used to localize the origin of abnormal activity before seizures. Alumina gel injections in the amygdala, perirhinal and entorhinal cortices, or
Increased numbers of glial cells occurred in various regions of the temporal lobe, where cell loss occurred following injections (Ribak et al., 1998). The increased gliosis
Neuropathology Cell Loss Blocks of tissue from the temporal lobe and homologous area in the contralateral nonepileptic temporal lobe were analyzed in light and electron microscopic preparations (Ribak et al., 1998). Nissl-stained sections were used to determine the full extent of the alumina gel injection sites into the different regions of the temporal lobe. Similar to results in the sensorimotor cortex, neurons were lost at injections sites. In addition, one injection site was associated with distant cell loss (Ribak et al., 1998). Thus alumina gel injections into the amygdala were accompanied by cell loss in the CA1 region of the hippocampus, hilar region of the dentate gyrus, and layer III of entorhinal and perirhinal cortex.
185
Temporal Lobe Model
FIGURE 4 Interictal EEG activites (during the first 5 seconds of this epoch) demonstrate asynchronous pathological delta slowing over both hemispheres, with greater delta slowing over the more medial left-sided electrodes. Fast activities (beta and alpha activities) are consistently of higher amplitude over the right side (contralateral to alumina gel injection) interictally. The recording instrument was turned off for about 5 seconds for pen adjustment (indicated by a gap after the interictal sample), and the electrographic seizure had begun when recording resumed. The electrographic seizure consisted initially of high amplitude, shaply contoured, rhythmic theta activities at LtSD1 with lower amplitude representation at the adjacent LtSD2 electrode, and with irregular slowing at other sites; at this time the animal responded to voice by orienting its head and gaze. Twelve seconds later, the ictal discharge had evolved into bursting polyspike activities and had spread to involve LtSD3 and LtSD1-2. By this time, the contralateral electrodes (RtSD1-4) are recording ictal activities of predominantly 2.5–3 Hz rhythmic slowing with superimposed spikes. The animal failed to respond to voice (Call) and gradually assumed a fixed posture of rightward ocular, cephalic, and truncal version. This posturing was maintained throughout the remainder of the electrographic seizure, which lasted 110 sec. The electrographic seizure did not spread to suprasylvian electrodes and the animal did not convulse. The recording was performed using published parameters (Ribak et al. 1998). Note: The wire of the right suprasylvian subdural electrode (RtSD4) was broken, so this channel was turned off during the recording. LtSD, left subdural contacts; RtSD, right subdural contacts; A1, left ear; A2, right ear. Reprinted with permission from Ribak et al. (1998).
was also observed in the molecular layer of the dentate gyrus. Electron microscopy confirmed the presence of reactive astrocytes in the hippocampus and dentate gyrus (Ribak et al., 1998). Plasticity and Mossy Fiber Sprouting In Timm-stained light microscopic preparations, the dentate granule cells exhibited aberrant mossy fiber sprouting into the inner molecular layer (Ribak et al. 1998). Electron microscopy showed that many of these mossy fibers formed synapses with the proximal dendrites and dendritic spines of granule cells (Figure 5). The presence of these mossy fibers on identified granule cells indicates increased recurrent excitatory circuitry in the brains from these monkeys. Light microscopy also showed dispersion of the granule cell layer (Ribak et al., 1998). Thus the granule cells were radially organized (Figure 6). Electron microscopy of these orthogonal rows of granule cells showed intervening radially oriented processes of reactive astrocytes. These processes arose from hypertrophied astrocytes in the subgranular zone (Ribak et al., 1998). Thus some of the morphologic features observed following injections of alumina gel into temporal lobe structures are similar to the neuropathologic changes found in human temporal lobe epilepsy.
Limitations Development of complex partial seizure activity is reasonably reliable to produce. The seizure pattern is frequently extremely stereotypic, but it requires electrophysiologic monitoring because the complex partial seizure may be easily misinterpreted as normal monkey behavior. There is high variability in the rate of seizure activity, and this variability tends to be site-specific. Seizures often develop with such severity that long-term studies are not possible. The temporal lobe alumina gel injection most likely models a mesial temporal lesion, but how effectively it mimics mesial temporal sclerosis remains to be determined. Nevertheless, it is a method of developing mesial temporal epilepsy in nonhuman primates that are anatomically far closer to human hippocampal structure than is the rat. The disadvantages of the model are similar to those of the sensorimotor focal epilepsy model. In addition, however, our experience is extremely limited with this model. Nevertheless it offers great promise for the future and needs to be evaluated further.
Insights into Human Disorders This temporal lobe epilepsy model in monkeys has the potential to provide useful information about the patho-
186
Chapter 14/Alumina Gel Injection Models of Epilepsy in Monkeys
FIGURE 5 Electron micrographs of a granule cell obtained from the dentate gyrus ipsilateral to the amygdala injected with alumina gel. A: The nucleus (N) and proximal apical dendrite (d) of the granule cell. Apposed to the ruffled surface of the dendrite is a large axon terminal that has the features of a mossy fiber. Also note the processes of astrocytes (as) with glial filaments. B: An enlargement of the mossy fiber in (A) showing that this mossy fiber forms asymmetrical synapses (arrows) with the proximal dendrite. A spine (s) appears within this mossy fiber. Scale bars = 1 mm. (Reprinted with permission from Ribak et al., 1998.)
physiologic mechanism of human temporal lobe epilepsy. It is well known that chronic seizures may cause hippocampal neuronal loss and behavioral changes in human temporal lobe epilepsy. Serial chronologic studies of this alumina gel model in monkeys might address this question and others. For example, demonstration of interictal disturbances of learning and other behaviors in this model could be used to develop therapies for the interictal impairments that occur in human temporal lobe epilepsy. Also, this model may be useful in testing new medical and surgical therapies for complex partial seizures in humans. This monkey model of temporal lobe epilepsy has the potential to provide valuable
information about the cellular mechanisms of temporal lobe epilepsy in humans because it is more like human temporal lobe epilepsy than existing rodent models.
Acknowledgments The authors gratefully acknowledge the technical assistance of previous technicians and the cooperation of previous collaborators. This work was supported by the Medical Research Service of the Department of Veterans Affairs, the Yerkes Regional Primate Research Center, National Institutes of Health Core Grant RR-00165 (R.A.E.B), National Institutes of Health Grants NS-15669 and NS-38331 (C.E.R.), and National Institutes of Health Training Grant T32-NS045540 (supporting L.A.S.).
References
A
187
B
FIGURE 6 Photomicrographs of Nissl-stained sections through the hippocampus from the control hemisphere (A) and the amygdala injected (B) side of a monkey. In (A) the granule cell layer (G) shows a normal appearance. In contrast, the granule cell layer (G) in B is dispersed. Scale bar = 200 mm. (Reprinted with permission from Ribak et al., 1998.)
References Bakay, R.A., and Harris, A.B. 1981. Neurotransmitter, receptor and biochemical changes in monkey cortical epileptic foci. Brain Res 206: 387–404. Harris, A.B. 1980. Structural and chemical changes in experimental epileptic foci. In Epilepsy: A Window to Brain Mechanisms Eds. J.S. Lockard and A.A. Ward Jr. pp. 11–49. New York: Raven Press. Harris, A.B., and Lockard, J.S. 1981. Absence of deizures or mirror foci in experimental epilepsy after excision of alumina and astrogliotic scar. Epilepsia 22: 107–122. Houser, C.R., Harris, A.B., and Vaughn, J.E. 1986. Time course of the reduction of GABA terminals in a model of focal epilepsy: a glutamic acid decarboxylase immunocytochemical study. Brain Res 383: 129–145. Lockard, J.S. 1980. A primate model of clinical epilepsy: mechanisms of action through quantification of therapeutic effects. In Epilepsy: A Window to Brain Mechanisms Eds. J.S. Lockard and A.A. Ward Jr. pp. 11–49. New York: Raven Press. Lockard, J.S., and Ward, A.A. Jr. 1980. Epilepsy: A Window to Brain Mechanisms. New York: Raven Press. Lockard, J.S., Congdon, W.C., DuCharme, L.L., and Huntsman, B.J. 1976a. Prophylaxis with diphenylhydantoin and phenobarbital in alumina-gel monkey model I. Twelve months of treatment: Seizure, EEG, blood, and behavioral data. Epilepsia 17: 37–47. Lockard, J.S., DuCharme, L.L., Congdon, W.C., and Franklin, S.C. 1976b. Prophylaxis with diphenylhydantoin and phenobarbital in alumina-gel monkey model II. Four month period of post-treatment: Seizure, EEG, blood, and behavioral data. Epilepsia 17: 49–57. Lockard, J.S., Levy, R.H., Congdon, W.C., DuCharme, L.L., and Patel, I.H. 1977. Efficacy testing of valproic acid compared to ethosuximide in
monkey model II. Seizure, EEG and diurnal variation. Epilepsia 18: 205–224. Lockard, J.S , Levy, R.H., Congdon, W.C., DuCharme, L.L., Salonen, L.D. 1979. Clonazepam in a focal-motor monkey model: efficacy, tolerance, toxicity, withdrawal, and management. Epilepsia 20: 683–695. Oertel, W.H., Schmechel D.E., Tappaz M.L., and Kopin I.J. 1981. Production of a specific antiserum to rat brain glutamic acid decarboxylase by injection of an antigen-antibody complex. Neuroscience 6: 2689–2700. Ribak, C.E. 1985. Axon terminals of GABAergic chandelier cells are lost at epileptic foci. Brain Res. 326: 251–260. Ribak, C.E., Bradburne, R.M., and Harris, A.B. 1982. A preferential loss of GABAergic inhibitory synapses in epileptic foci: a quantitative ultrastructural analysis of monkey neocortex. J. Neurosci 2: 1725–1735. Ribak, C.E., Harris, A.B., Vaughn, J.E., and Roberts, E. 1979. Inhibitory, GABAergic nerve terminals decrease at sites of focal epilepsy. Science 205: 211–214. Ribak, C.E., Hunt, C.A., Bakay, R.A.E., and Oertel, W.H. 1986. A decrease in the number of GABAergic somata is associated with the preferential loss of GABAergic terminals at epileptic foci. Brain Res 363: 78–90. Ribak, C.E., Joubran, C., Kesslak, J.P., and Bakay, R.A.E. 1989. A selective decrease in the number of GABAergic somata occurs in pre-seizing monkeys with alumina gel granuloma. Epilepsy Res. 4: 126–138. Ribak, C.E., Seress, L., Weber, P., Epstein, C.M., Henry, T.R., and Bakay, R.A.E. 1998. Alumina gel injections into the temporal lobe of rhesus monkeys cause complex partial seizures and morphological changes found in human temporal lobe epilepsy. J Comp Neurol 401: 266–290. Sharbrough, F.W. 1987. Complex partial seizures. In Epilepsy: Electroclinical Syndromes. Eds. H. Luders and R.P. Lesser. pp. 279-302. London: Springer-Verlag. Wyler, A.R., and Ward, A.A.Jr. 1986. Neuronal firing patterns from epileptogenic foci of monkey and human. Adv Neurol 44: 967–989.
C
H
A
P
T
E
R
15 Modeling Epilepsy and Seizures in Developing Zebrafish Larvae SCOTT C. BARABAN
relevant seizure disorder is unclear. Each of these studies hints at the possibility of using simple organisms for epilepsy research. However, in none of these simple species has a systematic effort to develop and characterize a seizure model been presented. This chapter discusses a simple alternative to rodents—larval zebrafish—and describes some of the salient features of a pediatric zebrafish epilepsy model. Our early efforts to induce seizures in zebrafish larvae were largely “trial and error.” Nonetheless, we would like to recognize seminal comparative species studies done by Zdenek Servít, a Polish scientist working with turtles, frogs, and fish in the early 1970s. Using curarized adult tenches, Servít described the genesis and pattern of electrographic spikewave discharge elicited in the adult fish forebrain on topical exposure to penicillin or pentylenetetrazol (PTZ) (Servít, 1970, 1972; Servít and Strejcˇková, 1970). These lower vertebrate studies predate the use of zebrafish in neurobiology but are prescient in recommending that “one of the uses of an experimental model is to simplify a complex situation.”
Pediatric epilepsy models are confined primarily to rodents. Although using a rodent model of a human neurologic disorder has distinct advantages, there is no rationale to support our almost exclusive reliance on this species. Indeed research questions related to genetic modifiers of pediatric epilepsy syndromes, high-throughput anticonvulsant drug screening, and “rapid” genetic manipulations aimed at analysis of basic cellular mechanisms of epileptogenesis could be better suited to a simple vertebrate system. Exciting new discoveries in the general field of neurobiology exploit the experimental advantages of simpler organisms such as Caenorhabditis elegans (worms), Drosophila melanogaster (fruit flies), and Danio rerio (zebrafish). Analysis of Parkinson (parkin) gene function in flies (Pesah et al., 2004) and discovery of daf genes regulating the aging process in worms (Hsin and Kenyon, 1999; Lin et al., 1997) are just two examples. Similar discoveries are possible in the epilepsy field, but there is currently little evidence that mammalian-like seizures can be induced in any of these species. For example, hyperexcitable Shaker flies featuring a potassium channel mutation are characterized by a legshaking behavior that most closely resembles human episodic ataxia (Tempel et al., 1987), and it is unclear whether this motor behavior represents a human seizure disorder. In a second group of Drosophila mutants termed “bang-sensitive”, potential seizure suppressor genes were recently identified using a model of evoked electrical afterdischarge in the giant muscle fiber (Kuebler and Tanouye, 2000; Kuebler et al., 2001). In C. elegans a lissencephaly (LIS1) gene mutant was recently described, and these worms exhibited a rapid “head-bobbing” behavior on exposure to a convulsant agent (Williams et al., 2004); again, whether this putatively convulsive behavior resembles a clinically
Models of Seizures and Epilepsy
What Can One Model in Zebrafish Larvae? In choosing zebrafish for pediatric epilepsy studies, as in any animal model choice, it is of utmost importance to consider the type(s) of experimental question one seeks to address. Our laboratory interest in zebrafish larvae stems from a desire to understand better the genetic factors that modify seizure genesis, propagation, and termination in the developing animal. For example, are there gene mutations that render an organism resistant to the generation of seizures? Does introduction of a human epilepsy gene mutation in zebrafish yield a model in which to study the basic
189
Copyright © 2006, Elsevier Inc. All rights of reproduction in any form reserved.
190
Chapter 15/Modeling Epilepsy and Seizures in Developing Zebrafish Larvae
cellular elements required for generation of seizures? Can we use a zebrafish pediatric epilepsy model to uncover novel antiepileptic drug targets? As a well-accepted model of development, and a species with tremendous potential for genetic modification and forward-genetic screening strategies, zebrafish larvae are an ideal choice for these types of studies. In the premature infant, seizures often mimic the normal behavioral repertoire of infants; infantile spasms are one such example. As infants mature, pediatric epilepsy syndromes (benign rolandic epilepsy, for example) with generalized tonic-clonic behaviors can be observed. Rodent pediatric epilepsy models also exhibit age-dependent behavioral, electrical, and anatomic manifestations (Schwartzkroin et al., 1995). Over time, rodent models have been developed to mimic a wide spectrum of these human pediatric epilepsy disorders, for example, febrile seizures, limbic status epilepticus, hypoxia-induced seizures, malformation-associated epilepsies, and ion channelopathies. In each of these examples, as is evident elsewhere in this volume, specific behavioral, electrical, anatomical or molecular changes occur; in many cases these changes closely mimic the human condition. If it can be demonstrated that zebrafish also exhibit behavioral, electrical, and anatomic features of epilepsy resembling those seen clinically, then it is not too far-fetched an idea that we can begin to model human seizure syndromes in zebrafish. What to model? One suggestion is to start with the development of zebrafish models mimicking well-established rodent epilepsy models. After all, there is a wealth of evidence suggesting that rodent animal models provide important insights into the human condition. Here we describe one such model—generalized tonic-clonic seizures in immature zebrafish induced by exposure to a common convulsant agent. Methods Zebrafish (Danio rerio) are freshwater teleosts, and they have the salient features of being small-sized lower vertebrates with a relatively short life cycle (Nüsslein-Volhard and Dahm, 2002). A single pair of adult zebrafish can produce hundreds of offspring, and zebrafish enjoy a genetic tractability rivaling Drosophila. A further advantage of zebrafish larvae is that they develop ex utero in a transparent egg, making them the current species of choice for a large number of developmental studies (see reviews in Kimmel, 1989; Lewis and Eisen, 2003; Moorman, 2001). Larval life in zebrafish begins around 72 hours post fertilization, when the fish are nearly free-swimming, and proceeds over an approximately 27-day period. Maturation is highly asynchronous and commonly defined by changes in body length. The larval zebrafish brain shows signs of an everted telencephalic organization as early as 5 days post fertilization (DPF), with the ventricular region lying exter-
nally and olfactory bulbs that are well developed. In the larval diencephalon, all the major adult subdivisions are present and optic tectum, the largest visible brain structure in zebrafish, begins to take on a layered “cortical” organization at 5 DPF (Nüsslein-Volhard and Dahm, 2002). How these maturational stages compare with developing infants is unclear, but it is worth noting that genes identified as controlling development in zebrafish (hedgehog, cadherin, notch, Wnt, etc.) often have similar roles in higher vertebrates. The scientific study of chemical convulsant agents in experimental animals has its origins in the late 1800s (Wiedemann, 1877) and has come to include a wide variety of compounds. Some of these compounds have long since fallen out of favor (absinth and strychnine), and others were replaced as our knowledge of underlying mechanism advanced (penicillin), and finally a few remain as widely used models in the present day (picrotoxin and pentylenetetrazol). Because rodent pediatric models often begin by adapting what has been successful in adult models (Holmes and Thompson, 1988; Moshe and Albala, 1982; Nehlig et al., 1996; Priel et al., 1996), a similar strategy was applied. Using larval zebrafish, preliminary studies were made to test several commonly used convulsants, such as picrotoxin, PTZ (Metrazol), pilocarpine, and kainic acid. In general these drugs work by interfering with normal synaptic transmission (Kupferberg, 2001; White, 1997). Because glutamate, GABA, and acetylcholinergic receptors are highly conserved across species, it is likely that potential mechanisms of action in zebrafish are similar to those reported for higher vertebrates. An initial concern, therefore, was not the mechanism of convulsant action but rather a more practical consideration: how to administer drugs to zebrafish larvae. Convulsant administration in immature rodents requires invasive intraperitoneal, subcutaneous, or intraventricular drug injections, and compounds are not always evenly distributed (or accessible) to central nervous system (CNS) structures, such as compounds that can not cross the bloodbrain barrier. Drug microinjections in zebrafish are possible (Oulmi and Braunbeck, 1996) but not a desirable alternative; thus our experimental strategy was to add drugs directly to the normal bathing medium. Surprisingly, and in direct contrast with rodents, zebrafish larvae enjoy a distinct pharmacologic advantage in that drugs dissolved in bathing medium were readily absorbed through the zebrafish skin or gills. We have not observed drug penetration issues with any of the convulsant or anticonvulsant compounds tested to date. Of course a limitation of this approach is that virtually no information is currently available regarding the pharmacokinetic distribution of convulsant drugs in larval zebrafish, and when a drug fails, it is difficult to conclude that drug penetration was not a factor. For all the pharmacologic studies performed in our laboratory, drug concentrations are determined on an empiric basis; then those showing the most
191
Description of the Model
promise are further analyzed in concentration-response studies. The protocol described here is primarily focused on PTZ, a convulsive agent first described in 1926 (Hildebrandt, 1926), but it is worth noting that robust seizure activity can be elicited with any of the convulsant agents tested. Wildtype larval zebrafish (4 to 8 DPF) of the Tubingen line (TL) strain were used for all studies. Our procedure for seizure induction in zebrafish larvae is fairly simple and remarkably reproducible. PTZ was dissolved in normal bathing medium at drug concentrations between 2.5 and 15 mM. PTZ solutions were then adjusted to a pH of 7.0 before administration. Freely swimming fish were exposed to PTZ solution in individual 96-well Falcon plates (one fish per plate) or as groups of 20 to 50 fish in a Petri dish. For electrophysiology studies, a static bath recording chamber containing one or two agarembedded zebrafish was filled with about 0.5 ml of PTZ solution. Freely behaving zebrafish larvae respond to PTZ exposure in about 5 to 10 minutes; agar-embedded fish exhibit a slightly slower response time (15–45 minutes). Anesthetics can change the pattern of epileptiform activity produced by a chemical convulsant agent (Bowyer and Winters, 1981; Tuttle and Elliott, 1969) and are unavoidable problems with some types of rodent pediatric epilepsy models, for example, kindling. Because zebrafish embedded in agar (for electrophysiology) are nearly completely immobilized, additional anesthetic exposure was not necessary. All zebrafish larvae exposed to high concentrations of PTZ exhibited seizure activity. The various manifestations of seizures in developing zebrafish are described in the following section, with an emphasis on how each of these features mimic what has been observed in higher vertebrate systems.
DESCRIPTION OF THE MODEL Behavioral Manifestations The clinical significance of any experimental model of epilepsy is limited unless, like humans, a stereotyped set of behavioral changes are observed concomitant with a seizure. Because a wealth of behavioral information is available from the rodent literature, including a detailed and wellaccepted set of behavioral seizure stages (Racine, 1972), we began by investigating freely swimming zebrafish larvae exposed to PTZ. One approach to quantify seizure behaviors was to videotape the zebrafish and then review the recordings at a slower speed (and with the benefit of tape replay). For these studies, individual zebrafish were placed in 96-well Falcon plates and the solution was exchanged for normal bathing medium containing 15 mM PTZ. Fish were monitored for 30 to 60 minutes using a digital video camera. From these videotapes, three distinct stages of behavior were noted. In stage I, zebrafish larvae showed a general
increase in swim activity. This increase occurred in the first few minutes of PTZ exposure and was not seen on exposure to fresh bathing medium. Subsequently, stage II behaviors characterized by a rapid “whirlpool-like” circling around the outer edge of the well were observed. Finally, in stage III, zebrafish larvae exhibited brief head-to-tail convulsions followed by a loss of posture (e.g., fish floating on its side). Stage III convulsions, associated with very rapid movement across the dish (see dashed lines in Figure 1), lasted between 1 and 3 seconds and persisted as long as the fish were exposed to PTZ. Once established as distinct seizure stages, we compared the latency and prevalence of these episodes at varying concentrations of PTZ. As expected, seizure behaviors were elicited in a concentration-dependent fashion. These findings are not terribly surprising and are entirely consistent with well-established rodent pediatric epilepsy models (Jensen et al., 1991; Priel et al., 1996; Sankar et al., 1999). Visual observation of freely behaving animals is a reasonable and commonly used method to document seizure behaviors. However, automated observation systems can provide several distinct advantages. In particular, behaviors can be recorded more reliably because computer algorithms do not suffer from observer fatigue or interobserver variability. Further, computer automated detection is open to a wide array of measurements, for example, distance traveled, duration of movement, and velocity. For automated detection of zebrafish seizure behavior, we set up a computer-based locomotion tracking system. Using a stereomicroscope and high-speed charge-coupled device (CCD) camera acquiring images at 30 Hz, we can record the behavior of single zebrafish larvae during exposure to PTZ. Subsequently video output is digitized by a frame grabber and passed directly to a computer running EthoVision software (Noldus Information Technology, Wageningen, The Netherlands). Image-processing algorithms are then applied to analyze each frame and to distinguish the zebrafish against a background image and, on the basis of user-defined gray-scale values, track the position of the zebrafish in one well (Noldus et al., 2002). From these types of recordings, we obtain locomotion plots as shown in Figure 1. Note that each of the seizure stages defined initially by direct visual observation can be reproduced and quantified using this locomotion tracking system. Of many potential uses for an automated seizure detection system, one could be a comparison between epileptic phenotypes in various wild-type and mutant zebrafish, thus facilitating phenotype-genotype strategies currently in vogue (Lewis et al., 2004; Zumkeller et al., 2004).
Electrophysiologic Manifestations By definition, epilepsy models must exhibit some form of abnormal electrical discharge in a CNS structure, and the
192
Chapter 15/Modeling Epilepsy and Seizures in Developing Zebrafish Larvae
b
a
e
in
l se
Ba
e ag
St
e
g ta
I
S
II
ge
III
a
St
1 mm
FIGURE 1 Behavioral seizure stages. a: Frame-grabber image of a 7 days post fertilization zebrafish larvae in one well of a 96-well Falcon plate. b: Sample locomotion tracking plots are shown for individual zebrafish in normal Ringer’s medium (baseline), during stage I (increased swimming activity), stage II (circling), and stage III (clonus-like convulsions). Solid lines indicate movement; dashed lines indicate rapid convulsive seizure activity (this fish exhibited >25 convulsive episodes). Plots were obtained from recording epochs 2 minutes in duration. (See color insert.)
pattern of electrographic activity can be used to classify the model in clinical terms (Engel and Pedley, 1997). To meet this “gold standard,” we sought a means to document PTZ-induced electrographic seizure activity in developing zebrafish. The obvious problem with this model criterion is technical: how to record electrical events in a larval zebrafish brain. A standard experimental strategy in rodent pediatric epilepsy models is to implant indwelling electroencephalographic (EEG) recording electrodes in “complex” brain structures such as neocortex or hippocampus. At first glance, one might consider zebrafish larvae incapable of generating EEG-like discharge as their brains lack a highly ordered laminar cortical structure (Wulliman et al., 1996). Because larval zebrafish are only 3 to 4 mm long, implantation of a chronic EEG monitoring device in a freely swimming fish is not possible. As an alternative we developed a procedure to immobilize zebrafish larvae in a low-melting-point agar block. The principal advantage of this procedure is that invasive surgical techniques and anesthetic drugs (with their undesirable potential for interfering with CNS function) are not necessary. The limitation of this protocol is that we cannot simultaneous monitor electrical activity and behavior. Agar-embedded zebrafish can be placed on the recording chamber of an upright or stereo microscope, which allows for perfusion with various convulsant (or anticonvulsant) solutions. Because zebrafish larvae are translucent, we employed a relatively simple procedure to place glass microelectrodes in visualized central brain structures using a three-dimensional micromanipula-
tor. In our laboratory, successful field recordings have been obtained from the optic tectum, telencephalon, and cerebellum in zebrafish as young as 4 DPF. In 6 to 7 DPF zebrafish, bath application of 15 mM PTZ induced a progressive increase of tectal electrical activity, resulting in population bursts with typical features of interictal discharges, for example, abrupt in onset, primarily monophasic, and brief duration. Interictal-like events were observed within 10 to 20 minutes of drug exposure. Continuous application of PTZ resulted in interictal activity followed by ictal-like discharges lasting 4 to 6 seconds and composed of large-amplitude population spikes. Ictal-like discharge was usually followed by a period of suppressed electrical activity or postictal depression (Figure 2a). Simultaneous field recordings in optic tectum and telencephalon indicate a seizure pattern that could be classified as “generalized” epilepsy; epileptic discharge appeared nearly simultaneously in all brain regions (Figure 2c). Electrographic seizure events generated in CNS structures (optic tectum or telencephalon) preceded convulsive activity monitored as an electromyogram in the fish-tail muscle (Figure 2c). Electrographic activity was similar in fish exposed to curare (10–250 mM, a neuromuscular blocking agent), further demonstrating that agar-embedding is a sufficient method to immobilize zebrafish larvae for electrophysiology. Spontaneous discharges were never observed in fish exposed to normal bathing medium. Of course, convulsant agents effective in eliciting epileptiform-like activity in immature animals are not limited to PTZ, and this review
193
Description of the Model
FIGURE 2 Epileptiform-like electrographic activity. a: Representative tectal field recording from a zebrafish larva exposed to 15 mM pentylenetetrazol (PTZ) for 45 minutes. Note the presence of interictal, ictal, and postictal phases of the electrical recording. b: Schematic of the configuration used to obtain electrophysiologic recordings from agar-embedded zebrafish larvae. c: Representative dual field recordings from a zebrafish exposed to 15 mM PTZ. In one set of recordings (left), a nearly simultaneous epileptiform burst discharge is observed in the zebrafish forebrain and optic tectum. In a second set of recordings (right), an epileptiform burst discharge is seen to originate in the optic tectum prior to its appearance in a distal section of the zebrafish tail muscle. EMG, electromyelograph.
highlights one of what are potentially many methods to induce epilepsy in zebrafish. As a brief example of the possibilities, we also found that electrographic seizures were elicited on exposure to high potassium, picrotoxin, or pilocarpine (e.g., manipulations used to elicit seizure-like activity in rodent models) (Figure 3). In each case, a distinct pattern of abnormal electrical discharge was observed. These findings demonstrate the broad nature of using a zebrafish model and suggest that epilepsy research in this species is not limited to PTZ-induced seizures. A further application could be the introduction of gene mutations previously shown to elicit epileptic phenotypes (e.g., generation of “epileptic” zebrafish). In general, field potentials recorded in larval zebrafish are remarkably similar in waveform to those reported in chronic seizure models in vivo (Bragin et al., 1999a), acute seizure models in vitro (Dzhala et al., 2003), and in the epileptogenic region of patients with temporal lobe epilepsy (Bragin et al., 1999b). Research into the basic mechanisms of seizure genesis and propagation has provided evidence consistent with a critical role for excitatory glutamate-mediated synaptic transmission. In the context of pediatric epilepsy models, antagonists to the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) glutamate receptor subtype block hypoxia-induced seizures in the immature rat (Jensen et al., 1995), and 3-(RS)-2-carboxypiperazine-4-yl)-propyl1-phosphonic acid (CPP) blocks 4-aminopyridine-induced spontaneous episodes of spreading depression in hippocam-
pal slices from immature rats (Psarropoulou and Avoli, 1996). As such, agents that block presynaptic glutamate release or activation of postsynaptic ionotropic glutamate receptors should be effective at terminating chemically induced seizures in larval zebrafish. Because ionotropic glutamate receptors are expressed in the larval zebrafish brain (Edwards and Michel, 2003), we predicted a role for glutamate-mediated synaptic transmission in the generation or propagation of electrographic seizure discharge in our model. Pharmacologic studies performed on zebrafish larvae at 7 DPF confirmed this hypothesis. First, bath application of tetrodotoxin (TTX) to block Na-dependent action potentials, and therefore synaptic transmission, abolished PTZ-induced electrographic seizures. Second, application of either a nonspecific glutamate receptor antagonist (kynurenate) or a “cocktail” of AMPA/N-methyl-D-aspartate (NMDA) receptor antagonists 6-cyano-7-introquinoxaline2,3-dione-2amino-5-phosphonovalerate (CNQX–APV) abolished PTZ-induced electrographic seizures. These types of studies further support the general concept that chemically induced seizure activity in zebrafish larvae is similar to that observed in higher vertebrates.
Molecular Alterations Revolutionary advances in molecular biology have contributed to our nascent understanding of the many changes in gene expression that can occur prior to, during, and after
194
Chapter 15/Modeling Epilepsy and Seizures in Developing Zebrafish Larvae
FIGURE 3 Electrographic seizure activity in zebrafish larvae with various convulsants. a: Representative 1-minute field recording traces are shown following 45 to 60 minutes of bath exposure to convulsant agents: 25 mM KCl or “highpotassium” model; 100 mM picrotoxin, a g-aminobutyric acid (GABA) receptor antagonist; and 120 mM pilocarpine, a muscarinic acetylcholine receptor agonist. b: Isolated burst discharge shown at a faster time resolution as indicated by the asterisk in (a). Note that different type of burst discharge waveforms are elicited with the different mechanisms of seizure initiation.
a seizure episode. These changes in gene expression presumably reflect (1) molecular mechanisms that contribute to an acute hyperexcitable state (e.g., upregulation of immediate early gene expression) (Morgan et al., 1987); (2) compensatory alterations in genes that may limit the spread of epileptic activity (e.g., increased neuropeptide Y expression) (Rizzi et al., 1993); or (3) molecular alterations that underlie a process of epileptogenesis (e.g., changes in GABAA receptor subunit expression) (Brooks-Kayal et al., 1998). Like most research in the epilepsy field, findings were first reported in adult seizure models (or tissue obtained from patients with intractable forms of epilepsy) and have only recently been studied in pediatric epilepsy models. Because zebrafish larvae represent a simple vertebrate system for “reductionist” questions related to how seizures develop in an immature nervous system, we were interested in reproducing at least one of the molecular alterations that would be expected in an established seizure model. Because one of the most robust and widely reproduced examples of a seizure-induced change in gene expression is the dramatic upregulation of the immediate early gene (IEG) c-fos in brain regions participating in seizure genesis, we began with this IEG (Dragunow and Robertson, 1987; Morgan et al., 1987). It is important to emphasize that c-fos experiments are discussed as “proof-of-principle” and are not intended to diminish the importance of other molecular alterations in epileptogenesis.
Because we observed robust electrographic seizure discharge and stage III seizure behavior in zebrafish larvae exposed to 15 mM PTZ, our molecular studies were performed at this concentration. Freely swimming zebrafish were exposed to PTZ and monitored for seizures. At 0, 15, 30, and 60 minutes following continuous PTZ exposure, zebrafish were removed and total RNA was isolated. From larval RNA samples, cDNA was synthesized and serial dilutions were amplified by reverse transcriptase (RT)-polymerase chain reaction (PCR). As expected, PTZ-induced seizures resulted in a significant upregulation of c-fos mRNA expression in all zebrafish. Levels of c-fos mRNA expression in untreated zebrafish larvae were fairly low. Further confirmation of a seizure-induced upregulation of cfos mRNA expression in the zebrafish CNS was obtained using whole-mount in situ hybridization techniques; an increase in expression was seen in the optic tectum, forebrain, and cerebellum. At present, antibodies raised against zebrafish c-fos are not available; thus we have not yet confirmed these results using immunohistochemistry. However, as additional zebrafish antibodies are developed, studies to localize the expression of IEGs in neurons participating in seizure genesis in the larval zebrafish brain will be mapped in greater detail. Analysis of postsynaptic GABA receptor subunits, neuropeptides, protein kinases, and the many genes whose expression levels are regulated by seizure activity remains to be performed. It is also likely that this
Advantages and Limitations of the Zebrafish Model
simple model of induced seizures can be combined with gene microarray analysis (or other molecular methodologies) to study an even wider range of known genes, expressed sequence tagging (EST), etc.
Antiepileptic Drugs It is a well-accepted maxim that testing of new therapeutic agents in humans follows on the preliminary screening and evaluation of these compounds in an experimental animal model. Discovery and screening of antiepileptic drugs have long followed this paradigm, and development of “ideal” animal models closely approximating human epilepsy is critical to this process. What, however, are the important criteria in the development of new animal models? Dixon Woodbury, a pioneer in antiepileptic drug (AED) screening, stated that an experimental model for evaluation of anticonvulsant drugs must meet two criteria: (1) electrographic evidence of epileptic-like activity and (2) clinical seizure-like behaviors manifest as tonic-clonic motor movements (Woodbury 1969). PTZ-induced seizure activity in rodents (commonly referred to as the Metrazol test) is a well-established experimental model fitting these criteria and has been successfully used to test anticonvulsant compounds. As we show here, PTZ-induced seizure activity in larval zebrafish also satisfies both of the Woodbury criteria. Because our zebrafish work is based on rodent PTZ data, and because a substantial literature exists on AEDs that suppress (or do not suppress) PTZ-induced seizures (Ferrendelli et al., 1989; Krall et al., 1978), we proposed an additional criterion: demonstration of an AED pharmacologic profile identical to that observed in rodents. For these studies we chose suppression of tectal electrographic epileptiform discharge as a sensitive outcome measure of AED efficacy in
195
zebrafish. In all electrophysiologic studies, agar-embedded zebrafish (7 DPF) were exposed to 15 mM PTZ until a stable level of baseline bursting was established (40–65 minutes; interictal + ictal activity). Next AEDs previously demonstrated to suppress (or abolish) PTZ-induced seizure in rodents were tested e.g., benzodiazepines (clonazepam and diazepam) or valproic acid (Figure 4). Both these agents suppressed PTZ-induced epileptiform discharge in a concentration-dependent manner. Reduction of ictal burst discharge amplitude and frequency could be observed within 30 to 45 minutes of drug exposure. Unlike in vitro slice studies, it was not possible to remove or “wash” the compounds efficiently from our in vivo preparation; thus recovery experiments were not performed. In separate control studies, we also tested AEDs previously shown to have little (or no) effect on PTZ-induced seizures in rodents (e.g., carbamazepine, phenobarbital, ethosuximide, phenytoin). As expected, these AEDs did not suppress electrographic discharge in zebrafish, and we present these findings as a critical validation of our model. Indeed, because rodent PTZ model successfully predicts drugs effective against generalized seizures of the absence (or petit mal) type, we anticipate that our chemically-induced zebrafish seizure model could also identify compounds with therapeutic potential in humans.
ADVANTAGES AND LIMITATIONS OF THE ZEBRAFISH MODEL The application of our larval zebrafish model to epilepsy research is probably limited only by one’s imagination. As discussed in the previous section, a simple application of this model would be to evaluate drugs useful in generalized epilepsy syndromes. One might also consider forward- and
FIGURE 4 Response to antiepileptic drugs. a: Representative tectal field recordings obtained from a zebrafish bathed in normal Ringer’s medium plus 15 mM pentylenetetrazol (PTZ) (baseline) and 45 minutes after application of 100 mM diazepam. b: Representative tectal field recordings obtained from a zebrafish bathed in normal Ringer’s medium plus 15 mM PTZ (baseline) and 45 minutes after application of 5 mM valproic acid.
196
Chapter 15/Modeling Epilepsy and Seizures in Developing Zebrafish Larvae
chemical-genetic screening, commonly used methods to identify gene mutations related to a specific behavior (or phenotype) in an unbiased manner (Malicki, 2000; Patton and Zon, 2001; Specht and Shokat, 2002). Such screening methods provide a strategy to test available AEDs on mutagenized zebrafish larvae, and perhaps will lead to a better understanding of why some patients are refractory to drug treatment. Pharmacogenic strategies (Weinshilboum and Wang, 2004) designed to identify gene mutations that underlie inter-individual variations in AED responsiveness are also possible. When designing zebrafish pharmacologic studies, it is important to consider an empirical testing of drug concentrations; as mentioned above, drug availability and distribution data are not available. Of course this model need not be limited to AED discovery; and not unlike many of the animal models described in this volume, it can be used to study directly how an epileptic brain functions. Epilepsy, particularly pediatric forms of epilepsy, is a neurologic disease that is defined by abnormal electrical discharge, and insights into the basis of this activity often follow from experimental animal model research. In particular the now widespread use of extracellular and intracellular recording techniques in rodent seizure models has provided evidence for intrinsic cellular and synaptic dysfunction that underlie generation of interictal and ictal epileptic seizures. Such research has led, for example, to identification of fuctional changes in H-channels in a febrile seizure model (Bender et al., 2004), and insight into how M-type potassium channel mutations lead to benign familial neonatal convulsions (BFNC) in mutant mice (Watanabe et al., 2000) have benefited from electrophysiology research. Extracellular recording techniques were demonstrated to be feasible (and relatively easy to obtain) in our zebrafish model, and it is not difficult to imagine that intracellular approaches are also possible. Because larval zebrafish possess far fewer neurons and synaptic circuits than immature rodents (but exhibit similar types of complex epileptiform discharge; see Figure 2), analysis of cellular mechanisms in this model could be a fruitful experimental strategy to identify the basic elements required for generation of epileptic seizures. Indeed, owing to the high degree of homology between zebrafish and human genomes, it is likely that identification of genes involved in the basic processes of seizure genesis, seizureinduced neurogenesis, and epileptogenesis will lead directly to insights into the human condition. If one combines this model with morpholino antisense oligonucleotides (Corey and Abrams, 2001) or transgenic methods (Stuart et al., 1990) to alter gene expression in developing zebrafish, a still wider set of experimental questions can be addressed. Perhaps the most significant application of our model, and one that our laboratory currently employs, is to use the zebrafish model to examine the genetic basis of epilepsy. Several types of applications can be envisioned, and we have chosen a forward-genetic screening strategy to identify
“seizure resistant” zebrafish mutants. This research program is based on a fundamental question of how to identify genes that prevent, or protect, an individual from developing epilepsy. Because larval zebrafish are a pediatric epilepsy model, perhaps these types of studies could lead to new therapies for the large number of children suffering with medically intractable forms of epilepsy. Although it is too early to speculate on how data from zebrafish will be extrapolated to human pediatric epilepsy disorders, especially considering the vast complexity of the human brain in relation to the relative simplicity of the zebrafish CNS, it is safe to predict that the process of discovery will lead to novel insights.
CONCLUSIONS Foremost, the potential usefulness of a zebrafish model of pediatric epilepsy should be evaluated with respect to the type of problem to be solved. In the preceding sections, I have tried to provide examples of the features of this model that are clinically relevant. These features include distinct stages of seizure behavior, evidence of abnormal electrical discharge in a CNS structure, seizure-induced expression of c-fos, and AED sensitivity. There are many more features of this model that need to be evaluated, and it is premature to propose that larval zebrafish replace existing rodent seizure models. However, it is not too soon to consider how this simple vertebrate, with striking similarities to commonly used rodent models, may help to open new research directions. Our work was initiated to allow more rapid investigation of genetic modifiers of epilepsy in the developing brain, a fundamental unsolved problem. This goal required establishment of a reliable method to induce and monitor seizures in immature zebrafish. Our methods are described here in detail for the first time, with the intent of encouraging a wider utilization of simple vertebrate systems in pediatric epilepsy research.
Acknowledgments I am grateful for the devotion and effort of my laboratory technicians, graduate students, and postdoctoral fellows, P.A. Castro, S. Guyenet, D.K. Takahashi, D. Botello, J. Greenwood, J. Hsu, M. Dinday, and M.A. Taylor, who have shared in the development of this project. Moral and conceptual support from trusted colleagues, N.M. Barbaro and D.H. Lowenstein, is also gratefully appreciated. I would also like to thank a local zebrafish expert and highly valued collaborator, H. Baier. My research efforts in creating this line of research were supported by grants from the NIH/NINDS, Klingenstein Fund, Epilepsy Foundation of America, and UCSF Innovations in Basic Sciences Fund.
References Bender, R.A., Dube, C., and Baram, T.Z. 2004. Febrile seizures and mechanisms of epileptogenesis: insights from an animal model. Adv Exp Med Biol 548: 213–225.
References Bowyer, J.F., and Winters, W.D. 1981. The effects of various anesthetics on amygdaloid kindled seizures. Neuropharmacology 20: 199–209. Bragin, A., Engel, J. Jr., Wilson, C.L., Vizentin, E., and Mathern, G.W. 1999a. Electrophysiologic analysis of a chronic seizure model after unilateral hippocampal KA injection. Epilepsia 40: 1210–1221. Bragin, A., Engel, J. Jr., Wilson, C.L., Fried, I., and Mathern, G.W. 1999b. Hippocampal and entorhinal cortex high-frequency oscillations (100–500 Hz) in human epileptic brain and in kainic acid–treated rats with chronic seizures. Epilepsia 40: 127–137. Brooks-Kayal, A.R., Shumate, M.D., Jin, H., Rikhter, T.Y.M., and Coulter, D.A. 1998. Selective changes in single cell GABA(A) receptor subunit expression and function in temporal lobe epilepsy. Nat Med 4: 1166–1172. Corey, D.R., and Abrams, J.M. 2001. Morpholino antisense oligonucleotides: tools for investigating vertebrate development. Genome Biol 2: 1015. Dragunow, M., and Robertson, H.A. 1987. Kindling stimulation induces cfos protein(s) in granule cells of the rat dentate gyrus. Nature 329: 441–442. Dzhala, V.I., and Staley, K. J. 2003. Transition from interictal to ictal activity in limbic networks in vitro. J Neurosci 23: 7873–7880. Edwards, J.G., and Michel, W. C. 2003. Pharmacological characterization of ionotropic glutamate receptors in the zebrafish olfactory bulb. Neuroscience 122: 1037–1047. Engel, J. Jr., and Pedley, T.A. 1997. In Epilepsy: A Comprehensive Textbook. Vols. 1, 2 and 3. Philadelphia: Lippincott-Raven Publishers. Ferrendelli, J.A., Holland, K.D., McKeon, A.C., and Covey, D.F. 1989. Comparison of the anticonvulsant activities of ethosuximide, valproate , and a new anticonvulsant, thiobutyrolactone. Epilepsia 30: 617–622. Hildebrandt, F. 1926. Pentamethylenetetrazol (Cardiazol®). Archiv für experimentelle Pathologie und Pharmakologie 116: 100–109. Holmes, G.L., and Thompson, J.L. 1988. Effects of kainic acid on seizure susceptibility in the developing brain. Brain Res 467: 51–59. Hsin, H., and Kenyon, C. 1999. Signals from the reproductive system regulate the lifespan of C. elegans. Nature 399: 362–366. Jensen, F.E., Applegate, C.D., Holtzman, D., Belin, T.R., and Burchfiel, J.L. 1991. Epileptogenic effect of hypoxia in the immature rodent brain. Ann Neurol 29: 629–637. Jensen, F.E., Blume, H., Alvarado, S., Firkusny, I., and Geary, C. 1995. NBQX blocks acute and late epileptogenic effects of perinatal hypoxia. Epilepsia 36: 966–972. Kimmel, C.B. 1989. Genetics and early development of zebrafish. Trends Genet 5: 283–288. Krall, R.L., Penry, J.K., White, B.G., Kupferberg, H.J., and Swinyard, E.A. 1978. Antiepileptic drug development: II. Anticonvulsant drug screening. Epilepsia 19: 409–428. Kuebler, D., and Tanouye, M.A. 2000. Modifications of seizure susceptibility in Drosophila. J Neurophysiol 83: 998–1009. Kuebler, D., Zhang, H., Ren, X., and Tanouye, M.A. 2001. Genetic suppression of seizure susceptibility in Drosophila. J Neurophysiol 86: 1211-1225. Kupferberg, H. 2001. Animal models used in the screening of antiepileptic drugs. Epilepsia 42(Suppl 4): 7–12. Lewis, K.E., and Eisen, J.S. 2003. From cells to circuits: development of the zebrafish spinal cord. Prog Neurobiol 69: 419–449. Lewis, J.C., Thomas, H.V., Murphy, K.C., and Sampson, J.R. 2004. Genotype and psychological phenotype in tuberous sclerosis. J Med Genet 41: 203–207. Lin, K., Dorman, J.B., Rodan, A., and Kenyon, C. 1997. daf-16: An HNF3/forkhead family member that can function to double the life-span of Caenorhabditis elegans Science 278: 1319–1322. Malicki, J. 2000. Harnessing the power of forward genetics—analysis of neuronal diversity and patterning in the zebrafish retina. Trends Neurosci 23: 531–541.
197
Moorman, S.J. 2001. Development of sensory systems in zebrafish (Danio rerio). Ilar J 42: 292–298. Morgan, J.I., Cohen, D.R., Hempstead, J.L., and Curran, T. 1987. Mapping patterns of c-fos expression in the central nervous system after seizure. Science. 237: 192-197. Moshe, S.L., and Albala, B.J. 1982. Kindling in developing rats: persistence of seizures into adulthood. Brain Res 256: 67–71. Nehlig, A., and Pereira de Vasconcelos, A. 1996. The model of pentylenetetrazol-induced status epilepticus in the immature rat: short- and longterm effects. Epilepsy Res 26: 93–103. Noldus, L.P.J.J., Spink, A.J., and Tegelenbosch, R.A.J. 2002. Computerised video tracking, movement analysis and behaviour recognition in insects. Comput Electron Agric 35: 201–227. Nüsslein-Volhard, C., and Dahm, R. 2002. Zebrafish. Oxford: Oxford University Press. Oulmi, Y., and Braunbeck, T. 1996 Toxicity of 4-chloroaniline in early lifestages of zebrafish (Brachydanio rerio): I. cytopathology of liver and kidney after microinjection. Arch Environ Contam Toxicol 30: 390–402. Patton, E.E., and Zon, L.I. 2001. The art and design of genetic screens: zebrafish. Nat Rev Genet 2: 956–966. Pesah, Y., Pham, T., Burgess, H., Middlebrooks, B., Verstreken, P., Zhou, Y., Harding, M. et al. 2004. Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress. Development 131: 2183–2194. Priel, M.R., dos Santos, N.F., and Cavalheiro, E.A. 1996. Developmental aspects of the pilocarpine model of epilepsy. Epilepsy Res 26: 115–121. Psarropoulou, C., and Avoli, M. 1996. Developmental features of 4aminopyridine induced epileptogenesis. Dev Brain Res 94: 52–59. Racine, R.J. 1972. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysio 32: 281–294. Rizzi, M., Monno, A., Samanin, R., Sperk, G., and Vezzani, A. 1993. Electrical kindling of the hippocampus is associated with functional activation of neuropeptide Y-containing neurons. Eur J Neurosci 5: 1534–1538. Sankar, R., Shin, D., Mazarati, A.M., Liu, H., and Wasterlain, C.G. 1999. Ontogeny of self-sustaining status epilepticus. Dev Neurosci 21: 345–351. Schwartzkroin, P.A., Moshe, S.L., Noebels, J.L., and Swann, J.W. 1995. Brain development and epilepsy. Oxford: Oxford University Press. Servít, Z. 1970. Focal epileptic activity and its spread in the brain of lower vertebrates. A comparative electrophysiological study. Epilepsia 11: 227–240. Servít, Z., and Strejckova, A. 1970. An electrographic epileptic focus in the fish forebrain. Conditions and pathways of propagation of focal and paroxysmal activity. Brain Res 17: 103–113. Servít, Z. 1972. Phylogenetic correlations. In Experimental Models of Epilepsy—A Manual for the Laboratory Worker. Eds. D.P. Purpura, J.K. Penry, D. Tower, D.M. Woodbury, and R. Walter. pp. 509–530. New York: Raven Press. Stuart, G.W., Vielkind, J.R., McMurray, J.V., and Westerfield, M. 1990. Stable lines of transgenic zebrafish exhibit reproducible patterns of transgene expression. Development 109: 577–584. Tempel, B.L., Papazian, D.M., Schwarz, T.L., Jan, Y.N., and Jan, L.Y. 1987. Sequence of a probable potassium channel component encoded at Shaker locus of Drosophila. Science 237: 770–775. Tuttle, W.W., and Elliott, H.W. 1969. Electrographic and behavioral study of convulsants in the cat. Anesthesiology 30: 48–64. Weinshilboum, R., and Wang, L. 2004. Pharmacogenomics: bench to bedside. Nat Rev Drug Discov 3: 739–748. White, H.S. 1997. Clinical significance of animal seizure models and mechanism of action studies of potential antiepileptic drugs. Epilepsia. 38(Suppl 1): S9–S17. Wiedeman, C. 1877. Beiträge zur Pharmakologie des Camphers. Archiv für experimentelle Pathologie und Pharmakologie 6: 216–232.
198
Chapter 15/Modeling Epilepsy and Seizures in Developing Zebrafish Larvae
Williams, S.N., Locke, C.J., Braden, A.L., Caldwell, K.A., and Caldwell, G.A. 2004. Epileptic-like convulsions associated with LIS-1 in the cytoskeletal control of neurotransmitter signaling in Caenorhabditis elegans. Hum Mol Genet 13: 2043–2059. Woodbury, D.M. 1969. Role of pharmacological factors in the evaluation of anticonvulsant drugs. Epilepsia 10: 121–144.
Wullimann, M.F., Rupp, B., and Reichert, H. 1996. Neuroanatomy of the Zebrafish Brain. A Topological Atlas. Basel: Birkhäuser Verlag. Zumkeller, W., Volleth, M., Muschke, P., Tonnies, H., Heller, A., Liehr, T., Wieacker, P. et al. 2004. Genotype/phenotype analysis in a patient with pure and complete trisomy 12p. Am J Med Genet 129A(3): 261–2644.
a
1 mm
FIGURE 15--1 Behavioral seizure stages, a: Frame-grabber image of a 7 days post fertilization zebrafish larvae in one well of a 96-well Falcon plate, b: Sample locomotion tracking plots are shown for individual zebrafish in normal Ringer's medium (baseline), during stage I (increased swimming activity), stage II (circling), and stage III (clonus-like convulsions). Blue lines indicate movement; dashed lines indicate rapid convulsive seizure activity (this fish exhibited <25 convulsive episodes). Plots were obtained from recording epochs 2 minutes in duration.
~?
Cx FP L
/ !
:"
]"
:
:
~I
(
~y ¸
/
, ~,
,1500 pV 2s
(Hz) 50 30 10 II
%%
%%
II
ii
Cx FP L~\ ~ ;% :! :,, ,%,, L', ~.~'~f..J,.i,. r , ,
%~,
: ,.,.2~.~,.;'
~,~,,r r,3. ls
1500 ~tV
FIGURE 18-1 Example of cortical electroencephalographic (EEG) recording of a spike-and-wave discharge in the genetic abscense epilepsy rats from Strasbourg (GAERS) and corresponding spectral analysis. Bottom, lower speed recording of the discharge showing the spike-wave complex. Cx FP R, right frontoparietal derivation; CxFP L, left frontoparietal derivation. (Courtesy of Colin Deransart.)
C
H
A
P
T
E
R
16 Transgenic and Gene Replacement Models of Epilepsy: Targeting Ion Channel and Neurotransmission Pathways in Mice DANIEL L. BURGESS
spontaneously (see Chapter 17) without any deliberate mutagenesis by humans. Second, in each case, altered function of a single gene was alone sufficient to cause the phenotype (i.e., the mutations produced highly-penetrant “monogenic” disorders). Indeed, because genes involved with polygenic disorders are, for biological and statistical reasons, substantially more difficult to map and identify, virtually all the mutant genes isolated from epileptic mice to date have been associated with single gene disorders. Significant advances in the development of technical tools have made identification of mouse monogenic disease mutations a fairly straightforward proposition today, but researchers no longer need to wait for these mutations to occur naturally and then spend months or years identifying the defective gene. The development and refinement of two powerful molecular techniques—transgenesis and gene replacement by homologous recombination in embryonic stem cells— has taken the waiting out of mouse model development and yielded a wealth of knowledge about the basic molecular mechanisms of epilepsy in just a short time. By identifying all the genes that specify the development and function of mouse and human, the respective genome projects have supplied all the necessary raw material to fuel a revolution in the genetic modeling of human disorders.
“MOUSEQERADING” AS HUMAN The availability of numerous existing inbred mouse strains and the practicality of maintaining large breeding colonies have made the mouse—because of its small size, rapid generation time, and low cost—an easy choice for biomedical researchers seeking animal models. These mouse strains exhibit wide differences in susceptibility to disorders that are important to humans: cancer, diabetes, obesity, cardiovascular and hematologic defects, developmental abnormalities, infertility, endocrine dysfunction, blindness, behavioral abnormalities, and epilepsy, among others. The cumulative health benefits that have been derived over the past century from studies using mice as models of human disease—to learn about pathologic mechanisms and develop new therapies—are incalculable, but they certainly surpass billions of health care dollars and millions of lives saved. Over the most recent decade, we witnessed what may be the most important advance yet for the study of mouse models of disease: the nearly simultaneous completion of the human and the mouse genome sequencing projects. Comparison of the two genomes indicates a remarkable degree of similarity; very few genes are present in one species that are not represented by orthologs in the other. Thus, one reason the mouse has provided such good models of human diseases is that the mouse genome is such a good model of the human genome!
MODELING GENOTYPES VERSUS MODELING PHENOTYPES Many research approaches might drive the development of a mouse model of inherited epilepsy. Most can be characterized as either an attempt to model a phenotype or an attempt to model a genotype. These concepts are illustrated
WAITING FOR THE RIGHT MUTATION The earliest epilepsy-associated mutations isolated from mice shared two characteristics. First, these mutations arose
Models of Seizures and Epilepsy
199
Copyright © 2006, Elsevier Inc. All rights of reproduction in any form reserved.
200
Chapter 16/Transgenic and Gene Replacement Models of Epilepsy
by considering some common questions an investigator might pose in the course of planning a study:
Question 1: What Does this Gene Do? An investigator beginning to study a recently identified gene (let us call it Xyz) may not have any initial clue about the gene’s function—and no interest at all in seizures or epilepsy. Because an increasingly popular approach to probing gene function is to inactivate the gene in the mouse germline (by homologous recombination in embryonic stem cells, a gene “knockout”) and then observe the resulting phenotype, our researcher decides to knock out Xyz. The possible outcomes of a mutated Xyz gene might include anything: a new coat color, extra toes, early embryonic lethality, or seizures. Although the investigator may not have had any initial interest in epilepsy research, this scenario could lead—and has led—to the development of an animal model that is useful for the epilepsy field. For example, the Beta2 (NeuroD1) gene, expressed in pancreatic endocrine cells, intestine, and brain, was originally knocked out to investigate the importance of this gene in pancreatic endocrine cell differentiation (Naya et al., 1997). It was subsequently discovered that loss of this gene causes both malformation of the dentate gyrus and seizures, and produces a good model of developmental brain malformation-associated epilepsy (Liu et al., 2000).
Question 2: Is this Gene Involved in Epilepsy? Alternatively, a researcher might begin with the hypothesis that gene Xyz is involved in epilepsy but have no direct evidence. The experimental approach taken to address this hypothesis might be identical to that following question 1 (i.e., targeted inactivation of Xyz in mouse ES cells). However, in this case, the investigator predicts a specific outcome: a seizure phenotype. For example, genes involved in the inhibitory GABA (g-aminobutyric acid) neurotransmitter pathway had long been considered excellent candidates for mutations in epilepsy, but no spontaneous mutations had ever been found to support this belief. In 1997 Kash et al. knocked out the mouse Gad2 (glutamic acid decarboxylase 2) gene (which catalyzes the formation of GABA) and observed spontaneous seizures. This outcome provided some of the first direct evidence supporting a role for GABA pathway genes in epilepsy. Seizures in some mice can be subtle or infrequent, and if this phenotype is not expected or screened for appropriately (e.g., by electroencephalographic [EEG] analysis), even a relevant phenotype can be easily overlooked. Several knockout mice may exist with yet unrecognized neuronal excitability defects.
Question 3: Is this Human Mutation Involved in Epilepsy? Occasionally the first indication that gene Xyz might be associated with epilepsy is identification of a sequence difference that is present in human epilepsy patients but not in unaffected controls. Perhaps Xyz itself had never before been associated with epilepsy; alternatively, maybe other epilepsy mutations had been found in Xyz, but this particular sequence variant had not yet been described. In either case, how can we determine whether the human sequence variant (often a missense change) is a causative epilepsy mutation or whether it is only a rare, but functionally neutral, polymorphism? To help address this question, an investigator might create a mouse model in which the candidate human Xyz mutation is inserted (by homologous recombination) into the identical molecular context in the orthologous mouse gene. This method (termed a gene knock-in) allows the variant mRNA and protein to be expressed and is thus a better reflection of the human mutation than obliteration of the mouse Xyz gene would be. Because this method is labor intensive and time consuming, it has not been widely used to investigate whether a genetic variant might be a causative mutation rather than simply a polymorphism. More frequently, knock-in mutations are created to produce a viable mouse model when the complete inactivation of a gene results in a lethal phenotype. A good example of this approach has focused on the human DKPQ mutation in SCN5A, which causes long-QT syndrome type 3 (LQT3). A complete knockout mutation of the mouse Scn5a gene results in embryonic lethality in homozygotes, but mice heterozygous for a knock-in of the human DKPQ deletion survive and exhibit all the essential features of LQT3, including ventricular arrhythmias (Nuyens et al., 2001).
Question 4: How Can I Produce a Mouse Model of a Particular Epilepsy Phenotype? In some cases, an investigator may desire to study a mouse model of epilepsy with a particular seizure phenotype but not particularly care whether or how the mouse genome is altered to produce it. Application of convulsant drugs has often been used to generate such models. However, an inherited phenotype may produce a seizure-relevant phenomenon that is unique, more consistent among individuals, or present at ages earlier than can be produced with convulsants. As in the preceding scenarios, gene replacement mice can be useful in some cases. In other situations, creation of a transgenic mouse might result in the optimal model. For example, Kearney and colleagues (2001) used a transgene to overexpress in mouse neurons a mutant Scn2a protein with slow inactivation and increased persistent current. These transgenic mice displayed seizures beginning at 2 months of age that were accompanied by
Genome-Environment Interactions in Mouse Epilepsy Models
behavioral arrest and other abnormal behaviors. Transgenes can be designed to overexpress a gene that is endogenous to the mouse, from a different species, or even an artificial gene. They can be used to express genes ectopically (i.e., in a cell type or at a developmental stage where they are not normally expressed). Transgenes can even be designed to be turned on and off simply by adding chemicals to the mouse’s drinking water, providing much more flexibility in manipulating gene expression than is possible with gene replacement strategies. The preceding scenarios provide some general examples of how or why a mouse model of epilepsy might be developed in the first place. In the initial three cases, we are primarily modeling a genotype and are particularly interested in the role of the gene product or genetic pathway in epilepsy. In the fourth example, the mouse genome may be altered in such a way that could not occur naturally in humans but nevertheless produces a mouse model of a phenotype. Whether it is the goal of an investigator to produce a mouse model from scratch or to study an available model, an understanding of the conceptual pathway that leads to development of the model is important for guiding the way that model is studied and in deciding how we interpret the resulting data in reference to the human epileptic condition.
GENOME-ENVIRONMENT INTERACTIONS IN MOUSE EPILEPSY MODELS Although this chapter is concerned specifically with transgenic and gene replacement mouse models of epilepsy, a preliminary general discussion of the genome-environment interaction as it relates to mouse seizure phenotypes provides a useful framework for subsequent discussions. Let us begin by considering the commonly (mis)applied distinction between wild-type and mutant mice. If all mice of a given strain exhibited an epilepsy phenotype, and genetic analysis indicated that the phenotype was linked to a single chromosome locus, we would probably feel comfortable referring to that mouse strain as a mutant strain. But then imagine that we moved these mice to a different animal facility (perhaps one with a different temperature, light-dark cycle, or brand of mouse food) and the mice were no longer observed to have seizures. No change in the genome of this mouse strain has occurred, so something in the environment must be responsible for the change in phenotype. Are these mice still mutant? Another example makes a similar point: Multiple studies have now demonstrated that some inbred strains of so-called wild-type mice, even if they never show spontaneous seizures, can be much more easily induced to have seizures than other wild-type strains. Given this information, is it really accurate to imply that the seizuresusceptible and seizure-resistant mouse strains are all equally wild type? Clearly mice are only wild type with
201
respect to a specific genetic locus and according to a specific user-defined assay for the structure or function of that locus in a controlled laboratory environment. Every mouse carries multiple genetic differences (mutations or polymorphisms) that distinguish it from mice of other strains, although only some of these differences produce phenotypes that are obvious to a biologist. It can be argued that the terms mutant and wild type refer primarily to the interaction of that mouse’s genome and its environment rather than the genome alone. Further, this interaction can be very dynamic. The practical implications of these observations may be vital for anyone planning to generate or analyze targeted gene models of epilepsy. Figure 1 provides a visual schematic that helps to explain the interaction of the genome and the environment as it relates to seizure susceptibility and epilepsy. Six hypothetical mouse strains (A–F) exhibit a low to high risk (left to right) of genetically determined epilepsy within environment 1 (Figure 1A). In this environment, the sum of seizure triggers (theoretical constructs that may occur in the external environment, such as flashing light, loud sound, or in the internal environment, such as hormone levels, blood pressure) present at any one time may range from a level of 0 to about 2.5 (on an arbitrary scale of 0 to 5). This same scale that measures the sum level of seizure triggers can be thought of as measuring an animal’s genetic resistance to seizures in that environment. In environment 1, mouse strains D–F (but not strains A–C) exhibit seizures. Figure 1B examines temporal and quantitative aspects of seizures among mouse strains D–F in environment 1. Genetically determined resistance to seizures in each animal (highest in D, lowest in F) is stable over time (dashed lines) because the genome of each animal is stable over the lifespan of that animal, but the level of seizure triggers in environment 1 is highly variable (shaded area). Mouse strain F has such a low intrinsic resistance to seizures (about 0.4) that the sum of seizure triggers is always greater than the threshold for seizures, so that strain F animals would persist in status epilepticus. Strain E has a moderate intrinsic genetic resistance to seizures (~1.3), so that the sum of seizure triggers only occasionally surpasses this threshold; in this example, a mouse from strain E would have a total of five seizures over the period shown (i.e., recurrent seizures, or “epilepsy”). Mice from strain D have a higher intrinsic genetic resistance to seizures (about 2.2). In this example, the seizure triggers in environment 1 surpass the strain D seizure threshold only once over the indicated time period. Figure 1C represents the propensity of an individual mouse (or an entire mouse strain) to appear epileptic in one environment and nonepileptic in another. Here the genetic resistance to seizures across strains remains constant, but environments with different seizure trigger ranges are shown. Mice from strain A (with the highest genetic seizure resistance) do not exhibit seizures in any of the three
202
Genetic Resistance to Seizure Triggers
A.
Chapter 16/Transgenic and Gene Replacement Models of Epilepsy
5
A
4
B
3
C D
2 Environment 1 Seizure Trigger Range
1
E F
0 LOW
Genetic Resistance to Seizure Triggers
B.
Genetically Determined Risk of Epilepsy in Environment 1
HIGH
3 D
2
E 1 F 0 Time
Genetic Resistance to Seizure Triggers
C.
5
A
4
B
3
Seizure Trigger Ranges
2
Environment 2
C D E
1 Environment 3
environments. Mice from strain B also have a relatively high intrinsic seizure resistance (~4.0) but would be expected to have occasional seizures in environment 2. The other strains (C–F) show corresponding environment-dependent shifts in seizure and epilepsy risk. Now consider a scenario in which a researcher selects strain A mice for creating a gene knockout, with the intention of creating a model of epilepsy. After mutating the Xyz gene in strain A, no seizure phenotype is observed. Is this result strong evidence that gene Xyz is not involved in epilepsy? No, the targeted mutation in Xyz might have actually lowered the intrinsic resistance of strain A, but a relatively moderate environmental seizure trigger range “prevented” the appearance of spontaneous seizures. Introduction of the Xyz-mutated strain A mouse into a different environment might expose the latent seizure phenotype and thus the potential role of gene Xyz in epilepsy. The exposure of gene-modified and control animals to electrical or chemical convulsants to examine changes in latent hyperexcitability phenotypes is theoretically equivalent to moving animals to an environment with a higher average sum seizure trigger level. Creation of the Xyz gene knockout using strain B or C originally, rather than strain A, would have accomplished a similar goal. In summary, a genetic epilepsy phenotype cannot be evaluated in terms of only a single gene of interest but should be viewed instead as a dynamic interaction of gene, genome, and environment.
F
0 LOW
Genetically Determined Risk of Epilepsy in Environments 2 & 3
HIGH
FIGURE 1 A model of genome-environment interaction in mouse epilepsy models. All mice, whether described as mutant or wild-type, can be considered to have some genetically determined risk of epilepsy in any given environment. Because epilepsy is defined as recurrent, spontaneous seizures, this risk of epilepsy is directly correlated with the animal’s genetic resistance to seizure triggers in that environment. This model assumes that all seizures have some proximal trigger, either endogenous or exogenous (the precise nature of which is unimportant for the model). Genetic resistance to seizure triggers should be stable at any point during its life as long as the animal’s genome remains unchanged. A: The range of seizure triggers in environment 1 has a maximum and minimum level, and any individual mouse or mouse strain (e.g., A, B, or C) whose genetic resistance is stronger than the maximum seizure trigger level will never exhibit seizures in that environment. Any mouse (e.g., D, E, or F) with a genetic resistance within the seizure trigger range of environment 1 will eventually have one or more seizures. B: Seizure trigger levels are not constant within their range in a given environment. Whereas the genetic resistances of mouse strains D–F are all within the seizure trigger range for environment 1, seizure frequency can vary depending on temporal fluctuations in actual seizure trigger levels. C: The range of seizure triggers can vary among different environments. Thus, a mouse may be normal in one environment but experience seizures if moved to another. This model provides a useful framework for interpreting the genotype-phenotype relationship for mouse epilepsy models.
TRANSGENIC APPROACHES TO MODELING EPILEPSY The Basic Concept The term transgenesis most broadly refers to the introduction of genetic material into the germline of a recipient organism; the donated genetic material may come from either the same or different species, or the introduced DNA may be artificial (i.e., generated by DNA synthesis and not present in nature). Technically speaking, the process of carrying out “gene replacement” by homologous recombination can also be considered transgenesis because some introduced foreign DNA is always left at the recombination site. However, for the purpose of clarity, we will refer to homologous recombination as the process of introducing exogenous DNA into a specific site in the genome of a recipient animal (this topic will be discussed later in this chapter) and to transgenesis as the introduction of DNA into a random site. Transgenes can be introduced into mice for a variety of purposes, including to study and define gene promoters, to introduce biomarkers (e.g., green fluorescent protein, bgalactosidase) into specific cell types to distinguish those cells for subsequent in vivo analysis, to selectively “rescue” a gene’s function when endogenous copies of that gene have
203
Transgenic Approaches to Modeling Epilepsy
been mutated, to explore the effect of expressing a mutant protein in vivo, or to produce an animal model with a very specific phenotype (such as epilepsy). When considering a transgenic approach to developing a mouse epilepsy model, three questions must be addressed: (1) What sort of transgene would cause a mouse to have seizures? (2) Where in the mouse would it need to be expressed? (3) When during the animal’s life should it be expressed? Because there are so many different possible transgenes (and a similarly wide range of mechanisms) that could cause seizures or epilepsy in a mouse, the choice of transgene depends on the specific needs or interests of the investigator. In this chapter, we discuss primarily ion channel genes. Two general categories of ion channel genes can be used to create a transgenic mouse model of epilepsy: wild-type and mutant. A wild-type transgene can be expressed in the same cell type as the endogenous version of that gene if the appropriate promoter is available, or it can be expressed in a cell type that does not normally express the endogenous gene. It might seem intuitive that overexpressing a gene that increases membrane excitability (e.g., a voltage-gated Na+ channel) would favor the development of seizures and epilepsy, whereas overexpressing a gene that decreases membrane excitability (e.g. a K+ channel) would inhibit seizures. However, this scenario is not always realized. In some cases the genome can employ feedback regulation to alter the expression of endogenous genes to compensate for the effects of a transgene. Transgenic expression of a mutant ion channel gene can also be used to create an epilepsy model, but not all ion channel mutations associated with human epilepsy are good candidates for this purpose. Because a transgenic mouse already has two functioning endogenous copies of every gene, only those mutant ion channel transgenes that carry gain-of-function mutations (not those that carry loss-of-function mutations) might be expected to replicate a human seizure phenotype.
Methods The technique of transgenesis via microinjection into mouse embryos was described more than 25 years ago (Gordon et al., 1980). An overview of that process is shown in Figure 2. Most transgenes consist of the same elements as endogenous genes and include a promoter, a region of transcribed sequences that encode a protein, and a poly(A)addition signal. The protein coding segment usually consists of an intronless cDNA fragment rather than a fragment of genomic DNA containing the gene because the latter tends to be too large for simple cloning procedures (notable exceptions include transgenes consisting of entire bacterial artificial chromosomes, or BACs). A transgene is constructed by standard recombinant DNA techniques in a plasmid vector and is amplified by growth in Escherichia coli. The vector portion (which can interfere with transgene expression) is
Promoter
Poly(A)
Gene
Transgene plasmid
1.
Promoter
E. coli
Gene
Poly(A)
2. male pronucleus
3.
female pronucleus
4.
Mouse zygote
Transgene array inserted into chromosome
FIGURE 2 Construction of a transgenic mouse model. A typical transgene plasmid contains a promoter, structural gene, and poly(A) addition signal. This is amplified in Escherichia coli (1), linearized to remove vector sequences (2), and purified. The purified transgene fragment is microinjected into one pronucleus of a recently fertilized mouse zygote (3). The transgene usually inserts as a multicopy tandem array at a single site in the genome (bottom). The transgenic zygote is implanted into a surrogate female (4) to develop until birth about 20 days later.
removed, and the purified transgene fragment is diluted in a physiologically buffered solution. This transgene-containing solution is then microinjected into one of the two pronuclei of a newly fertilized zygote that has been surgically removed from a recently mated female donor mouse (the female is usually treated with hormones before mating to cause “superovulation,” the production of a greater number of mature ova than generated during a normal cycle). Following fertilization, the haploid egg and sperm pronuclei do not fuse immediately. Because the male pronucleus is usually larger than the female pronucleus, it is generally an easier target for the microinjection needle. Thus, most transgenes actually insert into the paternal genome. It is also interesting to note that certain mouse strains produce zygotes with larger pronuclei than others or that can survive the process of microinjection better and therefore are technically easier to access. These practical concerns are often balanced by a desire to create the transgenic mouse on a specific background strain. Following microinjection, multiple copies of the transgene concatemerize (head-to-tail, head-to-head, tail-to-tail, or a combination of these) and insert into a single site in the genome. More rarely multiple transgene arrays insert into different sites in the genome. It remains unclear whether the resulting copy number in the transgene array is correlated with the concentration of transgene DNA in the microinjection solution. The insertion site in the genome is believed to
204
Chapter 16/Transgenic and Gene Replacement Models of Epilepsy
be essentially random. In fact, 3 to 5% of transgenes insert into an endogenous gene, resulting in an insertional mutation that can confound analysis of the transgenic mouse phenotype (Meisler, 1992). The microinjected embryos are then implanted into a pseudopregnant surrogate female that had been previously treated with hormones to facilitate implantation. The mice that are born about 20 days later (referred to as “founders,” or F0-generation pups) may or may not carry the transgene; they must be screened, for example, by carrying out polymerase chain reaction (PCR) genotyping of genomic DNA extracted from a blood sample, a tail clipping, or an ear-punch tissue sample. An alternate approach to creating transgenic mice is to infect mouse embryos with a retrovirus engineered to express a transgene, which then inserts itself into the genome using natural viral mechanisms (Ivics and Izsvak, 2004). This approach is used less frequently than embryo microinjection. However, because retroviral transgenes tend to insert as a single unit rather than as a variably sized tandem array, this approach may provide the investigator with some control over transgene copy
Basic transgene:
Promoter
number. It is unclear whether retroviral transgenes insert at random into the target genome or preferentially at certain sites (Wu and Burgess, 2004). Variations of the Basic Transgene Although a basic transgene contains a promoter, a protein-coding gene segment, and a poly(A)-addition signal, there are variations that can be useful (Figure 3). Some studies have shown that inclusion of a single intron in the transgene can increase expression significantly, perhaps by increasing pre-mRNA stability or mRNA nuclear export. This intron does not need to be derived from the same gene that is being expressed and is usually positioned between the promoter and the translation start site (first ATG codon) of the transcribed gene. Another variation is the addition of chromatin scaffold attachment regions, or SARs (also known as matrix attachment regions, MARs, or insulators). These are fragments of DNA that are thought to regulate local chromatin structure (Bode et al., 2003; McKnight et
Gene
Poly(A)
(~ 2 - 10 kb)
Intron added:
Promoter
Gene
Poly(A)
intron
SARs added:
SAR
Promoter
Epitope added:
Promoter
IRES vector:
Promoter
BAC transgene: (~ 80 - 300 kb)
Native promoter
Gene
Gene 1
Gene
Poly(A)
SAR
Epitope tag Poly(A)
IRES
Gene 2
Poly(A)
Native Poly(A)
FIGURE 3 Alternative transgene designs. Modifications (gray boxes) to the basic transgene design include the addition of introns to increase mRNA stability and nuclear export, chromatin scaffold attachment regions (SARs) to insulate the transgene from position-dependent effects on transcription, epitope tags (including GFP or LacZ) for identification or localization in vivo and an internal ribosome entry site (IRES) to allow the translation of two independent proteins from a single mRNA molecule. The bottom panel indicates that an entire bacterial artificial chromosomes (~80–300 kb) can be used as a transgene, with no additional modification, to preserve native regulatory features that might be lost when using cDNAs for transgenes.
205
Transgenic Approaches to Modeling Epilepsy
al., 1992). By insulating the transgene and its promoter from the DNA environment into which the transgene inserts, flanking SARs can help to ensure that the transgene is expressed in the intended tissue and not influenced by nearby endogenous enhancer or repressor elements. This process can improve concordance between different mouse lines carrying the same transgene. Transgenes may also incorporate small (£20 amino acids) epitope tags at the nterminus, c-terminus, or inside the transgene. These tags are translated as an integral part of the transgene protein and allow the use of existing antibodies to the epitope tag (myc, HA, and His tags are popular) to detect or immunoprecipitate the protein. Larger proteins can also be fused directly to the target gene, such as green fluorescent protein (GFP) or b-galactosidase (LacZ), which allows visualization of transgene expression without antibodies. However, the addition of these larger proteins may interfere with the functions of the gene under study. Finally some transgene vectors allow the simultaneous expression of two genes separated by an internal ribosome entry site (IRES). With this system, a single mRNA is transcribed, but then two separate proteins are translated from that transcript. This process can be useful for expressing a protein with a separate visualization label. The choice of genes that can be expressed transgenically is practically unlimited. Currently the major constraint on transgene design is the availability of well-characterized promoters to drive tissue- or developmental stage-specific transgene expression. Promoters can be cloned from endogenous genes in an attempt to express the transgene in its native pattern; alternatively, promoters can be obtained from viral, bacterial, or even plant genes to drive expression in the mouse. With regard to expression in the central nervous system (CNS), a review of the literature reveals transgenes that incorporate Purkinje or granule neuron-specific, GABAergic neuron-specific, hippocampal, or pan-neuronal promotors. However, for a large number of interesting and functionally discrete brain regions or cell types, there are no currently available transgene promoters. It is extremely time consuming to clone and characterize new gene promoters, and some promoters are simply too complex or large to incorporate into a standard transgene construct. An increasingly popular approach is to express a gene from its native promoter via a BAC transgene (Gong et al., 2003; Heintz, 2000). The large size of most BACs (80–300 kb) increases the likelihood that the complete promoter, intronic, and 3¢ regulatory sequences will also be contained within that clone. Unlike a standard transgene construct, a BAC does not need to be linearized or separated from its relatively small vector segments, but it can simply be purified, resuspended in the appropriate buffer, and directly microinjected into the zygote pronucleus. The technology to modify genes within a BAC clone (e.g., to introduce epitope tags, mutations, or other complex alterations)
is rapidly advancing (Giraldo and Montoliu, 2001; Testa et al., 2004). In addition to autonomous promoters that either direct constitutive transgene expression or direct transgene expression in response to developmental cascades or natural cues, significant progress has been made toward developing transgene promoters that are truly inducible (Yamamoto et al., 2001). Much of this work has been driven by gene therapy and agricultural genetic research. The most commonly utilized technique for development of mouse transgenic models is the tetracycline (tet)-inducible promoter. Two versions are commercially available so that an investigator can select a transgene promoter that is always activated until tet is added, or always inactivated until tet is added (Backman et al., 2004). Tetracycline (or the analogue doxycycline) can simply be added to the transgenic mouse’s water supply to induce the promoter to express the transgene or turn it off. Another benefit of this technique is its capacity to regulate the activity of the promoter quantitatively, that is, by adding more or less tet to the water. Inducible promoters provide a powerful opportunity to address cause-and-effect relationships between transgene expression and resulting mouse phenotypes, including the roles of development and plasticity. Additional resources describing the theory and methodology of transgenesis, including more detailed protocols, include Jackson and Abbott (2000), Hofker and Deursen (2002), Nagy et al. (2002), Pinkert (2002), and Houdebine (2003).
Examples Compared with homologous recombination-mediated gene knockouts, only a relatively small number of studies have used transgenically expressed ion channels to study epilepsy and neuronal excitability in mice (Table 1). Some examples include the following: AKv1.1a In 1999 Sutherland et al. created three transgenic mouse lines with a human HPRT promoter driving the CNSspecific overexpression of an Aplysia shaker-type K+ channel cDNA with a small 11-amino acid epitope tag. Transgene expression was detected in neurons, but not glia, in several brain areas, including the neocortex, hippocampus, and cerebellum. Electroencephalographic (EEG) activity from adult neocortex showed spontaneous cortical discharges similar to those seen in spike-wave epilepsy. Because overexpression of shaker K+ channel currents in Aplysia neurons shortened action potential duration, enhanced the hyperpolarizing afterpotential, and depressed transmitter release from terminals (Kaang et al., 1992), the presence of an epilepsy phenotype in transgenic mice expressing the same gene was surprising. Further analysis revealed extensively
TABLE 1 Transgenic and Targeted Gene Knockout Models of Ion Channels, Transporters, and Neurotransmission Pathways Associated with Seizure Phenotypes Gene symbol
Speciesa
Phenotype or syndromeb
Abcc8
Mouse Mouse Human
KO Transgene overexpression Inherited
No seizures reported. Failure of insulin secretion in response to glucose Suppressed kainic acid-induced seizures and excitotoxic neuron damage Persistent hyperinsulinemic hypoglycemia of infancy (PHHI); occasional seizures
AKv1.1a
Mouse
Aplysia K+ channel transgene
Spontaneous cortical discharges similar to those seen in spike-wave epilepsy
Atp1a2
Mouse
KO
Mouse Human
KI Inherited
No seizures reported, but homozygotes show perinatal lethality and selective neural damage consistent with excitotoxicity No seizures reported Familial hemiplegic migraine-2 (FHM) ± benign familial infantile convulsions (BFIC)
Aqp4
Mouse
KO
Reduced susceptibility and increased latency to PTZ-induced seizures
Cacna1a
Mouse Mouse
KO KI
Mouse Human Human Human
Spontaneous Inherited Inherited Inherited
Lethality ~30 days; behavioral absences Reduced threshold for, and increased velocity of, cortical spreading depression Absence epilepsy, ataxia Familial hemiplegic migraine (FHM); episodic ataxia type-2 (EA-2) Spinocerebellar ataxia type 6 (SCA6). Primary generalized epilepsy, ataxia, mild learning difficulties; absence epilepsy
Cacna1g
Mouse
KO
Thalamus was resistant to the generation of spike-and-wave discharges in response to GABA-B receptor activation
Cacna1h
Mouse Human
KO Inherited
No seizures reported CAE
Chrna4
Mouse Mouse Mouse Human
KO KI Spontaneous deletion (Szt1) Inherited
No seizures reported Reduced threshold to nicotine induced seizures Low electroconvulsive threshold Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE)
Chrna5
Mouse Mouse
KO KO
Shorter latency time to induced seizures Resistant to nicotine-induced seizures
Chrnb2
Mouse Human
KO Inherited
No seizures reported Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE)
Chrnb4
Mouse Mouse
KO KO
No seizures reported Resistant to nicotine-induced seizures
Clcn2
Mouse Human
KO Inherited
Abnormalities of eye and testis Multiple seizure types (CAE, JAE, JME, EGMA)
Gabbr1
Mouse Mouse
KO (gene trap) KO
Mouse
KO
Homozygotes are neonatal lethal Spontaneous seizures (clonic, tonic-clonic, absence), hyperalgesia, memory impairment. Growth retardation, generalized epilepsy, premature death
Gabra1
Mouse Mouse
KO KI
Human
Inherited
Gabrb3
Mouse Mouse Mouse Human
KO KI Spontaneous (cleft palate, Cp1) Rearrangements of 15q11-q13
Human
Inherited
Myoclonus and occasional epileptic seizures; cleft palate Reduced sensitivity to some anesthetics Cleft palate Angelman syndrome (AS) and Prader-Willi syndrome (PWS)-associated seizures Chronic insomnia
Gabrg2
Mouse Mouse Mouse Human Human
KO (partial) KO KO (conditional) Inherited Inherited
No seizures reported Perinatal lethality Epilepsy, lethality around 4 wk Generalized epilepsy with febrile seizures plus (GEFS+) CAE; FS
Gad2
Mouse Mouse Mouse
KO KO KO
Spontaneous seizures (genetic strain-dependent), increased mortality Spontaneous seizures, increased mortality No spontaneous seizures, but seizures more easily induced by PTZ, picrotoxin
Mutation type
No seizures reported No spontaneous seizures but diazepam was less effective against PTZinduced tonic convulsions in mutants Juvenile myoclonic epilepsy
(continues)
TABLE 1 (continued) Gene symbol
Speciesa
Mutation type
Phenotype or syndromeb
Glra1
Mouse Mouse Mouse Human
KI Spontaneous (spasmodic, spd) Spontaneous (oscillator, spd-ot) Inherited
Seizures and lethality by 3 wk; hyperekplexia Tremors, stiff posture, difficulty in righting Seizures and early death Hyperekplexia; no seizures reported
Gria2
Mouse Mouse Mouse
KO KI KI; disruption of intronic mRNA editing site
No seizures reported No seizures reported Seizures; premature lethality
Hcn2
Mouse
KO
Spontaneous absence seizures
Htr2c
Mouse
KO
Spontaneous death from seizures; susceptible to audiogenic seizures
Kcna1
Mouse Mouse
KO KI
Mouse Human Human
Spontaneous (mceph) Inherited Inherited
Homozygotes viable; frequent spontaneous seizures through adult life Homozygous lethality; higher frequency of spontaneous IPSCs in heterozygotes Megencephaly; recurrent behavioral seizures Episodic ataxia/myokymia syndrome; no seizures reported; normal EEG Tonic-clonic and simple partial seizures with myokymia and no ataxia
Kcnc2
Mouse
KO
Spontaneous tonic-clonic convulsions
Kcnj6
Mouse Mouse
KO Spontaneous (weaver, wv)
Spontaneous and stress-induced seizures; reduced threshold to PTZ Spontaneous seizures
Kcnj11
Mouse Human
KO Inherited
No seizures reported. Failure of insulin secretion in response to glucose Persistent hyperinsulinemic hypoglycemia of infancy (PHHI); occasional seizures
Kcnn2
Mouse
Viral transgene
Kcnn2 (SK2) protected neurons against excitotoxic insult
Kcnq2
Mouse
KO
Mouse Mouse Human
Spontaneous deletion (Szt1) Conditional dominant-negative Kcnq2 transgene Inherited
Homozygous lethality; heterozygotes show decreased PTZ seizure threshold Low electroconvulsive threshold Spontaneous seizures, behavioral hyperactivity and morphologic changes in the hippocampus Benign familial neonatal convulsions (BFNC)
Scn1b
Mouse Human
KO Inherited
Spontaneous generalized seizures Generalized epilepsy with febrile seizures plus (GEFS+)
Scn2a
Mouse Mouse Human Human Human
KO Transgenic Inherited Inherited Deletion including SCN1A and SCN2A
Perinatal lethal; no seizures reported Spontaneous seizures Generalized epilepsy with febrile seizures plus (GEFS+) Benign familial neonatal-infantile seizures (BFNIS) Severe epilepsy, retardation, and dysmorphic features
Scn2b
Mouse
KO
Increased susceptibility to pilocarpine-induced seizures
Slc2a1
Mouse
Antisense transgene
Rat Human Human
Viral transgene Inherited Inherited
No seizures reported; growth retardation and developmental malformations Protection against kainic acid seizure-induced neuron loss Infantile seizures, acquired microcephaly, developmental delay Mild to severe seizures, developmental delay, ataxia
Slc9a1
Mouse Mouse
K.O. Spontaneous (slow-wave epilepsy, swe)
Unspecified seizures 3-Hz absence seizures; tonic-clonic seizures
Slc12a5
Mouse
KO
Mouse
KO
No seizures reported; homozygotes mutants died immediately after birth due to severe motor and respiratory deficits Frequent seizures, death between P7–P17; heterozygotes show increased susceptibility for PTZ-induced seizures
Mouse
Deletion [Df(11)17] or duplication [Dp(11)17] of the mouse SMS region
Smith-Magenis syndrome (SMS)
a
Df(11)17/+ mice exhibit seizures, obesity, craniofacial abnormalities, male-specific reduced fertility. Dp(11)17/+ animals are underweight, and have no seizures, craniofacial defects, or reduced fertility.
The corresponding spontaneous mouse and human mutations are listed if known. Data are taken from the following databases, which contain full literature references: Mouse Genome Informatics (MGI) at The Jackson Laboratory (URL: http://www.jax.org/), and Online Mendelian Inheritance in Man (OMIM) and LocusLink/Entrez Gene at the National Center for Biotechnology Information (NCBI) (http://www.ncbi.nlm.nih.gov/). CAE, childhood absence epilepsy; EGMA, epilepsy with grand mal seizures on awakening; FS, febrile seizures; JAE, juvenile absence epilepsy; JME, juvenile myoclonic epilepsy; KO, gene “knockout” (generally refers to a functionally null allele); KI, gene “knock-in” (generally refers to an incompletely inactivated allele); PTZ, pentylenetetrazol. b
208
Chapter 16/Transgenic and Gene Replacement Models of Epilepsy
altered regulation of endogenous ion channel genes within the CNS secondary to expression of the Aplysia K+ channel transgene, which could explain the phenotype. This study provides an excellent example of how brain plasticity can complicate a transgene-based approach to studying ion channel gene effects in the brain. Scn2a In 2001 Kearney et al. developed three transgenic mouse lines with a neuron-specific enolase promoter driving overexpression of a mutant rat brain sodium channel (Scn2a; NaV1.2). The three-amino-acid substitution (879–881 GAL>QQQ) was not based on any spontaneous human or mouse epilepsy mutation but was originally generated for use in basic structure-function studies, where the mutation resulted in slowed channel inactivation and increased persistent Na+ current when expressed in Xenopus oocytes. These channel properties would be predicted to cause a gainof-function hyperexcitability phenotype if expressed in mouse neurons. The transgenic mice did exhibit seizures beginning at 2 months of age. Clinically the seizures were characterized by a combination of behavioral arrest and repetitive behaviors. EEG monitoring detected focal seizure activity in the hippocampus, which sometimes generalized to involve the cortex. Hippocampal CA1 neurons isolated from presymptomatic transgenic mice showed increased persistent sodium current. Seizure onset was followed morphologically by progressive cell loss and gliosis within CA1, CA2, CA3, and hilar regions. Four independent transgenic lines expressing the wild-type sodium channel, an important control for such studies, did not exhibit any such abnormalities. It is relevant to note that mutations in the Scn2a gene have been associated with epilepsy in humans (Heron et al., 2002; Pereira et al., 2004), but a functionally null knockout of the endogenous Scn2a gene in mice results in perinatal lethality (with no seizures reported) (Planells-Cases et al., 2000).
the mutant Kcnq2 protein (which retained the ability to bind other channel subunits but was otherwise dysfunctional) interfered with the production of normal M-channels. Depending on when the transgene was expressed, the transgenic mice exhibited seizures, hyperactivity, cognitive deficits, or changes in brain morphology. The creative approach used in this study to examine the role of Kcnq2 in brain development and function demonstrates that transgenes can be used in certain circumstances to produce loss-of-function, or hypomorph, phenotypes through the dominant-negative suppression of endogenous proteins. Furthermore, the use of transgenes for this purpose can be implemented much more quickly and cost-effectively than production of a gene replacement model using homologous recombination approaches.
Limitations and Pitfalls Transgene Lethality The expression of a particular transgene might result in the death of the transgenic animals. Depending on the pathophysiologic insult, this lethality could occur at any age and could be dose dependent. This pitfall may be unavoidable if the hypothesis being addressed requires overexpression of this transgene at a certain level or in a certain cell type. Chimeric Founders Occasionally an F0 (founder) pup will be born “chimeric” for the transgene and carry it in some cells but not others. This phenomenon occurs when the microinjected transgene remains in the zygotic nucleoplasm and does not insert into a chromosome until after one or more cell divisions have occurred. To verify that a mouse carries the transgene in every cell, it is necessary to cross the F0 animal with a wild-type mouse. All the transgenic offspring from this cross (the number should be 50%) will be transgenic in their germline.
Kcnq2 Mutations in human KCNQ2, which coassembles with KCNQ3 to produce the neuronal M-type K+ current, result in benign familial neonatal convulsions (BFNCs). Complete inactivation of the mouse Kcnq2 gene by gene replacement results in perinatal lethality (Watanabe et al., 2000), which makes functional analysis of this gene impossible in older animals. In 2005 Peters and colleagues created transgenic mice that conditionally expressed—using the inducible TetOff promoter system—dominant-negative mutant Kcnq2 subunits in the brain (Backman et al., 2004). These mice survived early postnatal development, during which time the endogenous Kcnq2 genes were free to function normally. When expression of the transgene was turned on in later life,
Insertional Mutation The insertion of transgene DNA at random into the genome can cause an unintended loss of function if it interrupts or disturbs the expression of an endogenous gene. This is believed to occur in as many as 5% of all transgenic lines (Meisler, 1992). The potential phenotype produced by this insertional mutation is unpredictable, but it can clearly interfere with interpretation of any phenotype produced by expression of the transgene itself. This pitfall can best be avoided through comparative analysis of multiple independent transgenic lines (≥3) containing the same construct.
Gene Replacement (Knockout) Approaches to Modeling Epilepsy
209
Insertion Site and Copy Number Variability
Transgene Instability
The phenotype may vary considerably among multiple independent transgenic lines produced with the same construct as a result of differences in the level or site of transgene expression. Differences in expression levels among transgenic lines are likely due to either transgene copy number variation (transgenes seldom insert as a single copy; rather, they tend to concatemerize before integration as an array) or are due to insertion site variability (i.e., positiondependent expression). Insertion site variability is believed to occur when transgenes insert near a strong gene enhancer (possibly a component of a nearby gene) that overrides the transgene’s own promoter and alters the transgene levels or site of expression. Insertion site variability could also be caused by insertion of a transgene into a site that is transcriptionally suppressed as a result of the general chromatin structure of the region. These pitfalls may be minimized by analyzing multiple transgenic lines for each construct or by designing transgenes flanked by insulator elements (SARs).
Transgenes are exogenous fragments of DNA introduced into the genome at random sites. They may also be quite large, especially when concatemerized into a high copynumber tandem array. Furthermore, when maintained in the hemizygous state, there is no balancing transgene on the paired chromosome during meiosis. This situation may cause the transgene to become unstable and rearrange, perhaps progressively to lose copy number either within somatic cells of an individual animal or in the germline from generation to generation. As a direct result the phenotype of transgenic mice could vary from animal to animal. To monitor for instability, DNA from transgenic individuals, especially those from progressive generations, should be sampled occasionally by Southern blot analysis to determine whether the transgene copy number or the restriction pattern exhibits any variability compared with DNA from the original founder animal.
GENE REPLACEMENT (KNOCKOUT) APPROACHES TO MODELING EPILEPSY Multiple Insertion Sites Although transgenes usually concatemerize and insert into a single site in the genome of the founder zygote as a transgene array, occasionally two or more independent insertions occur. When such a founder animal is bred, the transgene arrays assort independently (as long as the insertions are unlinked on different chromosomes), and the resulting progeny may inherit zero, one, or more of the transgene arrays. To detect this event, Southern blot analysis should be conducted on tail DNA from all the offspring of the founder to see whether the restriction pattern or copy number varies. PCR, which is usually used to identify transgene-carrying animals, will not distinguish between different arrays at different insertion sites.
Gender-Dependent Transgenes In some instances either transgene inheritance or transgene expression is gender dependent. In the first case, the transgene may insert into the Y chromosome and therefore be carried only by males. This may limit subsequent analysis in some cases, depending on the purpose of the study. In the second case, a transgene may be carried on an autosome but only be expressed in some of the heterozygous transgenic animals. One possible explanation for this pattern is the phenomenon of “imprinting,” in which a gene will be expressed if it is inherited from the paternal side and suppressed if inherited from the maternal side or vice-versa. Imprinting of transgenes is rarely observed, but it does occur (Surani, 1991).
The Basic Concept Whereas transgenesis introduces extra copies of a gene into the mouse germline, gene knockout strategies (also known as gene replacement) alter the mouse’s endogenous genes. Because a transgenic mouse always carries at least two functioning copies of each gene, transgenic approaches are generally limited to producing gain-of-function phenotypes (however, see preceding discussion for an example of “dominant negative” loss of function). Gene replacement, on the other hand, can be employed to study either gain-offunction or loss-of-function phenotypes. It is therefore a more versatile technique, albeit more expensive and time consuming. Gene replacement was developed beginning in the late 1980s (Capecchi, 1989a, 1989b), and technical improvements continue. The basic concept is that a piece of DNA, when introduced into a cell nucleus, will find its matching sequence in the host genome and “trade places” through a mechanism called homologous recombination. As a result, researchers are able to replace a specific target gene with a completely inactive copy (i.e., a “knockout”) or perhaps a more subtly mutated version and study the resulting phenotype. In a conventional gene knockout, one or both alleles are replaced, and the alterations are present in every cell of the organism from the very beginning of embryonic development. As a result many gene knockouts produce lethal phenotypes that provide little information on gene function. A recent improvement of the method is the “conditional” (or inducible) knockout. When this technique is used, the replaced allele functions normally, but small DNA elements are left in place that allow the gene to be
210
Chapter 16/Transgenic and Gene Replacement Models of Epilepsy
inactivated at a later stage, or in a subset of cell types, at a time and place determined by the researcher. Thus a gene that would have produced a lethal phenotype if knocked out from the single-cell stage can be left intact; the animal is born and matures normally, and only then is the gene knocked out (perhaps only in a single tissue type) to study the phenotype.
1
Methods The basic approach for mouse gene replacement to create a functionally null mutant allele is outlined in Figure 4. The first step is to define the genomic target (including the intron/exon organization) and to identify some part of the gene that is critical for gene function. This may include an
3
2
4 Genomic Target
Homology Arm 1
1.
Homology Arm 2
2r neo
2
tk
Targeting Plasmid
Embryonic Stem (ES) cells
2.
3.
4. 2
neo r
tk
1
Incorrect Genomic Targeting
2
neo r
7.
tk
2
neo r
2
3
tk
4
Correct Genomic Targeting
1
6.
2
neo r
4
Blastocyst
5.
FIGURE 4 Construction of a gene replacement mouse model. A basic gene replacement construct consists of two genomic homology arms (~1–5 kb) derived from sequences flanking the exon to be deleted (1), an intervening marker (e.g., neomycin resistance, neor) for positive selection in embryonic stem (ES) cell culture, and a distal marker (e.g., thymidine kinase, TK) for negative selection in ES cells. The construct is transfected into ES cells, and the cells are grown in media containing neomycin (positive selection) and gancyclovir (negative selection). Cells with random insertions (3) retain both the neor marker and the TK marker and are killed by the conversion of gancylovir to a toxic product by TK. Correct homologous recombinants (4) retain the neor marker but lose the TK marker and thus survive the selection. Clones with correctly targeted genes are injected into donor blastocysts (5), which are then implanted into surrogates to give birth to mice chimeric for the mutation. The chimeric mice are bred to produce mice carrying the mutation in their germline.
Gene Replacement (Knockout) Approaches to Modeling Epilepsy
enzymatic active site, an ion channel pore-forming region, the DNA-binding region of a transcription factor, among others. In some cases, the promoter can be targeted to disrupt gene function; however, because cryptic promoters may be present that can take over and drive expression even after the core promoter is deleted, protein coding regions of genes are generally considered better targets. Next a gene replacement plasmid is constructed that contains four basic elements: a 5¢ homology arm, a 3¢ homology arm, a positive selection cassette, and a negative selection cassette. The homology arms, which are the critical component regulating homologous recombination, flank the exon(s) targeted for deletion. The size of these arms may vary, but both are usually larger than 1 kilobase (kb). A typical construct might contain one arm that is 1 kb long and the other of 3 to 5 kb long. Larger homology arms may not improve targeting efficiency appreciably, but it may be helpful to select arms that do not contain repetitive elements such as L1, B1, or B2 retrotransposons. Homology arms may contain exons or other functional elements in the gene that are not targeted for deletion. It is arguable whether or not the DNA cloned into the targeting construct should be isogenic with the strain of embryonic stem cell line, but this may improve efficiency. The selection cassettes are meant to function in cultured embryonic stem cells and usually consist of a strong, ubiquitous promoter, such as the phosphoglycerate kinase (PGK) or herpes simplex virus (HSV) promoter, driving expression of the selectable marker. The purpose of both markers is to allow identification of embryonic stem cell clones that have undergone successful homologous recombination. The positive selection marker (usually the neomycin resistance gene, neor) allows for survival of embryonic stem cells that have integrated the targeting construct (by either homologous or nonhomologous recombination) when the cells are grown in media containing neomycin, or G418. The positive selection marker is cloned between the two homology arms. The negative selection marker enriches for embryonic stem cells that have incorporated the targeting construct by homologous recombination, and it eliminates those that integrated the targeting construct by random, nonhomologous insertion. A common negative selection marker is thymidine kinase (TK), which converts gancyclovir added to the embryonic stem cell culture medium into a toxic product. The negative selection marker is cloned at one end of the targeting vector. On random, nonhomologous insertion (like a typical transgene), the entire vector is inserted, including both the neor and TK selectable markers. In cells that have undergone homologous recombination, only the positive selection marker (neor) is inserted; the negative selection marker (TK) lies outside the region of homology and does not integrate into the chromosome. Many investigators, however, do not use negative selection cassettes in their targeting construct, arguing that it does not significantly
211
increase the percent of embryonic stem cell clones that are accurately targeted. The gene replacement plasmid is transfected into embryonic stem cells by electroporation or lipofection, and (in our example) the cells are selected in media containing G418 (positive selection) and gancyclovir (negative selection). Genetically altered mice can exhibit variable phenotypes as a result of differences in genetic background, and this feature is partly controlled by the choice of embryonic stem cell strain. Historically most mouse strains proved refractory to the derivation of embryonic stem cell lines (Gardner and Brook, 1997), and investigators were limited to using only one or two strains, such as 129/SvJ or C57BL/6J. However, recent advances in cell culture technology are overcoming the biological barriers and permitting the efficient derivation of embryonic stem cell lines from additional mouse strains (Schoonjans et al., 2003). Following selection, the genomic DNA of surviving targeted ES cell clones is tested by PCR or Southern blot analysis to verify that the correct homologous recombination event has occurred. This assay is a critical step; sometimes only a small fraction of clones (<5%) will be accurately targeted even though those cells survived the selection process. Some investigators perform a karyotype analysis of targeted clones to identify chromosomal rearrangements or polyploidy-aneuploidy events that may have occurred in culture. Correctly targeted embryonic stem cells are microinjected into normal donor mouse blastocysts, where they mix with the population of normal embryonic stem cells that constitute the inner cell mass of the early embryo. The injected blastocysts are implanted into surrogate females, where they implant in the uterus and develop until birth about 18 to 20 days later. These mice will be chimeric; that is, their bodies will be composed of a mixture of cells derived from the targeted embryonic stem cells and from the normal recipient blastocyst. Usually the targeted embryonic stem cells and the recipient blastocysts are derived from mouse strains with different coat colors so that when the chimeric mice are born, they are visibly chimeric (e.g., black and white patched coats). These chimeric mice may or may not show a phenotype, depending on the function of the targeted gene, whether or not it acts in a cell-autonomous fashion, the overall percentage of cells in the chimeric animal that are targeted, and which tissues these cells constitute. It is also important to remember that the targeted cells in a chimeric animal are heterozygous for the mutation. However, methods do exist to knockout both alleles of a gene during the embryonic stem cell culture phase, utilizing two different positive selection markers and a sequential transfection-selection approach so that targeted cells in the chimeric mice are homozygous for the mutation. The chimeric mice are then bred with wild-type mice. For those chimeras where the targeted embryonic stem cells had populated the germ tissue, 50% of the offspring will be
212
Chapter 16/Transgenic and Gene Replacement Models of Epilepsy
heterozygous for the mutation in every cell. These heterozygotes are then bred to produce wild-type offspring that are heterozygous for the targeted alteration or homozygous for the alteration (with a 1 : 2 : 1 ratio). Alterations from this ratio might be observed if the targeted gene affects prenatal viability. Variations of the Basic Gene Replacement Strategy Numerous variations of the basic gene replacement strategy have been developed to add efficiency, flexibility, and power to the approach (Figure 5). Many of these rely on use of the Cre-loxP or flipase-frt site-specific recombinase (SSR) systems. SSRs are enzymes that recognize specific DNA sequence motifs and recombine the DNA between them. If two recombinase recognition sites are placed on the same DNA strand in the same orientation, the recombinase will delete the sequences between them. If the sites are oriented in the opposite directions, the recombinase will invert the sequences between them. The distance between the two recognition sites may be very short (<100 base pairs [bp]) or very large (>100 kb). If the sites are placed on different DNA fragments, even on different chromosomes, the recombinase will mediate a translocation event. Cre recombinase is a native component of the P1 bacteriophage, while Flp recombinase (flipase) was isolated from Saccharomyces cerevisiae (yeast). The Cre and Flp recombinases recognize 34-bp target sites, called loxP and frt, respectively. Their small size allows loxP and frt sites to be placed into a gene intron, promoter, or untranslated region without noticeably disrupting gene function. One use of the SSR system is to create an excisable selection cassette (see Figure 5). The presence of a positive selection marker (e.g., neor) is required for selection in embryonic stem cells, but is often undesirable after the knockout is established. If the selection cassette is flanked by loxP sites, it can be deleted (after a viable targeted embryonic stem cell clone is identified but before they are injected into blastocysts) by the transient expression of Cre recombinase in those cells. All that remains at the site formerly occupied by the selection marker is one copy of the 34-bp recognition site. Another important use for an SSR system is to produce a gene knock-in. With a knockout, the goal is to obliterate gene function completely, so it is largely irrelevant whether large fragments of foreign DNA are incorporated into the locus in the homologous recombination process. However, in a gene knock-in, the goal is to replace an endogenous exon with a mutant version of the same exon and to allow the gene to continue to function so that the effect of that mutation on protein expression can be assessed. In this case removal of the positive selection cassette is absolutely critical because even if it is located in an intron, it will significantly disrupt either or both expression and splicing patterns of the gene. Positioned correctly, so as not to inter-
fere with intronic enhancer elements or splicing donor or acceptor sites, the residual 34-bp recognition motif should not interfere with gene function. One benefit of producing a knock-in construct is that once a correctly targeted embryonic stem cell clone is identified, it can be used to produce both a mild knock-in and a severe knockout allele by either expressing Cre or not before injection of the cells into blastocysts. The SSR systems can also be used to create inducible (i.e., “conditional”) gene knockout models. The goal with an inducible knockout is to produce a targeted allele where a critical exon(s) is flanked by two loxP (or frt) recognition sites that do not interfere with normal gene function. This requires a much more complicated series of manipulations than necessary for a basic gene replacement, including the employment of two distinct SSR systems. First a targeted allele must be produced and the selectable marker removed (e.g., using the flipase-frt system) while the targeted exon remains intact but flanked with different SSR recognition sites (e.g., loxP sites). These embryonic stem cells are microinjected to produce a mouse with a normally functioning, but silently targeted, allele. A gene with two loxP sites in place, waiting to be recombined to delete an exon, is said to be floxed. A floxed gene can be disrupted, or “turned off,” by later expressing the second recombinase (e.g., Cre) in the mouse. The power of the inducible knockout is that the Cre can be expressed in only some of the cells of the floxed mouse, or only at a specific stage of development, if desired. There are two general strategies to express Cre in a floxed mouse: either as a transgene or, less commonly, as delivered by a viral vector. In either case, the approach is limited only by the availability of well-characterized tissue-specific promoters that can be used to drive Cre expression. Alternatively Cre can be expressed under the control of an inducible promoter, such as the tetracycline-inducible promoter described previously, to add an additional level of spatiotemporal control over recombination of the floxed gene. One of the drawbacks of conditional knockouts is that 100% recombination of the targeted gene is rarely achieved (depending on what method or promoter is used to drive Cre expression), but the levels achieved are usually acceptable for most purposes. Additional resources on the theory and method of gene replacement, including detailed protocols, include the following: Joyner (2000), Turksen (2001), Tymms and Kola (2001), and Nagy et al. (2002).
Examples As of this writing, 26 genes encoding ion channels, transporters, or other critical components of neurotransmission pathways have been altered by gene replacement in the mouse (see Table 1). Of these, spontaneous seizures were reported in 15 cases, a reduced threshold to chemically or
213
Gene Replacement (Knockout) Approaches to Modeling Epilepsy
Genomic target
Basic knock-out
exon
exon
exon
1
2
3
a.
a.
1
b.
1
Arm 2
TK
neo r
1
Arm 1
Excisable selection cassette
neo r
Arm 1
3
loxP neo r loxP
loxP
Arm 2
TK
neo r loxP
3
loxP
3
* Arm 1
Knock-in
loxP neo r loxP
Arm 2
TK
*
a.
1
2
b.
1
loxP neo r loxP
3
2
loxP
3
loxP
2
loxP
frt
neo r
frt
neo r
frt
*
Arm 1
Inducible knock-out
2
Arm 2 TK
a.
1
loxP
2
loxP
frt
b.
1
loxP
2
loxP
frt
3
c.
1
loxP
frt
3
3
FIGURE 5 Alternative gene replacement designs. The use of site-specific recombination (SSR) systems (gray arrows) permits useful modifications to the basic knockout construct design. An excisable selection cassette flanked by 34-bp loxP sites allows added Cre recombinase to delete the marker after positive selection in ES cells but before introduction into mice, thus preventing read-through transcription by the selectable marker promoter from transcribing downstream gene elements or interfering with the expression of neighboring genes. A knock-in is similar, but it replaces an endogenous exon with a mutant exon (asterisk), leaving only a single 34-bp loxP recognition site within an intron. Rather than obliterating gene function completely, a gene knock-in allows the gene to continue expressing in a normal pattern and thus allows for analysis of more subtle or gain-of-function mutations. An inducible, or conditional, knockout utilizes two different SSR systems (e.g., Cre-loxP and flipase-frt) to allow the targeted allele to function normally (b) until the investigator decides to induce deletion of the “floxed” exon (c). This permits mutations that would normally result in embryonic lethality to be studied in adult mice or limits the mutation to a specific subset of cells. The diagonal lines represent recombination events; a, b, and c represent sequential steps in the modification of targeting constructs following homologous recombination in embryonic stem cells.
214
Chapter 16/Transgenic and Gene Replacement Models of Epilepsy
audiogenically induced seizures in 6 cases, and increased resistance to induced seizures in 2 cases. A mouse model of Smith-Magenis syndrome (SMS), which relied on gene replacement to alter an entire chromosome region rather than just a single gene, also exhibited spontaneous seizures (Walz et al., 2003). In some mutated strains, the seizure or excitability phenotype was not investigated (or at least not reported), presumably because the model was generated for purposes other than epilepsy research. In other cases, independent models were created by targeting the same gene; in these cases differences in targeting strategies, mouse genetic strains, or subsequent methods of analyses led to discordant reported phenotypes. Finally, in some cases the mouse phenotype was similar (i.e., obviously relevant) to the clinical phenotype of human epilepsy patients carrying mutations in the same gene; in other cases, there was no apparent correspondence between the mouse and human phenotypes. A few of these cases are considered in greater detail to illustrate particular points regarding the development and analysis of mouse gene replacement models of epilepsy: Cacna1a Spontaneous mutations in the voltage-gated Ca2+ gene, Cacna1a, are responsible for a phenotype that includes ataxia and generalized absence-like seizures (Fletcher et al., 1996) as well as an altered threshold for cortical spreading depression (Ayata et al., 2000) in the tottering mouse. A functionally null knockout of mouse Cacna1a also produces ataxia and absence-like seizures but results in lethality by postnatal day 30. Mutations in human Cacna1a are associated with several distinct disorders, including familial hemiplegic migraine (FHM), episodic ataxia type 2 (EA-2), and spinocerebellar ataxia type 6 (SCA-6) (Ophoff et al., 1996; Zhuchenko et al., 1997). Given these phenotypes, the spontaneous and knockout mutations in mouse Cacna1a originally appeared to be more accurate models of human ataxia and FHM caused by mutations in this gene. Recently, however, Jouvenceau et al. (2001) and Imbrici et al. (2004) identified human mutations that were associated with inherited ataxia plus primary generalized epilepsy. Thus Cacna1a provides an example of a mouse model of epilepsy where the complex phenotype (ataxia plus seizures) corresponds to only a small subset of human patients with mutations in this gene. Cacna1g Synchronized thalamocortical spike-wave discharges are a basic pathophysiologic finding in absence epilepsy and are believed to depend strongly on the activity of the lowvoltage-activated T-type Ca2+ channel. Three genes can encode a pore-forming alpha subunit capable of mediating T-type Ca2+ currents: Cacna1g, Cacna1h, and Cacna1i. To
examine the role of one of these genes in absence seizures, Kim et al. (2001) inactivated mouse Cacna1g by gene replacement. These authors reported a lack of burst firing by thalamocortical relay neurons and resistance to the generation of spike-and-wave discharges in response to GABAB receptor activation. Subsequent analysis of double-mutant mice (Cacna1g -/- and Cacna1a -/-) extended these findings to show a complete loss of T-type Ca2+ currents in thalamocortical neurons and no evidence of the spike-wave discharges seen in Cacna1a single-mutant mice. Mutations in human Cacna1g have not yet been identified. Whereas the Cacna1g knockout mouse cannot be considered a model of epilepsy in the strictest sense (because it does not exhibit spontaneous seizures), it nonetheless demonstrates the importance of the a1G T-type Ca2+ channel for mediating absence seizures in the thalamocortical pathway and the value of the gene replacement approach for elucidating seizure mechanisms. Clcn2 Haug et al. (2003) reported mutations in the human voltage-dependent Cl- channel gene CLCN2 in patients with a variety of seizure types, including childhood absence epilepsy (CAE), juvenile absence epilepsy (JAE), juvenile myoclonic epilepsy (JME), and epilepsy with grand mal seizures on awakening (EGMA). Bosl et al. (2001) previously described the phenotype of mice with targeted inactivation of the Clcn2 gene but reported the conspicuous absence of expected seizures. Instead, Clcn2-null mice exhibited a severe degeneration of cells in the retina and testes, suggesting a possible role for Clcn2 in controlling the ionic environment of these cells. The basis for this dramatic interspecies difference in mutant phenotypes is unclear. Gabbr1, Gabra1, Gabrb3, Gabrg2 Genes encoding subunits of the ionotropic GABAA receptors and metabotropic GABAB receptors are excellent candidates for involvement in epilepsy, given the central role of GABA in mediating inhibition in brain. Mutations in two of these genes have been associated with epilepsy in humans: GABRA1 with juvenile myoclonic epilepsy (Cossette et al., 2002), and GABRG2 with generalized epilepsy with febrile seizures plus (GEFS+), childhood absence epilepsy, and febrile seizures (Baulac et al., 2001; Wallace et al., 2001). Mice carrying knockouts in these genes and two other GABA receptor genes (Gabbr1 and Gabrb3) have been produced. Null mutations in Gabbr1 resulted in spontaneous clonic, tonic-clonic, and absence seizures as well as hyperalgesia, memory impairment and premature death (Prosser et al., 2001; Schuler et al., 2001). Seizures were not reported to result from inactivation of Gabra1 (Sur et al., 2001; Vicini et al., 2001). A knockout of Gabrb3 caused fre-
Gene Replacement (Knockout) Approaches to Modeling Epilepsy
quent myoclonus and occasional epileptic seizures in addition to cleft palate (Homanics et al., 1997). It is possible that the Gabrb3-null mouse seizures are a model of the seizures observed in some Angelman and Prader-Willi syndrome patients because this gene is contained within the region (15q11–q13) affected by the large deletions and translocations that are associated with these two syndromes (Dooley et al., 1981; Veenema et al., 1984; Wagstaff et al., 1991). However, mutations in human GABRB3 were also recently found in patients with chronic insomnia (Buhr et al., 2002). Finally, a knockout mutation of mouse Gabrg2 was shown to result in perinatal lethality in one study (Gunther et al., 1995), but to cause epilepsy with lethality around 4 weeks in another (Schweizer et al., 2003). The reason for this age disparity in mortality between the two knockouts is unclear, but it might relate to differences in the genetic background of the mice. Gad2 No mutations in the human GAD2 (glutamate decarboxylase 2) gene have yet been associated with seizures, although this gene is believed to be critical for mediating inhibition in brain through production of the inhibitory neurotransmitter, GABA. Three knockout studies of mouse Gad2 have been reported. Interestingly, the phenotypes varied. In one case, the Gad2-null mice exhibited no spontaneous seizures, but seizures were more easily induced by PTZ or picrotoxin (Asada et al., 1996). In the other two studies, spontaneous seizures and increased mortality were observed (Kash et al., 1997; Yamamoto et al., 2004). Interestingly, Kash et al. (1997) reported that the seizures were genetic strain-dependent—which might explain the phenotypic variability observed in the different studies. Gria2 AMPA-type ionotropic glutamate receptors, composed of four related subunits (GRIA1-4) in various combinations, mediate the fast component of excitatory postsynaptic currents in CNS neurons. Inclusion of the GRIA2 subunit in AMPA receptors decreases Ca2+ permeability significantly (Hollmann et al., 1991). The human and mouse GRIA2 genes both undergo functionally important mRNA editing at a site corresponding to the second transmembrane domain of the receptor. No human mutations in GRIA2 have yet been associated with epilepsy and, consistent with this, both knock-out and knock-in mutations of mouse Gria2 protein coding sequences do not result in seizure phenotypes (Jia et al., 1996; Kask et al., 1998; Sans et al., 2003). Interestingly, a knock-in mutation that alters the intronic mRNA editing site of Gria2 resulted in seizures and early lethality (Brusa et al., 1995; Feldmeyer et al., 1999). This example demonstrates a potential role for mRNA editing in epilepsy, and shows that gene replacement approaches can be useful for
215
studying non-coding gene regions as well as coding sequences. Kcna1 Mutations in human KCNA1 usually result in episodic ataxia-myokymia syndrome without any seizures or EEG abnormalities (Browne et al., 1994), but rare mutant alleles have been identified that result in tonic-clonic and simple partial seizures with myokymia and no ataxia (Eunson et al., 2000). A spontaneous mutation in mouse Kcna1 is associated with megencephaly and recurrent behavioral seizures (Donahue et al., 1996; Petersson et al., 2003). Complete inactivation of mouse Kcna1 via gene replacement resulted in frequent spontaneous seizures through adult life as well as abnormal axonal action potential conduction in peripheral nerve which may be related to the pathophysiology of episodic ataxia-myokymia (Smart et al., 1998). Kcnq2 The protein products of the KCNQ2 and KCNQ3 genes co-assemble into a channel to produce the M-type K+ current in neurons, a slowly activating and deactivating current important for regulating intrinsic membrane excitability and response to synaptic input. Mutation of either of these genes in humans results in benign familial neonatal convulsions (BFNC) (Biervert et al., 1998; Charlier et al., 1998; Singh et al., 1998). Complete inactivation of Kcnq2 by gene replacement in mice resulted in homozygous perinatal lethality. Mice heterozygous for the mutation did not exhibit spontaneous seizures but showed a decreased threshold for seizures induced by the convulsant PTZ (Watanabe et al., 2000). Peters et al. (2005) used a novel transgenic approach to conditionally suppress M-channels in mouse brain and demonstrated their function in neuronal excitability and behavior. In this way these investigators obtained information similar to what might have been obtained by a knockin mutation with incomplete loss of function but in only a fraction of the time. Scn1b, Scn2a, Scn2b Mutations in human SCN1B are associated with generalized epilepsy with febrile seizures plus (GEFS+) (Wallace et al., 1998). A complete knock-out of the orthologous mouse gene, Scn1b, also results in spontaneous generalized seizures and should be a good model for studying the human disorder (Chen et al., 2004). Targeted inactivation of the closely related mouse Scn2b gene did not cause spontaneous seizures but did lead to increased susceptibility to pilocarpine-induced seizures (Chen et al., 2002). Mutations in human SCN2A are also associated with generalized epilepsy with febrile seizures plus (GEFS+) (Sugawara et al., 2001) but cause benign familial neonatal-infantile seizures
216
Chapter 16/Transgenic and Gene Replacement Models of Epilepsy
(BFNIS) in other cases (Heron et al., 2002). While a transgenic mouse overexpresing a mutant form of Scn2a does exhibit spontaneous seizures (Kearney et al., 2001), the functionally null knockout of Scn2a causes recessive perinatal lethality with no seizures reported (Planells-Cases et al., 2000). A wide variety of different human Na+ channel mutations have been reported, associated with a range of seizure phenotypes; it seems likely that these genes will continue to provide a rich source of mutations to be modeled by knock-in approaches in the future.
Limitations and Pitfalls
partial function or gain a novel function. A targeted allele might skip a deleted region by alternative pre-mRNA splicing, use alternative or cryptic promoters to produce a novel protein fragment, or transcribe straight through an inserted selection cassette (allowing initiation of translation from downstream start codons). Even a small protein fragment could retain the ability to interact with other proteins in the original pathway or multi-subunit complex and produce a dominant-negative effect. This pitfall can be minimized by careful initial design of the targeting construct and by post knockout screening for residual mRNA and protein products expressed from the targeted locus.
Expense and Time
Selection Cassette Interference
Gene knockout models are at least an order of magnitude more costly to produce, on average, than standard transgenic models. Much of this extra cost is due to the extensive embryonic stem cell culturing and analysis that must be carried out to produce a knockout model. Knockout models also require significantly more time to generate than transgenics. Hemizygous transgenic mice (the founder generation) can be born as few as about 20 days after the transgene construct is microinjected into donor zygotes. Knockout mice, on the other hand, typically require several months after the targeting construct is built just to obtain a clonal embryonic stem cell line with an appropriately targeted gene. The embryonic stem cells must then be microinjected into blastocysts and implanted into surrogate mothers to wait another 20 days before heterozygous chimeric mice can be born. These heterozygous chimeric mice must then be raised to breeding age and interbred at least once to produce homozygous germline mutants (total time from construct to mutant is 1 to 2 years).
The selection cassettes used in standard replacement-type constructs usually contain very strong promoters. Transcription from these promoters may lead to transcription of any remaining parts of a target gene or interference with the normal expression pattern of a neighboring gene and thus confuse interpretation of the experiment. The solution to this problem is to remove the selection cassette following confirmation of homologous recombination in embryonic stem cells using one of the available recombinase systems, such as CRE or FLP (see preceding discussion).
Genomic Redundancy and Cooperative Pathways One of the problems that complicates evaluation of mouse gene knockout phenotypes is the relatively common phenomenon of redundant or interacting genetic pathways (for an example of how this can occur in a mouse epilepsy model, see Burgess et al., 1999). Thus the absence of an abnormal phenotype in a knock-out mouse does not necessarily indicate that the targeted gene is not important for regulating neuronal excitability or synchronization. Elucidating its role might only be revealed by inactivating a compensating gene or gene pathway. Incomplete Inactivation When the goal of a gene knockout project is to obliterate gene function to create an epilepsy phenotype, but a targeting strategy cannot be designed that will completely delete all coding sequences of the target gene, the targeted allele might express a truncated form of the protein and thus retain
Disruption of Overlapping or Adjacent Genes The creation of a significant alteration in a target gene could also lead to the unintentional mutation of as yet unidentified genes, for example, genes residing in introns of the target gene or overlapping the target gene but encoded by the opposite strand. It is also conceivable that the target gene contains within its structure one or more regulatory elements important for controlling the expression of unrelated nearby genes. A related possibility is that any alteration in chromatin structure in a knocked-out gene, regardless of how minor, could be propagated to affect one or more adjacent genes. If any of these situations occurred, the resulting phenotype would not accurately reflect alterations in the target gene alone. A brief analysis of the expression function of adjacent genes is recommended to detect this potential problem.
ANALYZING MOUSE GENETIC EPILEPSY MODELS AND INTERPRETING PHENOTYPES Creating a mouse strain with a targeted alteration of one or more endogenous genes in its genome, or carrying an added transgene, is only the first step in the process of developing a seizure or epilepsy model. An exhaustive characterization of the phenotype must then be performed. Typically the first question asked is, Do the mice exhibit seizures? What is usually meant by this question, however, is, Do the
Analyzing Mouse Genetic Epilepsy Models and Interpreting Phenotypes
mice exhibit spontaneous seizures? This question is more difficult to answer than it might initially appear.
Spontaneous Versus Induced Seizures As a platform for launching investigations into the causes, pathophysiologies, and treatments of seizures and epilepsy, mouse models are typically placed into either of two categories: induced models or spontaneous models. Induced Models Mice carrying various mutations may have altered thresholds for seizure induction even if they do not exhibit spontaneous seizures. Depending on the specific stimulating paradigm, induced seizures may also lead to epilepsy (defined as recurrent unprovoked seizures) in which the seizures no longer occur only as an immediate and one-time response to the stimulus but instead persist long after the stimulus is applied (perhaps for the lifetime of the animal). In this case the brain structure and function presumably have been altered by the induction process or, secondarily, by the induced seizures themselves in a more significant and permanent way. Spontaneous Models Spontaneous seizures are often defined as “seizures that the investigator did not intentionally provoke,” a definition that applies equally well to the seizures of both spontaneously occurring mutants and gene-targeted strains of epileptic mice. However, because we do not yet really understand what triggers individual seizures in most cases (an exception being true “reflex seizures”), the word spontaneous is not especially informative. Largely because of the difficulty in precisely defining spontaneous seizures, there appear to be no clear biological criteria with which to separate mice with spontaneous seizures epilepsy from mice with induced seizures-epilepsy. As an alternative to a binary “spontaneous or induced” system of classification, a more realistic model postulates that all mice (strains of mice as well as individuals within a strain) exist along a continuum of high-to-low intrinsic seizure susceptibility (i.e., determined genetically) and that fluctuations in the internal or external environment of the animal are responsible for triggering seizures as well as determining seizure frequency and possibly modulating duration and severity (see Figure 1).
Analyses of Model Phenotypes The following outline offers some minimal analyses that should be performed to characterize a potential mouse seizure or epilepsy model.
217
Visual Observation Does the animal’s size and weight and other gross morphology appear normal compared with controls? Autopsy of a few heterozygous and homozygous animals should be performed to inspect internal organs for gross abnormalities. Does the mouse’s diurnal and nocturnal behavior appear normal? Are there any “spontaneous” behavioral seizures? Are there signs of lethargy or hyperactivity? Do the animals interact normally with littermates? Viability-Mortality and Fertility-Fecundity Do colony records indicate any change in average lifespan or number of offspring (compared with wild-type controls of the identical background strain)? Video Electroencephalography Behavioral convulsions and seizures and other abnormal motor activities do not always correlate with atypical electrical activity in brain, and abnormal electrical activity in brain does not always produce aberrant motor behaviors in the behaving animal. Video-EEG (V-EEG) should be performed to evaluate the correlation of behavioral and electrical phenotypes and allow spatiotemporal correlation of any behavioral and electrical activity. V-EEG should be carried out at different times of night and day and in mice of different ages and genders. When possible, depth electrodes should also be used to detect limited focal abnormalities. Seizure Thresholds In conjunction with visual observation and V-EEG, several methods can be used to determine whether a mouse has a lowered threshold for seizures, even when no spontaneous seizures are detected. These include testing the threshold for seizure activity (time to onset, duration, frequency, severity, and refractory period) after treatment with chemical convulsants (e.g., pilocarpine, kainic acid, pentylenetetrazole), electroconvulsive stimulation, physical handling, loud noises, and temperature extremes. Pathology The brain should be examined for major structural abnormalities (e.g., dysplasia, heterotopia) and changes in the onset and frequency of necrotic and apoptotic cell death. Are average cell counts normal for different brain regions? Is gliosis apparent? The microanatomy of various neuron populations should be examined and compared with normal controls. Is axonal sprouting evident? Are dendritic branching patterns normal? Are dendrites hyperspiny or hypospiny?
218
Chapter 16/Transgenic and Gene Replacement Models of Epilepsy
Electrophysiologic Analyses The electrophysiologic properties of cells expected to express the targeted defect should be analyzed by appropriate techniques. For example, if the model is a Ca2+ channel gene knockout in hippocampal CA1 neurons, studies should be carried to determine whether these neurons show abnormal Ca2+ currents, abnormal transmitter release, and other abnormalities. Genomic Analyses One form of molecular analysis that is becoming common is to screen for global changes in gene expression by hybridization to cDNA microarrays. A targeted mutation might result in no obvious seizure phenotype, but there may be evidence from gene expression studies that the genome of that organism is compensating by changing the expression of a few (or many) other genes. Such information can be very valuable for elucidating activity-dependent regulatory pathways that could lead to clues about seizure prevention. Genetic Analyses An attempt to create a mouse model of epilepsy by any form of genomic manipulation should not be considered a failure until the alteration is studied on the genetic background of several different mouse strains. From the very beginning, if possible, a targeted mutation or transgene should be bred onto at least two genetically distinct strains. It is quite clear that different mouse strains can have dramatically different seizure thresholds; a gene knockout on one strain may cause frequent seizures while the same mutation on a different strain could cause no obvious change in phenotype. Furthermore, a strain that is exquisitely sensitive to one kind of seizure (or seizure-induction method) is not necessarily the most sensitive to another method of seizure induction.
CURRENT MOUSE MODELS OF SEIZURE AND EPILEPSY TARGETING ION CHANNELS AND NEUROTRANSMISSION PATHWAYS A current summary of mouse models of seizures and epilepsy resulting from the targeting of genes for ion channels, transporters, and neurotransmission pathways is presented in Table 1. Several of the mutations in this table were discussed in more detail in preceding sections of this chapter. Thirty-three individual genes are represented as well as a large targeted mouse chromosomal rearrangement
associated with seizures (a model of SMS). The corresponding spontaneous mouse and human mutations are also listed, if they are known, for comparison. In some cases the mouse model appears to recapitulate faithfully a human seizure disorder caused by mutation of the orthologous gene (e.g., Scn1b), but in other cases it does not (e.g., Clcn2). Unfortunately, most mouse models shown belong to the latter category. As discussed previously, such results should not lead to dismissing that model out of hand but rather to studying it further, such as via introduction of a different mutation into that same mouse gene, selection of a different genetic strain background to carry the mutation, a change in the habitat-environment of the mouse, or more extensive phenotyping.
OUTSOURCING MOUSE MODEL PRODUCTION Maximizing Efficiency Two of the most important questions an investigator should ask before committing the significant resources needed to develop a mouse model are, Is the mouse I want to make already available? and Should I do some or all of the work in my own laboratory? The first question can be much more difficult to answer than it first appears. Although most scientists are familiar with the literature in their own areas of expertise and would probably be aware of a published model, many transgenic and gene knockout mice are in various stages of production in academic laboratories or have been commercially developed and not yet been publicized. Thus it is always a good idea first to contact prominent researchers in the field who might have heard that a mouse already exists, is being made, or is about to be published. Commercial mouse vendors can also be good sources of this information. A small amount of preliminary detective work could save months or years of bench work that otherwise would have been spent duplicating an existing resource. The second question is usually much easier to answer. Most laboratories that intend to develop a new animal model, including those focused on epilepsy research, are not at all equipped to carry out each of the steps involved in making either transgenic or gene replacement models. Typically the individual laboratory builds the transgene or genetargeting construct, which requires only the most basic molecular biology skills and equipment. The subsequent steps—microinjection into fertilized eggs (transgenics) or embryonic cell transfection-selection or microinjection into blastocysts (gene replacement)—are usually performed through either an academic core facility or a commercial animal production service.
219
References
Academic and Commercial Transgenic and Knockout Facilities Access to on-campus transgenic and knockout core facilities at most major research universities and medical centers provides a significant advantage to scientists who wish to create genetic animal disease models. These facilities usually provide staff that can assist researchers with designing transgene and knockout constructs, providing a wide range of vectors and protocols, engineering the constructs, creating the mice, genotyping and housing them, and arranging maintenance and test-breeding schemes (all for a fee). Many academic facilities will also provide at least some forfee services to investigators outside of the institution, which can prove an invaluable resource for small college laboratories and clinician-investigators associated with hospitals. Finally, several academic core facilities provide Internetbased learning resources and specific protocols that can help guide investigators through every technical aspect of mouse model development. A perusal of these diverse resources is highly recommended for anyone planning to work with transgenic or knockout mouse models, for example, the University of Michigan Transgenic Animal Model Core (URL: http://www.med.umich.edu/tamc/) and the Darwin Transgenic Mouse Core Facility at Baylor College of Medicine (URL: http://imgen.bcm.tmc.edu/dtmc/). Several commercial and nonprofit entities either sell existing mouse disease models or work with investigators to develop custom transgenic and gene knockout mice. A custom-made, conditional gene knockout can be made commercially from start to finish, but the prices are more than most academic researchers can afford. The world’s largest current supplier of different mouse strains, including transgenic mice, spontaneous mutants, and gene knockout mice, is The Jackson Laboratory, a nonprofit institution located in Bar Harbor, Maine. The Jackson Laboratory also maintains extensive public databases with information on practically every aspect of mouse genetics and bioinformatics. Other significant mouse model resources, several of which offer custom transgenic, gene knockout, and model development services, are Taconic, Harlan, Charles River Laboratories, Lexicon Genetics, B&K Universal Ltd, Xenogen, Deltagen, Ozgene, and Genoway.
phenotypes (Austin et al., 2004; Auwerx et al., 2004). Complementary projects will study the expression patterns of all these genes (Su et al., 2002; Zhang et al., 2004) and begin looking at the proteome produced after this genome is translated (Marcuset et al., 2004). From the phenotype and genotype starting lines, analyses of mechanistic pathways will proceed in both directions, each toward the other, and one day meet in the middle (Ashburner et al., 2000). If successful, epilepsy research will benefit tremendously. Of course, not everybody is enthusiastic about the prospects (or wisdom) of such grandiose biology projects (Accili, 2004; Huber, 2003). In the meantime, several techniques are emerging that will be of much more immediate use for facilitating the creation of novel mouse models of epilepsy. In particular the ongoing development of RNA-interference (RNAi) techniques promises to add a versatile tool to the kit of molecular biologists (Dykxhoorn et al., 2003; Novina and Sharp, 2004). RNAi is a form of posttranscriptional gene silencing that was originally recognized in plants but is now being discovered in a wide range of different organisms (Cogoni and Macino, 2000). Very briefly, expression of a small, doublestranded fragment of RNA (dsRNA), homologous to a target gene, is able to suppress the expression of that gene in that cell. Thus RNAi is similar in effect to a gene knockout by homologous recombination but with the following differences: (1) it is cheaper, (2) it is faster, (3) it is rapidly reversible, (4) it allows for the generation of a graded series of “knock-down” phenotypes rather than only an all-or-none knockout, and (5) multiple genes can be targeted simultaneously in the same animal. On the downside, RNAi will not permit evaluation of most gain-of-function mutations. Further, the methods for delivering the dsRNA payload to target cells in mammals are yet very crude, but these shortcomings seem to be minor in light of the tremendous advantages RNAi promises. The RNAi technique has already been applied to study seizure and epilepsy phenotypes in nonmammalian model organisms (Williams et al., 2004; Zhang et al., 2002), and extension of the methods to mouse and rat models is on the horizon (Hasuwa et al., 2002; Kunath et al., 2003; Kuwabara et al., 2004; Prawitt et al., 2004; Xia et al., 2004).
References SUMMARY AND FUTURE PROSPECTS The use of gene targeting (transgenesis, gene knock-outs and knock-ins) to generate mouse models of epilepsy is expanding rapidly. In the years ahead projects will be initiated that aim to generate a wide variety of mutant alleles for each of the estimated approximately 20,000 to 25,000 genes in the mouse genome and to measure all of the associated
Accili, D. 2004. A note of caution on the Knockout Mouse Project. Nat Genet 36: 1132. Asada, H., Kawamura, Y., Maruyama, K., Kume, H., Ding, R., Ji, F.Y., Kanbara, N. et al. 1996. Mice lacking the 65 kDa isoform of glutamic acid decarboxylase (GAD65) maintain normal levels of GAD67 and GABA in their brains but are susceptible to seizures. Biochem Biophys Res Commun 229: 891–895. Ashburner, M., Ball, C.A., Blake, J.A., Botstein, D., Butler, H., Cherry, J.M., Davis, A. et al. 2000. Gene ontology: tool for the unification of biology. Nat Genet 25: 25–29.
220
Chapter 16/Transgenic and Gene Replacement Models of Epilepsy
Austin, C.P., Battey, J.F., Bradley, A., Bucan, M., Capecchi, M., Collins, F.S., Dove, W.F. et al. 2004. The knockout mouse project. Nat Genet 36: 921–924. Auwerx, J., Avner, P., Baldock, R., Ballabio, A., Balling, R., Barbacid, M., Berns, A. et al. 2004. The European dimension for the mouse genome mutagenesis program. Nat Genet 36: 925–927. Ayata, C., Shimizu-Sasamata, M., Lo, E.H., Noebels, J.L., and Moskowitz, M.A. 2000. Impaired neurotransmitter release and elevated threshold for cortical spreading depression in mice with mutations in the a1A subunit of P/Q type calcium channels. Neuroscience 95: 639–645. Backman, C.M., Zhang, Y., Hoffer, B.J., and Tomac, A.C. 2004. Tetracycline-inducible expression systems for the generation of transgenic animals: a comparison of various inducible systems carried in a single vector. J Neurosci Methods 139: 257–262. Baulac, S., Huberfeld, G., Gourfinkel-An, I., Mitropoulou, G., Beranger, A., Prud’homme, J.F., Baulac, M. et al. 2001. First genetic evidence of GABAA receptor dysfunction in epilepsy: a mutation in the g2-subunit gene. Nat Genet 28: 46–48. Biervert, C., Schroeder, B.C., Kubisch, C., Berkovic, S.F., Propping, P., Jentsch, T.J., and Steinlein, O.K. 1998. A potassium channel mutation in neonatal human epilepsy. Science 279: 403–406. Bode, J., Goetze, S., Heng, H., Krawetz, S.A., and Benham, C. 2003. From DNA structure to gene expression: mediators of nuclear compartmentalization and dynamics. Chrom Res 11: 435–445. Bosl, M.R., Stein, V., Hubner, C., Zdebik, A.A., Jordt, S.E., Mukhopadhyay, A.K., Davidoff, M.S., et al. 2001. Male germ cells and photoreceptors, both dependent on close cell-cell interactions, degenerate upon ClC-2 Cl- channel disruption. EMBO J 20: 1289–1299. Browne, D.L., Gancher, S.T., Nutt, J.G., Brunt, E.R., Smith, E.A., Kramer, P., and Litt, M. 1994. Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1. Nat Genet 8: 136–140. Brusa, R., Zimmermann, F., Koh, D.S., Feldmeyer, D., Gass, P., Seeburg, P.H., and Sprengel, R. 1995. Early-onset epilepsy and postnatal lethality associated with an editing-deficient GluR-B allele in mice. Science 270: 1677–1680. Burgess, D.L., Biddlecome, G.H., McDonough, S.I., Diaz, M.E., Zilinski, C.A., Bean, B.P., Campbell, K.P., et al. 1999. b subunit reshuffling modifies N- and P/Q-type Ca2+ channel subunit compositions in lethargic mouse brain. Mol Cell Neurosci 13: 293–311. Buhr, A., Bianchi, M.T., Baur, R., Courtet, P., Pignay, V., Boulenger, J.P., Gallati, S., et al. 2002. Functional characterization of the new human GABAA receptor mutation b3 (R192H). Hum Genet 111: 154–160. Capecchi, M.R. 1989a. The new mouse genetics: altering the genome by gene targeting. Trends Genet 5: 70–76. Capecchi, M.R. 1989b. Altering the genome by homologous recombination. Science 244: 1288–1292. Charlier, C., Singh, N.A., Ryan, S.G., Lewis, T.B., Reus, B.E., Leach, R.J., and Leppert, M. 1998. A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family. Nat Genet 18: 53–55. Chen, C., Westenbroek, R.E., Xu, X., Edwards, C.A., Sorenson, D.R., Chen, Y., McEwen, D.P., et al. 2004. Mice lacking sodium channel b1 subunits display defects in neuronal excitability, sodium channel expression, and nodal architecture. J Neurosci 24: 4030–4042. Chen, C., Bharucha, V., Chen, Y., Westenbroek, R.E., Brown, A., Malhotra, J.D., Jones, D., et al. 2002. Reduced sodium channel density, altered voltage dependence of inactivation, and increased susceptibility to seizures in mice lacking sodium channel b2-subunits. Proc Natl Acad Sci U S A 99: 17072–17077. Cogoni, C., and Macino, G. 2000. Post-transcriptional gene silencing across kingdoms. Genes Dev 10: 638–643. Cossette, P., Liu, L., Brisebois, K., Dong, H., Lortie, A., Vanasse, M., SaintHilaire, J.M., et al. 2002. Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy. Nat Genet 31: 184–189.
Donahue, L.R., Cook, S.A., Johnson, K.R., Bronson, R.T., and Davisson, M.T. 1996. Megencephaly: a new mouse mutation on chromosome 6 that causes hypertrophy of the brain. Mamm Genome 7: 871–876. Dooley, J.M., Berg, J.M., Pakula, Z., and MacGregor, D.L. 1981. The puppet-like syndrome of Angelman. Am J Dis Child 135: 621–624. Dykxhoorn, D.M., Novina, C.D., and Sharp, P.A. 2003. Killing the messenger: short RNAs that silence gene expression. Nat Rev Mol Cell Biol 4: 457–467. Eunson, L.H., Rea, R., Zuberi, S.M., Youroukos, S., Panayiotopoulos, C.P., Liguori, R., Avoni, P., et al. 2000. Clinical, genetic, and expression studies of mutations in the potassium channel gene KCNA1 reveal new phenotypic variability. Ann Neurol 48: 647–656. Fletcher, C.F., Lutz, C.M., O’Sullivan, T.N., Shaughnessy, J.D. Jr., Hawkes, R., Frankel, W.N., Copeland, N.G., et al. 1996. Absence epilepsy in tottering mutant mice is associated with calcium channel defects. Cell 87: 607–617. Gardner, R.L., and Brook, F.A. 1997. Reflections on the biology of embryonic stem (ES) cells. Int J Dev Biol 41: 235–243. Giraldo, P., and Montoliu, L. 2001. Size matters: use of YACs, BACs and PACs in transgenic animals. Transgenic Res 10: 83–103. Gong, S., Zheng, C., Doughty, M.L., Losos, K., Didkovsky, N., Schambra, U.B., Nowak, N.J., et al. 2003. A gene expression atlas of the central nervous system based on bacterial artificial chromosomes. Nature 425: 917–925. Gordon, J.W., Scangos, G.A., Plotkin, D.J., Barbosa, J.A., and Ruddle, F.H. 1980. Genetic transformation of mouse embryos by microinjection of purified DNA. Proc Natl Acad Sci U S A 77: 7380–7384. Gunther, U., Benson, J., Benke, D., Fritschy, J.M., Reyes, G., Knoflach, F., Crestani, F. et al. 1995. Benzodiazepine-insensitive mice generated by targeted disruption of the gamma 2 subunit gene of gamma-aminobutyric acid type A receptors. Proc Natl Acad Sci U S A 92: 7749–7753. Hasuwa, H., Kaseda, K., Einarsdottir, T., and Okabe, M. 2002. Small interfering RNA and gene silencing in transgenic mice and rats. FEBS Lett 532: 227–230. Haug, K., Warnstedt, M., Alekov, A.K., Sander, T., Ramirez, A., Poser, B., Maljevic, S., et al. 2003. Mutations in CLCN2 encoding a voltage-gated chloride channel are associated with idiopathic generalized epilepsies. Nat Genet 33: 527–532. Heintz, N. 2000. Analysis of mammalian central nervous system gene expression and function using bacterial artificial chromosome-mediated transgenesis. Hum Mol Genet 9: 937–943. Heron, S.E., Crossland, K.M., Andermann, E., Phillips, H.A., Hall, A.J., Bleasel, A., Shevell, M., et al. 2002. Sodium-channel defects in benign familial neonatal-infantile seizures. Lancet 360: 851–852. Hofker, M.H., and Deursen, J.V. 2002. Transgenic Mouse: Methods and Portocols. Totowa: Humana Press. Hollmann, M., Hartley, M., and Heinemann, S. 1991. Ca2+ permeability of KA-AMPA-gated glutamate receptor channels depends on subunit composition. Science 252: 851–853. Homanics, G.E., DeLorey, T.M., Firestone, L.L., Quinlan, J.J., Handforth, A., Harrison, N.L., Krasowski, M.D., et al. 1997. Mice devoid of gamma-aminobutyrate type A receptor b3 subunit have epilepsy, cleft palate, and hypersensitive behavior. Proc Natl Acad Sci U S A 94: 4143–4148. Houdebine, L.M. 2003. Animal Transgenesis and Cloning. Hoboken: John Wiley & Sons. Huber, L.A. 2003. Is proteomics heading in the wrong direction? Nat Rev Mol Cell Biol 4: 74–80. Imbrici, P., Jaffe, S.L, Eunson, L.H., Davies, N.P., Herd, C., Robertson, R., Kullmann, D.M., et al. 2004. Dysfunction of the brain calcium channel CaV2.1 in absence epilepsy and episodic ataxia. Brain 127: 2682–2692. Ivics, Z., and Izsvak, Z. 2004. Transposable elements for transgenesis and insertional mutagenesis in vertebrates: a contemporary review of experimental strategies. Methods Mol Biol 260: 255–276.
References Jackson, I.J., and Abbott, C.M. 2000. Mouse Genetics and Transgenics: A Practical Approach. Oxford: Oxford University Press. Jia, Z., Agopyan, N., Miu, P., Xiong, Z., Henderson, J., Gerlai, R., Taverna, F.A., et al. 1996. Enhanced LTP in mice deficient in the AMPA receptor GluR2. Neuron 17: 945–956. Jouvenceau, A., Eunson, L.H., Spauschus, A., Ramesh, V., Zuberi, S.M., Kullmann, D.M., and Hanna, M.G. 2001. Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel. Lancet 358: 801–807. Joyner, A.J. 2000. Gene Targeting: A Practical Approach. Oxford: Oxford University Press. Kaang, B.K., Pfaffinger, P.J., Grant, S.G.N., Kandel, E.R. and Furukawa, Y. 1992. Overexpression of an Aplysia shaker K+ channel gene modifies the electrical properties and synaptic efficacy of identified Aplysia neurons. Proc Natl Acad Sci U S A 89: 1133–1137. Kash, S.F., Johnson, R.S., Tecott, L.H., Noebels, J.L., Mayfield, R.D., Hanahan, D., and Baekkeskov, S. 1997. Epilepsy in mice deficient in the 65–kDa isoform of glutamic acid decarboxylase. Proc Natl Acad Sci U S A 94: 14060–14065. Kask, K., Zamanillo, D., Rozov, A., Burnashev, N., Sprengel, R., and Seeburg, P.H. 1998. The AMPA receptor subunit GluR-B in its Q/R siteunedited form is not essential for brain development and function. Proc Natl Acad Sci U S A 95: 13777–13782. Kearney, J.A., Plummer, N.W., Smith, M.R., Kapur, J., Cummins, T.R., Waxman, S.G., Goldin, A.L., and Meisler, M.H. 2001. A gain-offunction mutation in the sodium channel gene Scn2a results in seizures and behavioral abnormalities. Neuroscience 102: 307–317. Kim, D., Song, I., Keum, S., Lee, T., Jeong, M.J., Kim, S.S., McEnery, M.W., et al. 2001. Lack of the burst firing of thalamocortical relay neurons and resistance to absence seizures in mice lacking a1G T-type Ca2+ channels. Neuron 31: 35–45. Kunath, T., Gish, G., Lickert, H., Jones, N., Pawson, T., and Rossant, J. 2003. Transgenic RNA interference in ES cell-derived embryos recapitulates a genetic null phenotype. Nat Biotechnol 21: 559– 561. Kuwabara, T., Hsieh, J., Nakashima, K., Taira, K., and Gage, F.H. 2004. A small modulatory dsRNA specifies the fate of adult neural stem cells. Cell 116: 779–793. Liu, M., Pleasure, S.J., Collins, A.E., Noebels, J.L., Naya, F.J., Tsai, M.J., and Lowenstein, D.H. 2000. Loss of BETA2/NeuroD leads to malformation of the dentate gyrus and epilepsy. Proc Natl Acad Sci U S A 97: 865–870. Marcus, K., Schmidt, O., Schaefer, H., Hamacher, M., van Hall, A., and Meyer, H.E. 2004. Proteomics–application to the brain. Int Rev Neurobiol 61: 285–311. McKnight, R.A., Shamay, A., Sankaran, L., Wall, R.J., and Hennighausen, L. 1992. Matrix-attachment regions can impart position-independent regulation of a tissue-specific gene in transgenic mice. Proc Natl Acad Sci U S A 89: 6943–6947. Meisler, M.H. 1992. Insertional mutation of ‘classical’ and novel genes in transgenic mice. Trends Genet 8: 341–344. Nagy, A., Gertsenstein, M., Vintersten, K., and Behringer R. 2002. Manipulating the Mouse Embryo: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press. Naya, F.J., Huang, H.P., Qiu, Y., Mutoh, H., DeMayo, F.J., Leiter, A.B., and Tsai, M.J. 1997. Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/neuroD-deficient mice. Genes Dev 11: 2323–2334. Novina, C.D., and Sharp, P.A. 2004. The RNAi revolution. Nature 430: 161–164. Nuyens, D., Stengl, M., Dugarmaa, S., Rossenbacker, T., Compernolle, V., Rudy, Y., Smits, J.F., et al. 2001. Abrupt rate accelerations or premature beats cause life-threatening arrhythmias in mice with long-QT3 syndrome. Nature Med 7: 1021–1027.
221
Ophoff, R.A., Terwindt, G.M., Vergouwe, M.N., van Eijk, R., Oefner, P.J., Hoffman, S.M., Lamerdin, J.E., et al. 1996. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 87: 543–552. Pereira, S., Vieira, J.P., Barroca, F., Roll, P., Carvalhas, R., Cau, P., Sequeira, S., et al. 2004. Severe epilepsy, retardation, and dysmorphic features with a 2q deletion including SCN1A and SCN2A. Neurology 63: 191–192. Peters, H.C., Hu, H., Pongs, O., Storm, J.F., and Isbrandt, D. 2005. Conditional transgenic suppression of M-channels in mouse brain reveals functions in neuronal excitability, resonance and behavior. Nat Neurosci 8: 51–60. Petersson, S., Persson, A.S., Johansen, J.E., Ingvar, M., Nilsson, J., Klement, G., Arhem, P., et al. 2003. Truncation of the Shaker-like voltage-gated potassium channel, Kv1.1, causes megencephaly. Eur J Neurosci 18: 3231–3240. Pinkert, C. 2002. Transgenic Animal Technology: A Laboratory Handbook. San Diego: Academic Press. Planells-Cases, R., Caprini, M., Zhang, J., Rockenstein, E.M., Rivera, R.R., Murre, C., Masliah, E., et al. 2000. Neuronal death and perinatal lethality in voltage-gated sodium channel alpha-II deficient mice. Biophys J 78: 2878–2891. Prawitt, D., Brixel, L., Spangenberg, C., Eshkind, L., Heck, R., Oesch, F., Zabel, B., et al. 2004. RNAi knock-down mice: an emerging technology for post-genomic functional genetics. Cytogenet Genome Res 105: 412–421. Prosser, H.M., Gill, C.H., Hirst, W.D., Grau, E., Robbins, M., Calver, A., Soffin, E.M., et al. 2001. Epileptogenesis and enhanced prepulse inhibition in GABAB1-deficient mice. Mol Cell Neurosci 17: 1059–1070. Sans, N., Vissel, B., Petralia, R.S., Wang, Y.X., Chang, K., Royle, G.A., Wang, C.Y., et al. 2003. Aberrant formation of glutamate receptor complexes in hippocampal neurons of mice lacking the GluR2 AMPA receptor subunit. J Neurosci 23: 9367–9373. Schoonjans, L., Kreemers, V., Danloy, S., Moreadith, R.W., Laroche, Y., and Collen, D. 2003. Improved generation of germline-competent embryonic stem cell lines from inbred mouse strains. Stem Cells 21: 90–97. Schuler, V., Luscher, C., Blanchet, C., Klix, N., Sansig, G., Klebs, K., Schmutz, M., et al. 2001. Epilepsy, hyperalgesia, impaired memory, and loss of pre- and postsynaptic GABAB responses in mice lacking GABAB1. Neuron 31: 47–58. Schweizer, C., Balsiger, S., Bluethmann, H., Mansuy, I.M., Fritschy, J.M., Mohler, H., and Luscher, B. 2003. The gamma 2 subunit of GABAA receptors is required for maintenance of receptors at mature synapses. Mol Cell Neurosci 24: 442–450. Singh, N.A., Charlier, C., Stauffer, D., DuPont, B.R., Leach, R.J., Melis, R., Ronen, G.M., et al. 1998. A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat Genet 18: 25–29. Smart, S.L., Lopantsev, V., Zhang, C.L., Robbins, C.A., Wang, H., Chiu, S.Y., Schwartzkroin, P.A., et al. 1998. Deletion of the KV1.1 potassium channel causes epilepsy in mice. Neuron 20: 809–819. Su, A.I., Cooke, M.P., Ching, K.A., Hakak, Y., Walker, J.R., Wiltshire, T., Orth, A.P., et al. 2002. Large-scale analysis of the human and mouse transcriptomes. Proc Natl Acad Sci U S A 99: 4465–4470. Sugawara, T., Tsurubuchi, Y., Agarwala, K.L., Ito, M., Fukuma, G., MazakiMiyazaki, E., Nagafuji, H., et al. 2001. A missense mutation of the Na+ channel alpha-II subunit gene Nav1.2 in a patient with febrile and afebrile seizures causes channel dysfunction. Proc Natl Acad Sci U S A 98: 6384–6389. Sur, C., Wafford, K.A., Reynolds, D.S., Hadingham, K.L., Bromidge, F., Macaulay, A., Collinson, N., et al. 2001. Loss of the major GABAA receptor subtype in the brain is not lethal in mice. J Neuroscience 21: 3409–3418.
222
Chapter 16/Transgenic and Gene Replacement Models of Epilepsy
Surani, M.A. 1991. Influence of genome imprinting on gene expression, phenotypic variations and development. Hum Reprod 6: 45–51. Sutherland, M.L., Williams, S.H., Abedi, R., Overbeek, P.A., Pfaffinger, P.J., and Noebels, J.L. 1999. Overexpression of a Shaker-type K+ channel in mammalian central nervous system dysregulates native potassium channel gene expression. Proc Natl Acad Sci U S A 96: 2451–2455. Testa, G., Vintersten, K., Zhang, Y., Benes, V., Muyrers, J.P., and Stewart, A.F. 2004. BAC engineering for the generation of ES cell-targeting constructs and mouse transgenes. Methods Mol Biol 256: 123–139. Turksen, K. 2001. Embryonic Stem Cells: Methods and Protocols. Totowa: Humana Press. Tymms, M.J., and Kola, I. 2001. Gene Knockout Protocols. Totowa: Humana Press. Veenema, H., Beverstock, G.C., Zvelebil-Tarasevitch, N., Doorn, J.L., van Parys, J.A., and Kamp, J.J. 1984. Duplication in the proximal portion of the long arm of chromosome 15, in a girl without phenotypic features of the Prader-Willi syndrome. Clin Genet 26: 65–68. Vicini, S., Ferguson, C., Prybylowski, K., Kralic, J., Morrow, A.L., and Homanics, G.E. 2001. GABAA receptor a1 subunit deletion prevents developmental changes of inhibitory synaptic currents in cerebellar neurons. J Neurosci 21: 3009—3016. Wagstaff, J., Knoll, J.H., Fleming, J., Kirkness, E.F., Martin-Gallardo, A., Greenberg, F., Graham, J.M.J., et al. 1991. Localization of the gene encoding the GABAA receptor b3 subunit to the Angelman/PraderWilli region of human chromosome 15. Am J Hum Genet 49: 330– 337. Wallace, R.H., Marini, C., Petrou, S., Harkin, L.A., Bowser, D.N., Panchal, R.G., Williams, D.A., et al. 2001. Mutant GABAA receptor g2-subunit in childhood absence epilepsy and febrile seizures. Nat Genet 28: 49–52. Wallace, R.H., Wang, D.W., Singh, R., Scheffer, I.E., George, A.L.J., Phillips, H.A., Saar, K., et al. 1998. Febrile seizures and generalized epilepsy associated with a mutation in the Na+-channel b1 subunit gene SCN1B. Nat Genet 19: 366–370.
Walz, K., Caratini-Rivera, S., Bi, W., Fonseca, P., Mansouri, D.L., Lynch, J., Vogel, H., et al. 2003. Modeling del(17)(p11. 2p11. 2) and dup(17)(p11. 2p11. 2) contiguous gene syndromes by chromosome engineering in mice: phenotypic consequences of gene dosage imbalance. Mol Cell Biol 23: 3646–3655. Watanabe, H., Nagata, E., Kosakai, A., Nakamura, M., Yokoyama, M., Tanaka, K., and Sasai, H. 2000. Disruption of the epilepsy KCNQ2 gene results in neural hyperexcitability. J Neurochem 75: 28–33. Williams, S.N., Locke, C.J., Braden, A.L., Caldwell, K.A., and Caldwell, G.A. 2004. Epileptic-like convulsions associated with LIS-1 in the cytoskeletal control of neurotransmitter signaling in Caenorhabditis elegans. Hum Mol Genet 13: 2043–2059. Wu, X., and Burgess, S.M. 2004. Integration target site selection for retroviruses and transposable elements. Cell Mol Life Sci 61: 2588–2596. Xia, H., Mao, Q., Eliason, S.L., Harper, S.Q., Martins, I.H., Orr, H.T., Paulson, H.L., et al. 2004. RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia. Nat Med 10: 816–820. Yamamoto, A., Hen, R., and Dauer, W.T. 2001. The ons and offs of inducible transgenic technology: a review. Neurobiol Dis 8: 923–932. Yamamoto, T., Yamato, E., Tashiro, F., Sato, T., Noso, S., Ikegami, H., Tamura, S., et al. 2004. Development of autoimmune diabetes in glutamic acid decarboxylase 65 (GAD65) knockout NOD mice. Diabetologia 47: 221–224. Zhang, H., Tan, J., Reynolds, E., Kuebler, D., Faulhaber, S., and Tanouye, M. 2002. The Drosophila slamdance gene: a mutation in an aminopeptidase can cause seizure, paralysis and neuronal failure. Genetics 162: 1283–1299. Zhang, W., Morris, Q.D., Chang, R., Shai, O., Bakowski, M.A., Mitsakakis, N., Mohammad, N., et al. 2004. The functional landscape of mouse gene expression. J Biol 3: 21. Zhuchenko, O., Bailey, J., Bonnen, P., Ashizawa, T., Stockton, D.W., Amos, C., Dobyns, W.B., et al. 1997. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nat Genet 15: 62–69.
C
H
A
P
T
E
R
17 Spontaneous Epileptic Mutations in the Mouse JEFFREY L. NOEBELS
nization, it is worth beginning this discussion with a reminder that it was the entire group of spontaneous mouse mutants that played the groundbreaking role in the neurogenetic analysis of seizure disorders: this model system was the first to demonstrate the significance of single genes in the hereditary transmission of epilepsy in the mammalian nervous system.
Spontaneous mutations in mice, along with those generated by genetic engineering approaches, are essential tools to understand the pathogenesis of human epilepsies. For every inherited seizure disorder in man, a genetically defined mouse mutant can help identify the key molecular mechanisms of excitability and plasticity in the developing epileptic brain, uncover new molecular targets for therapy, and serve as a reproducible biological test system for experimental strategies to prevent or reverse the onset of seizures. This chapter reviews some basic considerations for those investigators in search of a naturally occurring mouse model and provides a coherent experimental framework to analyze a specific pattern of epilepsy. Even for this somewhat limited purpose, the individual models are hardly an end to themselves; in fact, certain questions that arise in their analysis may be better answered using entirely different approaches in other model systems. Furthermore, because species differences may distort the molecular and cellular patterns of a gene defect, the physiologic findings in mouse models must be continuously validated using direct comparisons with previously known or emerging information from the human disease. In many cases the mismatches between human clinical disorders and mouse models are equally as important as the similarities in tracing the molecular pathways leading to epilepsy; in other cases, the differences may point to functionally irrelevant reactive changes. Nevertheless the developmental analysis of these mouse mutants offers an unparalleled opportunity to understand precisely how a single inherited molecular defect alters excitability to give rise to an episodic seizure phenotype. Whereas experimentally engineered epileptic mouse mutants are favored models in neurobiology and neuropharmacology for the study of abnormal brain synchro-
Models of Seizures and Epilepsy
THE MOUSE AND MENDELIAN INHERITANCE OF EPILEPSY Early human genetic studies of epilepsy developed clear evidence for the heritability of idiopathic epilepsy through twin studies. Yet multigenerational pedigrees of epilepsy that demonstrate the influence of single “major” genes are difficult to find, and until relatively recently relied largely on models of complex polygenic inheritance to explain the heredity of idiopathic seizure disorders. One decade before the first of many reports of family studies revealing single loci for human idiopathic generalized epilepsies appeared (Leppert et al., 1989; Scheffer and Berkovic, 2003), several fundamental principles governing the hereditary transmission of epilepsy were derived from the study of single locus spontaneous neurological mutations in the mouse (Noebels, 1979). The first stated that epileptic disorders featuring spontaneous age-dependent seizures resembling those in human generalized epilepsy can be inherited as individual Mendelian traits. At the neurobiological level, this tenet translated directly into both the search for hereditary defects in single molecules that could alter the firing properties of neurons, and the overall strategy of exploring how the expression of these single genetic errors could trigger
223
Copyright © 2006, Elsevier Inc. All rights of reproduction in any form reserved.
224
Chapter 17/Spontaneous Epileptic Mutations in the Mouse
abnormal excitability changes within a restricted set of neuronal pathways at a specific developmental stage. The second principle was derived from the genetic mapping information then available in the mouse, namely, that both convulsive and generalized absence seizure phenotypes observed in spontaneous mouse mutants were genetically heterogeneous. Even without knowing the genes responsible, this evidence for locus heterogeneity foretold the extensive biochemical diversity of inherited epilepsies and predicted both the wide range of clinical variation and the pharmacologic sensitivity of molecular lesions in the human brain that share epilepsy as a common manifestation. Today, now that Mendelian inheritance of human idiopathic epilepsy has been demonstrated many times, the genetics derived from single-locus mutant mice remain of strategic importance in deciphering nonfamilial cases of epilepsy, which constitute the largest fraction of the human patient population. Knowing that a dominant mutation at only a single locus may be sufficient to produce a seizure disorder means that de novo mutation is a far more likely cause of common sporadic cases than if the seizure phenotype required simultaneous mutations in multiple genes. In addition, the recognition that inherited epilepsy is genetically heterogeneous, that is, that many different single genes give rise to the disorder, is a key factor in designing surrogate markers for epilepsy—markers that can be used in epidemiologic surveys, clinical diagnostic screening and even drug discovery. Genetic heterogeneity implies that any single biochemical marker associated with the primary cause (rather than the effect) of cerebral seizure activity will a priori detect only a subset of the population at risk for epilepsy.
A RATIONALE FOR ANALYZING BOTH SPONTANEOUS AND ENGINEERED SINGLE-GENE MODELS Spontaneous mutants with epilepsy arise in both large and small mouse breeding colonies and have been available since the 1950s. Their numbers are limited only by the mutation rate and by the practical difficulties of detecting seizures, an episodic and often subtle neurologic phenotype. Both convulsive and absence seizure phenotypes were represented in the first group of mice analyzed, and at first glance these few models seemed sufficient for basic epilepsy research, particularly once the gene in question was identified. However, by the mid-1990s, genetic engineering technology added an entirely new dimension to epilepsy gene discovery and model building. This “reverse genetic” strategy was built around the premise that if a preselected gene was inactivated and epilepsy was the resulting phenotype, the gene would serve as an excellent candidate for human disease. The first gene deletion study that produced epilepsy
in a mouse, which targeted the protooncogene BMI-1, described seizures as an incidental finding (van der Lugt et al., 1994). This report was rapidly followed by a dozen others demonstrating the molecular diversity of brain synchronization defects (Noebels, 1996). Now, genetically engineered mice with spontaneous seizure phenotypes currently number more than 50, with additional genotypes being continually reported. Genetic access to the brain in these models allows the design and introduction of specific molecular defects into identified cellular pathways, and places every synaptic network within experimental reach (see Chapter 16). In addition, engineered models enable a “gene-forward” approach, with enormous advantages in defining new candidate gene families and signaling pathways for de novo epilepsy model building; these approaches have proven extremely informative in deducing convergent biological pathways for epileptogenesis (Noebels, 2003). Given these experimental advantages, the transgenic animal must be considered an attractive alternative to spontaneous mutants as strategic analytic tools in epilepsy research. Both approaches have provided important insights.
ORTHOLOGOUS VERSUS ORPHAN GENE MODELS OF EPILEPSY In addition to the preceding issue—whether to use a gene-driven or phenotype-driven modeling approach—there is a parallel question that the genetic modeler must address: Which should come first, the human disease or the disease model? Despite the attraction of the transgenic approach, if the goal is to obtain a mouse model of human epilepsy, there is significant risk in selecting an engineered model of epilepsy for study. If a gene is deleted and no seizures result in the animal, has the involvement of that gene in epilepsy been excluded? The answer to this question is clearly no. A null mutation is only one of many potential perturbations of the gene; because epilepsies begin (and end) at different ages and may be present only when the mutant gene is expressed on certain genetic backgrounds, substantial effort must be expended in phenotyping the mutant before it can be assumed that the loss of a particular gene does not produce epilepsy. In fact, a firm conclusion that a given null mutation is not involved in epilepsy is almost impossible to support (the difficulty of “proving” the negative). Thus, although the engineered models can tell us what can happen (if epilepsy is found in the transgenic mouse), they offer no assurance that it actually does or ever will (in humans). This distinction is irrelevant if the goal of the study is strictly to understand the mechanisms of cortical synchronization of the nervous system, but it is critical if the purpose is to obtain models of real human epilepsy, as encountered in the clinic.
Orthologous Versus Orphan Gene Models of Epilepsy
Thus, in asking which genetic model system—spontaneous or transgenic—to select for further study, the answer depends primarily on the purpose of the model. Both spontaneous mouse mutations and transgenic mutants, created without foreknowledge of an epileptic phenotype, are examples of “orphan’ ” epilepsy models, that is, an epileptic lesion with no human counterpart. These models join those created by other nongenetic strategies (chemical-induced, electrical stimulation, focal lesions) in teaching us something important about epileptogenesis. However, they do not precisely recapitulate a clinically relevant molecular mechanism, and thus they cannot be considered an exact model of a human disease until a similar molecular lesion is described in human. In contrast either spontaneous or engineered mutation in a gene shared by both human and mouse, even if the mutation is extremely rare, constitutes an inherently valid orthologous gene model pairing. Such gene pairs are highly prized as intrinsically valid models of human disease. Fortunately, although only a few of the spontaneous mouse mutants are known to have human counterparts, it is safe to predict such genes will be found in the future. One recent example is the report of human absence seizures in a family bearing a mutation of CACNAA1A, the gene encoding the alpha subunit of a P/Q type calcium ion channel. This is the same gene that is mutated in the tottering mouse, the first absence seizure model in mouse, reported 25 years ago (Imbrici et al., 2004; Noebels and Sidman, 1979). A more recent example is the finding of febrile seizures in a family bearing nonsense mutations in MASS1, a gene that was discovered in the Frings audiogenic seizure model only a year earlier (Nakayama et al., 2002; Skradski et al., 2001). The reverse scenario can also be expected. For example, a mouse strain with a decreased seizure threshold was determined to contain a deletion of two contiguous genes previously implicated in human epilepsy syndromes: KCNQ2, a voltage-gated potassium channel that contributes to the hyperpolarizing m-current, and CHRNA4, a nicotinic cholinergic receptor alpha subunit (Yang et al., 2003). Inherited defects in these channel genes had been found a few years earlier to cause BNE1, a benign neonatal epilepsy syndrome, and ADNFLE1, an autosomal-dominant frontal lobe epilepsy (Biervert et al., 1998; Singh et al., 1998; Steinlein et al., 1995). Finally, although certain attributes of both types of genetic models may seem obvious, they are worth restating clearly at the outset. The major virtues of a genetic lesion to an experimentalist are its innate reproducibility and the opportunity it affords the investigator to study the natural history of the disease from embryonic stages through adulthood. The major drawbacks of these genetic models are similar to those encountered when directly studying human patients themselves, namely, the need for comprehensive seizure monitoring (to detect and characterize unprovoked
225
and therefore unpredictable seizure events), the difficulty in designing “before and after” studies (it is not currently possible to know conclusively whether an animal has ever had a seizure before analysis commences, and thus the brain can never be considered truly “preclinical” or “naïve”), and the significant time required to breed adequate numbers of affected mice of a specified age (a significant practical problem confronting investigators planning neurophysiologic or neuropharmacologic studies).
Classic Mouse Mutants with Epilepsy: Finding a Spontaneous Mutant With these considerations in mind, the initial step is to identify and obtain an interesting model for study. The first listing of epileptic phenotypes in mouse mutants appeared in 1965 in the slender volume, Catalog of the Neurological Mutants of the Mouse, by Richard L. Sidman, Margaret Green, and Stanley H. Appel. This list was based on purely behavioral observations of “seizures” in mutant mice that arose at The Jackson Laboratory (TJL) in Bar Harbor, Maine. Because of the large mouse breeding colonies in this production facility, behavioral deviants were (and are) relatively common. To this day, FLMs (“funny looking mice”) are collected weekly by the mouse handlers at TJL and displayed for potential selection and further characterization of the phenotype. Once selected, the deviant trait is genetically mapped to a chromosomal linkage region and evaluated for allelism by complementation testing with other known mutants mapped at or near the locus. Remutation of previously known genes is not uncommon, and when available, multiple alleles (an “allelic series”) of the same gene can provide an extremely important resource for genotypephenotype correlations. Such studies can clarify how different alterations in a protein are linked to the pathogenesis and variable phenotypes of the disorder. The initial list of neurologic mutants comprised 92 mice, from agitans to zigzag. Of these, 15 mice were considered to display behavioral “convulsions,” although in retrospect, some of these assumed seizures proved to be nonepileptic paroxysmal movement disorders. At the time, the mice were assigned to a genetic linkage group on a particular chromosome. Since that first listing, almost all of these mutated genes have been molecularly defined, and a few more of special interest to epilepsy research have been added. At least 19 models of epilepsy arising from spontaneous mutations in the mouse are currently known (Table 1). The genes identified in these models constitute only a small fraction of the total number that have been so far linked to human and murine epilepsy (Noebels, 2003). Yet they show a similar distribution in gene function, namely, a majority of genes associated with ion channels compared with other genes of unrelated function.
226
Chapter 17/Spontaneous Epileptic Mutations in the Mouse
TABLE 1 Spontaneous Single-Locus Mouse Mutants with Epileptic Phenotypes Mutant Spike wave Tottering (tg) Lethargic (lh) Ducky (du) Stargazer (stg) SWE (swe) Mocha2j (mh) Coloboma (Cm) Convulsions Dilute lethal (dl) Jimpy (jp) Jittery (ji) Megencephaly (mceph) Quaking (qk) Staggerer (sg) Torpid (td) Varitint waddler (Va) Wabbler-lethal (wl) Weaver (wv) Writher (wh)
Chr.
Gene
Protein
Ref
8 2 9 15 4 10 2
Cacnala Cacnb4 Cacna2d2 Cacng2 NHE1 AP3d Cm
P/Q type calcium channel alpha subunit Calcium channel beta 4 subunit Alpha2delta2 subunit Gamma2 subunit Sodium hydrogen exchanger Delta subunit AP3 adaptor protein Microdeletion including SNAP25 and phospholipase C isoform b1
Fletcher et al., 1996 Burgess et al., 1997 Brodbeck et al., 2002 Letts et al., 1998 Cox et al., 1997 Kantheti et al., 2003 Zhang, Hess et al., 1994
9 X 10 6 17 9
Myo5a plp
Myosin Va Proteolipid protein Novel protein Potassium ion channel Microdeletion, including parkin Nuclear receptor Unknown TRP ion channel Unknown G-protein-coupled potassium channel
Mercer et al., 1991 Dautigny et al., 1986 Bomar et al., 2003 Peterson, 2003 Lorenzetti, 2004 Matysiak-Scholze, 1997
Novel protein Glutamate Receptor delta subunit
Skratski et al., 2001 Zuo et al., 1997
3 14 16
Kv1.1 RORa mcoln3 GIRK2
Convulsions evoked by sensory stimuli Frings 13 Mass1 Lurcher (Lu) 6 GluR d2
Periodically new spontaneous mutants are found in both large and smaller breeding colonies in laboratories around the world. When this occurs, the founder animal is backcrossed to determine whether the deviant trait arises from a germline, rather than somatic, mutation and can be propagated for further study. Traditionally a nickname evocative of some behavioral trait is chosen for the new mutant, although the reader should be aware that there is a committee responsible for adherence to the “Standardized Genetic Nomenclature for Mice,” which asks that the newly discovered mutation be shown through appropriate genetic testing not to be allelic with other mutants—or if it is, that if differs in phenotype from other allelic mutations at that locus. The final name assigned is that of the mutated gene. For example, the mutant mouse rocker is allelic to tottering. Both are mutations of the calcium channel alpha subunit Cacnala, and both display ataxia and absence epilepsy. However, dendritic arbors of rocker Purkinje cells display a distinct “weeping willow” appearance, whereas those of tottering are unaffected (Fletcher et al., 1996; Zwingman et al., 2001). Strains with mutant and wild-type alleles on the same genetic background (congenic strains) are developed by repeated crossing of the mutant to an inbred strain or by brother-sister mating with forced heterozygosis of the mutant. Proper maintenance of strains requires vigilance and a well-defined breeding scheme. Difficulties with viability and fertility are often encountered with neurologic mutants, and propagation of the mutant may be assisted in various
DiPalma, 2002 Slesinger et al., 1996 unknown
ways (Green, 1975); however, the strain designation must reflect any changes in this background. Because mutants originate from many different colonies, the designation of strain origin can be very informative.
Gene Identification and Induced Mutagenesis Strategies Early mutant genes were isolated in a lengthy process by mapping the disease locus, followed by laborious strategies to identify genes contained within the region, allowing the final evaluation of each gene for a mutation. With the application of comparative and functional genomic identification strategies, informative marker strains, and publication of the entire sequence of the mouse genome (Waterston et al., 2002), the initial mapping step narrows the disease locus to a precise region containing a small number of genes (positional candidate gene cloning) that can all be sequenced. The process can now lead to rapid identification of the mutation. Once the fine structure of the single locus mutation has been characterized, mutant alleles are generally found to fall into several different categories. Traits that are transmitted in a Mendelian pattern are often point mutations (e.g., single amino acid substitutions, sequence inversions, or repetitive elements) that lead to gain or loss of function in a single gene. However, there are other possibilities, including duplications or small deletions that encompass several closely linked genes, similar to small contiguous gene deletion syn-
Orthologous Versus Orphan Gene Models of Epilepsy
dromes in man. The pink eye dilution (p) mutation, for example, has seizures and is missing three closely linked subunit genes for GABAA receptors on chromosome 7 (Culiat et al., 1994), and more than 36 variants at this locus have been studied (Johnson et al., 1995). Although the discovery of rare epileptic mutant phenotypes depends on relatively infrequent spontaneous mutation rates, ancillary strategies have been recently employed to accelerate the pace. Induced (but untargeted) point mutations can be obtained by ethylnitrosourea (ENU) mutagenesis in mice, followed by phenotypic screening for excitability variants (Balling, 2001; Bult et al., 2004; O’Brien and Frankel, 2004). Accelerating the mutation rate by the introduction of random single- base-pair changes is a valuable strategy to generate novel phenotypes. However, the phenotype of either epilepsy or altered seizure threshold must still be ascertained in the mutagenized mice, which then require the same detailed gene isolation procedure as spontaneous mutants. Nevertheless, there are two advantages to this approach: first, the acquisition of novel phenotypes arising from random mutation of as yet unstudied genes; and second, the possibility of generating an expanded series of gain of function alleles that differ from those obtained by targeted deletion strategies. Advanced regional chromosomal saturation methods and “oligogenic chromosomal lesions” are also within the reach of gene targeting technology if required to model a human mutation (van der Weyden et al., 2002).
Validating the Epileptic Phenotype Electroencephalographic Recording To satisfy the currently accepted definition of an epileptic seizure, the model must display abnormal synchronous electroencephalographic (EEG) activity as an electrocortical correlate of any paroxysmal behavior. Not uncommonly a spontaneous epileptiform behavioral disturbance originates as a subcortical event, as evidenced by the lack of change in the EEG. This is the case for the sudden myoclonic jerks in spasmodic mice (mutation of the alpha1 subunit of the glycine receptor), which is therefore considered a model of the movement disorder, hyperekplexia, or “startle disease,” rather than epileptic myoclonus (Buckwalter et al., 1993). Some mice may display both an epileptic seizure as well as nonepileptic paroxysmal dyskinesia, two separable disorders arising in independent brain networks. For example, tottering mice display spike-wave seizures with behavioral arrest involving the thalamocortical circuitry; they also exhibit paroxysmal dyskinesias with dystonic features involving pontocerebellar circuitry that are unaccompanied by EEG discharges (Campbell and Hess, 1998; Noebels and Sidman, 1979). To validate the mutant as a model of epilepsy, repeated spontaneous seizures must be recorded
227
from neocortex or hippocampus in multiple mutants and compared with control recordings in mice of the same strain that are wild-type for the mutant allele. We have carried out an EEG/photic screen of a large number of mutants in the Jackson Laboratory Mutant Mouse Resource over the years (J.L. Noebels, X. Qiao, and M. Davisson, unpublished). Although the screen validated epilepsy in several mutant strains, more than 100 others, many with neurologic abnormalities, failed to show epilepsy during the EEG monitoring process. Although it is not possible to state categorically that these mice do not have epilepsy at some point in their development, seizures were sufficiently rare to escape detection during the screen (in this case, typically restricted to three affected adult mice for periods from 2 to 10 hours on two or more separate recording days). With that significant caveat, this experience substantially confirms what is well known to clinical neurologists: that seizure disorders, though common, are not an inevitable result of aberrant circuitry or cortical damage and hence represent a specific subset of latent excitability defects in neural networks. Phenotypic Discovery: Surrogate Markers for Screening Because episodic seizure disorders require an abnormal EEG to identify correctly the phenotype, many mutant models of epilepsy have gone unrecognized. Although both video monitoring and EEG seizure-detection algorithms are available to facilitate this step, prolonged monitoring may be required to detect rare events, making alternative screening strategies desirable. Unfortunately only a few reliable or specific biochemical indicators of past seizure history are currently available for this purpose. Regional anatomic rearrangements and molecular plasticity of varying longevity are seen in both human and rodent models of limbic epilepsy and can serve as useful (if not specific) indicators of prior seizure events. One such marker is granule cell axonal sprouting, readily visualized by Timm or dynorphin staining of mossy fibers in the inner molecular layer of the dentate gyrus. Dispersion of granule cell bodies and aberrant axonal reorganization appear to be essentially permanent network changes closely linked to prolonged hippocampal seizures (Houser, 1990; Sutula et al., 1989). Molecular markers induced by seizure-induced changes in gene expression and cell death are also abundant in the hippocampus, but they tend to be shorter lasting (Borges et al., 2003) and are drastically modified by genetic background (Morrison et al., 1996; Schauwecker, 2002). Several other molecules that may be useful for indirect detection of recent seizure activity in adult (Frankel et al., 1994; Storey et al., 2002), but not immature (Storey et al., 2002), brains include the reactive transcription factors C-Fos and JunB and the ectopic expression of neuropeptide Y (NPY) in granule
228
Chapter 17/Spontaneous Epileptic Mutations in the Mouse
cell axons (Tonder et al., 1994). Both mossy fiber sprouting and ectopic axonal NPY expression have been observed in spontaneous epileptic mutants, such as stargazer (Chafetz et al., 1995; Qiao and Noebels, 1993). Identification of seizureinduced neurogenesis among cells located in the infragranular layer of the dentate hilus is not a useful screening tool because the cell division must be labeled at the time of the seizure (Parent et al., 1997). C-Fos activation distinguishes between convulsive (Frankel et al., 1994; Morgan et al., 1987) and absence epilepsy models (Morgan et al., 1987). This observation reinforces the genetic evidence for fundamental differences not only in the circuitry but also in the biology of neuronal synchronization among major EEG and clinical seizure types in the brain. An alternative screening method for detecting epileptic mutants involves acute testing for a lowered seizure threshold induced by auditory activation, convulsant drugs, or maximal electroshock (White et al., 1995). The validity of this approach relies on the assumption that epilepsies arise from circuits that are disinhibited or otherwise more likely to engage in rhythmic bursting; however, this relationship may not always be true. The “seizure threshold” is a separable trait from spontaneous seizures, and mutant mice (like humans) with latent hyperexcitable neural circuits may never display epilepsy; in turn, spontaneously epileptic mice may show only a reduced threshold for triggering seizures if the correct circuit or pattern of activation is applied. For example, P/Q-type calcium ion channel mutants such as tottering and leaner show thalamocortical spike-wave epilepsies; yet cortical excitability is reduced as a result of decreased calcium currents and impaired neurotransmitter release (Ayata et al., 2000; Qian and Noebels, 2000). Mutant mice with a lowered threshold for seizures evoked by one modality may demonstrate an elevated threshold through another pathway. Finally, significant differences in the convulsive threshold exist among inbred strains, which may confound the interpretation of mutations on different backgrounds (Frankel et al., 2001). Nevertheless, the threshold method, though not infallible, has been valuable in identifying certain gene mutations of interest (Yang et al., 2003).
MATCH AND MISMATCH WITH HUMAN SEIZURE DISORDERS: WHAT DOES THE MUTATION MODEL AND HOW WELL? Inherited lesions in the same gene may show widely disparate phenotypes in mice and humans. The correct explanation, most of the time, is that two different functional alleles are being compared. For example, in the Kv1.1 potassium ion channel gene, dominant human point mutations may alter the kinetics of pore inactivation, thereby prolonging depolarization; such mutations are associated with myokymia, episodic ataxia, or a temporal lobe epilepsy phe-
notype (Browne et al., 1994; Zuberi et al., 1999). In the mouse, a deletion of the same channel leads to a more severe convulsive phenotype with cold-induced neuromyotonia (Smart et al., 1998; Zhou et al., 1998); a truncation of the same channel is linked to a dominant negative syndrome of epilepsy and megencephaly (Petersson et al., 2003). It is noteworthy that insertion of a human ataxia mutation in mouse produces the expected phenotype (Herson et al., 2003). It should also be recalled that many of the human disorders are clinically apparent in heteroygotes, whereas many of the mouse models are studied in their more severe homozygous forms. However, in a variety of murine disorders, an apparently identical functional change may still create dissimilar phenotypes. When this occurs, what conclusions can be drawn about the similarity of the intervening mechanisms? Reconciling species-specific phenotypic differences requires an ability to compare key elements of the disorder in mice with those assembled for human epilepsy syndromes, beginning with the electrographic and behavioral semiology of the seizure phenotype (Blume et al., 2001) and then working backward toward the precise mutation of the gene. The cortical EEG, which is readily but subjectively described, exhibits important differences in background rhythmicity even between normal rodent and human brains. For example, mice and rats lack spontaneous alpha (7– 12 Hz) rhythms and other complex discharges and sleep stages normally present in the human EEG. Would these background oscillatory differences alter the synchronization patterns of an otherwise identical epileptogenic lesion? The behavioral correlate of the seizure is also often difficult to compare because the semiology of spontaneous seizures in rodents has not been formalized, and many model descriptions are incomplete. Terms such as epileptic seizures, behavioral arrest, convulsions, wild running, and Straub tail phenomenon are typically the only seizure descriptions reported. Ictal durations are rarely recorded, and the changing behavior pattern throughout an ictal episode, well described for the kindling model (Engel et al., 1978), is usually overlooked. Finally, the pharmacological sensitivity and natural history (onset and duration of seizures over the life span), two key descriptors of an epilepsy syndrome, are difficult to determine precisely and rarely mentioned in descriptions of murine epilepsies. At the neuropathological level, the assumption that an orthologous gene model should show molecular or cellular lesions in the mouse that are identical to those in human may also be premature (at least in some cases). Several basic explanations for potential differences are routinely overlooked. For example, murine genes may be spliced differently than those in human, leading to proteins that differ in functional properties or interaction domains with other molecules. Anatomically, the cellular context and neurobiology of the mouse and human brain vary; for example, some
Spontaneous Mutants with Absence Epilepsy Phenotypes
mouse brain regions lack cellular components present in humans. Additional differences may reside in the temporal and regional expression of brain genes, in compensatory gene family members, or directly interacting partners such as channel regulatory subunits, transmitter receptors, or other members of the molecular pathway. Finally, the mouse or human may coexpress an unknown number of mutations in modifying genes that mask the penetrance of the phenotype.
ANALYSIS OF PATHOGENIC MECHANISMS IN SPONTANEOUS MOUSE MODELS Working Backward from the Phenotype In the absence of an identified gene, pathological analysis of the nervous system in the spontaneous mutant models was historically descriptive and phenotype-driven using hypotheses generated from acute experimental models of epilepsy rather than driven by any inherently logical approach. Routine neuropathological studies of major neurotransmitter systems, using available antibodies or other functional assays, were typically followed by neurophysiologic analyses of firing properties in well-studied neural circuits (such as the hippocampus). This approach leads to the discovery of a wide range of interesting, yet seemingly unconnected, “endophenotypes;” it has largely been replaced by a more focused strategy based upon knowledge of the mutant gene.
The Gene-Forward Approach At the subcellular level, once the gene has been identified, a direct strategy working forward from the gene is productive. Molecular genetic studies can define the precise effects of the mutation on the sequence of the transcribed protein, and cell biology methods can describe its heteromeric interactions and longevity. At the cellular level, molecular anatomic techniques are required to determine where and when the mutant gene and related members of the gene family are expressed and the cell types and subcellular compartments in which the various isoforms are localized. Many mutations impair protein trafficking, and the levels and distribution of the mutant protein must be carefully examined, along with its physiologic or biochemical behavior, to understand how overall function has been impaired. If the hereditary transmission pattern suggests a dominant trait, evaluation must include the possible negative effects of the mutant protein on the function of its wildtype allele, which can explain defective neural activity in the heterozygous animal. At the network level of analysis, a priority list of questions includes the following: How do mutant neurons inter-
229
act with cells not expressing the mutation? Does the mutation result in a gain or loss of function (e.g., of connectivity) within the circuit, and how does this interaction impact overall network signaling properties? What developmental plasticity changes add to, or compensate for, the abnormal signaling? Finally, how does this pattern fit with what is known about existing mechanisms of epileptogenesis derived from other acute and chronic models? At each level of analysis, once defects are identified in the brain of the mutant, the major challenge is to determine whether these changes are the cause of the epilepsy, the result, or functionally unrelated. Age-specific studies may help untangle this complex lesion. Is there significant damage in the brain before seizures occur? What pathological changes follow a prolonged history of seizures? Serial developmental studies may be required to visualize pathogenic changes before they are obscured by a misleading sequence of seizure-induced events.
SPONTANEOUS MUTANTS WITH ABSENCE EPILEPSY PHENOTYPES Summarizing the experimental analysis of spontaneous mutants with an absence epilepsy phenotype is a useful way of comparing the relative contributions of the two-directional approaches. Spontaneous mutations in the past provided the only model of this seizure type; however, two transgenic models have recently been reported (Ludwig et al., 2003; Song et al., 2004). Before the causative genes were identified by positional cloning, EEG recordings were employed to validate spike wave absence epilepsy in four neurologic mutants with ataxia, including tottering, lethargic, ducky, and stargazer (Noebels, 1999). Following the phenotype-driven approach, analysis of tottering forebrain identified multiple abnormalities relating to network synchronization: noradrenergic hyperinnervation accompanied by cortical norepinephrine (NE) subsensitivity (Levitt and Noebels, 1981; Magistretti et al., 1987), elevated cortical cyclic adenosine monophosphate (cAMP) and protein kinase A (PKA) levels (Tehrani and Barnes, 1990, 1995), decreased synaptosomal sodium channels, and muscarinic acetylcholine (ACh) receptor density (Liles et al., 1986; Willow et al., 1986), increased hippocampal network excitability in response to convulsants (Noebels and Rutecki, 1990; Psarropoulou and Kostopoulos, 1990), depressed cellular inhibition with prolonged depolarizations, and reduced hippocampal pyramidal cell afterhyperpolarization (Helekar and Noebels, 1991, 1992, 1994). Hippocampal mossy fiber sprouting was also detected (Stanfield, 1989). These changes generally favor hypersynchronization within tottering circuits, and at least one of these abnormalities was present at the onset of epilepsy (Helekar and Noebels, 1991). Once the mutation in
230
Chapter 17/Spontaneous Epileptic Mutations in the Mouse
the Cacna1a gene had been identified (Fletcher et al., 1996), gene-driven hypotheses refocused on a variety of direct alterations in mutant channel behavior: decreased currents through neuronal P/Q type calcium channels (Wakamori 1998), decreased excitatory transmission in thalamus (Caddick et al., 1999), and impaired neurotransmitter release (43, 72Ayata et al., 2000; Leenders et al., 2002; Qian and Noebels, 2000). Recent analysis of thalamocortical relay neurons involved in spike-wave electrogenesis has uncovered a secondary elevation of low-voltage activated (T-type) calcium currents (Zhang et al., 2002) known to favor rebound bursting in this cell type (Crunelli and Leresche, 2002). Taken together, the data from both backward and forward approaches provide several candidate mechanisms for epileptogenesis in calcium channelopathy mice. Interestingly, the impaired calcium currents that result directly from the primary inherited defect are unlikely to elevate membrane excitability. However, many of the secondary developmental effects of reduced transmitter release are strong contenders for enhanced neuronal bursting and network oscillations. Downstream plasticity therefore appears to be a critical step in this model of epileptogenesis. Not surprisingly, the evidence for this component is seen first by testing network hypotheses rather than by working forward from the mutant gene. Our insight into the seizure disorder associated with calcium channelopathy suggests that a bidirectional approach may prove the most efficient strategy to outline the key steps of the disease pathway. This example also emphasizes the need to search for selective vulnerability mechanisms that create excitability defects in thalamocortical circuits at specific developmental ages while sparing other central synaptic pathways also expressing the mutant gene. Although calcium channelopathy represents only one of several molecular pathways defined by spontaneous mouse mutants that lead to the expression of spike-wave epilepsy, the results obtained from studies of this model clearly illustrate the promise—as well as the remaining challenges—for gaining a full understanding about how single gene defects lead to epileptic phenotypes.
Acknowledgments We are indebted to the dedicated mouse handlers of the Jackson Laboratory for their careful observations and genetic analyses of mutants maintained over the years in the Neurological Mutant Resource and funded by the National Institutes of Health. I also thank Muriel Davisson, Ken Johnson, Carol Spencer, Sue Cook, and Wayne Frankel as well as the many members of the Developmental Neurogenetics Laboratory for their invaluable collaboration. The laboratory at Baylor is supported by grants from the National Institute of Neurologic Disorders and Stroke (NINDS) and the Blue Bird Circle Foundation for Pediatric Neurology.
References Ayata, C., Shimizu-Sasamata, M., Lo, E.H., Noebels, J.L., and Moskowitz, M.A. 2000. Impaired neurotransmitter release and elevated threshold
for cortical spreading depression in mice with mutations in the alpha1A subunit of P/Q type calcium channels. Neuroscience. 95: 639–645. Balling, R. 2001. ENU mutagenesis: analyzing gene function in mice. Annu Rev Genomics Hum Genet 2: 463–492. Biervert, C., Schroeder, B.C., Kubisch, C., Berkovic, S.F., Propping, P., Jentsch, T.J., and Steinlein, O.K. 1998. A potassium channel mutation in neonatal human epilepsy. Science 279: 403–406. Blume, W.T., Luders, H.O., Mizrahi, E., Tassinari, C., van Emde Boas, W., and Engel, J. Jr. 2001. Glossary of descriptive terminology for ictal semiology: report of the ILAE task force on classification and terminology. Epilepsia 42: 1212–1218. Bomar, J.M., Benke, P.J., Slattery, E.L., Puttagunta, R., Taylor, L.P., Seong, E., Nystuen, A. et al. 2003. Mutations in a novel gene encoding a CRAL-TRIO domain cause human Cayman ataxia and ataxia/dystonia in the jittery mouse. Nat Genet 35: 264–269. Borges, K., Gearing, M., McDermott, D.L., Smith, A.B., Almonte, A.G., Wainer, B.H., and Dingledine, R. 2003. Neuronal and glial pathological changes during epileptogenesis in the mouse pilocarpine model. Exp Neurol 182: 21–34. Brodbeck, J., Davies, A., Courtney, J.M., Meir, A., Balaguero, N., Canti, C., Moss, F.J. et al. 2002. The ducky mutation in Cacna2d2 results in altered Purkinje cell morphology and is associated with the expression of a truncated alpha 2 delta-2 protein with abnormal function. J Biol Chem 277: 7684–7693. Browne, D.L., Gancher, S.T., Nutt, J.G., Brunt, E.R., Smith, E.A., Kramer, P., and Litt, M. 1994. Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1. Nat Genet 8: 136–140. Buckwalter, M.S., Testa, C.M., Noebels, J.L., and Camper, S.A. 1993. Genetic mapping and evaluation of candidate genes for spasmodic, a neurological mouse mutation with abnormal startle response. Genomics 17: 279–286. Burgess, D.L., Jones, J.M., Meisler, M.H., and Noebels, J.L. 1997. Mutation of the Ca2+ channel beta subunit gene Cchb4 is associated with ataxia and seizures in the lethargic (lh) mouse. Cell 88: 385–392. Bult, C., Kibbe, W.A., Snoddy, J., Vitaterna, M., Swanson, D., Pretel, S., Li, Y. et al. 2004. A genome end-game: understanding gene function in the nervous system. Nat Neurosci 7: 484–455. Caddick, S.J., Wang, C., Fletcher, C.F., Jenkins, N.A., Copeland, N.G., and Hosford, D.A. 1999. Excitatory but not inhibitory synaptic transmission is reduced in lethargic (Cacnb4(lh)) and tottering (Cacna1atg) mouse thalami. J Neurophysiol 81: 2066–2074. Campbell, D.B., and Hess, E.J. 1998. Cerebellar circuitry is activated during convulsive episodes in the tottering (tg/tg) mutant mouse. Neuroscience 85: 773–783. Chafetz, R.S., Nahm, W.K., and Noebels, J.L. 1995. Aberrant expression of neuropeptide Y in hippocampal mossy fibers in the absence of local cell injury following the onset of spike-wave synchronization. Brain Res Mol Brain Res 31: 111–121. Cox, G.A., Lutz, C.M., Yang, C.L., Biemesderfer, D., Bronson, R.T., Fu, A., Aronson, P.S. et al. 1997. Sodium/hydrogen exchanger gene defect in slow-wave epilepsy mutant mice. Cell 91: 139–148. Crunelli, V., and Leresche, N. 2002. Childhood absence epilepsy: genes, channels, neurons and networks. Nat Rev Neurosci 3: 371–382 Culiat, C.T., Stubbs, L.J., Montgomery, C.S., Russell, L.B., and Rinchik, E.M. 1994. Phenotypic consequences of the deletion of the 3, 5, or 3 subunit of the type A-aminobutyric acid receptor in mice. Proc Natl Acad Sci U S A 91: 2815–2818. Dautigny, A., Mattei, M.G., Morello, D., Alliel, P.M., Pham-Dinh, D., Amar, L., Arnaud, D. et al. 1986. The structural gene coding for myelinassociated proteolipid protein is mutated in jimpy mice. Nature 321: 867–869. Di Palma, F., Belyantseva, I.A., Kim, H.J., Vogt, T.F., Kachar, B., and Noben-Trauth, K. 2002. Mutations in Mcoln3 associated with deafness
References and pigmentation defects in varitint-waddler (Va) mice. Proc Natl Acad Sci 99: 14994–14999. Engel, J. Jr., Wolfson, L, and Brown, L. 1978. Anatomic correlates of electrical and behavioral events related to amygdaloid kindling. Ann Neurol 3: 1212–1218. Fletcher, C.F., Lutz, C.M., O’Sullivan, T.N., Shaughnessy, J.D. Jr., Hawkes, R., Frankel, W.N., et al. 1996. Absence epilepsy in tottering mutant mice is associated with calcium channel defects. Cell 87: 607–617. Frankel, W.N., Taylor, L., Beyer, B., Tempel, B.L., and White, H.S. 2001. Electroconvulsive thresholds of inbred mouse strains. Genomics 74: 306–312. Frankel, W.N., Taylor, B.A., Noebels, J.L., and Lutz, C.M. 1994. Genetic epilepsy model derived from common inbred mouse strains. Genetics 138: 481–489. Green, E.L. Breeding systems. 1975. In The Biology of the Laboratory Mouse, 2nd ed. Ed. George D. Shell. Pp. 11–22. Dover, NY: The Jackson Laboratory. Helekar, S.A., and Noebels, J.L. 1991. Synchronous hippocampal bursting reveals network excitability defects in an epilepsy gene mutation. Proc Natl Acad Sci U S A 88: 4736–4470. Helekar, S.A., and Noebels, J.L. 1992. A burst-dependent hippocampal excitability defect elicited by potassium at the developmental onset of spike-wave seizures in the Tottering mutant. Brain Res Dev Brain Res 65: 205–210. Helekar, S.A., and Noebels, J.L. 1994. Analysis of voltage-gated and synaptic conductances contributing to network excitability defects in the mutant mouse tottering. J Neurophysiol 71: 1–10. Herson, P.S., Virk, M., Rustay, N.R., Bond, C.T., Crabbe, J.C., Adelman, J.P., and Maylie, J. 2003. A mouse model of episodic ataxia type-1. Nat Neurosci 6: 378–383. Hess, E.J., Collins, K.A., Copeland, N.G., Jenkins, N.A., and Wilson, M.C. 1994. Deletion map of the coloboma (Cm) locus on mouse chromosome 2. Genomics 21: 257–261. Houser, C.R. 1990. Granule cell dispersion in the dentate gyrus of humans with temporal lobe epilepsy. Brain Res 535: 195–204. Imbrici, P., Jaffe, S.L., Eunson, L.H., Davies, N.P., Herd, C., Robertson, R., Kullmann, D.M. et al. 2004. Dysfunction of the brain calcium channel CaV2.1 in absence epilepsy and episodic ataxia. Brain 127: 2682– 2692. Johnson, D.K., Stubbs, L.J., Culiat, C.T., Montgomery, C.S., Russell, L.B., and Rinchik, E.M. 1995. Molecular analysis of 36 mutations at the mouse pink-eyed dilution (p) locus. Genetics 141: 1563–1571. Kantheti, P., Diaz, M.E., Peden, A.E., Seong, E.E., Dolan, D.F., Robinson, M.S., Noebels, J.L. et al. 2003. Genetic and phenotypic analysis of the mouse mutant mh2J, an Ap3d allele caused by IAP element insertion. Mamm Genome 14: 157–167. Leenders, A.G., van den Maagdenberg, A.M., Lopes da Silva, F.H., Sheng, Z.H., Molenaar, P.C., and Ghijsen, W.E. 2002. Neurotransmitter release from tottering mice nerve terminals with reduced expression of mutated P- and Q-type Ca2+-channels. Eur J Neurosci 15: 13–18. Leppert, M., Anderson, V.E., Quattlebaum, T., Stauffer, D., O’Connell, P., Nakamura, Y., Lalouel, J.M. et al. 1989. Benign familial neonatal convulsions linked to genetic markers on chromosome 20. Nature 337: 647–648. Letts, V.A., Felix, R., Biddlecome, G.H., Arikkath, J., Mahaffey, C.L., Valenzuela, A., Bartlett, F.S. II et al. 1998. The mouse stargazer gene encodes a neuronal Ca2+-channel gamma subunit. Nat Genet 19: 340–347. Levitt, P., and Noebels, J.L. 1981. Mutant mouse tottering: selective increase of locus ceruleus axons in a defined single-locus mutation. Proc Natl Acad Sci U S A 78: 4630–4634. Liles, W.C., Taylor, S., Finnell, R., Lai, H., and Nathanson, N.M. 1986. Decreased muscarinic acetylcholine receptor number in the central nervous system of the tottering (tg/tg) mouse. J Neurochem 46: 977–982.
231
Lorenzetti, D., Antalffy, B., Vogel, H., Noveroske, J., Armstrong, D., and Justice, M. 2004. The neurological mutant quaking (viable) is Parkin deficient. Mamm Genome 15: 210–217. Ludwig, A., Budde, T., Stieber, J., Moosmang, S., Wahl, C., Holthoff, K., Langebartels, A. et al. 2003. Absence epilepsy and sinus dysrhythmia in mice lacking the pacemaker channel HCN2. EMBO J 22: 216–224 Magistretti, P.J., Hof, P.R., and Celio, M.R. 1987. Noradrenergic sub-sensitivity in the cerebral cortex of the tottering mouse, a spontaneously epileptic mutant. Brain Res 403: 181–185. Matysiak-Scholze, U., and Nehls, M. 1997. The structural integrity of ROR alpha isoforms is mutated in staggerer mice: cerebellar coexpression of ROR alpha1 and ROR alpha4. Genomics 43: 78–84. Mercer, J.A., Seperack, P.K., Strobel, M.C., Copeland, N.G., and Jenkins, N.A. 1991. Novel myosin heavy chain encoded by murine dilute coat colour locus. Nature 349: 709–713. Morgan, J.I., Cohen, D.R., Hempstead, J.L., and Curran, T. 1987. Mapping patterns of c-fos expression in the central nervous system after seizure. Science 237: 192–197. Morrison, R.S., Wenzel, H.J., Kinoshita Y., Robbins C.A., Donehower L.A., and Schwartzkroin, P.A. 1996. Loss of the p53 tumor suppressor gene protects neurons from kainate-induced cell death. J Neurosci 16: 1337–1345. Nahm, W.K., and Noebels, J.L. 1998. Nonobligate role of early or sustained expression of immediate-early gene proteins c-fos, c-jun, and Zif/268 in hippocampal mossy fiber sprouting. J Neurosci 18: 9245–9255. Nakayama, J., Fu, Y.H., Clark, A.M., Nakahara, S., Hamano, K., Iwasaki, N., Matsui, A. et al. 2002. A nonsense mutation of the MASS1 gene in a family with febrile and afebrile seizures. Ann Neurol 52: 654–657. Noebels, J.L. 1979. Analysis of inherited epilepsy using single locus mutations in mice. Fed Proc 38: 2405–2410. Noebels, J.L. 1996. Targeting epilepsy genes. Neuron 16: 241–244. Noebels, J.L. 1999. Single-gene models of epilepsy. Adv Neurol 79: 227–238. Noebels, J.L. 2003. The biology of epilepsy genes. Annu Rev Neurosci 26: 599–625. Noebels, J.L., and Rutecki, P.A. 1990. Altered hippocampal network excitability in the hypernoradrenergic mutant mouse tottering. Brain Res 524: 225–230. Noebels, J.L., and Sidman, RL. 1979. Inherited epilepsy: spike-wave and focal motor seizures in the mutant mouse tottering. Science 204: 1334–1336. O’Brien, T.P., and Frankel, W.N. 2004. Moving forward with chemical mutagenesis in the mouse. J Physiol 554: 13–21. Parent, J.M., Yu, T.W., Leibowitz, R.T., Geschwind, D.H., Sloviter, R.S., and Lowenstein, D.H. 1997. Dentate granule cell neurogenesis is increased by seizures and contributes to aberrant network reorganization in the adult rat hippocampus. J Neurosci 17: 3727–3738. Petersson, S., Persson, A.S., Johansen, J.E., Ingvar, M., Nilsson, J., Klement, G., Arhem, P. et al. 2003. Truncation of the Shaker-like voltage-gated potassium channel, Kv1.1, causes megencephaly. Eur J Neurosci 18: 3231–3240. Psarropoulou, C., and Kostopoulos, G. 1990. Long-term enhancement of postsynaptic excitability after brief exposure to Mg2(+)-free medium in normal and epileptic mice. Brain Res 508: 70–75. Qiao, X., and Noebels, J.L. 1993. Developmental analysis of hippocampal mossy fiber outgrowth in a mutant mouse with inherited spike-wave seizures. J Neurosci 13: 4622–4635. Qian, J., and Noebels, J.L. 2000. Presynaptic Ca(2+) influx at a mouse central synapse with Ca(2+) channel subunit mutations. J Neurosci 20: 163–170. Schauwecker, P.E. 2002. Complications associated with genetic background effects in models of experimental epilepsy. Prog Brain Res 135: 139–148. Scheffer, I.E., and Berkovic, S.F. 2003. The genetics of human epilepsy. Trends Pharmacol Sci 24: 428–433.
232
Chapter 17/Spontaneous Epileptic Mutations in the Mouse
Sidman, R.L., Green, M., and Appel, S.A. 1965. Catalog of the Neurological Mutations of the Mouse. Cambridge: Harvard University Press. Singh, N.A., Charlier, C., Stauffer, D., DuPont, B.R., Leach, R.J., Melis, R., Ronen, G.M. et al. 1998. A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat Genet 18: 25–29. Skradski, S.L., Clark, A.M., Jiang, H., White, H.S., Fu, Y.H., and Ptacek, L.J. 2001. A novel gene causing a mendelian audiogenic mouse epilepsy. Neuron 31: 537–544. Slesinger, P.A., Patil, N., Liao, Y.J., Jan, Y.N., Jan, L.Y., and Cox, D.R. 1996. Functional effects of the mouse weaver mutation on G proteingated inwardly rectifying K+ channels. Neuron 16: 321–331. Smart, S.L., Lopantsev, V., Zhang, C.L., Robbins, C.A., Wang, H., Chiu, S.Y., Schwartzkroin. P.A. et al. 1998. Deletion of the K(V)1.1 potassium channel causes epilepsy in mice. Neuron 20: 809–819. Song, I., Kim, D., Choi, S., Sun, M., Kim, Y., and Shin, H.S. 2004. Role of the alpha1G T-type calcium channel in spontaneous absence seizures in mutant mice. J Neurosci 24: 5249–5257. Stanfield, B.B. 1989. Excessive intra- and supragranular mossy fibers in the dentate gyrus of tottering (tg/tg) mice. Brain Res 480: 294–299. Steinlein, O.K., Mulley, J.C., Propping, P., Wallace, R.H., Phillips, H.A., Sutherland, G.R., Scheffer, I.E. et al. 1995. A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet 11: 201–203. Storey, T.W., Rho, J.M., White, S.S., Sankar, R., and Szot, P. 2002. Agedependent differences in flurothyl-induced c-fos and c-jun mRNA expression in the mouse brain. Dev Neurosci 24: 294–299. Sutula, T., Cascino, G., Cavazos, J., Parada, I., and Ramirez, L. 1989. Mossy fiber synaptic reorganization in the epileptic human temporal lobe. Ann Neurol 26: 321–330. Tehrani, M.H., and Barnes, E.M. Jr. 1990. Basal and drug-induced cAMP levels in cortical slices from the tottering mouse. Epilepsy Res 7: 205–209. Tehrani, M.H., and Barnes, E.M. Jr. 1995. Reduced function of gammaaminobutyric acidA receptors in tottering mouse brain: role of cAMPdependent protein kinase. Epilepsy Res 22: 13–21. Tonder, N., Kragh, J., Finsen, B.R., Bolwig, T.G., and Zimmer, J. 1994. Kindling induces transient changes in neuronal expression of somatostatin, neuropeptide Y, and calbindin in adult rat hippocampus and fascia dentata. Epilepsia 35: 1299–1308. van der Lugt, N.M., Domen, J., Linders, K., van Roon, M., RobanusMaandag, E., te Riele, H., van der Valk, M. et al. 1994. Posterior trans-
formation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene. Genes Dev 8: 757–769. van der Weyden, L., Adams, D.J., and Bradley, A. 2002. Tools for targeted manipulation of the mouse genome. Physiol Genomics 11: 133–164. Wakamori, M., Yamazaki, K., Matsunodaira, H., Teramoto, T., Tanaka, I., Niidome, T., Sawada, K. et al. 1998. Single tottering mutations responsible for the neuropathic phenotype of the P-type calcium channel. J. Biol. Chem. 273: 34857–34867. Waterston, R.H., Lindblad-Toh, K., Birney, E., Rogers, J., Abril, J.F., Agarwal, P. et al. 2002. Initial sequencing and comparative analysis of the mouse genome. Nature 420: 520–562. White, H.S., Johnson, M., Wolf, H.H., and Kupferberg, H.J. 1995. The early identification of anticonvulsant activity: role of the maximal electroshock and subcutaneous pentylenetetrazol seizure models. Ital J Neurol Sci 16: 73–77. Willow, M., Taylor, S.M., Catterall, W.A., and Finnell, R.H. 1986. Down regulation of sodium channels in nerve terminals of spontaneously epileptic mice. Cell Mol Neurobiol 6: 213–220. Yang, Y., Beyer, B.J., Otto, J.F., O’Brien, T.P., Letts, V.A., White, H.S., and Frankel, W.N. 2003. Spontaneous deletion of epilepsy gene orthologs in a mutant mouse with a low electroconvulsive threshold. Hum Mol Genet 12: 975–984. Zhang, Y., Mori, M., Burgess, D.L., and Noebels, J.L. 2002. Mutations in high-voltage-activated calcium channel genes stimulate low-voltageactivated currents in mouse thalamic relay neurons. J Neurosci 22: 6362–6371. Zhou, L., Zhang, C.L., Messing, A., and Chiu, S.Y. 1998. Temperature-sensitive neuromuscular transmission in Kv1.1 null mice: role of potassium channels under the myelin sheath in young nerves. J Neurosci 18: 7200–7215. Zuberi, S.M., Eunson, L.H., Spauschus, A., De Silva, R., Tolmie, J., Wood, N.W., McWilliam, R.C. et al. 1999. A novel mutation in the human voltage-gated potassium channel gene (Kv1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsy. Brain 122: 817– 825. Zuo, J., De Jager, P.L., Takahashi, K.A., Jiang, W., Linden D.J., and Heintz, N. 1997. Neurodegeneration in Lurcher mice caused by mutation in delta2 glutamate receptor gene. Nature 388: 769–773. Zwingman, T.A., Neumann, P.E., Noebels, J.L., and Herrup, K. 2001. Rocker is a new variant of the voltage-dependent calcium channel gene Cacna1a. J Neurosci 21: 1169–1178.
C
H
A
P
T
E
R
18 Genetic Models of Absence Epilepsy in the Rat Antoine Depaulis and Gilles van Luijtelaar
et al., 1994; Loiseau et al., 1995; Panayiotopoulos, 1999). Because typical absence epilepsies mainly affect children and teenagers and have moderate consequences, studies of their pathophysiological mechanisms cannot be conducted in humans for ethical reasons. Therefore, animal models are mandatory to understand this form of epilepsy and the mechanisms underlying the generation and control of SWD. Models displaying electrical, behavioral and pharmacologic characteristics of absence seizures have been used in rodents, cats or primates by injection of pentylenetetrazol, penicillin, gamma-hydroxybutyrate or GABA agonists (see Chapter 10). However, although these models have contributed to our understanding of SWD generation, the lack of recurrence of the seizures does not allow us to study the development of the disease. About 20 years ago, our two groups reported for the first time the spontaneous occurrence of SWDs evocative of absence seizures in untreated rats, as seen during cortical EEG recordings (Vergnes et al., 1982; van Luijtelaar and Coenen, 1986). These first observations led to the development and characterization of two genetic models of absence epilepsy in rats from two different initial breeding colonies. In Strasbourg (France), a fully inbred strain of rats, with 100% of animals displaying the EEG and behavioral characteristics of absence seizures, was derived from an outbred Wistar colony: the Genetic Absence Epilepsy Rats from Strasbourg (GAERS). The Wistar Albino Glaxo strain was inbred in the United Kingdom and then kept in Rijswijk (WAG/Rij) and later at Nijmegen (The Netherlands). It was already fully inbred when it was discovered that these rats had absence seizures. A strain of nonepileptic control animals was also selected in Strasbourg from the same
GENERAL DESCRIPTION OF THE MODELS: WHAT DO THEY MODEL? Absence epilepsy is a particular epileptic syndrome in which patients show generalized nonconvulsive seizures characterized by a brief unresponsiveness to environmental stimuli and cessation of activity, which may be accompanied by automatisms or moderate tonic or clonic components affecting the limbs, the eyeballs, or the eyelids (Loiseau et al., 1995; Panayiotopoulos, 1999). Typical absences seizures are associated on the electroencephalogram (EEG) with bilateral, synchronous and regular three cycles per second (c/s) spike-and-wave discharges (SWDs), which start and end abruptly. In contrast to generalized convulsive or partial seizures, there is no postictal depression or slowing following typical absences. They occur as frequently as several hundred times per day, mainly during quiet wakefulness, inattention, and at transitions between sleep and awakening, and generally last 10 to 20 seconds. The pharmacologic reactivity of absence seizures is also unique: They are suppressed by ethosuximide, which is ineffective in all other forms of seizures, whereas they are aggravated by carbamazepine, phenytoin, and some of the other antiepileptic drugs (AEDs) effective in generalized convulsive and partial seizures. Absences seizures are found in five nonlesional idiopathic generalized epileptic syndromes (Hirsch et al., 1994; Loiseau et al., 1995; Porter, 1993): childhood absence epilepsy, juvenile absence epilepsy, juvenile myoclonic epilepsy, myoclonic absence epilepsy, and eyelid myoclonia with absences. Besides absence seizures, patients do not present any other neurologic or neuropsychological disorders. In childhood absence epilepsy, remission is observed during adolescence in about 70% of the patients (Hirsch
Models of Seizures and Epilepsy
233
Copyright © 2006, Elsevier Inc. All rights of reproduction in any form reserved.
234
Chapter 18/Genetic Models of Absence Epilepsy in the Rat
initial breeding colony as the GAERS, whereas the Nijmegen group used another inbred strain as controls (August Copenhague Irish or ACI rats): These rats have no or very few absence seizures (Inoue et al., 1990). GAERS and WAG/Rijs have many similarities in the characteristics of their seizures, ontogeny, and pharmacologic reactivity. Yet they seem to differ in some features. Their study using different approaches, from electrophysiology to molecular genetics, has generated an incredible amount of data during the last 20 years on the mechanisms underlying SWD and has led to the publication of more than 400 articles. The present chapter reviews the data obtained in these two models and compares their respective features.
spontaneous SWD are usually associated with other neurologic disorders. For instance, lethargic mice (lh/lh) exhibit spontaneous SWDs together with ataxia and lethargic behavior (Hosford et al., 1992), whereas the tottering mice also display paroxysmal abnormal movements and postures (Noebels and Sidman, 1979) (see also Chapter 17). Spontaneous SWDs have also been reported in transgenic mice (see Chapter 16). A strain of mice that was selected for their sensitivity for a b-carboline was found to display spontaneous SWDs with behavioral and pharmacologic features similar to those of GAERS and WAG/Rij (Rinaldi et al., 2003).
Procedures METHODS OF GENERATION Animal Issues For the GAERS strain, epileptic rats were first selected from Wistar colonies that displayed spontaneous SWDs on routine cortical EEG. Breeding of selected pairs over three or four generations produced a strain with 100% of rats displaying SWDs (Vergnes et al., 1982; for review, see Danober et al., 1998). A control strain, free of SWD, was also selected over five or six generations. Since then more than 50 generations have been bred (see genetic description later). Through serendipity it was discovered in Nijmegen that the already fully inbred WAG/Rij strain of rats showed SWDs in their cortical EEG (van Luijtelaar and Coenen, 1986). The spontaneous occurrence of high-voltage rhythmic activities on cortical EEG of various types of laboratory rodents was also described by many authors (Buszaki et al., 1990; Chocholova, 1983; Inoue et al., 1990; Jando et al., 1995; Klingberg and Pickenhain, 1968; Libouban and Oswaldo-Cruz, 1958; Noebels, 1984; Semba and Komisaruk, 1984; Shaw, 2004; Willoughby and MacKenzie, 1992). The percentage of animals with such activities varies from 0 to 100%, depending on the species and the strain. However, in Wistar rats recorded at old age (i.e., 84 to 94 weeks), 100% of the animals display SWDs that are indistinguishable from those observed in GAERS and WAG/Rij rats (van Luijtelaar et al., 1995). This finding suggests that aging is associated with aggravation of SWDs. In Long Evans rats, several studies reported the occurrence of “highvoltage rhythmic spike discharges” concomitant with immobility and whisker twitching. These discharges have been suggested to be associated with movement disorder such as alpha tremors or a dynamic process of sensory information from vibrissa. Recently a detailed analysis of the EEG, behavioral, and pharmacologic characteristics of theses discharges has demonstrated that they are similar to absencelike SWD (Shaw et al., 2004). Contrary to what is observed with rats, most strains of mice do not present spontaneous SWDs. When observed,
In rats SWDs can be easily recorded through chronically implanted monopolar electrodes positioned over the cortex. Usually stainless steel jewelry screws or epidural wire electrodes are fixed in the skull of the frontal and parietal cortices in both sides of the brain with the rat under generalized anesthesia. A reference electrode is also fixed over the occipital cortex or over the cerebellum to allow referential recording. All electrodes are soldered to a female connector, which is fixed to the cranium of the animals with acrylic dental cement. After surgery the animals are habituated to the recording procedure by placing them in the test cage once or twice for a few hours. Depth electrodes can be also implanted using stereotaxic procedures, and animals can be equipped with multiunit electrodes, microinjection cannulae, or microdialysis probes as described for other models.
Monitoring Once implanted and habituated to the recording conditions, SWDs can be EEG recorded in freely moving animals for several hours or even days. As in humans, the level of vigilance plays a critical role in the occurrence of absence seizures (Coenen et al., 1991; Lannes et al., 1988). When GAERS or WAG/Rij rats are continuously recorded for 24 hours, most SWDs occur during a state of passive wakefulness or drowsiness and often are followed by or preceded slow-wave sleep. On the contrary, SWDs are sporadic during active arousal, deep slow-wave sleep, and paradoxical sleep. In addition, a sudden noise or handling of the animals generally interrupts SWDs. Because of these observations, the recording conditions are critical: Very few SWDs are recorded when the animals are placed in a new cage, when the cage has previously hosted a female or a mouse, or during performance of various motivated tasks. For methods that require a complete immobility of the animals (e.g., in vivo extra and intracellular electrophysiology, functional magnetic resonance imaging [fMRI]), most anesthetics cannot be used because they suppress SWDs. Instead, neuroleptic analgesia and local injections of lido-
Characteristics of Genetic Absence Seizures in the Rat
caine have been used to allow the fixation of the animals into a stereotaxic frame (Pinault et al., 1998). Using this preparation, spontaneous SWDs and extracellular unit activity can be recorded with the same pattern and occurrence as in the awake, freely moving rats (Deransart et al., 2003; Pinault et al., 2001), although an increase in the number of SWDs and a decrease in the frequency of interspikes has been found in WAG/Rij rats after anesthetic doses of Hypnorm (Inoue et al., 1994).
CHARACTERISTICS OF GENETIC ABSENCE SEIZURES IN THE RAT EEG Characteristics In both WAG/Rij and GAERS, SWDs start and end abruptly on a normal cortical desynchronized EEG background (Figure 1). In adult animals the frequency of spikewave complexes within a discharge can range from 7 to 11 c/s; the frequency is always higher at the beginning of the seizures and slows down toward the end (Drinkenburg et al., 1993; Midzianovskaia et al., 2001; Meeren et al., 2002; Slaght et al., 2002) (see Figure 1). The mean frequency is 8.0 ± 1.0 c/s in both strains. Their voltage varies from 300 to 1000 mV, depending on the structure that is recorded (see later discussion). When GAERS are maintained in a state of quiet wakefulness, SWDs generally last for about 25 ± 8
235
seconds, a duration that varies from one animal to the next because some animals can display SWDs lasting up to 60 seconds. In this strain, absence seizures occur about every minute on average, depending on the time of the day and the recording conditions (Vergnes et al., 1982; Marescaux et al., 1992a, 1984; Vergnes et al., 1982). In undisturbed WAG/Rij rats, SWDs last about 5 seconds. In 6-month-old WAG/Rij rats, the number of SWDs is about 15 to 20 per hour, and the circadian distribution shows few SWDs during the beginning of the sleep period, when rats have the largest amount of deep slow-wave sleep, which seems incompatible with the occurrence of SWDs. The maximum number of SWDs can be found during the dark period of the 24-hour light-dark cycle (van Luijtelaar and Coenen, 1988). Postictal depression of the EEG is never observed in either strain. In WAG/Rij rats two types of SWDs have been described (van Luijtelaar and Coenen, 1986). The first type occurs commonly in all animals and is similar to the SWDs described in GAERS (Figure 2). It is the most often studied absence seizure type. The second type of SWD, which is seen in about 60% of the WAG/Rij rats, is a “local” SWD that is recorded bilaterally at the occipital and parietal cortices (Midzianovskaia et al., 2001). Its frequency is 6 to 7 c/s (i.e., lower than that of the first type), and its duration is 1 to 2 seconds. In addition, the polarity of the spikes is opposite that of the first type (Figure 2). Finally the number of SWDs per hour is three to five, which is also less than that of the first type. The number of this type of SWD and the number of animals with this type of SWD also increase with age.
Cx FP R
Behavioral Characteristics
Cx FP L
500 µV 2s
(Hz) 50 30 10
Cx FP R Cx FP L 500 µV 1s
FIGURE 1 Example of cortical electroencephalographic (EEG) recording of a spike-and-wave discharge in the genetic abscense epilepsy rats from Strasbourg (GAERS) and corresponding spectral analysis. Bottom, lower speed recording of the discharge showing the spike-wave complex. Cx FP R, right frontoparietal derivation; CxFP L, left frontoparietal derivation. (Courtesy of Colin Deransart.) (See color insert.)
The SWDs are always concomitant with behavioral immobility and sometimes rhythmic twitching of the vibrissae and facial muscles. Muscle tone in the neck is generally diminished, inducing a gradual and slight lowering of the head. Simultaneously with the end of the SWD, the animal resumes its behavior and the muscle tone of the neck is restored (Marescaux et al., 1992a, 1984; van Luijtelaar and Coenen, 1986; Vergnes et al., 1982). Comparisons with nonepileptic rats have shown that spontaneous activity, exploration, feeding, social interactions, or learning of positively or negatively reinforced tasks are not impaired in GAERS or WAG/Rij rats. Similarly sexual and reproductive behaviors also appear normal (Coenen et al., 1991; Vergnes et al., 1991). However, recent data reported that WAG/Rij rats show decreased exploration, increased immobility in the forced swim test, and reduced sucrose intake compared with Wistar control rats (Sarkisova et al., 2004). When GAERS were trained to press on a lever to obtain food reward, they always interrupted their conditioned behavior during SWDs and resumed it on cessation of the seizure (Vergnes et al., 1991). The absence of motor responses in a positively moti-
236
Chapter 18/Genetic Models of Absence Epilepsy in the Rat
FIGURE 2 The two types of seizures in the Wistar Albino Glaxo/Rijswijk strain (WAG/Rij) of rat. The first is a type II SWD, which is followed by a type I SWD (similar to that shown in Figure 1). The trace shows a differential electroencephalographic (EEG) recording with two active EEG electrodes, one at the frontal and one at the parietal cortex (courtesy of Ulrich Schridde).
vated discrimination task during the presence of a SWD was also typical for WAG/Rij rats, although the postictal responses were less accurate. In addition, WAG/Rij rats do not evaluate correctly the time that has passed when a SWD occurs, just as in children with absence epilepsy (van Luijtelaar et al., 1991a, b). Together, these findings suggest that the animals are less able to initiate or execute an adequate motor response during or after a SWD and that their perception of elapsed time is disturbed (Drinkenburg et al., 1995). However, this disturbance does not imply that all cognitive functions are impaired during SWDs: When auditory stimuli were presented during a SWD, WAG/Rij rats were able to discriminate between a previously rewarded and a previously nonrewarded tone (Drinkenburg et al., 2003).
Ontogeny In GAERS, SWDs are first detected around 30 days of age, whereas they are observed at around 60 to 80 days in WAG/Rij (Vergnes et al., 1986; Coenen and van Luijtelaar, 1987; Schridde and van Luijtelaar, 2004). At 40 days about 30% of the GAERS are affected, and this percentage increases gradually with age to reach 100% at the age of 3 months. The first SWDs are rare (1 or 2 per hour) and shortlasting (1–3 seconds), with a lower frequency of SWDs during a discharge (4–5 per second). With age, the number, the duration, and the frequency of SWDs increase, whereas their amplitude is not modified. Their number reaches a maximum at around 4 to 6 months. A similar but delayed development can be observed in WAG/Rij rats. At the age of 3 months, 50% of the WAG/Rij display fully developed SWDs, and at 6 months of age 100% of the animals show SWDs (Coenen and van Luijtelaar, 1987). SWDs can be recorded in both strains until the death of the animals (van Luijtelaar et al., 1995; Vergnes et al., 1986).
Neuropathology Depth-recording EEG, intracerebral microinjection, and lesion and in vivo electrophysiologic studies have shown
that the thalamocortical interconnections are critical in the generation of SWDs in both GAERS and WAG/Rij (see later discussion on generating circuits). In these structures, no gross histologic modifications were ever observed. In particular, no neuronal loss was detected in the reticular and ventrolateral-posterior nuclei of the thalamus in GAERS (Sabers et al., 1996). Furthermore the synaptic organization of the reticular nucleus of WAG/Rij appears very similar to that of controls (van de Bovenkamp-Janssen et al., 2004b). An increase of glial fibrillary acidic protein (GFAP) expression has been reported in the cortex and the thalamus in both adult and young GAERS, suggesting that reactive astrocytes are already present before the onset of absence seizures (Dutuit et al., 2000). Recently, detailed morphometric studies of the upper granular layer showed that pyramidal cells in layer II-III of the somatosensory cortex in WAG/Rij rats exhibit aberrant dendritic arborization, increased length of dendritic segments, and differences in the number of free terminations of apical dendrites compared with control rats (Karpova et al., 2005). How these dendritic changes are related to increased excitability or capacity to synchronize remains to be established.
Imaging and Metabolic Changes Local cerebral metabolic rates for glucose (LCMRglc) have been measured in several brain structures using the [14C]-2-deoxyglucose method in adult GAERS to map the neuronal circuits involved in the generation and control of SWDs (Nehlig et al., 1991, 1994) (see also Chapter 47). An overall increase in LCMRglc was observed in most structures whether they exhibit SWDs (i.e., neocortex and thalamus) or not (e.g., limbic and brainstem structures). However, because of the long duration of a 2-deoxyglucose experiment (i.e., 45 minutes), the cerebral metabolic level recorded represents a combination of ictal and interictal phases. These results suggest that GAERS may have a higher glucose metabolism than nonepileptic controls, which seems to reflect primarily the interictal periods (see Chapter 47).
237
Characteristics of Genetic Absence Seizures in the Rat
Using laser-Doppler flowmetry, it was shown that SWD in GAERS were associated with a decrease in the level of cerebral blood flow at the surface of the parietal cortex, which started 2 to 7 seconds after the onset of the cortical SWDs. At the end of SWDs, cerebral blood flow returned to baseline level (Nehlig et al., 1996). In a recent study using an intracerebral probe that combines laser-Doppler flowmetry and extracellular microelectrode recording, a parallel increase of cerebral blood flow and neuronal activity was observed in the somatosensory cortex of WAG/Rij (Nersesyan et al., 2004). Whether these opposite data are due to the difference in the techniques used, to the difference between the two strains, or to the differences in localization remains to be further examined. Two studies used functional magnetic resonance imaging (fMRI) to characterize more fully, in a noninvasive way, the neural circuits involved in the generation of absence seizures in the WAG/Rij (Nersesyan et al., 2004; Tenney et al., 2004). Using T2-weighted echo planar imaging, the bloodoxygenation-level dependent (BOLD) signal coupled with EEG was analyzed (1) in awake rats previously habituated to the experimental conditions (Tenney et al., 2004) or (2) in fentanyl-haloperidol anesthetized animals (Nersesyan et al., 2004). Comparisons of images during spontaneous SWDs and interictal activity showed in both studies an increase of more than 6% of the BOLD signal in the sensory, parietal, and temporal cortices as well as in the reticular, mediodorsal, ventroposterior, and posterior nuclei of the thalamus. No significant changes were seen in temporal or limbic structures (e.g., hippocampus), and no significant negative BOLD signal was observed for any seizures. These data are thus in agreement with neurophysiologic data showing the role of the sensorimotor cortex and relay thalamic nuclei in the generation of SWD (see later). When seven Tesla MRI was used, however, an increase in BOLD signal was also observed in the hippocampus, the basal ganglia nuclei, and the tectum and tegmental nuclei. The local changes in BOLD signal recorded with a 7 Tesla magnet are also in agreement with increases in LCMRglc recorded in 21-day-old GAERS before the occurrence of SWD in this strain (Nehlig et al., 1998). These changes confirm that although SWDs are recorded only in the thalamocortical circuit, the mutations allowing the expression of absence epilepsy are ubiquitously expressed across the whole nervous system and most likely affect also the functional activity of structures located outside the generating circuit. It must be noted that no significant or consistent SWD-related decreases of fMRI have been observed in both studies using WAG/Rij. This contrasts with other fMRI/EEG studies performed on either other animal models (Tenney et al., 2003) or in patients (Archer et al., 2003; Salek-Haddadi et al., 2003). In these studies, numerous cortical areas have shown a decrease in BOLD signal following SWD. However, more work is necessary to draw any conclusion
about the functional significance of the distinction between increase and decrease in the BOLD signal. fMRI/EEG is a promising technique that will certainly be of great help in understanding the organization of the different circuits involved in the generation, propagation, and control of SWD. It should bring further insights in epileptic mechanisms when it becomes possible to disentangle neuronal processes from fMRI data by using detailed generative model of fMRI signals (Aubert and Costalat, 2002; Friston et al., 2003).
Response to Antiepileptic and Proconvulsant Drugs Classic AEDs have been tested on GAERS and WAG/Rij rats to check how pharmacologically predictable models are. Indeed, SWDs are suppressed by the four main AEDs that are effective against human absence seizures (ethosuximide, trimethadione, valproate, and benzodiazepines). On the contrary, they are worsened by drugs that are either ineffective or aggravating in humans (carbamazepine, phenytoin) (Table 1) (Micheletti et al., 1985). Phenobarbital evokes biphasic effects: it is suppressive at 2.5 to 10 mg/kg, but not at 20 mg/kg (Micheletti et al., 1985; Peeters et al., 1988). Almost all recently developed AEDs have been tested in either GAERS or WAG/Rij to evaluate their possible efficacy on absence seizures (see Table 1). Drugs like vigabatrin, tiagabine, and gabapentin have been shown
TABLE 1 Effects of Antiepileptic Drugs on Spike-Wave Discharges in Humans with Typical Absence Epilepsy and in Rat Models of Absence Epilepsy Antiepileptic drugs
Humans*
Rat models
Benzodiazepines
Suppression
Barbiturates
Biphasic effects
Suppression Biphasic effects
Valproate
Suppression
Suppression
Ethosuximide
Suppression
Suppression
Trimethadione
Suppression
Suppression
Carbamazepine
Aggravation
Aggravation
Phenytoin
Aggravation
Aggravation
Gabapentin
Aggravation
Aggravation
Lamotrigine
Suppression
No effects
Levetiracetam
Suppression
Suppression
Pregabalin
Suppression
Suppression
Progabide
No effects
No effects
Tiagabine
Aggravation
Aggravation
Topiramate
Suppression
Suppression
Vigabatrin
Aggravation
Aggravation
* From Panayiotopoulos 1999.
238
Chapter 18/Genetic Models of Absence Epilepsy in the Rat
to aggravate SWDs, whereas progabide is ineffective (Bouwman et al., 2004; Coenen et al., 1995; Marescaux et al., 1992a, b; van Luijtelaar et al., 2002). On the contrary, topiramate, levetiracetam, and pregabalin suppress SWDs (Gower et al., 1995; Rigoulot et al., 2003). Together, the data in the two animal models show a great similarity with the pharmacologic reactivity of typical absence epilepsy in human (Panayiatopoulos, 1999; Schlumberger et al., 1994). The pharmacologic predictability of these models is further confirmed by the aggravation of SWDs induced by drugs like pentylenetetrazol, gamma-hydroxybutyrate, tetrahydroisoxazolopyridinol (THIP), or penicillin that are known to induce “absence-like” discharges in normal rats (Marescaux et al., 1984, 1992a; Snead, 1988, 1994). More generally the reactivity of seizures to g-aminobutyric acid (GABA)ergic compounds differs from what is generally observed in models of convulsive seizures. In GAERS, intraperitoneal administration of GABAA agonists (muscimol and THIP), GABA transaminase inhibitors (gammavinyl GABA and l-cycloserine), or GABA reuptake inhibitors (SKF 89976 and tiagabine) induces a dosedependent increase in the duration of SWDs (Coenen et al., 1995; Marescaux et al., 1992b; Vergnes et al., 1984). Similarly the injection of R-baclofen, a GABAB agonist, increased SWDs in GAERS or in old Wistar rats, whereas administration of CGP 35348 and other GABAB antagonists suppresses seizures (Marescaux et al., 1992c; Puigcerver et al., 1996). GAERS and WAG/Rij also appear more sensitive to the convulsive effects of systemic injections of GABAA antagonists (picrotoxin, bicuculline, or pentylenetetrazol [PTZ]) and benzodiazepine inverse agonists compared with rats of the nonepileptic strain (Klioueva et al., 2001; Vergnes et al., 2001). This sensitivity suggests a possible dysfunction of GABAA receptors in absence epilepsy (see later discussion). It is interesting to note that SWDs also appear to be modulated by ligands of the dopamine receptors, as in human patients (see Starr, 1996). Systemic injections of agonists of the D1 and D2 receptors were shown to suppress absence seizures in both GAERS and WAG/Rij (van Luijtelaar et al., 1996; Warter et al., 1988). On the contrary, antagonists of these receptors such as haloperidol significantly increase the number and duration of SWD and may lead to an absence status. However, no seizures are induced by these compounds in nonepileptic animals. This pharmacologic reactivity to dopaminergic ligands may result from their effects on the basal ganglia circuits known to modulate SWDs (De Bruin et al., 2001; Deransart et al., 2000). It is interesting to note that, in the WAG/Rij, an inverse reactivity to dopaminergic agonists is observed for type II SWDs, which are suppressed by haloperidol but aggravated by the DA agonist apomorphine (Midzianovskaia et al., 2001). However, AEDs like tiagabine or vigabatrin increased both type I and type II SWDs (Bouwman et al., 2004; Coenen et al., 1995).
Many other ligands of receptors influence SWDs. The best studied are the effects of glutamatergic and cholinergic drugs and opioid peptides (e.g., Danober et al., 1998; Lason et al., 1995; Peeters et al., 1990a). However, it is beyond the scope of this review to discuss the effects of these compounds.
Genetic Transmission and Chromosomal Mapping WAG/Rij are fully inbred rats, which means that they are homozygous for all autosomal genes. All individuals display SWDs on their EEG. In the initial colonies of Wistar rats in Strasbourg, 30% of the animals showed spontaneous SWDs. Breeding of selected parents over three or four generations produced a strain in which 100% of the rats were affected. Indeed, both data sets demonstrate that transmission of SWDs is inherited (Marescaux et al., 1992a; Peeters et al., 1990b, 1992). In epileptic ¥ nonepileptic F1 generations, more than 95% of the animals showed SWDs after 6 months, suggesting a dominant transmission, and similar SWDs were recorded in male and female animals, indicating that the transmission is autosomal. Interindividual variability for age of appearance and duration of SWDs is extremely high, supporting the view that the inheritance of SWD is probably not due to a single gene locus or that environmental effects might play a role. This mode of inheritance was confirmed in F2 (F1 ¥ F1) and backcross (F1 ¥ control) generations in both GAERS and WAG/Rij (Marescaux et al., 1992a; Peeters et al., 1992). Recent efforts to manipulate characteristics (e.g., the number, incidence, mean duration) of type I and type II SWDs by housing WAG/Rij in an enriched environment demonstrated that type I SWDs were less sensitive to environmental factors such as housing. This result demonstrates that genetic factors are more important than the contribution of the environment to the phenotypical expression of SWD. Type II SWD, however, appear more easily affected by the environment (Schridde and van Luijtelaar, 2004). After EEG recordings in an F2 population of rats resulting from the breeding of GAERS and Brown Norway rats, the polygenic inheritance of SWD-related phenotypes was demonstrated (Rudolf et al., 2004). Three quantitative trait loci (QTLs) were identified on chromosomes 4, 7, and 8, which appear to control different variables of SWD (e.g., frequency, amplitude, severity). In this study, age was a major factor influencing the detection of genetic linkage to the various components of the SWDs. Using a similar method, two different QTLs were characterized in a WAG/Rij ¥ ACI F2 population, which are located in chromosomes 5 and 9 (Gauguier et al., 2004). Each of these QTLs appear to control independently the two types of SWDs which have been described in this model. Although some differences in the experimental designs may account for different QTLs for GAERS and WAG/Rij rats, the
239
Insights Into Human Disorders
identification of distinct QTLs suggests that SWDs have been fixed in these two strains (Gauguier et al., 2004).
VALIDITY OF THE MODELS AND THEIR LIMITATIONS In both GAERS and WAG/Rij, the behavioral and EEG patterns during SWD share several points of similarity with those observed in humans during absence seizures (Loiseau, 1992; Loiseau and Cohadon, 1970; Panayiatopoulos, 1999). Furthermore, as in humans, SWDs occur within restricted limits of vigilance state, corresponding to quiet wakefulness or somnolence (Mirsky et al., 1986; Niedermeyer, 1996). Both genetic models have an almost identical pharmacologic reactivity to human absence epilepsy. However, several discrepancies exist with human absence epilepsy. First, in patients with typical absence epilepsy, the frequency of SWDs is around 3 c/s, whereas it varies from 7 to 11 c/s in the two rat models. A frequency of 3 c/s appears difficult, if not impossible, to observe in rodents (Avoli, 1980; McQueen and Woodbury, 1975), and SWDs with such a rhythmicity have been observed only in primates during pharmacologically induced absence seizures. This finding suggests that the frequency of SWDs, like other oscillations, is species dependent (Snead, 1978). Second, absence epilepsies are known to be associated with brain development and maturation (see Crunelli and Leresche, 2002). In humans, typical childhood absence epilepsy occurs between the ages of 2 and 8 years and remissions occur around puberty in most patients (Loiseau, 1992; Loiseau and Cohadon, 1970; Loiseau et al., 1995). In GAERS and WAG/Rij, SWDs first occur around 30 or 60 days, that is, when brain maturation is finished in the rat. Furthermore, unlike in humans, they persist throughout the life of the animals. The mechanisms underlying the remission of SWD in human remain unknown, but it is very likely that they belong to brain maturation processes that may not exist in rodents. Definite evidence to validate these strains as models of absence epilepsy will come from our knowledge of the genetic mechanisms at the origin of SWD generation. Indeed, human absence epilepsies appear to be genetically determined. In homozygous twins, concordance rates of 84% for EEG discharges and 75% for absence seizures were found, whereas heterozygous twins showed no concordance (Lennox and Lennox, 1960). In some families, the high incidence of 3 c/s SWDs during scalp EEG performed in firstdegree relatives suggests a monogenic autosomal-dominant mode of inheritance (Gloor et al., 1982). In addition, evidence of genetic linkage to human 8q24 has been found in absence epilepsy associated with tonic-clonic seizures (Sugimoto et al., 2000). Furthermore, an association was found between absence epilepsy and the genetic variants in the GABAA receptor subunit b-3 located on human
15q11-q13 (Feucht et al., 1999). Finally, a mutation of the GABAA receptor g-2 subunit gene located on chromosome 5 was found in a family with childhood absence epilepsy and febrile seizures (Marini et al., 2003; Wallace et al., 2001). In this latter case, the mutation seems to be associated with febrile seizure rather than with absence epilepsy. In summary, absence epilepsy appear to result from a polygenic control in both rodents and humans. It is quite possible that the occurrence of SWDs is the result of a combination of several genes.
INSIGHTS INTO HUMAN DISORDERS Because most characteristics of absence seizures in GAERS and WAG/Rij are highly reminiscent of human absence epilepsy, these two strains have become models of reference for studying the mechanisms underlying SWDs. Several articles have addressed this issue, which is still under debate. Only a general overview is presented in the following sections of this chapter.
Underlying Mechanisms Neurophysiologic experiments in either the GAERS or the WAG/Rij animal models have clearly implicated the coupling of thalamic oscillations and cortical rhythms as the cause of SWDs. This is partly in agreement with the previous hypothesis proposed from data collected from cats, in which SWDs were elicited by injection of penicillin (see Gloor, 1968). Early accumulated data suggest a predominant role of the thalamic neurons in the generation of SWD (Danober et al., 1998). In addition, multisite recordings have provided evidence for a critical role of the sensorimotor cortex (Meeren et al., 2002). Role of Thalamic Hypersynchronization Depth EEG recordings performed with bipolar electrodes, as well as electrolytic or chemical lesions, have shown that the relay nuclei of the thalamus are critical in the generation of SWD. Indeed, in addition to the lateral frontoparietal cortex, where they were first recorded, highamplitude SWDs were also collected in the posterolateral thalamus. On the contrary, SWDs are strongly reduced and delayed in the anterior and midline nuclei of the thalamus, the striatum, the lateral hypothalamus, and the ventral tegmentum (Marescaux et al., 1992a; Vergnes et al., 1990). The importance of the relay nuclei was confirmed by lesion studies in which they abolished SWDs (Vergnes and Marescaux, 1992, 1995). It is noteworthy that SWDs have never been recorded in the hippocampus or in any limbic structures (i.e., septum, amygdala, cingular and piriform cortex) in GAERS (Marescaux et al., 1992a; Vergnes et al.,
240
Chapter 18/Genetic Models of Absence Epilepsy in the Rat Cortex
I
Glutamatergic synapse γA GABAA
II-III
γB GABAB Electrical coupling
IV γA γB
V VI
γA γB Thalamic relay nucleus
nRT γA
Pre-thalamic afferent
FIGURE 3 A schematic representation of the thalamocortical interactions. NRT, nucleus reticularis of the thalamus. (Courtesy of Pierre-Olivier Polack.)
1987, 1990) or in the WAG/Rij model (Inoue et al., 1993; Kandel et al., 1996). Organization of the Thalamocortical Circuit The thalamus is the major source of subcortical inputs to the cerebral cortex. Most of the thalamocortical axons terminate in cortical layers IV and III (Alloway et al., 1993; Jones, 1985; Lu and Lin, 1993). Reciprocally, pyramidal cells from the cortical layers V and VI provide an important innervation to the thalamus (Boussara et al., 1995; Burkhaler and Charles, 1990; Chmielowska et al., 1989; Jones, 1985), and thalamocortical and corticothalamic connections are mainly glutamatergic (Deschênes and Hu, 1990; Fonnum et al., 1981; Kanedo and Mizumo, 1988; Kharazia and Weinberg, 1994; Ottersen et al., 1983; Zilles et al., 1990). In addition, all thalamic relay nuclei receive a massive GABAergic inhibitory projection from the reticular thalamic nucleus, the primary source of GABA in the rat thalamus (Cox et al.,
1996; De Biasi et al., 1988; Jones, 1985; Pinault et al., 1995). Reticular thalamic neurons do not project directly to the cerebral cortex; rather, they receive excitatory collaterals from thalamocortical and corticothalamic neurons (Bourassa et al., 1995; Contreras et al., 1993; de Curtis et al., 1989; Frassoni et al., 1984; Harris, 1987; Jones, 1985; Luebke, 1993; Spreafico et al., 1991; Warren et al., 1994) (Figure 3) (see also Chapter 7). Electrophysiologic in vitro and in vivo studies have shown that thalamocortical neurons spontaneously exhibit two different modes of intrinsic activity during various states of the wakefulness-sleep cycle (Llinas, 1988; McCormick, 1992; McCormick and Bal, 1997; Steriade, 1993; Steriade and Deschênes, 1984; Steriade et al., 1993). Periods of wakefulness and attentiveness are associated with a tonic mode of discharge of fast, sodium- and potassiummediated action potentials, allowing transmission of information to the cortex (Llinas, 1988; McCormick, 1992). On
Insights Into Human Disorders
the contrary, during stages of drowsiness and slow-wave sleep, thalamocortical neurons generate bursts of spikes triggered by rhythmic low-threshold calcium spikes (Leresche et al., 1991; Llinas, 1988; McCormick, 1992; McCormick and Pape, 1990; Steriade, 1993; Steriade and Deschênes, 1984; Steriade et al., 1993). For more information about the organization and functions of the reticular nucleus, see the review by Pinault (2004). Neurons of the thalamocortical and reticular nuclei have the capability of generating spindles, a typical oscillatory activity (Crunelli and Leresche, 1991; Gloor et al., 1990; McCormick, 1992; McCormick and Bal, 1997; Steriade, 1990; Steriade et al., 1993). Spindles consist of rhythmic oscillations of 7 to 14 c/s that occur during the initial phase of slow-wave sleep (Steriade, 1993; Steriade and Deschênes, 1984). In vivo and in vitro recordings have demonstrated that these oscillations are generated by GABAergic inhibitory neurons of the reticular thalamic nucleus, imposing synchronous inhibitory postsynaptic potentials (ipsps) in a rhythmic manner to thalamocortical neurons (Bal and McCormick, 1993; Destexhe et al., 1996; Steriade, 1993; Steriade and Deschênes, 1984; Steriade et al., 1993; Von Krosigk et al., 1993). Recent in vivo studies indicate that corticothalamic glutamatergic projections to the reticular and relay thalamic neurons strongly reinforce the synchronization of spindles throughout the thalamocortical circuit (Contreras and Steriade, 1996; Contreras et al., 1996). Activity of Thalamocortical and Reticular Neurons During SWDs and Their Relationship with Spindles In GAERS models, in vivo extracellular and intracellular recordings showed that thalamocortical neurons fire during the spike component of the SWD (Pinault et al., 1998). Similarly, extracellular recordings showed that thalamic neurons located in the ventrolateral and ventroposterior nuclei fire in phase with the spike component of the SWDs in WAG/Rij rats (Inoue et al., 1993). In these neurons, the phasic discharges are generated by a rhythmic excitatory postsynaptic potential/GABAA inhibitory postsynaptic potential sequence superimposed on a tonic hyperpolarization (Pinault et al., 1998). The GABAA-mediated inhibition appears to result from reticular inputs. Similarly, a large-amplitude hyperpolarization was recorded in the reticular neurons at the start of a SWD and a short interruption of burst firing was shown to occur during the early phase of a SWD, which is mediated by a slowly decaying depolarization (Slaght et al., 2002). During the full development of SWD, thalamocortical and reticular neurons progressively discharge in synchrony about 12 ms before the spike component of the SWD complex, suggesting that both types of neurons are driven by a common input (Pinault et al., 2001). It has been suggested that thalamic circuits underlying SWDs are the same as those generating spindles (van
241
Luijtelaar, 1997), and the reticular nucleus has been proposed to be a pacemaker for both kinds of oscillations (Avanzini et al., 1992, 1993, 2000; Seidenbecher et al., 1998). However, this hypothesis has never been conclusively demonstrated. In particular, SWDs do not always occur during the same state of vigilance as spindles, and this hypothesis does not explain the bilateral and widespread generalization of SWDs. Furthermore, short-lasting (<3 seconds) bursts of 5- to 9-c/s oscillations of medium voltage were recorded interictally in the GAERS but also in nonepileptic rats and are concomitant with immobility (Pinault et al., 2001). These bursts occur during quiet wakefulness associated with desynchronized EEG and are distinct from spindles, which are observed during sleep, with a higher frequency (10 to 16 c/s) and for a shorter duration. Such 5- to 9-c/s bursts often precede SWDs in GAERS, and the extracellular patterns of discharges of thalamocortical and reticular neurons in both GAERS and nonepileptic rats are very similar to what is recorded during SWDs. These observations suggest that SWDs and medium-voltage 5- to 9-c/s oscillations share similar cellular mechanisms and that SWD may evolve from 5- to 9-c/s oscillations in GAERS, probably as a result of some genetically mediated dysfunctions in the thalamocortical network (Pinault et al., 2001). Role of GABAergic Neurotransmission The possibility that the thalamus, and more particularly the GABAergic projections coming from the reticular thalamic nucleus, play a critical role in the generation of SWD was raised by the key role of the GABAergic receptors in the capability of the thalamic neurons to generate rhythmic oscillations (Crunelli and Leresche, 1991; McCormick, 1992; Steriade et al., 1993). The aggravating effect observed following microinjections of GABAA and GABAB agonists into relay nuclei, as well as the suppression of SWD induced by injection of GABAB antagonists into the same sites (Liu et al., 1991; 1993; Marescaux et al., 1992c), suggested that a thalamic enhancement of GABAergic neurotransmission could underlie absence seizures by increasing thalamic synchronizing mechanisms. Indeed, an increase in the extracellular concentration of GABA in thalamic relay nuclei was shown in GAERS by microdialysis (Richards et al., 1995). This increase appears to result from a lower uptake of GABA that is probably mediated by the GABA transporter-1 in the thalamus of GAERS (Sutch et al., 1999). However, no differences in the number of GABAergic neurons that are immunoreactive to GABA and to its synthesis enzyme glutamic acid decarboxylase (GAD) (Spreafico et al., 1993) were observed in the thalamic reticular nucleus between adult GAERS and nonepileptic control rats. Likewise autoradiographic and immunocytochemical studies have reported that the number, affinity, and expression of GABAA receptor subtypes were identical in the reticular and relay thalamic nuclei between adult GAERS and control nonepileptic
242
Chapter 18/Genetic Models of Absence Epilepsy in the Rat
rats (Knight and Bowery, 1992; Snead et al., 1992; Spreafico et al., 1993). Nevertheless GAERS were reported to be more sensitive to the convulsive effects of antagonists of the GABAA receptor as well as to benzodiazepine inverse agonists, whereas no differences were found for convulsions induced by glutamate analogues (Vergnes et al., 2000). In particular, the b-carbolines (FG 7142 and DMCM) and the imidazobenzodiazepines (RO 19-4603) were several times more convulsant in GAERS than in nonepileptic rats (Vergnes et al., 2001). These convulsions mainly involve the cortex and the hippocampus and suggest that, in these structures, the number of GABAA receptors and their intrinsic binding properties are different in GAERS. However, no differences were found in the number and sensitivity of the GABAA receptors in the two strains (Vergnes et al., 2001); these findings are in agreement with previous studies. Furthermore the inhibitory response to clonazepam was not significantly modified in the nucleus reticularis in GAERS (Badiu, 2004). It is presently difficult to explain, at the cellular level, the increased sensitivity of rats with absence epilepsy to drugs reducing the GABAA mediated neurotransmission. GABAB receptor activation mediates a late and longlasting inhibitory postsynaptic potential, which produces the hyperpolarization necessary to elicit rhythmic low-threshold calcium currents (IT). Such de-inactivation of these calcium channels results in repeated bursts of action potentials in thalamocortical neurons and may be involved in the generation of SWDs (Crunelli and Leresche, 1991). In particular, intracellular recordings of nRT neurons suggested that the large-amplitude hyperpolarization of these neurons during SWD is mediated by GABAB (Slaght et al., 2002). Using an autoradiographic method, no significant difference in [3H]GABA binding to GABAB receptor in the thalamus was found between adult GAERS and control nonepileptic rats (Knight and Bowery, 1992). Similarly, the density and affinity of GABAB receptors, measured with GABAB agonist and antagonist radioligands [3H]-CGP 27492 and [3H]-CGP 54626, respectively, on thalamic membranes (Mathivet et al., 1994; 1996) appeared similar in adult GAERS and in control rats. However, a recent study using in situ hybridization and immunohistochemistry showed an increase of mRNA coding for the GABAB1 subunit in the somatosensory cortex in GAERS, whereas a decrease was observed in the ventrobasal nuclei (Princivalle et al., 2003). On the contrary, an increase in both B1 and B2 subunits was observed in all regions, suggesting the existence of an up-regulation of the GABAB receptor in GAERS. These data were obtained in adult rats and may result from reiteration of SWD. It is thus difficult to determine whether an overexpression of GABAB receptor is a key factor in SWD ontogeny. In GAERS, the amplitude of the IT calcium current was found to be increased in the reticular neurons,
which could strengthen the synchronizing mechanisms in thalamocortical circuits (Tsakiridou et al., 1995). Although this finding remains controversial (Guyon et al., 1993), a significant increase in mRNA levels of alpha-1G in ventrobasal nuclei and of alpha 1H in the nRT was found using in situ hybridization (Talley et al., 2000). The increase in alpha-1H was also found in juvenile GAERS before they express SWD. This suggests that this modest but significant increase could facilitate IT current and thus participate in the occurrence of SWDs. Other calcium-channel changes were found in WAG/Rij rats. Quantification of channel expression indicated that the development of SWDs in WAG/Rij rats is concomitant with an increased expression of the P/Q type in the nRT. These channels are mainly presynaptic, as revealed by double immunofluorescence involving the presynapse marker syntaxin (van de Bovenkamp-Janssen et al., 2004a). Dysfunction of the P/Q type of calcium channels (i.e., reshuffling of the beta subunit in this type of channel) was proposed to underlie the pathological phenotype of lethargic mice (Burgess and Noebels, 2000). Role of the Cortex The first mapping data in GAERS showed that SWDs of maximal amplitude were recorded primarily recorded in the sensorimotor cortex (Vergnes et al., 1990). In addition, they suggested that SWDs occur simultaneously in the thalamus and cortex but that thalamus was sometimes leading, whereas the reverse never seems to occur. Using multisite electrode recordings in WAG/Rij and nonlinear association analysis of the signals, a consistent cortical focus was found within the perioral subregion of the somatosensory cortex (Meeren et al., 2002). Coupling between this region and connected thalamic sites in the ventrobasal nuclei was found to change direction during the course of the seizure. During the first 500 msec of a SWD, the cortical focus appears to lead the thalamus. This is further supported by the observation that cortical SWDs can sometimes occur without concomitant thalamic discharge, whereas the reverse was never observed (Meeren et al., 2002). Furthermore, it is consistent with the fact that rhythmic unit firing was reported to start a few cycles earlier in the cortex than in the thalamus in GAERS (Seidenbecher et al., 1998). This study also suggested a fast intracortical spread of the SWDs, with the intrahemispheric spread being slower than the interhemispheric one. Although the existence of the cortical perioral focus remains to be confirmed in GAERS, the intrahemispheric versus the interhemispheric spread could explain the discrepancies with the previous studies suggesting the leading role of the thalamic nuclei. Indeed, in the first mapping studies, the cortical electrode was never located in the perioral area and was generally placed in a more posterior region. In this region, cortical activity occurs a few
243
Acknowledgments
cycles later according to the study of Meeren et al. (2002). These findings led this group of investigators to suggest that absence seizures have a focal origin. The primary driving source for the rhythmic activity could be the cortex (or at least a specific region of the cortex), not the thalamus. However, once the seizure is initiated, the cortex and the thalamus form an oscillatory network in which both structures drive each other (Meeren et al., 2002). The generalized and synchronous aspects of these seizures could be due to the very fast cortical spread of seizure activity. The focal cortical origin of SWDs is in agreement with the recent finding that application of ethosuximide at the somatosensory cortex suppresses absence seizures in GAERS, whereas no or weak effects were observed when this compound was injected in the thalamus. Moreover, local injections at other cortical areas were not effective (Manning et al., 2004). This finding is also in agreement with the fact that focal unilateral injection of lidocaine into the perioral region of the cortex in WAG/Rij caused a general decrease in the number of SWDs recorded in other cortical areas in both hemispheres (Sitnikova and van Luijtelaar, 2004). This finding is consistent with clinical data suggesting that generalized SWD tend to begin in the cortex (see Sitnikova and van Luijtelaar, 2004). In addition, the somatosensory region of the cortex is known to produce physiologic oscillations in the frequency domain of 7 to 12 c/s (Ritz et al., 1997). This “somatosensory rhythm” is supposed to be due to the synchronous functioning of the cortical pyramidal cells and inhibitory interneurons (Silva et al., 1991). Because SWD share several similarities with somatosensory rhythms, it has been suggested that SWD could derive from these cortical physiologic oscillations (Sitnikova and van Luijtelaar, 2004). Several data are also in agreement with the existence of a cortical and eventually “focal” generator of SWD. In the cerebral cortex, the main source of inhibition comes from local nonpyramidal GABAergic interneurons (basket cells, chandelier cells, double bouquet cells, and bipolar cells), which strongly control the activity of cortical pyramidal neurons (Beaulieu, 1993; Defelipe, 1993; Meinecke and Peters, 1987; Somogyi and Cowey, 1981). In WAG/Rij rats, extracellularly and intracellularly recorded synaptic responses revealed an intracortical hyperexcitability accompanied by a reduction of the efficiency of GABA-ergic inhibition in slices of the frontal cortex (Luhmann et al., 1995). In addition, immunocytochemical studies on the WAG/RiJ cortex showed that some areas lacked the calcium-binding protein parvalbumin, which is co-localized with GABA (van de Bovenkamp-Janssen et al., 2004b). Finally, it was shown that voltage-gated sodium channels, as measured by quantitative polymerase chain reaction (PCR) and immuno-cytochemistry, are upregulated selectively at the facial somatosensory cortex in WAG/Rij rats (Klein et al., 2004). Further experiments are required to determine the cellular mechanisms underlying SWD in the
focal cortical generator and whether such a focus also exists in the GAERS and can be assessed in the human patients.
Usefulness for Treatment Assessment Both genetic models, GAERS and WAG/Rij rats, offer a very high predictability for an antiabsence effect of an AED under development (see preceding discussion). In addition, both models have been useful in predicting adverse effects of some AEDs, such as vigabatrin and tiagabine, which should not be prescribed in cases of childhood absence epilepsy or in other cases of generalized absence seizures. In general, GAERS and WAG/Rij are very useful models to estimate the potential antiepileptic or adverse effect of a new drug candidate for the central nervous system (van Luijtelaar et al., 2002). Designing new drugs dedicated to suppressing oscillatory rhythms in the cortex or the thalamus may lead to important cognitive or vigilance side effects.
GENERAL CONCLUSIONS During the last 20 years, the GAERS and the WAG/Rij strains of Wistar rats have proven to be valid and predictive models of human absence epilepsy. Although some features of this form of epilepsy appear species specific (e.g., frequency, ontogeny, and aging), the pharmacologic reactivity and the underlying circuits described in both strains appear very similar to the human pathology. Differences between the two strains and recent identification of QTLs suggest that several genetic mechanisms can lead to the generation of SWDs. However, in both models the thalamocortical circuits clearly appear as the critical generator of absence seizures. Multidisciplinary studies of these two strains, and also other strains and species, will improve our understanding of the role of the cortex and the thalamus, and probably other subcortical circuits, in the generation of SWDs.
Acknowledgments The authors thank L. Danober, O. David, C. Deransart, I. Guillemain, P. Kahane, A. Nehlig, and B. Martin for their help in the preparation of the manuscript. A.D. wishes to thank Any Boehrer, Christian Marescaux, and Marguerite Vergnes for their fruitful collaboration during the past 20 years.
References Alloway, K.D., Johnson, M.J., and Wallace, M.B. 1993. Thalamocortical interactions in the somatosensory system: interpretations of latency and cross-correlation analyses. J Neurophysiol 70: 892–908.
244
Chapter 18/Genetic Models of Absence Epilepsy in the Rat
Archer, J.S., Abbott, D.F., Waites, A.B., and Jackson, G.D. 2003. fMRI “deactivation” of the posterior cingulate during generalized spike and wave. Neuroimage 20: 1915–1922. Aubert, A., and Costalat, R. 2002. A model of the coupling between brain electrical activity, metabolism, and hemodynamics: application to the interpretation of functional neuroimaging. Neuroimage 17: 1162–1181. Avanzini, G., Panzica, F., and de Curtis, M. 2000. The role of the thalamus in vigilance and epileptogenic mechanisms. Clin Neuro-physiol 111(Suppl 2): S19–S26. Avanzini, G., de Curtis, M., Marescaux, C., Panzica, F., Spreafico, R., and Vergnes, M. 1992. Role of the thalamic reticular nucleus in the generation of rhythmic thalamo-cortical activities subserving spike and waves. J Neural Transm 35: 85–95. Avanzini, G., Vergnes, M., Spreafico, R., and Marescaux, C. 1993. Calcium-dependent regulation of genetically determined spike and waves by the reticular thalamic nucleus of rats. Epilepsia 34: 1–7. Avoli, M. 1980. Electroencephalographic and pathophysiologic features of rat parenteral penicillin epilepsy. Exp Neuropharmacol 69: 373–382. Badiu, C.I. 2004 Sensitivity of thalamic GABAergic currents to clonazepam does not differ between control and genetic absence epilepsy rats. Brain Res 1026: 261–266. Bal, T., and McCormick, D.A. 1993. Mechanisms of oscillatory activity in guinea-pig nucleus reticularis thalami in vitro: a mammalian pacemaker. J Physiol 468: 669–691. Beaulieu, C. 1993. Numerical data on neocortical neurons in adult rat, with special reference to the GABA population. Brain Res 609: 284–292. Bourassa, J., Pinault, D., and Deschênes, M. 1995. Corticothalamic projections from the cortical barrel field to the somatosensory thalamus in rats: a single-fibre study using biocytin as an anterograde tracer. Eur J Neurosci 7: 19–30. Bouwman, B.M., Heesen, E., and van Rijn, C.M. 2004. The interaction between vigabatrin and diazepam on the electroencephalogram during active behaviour in rats: an isobolic analysis. Eur J Pharmacol 495: 119–128. Burgess, D.L., and Noebels, J.L. 2000. Calcium channel defects in models of inherited generalized epilepsy. Epilepsia 41: 1074–1075. Burkhalter, A., and Charles, V. 1990. Organization of local axon collaterals of efferent projection neurons in rat visual cortex. J Comp Neurol 302: 920–934. Buzsàki, G., Smith, A., Berger, S., Fisher, L.J., and Gage, F.H. 1990. Petit mal epilepsy and parkinsonian tremor: hypothesis of a common pacemaker. Neuroscience 36: 1–14. Chmielowska, J., Carvell, G., and Simons, D.J. 1989. Spatial organization of thalamocortical and corticothalamic projection system in the rat SmI barrel cortex. J Comp Neurol 285: 325–338. Chocholova, L. 1983. Incidence and development of rhythmic episodic activity in the electro-encephalogram of a large rat population under chronic conditions. Physiol Bohemoslov 32: 10–18. Coenen, A.M.L., and van Luijtelaar, E.L.J.M. 1987. The WAG/Rij rat model for absence epilepsy: age and sex factors. Epilepsy Res 1: 297–301. Coenen, A.M.L., Blezer, E.H.M., and van Luijtelaar, E.L J.M. 1995. Effects of the GABA-uptake inhibitor tiagabine on electroencephalogram. Epilepsy Res 21: 89–94. Coenen, A.M.L., Drinkenburg, W.H.I.M., Peeters, B.W.M.M., Vossen, J.M.H., and van Luijtelaar, E.L.J.M. 1991. Absence epilepsy and the level of vigilance in rats of the WAG/Rij strain. Neurosci Biobehav Rev 15: 259–263. Contreras, D., and Steriade, M. 1996. Spindle oscillation in cats: the role of corticothalamic feedback in a thalamically generated rhythm. J Physiol (Lond) 490: 159–179. Contreras, D., Destexhe, A., Sejnowski, T.J., and Steriade, M. 1996. Control of spatiotemporal coherence of a thalamic oscillation by corticothalamic feedback. Science 274: 771–774.
Cox, C.L., Huguenard, J.R., and Prince D.A. 1996 Heterogeneous axonal arborizations of rat thalamic reticular neurons in the ventrobasal nucleus. J Comp Neurol 366: 416–430. Crunelli, V., and Leresche, N. 2002 Childhood absence epilepsy: genes, channels, neurons and networks. Nat Rev Neurosci 3: 371–382. Crunelli, V., and Leresche, N. 1991. A role for GABAB receptor in excitation and inhibition of thalamocortical cells. Trends Neurosci 14: 16–21. Danober, L., Deransart, C., Depaulis, A., Vergnes, M., and Marescaux, C. 1998. Pathophysiological mechanisms of genetic absence epilepsy in the rat. Prog Neurobiol 55: 27–57. De Biasi, S., Frassoni, C., and Spreafico, R. 1988. The intrinsic organization of the ventroposterolateral nucleus and related reticular thalamic nucleus of the rat: a double-labelling ultrastructural investigation with gamma-aminobutyric acid immunogold staining and lectinconjugated horseradish peroxidase. Somatosensory Res 5: 187–203. de Bruin, N.M., van Luijtelaar, E.L., Cools, A.R., and Ellenbroek, B.A. 2001. Dopamine characteristics in rat genotypes with distinct susceptibility to epileptic activity: apomorphine-induced stereotyped gnawing and novelty/amphetamine-induced locomotor stimulation. Behav Pharmacol 12: 517–525. De Curtis, M., Spreafico, R., and Avanzini, G. 1989. Excitatory amino acids mediate responses elicited in vitro by stimulation of cortical afferents to reticularis thalami neurons of the rat. Neuroscience 33: 275–283. DeFelipe, J. 1993. Neocortical neuronal diversity: chemical heterogeneity revealed by colocalization studies of classic neurotransmitters, neuropeptides, calcium-binding proteins, and cell surface molecules. Cerebral Cortex 3: 273–289. Deransart, C., Hellwig, B., Heupel-Reuter, M., Leger, J.F., Heck, D., and Lucking, C.H. 2003. Single-unit analysis of substantia nigra pars reticulata neurons in freely behaving rats with genetic absence epilepsy. Epilepsia 44: 1513–1520. Deransart, C., Riban, V., Lê, B.T., Marescaux, C., and Depaulis, A. 2000 Dopamine in the striatum modulates seizures in a genetic model of absence epilepsy in the rat. Neuroscience 100: 335–344. Deschênes, M., and Hu, B. 1990. Electrophysiology and pharmacology of the corticothalamic input to lateral thalamic nuclei: an intracellular study in the cat. Eur J Neurosci 2: 140–152. Destexhe, A., Bal, T., McCormick, D.A., and Sejnowski, T.J. 1996. Ionic mechanisms underlying synchronized oscillations and propagating waves in a model of ferret thalamic slices. J Neurophysiol 76: 2049–2069. Drinkenburg, W.H.I.M., Van Luijtelaar, E.L.J.M., Van Schaijk, W.J., and Coenen, A.M.L. 1993. Aberrant transients in the EEG of epileptic rats: a spectral analytical approach. Physiol Behav 54: 779–783. Drinkenburg, W.H., Coenen, A.M., Vossen, J.M., and van Luijtelaar, E.L. 1995. Sleep deprivation and spike-wave discharges in epileptic rats. Sleep 18: 252–256. Drinkenburg, W.H., Schuurmans, M.L., Coenen, A.M., Vossen, J.M., and van Luijtelaar, E.L. 2003. Ictal stimulus processing during spike-wave discharges in genetic epileptic rats. Behav Brain Res 143: 141–146. Dutuit, M., Didier-Bazes, M., Vergnes, M., Mutin, M, Conjard, A., Akaoka, H., Belin, M.F. et al. 2000. Specific alteration in the expression of glial fibrillary acidic protein, glutamate dehydrogenase, and glutamine synthetase in rats with genetic absence epilepsy. Glia 32: 15–24. Feucht, M., Fuchs, K., Pichlbauer, E., Hornik, K., Scharfetter, J., Goessler, R., Fureder, T. et al. 1999. Possible association between childhood absence epilepsy and the gene encoding GABRB3. Biol Psychiatry 46: 997– 1002. Fonnum, F., Storm-Mathisen, J., and Divac, I. 1981. Biochemical evidence for glutamate as neurotransmitter in corticostriatal and corticothalamic fibers in rat brain. Neuroscience 6: 863–873. Frassoni, C., Speafico, R., and Battaglia, G. 1984. Afferent and efferent connections of the nucleus reticularis thalami of the rat: an HRP study. Neurosci Lett Suppl 18: 951–954.
References Friston, K.J., Harrison, L., and Penny, W. 2003. Dynamic causal modelling. Neuroimage 19: 1273–1302. Gauguier, D., van Luijtelaar, G., Bihoreau, M.T., Wilder, S.P., Godfrey, R.F., Vossen, J., Coenen, A. et al. 2004. Chromosomal mapping of genetic loci controlling absence epilepsy phenotypes in the WAG/Rij rat. Epilepsia 45: 908–915. Gloor, P. 1968. Generalized cortico-reticular epilepsies. Some considerations on pathophysiology of generalized bilaterally synchronous spikeand-wave discharges. Epilepsia 9: 249–263. Gloor, P., Metrakos, J., Metrakos, K., Andermann, E., and Van Gelder, N. 1982. Neurophysiologial, genetic and biochemical nature of the epileptic diathesis. In Henri Gastaut and the Marseille Scool’s Contribution to the Neurosciences. Ed. R.J. Broughton. pp. 45–56. Amsterdam: Elsevier Biochemical Press. Gower, A.J., Hirsch, E., Boehrer, A., Noyer, M., and Marescaux, C. 1995. Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy. Epilepsy Res 22: 207–213. Guyon, A., Vergnes, M., and Leresche, N. 1993. Thalamic low threshold calcium current in a genetic model of absence epilepsy. Neuro-report 4: 1231–1234. Harris, R.M. 1987. Axon collaterals in the thalamic reticular nucleus fron thalamocortical neurons in the rat ventrobasal thalamus. J Comp Neurol 258: 397–406. Hirsch, E., Blanc-Platier, A., and Marescaux, C. 1994. What are the relevant criteria for a better classification of epileptic syndromes with typical absences? In Idiopathic Generalized Epilepsies: Clinical, Experimental and Genetic Aspects. Eds. A. Malafosse, P. Genton, E. Hirsch, C. Marescaux, D. Broglin, and R. Bernasconi. pp. 87–93. London: John Libbey. Hosford, D.A., Clark, S., Cao, Z., Wilson, W.A., Lin, F., Morrisett, R.A., and Huin A. 1992. The role of GABAB receptor activation in absence seizures of lethargic (lh/lh) mice. Science 257: 398–401. Inoue, M., Ates, N., Vossen, J.M., and Coenen, A.M. 1994. Effects of the neuroleptanalgesic fentanyl-fluanisone (Hypnorm) on spikewave discharges in epileptic rats. Pharmacol Biochem Behav 48: 547–551. Inoue, M., Duysens, J., Vossen, J.M., and Coenen, A.M. 1993. Thalamic multiple-unit activity underlying spike-wave discharges in anesthetized rats. Brain Res 612: 35–40. Inoue, M., Peeters, B.W., van Luijtelaar, E.L., Vossen, J.M., and Coenen, A.M. 1990. Spontaneous occurrence of spike-wave discharges in five inbred strains of rats. Physiol Behav 48: 199–201. Jando, G., Carpi, D., Kandel, A., Urioste, R., Horvath, Z., Pierre, E., Vadi, D. et al. 1995. Spike-and-wave epilepsy in rats: sex differences and inheritance of physiological traits. Neuroscience 64: 301–317. Jones, E.G. 1985. The thalamus. In Chemical Neuroanatomy. Ed. P.C. Emson. pp 257–293. New York: Raven Press. Kandel, A., Bragin, A., Carpi, D., and Buzsaki, G. 1996. Lack of hippocampal involvement in a rat model of petit mal epilepsy. Epilepsy Res 23: 123–127. Kanedo, T., and Mizumo, N. 1988. Immunohistochemical study of glutaminase-containing neurons in the cerebral cortex and thalamus of the rat. J Comp Neurol 267: 590–602. Karpova, A.V., Bikbaev, A.F., Coenen, A.M.L., and van Luijtelaar, G. 2005. Morphometric Golgi study of cortical locations in WAG/Rij rats: The cortical focus theory. Neuroscience Res 51: 119–128. Kharazia, V.N., and Weinberg, R.J. 1994. Glutamate in thalamic fibers terminating in layer IV of primary sensory cortex. J Neurosci 14: 6021–6032. Klein, J.P., Khera, D.S., Nersesyan, H., Kimchi, E.Y., Waxman, S.G., and Blumenfeld, H. 2004. Dysregulation of sodium channel expression in cortical neurons in a rodent model of absence epilepsy. Brain Res 1000: 102–109.
245
Klingberg, F., and Pickenhain, L. 1968. Das Auftreten von “Spindelentladungen” bei der Ratte in Bezeihung zum Verhalten. Acta Biol Med Germ 20: 45–54. Klioueva, I.A., van Luijtelaar, E.L., Chepurnova, N.E., and Chepurnov, S.A. 2001. PTZ-induced seizures in rats: effects of age and strain. Physiol Behav 72: 421–426. Knight, A.R., and Bowery, N.G. 1992. GABA receptors in rats with spontaneous generalized nonconvulsive epilepsy. J Neural Transm 35(Suppl): 189–196. Lannes, B., Micheletti, G., Vergnes, M., Marescaux, C., Depaulis, A., and Warter, J.M. 1988. Relationship between spike-wave discharges and vigilance levels in rats with spontaneous petit mal-like epilepsy. Neurosci Lett 94: 187–191. Lason, W., Przewlocka, B., Coenen, A.M.L., Przewlocki, R., and van Luijtelaar, E.L.J.M. 1995. The role of the opioid system in absence epilepsy in rats. In Typical Absences and Related Epileptic Syndromes. Eds. J.S. Duncan and C.P. Panayiotopoulos. pp 59–68. London: Churchill Communications. Lennox, W.G., and Lennox, M.A. 1960. In Epilepsy and Related Disorders. Boston: Little, Brown. Leresche, N., Lightowler, S., Soltesz, I., Jassik-Gerschenfeld, D., and Crunelli, V. 1991. Low frequency oscillatory activities intrinsic to rat and cat thalamocortical cells. J Physiol (Lond) 441: 155–174. Libouban, S., and Oswaldo-Cruz, E. 1958. Quelques observations relatives aux activitás ávoquáes et spontanáes du cerveau du rat blanc. J Physiol (Paris) 50: 380–383. Liu, Z., Vergnes, M., Depaulis, A., and Marescaux, C. 1991. Evidence for a critical role of GABAergic transmission within the thalamus in the genesis and control of absence seizures in the rat. Brain Res 545: 1–7. Liu, Z., Vergnes, M., Depaulis, A., and Marescaux, C. 1992. Involvement of intrathalamic GABAB neurotransmission in the control of absence seizures in the rats. Neuroscience 48: 87–93. Llinas, R.R. 1988. The intrinsic electrophysiological properties of mammalian neurons; insight into central nervous system function. Science 242: 1654–1664. Loiseau, P. 1992. Childhood absence epilepsy. In Epileptic Syndromes in Infancy, Childhood and Adolescence. Eds. J. Roger, M. Bureau, C. Dravet, F.E. Dreifuss, A. Perret, and P. Wolf. pp. 135–150. London: John Libbey. Loiseau, P., and Cohadon, F. 1970. Considerations on epilepsia partialis continua and its relationship with somatomotor epilepsy. Encephale 59: 362–389. Loiseau, P., Duchá, B., and Pádespan, J.M. 1995. Absence epilepsies. Epilepsia 36: 1182–1186. Luebke, J.I., McCarley, R.W., and Greene, R.W. 1993. Inhibitory action of muscarinic agonists on neurons in the rat laterodorsal tegmental neurons in vitro. J Neurophysiol 70: 1–8. Luhman, H.J., Mittman, T., Van Luijtelaar, G., and Heineman, U. 1995. Impairment of intracortical GABAergic inhibition in a rat model of absence epilepsy. Epilepsy Res 22: 43–51. Manning, J.P., Richards, D.A., Leresche, N., Crunelli, V., and Bowery, N.G. 2004. Cortical-area specific block of genetically determined absence seizures by ethosuximide. Neuroscience 123: 5–9. Marescaux, C., Micheletti, G., Vergnes, M., Depaulis, A., Rumbach, L., and Warter, J.M. 1984. A model of chronic spontaneous petit mal-like seizures in the rat: comparison with pentylenetetrazol-induced seizures. Epilepsia 25: 326–331. Marescaux, C., Vergnes, M., and Bernasconi, R. 1992c. GABAB receptor antagonists: potential new anti-absence drugs. J Neural Transm 35(Suppl): 179–188. Marescaux, C., Vergnes, M., and Depaulis A. 1992a. Genetic absence epilepsy in rats from Strasbourg—A review. J Neural Transm 35: 37–69.
246
Chapter 18/Genetic Models of Absence Epilepsy in the Rat
Marescaux, C., Vergnes, M., and Depaulis, A. 1992b. Neurotransmission in rats’ spontaneous generalized nonconvulsive epilepsy. Epilepsy Res 8: 335–343. Marini, C., Harkin, L.A., Wallace, R.H., Mulley, J.C., Scheffer, I.E., and Berkovic, S.F. 2003. Childhood absence epilepsy and febrile seizures: a family with a GABA(A) receptor mutation. Brain 126: 230–240. Mathivet, P., Bernasconi, R., de Barry, J., Mickel, S., Froestl, W., and Bittiger, H. 1994. Characteristics of GABAB receptor binding sites in genetic absence epilepsy rats from Strasbourg (GAERS) and in nonepileptic rats. In Idiopathic Generalized Epilepsies: Clinical, Experimental and Genetic Aspects. Eds. A. Malafosse, P. Genton, E. Hirsch, C. Marescaux, D. Broglin, and R. Bernasconi. pp. 177–185. London: John Libbey. Mathivet, P., Bernasconi, R., Reymann, N., Marescaux, C., Vergnes, M., and Bittiger, H. 1996. Different binding characteristics of cortical GABAB receptors in GAERS compared to non-epileptic control rats using agonist and antagonist radioligands. Pharmacol Rev Commun 8: 203–207. McCormick, D.A. 1992. Neurotransmitter actions in the thalamus and cerebral cortex and their role in neuromodulation of thalamocortical activity. Prog Neurobiol 39: 337–388. McCormick, D.A., and Bal, T. 1997. Sleep and arousal: thalamocortical mechanisms. Ann Rev Neurosci 20: 185–215. McCormick, D.A., and Pape, H.C. 1990. Properties of a hyperpolarizationactivated cations current and its role in rhythmic oscillations in thalamic relay neurons. J Physiol (Lond) 431: 291–318. McQueen, J.K., and Woddbury, D.M. 1975. Attempts to produce spike-andwave complexes in the electro-corticogram of the rat. Epilepsia 16: 295–299. Meeren, H.K., Pijn, J.P., Van Luijtelaar, E.L., Coenen, A.M., and Lopes da Silva, F.H. 2002. Cortical focus drives widespread corticothalamic networks during spontaneous absence seizures in rats. J Neurosci 22: 1480–1495. Meinecke, D.L., and Peters, A. 1987. GABA immunoreactive neurons in rat visual cortex. J Comp Neurol 261: 388–404. Micheletti, G., Vergnes, M., Marescaux, C., Reis, J., Depaulis, A., Rumbach, L., and Warter, J.M. 1985. Antiepileptic drug evaluation in a new animal model: sponatneous petit mal epilepsy in the rat. Arzheimittelfschung 35: 483–495. Midzianovskaia, I.S., Kuznetsova, G.D., Coenen, A.M., Spiridonov, A.M., and van Luijtelaar, E.L. 2001. Electrophysiological and pharmacological characteristics of two types of spike-wave discharges in WAG/Rij rats. Brain Res 911: 62–70. Mirsky, A.F., Duvan, C.C., and Myslobodsky, M.S. 1986. Petit mal epilepsy: a review and integration of recent information. J Clin Neurophysiol 3: 179–208. Nehlig, A., Vergnes, M., Boyet, S., and Marescaux, C. 1998. Functional activity is increased in discrete brain regions before the occurrence of absence seizures in weanling rats with genetic absence epilepsy. Dev Brain Res 108: 69–75. Nehlig, A., Vergnes, M., Hirsch, E., and Marescaux, C. 1994. Brain metabolism and blood flow in models of generalized idiopathic epilepsies in rodents. In Idiopathic Generalized Epilepsies: Clinical, Experimental and Genetic Aspects. Eds. A. Malafosse, P. Genton, E. Hirsch, C. Marescaux, D. Broglin, and R. Bernasconi. pp. 169–176. London: John Libbey. Nehlig, A., Vergnes, M., Marescaux, C., Boyet, S., and Lannes, B. 1991. Local cerebral glucose utilization in rats with petit mal-like seizures. Ann Neurol 29: 72–77. Nehlig, A., Vergnes, M., Waydelich, R., Hirsch, E., Charbonne, R., Marescaux, C., and Seylaz, J. 1996. Absence seizures induce a decrease in cerebral blood flow: human and animal data. J Cereb Blood Flow Metab 16: 147–155.
Nersesyan, H., Herman, P., Erdogan, E., Hyder, F., and Blumenfeld, H. 2004. Relative changes in cerebral blood flow and neuronal activity in local microdomains during generalized seizures. J Cereb Blood Flow Metab 24: 1057–1068. Nersesyan, H., Hyder, F., Rothman, D.L., and Blumenfeld, H. 2004. Dynamic fMRI and EEG recordings during spike-wave seizures and generalized tonic-clonic seizures in WAG/Rij rats. J Cereb Blood Flow Metab 24: 589–599. Niedermeyer, E. 1996. Primary (idiopathic). generalized epilepsy and underlying mechanisms. Clin Electroencephalogr 27: 1–21. Noebels, J.L. 1984. Isolating single genes of the inherited epilepsies. Ann Neurol 16: S18–S21. Noebels, J.L., and Sidman, R.L. 1979. Inherited epilepsy: spike-wave and focal motor seizures in the mutant mouse tottering. Science 204: 1334–1336. Ottersen, O.P., Fischer, B.O., and Storm-Mathisen, J. 1983. Retrograde transport of D-[3H]aspartate in thalamocortical neurones. Neurosci Lett 42: 19–24. Panayiotopoulos, C.P. 1999. Typical absence seizures and their treatment. Arch Dis Child 81: 351–355. Peeters, B.W.M.M., Kerbusch, J.M.L., van Luijtelaar, E.L.J.M., Vossen, J.M.H., and Coenen, A.M.L. 1990b. Genetics of absence epilepsy in rats. Behav Genet 20: 453–460. Peeters, B.W.M.M., Sporen, W.P.J.M., van Luijtelaar, E.L. J.M., and Coenen, A.M.L. 1988. The WAG/Rij rat model for absence epilepsy: anticonvulsant drug evaluation. Neurosci Res Commun 2: 93–97. Peeters, B.W.M.M., van Rijn, C.M., Vossen, J.M.H., and Coenen, A.M.L. 1990a. Involvement of NMDA receptors in non-convulsive epilepsy in WAG/Rij rats. Life Sci 47: 523–529. Peeters, B.W.M.M., Kerbusch, J.M.L., Coenen, A.M.L., Vossen, J.M.H., and van Luijtelaar, E.L.J.M. 1992. Genetics of spike-wave discharges in the electroencephalogram (EEG) of the WAG/Rij inbred strain: a classical Mendelian crossbreeding study. Behav Genet 22: 361–368. Pinault, D., and Deschenes, M. 1998. Anatomical evidence for a mechanism of lateral inhibition in the rat thalamus. Eur J Neurosci 10: 3462–3469. Pinault, D., Leresche, N., Charpier, S., Deniau, J.M., Marescaux, C., Vergnes, M., and Crunelli, V. 1998. Intracellular recordings in thalamic neurones during spontaneous spike and wave discharges in rats with absence epilepsy. J Physiol 509: 449–456. Pinault, D., Vergnes, M., and Marescaux, C. 2001. Mediumvoltage 5–9-Hz oscillations give rise to spike-and-wave discharges in a genetic model of absence epilepsy: in vivo dual extracellular recording of thalamic relay and reticular neurons. Neuroscience 105: 181– 201. Pinault, D. 2003. Cellular interactions in the rat somatosensory thalamocortical system during normal and epileptic 5–9 Hz oscillations. J Physiol 552: 881–905. Pinault, D. 2004. The thalamic reticular nucleus: structure, function and concept. Brain Res Brain Res Rev 46: 1–31. Pinault, D., Bourassa, J., and Deschênes, M. 1995. The axonal arborization of single thalamic reticular neurons in the somatosensory thalamus of the rat. Eur J Neurosci 7: 31–40. Porter, R.J. 1993. The absence epilepsies. Epilepsia 34(Suppl 3): S42– S48. Princivalle, A.P., Richards, D.A., Duncan, J.S., Spreafico, R., and Bowery, N.G. 2003. Modification of GABA(B1) and GABA(B2) receptor subunits in the somatosensory cerebral cortex and thalamus of rats with absence seizures (GAERS). Epilepsy Res 55: 39–51. Puigcerver, A., van Luijtelaar, E.L., Drinkenburg, W.H., and Coenen, A.L. 1996. Effects of the GABAB antagonist CGP 35348 on sleep-wake states, behaviour, and spike-wave discharges in old rats. Brain Res Bull 40: 157–162.
References Richards, D.A., Lemos, T., Whitton, P.S., and Bowery, N.G. 1995. Extracellular GABA in the ventrolateral thalamus of rats exhibiting spontaneous absence epilepsy: a microdialysis study. J Neurochem 65: 1674–1680. Rigoulot, M.A., Boehrer, A., and Nehlig, A. 2003. Effects of topiramate in two models of genetically determined generalized epilepsy, the GAERS and the Audiogenic Wistar AS. Epilepsia 44: 14–19. Rinaldi, D., Depaulis, A., and Martin, B. 2002. Les lignáes de souris BS/Orl et BR/Orl : deux modèles gánátiques d’ápilepsie-absences et de la rásistance à l’ápilepsie-absences. Epilepsies 14: 245–248. Ritz, R., and Sejnowski, T.J. 1997. Synchronous oscillatory activity in sensory systems: new vistas on mechanisms. Curr Opin Neurobiol 7: 536–546. Rudolf, G., Therese Bihoreau, M.F., Godfrey, R.P., Wilder, S.D., Cox, R., Lathrop, M., Marescaux, C. et al. 2004. Polygenic control of idiopathic generalized epilepsy phenotypes in the genetic absence rats from Strasbourg (GAERS). Epilepsia 45: 301–308. Sabers, A., Moller, A., Scheel-Kruger, J., and Mouritzen Dam, A. 1996. No loss in total neuron number in the thalamic reticular nucleus and neocortex in the genetic absence epilepsy rats from Strasbourg. Epilepsy Res 26: 45–48. Salek-Haddadi, A., Lemieux, L., Merschhemke, M., Diehl, B., Allen, P.J., and Fish, D.R. 2003. EEG quality during simultaneous functional MRI of interictal epileptiform discharges. Magn Reson Imaging 21: 1159–1166. Schlumberger, E., Chavez, F., Palacios, L., Rey, E., Pajot, N., and Dulac, O. 1994. Lamotrigine in treatment of 120 children with epilepsy. Epilepsia 35: 359–367. Schridde, U., and van Luijtelaar, G. 2004. The influence of strain and housing on two types of spike-wave discharges in rats. Genes Brain Behav 3: 1–7. Seidenbecher, T., Staak, R., and Pape, H.C. 1998. Relations between cortical and thalamic cellular activities during absence seizures in rats. Eur J Neurosci 10: 1103–1112. Semba, K., and Komisaruk, B.R. 1984. Neural substrates of two diffeent rhythmical vibrissal movements in the rat. Neuroscience 12: 761–774. Shaw, F.Z. 2004. Is spontaneous high-voltage rhythmic spike discharge in Long Evans rats an absence-like seizure activity? J Neurophysiol 91: 63–77. Silva, L.R., Amitai, Y., and Connors, B.W. 1991. Intrinsic oscillations of neocortex generated by layer 5 pyramidal neurons. Science 251: 432–435. Sitnikova, E., and van Luijtelaar, G. 2004. Cortical control of generalized absence seizures: effect of lidocaine applied to the somato-sensory cortex in WAG/Rij rats. Brain Res 1012: 127–137. Slaght, S.J., Leresche, N., Deniau, J.M., Crunelli, V., and Charpier, S. 2002. Activity of thalamic reticular neurons during spontaneous genetically determined spike and wave discharges. J Neurosci 22: 2323–2334. Snead, O.C. III. 1978 Gamma-hydroxybutyrate in the monkey. Neurology 28: 636–642. Snead, O.C. III. 1988. Gamma-hydroxybutyrate model of generalized absence seizures: Further characterization and comparison with other absence models. Epilepsia 29: 361–368. Snead, O.C. III. 1994. Pathophysiological mechanisms of experimental generalized absence seizures in rats. In Idiopathic Generalized Epilepsies: Clinical, Experimental and Genetic Aspects. Eds. A. Malafosse, P. Genton, E. Hirsch, C. Marescaux, D. Broglin, and R. Bernasconi. pp. 133–150. London: John Libbey. Snead, O.C. III., Depaulis, A., Banerjee, P.K., Hechler, V., and Vergnes, M. 1992. The GABAA receptor complex in experimental absence seizures in rat: an autoradiographic study. Neurosci Lett 140: 9–12.
247
Somogyi, P., and Cowey, A. 1981. Combined Golgi and electron microscopic study on the synapses formed by double bouquet cells in the visual cortex of the cat and monkey. J Comp Neurol 195: 547–566. Spreafico, R., Battaglia, G., and Frassoni, C. 1991. The reticular thalamic nucleus (RTN) of the rat: cytoarchitectural, Golgi, immunocytochemical, and Horseradish peroxydase study. J Comp Neurol 304: 478–490. Spreafico, R., Menini, T., Danober, L., Cagnotto, A., Regondi, M.C., Miari, A., De Blas, A. et al. 1993. GABA-A receptor impairment in the genetic absence epilepsy rats from Strasbourg (GAERS): an immunocytochemical and receptor binding autoradiographic study. Epilepsy Res 15: 229–238. Starr, M.S. 1996. The role of dopamine in epilepsy. Synapse 22: 159–194. Steriade, M. 1990. Spindling, incremental thalamocortical responses, and spike-wave epilepsy. In Generalized Epilepsy: Neurobiological Approaches. Eds. M. Avoli, P. Gloor, R. Naquet, and G. Kostopoulos. Birkhäuser. pp. 161–180. Boston: Boston Inc. Steriade, M. 1993. Oscillations in interacting thalamic and neocortical neurons. Trends Pharmacol Sci 8: 111–116. Steriade, M., and Deschênes, M. 1984. The thalamus as a neuronal oscillator. Brain Res Rev 8: 1–63. Steriade, M., McCormick, D.A., and Sejnowski, T.J. 1993. Thalamocortical oscillations in the sleeping and aroused brain. Science 262: 679–685. Sugimoto, Y., Morita, R., Amano, K., Fong, C.Y., Shah, P.U., Castroviejo, I.P., Khan, S. et al. 2000. Childhood absence epilepsy in 8q24: refinement of candidate region and construction of physical map. Genomics 68: 264–272. Sutch, R.J., Davies, C.C., and Bowery, N.G. 1999. GABA release and uptake measured in crude synaptosomes from Genetic Absence Epilepsy Rats from Strasbourg (GAERS). Neurochem Int 34: 415– 425. Talley, E.M., Solorzano, G., Depaulis, A., Perez-Reyes, E., and Bayliss, D.A. 2000. Low-voltage-activated calcium channel subunit expression in a genetic model of absence epilepsy in the rat. Brain Res Mol Brain Res 75: 159–165. Tenney, J.R., Duong, T.Q., King, J.A., and Ferris, C.F. 2004. fMRI of brain activation in a genetic rat model of absence seizures. Epilepsia 45: 576–582. Tenney, J.R., Duong, T.Q., King, J.A., Ludwig, R., and Ferris, C.F. 2003. Corticothalamic modulation during absence seizures in rats: a functional MRI assessment. Epilepsia 44: 1133–1140. Tsakiridou, E., Bertollini, L., de Curtis, M., Avanzini, G., and Pape, H.C. 1995. Selective increase in T-type calcium conductance of reticular thalamic neurons in a rat model of absence epilepsy. J Neurosci 15: 3110–3117. van de Bovenkamp-Janssen, M.C., Korosi,A., Veening, J.G., Scheenen, W.J.J.M., van Luijtelaar, E.L.J.M., and Roubos, E.W. 2004a. Neuronal parvalbumin and absence epilepsy in WAG/Rij rats. Eds. G. van Luijtelaar, G.D. Kuznetsova, A. Coenen, and S.A. Chepurnov. In The Wag/Rij Model of Absence Epilepsy: The Nijmegen-Russian Federation Papers. pp. 29–36. Nijmegen: Nici. van de Bovenkamp-Janssen, M.C., Scheenen, W.J., Kuijpers-Kwant, F.J., Kozicz, T, Veening, J.G., van Luijtelaar, E.L., McEnery, M.W. et al. 2004b. Differential expression of high voltage-activated Ca2+ channel types in the rostral reticular thalamic nucleus of the absence epileptic WAG/Rij rat. J Neurobiol 58: 467–478. van Luijtelaar, E.L., and Coenen, A.M. 1988. Circadian rhythmicity in absence epilepsy in rats. Epilepsy Res 2: 331–336. van Luijtelaar, E.L., Drinkenburg, W.H., van Rijn, C.M., and Coenen, A.M. 2002. Rat models of genetic absence epilepsy: what do EEG spike-wave discharges tell us about drug effects? Methods Find Exp Clin Pharmacol 24(Suppl D): 65–70. van Luijtelaar, E.L. 1997. Spike-wave discharges and sleep spindles in rats. Acta Neurobiol Exp (Wars) 57: 113–121.
248
Chapter 18/Genetic Models of Absence Epilepsy in the Rat
van Luijtelaar, E.L., Ates, N., and Coenen, A.M. 1995. Role of L-type calcium channel modulation in nonconvulsive epilepsy in rats. Epilepsia 36: 86–92. van Luijtelaar, E.L., de Bruijn, S.F., Declerck, A.C., Renier, W.O., Vossen, J.M., and Coenen, A.M. 1991b. Disturbances in time estimation during absence seizures in children. Epilepsy Res 9: 148–153. va